Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,regulation of immune response (GO:0050776),0.6694892385666713,2.109031704872482,0.0,0.0009911636029298332,0.001,40/135,9.73%,ITGB7;JAML;ITGA4;FGR;ITGAL;SLAMF7;CD300E;KLRD1;FOXP1;CD300C;CD226;LYN;TREML4;PTPN22;SAMHD1;LILRB1;CD40;SYK;BCL6;PLSCR1;CD300A;DHX58;PILRA;SELL;CD300LG;KLRK1;BIRC3;SPN;ITGB2;IRF4;CD276;DENND1B;TIRAP;AHR;TRAF3;CLEC2D;SPPL2A;ICAM1;CD300LD;IRF7
prerank,positive regulation of immune effector process (GO:0002699),0.7972200447086998,2.0852014884503136,0.0,0.0019823272058596664,0.003,6/27,3.27%,CCR2;PTPRC;IL1B;LILRB1;DHX58;ANKRD17
prerank,leukocyte cell-cell adhesion (GO:0007159),0.8001195352227722,2.010426409463536,0.0,0.01585861764687733,0.038,11/24,9.15%,ITGA4;ITGAL;PECAM1;SYK;MSN;CD177;OLR1;ITGB2;F11R;EZR;ICAM1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.8792994629617213,2.0048975602919206,0.0,0.01338070863955275,0.043,4/16,1.35%,PTPRC;KLRD1;CYRIB;LILRB1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.8259134081508025,1.9890156440356277,0.0,0.0154621522057054,0.064,8/21,2.88%,CARD11;PTPRC;FOXP1;TESPA1;CD226;STAP1;NFAM1;PRKCH
prerank,regulation of dendritic spine development (GO:0060998),-0.6993255630859727,-1.9754926653855833,0.0,0.2956883385498353,0.23,6/19,4.60%,TANC2;APOE;MEF2C;NLGN1;CAMK1;KIF1A
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.7145891158259721,1.974992540296804,0.0,0.019327690257131748,0.089,17/45,10.77%,CIITA;CD44;SP100;HCK;IFNGR1;OAS2;JAK2;TRIM26;TRIM62;IRF2;STAT1;IRF4;OASL;TRIM25;ICAM1;IRF7;B2M
prerank,innate immune response (GO:0045087),0.5914606940828393,1.9660318588424415,0.0,0.02010646165943376,0.112,49/217,10.88%,CD74;CIITA;FGR;CD300E;KLRD1;IFNLR1;SP100;CYBB;ALPK1;HCK;LYN;KYNU;PLCG2;FYN;PPARG;CD40;SYK;PTX3;TRIM26;MSRB1;DHX58;REL;SLA;ANKRD17;CXCL10;CORO1A;MALT1;POLR3A;SLPI;IKBKB;ZAP70;TRIM62;STYK1;IFIH1;IRAK4;CXCL16;PTK2B;TRIM25;TLR3;CAPZA1;NRROS;IRF7;NCF2;MBL2;CYLD;B2M;TRIM14;SETD2;RNASE6
prerank,T cell activation (GO:0042110),0.6613440159947283,1.9558291028690191,0.0,0.022920658317752394,0.141,13/69,5.71%,CD74;DPP4;JAML;CD44;PTPRC;LCP1;PTPN22;MSN;LFNG;ZAP70;PPP3CA;IRF4;CD276
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.6580842921440585,1.9426130956842291,0.0,0.029294390931037296,0.198,26/70,10.65%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.9296628637313532,1.9381953479564265,0.0,0.029536675367309032,0.219,5/10,1.72%,BTLA;FGR;LYN;LILRB1;CD40
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.6244042980861212,1.9355737319123743,0.0011402508551881414,0.0285635329207961,0.229,32/105,13.51%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;PSMB7;IKBKB;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.6522870167647559,1.935371754665231,0.0,0.026265835477640588,0.23,26/71,10.65%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.6499396078559825,1.9332272189738247,0.0,0.02516030684360346,0.239,26/73,10.65%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,regulation of B cell proliferation (GO:0030888),0.7024786318296363,1.9328907716241501,0.0,0.023504736869478907,0.241,12/44,8.44%,CD74;VAV3;PTPRC;LYN;TNFSF13B;CD40;CD300A;RC3H1;TIRAP;AHR;IKZF3;EPHB2
prerank,cellular response to lectin (GO:1990858),0.6244127552015599,1.9315322035681481,0.001148105625717566,0.021867546989639445,0.253,32/104,13.51%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;PSMB7;IKBKB;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.6244127552015599,1.9315322035681481,0.001148105625717566,0.021867546989639445,0.253,32/104,13.51%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;PSMB7;IKBKB;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,catecholamine metabolic process (GO:0006584),-0.7523852662632119,-1.9313955968035665,0.0,0.2900804562669936,0.394,4/14,1.79%,PRKN;RNF180;SNCAIP;COMT
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.7234285906492828,1.9306866894818977,0.0,0.020872739402875314,0.256,15/33,15.29%,CARD11;TESPA1;CD226;PTPN22;CD300A;LAPTM5;RC3H1;PRNP;EZR;KCNN4;RPS3;LGALS3;PTPRJ;RAB29;RELA
prerank,negative regulation of platelet activation (GO:0010544),-0.7279562042435271,-1.9288551343276665,0.00273224043715847,0.20256350548931243,0.413,5/16,8.53%,APOE;PRKG1;SERPINE2;CD9;PDGFA
prerank,positive regulation of interleukin-2 production (GO:0032743),0.7594449744459558,1.9250706525243162,0.0,0.022246116421314036,0.286,8/25,5.82%,CCR2;CARD11;PTPRC;IL1B;PLCG2;MALT1;IRF4;GLMN
prerank,regulation of interleukin-8 production (GO:0032677),0.6450390581600804,1.9204143318052245,0.0,0.02384009297573336,0.315,20/69,12.51%,CD74;PTPRC;IL1B;PTPN22;BCL3;KLF4;SYK;STAT3;HSPA1A;TIRAP;ANXA4;AFAP1L2;CD2;TLR3;IL6;ANXA1;RIPK1;CACTIN;MAP2K5;TLR2
prerank,inflammatory response (GO:0006954),0.5820820177377599,1.9179493648852248,0.0,0.024233950091634426,0.331,48/195,10.39%,CIITA;CCR2;ITGAL;CD44;IL1B;CYBB;FPR1;GPR68;CD40;LTB4R;XCR1;ITCH;FPR3;CCR1;NFKB1;PTX3;ADGRE5;STAT3;NFAM1;FOS;PTGER2;REL;MAPKAPK2;CXCL10;PTGER4;IKBKB;OLR1;PARP4;HP;HPR;TRAF3IP2;ITGB2;HSPG2;TAC4;ADORA1;CCRL2;F11R;AFAP1L2;NOX1;RAC1;HDAC9;IL6;TACR1;NRROS;HRH1;NLRC4;PTGER3;ANXA1
prerank,anterior/posterior axis specification (GO:0009948),-0.7199743343196394,-1.8927226132010488,0.005305039787798408,0.24929585784632666,0.586,3/15,5.60%,SKI;WLS;TASOR
prerank,camera-type eye morphogenesis (GO:0048593),-0.8194153505872692,-1.8912628762266208,0.0,0.202903377142818,0.594,6/10,11.94%,SKI;LRP6;NF1;KDM2B;SHROOM2;VEGFA
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7707078207482405,1.8899792679999141,0.0,0.04361119852891267,0.509,7/23,8.19%,CD74;DPP4;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.7486080039374271,-1.8706890524907132,0.002421307506053269,0.22278586887289314,0.682,5/13,7.61%,KCNMA1;ATP1B3;KCNJ2;ATP1B1;ATP1A2
prerank,tryptophan metabolic process (GO:0006568),0.8611351089418321,1.8646557632033913,0.0,0.06609259115900297,0.683,5/11,10.19%,KMO;KYNU;HAAO;ATP7A;KYAT1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.7970854443602172,1.8595484082545755,0.0,0.07041570987771077,0.715,1/17,0.01%,PLBD1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.8598355250227911,1.8521271893627902,0.003395585738539898,0.07681517922706209,0.748,2/11,2.34%,CIITA;JAK2
prerank,acute inflammatory response (GO:0002526),0.753090277527298,1.8517545934818957,0.0,0.07425797713150312,0.748,6/23,10.22%,PLSCR1;IL6R;HP;HPR;IL6;MBL2
prerank,central nervous system neuron differentiation (GO:0021953),-0.5773332581128566,-1.8510754362914452,0.0032258064516129032,0.2473294575653302,0.764,10/33,6.91%,OPHN1;LRP6;NTRK2;MAP2;CTNNB1;MDGA2;SPOCK1;GRID2;RYK;FAIM2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8400355737946956,1.8429615473498373,0.0,0.08402017618682125,0.792,7/12,8.53%,PTPRC;LYN;PTPN22;CD300A;RC3H1;CBFB;ELF1
prerank,mesonephric tubule development (GO:0072164),-0.7001005126780208,-1.8426536838680954,0.0024752475247524753,0.24203110125264538,0.802,6/15,9.40%,SALL1;ROBO2;NPNT;PKD2;FGFR2;SLIT2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.7575502242973099,1.8400224982680995,0.006430868167202572,0.08461600387975059,0.805,5/20,1.06%,IL1B;HCK;LYN;PRKCE;PTPN22
prerank,regulation of viral entry into host cell (GO:0046596),0.7056455730977208,1.8395067621889187,0.0,0.08237277514349008,0.806,7/30,7.47%,CD74;CIITA;PTX3;TRIM26;TRIM62;LGALS1;TRIM25
prerank,regulation of cytokine production (GO:0001817),0.5824069173949401,1.8369111486498295,0.0,0.08295014014864502,0.82,32/126,10.39%,CCR2;CLEC9A;FGR;FFAR4;PTPRC;FOXP1;LYN;CD47;BCL6;ACE2;NFAM1;PLD4;MAPKAPK2;NPTN;PTGER4;EIF2AK2;ATP2B1;IL33;ADRA2A;SRGN;IFIH1;MAPK14;CD276;RPS6KA5;GLMN;TRAF3;AFAP1L2;HDAC9;IL6;IRF7;IGF2BP3;ANXA1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.7524188574251977,1.834480063428474,0.0030816640986132513,0.0837202856608066,0.832,3/22,3.22%,CCR2;LILRB1;LAPTM5
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6817572897212489,-1.8339593993932768,0.0,0.24153545509128307,0.843,10/17,12.12%,CACNA1D;SLC8A1;CACNB2;CACNA2D1;KCNJ2;CACNA1C;ANK2;ATP1A2;HCN2;SCN1B
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.8391050556892028,1.8317465909900237,0.003472222222222222,0.08479244757967477,0.843,2/12,0.33%,CCR2;IL1B
prerank,Fc receptor signaling pathway (GO:0038093),0.5917821644065275,1.8272964129693825,0.0,0.0890498549507272,0.866,38/110,13.51%,CARD11;GRAP2;VAV3;LYN;PLCG2;SYK;PSME3;PAK1;NFKB1;FOS;MALT1;PSMB7;IKBKB;PSME2;PPP3CA;FBXW11;MAP3K1;GRB2;PDPK1;PAK2;RAC1;PSME4;SOS1;PSMB8;PSMA5;PSMD9;PIK3CA;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;BTK;MAPK8;KIT;FCER1G
prerank,positive regulation of cytokine production (GO:0001819),0.5424430059078429,1.8265316174096158,0.0,0.08743264388268925,0.868,53/292,8.62%,CD74;CCR2;CLEC9A;CARD11;FGR;PTPRC;IL1B;FOXP1;RARA;CYRIB;CD226;PTPN22;PAEP;PLCG2;LILRB1;SULF2;CD40;SYK;POLR3F;NFKB1;STAT3;NFAM1;HSPA1A;DHX58;LAPTM5;SORL1;MALT1;POLR3A;PTGER4;MRE11;EIF2AK2;IL6R;LRRFIP1;IL33;ADRA2A;RAB7B;IRF4;IFIH1;MAPK14;CD276;GLMN;TIRAP;IL17RA;ADAM17;DDX41;TMED10;PLCB1;AFAP1L2;CD2;NOX1;TLR3;IL6ST;IL6
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.772215402977345,1.8262255873840907,0.0014925373134328358,0.08524006985196567,0.869,6/19,8.19%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,positive regulation of macrophage migration (GO:1905523),-0.6417984047956644,-1.8219980322024922,0.0056022408963585435,0.25255862571998,0.867,10/19,17.36%,CSF1R;TREM2;CMKLR1;P2RY12;CSF1;P2RX4;AKIRIN1;MDK;CX3CL1;CCL3
prerank,T cell activation involved in immune response (GO:0002286),0.8383902965389395,1.8208117139551527,0.0034071550255536627,0.09166847379096772,0.89,4/12,1.35%,CD74;ITGAL;LCP1;LILRB1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.8107458479594818,1.8203828014024404,0.0,0.0897003060651499,0.891,5/15,4.94%,KMO;TAT;KYNU;HGD;HAAO
prerank,positive regulation of B cell proliferation (GO:0030890),0.7112497708663745,1.8170261528769922,0.0028735632183908046,0.09231215609989746,0.907,5/29,1.72%,CD74;VAV3;PTPRC;TNFSF13B;CD40
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.5888767441714596,1.8162314286776555,0.0,0.09079580267891448,0.911,37/109,13.51%,CARD11;GRAP2;VAV3;LYN;PLCG2;SYK;PSME3;PAK1;NFKB1;FOS;MALT1;PSMB7;IKBKB;PSME2;PPP3CA;FBXW11;MAP3K1;GRB2;PDPK1;PAK2;RAC1;PSME4;SOS1;PSMB8;PSMA5;PSMD9;PIK3CA;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;BTK;MAPK8;FCER1G
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.793862888767116,1.8154496883332722,0.00510204081632653,0.08996715780440026,0.912,2/15,1.94%,CCR2;SYK
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7326570602108563,1.8149872563028688,0.007656967840735069,0.0882878979309749,0.912,9/21,8.53%,FOXP1;LYN;PTPN22;STAP1;NFAM1;PRKCH;CD300A;CBFB;ELF1
prerank,response to cytokine (GO:0034097),0.5564970613275539,1.8103702169119766,0.0,0.09254083590281469,0.93,24/141,6.24%,CD74;CIITA;PID1;IL1B;IFNLR1;SP100;KYNU;FLT3;CD40;MCL1;MAPKAPK3;PLSCR1;JAK2;STAT3;REL;MAPKAPK2;TAF9;PTPN6;PTPN7;EIF2AK2;IL6R;PTPN12;STAT1;CXCL16
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.8429286180350963,1.8103517475940374,0.0035460992907801418,0.09036108180043646,0.93,2/12,0.33%,CCR2;IL1B
prerank,indolalkylamine catabolic process (GO:0046218),0.8582706285108246,1.8096206449931018,0.0,0.089204724263685,0.93,4/10,10.19%,KMO;KYNU;HAAO;KYAT1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.8160108020595029,1.8091846656409454,0.006493506493506494,0.08762787307720571,0.93,4/13,7.20%,CD74;CD44;PTTG1IP;DYRK1A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6908034631567535,-1.808775937634369,0.005154639175257732,0.2734421939567442,0.912,10/14,25.53%,PRKG1;MEF2C;LRP1;AIF1;SLIT2;SERPINE1;IGFBP5;TRIB1;CORO1B;NDRG4
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.7452014413972802,1.8086871758725007,0.006069802731411229,0.08660567303822454,0.934,9/22,17.38%,IL1B;CYRIB;MALT1;FBXO38;STX7;B2M;MAP3K7;TRAF2;HSPD1
prerank,negative regulation of immune response (GO:0050777),0.5568384740524226,1.8075571099184504,0.0,0.0862096864200492,0.935,37/154,13.33%,CCR2;FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;LILRB1;FYN;ITCH;SYK;RXFP2;CD300A;PTGER2;DHX58;SPI1;PTGER4;HTR4;MYH9;DPEP1;RC3H1;MAPK14;ADAM17;CYSLTR1;SAMSN1;GNB1;IL6;PRKAR2A;ADCY7;CACTIN;GLP2R;ACOD1;FCGR2B;ADCY5;LGALS3;GNG2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7625320155569861,1.797783995012237,0.0015267175572519084,0.09799866516627521,0.957,4/19,8.62%,CIITA;VIM;SCX;IL6
prerank,regulation of glucose transmembrane transport (GO:0010827),0.7697768973819089,1.797260464272572,0.0015600624024961,0.09678299597775268,0.958,9/18,15.17%,FFAR4;IL1B;PRKAG2;C2CD5;RTN2;BRAF;CLIP3;OCLN;SLC2A1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.8494313297060365,1.7960562326294092,0.0,0.09642605908503092,0.961,3/11,3.75%,CD74;CD44;TAF9
prerank,regulation of B cell activation (GO:0050864),0.7243462213184627,1.7958218759576507,0.0014947683109118087,0.09479488698420925,0.961,10/25,11.70%,FOXJ1;LAPTM5;THEMIS2;AHR;IKZF3;SAMSN1;ZFP36L2;IL6;SLAMF8;FCGR2B
prerank,response to interferon-gamma (GO:0034341),0.6099801610270076,1.7944148374793132,0.0,0.09521000962261282,0.963,7/67,1.72%,CD74;CIITA;SP100;CD47;KYNU;DAPK1;CD40
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.775479560571443,-1.7936060290990277,0.002257336343115124,0.2973876968173631,0.943,3/10,4.00%,ABCA1;APOE;PRKACA
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.8355277117024943,1.793383018906847,0.0,0.09507546252719247,0.966,3/12,3.75%,CD74;CD44;TAF9
prerank,positive regulation of interferon-gamma production (GO:0032729),0.6217412219968216,1.791251400850285,0.0,0.09647949108518886,0.968,9/48,8.53%,CCR2;IL1B;CYRIB;CD226;PTPN22;LILRB1;CD276;CD2;TLR3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8019871473374695,1.7910055443120514,0.0017301038062283738,0.09500486682897809,0.968,4/14,3.22%,CD74;PLCG2;LILRB1;LAPTM5
prerank,positive regulation of immune response (GO:0050778),0.6036732850078776,1.78958420811899,0.0,0.09538598091468378,0.97,15/64,13.31%,CD74;PTPRC;CD226;LILRB1;POLR3F;PLSCR1;CD177;ITGB2;IL6ST;IFI35;SLC15A4;FCGR2B;NLRP3;MYB;GBP5
prerank,calcium ion import across plasma membrane (GO:0098703),-0.6747397463356265,-1.7857004794856257,0.0,0.30164916447285584,0.955,5/14,13.66%,SLC8A1;CACNA2D1;TRPV2;TRPM2;TRPV4
prerank,melanocyte differentiation (GO:0030318),-0.7478208438890541,-1.7782112535361396,0.004694835680751174,0.3053746806747437,0.962,4/11,3.14%,LRMDA;MITF;MEF2C;ENPP1
prerank,positive regulation of B cell activation (GO:0050871),0.6266182210213818,1.7748004484439888,0.001314060446780552,0.11585994544247659,0.984,10/50,8.62%,CD74;VAV3;PTPRC;TNFSF13B;CD40;SYK;MAD2L2;TIRAP;EPHB2;IL6
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7722256576915081,1.7741139213859227,0.0031201248049922,0.11504453328041715,0.984,6/17,8.19%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,tryptophan catabolic process (GO:0006569),0.8394593899736309,1.7737043434773927,0.0,0.11381292406056362,0.984,4/11,10.19%,KMO;KYNU;HAAO;KYAT1
prerank,regulation of interleukin-2 production (GO:0032663),0.6377371016177336,1.773122801033096,0.0013717421124828531,0.11263986368889037,0.984,13/43,10.39%,CCR2;CARD11;PTPRC;IL1B;PLCG2;LAPTM5;MALT1;IRF4;GLMN;PRNP;EZR;RPS3;ANXA1
prerank,protein autophosphorylation (GO:0046777),0.5411918892416737,1.770911701979439,0.0,0.11451243492516007,0.986,55/157,16.97%,FGR;LRRK2;GRK5;STK10;MAP4K1;HCK;LYN;FLT3;SIK1;STK24;VRK1;DAPK1;SLK;LMTK2;MAPKAPK3;PIM1;PAK1;STK17B;JAK2;ERN1;MAPKAPK2;EIF2AK2;EIF2AK1;VRK2;TAOK3;STK4;PTK2B;PDPK1;MKNK2;DYRK1A;PAK2;SIK2;MINK1;PIKFYVE;OXSR1;CAMKK2;RIPK1;CAD;SMG1;CDK12;EIF2AK3;AKT1;KIT;MARK3;STK39;FGFR3;MAP3K13;AURKB;TAF1;INSR;DAPK3;FES;MAP3K9;HTATIP2;MAP3K3
prerank,calcium ion import into cytosol (GO:1902656),-0.6551824422233564,-1.769405632395046,0.00821917808219178,0.3147891254768477,0.978,5/15,13.66%,SLC8A1;CACNA2D1;TRPV2;TRPM2;TRPV4
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.7846415436529091,1.7675305461091655,0.0016835016835016834,0.11851716917656074,0.988,10/13,14.21%,IL27RA;OAS2;JAK2;STAT3;STAT1;OASL;IL6ST;EBI3;TYK2;CANX
prerank,response to axon injury (GO:0048678),-0.6559136055099728,-1.7674269830969132,0.005405405405405406,0.3012324948976447,0.98,12/18,27.26%,RTN4RL1;TREM2;P2RY12;APOD;P2RX4;NREP;DPYSL3;MTR;TYROBP;SOD1;DHFR;MORN4
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6696396340232516,-1.7668475189641337,0.002652519893899204,0.28579207569776166,0.98,9/16,11.22%,SIRPA;TREM2;ABCD2;APPL2;APOD;NLRC3;PYCARD;CUEDC2;CHID1
prerank,receptor signaling pathway via STAT (GO:0097696),0.6989264264932702,1.7660788759831434,0.009009009009009009,0.11897160537102934,0.989,9/25,10.41%,CCR2;STAT4;STAT5A;JAK2;STAT3;STAT5B;STAT1;IFNAR1;IL31RA
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.8089504240010609,1.7628242743512692,0.0034482758620689655,0.12298295054130964,0.991,8/11,14.21%,STAT4;IL27RA;JAK2;STAT3;STAT1;IL6ST;EBI3;CANX
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5867417232574222,1.7622926625377118,0.0012453300124533001,0.12194409702296104,0.991,24/72,13.62%,CD74;PTPRC;TRAF1;IFNGR1;SYK;JAK2;PTPN6;IKBKB;VRK2;SUMO1;BIRC3;STAT1;HIPK1;CBFB;SPATA2;ELF1;SPPL2A;CYLD;PTPN1;RIPK1;RNF31;CLIP3;LIFR;AGPAT1
prerank,regulation of mRNA processing (GO:0050684),-0.5445204456647654,-1.7595537632766678,0.00964630225080386,0.2917231692589371,0.987,15/32,14.65%,QKI;SON;AHCYL1;CDK11B;SRSF3;SAFB2;SRPK1;KHDRBS3;TIA1;JMJD6;SRPK2;KHDRBS2;DHX9;IWS1;PTCD2
prerank,regulation of monocyte differentiation (GO:0045655),0.7809494530465471,1.7587198221335798,0.0016260162601626016,0.1263504863673323,0.994,2/14,0.38%,CD74;FOXP1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.7545772516533724,-1.7566966264144885,0.00980392156862745,0.2848482216011844,0.987,3/10,6.64%,LRP6;CTNNB1;RYK
prerank,positive regulation of cytokinesis (GO:0032467),0.6665418578086013,1.756538787485797,0.0029069767441860465,0.12852088051323507,0.994,10/32,9.33%,SVIL;CDC14A;PRKCE;RACGAP1;CUL3;KIF23;CDC42;PKN2;RHOA;SPAST
prerank,positive regulation of interleukin-8 production (GO:0032757),0.6217023998016159,1.7551576609423112,0.0027137042062415195,0.12888085535410013,0.994,10/49,8.62%,CD74;IL1B;SYK;STAT3;HSPA1A;TIRAP;AFAP1L2;CD2;TLR3;IL6
prerank,myotube differentiation (GO:0014902),-0.648118369425414,-1.754064045948368,0.012626262626262626,0.27901763394538764,0.987,9/17,16.06%,IGF1;SKI;MEF2C;PLD3;ADGRB3;SORT1;JAM2;ADAMTS5;MYEF2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.7497656073848805,1.7537033500479988,0.006339144215530904,0.12981328011313376,0.995,3/17,4.50%,KCNE3;RNF207;SUMO1
prerank,regulation of response to external stimulus (GO:0032101),0.5482735675888899,1.751150918712651,0.0,0.13264354651382726,0.996,36/121,15.78%,CCR2;FGR;FOXP1;CYRIB;HCK;SPAAR;PTPN22;SAMHD1;STK24;BCL6;ACE2;JAK2;CD36;DHX58;AKNA;ADGRA2;BIRC3;TIRAP;CAMKMT;TRAF3;SPATA2;EPHB2;SBNO2;ANXA1;CYLD;FCGR2B;NMT2;AREL1;PDE6B;ADAMTS12;CASP12;MYD88;XIAP;RELA;CELF1;LRP8
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6939791345018632,1.7500172828169995,0.00741839762611276,0.13268848747222098,0.996,3/24,3.75%,CD74;CD44;TAF9
prerank,response to molecule of bacterial origin (GO:0002237),0.58438040324779,1.749927759731433,0.0012642225031605564,0.13094527599270192,0.996,15/69,8.62%,IL1B;FOXP1;CYRIB;PTPN22;MAPKAPK3;JAK2;RPS6KA3;ERBIN;MAPKAPK2;SLPI;PELI1;TIRAP;ADAM17;IFNAR1;IL6
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8082830968713786,1.7498429136987756,0.010221465076660987,0.12923672089312882,0.996,4/11,6.46%,PTPRC;KLRD1;LILRB1;AHR
prerank,dendritic cell migration (GO:0036336),0.7546386799113368,1.7484587588205245,0.011308562197092083,0.12977454406579927,0.996,3/16,1.95%,CCR2;EPS8;CCR1
prerank,regulation of macrophage cytokine production (GO:0010935),0.7933396820583591,1.7481093041869682,0.0,0.12866375094248622,0.996,4/13,3.22%,CD74;PLCG2;LILRB1;LAPTM5
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5718023777011056,-1.7480292181558152,0.0,0.2823847909697606,0.99,7/29,8.98%,CACNA1D;WNK1;SLMAP;CD63;KCNN2;DPP10;SNTA1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6711543206055653,1.7470392173227776,0.010057471264367816,0.12875875977793821,0.996,9/29,10.41%,CCR2;STAT4;STAT5A;JAK2;STAT3;STAT5B;STAT1;IFNAR1;IL31RA
prerank,natural killer cell activation (GO:0030101),0.7080459478475386,1.7468951079513597,0.004457652303120356,0.1272341067129402,0.996,8/23,10.95%,SLAMF7;PTPRC;ELF4;RABL3;KLRK1;KAT7;CD2;PBX1
prerank,regulation of T cell mediated immunity (GO:0002709),0.8348793740452038,1.7463166236249568,0.007079646017699115,0.12653426255584754,0.996,2/10,0.33%,CCR2;IL1B
prerank,positive regulation of neutrophil migration (GO:1902624),0.7441150348837905,1.7444589724592119,0.006042296072507553,0.12798717703473436,0.996,6/18,8.19%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,immunoglobulin mediated immune response (GO:0016064),0.8281055946184838,1.7432546818509096,0.006745362563237774,0.12843723801509752,0.996,2/10,2.31%,CD74;GAPT
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.7832646705540316,1.7422131166173056,0.009966777408637873,0.12841763430459652,0.997,5/13,10.91%,FGR;SYK;CD177;ITGB2;AP1G1
prerank,positive regulation of type 2 immune response (GO:0002830),0.7685411567140794,1.7399324974103978,0.007936507936507936,0.1306745199467616,0.998,4/14,8.62%,CD74;RARA;DENND1B;IL6
prerank,regulation of cellular component size (GO:0032535),0.6699578279470365,1.7398346734703123,0.014184397163120567,0.1292018018502072,0.998,12/30,8.85%,VAV3;RAP1GAP2;RIN3;EPS8;MSN;PICALM;PTEN;MTPN;RARG;EZR;RAC1;PPP1R15A
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.8309091781467148,1.7371177750627156,0.008802816901408451,0.13229048666574328,1.0,2/10,4.50%,KCNE3;SUMO1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5974333652628179,1.735502360425022,0.0012706480304955528,0.13353569636139195,1.0,11/63,8.62%,CD74;VAV3;PTPRC;IL1B;TNFSF13B;CD40;CD276;TIRAP;EPHB2;IL6ST;IL6
prerank,cellular response to chemokine (GO:1990869),0.6140663595998928,1.735319045333607,0.002642007926023778,0.13225620687564907,1.0,11/46,13.88%,CCR2;CCR1;CXCL10;GPR35;RIPOR2;PTK2B;RHOA;OXSR1;DUSP1;STK39;LRCH1
prerank,tyrosine metabolic process (GO:0006570),0.8005351297031038,1.7342664125864238,0.00825082508250825,0.1325277938382576,1.0,2/11,1.12%,TAT;HGD
prerank,positive regulation of defense response to virus by host (GO:0002230),0.6875935487371547,1.7339590417264792,0.006153846153846154,0.13155133474748032,1.0,7/24,12.35%,PTPN22;LILRB1;DTX3L;TRAF3IP2;STAT1;PARP9;PQBP1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6773277818693723,1.7339343089299382,0.012968299711815562,0.1300676964390195,1.0,6/27,12.26%,CD74;CD44;PTTG1IP;DYRK1A;SPRED3;PSMD10
prerank,RNA catabolic process (GO:0006401),0.6198149337799227,1.7327507143423362,0.002635046113306983,0.13061086219282117,1.0,20/46,15.76%,DNA2;ZC3H12D;HSPA1A;ERN1;SND1;FEN1;XRN2;RNASEH2C;DCP2;LSM5;ZFP36L2;RNASE6;ZPR1;METTL3;RNASEH2A;RNASEH1;RNH1;PNPT1;NCBP1;SIDT2
prerank,cellular response to ATP (GO:0071318),-0.6811322443780702,-1.7326433018848795,0.010723860589812333,0.31659044524042707,0.996,5/14,7.78%,RYR3;P2RY12;P2RX7;P2RX4;HSP90B1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.6047837024165146,1.7314238643438138,0.004037685060565276,0.13131816445928146,1.0,19/46,13.66%,STAT4;LCP1;CNN2;ANXA2;MSN;JAK2;CDC42;PSME2;TALDO1;PDCD4;PAK2;ARF1;PLCB1;CAPZA1;LMNB1;RPLP0;SNRPA1;HSPA9;TYK2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5013972760574791,1.7312865297515,0.0,0.13010383776919626,1.0,135/532,13.80%,CIITA;CCR2;GRAP2;CD44;IL1B;IFNLR1;SP100;TRAF1;HCK;STAT4;LCP1;FPR1;FLT3;SAMHD1;IL27RA;IFNGR1;IL18RAP;FYN;ITGAX;TNFSF13B;OAS2;CD40;MCL1;MAP3K8;CNN2;ANXA2;STAT5A;SYK;CCR1;BCL6;PSME3;PIM1;NFKB1;MSN;JAK2;STAT3;VIM;MAP3K14;FOS;TRIM26;CRK;CD36;IFIT2;SLA;IL10RA;CXCL10;GPR35;PTPN6;SPI1;STAT5B;NFKBIA;MMP1;CBL;IL6R;PSMB7;IKBKB;CDC42;PSME2;TRIM62;IRF2;F13A1;IL33;BIRC3;TRAF3IP2;STAT1;IL2RG;ITGB2;PELI1;IRF4;FBXW11;IRAK4;RPS6KA5;UBE2N;IL17RA;CCND1;GRB2;PTK2B;ADAM17;CSF2RB;TALDO1;OASL;PDCD4;PAK2;TRAF3;TRIM25;ARF1;PLCB1;IFNAR1;PSME4;IL6ST;SOS1;IL6;HGF;IFI35;CAPZA1;OPRM1;ICAM1;IL1R2;IRF7;PSMB8;SMAD4;LMNB1;PSMA5;PSMD9;FN1;ANXA1;IL31RA;PIK3CA;RIPK1;B2M;YWHAZ;IL17RB;PSMB3;FOXO3;PSMD6;JAGN1;TAB3;PSMC4;RPLP0;MAP3K7;PSMD10;SNRPA1;EBI3;PSMB1;HSPA9;LIFR;AKT1;KIT;STAT2;CSK;FCER1G;JUNB;TNFRSF1B;TYK2;IFIT1
prerank,cellular response to interferon-gamma (GO:0071346),0.5676572292261458,1.728590365373008,0.0012091898428053204,0.13317144886756163,1.0,25/88,14.90%,CIITA;CD44;SP100;HCK;CD47;IFNGR1;DAPK1;OAS2;JAK2;TRIM26;TRIM62;IRF2;STAT1;IRF4;OASL;TRIM25;ICAM1;IRF7;B2M;ACOD1;TLR2;GBP5;SYNCRIP;GBP2;GBP3
prerank,acute-phase response (GO:0006953),0.7960682893447076,1.7250214780007895,0.007054673721340388,0.13782502917299574,1.0,4/12,10.22%,PLSCR1;IL6R;IL6;MBL2
prerank,cellular response to purine-containing compound (GO:0071415),-0.7281161610470518,-1.7245342345974073,0.009732360097323601,0.3288036592240073,0.997,4/10,13.02%,SLC8A1;RYR3;P2RY6;TRPM2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5848080086949041,1.7229772141747854,0.0012970168612191958,0.13961699219568002,1.0,16/69,8.62%,CCR2;PTPRC;IFNGR1;PLCG2;OAS2;SYK;JAK2;STAT3;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6
prerank,negative regulation of viral entry into host cell (GO:0046597),0.7965910512270433,1.7229033878664834,0.001658374792703151,0.13833513906575431,1.0,3/12,2.61%,CIITA;PTX3;TRIM26
prerank,ganglioside biosynthetic process (GO:0001574),0.7504542009583506,1.7207916062412776,0.01309328968903437,0.14041484374839305,1.0,5/15,8.26%,ST3GAL1;ST8SIA4;ST8SIA6;B4GALT5;ST6GALNAC3
prerank,positive regulation of locomotion (GO:0040017),-0.5646979823404883,-1.719826652065876,0.00949367088607595,0.3317147338214244,0.997,7/27,10.68%,CSF1R;TREM2;P2RY12;AIF1;CFAP20;PPM1F;CCDC25
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5796837051213222,1.7185019091111828,0.007575757575757576,0.1430136679031541,1.0,16/68,12.51%,CD74;IL1B;PLCG2;SYK;STAT3;IL6R;IL33;RAB7B;IFIH1;TIRAP;IL17RA;TLR3;IL6;MBP;APP;TLR2
prerank,regulation of defense response to virus by host (GO:0050691),0.6551483333755023,1.7181934427087762,0.00145985401459854,0.14201958481980326,1.0,8/30,12.35%,IFNLR1;PTPN22;LILRB1;DTX3L;TRAF3IP2;STAT1;PARP9;PQBP1
prerank,regulation of interferon-gamma production (GO:0032649),0.5708440622244081,1.7161023935119417,0.0,0.1446297919992361,1.0,13/71,8.53%,CCR2;IL1B;RARA;CYRIB;CD226;CD47;PTPN22;LILRB1;LAPTM5;CD276;PRNP;CD2;TLR3
prerank,response to peptide (GO:1901652),0.6506490737798551,1.7159485301194914,0.002840909090909091,0.14341146170791758,1.0,13/33,13.22%,STAT4;FYN;STAT5A;STAT3;CACNA1A;ERBIN;STAT5B;KAT7;STAT1;PRNP;ANXA1;GNAI1;STAT2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6990887382662468,1.7132804857748865,0.0015384615384615385,0.14674128073871087,1.0,1/23,0.01%,PLBD1
prerank,alpha-amino acid catabolic process (GO:1901606),0.666762234655559,1.7120696323215818,0.005961251862891207,0.14762507309519637,1.0,8/29,11.96%,KMO;TAT;KYNU;HGD;HAAO;KYAT1;MTRR;ACAT1
prerank,defense response to symbiont (GO:0140546),0.5520717738999701,1.7103515628372057,0.0,0.14930003203355693,1.0,31/92,15.45%,PTPRC;IFNLR1;SAMHD1;LILRB1;OAS2;CD40;PLSCR1;MAP3K14;IFIT2;EIF2AK2;IRF2;STAT1;IFIH1;FLNA;OASL;DDIT4;RNASE1;TLR3;IL6;IRF7;SETD2;RNASE6;ACOD1;PQBP1;TLR2;NT5C3A;STAT2;IFIT1;MYD88;RELA;IFITM3
prerank,regulation of lamellipodium organization (GO:1902743),0.7573372140940695,1.7092403807741672,0.009615384615384616,0.1496847648809227,1.0,5/14,8.19%,CD44;CDC42;CARMIL1;CAPZB;RAC1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.6835383278344979,1.7092403366419116,0.01002865329512894,0.14825919569158058,1.0,7/25,13.20%,CD226;PLCG2;LAPTM5;MALT1;B2M;MAP3K7;KIT
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6138715631030888,-1.7087842846803867,0.008695652173913044,0.353765606700865,0.997,7/20,7.61%,KCNMA1;SLC8A1;ATP1B3;KCNJ2;ATP6AP1;ATP1B1;ATP1A2
prerank,granulocyte differentiation (GO:0030851),0.7180396036626515,1.7083437079276294,0.017915309446254073,0.14853428143906042,1.0,4/18,6.24%,CBFA2T3;RARA;SPI1;DEK
prerank,cation transmembrane transport (GO:0098655),-0.5052843939469216,-1.7064992340793255,0.0044444444444444444,0.3482377249764638,0.997,14/44,13.02%,MFSD12;TRPM3;PKD2;SLC7A1;ATP1B1;SLC36A4;SFXN1;ATP1A2;SLC25A20;SLC22A5;SLC7A2;SLC7A8;SLC3A2;TRPM2
prerank,lipid droplet organization (GO:0034389),-0.5783607422622001,-1.7042006635395612,0.014577259475218658,0.3428927348700517,0.998,12/22,36.10%,PPIA;CDS1;RAB3GAP1;CDS2;AUP1;PPID;BSCL2;ZFYVE1;FITM2;FAF2;PLA2G4C;PNPLA3
prerank,manganese ion transport (GO:0006828),-0.6705097174681676,-1.703483425888839,0.01818181818181818,0.3335233365490075,0.998,7/14,16.27%,SLC11A1;TRPC4;SLC11A2;TRPC1;TRPC7;TRPC3;ATP2C1
prerank,B cell mediated immunity (GO:0019724),0.8037984656655112,1.70259683765936,0.008547008547008548,0.1582804904977763,1.0,1/10,0.02%,CD74
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.7867389977905412,1.6992304740794175,0.012152777777777778,0.16355117192419036,1.0,7/12,11.70%,NOTCH2;DOCK10;DOCK11;LFNG;PTK2B;IL6;FCGR2B
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.7694649862251537,1.6992117999187586,0.005208333333333333,0.16210526192137742,1.0,7/14,15.29%,CARD11;TESPA1;CD226;KCNN4;RPS3;RAB29;RELA
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.7069839992777911,-1.6953708001841838,0.007246376811594203,0.3482512477212983,0.999,3/11,6.64%,LRP6;CTNNB1;RYK
prerank,heart process (GO:0003015),0.7570455533676642,1.6928658046330685,0.004807692307692308,0.17312924969721652,1.0,4/14,7.08%,ACE;FYN;GPX1;SGCD
prerank,regulation of defense response (GO:0031347),0.5595416420642947,1.692754271371464,0.0024906600249066002,0.17179276177267624,1.0,27/76,15.78%,CCR2;FGR;FOXP1;HCK;PTPN22;SAMHD1;BCL6;ACE2;JAK2;DHX58;AKNA;BIRC3;TIRAP;TRAF3;SPATA2;SBNO2;ANXA1;CYLD;FCGR2B;AREL1;ADAMTS12;CASP12;MYD88;XIAP;RELA;CELF1;LRP8
prerank,negative regulation of viral life cycle (GO:1903901),0.7459136653036222,1.6923807993083364,0.011308562197092083,0.17106421825565785,1.0,3/15,2.61%,CIITA;PTX3;TRIM26
prerank,lymphocyte proliferation (GO:0046651),0.7007016118289058,1.6920259378914133,0.0029498525073746312,0.17040119747006965,1.0,5/22,2.53%,PTPRC;FLT3;CD40;MSN;ELF4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.7973074375296664,1.6901925023236788,0.011725293132328308,0.172462466909791,1.0,4/12,5.91%,CD74;FOXP1;KLF4;TIRAP
prerank,negative regulation of synaptic transmission (GO:0050805),0.6792007216255007,1.690084090985984,0.013761467889908258,0.17122135770264407,1.0,5/23,8.42%,LRRK2;IL1B;PTEN;ARF1;SLC30A1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.8045764459638631,1.6888455940517764,0.0016722408026755853,0.1721634089261484,1.0,2/12,0.33%,CD44;IL1B
prerank,regulation of leukocyte activation (GO:0002694),0.7698756181751177,1.687657426368966,0.008143322475570033,0.17291992703422016,1.0,3/14,2.32%,CD74;LYN;PLSCR1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5953797183121593,-1.6861800480371336,0.008241758241758242,0.36774112909301354,0.999,7/20,7.61%,SLC8A1;CACNA1C;PRKACA;ATP2A2;ATP1B1;ANK2;ATP1A2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6588698644593185,1.6860124044912264,0.00430416068866571,0.17510836974812063,1.0,6/29,4.56%,KLRD1;CYRIB;CD226;STAP1;SPI1;KLRK1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.7265619142171061,-1.6839510369309523,0.006787330316742082,0.3634105064112492,0.999,2/10,1.02%,BASP1;SALL1
prerank,apical junction assembly (GO:0043297),0.596973156726579,1.6832105049938617,0.005154639175257732,0.17952554871890444,1.0,15/53,15.92%,PECAM1;MARVELD3;FRMPD2;CLDN1;CTNNA1;AFDN;PKN2;PAK2;F11R;PDCD6IP;RHOA;CLDN14;TBCD;OCLN;APC
prerank,cellular response to interleukin-12 (GO:0071349),0.5861785963766182,1.6828834347296944,0.007978723404255319,0.1786324603380292,1.0,20/48,13.66%,STAT4;CD47;LCP1;CNN2;ANXA2;MSN;JAK2;CDC42;PSME2;TALDO1;PDCD4;PAK2;ARF1;PLCB1;CAPZA1;LMNB1;RPLP0;SNRPA1;HSPA9;TYK2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.7143628565051537,-1.6812139483824706,0.011933174224343675,0.36135791460061234,0.999,7/11,17.06%,P3H2;P4HA1;EGLN3;EGLN2;P4HB;OGFOD1;CRTAP
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5598707030028887,1.6808574043536764,0.0038119440914866584,0.1813829393361595,1.0,16/73,8.62%,CCR2;PTPRC;IFNGR1;PLCG2;OAS2;SYK;JAK2;STAT3;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6504142026584895,1.680720391591112,0.0109375,0.18007492835196523,1.0,6/26,8.62%,CCR2;IL1B;SULF2;NOX1;IL6ST;IL6
prerank,defense response to tumor cell (GO:0002357),0.7857389084962532,1.6781503282506232,0.01436265709156194,0.18376012033505623,1.0,4/10,3.78%,KLF4;DAPK1;LAPTM5;SPI1
prerank,T cell receptor signaling pathway (GO:0050852),0.5294039216362096,1.6776720837073187,0.0022026431718061676,0.18329332724825811,1.0,39/138,13.34%,CARD11;GRAP2;PTPRC;PTPN22;PLCG2;FYN;PSME3;PAK1;NFKB1;MALT1;PSMB7;IKBKB;ZAP70;PSME2;NFKBIZ;THEMIS2;BCAR1;RC3H1;FBXW11;CD276;DENND1B;UBE2N;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PIK3CA;NFKBID;RNF31;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;ICOSLG;PSMB1;CSK
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5321736750675079,1.676995135338437,0.0,0.1831035993508457,1.0,26/116,13.33%,FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;FYN;SYK;RXFP2;PTGER2;PTGER4;HTR4;MYH9;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;PRKAR2A;ADCY7;GLP2R;FCGR2B;ADCY5;GNG2
prerank,positive regulation of behavior (GO:0048520),-0.7252960827735655,-1.6766095029106853,0.009411764705882352,0.36607266824853174,0.999,4/10,14.35%,MEF2C;NLGN1;CFAP20;NPAS2
prerank,regulation of neuron apoptotic process (GO:0043523),-0.4241865662555017,-1.6748589429121024,0.0,0.3608837186722837,0.999,33/96,14.25%,PRKN;LGMN;APOE;TREM2;MEF2C;NTRK2;GRN;CTNNB1;NF1;RASA1;PPARGC1A;ADAM8;GRID2;NRBP2;FAIM2;ATF4;EGLN3;CDK5R1;KDM2B;NAE1;EGLN2;BACE1;SNX6;CPEB4;PTPRZ1;CDK5;MSH2;SET;EPHA7;SRPK2;MDK;TGFB2;BAX
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6914062563549165,1.6747561600945955,0.016666666666666666,0.1863466237286097,1.0,9/20,17.33%,IL1B;MALT1;DENND1B;IL6;B2M;NLRP3;MAP3K7;IL18;TRAF2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.6268023150956247,1.6727246831179545,0.010174418604651164,0.1893278570352349,1.0,2/33,1.95%,CD74;CCR1
prerank,fatty acid oxidation (GO:0019395),-0.4631969213237255,-1.672645058444246,0.005263157894736842,0.35759353258120474,0.999,28/57,28.87%,ABCD2;ECHS1;PPARGC1A;PECR;ABCD4;ECHDC1;ACAD10;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;ACADL;CPT2;ACADS;PHYH;ILVBL;ADIPOR2;PEX13;ACAT2;ADH5;ACAD11;ACOX1;CROT;PPARD;SLC27A2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6098841332916837,1.6705275813840474,0.009562841530054645,0.19246383867828912,1.0,8/42,10.85%,CCR2;CCR1;CXCL10;GPR35;PTK2B;CIB1;OXSR1;RBM15
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5914662332962726,1.669407440701553,0.008021390374331552,0.19311555035688707,1.0,19/47,18.44%,PID1;PLCG2;SYK;ACE2;CD36;CD177;ITGB2;MAPK14;GRB2;DHRS4;RIPK1;ACOD1;TGFB1;GSTP1;THBS1;RNF41;CYBA;MMP8;PRKCD
prerank,positive regulation of cell death (GO:0010942),0.5728117704869762,1.6683045189007648,0.0012674271229404308,0.1940317117766256,1.0,16/59,11.70%,LRRK2;FYN;MAP3K5;FOS;CD36;PICALM;HP;HPR;ITGB2;FAF1;PRNP;DDIT4;RARG;DAXX;RIPK1;FCGR2B
prerank,regulation of actin filament-based process (GO:0032970),0.5660907143028536,1.665879607989739,0.004987531172069825,0.19734748286426598,1.0,17/70,8.95%,RND3;IQGAP2;IQGAP1;CNN2;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;DLC1;F11R;RHOBTB3;EZR;RAC1;RHOA
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.5263741669953211,1.665580750791993,0.001145475372279496,0.19637804323806007,1.0,23/117,11.27%,FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;FYN;SYK;RXFP2;PTGER2;PTGER4;HTR4;MYH9;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;PRKAR2A;ADCY7;GLP2R
prerank,lymphocyte mediated immunity (GO:0002449),0.776939220318688,1.6650848750250014,0.01576182136602452,0.1959746561371867,1.0,3/12,6.89%,MYO1G;KLRD1;GNL1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.6052530941369686,1.663735310105993,0.00823045267489712,0.19753742671525468,1.0,19/44,16.05%,CD44;NGF;KLF4;NGFR;GPX1;RPS6KA3;DPEP1;CAST;CARD16;HGF;CSNK2A1;RPS6KA1;MAP2K5;SH3RF1;AKT1;DHCR24;XIAP;THBS1;USP47
prerank,endocrine system development (GO:0035270),-0.5631668447528722,-1.6627844420990745,0.008,0.3818458027134942,1.0,8/21,27.38%,SALL1;TGFBR1;NF1;MDK;DKK3;HOXD3;SOX2;WNT4
prerank,response to ATP (GO:0033198),-0.6152054111738046,-1.6627647145852196,0.017391304347826087,0.37158076020558983,1.0,7/18,14.64%,RYR3;P2RY12;P2RX7;P2RX4;HSP90B1;DGKQ;TRPC3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6284758991300516,1.6624089078397346,0.00860832137733142,0.19886412851079605,1.0,7/31,5.82%,LYN;LILRB1;CD300A;SPN;RC3H1;LST1;GLMN
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7073196568091757,-1.6623578250601336,0.0166270783847981,0.3629292619986454,1.0,3/10,2.51%,PRKG1;SERPINE2;CD9
prerank,cardiac muscle cell contraction (GO:0086003),-0.5958851066637295,-1.6622759048633513,0.008547008547008548,0.35385867924597886,1.0,10/19,22.18%,CACNA1D;CACNA2D1;SCN1A;KCNJ2;CACNA1C;SCN1B;PKP2;FGF12;SCN3B;GSN
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6533851959796063,-1.6620853714554447,0.015113350125944584,0.3454710389970619,1.0,7/14,14.18%,CSTF2;RTRAF;FAM98B;TSEN2;TSEN34;ZBTB8OS;RTCB
prerank,defense response to virus (GO:0051607),0.5329403309817828,1.661365288193689,0.0011655011655011655,0.19938421947760573,1.0,32/100,15.45%,PTPRC;IFNLR1;SAMHD1;LILRB1;OAS2;CD40;PLSCR1;MAP3K14;IFIT2;CXCL10;EIF2AK2;IRF2;STAT1;IFIH1;FLNA;OASL;DDIT4;RNASE1;TLR3;IL6;IRF7;SETD2;RNASE6;ACOD1;PQBP1;TLR2;NT5C3A;STAT2;IFIT1;MYD88;RELA;IFITM3
prerank,regulation of interleukin-6 production (GO:0032675),0.5429391270610707,1.6611437936903295,0.0011904761904761906,0.19834124214833126,1.0,19/96,8.62%,CD74;IL1B;CD47;PTPN22;PLCG2;SYK;STAT3;FOXJ1;MAPKAPK2;PTPN6;IL6R;IL33;RAB7B;IFIH1;TIRAP;IL17RA;AFAP1L2;TLR3;IL6
prerank,O-glycan processing (GO:0016266),0.5829745645463322,1.6589728668178338,0.0026560424966799467,0.20196035761437672,1.0,10/54,12.65%,ST3GAL1;ST3GAL4;MUC3B;MUC3A;GXYLT1;B4GALT5;GALNT2;GALNT10;GALNT5;XXYLT1
prerank,membrane depolarization during action potential (GO:0086010),-0.5464656070863663,-1.658498199347466,0.018867924528301886,0.3486834478391287,1.0,9/26,12.12%,CACNA1D;SLC8A1;SCN1A;KCNJ2;CACNA1C;SCN3A;ATP1A2;HCN2;SCN1B
prerank,positive regulation of chemokine production (GO:0032722),0.6033376570615433,1.6581635477964694,0.009485094850948509,0.20237564183274534,1.0,14/44,12.51%,CD74;IL1B;SYK;EIF2AK2;IL6R;IL33;TIRAP;IL17RA;ADAM17;TLR3;IL6;MBP;APP;TLR2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6896690473187506,1.6571910661783062,0.017054263565891473,0.203075262760281,1.0,9/18,9.94%,JAK2;STAT3;SPI1;CBL;IL6R;STAT1;IL6ST;IL6;SMAD4
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.7681738738239088,1.6563090543548784,0.03103448275862069,0.20343457211907362,1.0,2/12,1.13%,IL1B;PAEP
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.5138483780847831,1.6546599330546157,0.0021598272138228943,0.20557570727809474,1.0,44/163,13.34%,CARD11;GRAP2;VAV3;PTPRC;PTPN22;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;NFAM1;CD79B;MALT1;PSMB7;IKBKB;ZAP70;PSME2;NFKBIZ;THEMIS2;BCAR1;RC3H1;FBXW11;CD276;DENND1B;UBE2N;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PIK3CA;NFKBID;RNF31;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;ICOSLG;PSMB1;BTK;CSK
prerank,regulation of calcium-mediated signaling (GO:0050848),0.6540221652725939,1.6543947186198524,0.010294117647058823,0.2047896490361179,1.0,3/25,1.21%,ITPR1;LRRK2;PLCG2
prerank,lymphocyte migration (GO:0072676),0.6357193588750621,1.6541355213074564,0.008571428571428572,0.2038699635776301,1.0,5/32,5.36%,MYO1G;RET;MSN;ZAP70;CKLF
prerank,response to lipid (GO:0033993),0.5253614270525591,1.6539987239653513,0.00351288056206089,0.20268953899362357,1.0,20/105,8.17%,IL1B;FOXP1;RARA;PTPN22;PPARG;MAPKAPK3;JAK2;STAT3;CD36;RPS6KA3;ERBIN;MAPKAPK2;STAT5B;SLPI;PELI1;TIRAP;TRIM16;ADAM17;RARG;IFNAR1
prerank,tRNA modification (GO:0006400),-0.4479427430753127,-1.6515945047803802,0.005154639175257732,0.3630800321306516,1.0,45/62,36.77%,ALKBH8;NSUN2;TRMT1;ANKRD16;METTL6;DUS2;QTRT1;ELP5;TYW5;METTL2B;METTL2A;CDKAL1;METTL1;DTWD2;SSB;THUMPD1;OSGEP;THUMPD2;TRMT10A;WDR4;TRMT44;MTO1;TRMT6;TRMT12;TPRKB;NSUN6;LCMT2;TRMT112;GTPBP3;TRMT9B;TRMT5;BCDIN3D;DTWD1;PUS7;QTRT2;FTSJ1;ALKBH1;CTU2;AARS2;THG1L;TRMT61A;PUSL1;WDR6;CTU1;MOCS3
prerank,cellular response to interleukin-6 (GO:0071354),0.653937129082114,1.6503235271791126,0.0121580547112462,0.2087825030445486,1.0,13/26,10.00%,PID1;NFKB1;JAK2;STAT3;PTGIS;SPI1;CBL;IL6R;STAT1;IL6ST;IL6;SMAD4;SBNO2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5082046872013033,1.650277221164264,0.0,0.20748358087997845,1.0,60/153,16.12%,LRRK2;MAP4K1;SGK3;PRKCE;VRK1;CAMK1D;LMTK2;AKT3;MAPKAPK3;PKN1;ERN1;PRKCH;RPS6KA3;CSNK1G1;MAPKAPK2;STK38;IKBKB;VRK2;HIPK2;MAPK14;RPS6KA5;HIPK1;STK4;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;MAPK12;STK38L;CSNK1G3;TNKS;LATS1;PIKFYVE;CSNK2A2;CSNK2A1;TLK2;RIPK1;DMPK;NLK;LATS2;RPS6KA1;SMG1;MORC3;EIF2AK3;MAPK8;AKT1;PDK3;MARK3;STK39;ROCK1;TLK1;RPS6KA2;MAP3K13;BRSK1;MAPK1;TAF1;TBK1;DYRK2;RPS6KB1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.7555483869293597,1.6489731789933888,0.02152317880794702,0.2086667266222145,1.0,3/13,5.54%,CD74;TAF9;IFIH1
prerank,negative regulation of coagulation (GO:0050819),-0.6297681936032682,-1.6488099906933829,0.015424164524421594,0.36343345348462913,1.0,4/14,4.74%,APOE;HS3ST5;SERPINE2;CD34
prerank,second-messenger-mediated signaling (GO:0019932),0.5433921594032175,1.6473436984097996,0.0036319612590799033,0.21089832796837205,1.0,17/82,9.96%,CCR2;LRRK2;FPR1;PLCG2;XCR1;NDNF;CCR1;CD36;MCTP2;ACKR2;CCR9;PPP1R9B;CCRL2;PDPK1;GUCY1A1;HRH1;CAMKK2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6399289915073719,1.6443889918060035,0.015602836879432624,0.21582257065929478,1.0,8/28,11.18%,ITPR1;MAP3K5;ERN1;ATP2A3;BBC3;ATP2A1;PPP1R15A;AIFM1
prerank,negative regulation of secretion (GO:0051048),0.7839317440137885,1.643489361314208,0.01950354609929078,0.21617868939663,1.0,1/10,0.02%,CD74
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.5782115515964579,-1.6427121908875677,0.025787965616045846,0.3741755174423347,1.0,7/22,15.91%,MAN1C1;MAN1A2;DERL2;UBC;TRIM13;RNF103;RNF139
prerank,epithelial cell migration (GO:0010631),0.6004115724531983,1.6423098899641295,0.008379888268156424,0.2172408909974171,1.0,17/37,18.42%,DPP4;PKN1;ZEB2;ADGRA2;STAT1;FAP;PKN2;PLXND1;PXN;RHOA;PIK3CA;KIT;ROCK1;STARD13;KANK1;PKN3;PTP4A3
prerank,tight junction assembly (GO:0120192),0.5860000462197614,1.6417544439852754,0.01019108280254777,0.21710369820253272,1.0,13/49,15.92%,PECAM1;MARVELD3;FRMPD2;CLDN1;CLDN12;AFDN;PAK2;F11R;PDCD6IP;CLDN14;TBCD;OCLN;APC
prerank,B cell activation (GO:0042113),0.5578515322721191,1.6411200787037354,0.006150061500615006,0.21710988193267577,1.0,21/68,14.70%,ITGA4;PTPRC;FLT3;PLCG2;CD40;NFAM1;CD79B;RABL3;CHRNA4;MALT1;ZAP70;ADAM17;EPHB2;HDAC9;CTPS1;TPD52;SLC25A5;BTK;KIT;PTPRJ;GPS2
prerank,rRNA methylation (GO:0031167),-0.5645667763002792,-1.6410827694988952,0.019498607242339833,0.37030149554942204,1.0,13/22,29.05%,METTL15;ZCCHC4;DIMT1;NOP2;NSUN3;EMG1;FTSJ3;NSUN5;MRM1;TRMT112;MRM3;BUD23;FDXACB1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5227079687526128,1.6407149270188908,0.004651162790697674,0.21656604993822365,1.0,23/112,8.62%,CCR2;PTPRC;FOXP1;RARA;CD47;PTPN22;IFNGR1;PLCG2;LILRB1;OAS2;SYK;JAK2;STAT3;MAPKAPK2;PTPN6;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6
prerank,regulation of peptide hormone secretion (GO:0090276),0.5563929251763483,1.6406833394087514,0.0038412291933418692,0.21528581744663125,1.0,10/67,8.62%,DPP4;ITPR1;IL1B;RAP1A;CACNA1A;SLC8B1;RFX3;ADRA2A;CLOCK;IL6
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.6410836429454695,1.640185455286729,0.017167381974248927,0.21507618869180614,1.0,7/27,8.95%,CCR2;CD44;CYRIB;CD47;ITGB2;IL6;RHOA
prerank,negative regulation of B cell activation (GO:0050869),0.6769209520392778,1.6389746294739058,0.016200294550810016,0.21634968568255755,1.0,8/21,11.70%,LYN;FOXJ1;CD300A;LAPTM5;RC3H1;SAMSN1;ID2;FCGR2B
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.718414421435032,-1.6379905566972817,0.012195121951219513,0.3722259572164456,1.0,6/10,18.71%,HK3;HK1;PFKL;PFKP;GFPT1;PFKM
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5896112016885376,1.634906540196087,0.012875536480686695,0.2240092079954941,1.0,15/44,15.81%,IL1B;LYN;PTPN22;CD300A;RGS2;STK38;SORL1;PDCD4;PAQR3;PTPN1;DUSP1;RGS14;PTPRJ;GSTP1;IRAK3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7269699877252673,1.6344350729387929,0.025,0.2236560670011169,1.0,9/14,18.66%,DHX58;ANKRD17;OASL;PUM2;TLR3;USP15;TLR2;PUM1;ZDHHC5
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6919062559127569,1.6343738648261048,0.023622047244094488,0.22235308702248271,1.0,4/17,6.89%,MYO1G;BACH2;STAT3;GNL1
prerank,nucleotide catabolic process (GO:0009166),0.6984757221516071,1.630892634089401,0.025518341307814992,0.22838979094918363,1.0,6/16,14.74%,SAMHD1;GDA;GPX1;DERA;VCP;NT5C2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.6363385751521912,-1.6299110567374433,0.035443037974683546,0.39072946923118734,1.0,6/14,16.07%,CPEB2;CPEB1;CNBP;CPEB4;DHX9;CPEB3
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.5614700785931448,-1.6287033093744128,0.0160857908847185,0.3866464898192602,1.0,10/23,15.13%,PREB;DERL2;LMAN1;HSP90B1;AUP1;NPLOC4;TMED9;DERL1;SEC13;HERPUD1
prerank,bicellular tight junction assembly (GO:0070830),0.5867489724241493,1.6270992618891658,0.015523932729624839,0.2356658686818934,1.0,12/46,15.92%,PECAM1;MARVELD3;FRMPD2;CLDN1;AFDN;PAK2;F11R;PDCD6IP;CLDN14;TBCD;OCLN;APC
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6619251075568089,1.62682766055383,0.02909647779479326,0.23479698764526846,1.0,4/23,9.40%,CBFA2T3;SIK1;CRY1;GIT1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.7577317923959307,1.6249716714657951,0.027960526315789474,0.23748880631412705,1.0,4/11,5.41%,STAP1;CD177;SPI1;ITGB2
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.698090254236688,1.6226508017589165,0.023547880690737835,0.2412647452023239,1.0,7/18,8.62%,LYN;CAMK1D;SLC8B1;IL6R;PTK2B;ADAM17;IL6
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.6327272508836044,-1.6217285692485581,0.024096385542168676,0.4020820384094629,1.0,5/15,12.14%,LGMN;FGF2;P2RX4;VEGFA;PRKD1
prerank,hemidesmosome assembly (GO:0031581),-0.6943927575780899,-1.6210887931303495,0.014705882352941176,0.39618158905835865,1.0,2/11,0.87%,DST;ITGA6
prerank,negative regulation of cyclase activity (GO:0031280),0.7260115321657604,1.6210247230520396,0.017628205128205128,0.24331582674078708,1.0,1/14,0.04%,CCR2
prerank,ameboidal-type cell migration (GO:0001667),0.5740265599086548,1.6203004920362298,0.011764705882352941,0.24354305671990192,1.0,9/51,7.21%,ITGB7;ITGA4;SRGAP2;PKN1;SEMA4A;PDLIM1;GPC3;GDNF;PKN2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.7090616958053335,1.6194813830878845,0.03289473684210526,0.24408430074990417,1.0,4/15,5.48%,CD74;CD44;TAF9;PTTG1IP
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6846331129782534,1.6190823396475933,0.029173419773095625,0.2437212995863111,1.0,7/18,13.51%,PLCG2;DOCK2;SYK;DYSF;IFI35;SBNO2;FCER1G
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5631024985343037,-1.6171917614899223,0.03498542274052478,0.4019682038460438,1.0,9/21,21.23%,SLC8A1;CACNA1C;PRKACA;ANK2;ATP1A2;AKAP6;CALM1;GSTO1;RYR2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6629082005939215,1.6155192018468443,0.018867924528301886,0.25075859526286814,1.0,3/20,4.15%,GRK3;RGS2;CRY1
prerank,cellular response to interleukin-2 (GO:0071352),0.7711170321690828,1.6154175564318294,0.019642857142857142,0.24812319835656196,1.0,5/11,6.45%,STAT5A;SYK;STAT5B;IL2RG;PTK2B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.7711170321690828,1.6154175564318294,0.019642857142857142,0.24812319835656196,1.0,5/11,6.45%,STAT5A;SYK;STAT5B;IL2RG;PTK2B
prerank,cardiac muscle tissue development (GO:0048738),0.5719597318733083,1.6131441957902917,0.009067357512953367,0.25236506379655405,1.0,7/50,9.94%,NOTCH2;SIK1;GJA5;BMPR2;HCN4;SGCD;SMAD4
prerank,positive regulation of cell division (GO:0051781),0.5928090494445344,1.6130297000802756,0.018413597733711047,0.25125147765468764,1.0,10/38,9.33%,SVIL;CDC14A;PRKCE;RACGAP1;CUL3;KIF23;CDC42;PKN2;RHOA;SPAST
prerank,T cell migration (GO:0072678),0.73693270447458,1.612201732254677,0.01951219512195122,0.2517330286986565,1.0,5/13,6.24%,MYO1G;MSN;CXCL10;ZAP70;CXCL16
prerank,regulation of cellular respiration (GO:0043457),0.702062972990876,1.6121780024228705,0.024844720496894408,0.25037240593556936,1.0,7/17,14.19%,CBFA2T3;IFNLR1;NOA1;IFNAR1;PRELID1;PNPT1;VCP
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5764271830068843,1.6120354687717744,0.013679890560875513,0.2493110561459406,1.0,17/44,16.94%,ZC3HAV1;MEX3D;BTG2;RC3H1;GIGYF2;YTHDF3;ZFP36L2;EIF4ENIF1;METTL3;TNRC6B;ROCK1;PNPT1;TNRC6A;CELF1;PABPC1;PUM1;CNOT8
prerank,positive regulation of lymphocyte activation (GO:0051251),0.6311240183712863,1.6103885313761062,0.01167883211678832,0.2518496880003218,1.0,3/28,0.77%,CCR2;CYRIB;CD47
prerank,dendritic cell chemotaxis (GO:0002407),0.7203823153962242,1.6097430766932068,0.02823920265780731,0.2521575270498103,1.0,2/14,1.95%,CCR2;CCR1
prerank,keratan sulfate catabolic process (GO:0042340),-0.6780866903206116,-1.6096718480832186,0.01909307875894988,0.42014018767289923,1.0,3/11,3.81%,HEXB;GALNS;GNS
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7488943378879248,1.607762591520921,0.022530329289428077,0.25513974910335246,1.0,3/10,1.35%,PTPRC;KLRD1;LILRB1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.6258339728425883,1.6073203979009627,0.02654867256637168,0.2547181540452427,1.0,7/27,10.52%,PID1;IL1B;PIP4K2A;PTPRE;TNS2;PIP4K2B;PTPN1
prerank,neutrophil migration (GO:1990266),0.5607873460511594,1.6066951670009022,0.01507537688442211,0.2548482022331008,1.0,10/58,9.31%,JAML;PECAM1;SYK;CD177;CXCL10;CKLF;ITGB2;IRAK4;GBF1;PIKFYVE
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.6304610026275024,-1.606467951003416,0.028871391076115485,0.4234672549225097,1.0,4/15,12.14%,LGMN;FGF2;P2RX4;PRKD1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.5404055320036738,-1.6057076989532513,0.015822784810126583,0.417588971607162,1.0,8/28,11.52%,PRKN;APOE;TTC39B;PDK1;ARV1;PANK2;DGKQ;FMO5
prerank,regulation of phagocytosis (GO:0050764),0.5698958391497622,1.6051979762169397,0.013297872340425532,0.2568675891614626,1.0,12/53,5.37%,FGR;PTPRC;IL1B;HCK;CD47;DOCK2;CAMK1D;SYK;PLSCR1;DYSF;SCARB1;IL2RG
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7711273699263225,1.6049279703444606,0.02617801047120419,0.25616489376694124,1.0,5/10,3.80%,LYN;STAT5A;JAK2;STAT3;STAT5B
prerank,regulation of lymphocyte migration (GO:2000401),0.7584871098296732,1.6043754803145074,0.03350970017636684,0.2560772416064147,1.0,4/10,5.25%,STK10;MSN;SLC8B1;SPN
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.7314071041094999,1.6034552366464982,0.01639344262295082,0.25691808642360897,1.0,1/13,0.04%,CCR2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6587488065418425,1.6026495363812714,0.0188953488372093,0.2575127394760892,1.0,3/22,1.27%,CD44;IL1B;KLF4
prerank,regulation of B cell apoptotic process (GO:0002902),0.7366030105776714,1.600094318716987,0.026981450252951095,0.2618192744776292,1.0,3/12,1.98%,FOXP1;LYN;BCL6
prerank,regulation of plasminogen activation (GO:0010755),-0.6521533015416376,-1.599297414275983,0.01694915254237288,0.4326689738817935,1.0,5/12,12.11%,PLGRKT;SERPINE2;CTSZ;HPN;SERPINE1
prerank,positive regulation of cell killing (GO:0031343),0.7146264714594108,1.5989074382346224,0.03372681281618887,0.2631904531316629,1.0,7/13,18.68%,SYK;NOX1;RAC1;MAPK8;DVL2;CYBA;FZD7
prerank,positive regulation of viral life cycle (GO:1903902),0.6558045763846171,1.5988180906381797,0.030165912518853696,0.2619681727911196,1.0,3/22,6.48%,CD74;TSG101;LGALS1
prerank,neuron projection regeneration (GO:0031102),-0.6840709256085653,-1.5986989445892952,0.023148148148148147,0.4273097055065323,1.0,6/10,24.60%,RTN4RL1;PTN;NREP;MTR;OMG;DHFR
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.46517592055986756,-1.5980190861540708,0.0149812734082397,0.4221921455809566,1.0,11/39,11.94%,TGFBR2;LRP6;SALL1;NRP1;NPNT;FGF2;CTNNB1;PKD2;SEMA3E;SLIT2;VEGFA
prerank,protein hydroxylation (GO:0018126),-0.6241470403868997,-1.597969913708461,0.028720626631853787,0.41503602763514036,1.0,9/15,23.37%,ASPH;P3H2;P3H3;EGLN3;VPS33B;OGFOD1;PLOD3;VIPAS39;PLOD1
prerank,ceramide biosynthetic process (GO:0046513),0.577544506260828,1.5967415100055655,0.008547008547008548,0.2655544109287164,1.0,8/40,8.26%,CERS6;ST8SIA4;ST8SIA6;CERS1;SAMD8;SGMS1;SGMS2;ST6GALNAC3
prerank,T cell differentiation in thymus (GO:0033077),0.7230368791143954,1.5964043701206692,0.03779527559055118,0.264912866805868,1.0,4/14,8.58%,PTPRC;RABL3;ADAM17;ZFP36L2
prerank,positive regulation of vasculogenesis (GO:2001214),0.7631679236200106,1.595728693255528,0.02711864406779661,0.26509028196709966,1.0,3/10,3.14%,RIN2;RAP1A;RAPGEF2
prerank,endothelial cell development (GO:0001885),0.6449493511013448,1.5950493188208603,0.022970903522205207,0.265464110206238,1.0,7/25,9.15%,PECAM1;RAP1A;MSN;RAPGEF2;PDE2A;EZR;ICAM1
prerank,positive regulation of inflammatory response (GO:0050729),0.5222966932142242,1.5948812647045751,0.007237635705669481,0.264574941539214,1.0,18/86,12.51%,CCR2;IL1B;CD47;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;PDCD4;PDE2A;TLR3;IL6ST;IL6;IFI35;RIPK1;APP;TLR2
prerank,phosphorylation (GO:0016310),0.46633492524271275,1.594568167694051,0.0,0.26395139561880665,1.0,108/385,14.27%,GRK3;FGR;LRRK2;GRK5;RARA;STK10;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;LIMD1;DGKG;CERKL;SIK1;STK24;NADK;CDK13;VRK1;CREB1;DAPK1;FYN;RET;MAP3K5;LMTK2;AKT3;SYK;PIM1;PKN1;PAK1;STK17B;PRKAG2;JAK2;STAT3;ERN1;PRKCH;IP6K3;BMPR2;MAPKAPK2;BIRC6;STK38;EIF2AK2;BCR;IKBKB;ZAP70;VRK2;GMFG;TAOK3;SIK3;HIPK2;RPS6KA5;CDK14;MAP3K1;HIPK1;STK4;PTK2B;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;SIK2;COQ8A;EPHB2;ACVR2A;STK38L;MINK1;LATS1;OXSR1;CSNK2A1;BRAF;TLK2;CAMKK2;PPP4R1;GRK6;PIK3CA;YWHAZ;PRKG2;PRKAG1;DMPK;NLK;LATS2;MAP4K3;PRKAA1;APP;CCNT1;PIK3R4;CDK12;MORC3;MAP3K20;EIF2AK3;BTK;MAPK8;AKT1;PDK3;LIMK2;CSK;MARK3;TYK2;HCST;STK39;PRKAA2;ROCK1;TLK1;LMTK3;TGFB1;HASPIN
prerank,response to cholesterol (GO:0070723),-0.6018902379634486,-1.5944365008372767,0.014084507042253521,0.419320972914857,1.0,11/17,24.26%,TGFBR2;LRP6;TGFBR1;GRAMD1A;SMO;GPLD1;CCL3;PMVK;PTCH1;OSBPL7;MLC1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5209221732282316,1.5942059461221345,0.005980861244019139,0.26334916577238726,1.0,16/86,8.63%,CD74;CD44;PTPRC;PECAM1;PLCG2;FYN;JAK2;PTPN6;IL6R;ITGB2;PRNP;PTK2B;SAMSN1;PAK2;IL6;HGF
prerank,B cell receptor signaling pathway (GO:0050853),0.6120410774090802,1.5940992960120237,0.01881331403762663,0.2622300127168482,1.0,7/32,5.26%,VAV3;PTPRC;PLCG2;SYK;NFAM1;CD79B;BCAR1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6230714637336265,1.5933675511247156,0.029185867895545316,0.2626087965962593,1.0,7/25,8.44%,PPARG;ACE2;CBLB;CBL;TSG101;CNRIP1;EPHB2
prerank,modulation by host of viral genome replication (GO:0044827),-0.634766267053209,-1.5931636483856004,0.037037037037037035,0.41630878837895774,1.0,6/13,15.48%,PRKN;EIF2AK4;TBC1D20;IFI27;FBXL2;CCNK
prerank,positive regulation of JNK cascade (GO:0046330),0.5294407327523598,1.5931464042976544,0.01390644753476612,0.2618249883639922,1.0,25/70,18.68%,IL1B;TRAF1;MAP3K5;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;MBIP;MINK1;RIPK1;FCGR2B;APP;SH3RF1;NCF1;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7
prerank,regulation of protein targeting to membrane (GO:0090313),0.6191198798826598,1.591483206868968,0.023952095808383235,0.2644100647083165,1.0,8/28,10.60%,TCAF2;FYN;C2CD5;MYO1C;ITGB2;PRNP;CIB1;FIS1
prerank,regulation of interleukin-12 production (GO:0032655),0.5690794614769169,1.5912681111001983,0.017379679144385027,0.26355674937216494,1.0,11/47,8.53%,FOXP1;CD47;PLCG2;LILRB1;CD40;SYK;LAPTM5;MAPK14;TIRAP;PLCB1;TLR3
prerank,organophosphate catabolic process (GO:0046434),0.741575720422562,1.5908818579654112,0.030874785591766724,0.2632462508350064,1.0,1/11,0.01%,PLBD1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6385464852272943,1.5900647544754405,0.03194888178913738,0.26380907154468536,1.0,7/23,9.68%,IFNGR1;PPARG;JAK2;SUMO1;STAT1;PARP14;PARP9
prerank,regulation of inflammatory response (GO:0050727),0.48555291760908176,1.5897690447404889,0.0,0.26314912510407007,1.0,48/190,15.91%,CCR2;FFAR4;IL1B;FOXP1;HCK;CD47;KLF4;PPARG;METRNL;BCL6;ACE2;JAK2;PTGIS;AKNA;NFKBIA;PTGER4;SMPDL3B;NFKBIZ;IL33;BIRC3;IL17RA;ABCC1;PDCD4;PDE2A;SPATA2;TLR3;IL6;IFI35;SBNO2;ANXA1;CYLD;RIPK1;ACOD1;NLRP3;APP;TLR2;AREL1;ADAMTS12;TNFRSF1B;CASP12;IL18;GPS2;TNFAIP6;MYD88;XIAP;RELA;CELF1;PROC
prerank,regulation of T cell cytokine production (GO:0002724),0.7022112682864332,1.5892328887539682,0.038523274478330656,0.2631228130830927,1.0,5/15,13.54%,CCR2;MALT1;B2M;MAP3K7;TNFRSF1B
prerank,potassium ion export across plasma membrane (GO:0097623),0.7228465717060729,1.5886342064358094,0.034904013961605584,0.2632587711897191,1.0,2/13,3.31%,KCNE3;KCNQ1
prerank,organelle transport along microtubule (GO:0072384),0.6048866708457803,1.5884712242408923,0.020028612303290415,0.2624781432122368,1.0,10/31,12.06%,UXT;KIF5B;COPG2;CDC42;FBXW11;RAB6A;PAFAH1B1;PEX14;ARHGAP21;HTT
prerank,response to prostaglandin E (GO:0034695),0.7445282431414325,1.5871236584600603,0.031413612565445025,0.2644235699549571,1.0,4/10,13.33%,PTGER2;PTGER4;GNB1;GNG2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.6224716663256705,1.5869861634531672,0.029806259314456036,0.26351329210215574,1.0,11/27,15.13%,MAP3K5;MAP3K8;NFKB1;CCDC88C;IKBKB;KAT7;FBXW11;MAP3K7;MAP3K20;MAPK8;MAPK1
prerank,regulation of membrane depolarization (GO:0003254),0.6872584990232584,1.5866861448788643,0.020569620253164556,0.2628921197770968,1.0,4/18,3.90%,LRRK2;NEDD4L;GJA5;HCN4
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6752481072067169,1.5862799199386999,0.03215926493108729,0.26249083416746,1.0,7/17,12.11%,PTPN22;BCL3;KLF4;ANXA4;ANXA1;CACTIN;MAP2K5
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5007415669427998,1.585238923997296,0.0022650056625141564,0.2636773080130627,1.0,31/121,14.65%,CD74;CD44;PTPRC;NEDD9;LYN;FLT3;PECAM1;PLCG2;ACE;CD40;JAK2;STAT3;IL6R;PRNP;PTK2B;PARP14;PAK2;IL6ST;IL6;HGF;PARP9;IL31RA;PTPN1;UNC119;CASS4;KIT;HCLS1;TGFB1;FGFR3;PTPRJ;IL18
prerank,cellular response to cytokine stimulus (GO:0071345),0.4595935325875971,1.583315459272574,0.0,0.2670056444394888,1.0,104/416,14.69%,CCR2;GRAP2;PID1;IL1B;IFNLR1;HCK;STAT4;CD47;FPR1;FLT3;IL27RA;IFNGR1;DAPK1;FYN;ITGAX;CD40;MCL1;STAT5A;SYK;CCR1;BCL6;PIM1;NFKB1;JAK2;STAT3;VIM;FOS;CRK;CD36;PTGIS;ERBIN;SLA;IL10RA;CXCL10;RIPOR2;PTPN6;STAT5B;MMP1;PTPN7;CBL;IL6R;IKBKB;PTPN12;F13A1;STAT1;IL2RG;ITGB2;RC3H1;IRF4;IRAK4;CCND1;GRB2;ZFAND6;CSF2RB;NFE2L2;CIB1;PDE2A;IFNAR1;IL6ST;ZFP36L2;SOS1;IL6;HGF;RHOA;OPRM1;ICAM1;IL1R2;OXSR1;TANK;RPS3;SBNO2;FN1;ANXA1;IL31RA;PIK3CA;RIPK1;YWHAZ;CACTIN;FOXO3;DUSP1;ACOD1;TLR2;EBI3;LIFR;MAPK8;AKT1;KIT;STAT2;GBP5;CSK;ADAMTS12;JUNB;TNFRSF1B;HCLS1;TYK2;STK39;IFIT1;PNPT1;LRCH1;TGFB1;SYNCRIP;PTPRJ;IL18;GBP2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.6279103404718002,1.5830415507668032,0.03759398496240601,0.2664624039746874,1.0,8/24,10.60%,TCAF2;FYN;C2CD5;MYO1C;ITGB2;PRNP;CIB1;FIS1
prerank,melanosome localization (GO:0032400),-0.557591653694812,-1.5827666997537069,0.03273809523809524,0.445772317738019,1.0,9/21,17.70%,MLPH;BBS2;SHROOM2;MREG;MYO5A;ARL6;BLOC1S5;VPS33B;RAB11A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5307918698422994,1.5793662022885366,0.012376237623762377,0.2740635875714095,1.0,16/67,8.19%,NEDD9;DOCK5;NDNF;UTRN;JAK2;CRK;CD36;CDC42;CARMIL1;RSU1;PTK2B;PLEKHA2;FLNA;CIB1;S100A10;RAC1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6385284792553887,1.5789008980024515,0.025796661608497723,0.273861231462732,1.0,6/25,7.78%,ITGB7;ITGA4;ITGAX;ITGAD;ITGB2;CD2
prerank,regulation of vasculogenesis (GO:2001212),0.7003813355982166,1.5788902819677826,0.03194888178913738,0.27265145630731485,1.0,3/14,3.14%,RIN2;RAP1A;RAPGEF2
prerank,lymphocyte differentiation (GO:0030098),0.5357833609456977,1.5785974157618985,0.0050062578222778474,0.2721329777625942,1.0,20/68,14.70%,ITGA4;PTPRC;FLT3;PTPN22;PLCG2;NFAM1;CD79B;RABL3;LFNG;ZAP70;KAT7;ADAM17;HDAC9;PBX1;TPD52;SLC25A5;KIT;NFIL3;PTPRJ;GPS2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6985342084558338,1.5782045786741417,0.031825795644891124,0.27179858745862756,1.0,3/14,1.94%,CCR2;PTPN22;SYK
prerank,regulation of establishment of cell polarity (GO:2000114),0.6879551269619062,1.5774462416918775,0.030349013657056147,0.2723065734517724,1.0,10/16,19.13%,CYRIB;SHTN1;RIPOR2;PTK2B;BCAS3;ARFGEF1;ROCK1;KANK1;KRIT1;KIF20B
prerank,tRNA processing (GO:0008033),-0.4248798242156413,-1.5770847910747159,0.009523809523809525,0.4585307149859015,1.0,43/61,36.26%,NSUN2;TRMT1;ANKRD16;TRNT1;CSTF2;POP1;QTRT1;ELP5;TYW5;RTRAF;FAM98B;RPP30;TSEN2;CDKAL1;METTL1;DTWD2;PTCD1;TSEN34;ZBTB8OS;SSB;THUMPD1;RTCB;KARS1;TRMT10A;WDR4;TRMT6;NSUN6;LCMT2;ELAC2;TRMT9B;DTWD1;RPP40;QTRT2;FTSJ1;POP5;CTU2;AARS2;TSEN54;RPP21;POP7;THG1L;TRMT61A;CTU1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.6764237633150227,1.5760280677424918,0.0176,0.27431674998037425,1.0,7/18,13.40%,CCR2;IKZF3;CD2;ZFP36L2;SLAMF8;PRELID1;METTL3
prerank,positive regulation of T cell migration (GO:2000406),0.6503407305205352,1.5757572147869259,0.04643962848297214,0.2737337230716441,1.0,8/20,13.74%,CCR2;CXCL10;SPN;ADAM17;RHOA;OXSR1;APP;STK39
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6475487460676691,-1.5754734509012258,0.03218390804597701,0.45665802739584854,1.0,4/12,7.60%,BIN1;CTNNA3;CACNA1C;JUP
prerank,regulation of multicellular organismal development (GO:2000026),0.6344865918234898,1.57524302901916,0.03167420814479638,0.2737549819576514,1.0,7/25,10.70%,SPAAR;OAS2;RACGAP1;NIPBL;SCX;DUSP6;TDG
prerank,response to organic cyclic compound (GO:0014070),0.5434647810694025,1.5745553755248611,0.026785714285714284,0.274271634513389,1.0,12/52,14.65%,LRRK2;HLCS;IL1B;KYNU;STAT3;STAT5B;TIPARP;TLR3;ANXA1;STRN3;TGFB1;IL18
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.5165955802032368,1.5743332525819693,0.007159904534606206,0.2736746797552251,1.0,20/87,8.95%,RND3;IQGAP2;IQGAP1;NOTCH2;EPS8;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;DLC1;ARHGDIB;PTK2B;F11R;RHOBTB3;EZR;RAC1;RHOA
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6873773125788916,1.5740224975278163,0.0492845786963434,0.27310035027744733,1.0,7/14,10.52%,LYN;STAT5A;JAK2;STAT3;STAT5B;PXN;PTPN1
prerank,ganglion development (GO:0061548),-0.6584091252235356,-1.5739894218913248,0.0332541567695962,0.4543181223289684,1.0,4/11,12.10%,NRP1;NRP2;CTNNB1;TUBB3
prerank,phospholipid catabolic process (GO:0009395),0.6254328863446881,1.5734324247923746,0.029282576866764276,0.2734139947470636,1.0,4/24,5.58%,PLBD1;PRDX6;SMPDL3A;GPCPD1
prerank,regulation of cell communication (GO:0010646),0.5945258249178738,1.5732569714239268,0.031335149863760216,0.27265617894508937,1.0,9/35,10.52%,GRK3;GRK5;CRK;GJA5;CDC42SE2;MTCH1;GRK6;ANXA1;PTPN1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5676935919267563,1.5726819973760096,0.02099737532808399,0.27287463416418045,1.0,13/46,12.96%,ITGB7;ITGA4;ATRNL1;SRGAP2;NTNG2;LAMB1;RAC1;PXN;RHOA;FN1;MEGF9;ITGA8;USH2A
prerank,B cell differentiation (GO:0030183),0.5674204481766149,1.572678186030499,0.015810276679841896,0.27170272265314055,1.0,14/46,14.70%,ITGA4;PTPRC;FLT3;PLCG2;NFAM1;CD79B;RABL3;ADAM17;HDAC9;TPD52;SLC25A5;KIT;PTPRJ;GPS2
prerank,lipid catabolic process (GO:0016042),0.6650654281355883,1.5724621377827561,0.03767660910518053,0.27108111844078814,1.0,3/18,5.82%,PLA1A;HSD17B14;CEL
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.7427114063662703,1.5716646055267807,0.036585365853658534,0.27179485003931037,1.0,2/10,5.83%,DPP4;FAP
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.5578336146293678,-1.5712423993923683,0.03374233128834356,0.45681887507948554,1.0,15/18,37.12%,POLD3;PCNA;LIG3;GINS1;POLA1;RFC3;LIG1;GINS3;POLE;POLE3;RFC4;MCM4;GINS4;GINS2;POLD2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6351003125285889,1.57100179495975,0.04354587869362364,0.27220726710420645,1.0,4/20,5.23%,PRKCE;TCAF2;NEDD4L;ADRA2A
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5927519227435982,1.570074801016337,0.03524229074889868,0.27335116211987764,1.0,11/33,15.63%,GLI1;PLCG2;PSME3;PTPN6;FBXW7;PSME2;PTEN;ID2;EZH2;TAF1;INO80
prerank,endothelial cell migration (GO:0043542),0.5762260676093752,1.5700565583337267,0.024793388429752067,0.27224378506296776,1.0,9/37,10.65%,DPP4;MYH9;ADGRA2;STAT1;FAP;PLXND1;PXN;RHOA;PIK3CA
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.658072421525375,1.569857154716258,0.046251993620414676,0.27160797907344875,1.0,4/18,5.25%,ITGB7;ITGA4;SELL;SPN
prerank,epithelial tube morphogenesis (GO:0060562),-0.4868055718951274,-1.5676826986138008,0.029304029304029304,0.46265801269020207,1.0,8/32,9.40%,CSF1R;MEF2C;CTNNB1;PKD2;RHOB;ACVR1;SCRIB;SLIT2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.7255160601084991,1.567032859351929,0.043327556325823226,0.27713597878405455,1.0,1/11,0.08%,GRK3
prerank,positive regulation of acute inflammatory response (GO:0002675),0.690737515081457,1.565964746435304,0.03547297297297297,0.27866977681206817,1.0,4/14,10.38%,IL1B;IL6ST;IL6;PTGER3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6754635572842459,1.5658059401253077,0.034055727554179564,0.27789595290443503,1.0,12/18,22.67%,CYRIB;SHTN1;RIPOR2;PTK2B;BCAS3;ARFGEF1;ROCK1;KANK1;KRIT1;KIF20B;LLGL2;RAP1B
prerank,cardiac muscle cell action potential (GO:0086001),-0.5032624140971876,-1.5645297961223388,0.020134228187919462,0.46737932339385185,1.0,11/30,12.12%,CACNA1D;SLC8A1;CACNA2D1;SCN1A;KCNJ2;CACNA1C;ATP1B1;ANK2;ATP1A2;HCN2;SCN1B
prerank,vitamin D metabolic process (GO:0042359),-0.6265175471564338,-1.5638856867044806,0.03684210526315789,0.4628002317109871,1.0,1/13,0.16%,LGMN
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6021423326990989,1.5638814404485446,0.029045643153526972,0.2808638184748484,1.0,8/30,6.95%,LYN;NOTCH2;RASGRP4;NGF;JAK2;ERBIN;GRB2;SHOC2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6251414814843328,1.5637622878192683,0.02608695652173913,0.2800098361215232,1.0,5/26,4.76%,ITPR1;PTPRC;PLCG2;SLC8B1;IBTK
prerank,positive regulation of T cell proliferation (GO:0042102),0.5402717921126178,1.5633778463277603,0.018276762402088774,0.2797274919055499,1.0,12/55,12.82%,CCR2;PTPRC;IL1B;IL27RA;SYK;CD276;IL6ST;IL6;RPS3;ANXA1;EBI3;ICOSLG
prerank,positive regulation of T cell activation (GO:0050870),0.5373101170403094,1.5631538162050542,0.020330368487928845,0.27913998954512476,1.0,9/62,8.62%,CCR2;PTPRC;IL1B;CYRIB;CD47;ZAP70;CD276;IL6ST;IL6
prerank,leukocyte tethering or rolling (GO:0050901),0.6602743736855907,1.5626978136327632,0.04487179487179487,0.2789924086230625,1.0,4/17,5.25%,ITGB7;ITGA4;SELL;SPN
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5832558959630837,1.5619693652565219,0.0318118948824343,0.27963253307759284,1.0,8/36,8.44%,CCR2;JAK2;NCOA3;FBXW7;ADRA2A;ADAM17;BUD31;EPHB2
prerank,regulation of response to biotic stimulus (GO:0002831),0.6083152219854506,1.5619338879582794,0.03003003003003003,0.27860889485420004,1.0,9/28,7.46%,FGR;FOXP1;PTPN22;SAMHD1;CD36;DHX58;BIRC3;TIRAP;TRAF3
prerank,membrane protein proteolysis (GO:0033619),0.5772480241419256,1.5613035060661054,0.017379679144385027,0.278891146634831,1.0,14/37,15.29%,NAPSA;NGFR;RET;NFKB1;MYH9;PARL;ADAM17;SPPL2A;ADAM19;MBTPS1;BACE2;TGFB1;ADAM9;RELA
prerank,negative regulation of viral process (GO:0048525),0.5315281641745189,1.5611520857999879,0.02681992337164751,0.2780491432027003,1.0,15/57,10.78%,ZC3HAV1;OAS2;PTX3;PLSCR1;TRIM26;EIF2AK2;SLPI;FAM111A;TRIM62;STAT1;IFIH1;HEXIM1;OASL;MBL2;TRIM14
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5664360347203068,1.5605630399852182,0.023319615912208505,0.2781378819616048,1.0,9/43,10.52%,PID1;IL1B;PIP4K2A;PTPRE;SORL1;TNS2;SIK2;PIP4K2B;PTPN1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.51740247152802,-1.5602179828829037,0.02881844380403458,0.46883078046829707,1.0,7/24,6.21%,TGFBR2;NRP1;ROBO2;NRP2;ROBO1;ACVR1;FGFR2
prerank,regulation of T cell chemotaxis (GO:0010819),0.7315203176367406,1.5593004411305407,0.0391156462585034,0.2798660562161599,1.0,4/11,9.52%,CCR2;CXCL10;ADAM17;OXSR1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.7542432744406133,1.5591791821148369,0.04477611940298507,0.27901059540339845,1.0,2/10,0.33%,PID1;IL1B
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6031363013962739,-1.5559747250670617,0.039473684210526314,0.47779157049811316,1.0,8/15,22.60%,RAB3GAP2;ZFAND2A;SPCS3;RAB3GAP1;SEC61G;SRPRB;RYR2;ZFAND2B
prerank,establishment of melanosome localization (GO:0032401),-0.5527957928383318,-1.5556049166627317,0.03089887640449438,0.4724838283937898,1.0,8/19,17.70%,MLPH;BBS2;SHROOM2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A
prerank,positive regulation of defense response (GO:0031349),0.5053802434102962,1.5555633868356362,0.00954653937947494,0.2865282278438145,1.0,20/89,13.31%,CCR2;IL1B;CD47;POLR3F;PLSCR1;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;PDCD4;PDE2A;TLR3;IFI35;SLC15A4;RIPK1;APP;TLR2;GBP5
prerank,NAD biosynthetic process (GO:0009435),0.6340058751594905,1.5553458047780147,0.0464,0.28586713074932363,1.0,6/20,12.37%,KYNU;PTGIS;HAAO;NAXE;PARP9;NMNAT3
prerank,negative regulation of biosynthetic process (GO:0009890),0.6846712565640407,1.5552044069824635,0.03164556962025317,0.2850253553003341,1.0,2/16,3.48%,CIITA;ABCB7
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.5535269979572441,-1.554621871396481,0.036011080332409975,0.4693061082155911,1.0,7/19,10.47%,CUX1;PTPRD;IL1RAPL1;FBXW8;CDKL3;CAPRIN2;SS18L1
prerank,transport along microtubule (GO:0010970),0.7090583212807245,1.5543304126528816,0.032148900169204735,0.2859950511239872,1.0,9/13,17.87%,APBA1;COPG2;CDC42;ARHGAP21;APP;CLIP3;DYNC1I2;BAG3;BORCS5
prerank,protein phosphorylation (GO:0006468),0.451510582300388,1.5543091965735165,0.0,0.2849249603678063,1.0,129/479,14.27%,GRK3;FGR;LRRK2;GRK5;RARA;STK10;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;FLT3;SIK1;STK24;CDK13;VRK1;CREB1;DAPK1;FYN;SLK;CAMK1D;RET;MAP3K5;LMTK2;AKT3;MAPKAPK3;SYK;PIM1;PKN1;PAK1;STK17B;PRKAG2;JAK2;ERN1;PRKCH;RPS6KA3;IP6K3;BMPR2;CSNK1G1;MAPKAPK2;BIRC6;STK38;PTPN6;ABI1;EIF2AK2;EIF2AK1;CRY1;BCR;IKBKB;ZAP70;VRK2;GMFG;TAOK3;SIK3;HIPK2;MAPK14;RPS6KA5;CDK14;MAP3K1;HIPK1;STK4;PTK2B;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;MAPK12;CCNH;SIK2;COQ8A;EPHB2;ACVR2A;TLR3;STK38L;MINK1;CSNK1G3;TNKS;LATS1;USP15;OXSR1;CSNK2A2;CSNK2A1;BRAF;TLK2;CAMKK2;PPP4R1;GRK6;RIPK1;YWHAZ;PRKG2;PRKAG1;DMPK;NLK;LATS2;MAP4K3;PRKAA1;CAD;RPS6KA1;APP;CCNT1;MAP3K7;PIK3R4;SMG1;TLR2;CDK12;MORC3;MAP3K20;EIF2AK3;BTK;MAPK8;AKT1;PDK3;KIT;LIMK2;CSK;MARK3;TYK2;HCST;STK39;PRKAA2;ROCK1;TLK1;LMTK3;RPS6KA2;TGFB1;HASPIN;FGFR3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.6633820376512298,1.5540466109821935,0.047021943573667714,0.28446395404086217,1.0,4/17,7.20%,CD74;CD44;PTTG1IP;DYRK1A
prerank,peptidyl-serine modification (GO:0018209),0.47477862834866613,1.5534134183476453,0.0022222222222222222,0.28474224228322326,1.0,60/166,16.42%,LRRK2;MAP4K1;SGK3;PRKCE;VRK1;CAMK1D;LMTK2;AKT3;NDNF;MAPKAPK3;PKN1;PRKCH;RPS6KA3;CSNK1G1;MAPKAPK2;STK38;IKBKB;VRK2;HIPK2;MAPK14;RPS6KA5;HIPK1;STK4;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;MAPK12;GALNT2;STK38L;CSNK1G3;TNKS;LATS1;CSNK2A2;CSNK2A1;TLK2;DMPK;LATS2;RPS6KA1;SMG1;MORC3;EIF2AK3;MAPK8;AKT1;PDK3;MARK3;STK39;ROCK1;TLK1;RPS6KA2;MAP3K13;BRSK1;MAPK1;TAF1;TBK1;POGLUT1;DYRK2;RPS6KB1;NTMT1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5570527800736508,1.5530913050562118,0.023936170212765957,0.2845588930832884,1.0,20/50,16.05%,CD44;NGF;KLF4;NGFR;GPX1;RPS6KA3;DPEP1;PAK2;CARD16;HGF;CSNK2A1;RPS6KA1;MAP2K5;SH3RF1;AKT1;DHCR24;CAAP1;XIAP;THBS1;USP47
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5973568698727282,1.552703402923916,0.029197080291970802,0.2843239805549522,1.0,8/31,8.53%,PLCG2;CD40;SYK;LAPTM5;MAPK14;TIRAP;PLCB1;TLR3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5921138039774844,1.5520422292413938,0.0453257790368272,0.2848332849651478,1.0,4/30,7.20%,CD74;CD44;PTTG1IP;DYRK1A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5252002041181172,1.550454014534954,0.018820577164366373,0.2875237962241493,1.0,29/67,17.79%,VAV3;CYBB;FYN;MAPKAPK3;WASF2;CRK;MAPKAPK2;ABI1;CDC42;VEGFC;BCAR1;ELMO2;MAPK14;PTK2B;PAK2;RAC1;PXN;RHOA;PGF;NCF2;PIK3CA;NCF1;ROCK1;CYFIP2;ELMO1;SHB;PIK3R2;SH2D2A;CYBA
prerank,phosphatidylinositol metabolic process (GO:0046488),0.49770736077819794,1.5497445257441982,0.006920415224913495,0.2881144282916528,1.0,26/109,13.09%,PLBD1;PLCG2;PIP4K2A;PIK3C2A;IP6K3;MTMR14;OCRL;INPP5F;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;ARF1;PLCB1;MTMR4;SYNJ1;PITPNM1;PIKFYVE;PIP4K2B;PIK3CA;CDIPT;PIK3R4;PIP5K1A
prerank,signal release from synapse (GO:0099643),-0.4480301398730802,-1.5486620789906818,0.0234375,0.48454058349704,1.0,19/43,23.46%,SYT1;PTPRN2;PCLO;NRXN2;SNAP25;GAD2;CDK5;SNPH;STX1A;LIN7A;CPLX1;RIMS1;RAB3A;NRXN1;GAD1;SYN2;PDZD11;SLC32A1;CPLX2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.6289613341504914,-1.5484829342358803,0.034653465346534656,0.4787643382847682,1.0,7/12,32.31%,AHCYL1;SCN1B;PKP2;SCN3B;WNK3;SCN4B;NOS1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.7072344937959412,1.548367654424393,0.04504504504504504,0.29012029369968734,1.0,3/13,8.63%,LRRK2;NFE2L2;HGF
prerank,cellular lipid catabolic process (GO:0044242),0.6048502504727747,1.547915939161258,0.022026431718061675,0.28999887887969505,1.0,4/27,5.82%,PLBD1;SMPDL3B;NUDT19;CEL
prerank,regulation of T cell activation (GO:0050863),0.5656514644835444,1.5460012453366674,0.02361111111111111,0.2931884127696363,1.0,5/42,3.22%,CCR2;CYRIB;CD47;PTPN22;LAPTM5
prerank,phosphate-containing compound metabolic process (GO:0006796),0.46967976737028583,1.5455707956292295,0.0010893246187363835,0.29306754888413783,1.0,29/198,8.66%,PLBD1;LGALS13;LRRK2;PTPRC;LIMD1;CERKL;NADK;PLCG2;ITPKC;DUSP16;PIP4K2A;PAK1;STAT3;GPD2;IP6K3;PLD4;OCRL;ITPK1;PPP3CA;PTEN;INPP4A;IMPA1;PAK2;PXYLP1;PLCB1;PLCD4;COQ8A;EPHB2;SYNJ1
prerank,blood circulation (GO:0008015),0.5523144957389221,1.5454854865998007,0.021220159151193633,0.292198701120022,1.0,10/49,9.30%,ACE;TBC1D8;ACE2;GPX1;CXCL10;HCN4;OLR1;STAT1;SGCD;GUCY1A1
prerank,negative regulation of cellular component movement (GO:0051271),0.6800295057535385,1.5451940884631885,0.04974271012006861,0.29182270374231906,1.0,3/15,2.67%,SP100;CCDC125;CRK
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6887964773895972,1.5449989229105539,0.05555555555555555,0.29116524031214147,1.0,4/14,9.52%,CCR2;PTK2B;ADAM17;OXSR1
prerank,camera-type eye development (GO:0043010),-0.5149139020702163,-1.5441758053747925,0.027190332326283987,0.4879061509064386,1.0,11/25,24.99%,SKI;CACNA1C;NF1;RAB3GAP1;SHROOM2;VEGFA;EFEMP1;CEP290;CRYBA4;NES;FBN2
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6346852465343914,1.5436825394092917,0.03225806451612903,0.29310486750230175,1.0,8/22,15.06%,IL1B;CREB1;PPARG;ZBTB20;CREBL2;AKT1;SIRT4;ANGPTL3
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6688418644177485,-1.5432848381382136,0.03218390804597701,0.48449151406761354,1.0,4/10,7.25%,PLA2G15;ENPP2;PNPLA8;PLA2G4A
prerank,response to lipopolysaccharide (GO:0032496),0.47733537074167603,1.542872958801044,0.007927519818799546,0.29393788643529,1.0,39/138,15.81%,IL1B;FOXP1;TNIP3;PTPN22;STAP1;LILRB1;MAPKAPK3;NFKB1;JAK2;VIM;RPS6KA3;ERBIN;MAPKAPK2;CXCL10;SLPI;SCARB1;PELI1;MAPK14;TIRAP;ADAM17;PDCD4;CARD16;IFNAR1;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;NLRP3;MAPK8;TNFRSF1B;ADAM9;GSTP1;MYD88;RELA;SRR;IRAK3
prerank,regulation of cell-cell adhesion (GO:0022407),0.5695402588770739,1.5427927751380748,0.021505376344086023,0.2930492329578762,1.0,10/39,14.75%,DPP4;CD47;FUT4;AFDN;MINK1;MEGF10;NF2;CITED2;TGFB1;PTPRG
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5827042580493157,1.5422723701077075,0.02936857562408223,0.2931545914288702,1.0,4/33,1.94%,DPP4;LYN;RET;SYK
prerank,regulation of cell size (GO:0008361),0.6277946975365811,1.539281435671234,0.05239520958083832,0.2989485398338584,1.0,9/23,8.95%,VAV3;RAP1GAP2;MSN;PTEN;MTPN;RARG;EZR;RAC1;RHOA
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.7460433092347406,1.53892400538924,0.04576271186440678,0.2987181701722056,1.0,2/10,1.27%,PTPRC;KLF4
prerank,cellular response to interleukin-15 (GO:0071350),0.7012323356302513,1.5386487660805064,0.05110732538330494,0.297295982828793,1.0,6/13,7.50%,STAT5A;STAT3;STAT5B;IL2RG;GRB2;PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.7012323356302513,1.5386487660805064,0.05110732538330494,0.297295982828793,1.0,6/13,7.50%,STAT5A;STAT3;STAT5B;IL2RG;GRB2;PLCB1
prerank,neurotransmitter uptake (GO:0001504),-0.6262486373833431,-1.5385376497656404,0.04128440366972477,0.4954931455529013,1.0,5/12,11.89%,GLUL;SLC1A3;SNAP25;ATP1A2;SLC29A1
prerank,natural killer cell mediated immunity (GO:0002228),0.6785037469849011,1.5379537407325343,0.03785488958990536,0.2979169717688849,1.0,4/15,4.56%,SLAMF7;KLRD1;KIF5B;KLRK1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.7402206463102193,1.537579724520395,0.0535405872193437,0.29767243921749453,1.0,1/10,0.03%,DPP4
prerank,cellular response to type I interferon (GO:0071357),0.5568749367021383,1.5360151903247796,0.0364656381486676,0.2994535585288327,1.0,20/41,16.77%,SP100;SAMHD1;OAS2;IFIT2;IRF2;STAT1;IRF4;OASL;IFNAR1;IFI35;IRF7;PSMB8;STAT2;TYK2;IFIT1;GBP2;MYD88;IFITM3;IRF5;IFNAR2
prerank,type I interferon signaling pathway (GO:0060337),0.5568749367021383,1.5360151903247796,0.0364656381486676,0.2994535585288327,1.0,20/41,16.77%,SP100;SAMHD1;OAS2;IFIT2;IRF2;STAT1;IRF4;OASL;IFNAR1;IFI35;IRF7;PSMB8;STAT2;TYK2;IFIT1;GBP2;MYD88;IFITM3;IRF5;IFNAR2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5813429932797378,1.5353808852392026,0.04081632653061224,0.29992610624656757,1.0,13/32,17.71%,KLF4;AKT3;PIK3C2A;CIB1;HDAC9;RHOA;ANXA1;MAP2K5;THBS1;STARD13;MAP3K3;JCAD;HDAC7
prerank,phagolysosome assembly (GO:0001845),0.710564836292661,1.5352580345205697,0.044189852700491,0.2991338684856244,1.0,7/12,13.26%,CORO1A;RAB7A;RAB7B;RAB39A;RAB34;PIKFYVE;ARL8B
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6604090367300139,1.5345332087304229,0.051515151515151514,0.29966985419312714,1.0,5/17,11.90%,LYN;EIF2AK2;TAOK3;RNF13;KLHDC10
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5828595764791071,1.5343222008409783,0.034934497816593885,0.2990939418049411,1.0,12/33,15.29%,KLF4;NGFR;PPARG;STAT3;FOS;SPI1;KLF5;NR3C1;FOXO3;TEAD1;TGFB1;RELA
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5802934536445563,-1.534263755622817,0.04032258064516129,0.5039250862553559,1.0,8/16,21.23%,SLC8A1;CACNA1C;PRKACA;ANK2;ATP1A2;CALM1;GSTO1;RYR2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5784731263515149,1.5338570419174002,0.03824362606232295,0.29910162275125846,1.0,6/34,11.17%,PTPRC;PTPN22;LAPTM5;EPHB2;IL6;GPI
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5527448322222739,-1.5338038673186352,0.03869047619047619,0.4995338915422446,1.0,6/18,6.91%,NAPA;GRIA2;SLC17A6;GRID2;GRIK4;GRIK1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5173327273687105,-1.5332637186417162,0.03323262839879154,0.4951122796398902,1.0,8/24,9.66%,PLA2G15;LPCAT1;PNPLA8;SLC27A1;PLA2G4A;CDS2;SERAC1;GPAM
prerank,positive regulation of lipid transport (GO:0032370),-0.6275870058168057,-1.5327233023686484,0.04245283018867924,0.4910893636374935,1.0,4/12,3.75%,APOE;LRP1;SPP1;ABCB4
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.576736225778139,1.5308965458371107,0.03744798890429958,0.30488534206674406,1.0,11/34,15.84%,PTPN22;DUSP16;PTPRO;PTPN6;PTPN12;TNS2;DUSP6;PTPN1;DUSP1;PTPRJ;DUSP22
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5590969153397396,1.5307100407299332,0.02807486631016043,0.304208886708162,1.0,12/40,9.55%,XPO1;RPL5;LAPTM5;FBXW7;AXIN1;HIPK2;GLMN;PTEN;PTK2B;LATS1;CSNK2A2;CSNK2A1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4968953911623601,1.5301869403145634,0.014336917562724014,0.3043890579764722,1.0,31/93,18.68%,IL1B;TRAF1;MAP3K5;SPI1;EIF2AK2;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;MBIP;MINK1;MAP3K4;RELL1;RIPK1;FCGR2B;KLHDC10;APP;EMC10;SH3RF1;NCF1;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6579888915195715,-1.5292870604729007,0.046460176991150445,0.4970374245943047,1.0,4/10,12.62%,PDE3B;WNK1;SERPINE1;JAM3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6954610167374538,1.529170531840689,0.04961240310077519,0.3057113895016208,1.0,3/14,7.18%,ITGA4;CD40;PDCD4
prerank,cellular response to mechanical stimulus (GO:0071260),0.546687312793575,1.5283619719402626,0.029649595687331536,0.3067280507542929,1.0,12/46,10.49%,IL1B;CD40;CNN2;NFKB1;MAP3K14;PTGER4;MAP3K1;PDE2A;F11R;TLR3;PIEZO1;CASP2
prerank,peptidyl-tyrosine modification (GO:0018212),0.5282204672434518,1.528339166155761,0.026490066225165563,0.30575885205906317,1.0,21/56,17.11%,FGR;HCK;LYN;FLT3;FYN;SYK;JAK2;PTPN6;ABI1;ZAP70;PTK2B;DYRK1A;EPHB2;TPST1;BTK;KIT;FGFR3;INSR;RELN;FES;ABL2
prerank,neurotransmitter secretion (GO:0007269),-0.44214034903712424,-1.5280876997106996,0.032388663967611336,0.49491864493127397,1.0,19/44,23.46%,SYT1;PTPRN2;PCLO;NRXN2;SNAP25;GAD2;CDK5;SNPH;STX1A;LIN7A;CPLX1;RIMS1;RAB3A;NRXN1;GAD1;SYN2;PDZD11;SLC32A1;CPLX2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5911239303932344,1.5280113133653057,0.04252199413489736,0.30556636291134803,1.0,7/28,10.52%,PID1;IL1B;PIP4K2A;PTPRE;TNS2;PIP4K2B;PTPN1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6063712763636662,1.527607250368572,0.041728763040238454,0.30548196202487593,1.0,9/22,14.70%,PTPN22;CD300A;LAPTM5;PRNP;EZR;FCGR2B;LGALS3;PTPRJ;GPS2
prerank,B cell proliferation (GO:0042100),0.6690842698382866,1.5276051005211884,0.03622047244094488,0.30446350687447654,1.0,3/17,2.31%,PTPRC;CD40;GAPT
prerank,mucosal immune response (GO:0002385),0.6814465743735586,1.5272035021727028,0.04146730462519936,0.3043767291672819,1.0,1/15,0.53%,IFNLR1
prerank,Notch signaling involved in heart development (GO:0061314),0.700668728487316,1.527019960802672,0.05555555555555555,0.3037916442979939,1.0,2/11,5.11%,NOTCH2;RBPJ
prerank,dopamine metabolic process (GO:0042417),-0.5531953440821017,-1.5266727780508773,0.05013192612137203,0.49345722607005144,1.0,3/18,1.79%,PRKN;SNCAIP;COMT
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.40146086698055794,-1.5258601383790762,0.014354066985645933,0.4903388322475301,1.0,18/69,10.59%,PRKN;LGMN;APOE;CX3CR1;MEF2C;NTRK2;GRN;RASA1;PPARGC1A;HIF1A;ADAM8;NRBP2;KDM2B;SNX6;CPEB4;PTPRZ1;MSH2;SET
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6559602370227516,1.5255945154899007,0.05379746835443038,0.3062069881609475,1.0,6/16,13.54%,PTPN22;LST1;AHR;IKZF3;LGALS3;TNFRSF1B
prerank,muscle filament sliding (GO:0030049),0.5672555234272006,1.525530101178554,0.04103967168262654,0.30431993776952254,1.0,4/38,3.70%,TNNC1;TPM4;VIM;MYL4
prerank,actin-myosin filament sliding (GO:0033275),0.5672555234272006,1.525530101178554,0.04103967168262654,0.30431993776952254,1.0,4/38,3.70%,TNNC1;TPM4;VIM;MYL4
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4849220630973825,1.522713684866336,0.011876484560570071,0.30988860461864787,1.0,30/101,15.29%,IL1B;HCK;LYN;PRKCE;TNIP3;PTPN22;STAP1;LILRB1;NFKB1;VIM;CXCL10;MAPK14;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;NLRP3;MAPK8;TNFRSF1B;TGFB1;IL18;ADAM9;GSTP1;MYD88;RELA
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6705464383431111,1.5225222159271614,0.050156739811912224,0.30936003391642103,1.0,2/17,0.25%,CBFA2T3;PID1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.49460979692458845,1.522327002048985,0.015312131919905771,0.3087604186996095,1.0,11/90,8.29%,CCR2;PLAC8;FFAR4;SYK;JAK2;CD36;UCP2;IRF4;PRKAB2;THRA;ELOVL6
prerank,superoxide anion generation (GO:0042554),0.6862209877396097,1.5220711984207376,0.057233704292527825,0.3083196799758737,1.0,5/13,17.79%,CYBB;NOX1;NCF2;NCF1;CYBA
prerank,response to acidic pH (GO:0010447),-0.6042461964500574,-1.5205687531995637,0.04834605597964377,0.502610895595155,1.0,4/13,12.14%,LGMN;RAB11FIP5;IMPACT;CHP1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.615626278141344,1.520001002555368,0.035398230088495575,0.31216504590456345,1.0,4/24,4.76%,ITPR1;PTPRC;PLCG2;IBTK
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6762815826923887,1.5195600093910329,0.04739336492890995,0.3121684201848912,1.0,2/14,2.21%,ACE;ACE2
prerank,negative regulation of lyase activity (GO:0051350),0.6725236345477239,1.5186188624958845,0.037037037037037035,0.3135114422105962,1.0,1/16,0.04%,CCR2
prerank,regulation of stem cell proliferation (GO:0072091),0.6538517204484176,1.5182114392787764,0.04791344667697063,0.3134339770332486,1.0,3/17,4.04%,PTPRC;ACE;EIF2AK2
prerank,regulation of mast cell degranulation (GO:0043304),0.6907158384204732,1.5179291261868455,0.04690117252931323,0.3131378087845951,1.0,5/14,4.17%,FGR;LYN;SYK;CD300A;UNC13D
prerank,receptor internalization (GO:0031623),0.5411888195940064,1.5175197635598072,0.043596730245231606,0.31309686553508437,1.0,8/44,6.44%,GRK3;LILRB1;SYK;CD36;PICALM;SNX1;ITGB2;GRB2
prerank,establishment of endothelial barrier (GO:0061028),0.5957161851076576,1.5168258720189776,0.033236994219653176,0.3137411591910985,1.0,9/29,9.15%,PECAM1;RAP1A;MSN;RAPGEF2;AFDN;PDE2A;F11R;EZR;ICAM1
prerank,response to retinoic acid (GO:0032526),0.526038127233922,1.5164995568693962,0.034394904458598725,0.3134279571042562,1.0,8/59,7.87%,RARA;LYN;CREB1;RET;TRIM16;SETX;PTK2B;RARG
prerank,prostanoid biosynthetic process (GO:0046457),0.6817000726828404,1.5161710258934227,0.051926298157453935,0.31325161083734954,1.0,2/15,3.17%,CD74;PTGIS
prerank,receptor metabolic process (GO:0043112),0.5303221768303079,1.5155107323658277,0.02230971128608924,0.3138580519309043,1.0,10/53,6.44%,GRK3;UVRAG;LILRB1;LMTK2;SYK;CD36;PICALM;SNX1;ITGB2;GRB2
prerank,regulation of humoral immune response (GO:0002920),-0.44229902133750265,-1.5148805311962508,0.038461538461538464,0.5171557398013708,1.0,11/44,13.73%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,regulation of response to interferon-gamma (GO:0060330),0.6635734017784825,1.5147744822574059,0.06164383561643835,0.3145947041965939,1.0,5/14,9.68%,IFNGR1;JAK2;SUMO1;STAT1;PARP9
prerank,cardiac conduction system development (GO:0003161),0.612519473021681,1.5145607576255784,0.042899408284023666,0.31414604149788,1.0,6/24,17.00%,NOTCH2;GJA5;HCN4;SMAD4;MAML1;SMAD5
prerank,atrial septum development (GO:0003283),0.680712601907539,1.51358707050614,0.054817275747508304,0.31534489504464475,1.0,3/13,2.93%,NOTCH2;GJA5;BMPR2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6992387005781807,1.513479631745259,0.059422750424448216,0.3146342330571469,1.0,2/11,4.15%,SIK1;CRY1
prerank,calcium ion transport into cytosol (GO:0060402),-0.5334266173405919,-1.5134531022292392,0.0339943342776204,0.5165624293717596,1.0,8/21,22.55%,SLC8A1;CACNA2D1;CACNA1C;TRPM2;TRPV4;RYR2;ADRA1A;GRIN2B
prerank,negative regulation of hemostasis (GO:1900047),-0.6094647965590652,-1.513251241957208,0.0687960687960688,0.5116519522655635,1.0,4/12,12.11%,APOE;SERPINE2;CD34;SERPINE1
prerank,negative regulation of B cell proliferation (GO:0030889),0.7116623121785782,1.5099072015434232,0.0576271186440678,0.3222389842742625,1.0,4/11,11.70%,LYN;CD300A;RC3H1;FCGR2B
prerank,SNARE complex assembly (GO:0035493),0.729798475704273,1.5076539405174434,0.061837455830388695,0.3265745983845343,1.0,2/10,1.48%,UVRAG;STXBP6
prerank,negative regulation of glycolytic process (GO:0045820),0.73084939832807,1.5076502838131476,0.06418918918918919,0.32457405775081044,1.0,2/10,9.40%,CBFA2T3;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.73084939832807,1.5076502838131476,0.06418918918918919,0.32457405775081044,1.0,2/10,9.40%,CBFA2T3;GIT1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.655745668521388,1.5074670374835104,0.04730831973898858,0.32397368109630137,1.0,3/17,3.31%,KCNE3;NEDD4L;KCNQ1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6507024238643203,-1.506897825309486,0.04481132075471698,0.5282625110436884,1.0,3/10,10.10%,TGFBR2;LGALS9;NCKAP1L
prerank,cellular response to fatty acid (GO:0071398),0.7051733607805981,1.5068300290046057,0.05843071786310518,0.3244530103511169,1.0,1/12,0.25%,PID1
prerank,tRNA methylation (GO:0030488),-0.46347286180349956,-1.5053955177040668,0.03460207612456748,0.5277459808274267,1.0,20/34,25.13%,ALKBH8;NSUN2;TRMT1;METTL6;DALRD3;TRMT1L;METTL2B;METTL2A;METTL1;THUMPD2;TRMT10A;TRMT44;MTO1;TRMT12;NSUN6;LCMT2;TRMT112;GTPBP3;TRMT5;BCDIN3D
prerank,presynapse organization (GO:0099172),-0.6422845594588265,-1.5047374068025354,0.05185185185185185,0.5243259106743894,1.0,5/10,16.10%,NLGN1;LRRTM3;C5AR1;NLGN2;NLGN3
prerank,ventricular septum morphogenesis (GO:0060412),-0.4806889569803273,-1.504520921496274,0.045454545454545456,0.5194006317685742,1.0,11/27,16.72%,TGFBR2;TGFBR1;ROBO2;ROBO1;SMAD7;ACVR1;SLIT2;SLIT3;SOX4;TGFB2;SOX11
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6212669080593244,-1.503538811699876,0.03058823529411765,0.5172376531089103,1.0,4/11,6.11%,TGFBR2;TGFBR1;SMAD7;ACVR1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5107147901820951,1.5025170692198668,0.02340702210663199,0.33388917321622913,1.0,13/67,8.44%,FGR;HCK;LYN;FLT3;FYN;SYK;JAK2;PTPN6;ABI1;ZAP70;PTK2B;DYRK1A;EPHB2
prerank,response to peptide hormone (GO:0043434),0.5426689559617709,1.5018471883854747,0.03956343792633015,0.3344981337291864,1.0,13/43,13.81%,STAT4;CREB1;STAT5A;STAT3;STAT5B;CRY1;STAT1;TRIM16;ANXA1;GNAI1;AKT1;STAT2;ROCK1
prerank,hemopoiesis (GO:0030097),0.48132438062840927,1.5012093954822754,0.02278481012658228,0.3349231920081992,1.0,17/87,9.06%,PTPRC;RUNX2;RUNX3;NOTCH2;RASGRP4;FLT3;CDK13;ETV6;TET2;PLD4;GLRX5;TIRAP;HIPK1;MKNK2;ARIH2;ZFP36L2;KAT6A
prerank,integrin-mediated signaling pathway (GO:0007229),0.5070728980806045,1.5004804407598897,0.02132998745294856,0.33563015489663883,1.0,14/73,6.45%,ITGB7;FGR;NEDD9;HCK;CD47;SYK;CUL3;ERBIN;RCC2;MYH9;CDC42;BCAR1;ITGB2;PTK2B
prerank,regulation of programmed cell death (GO:0043067),0.4586130288199732,1.500457713109098,0.010893246187363835,0.3346759439133828,1.0,35/161,10.80%,LRRK2;FLT3;BCL3;DAPK1;SLK;ACER3;BCL6;JAK2;CXCL10;MALT1;PTPN6;BCL2L14;BIRC3;BCAR1;STAT1;DDX42;DFFA;LGALS1;WFS1;WRN;IKZF3;RARG;TOX3;TM7SF3;PHLPP1;HIP1;PIDD1;RPS3;NLRC4;RTN4;DAXX;CASP2;RIPK1;USP42;APAF1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6291866649252732,1.50036277525366,0.05925925925925926,0.3339090284308633,1.0,4/20,8.62%,ITGA4;CD40;PDCD4;IL6
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5831434458401771,1.4997329225715674,0.04850213980028531,0.33449991065463436,1.0,1/29,0.01%,PLBD1
prerank,regulation of cytoskeleton organization (GO:0051493),0.47881715131206176,1.4994560450433503,0.014823261117445839,0.334273623459739,1.0,32/108,15.13%,RND3;IQGAP2;IQGAP1;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;CLIC4;DLC1;DIAPH1;CAPN2;PAK2;PHLDB2;F11R;RHOBTB3;EZR;KATNBL1;RAC1;RHOA;CYLD;PRKAA1;PRKAA2;ROCK1;CLASP1;CAPN6;ARHGAP17;STMN3;RHOG;MAPK1
prerank,negative regulation of peptidase activity (GO:0010466),-0.4255177348393406,-1.499429295869356,0.0205761316872428,0.5258208015329775,1.0,8/47,12.35%,TIMP2;LRP1;SERPINE2;CST3;SPOCK1;TIMP3;SERPINE1;SERPINI1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.5392239733811468,-1.4989963063646088,0.046753246753246755,0.5218729239577841,1.0,7/18,18.39%,NUP133;NXF1;DDX19B;DDX19A;ZC3H11A;IWS1;MCM3AP
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5737493142441639,1.4973654692725864,0.03133903133903134,0.33840272332530263,1.0,9/30,13.31%,PTPRC;CD300A;PTPN6;INPP5F;SAMSN1;PARP14;SH3BP5;NF2;MVP
prerank,regulation of steroid metabolic process (GO:0019218),-0.5165948638704806,-1.4972424541016172,0.044444444444444446,0.5224528080676311,1.0,7/23,11.52%,APOE;TTC39B;STUB1;ARV1;PANK2;DGKQ;FMO5
prerank,negative regulation of cell development (GO:0010721),0.5879590273253448,1.496446425509062,0.04804804804804805,0.3396014735189796,1.0,8/25,11.91%,IL1B;LILRB1;SORL1;FBXW7;IL6;FBN1;B2M;REST
prerank,regulation of cartilage development (GO:0061035),0.6372321688480871,1.4956589507708375,0.054313099041533544,0.3404207110559719,1.0,3/18,4.20%,TRPS1;BMPR2;SCX
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.6636807637309763,1.4933362383255733,0.06540447504302926,0.3450389614907155,1.0,8/14,14.65%,RARA;MALT1;NFKBIZ;ANXA1;NFKBID;NLRP3;MYB;IL18
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6314107440480039,1.4927077250547478,0.07293354943273905,0.34542343080811433,1.0,10/18,18.79%,HEG1;CCDC125;CUL3;RIPOR2;DLC1;ITGA3;KCTD13;ABL2;KANK1;SCAI
prerank,protein dephosphorylation (GO:0006470),0.47012040430519897,1.4925166028217214,0.008928571428571428,0.3448202948468387,1.0,50/135,18.02%,PTPRC;DAPP1;PTPN22;DUSP16;PTPRE;PPP2R5A;PTPRU;PTPRO;PPP1R12A;SDHAF2;PTPN6;PTPN7;PPP3CA;PTPN12;TNS2;FBXW11;PTEN;MTMR3;SSU72;PPTC7;PPP2R2A;PPP4R2;MTMR4;DUSP6;PPP1R15A;PPP4R1;RPRD1B;PTPN1;PDP2;DUSP12;DUSP1;PPP2R3A;PPP1R15B;PPP1CB;PPM1D;TIMM50;PTPRJ;PPP2R5C;PTPRG;DUSP26;ILKAP;PPP2R5E;PPM1G;DUSP22;EYA3;LHPP;MTMR2;TAB1;PTPN4;PTPRA
prerank,mitochondrial fusion (GO:0008053),-0.5476300780137722,-1.4922927249680555,0.04054054054054054,0.535630789768565,1.0,9/18,15.53%,AFG3L2;GDAP1;MFF;MIGA2;SPG7;USP30;BAX;STOML2;MFN1
prerank,regulation of chemokine production (GO:0032642),0.5628476810674756,1.491193565235248,0.04558011049723757,0.34726083400660374,1.0,8/36,8.62%,CD74;FOXP1;EIF2AK2;IL6R;IL33;ADAM17;TLR3;IL6
prerank,polyol metabolic process (GO:0019751),0.5381480669923417,1.4909653618200294,0.03287671232876712,0.3467483280861963,1.0,12/46,8.66%,PLCG2;ITPKC;IP6K3;PLD4;OCRL;ITPK1;PTEN;INPP4A;IMPA1;PLCB1;PLCD4;SYNJ1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.5512138344439561,-1.4899909017832906,0.041237113402061855,0.5383772974348342,1.0,4/16,3.41%,SALL1;NPNT;FGF2;PKD2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5930001461637042,-1.4896280392190524,0.07397959183673469,0.5343700046571834,1.0,5/13,11.94%,TGFBR2;NRP1;CTNNB1;SEMA3E;VEGFA
prerank,negative regulation of cell junction assembly (GO:1901889),0.5942377015534868,1.4893005594909168,0.05812220566318927,0.34992685246692556,1.0,13/25,16.87%,IL1B;ACE;RCC2;IKBKB;DLC1;PTEN;PHLDB2;BCAS3;TLR2;ROCK1;THBS1;DUSP22;ARHGAP6
prerank,regulation of macrophage migration (GO:1905521),-0.6320196511626888,-1.4889629965706115,0.0625,0.5312496800220735,1.0,4/10,9.03%,CX3CR1;P2RY12;CSF1;MTUS1
prerank,negative regulation of inflammatory response (GO:0050728),0.4553649724482353,1.4889397381521534,0.009698275862068966,0.34979456369484596,1.0,39/182,14.87%,FGR;FFAR4;HCK;LYN;CRHR2;CYSLTR2;PLCG2;KLF4;CREB1;FYN;PPARG;SYK;METRNL;RXFP2;PTGER2;PTGIS;PTGER4;HTR4;MYH9;SMPDL3B;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;GIT1;SLAMF8;PRKAR2A;ADCY7;GLP2R;ACOD1;NLRP3;ADCY5;GNG2;TNFRSF1B;GPS2;GSTP1;TNFAIP6
prerank,phospholipid metabolic process (GO:0006644),0.5003943387955604,1.4884919526284601,0.02832512315270936,0.3498521054873257,1.0,4/71,2.41%,PLBD1;LGALS13;PIP4K2A;AGPAT4
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.46414995065874826,1.487418278650584,0.01021566401816118,0.35146032956454876,1.0,26/138,8.54%,FGR;NEDD9;HCK;LYN;RASGRP4;NGF;FLT3;STAP1;FYN;RET;LMTK2;PTPRU;SYK;JAK2;BMPR2;SLA;ABI1;ZAP70;CLNK;BCAR1;STYK1;POLR1G;PTK2B;EPHB2;ACVR2A;IL6ST
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4460242325271164,1.4870157110289077,0.0042643923240938165,0.3513845862662627,1.0,44/208,11.56%,CD74;CARD11;IL1B;TRAF1;ALPK1;TNIP3;PLCG2;CD40;SLC44A2;MAP3K14;REL;ANKRD17;MALT1;IKBKB;TRIM62;TRAF4;BIRC3;NLRX1;TRAF3IP2;STAT1;S100A4;PELI1;IRAK4;TIRAP;UBE2N;SHISA5;LGALS1;PDPK1;ZFAND6;FLNA;TRAF3;TRIM25;ZDHHC13;CARD16;RHOA;ZDHHC17;CPNE1;PIDD1;TANK;RIPK1;TRIM14;CACTIN;RNF31;TAB3
prerank,T-helper cell differentiation (GO:0042093),0.6566289044756153,1.48674104243998,0.06799336650082918,0.3510763961804589,1.0,4/14,8.62%,FOXP1;PTGER4;ATP7A;IL6
prerank,ureteric bud morphogenesis (GO:0060675),-0.5593151898690023,-1.4856946319565358,0.056555269922879174,0.5377469294215141,1.0,4/16,3.41%,SALL1;NPNT;FGF2;PKD2
prerank,neurotrophin signaling pathway (GO:0038179),0.6087891005777457,1.4855262139152223,0.0717628705148206,0.35313460034784944,1.0,11/21,15.14%,NGF;RAP1A;NGFR;RAPGEF2;BCAR1;GRB2;DDIT4;SOS1;KIDINS220;ZFYVE27;FRS2
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.637775340590512,-1.4848988785412212,0.03409090909090909,0.5355057369331064,1.0,2/10,1.98%,LRP6;ARHGAP12
prerank,regulation of organelle assembly (GO:1902115),0.496690294995373,1.484224726862431,0.024630541871921183,0.35540133543459534,1.0,21/73,11.37%,HCK;TBC1D1;SDCCAG8;TBC1D8;MSN;USP6NL;TBC1D10C;TBC1D2B;MTMR3;TSG101;ATG5;RABGAP1;IFT140;EZR;PDCD6IP;PIKFYVE;TBC1D5;CYLD;SENP6;STAM;TBC1D2
prerank,sensory perception of pain (GO:0019233),0.6155068352962532,1.483781803839441,0.0637329286798179,0.355526442242965,1.0,2/21,3.56%,CCR2;CHRNA4
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.5746962501112989,-1.4830871206254934,0.04336734693877551,0.5367586487819938,1.0,5/14,13.68%,CSF1R;CMKLR1;CSF1;AKIRIN1;MDK
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4952987832934266,1.4826582163026567,0.024301336573511544,0.35735238454640195,1.0,23/80,13.24%,CD44;NGF;KLF4;DAPK1;NGFR;MAP3K5;SYK;GPX1;RPS6KA3;MALT1;DPEP1;CARD16;HGF;CSNK2A1;FIS1;GRAMD4;NLRP3;REST;RPS6KA1;MAP2K5;SH3RF1;AKT1;DHCR24
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7113246198918662,1.4824684250326847,0.07599309153713299,0.356785298288539,1.0,3/10,9.52%,CCR2;ADAM17;OXSR1
prerank,positive regulation of lyase activity (GO:0051349),-0.5765778835932025,-1.482344642942809,0.056847545219638244,0.5342685286920653,1.0,3/14,4.00%,CACNA1D;CACNA1C;NF1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5921794060663236,1.4823025898220015,0.051829268292682924,0.35615998265955284,1.0,8/24,10.65%,ACTR3;WASF2;RAC2;CDC42;ACTR2;RAC1;ARPC2;PIK3CA
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7134715793214873,1.482139101171403,0.06896551724137931,0.35556880588138184,1.0,3/10,10.66%,LRRK2;NFE2L2;RIPK1
prerank,calcium-mediated signaling (GO:0019722),0.4823885031695193,1.482112064946085,0.015439429928741092,0.3546533295189269,1.0,22/93,13.04%,CCR2;LRRK2;PTPRC;PLCG2;XCR1;CCR1;MCTP2;ACKR2;CCR9;PPP3CA;PPP1R9B;PRNP;CCRL2;PDPK1;CAMKK2;FIS1;DMPK;PRKAA1;FKBP1B;CXCR6;EIF2AK3;BTK
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6577341866296905,1.4817111132973342,0.05057096247960848,0.354673221657336,1.0,3/15,2.62%,GLI1;PLCG2;CUL3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7083210505613411,1.4817014469910068,0.0595446584938704,0.35370736117590457,1.0,3/10,3.14%,LYN;LILRB1;RAPGEF2
prerank,epiboly involved in wound healing (GO:0090505),0.6511236223704301,1.4794310827049741,0.060655737704918035,0.3583799797293545,1.0,4/16,8.95%,CD44;LCP1;FLNA;RHOA
prerank,amino acid import (GO:0043090),-0.5039537721597634,-1.4783938225759825,0.043596730245231606,0.5431084896291737,1.0,9/21,25.44%,SLC1A3;SLC7A1;SLC36A1;SFXN1;SLC7A8;SLC22A4;SLC25A38;SLC1A1;SFXN2
prerank,regulation of macrophage activation (GO:0043030),0.5705820759065423,1.4768606532436495,0.049786628733997154,0.36362799881447955,1.0,5/30,11.70%,CD74;IL33;IL6;IL31RA;FCGR2B
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.6011137329836338,1.4763155502765,0.051036682615629984,0.3639295375984106,1.0,10/23,20.48%,PTPRC;CBLB;CBL;TSG101;SH3BP5;MVP;DUSP22;ZFYVE28;SOCS5;SH3BP5L
prerank,response to alcohol (GO:0097305),-0.48651386126431406,-1.476205553156302,0.03757225433526012,0.5458179936769583,1.0,9/27,22.55%,TGFBR2;TGFBR1;SDF4;SLIT2;SLIT3;CCL3;PMVK;SOD1;GRIN2B
prerank,carboxylic acid catabolic process (GO:0046395),-0.5925184967631719,-1.4748877422932967,0.05476190476190476,0.5457961120128697,1.0,5/12,2.95%,PON3;NPL;RENBP;AMDHD2;NAGK
prerank,carbohydrate homeostasis (GO:0033500),0.5087051836485019,1.4743631181360153,0.0327653997378768,0.36789644729464727,1.0,24/67,20.65%,NGFR;PPARG;STAT3;SLC8B1;CRY1;ADRA2A;WFS1;CRY2;CYB5R4;IL6;SELENOT;PRKAA1;BACE2;PRKAA2;TENT4B;INSR;GCK;PYGL;MBD5;BAD;RPS6;PARK7;ADIPOR1;STK11
prerank,filopodium assembly (GO:0046847),0.6381954845793548,1.4738257639214185,0.06862745098039216,0.36822544741922647,1.0,6/16,8.73%,SRGAP2;PPP1R9B;FGD4;EZR;FGD1;FGD3
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.6060833881813422,-1.4737841899911597,0.08983451536643026,0.5442124694765048,1.0,8/11,29.26%,TIMM9;TIMM10B;AGK;NDUFA13;TIMM13;TIMM8B;ROMO1;TIMM29
prerank,regulation of establishment of protein localization (GO:0070201),-0.5705623458896116,-1.4737772862004812,0.08616187989556136,0.5392836218441823,1.0,3/14,6.29%,CTSD;TREM2;CORO2B
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.597451184435364,1.4730536341102536,0.05564142194744977,0.36920708433300276,1.0,5/23,6.62%,KLRD1;CD226;LILRB1;KLRK1;PIK3R6
prerank,inositol phosphate dephosphorylation (GO:0046855),0.6983032866968741,1.4729566130828078,0.04770017035775128,0.36744082198750033,1.0,4/11,8.66%,OCRL;PTEN;IMPA1;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6983032866968741,1.4729566130828078,0.04770017035775128,0.36744082198750033,1.0,4/11,8.66%,OCRL;PTEN;IMPA1;SYNJ1
prerank,macrophage activation (GO:0042116),0.5630554361656076,1.4726879799014663,0.05439330543933055,0.36710760619384863,1.0,11/34,12.10%,FOXP1;IFNGR1;PLCG2;SYK;JAK2;DYSF;CD93;ITGB2;IFI35;SBNO2;APP
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.545671517484583,1.472423592285178,0.06285714285714286,0.36680305725010637,1.0,8/36,10.66%,CD74;HSPA1A;LAPTM5;ADAM17;PARP14;CPNE1;PARP9;RIPK1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.461502175392386,1.4721632463274579,0.0077348066298342545,0.36636889230999636,1.0,29/142,12.63%,CCR2;FPR1;XCR1;FPR3;CCR1;CACNA1A;CD36;LPAR3;PTGER2;ACKR2;CCR9;NPTN;GPR35;SLC8B1;PTGER4;ATP2B1;CAV2;TAC4;CCRL2;CYSLTR1;TACR1;CD52;SELENOT;PTGER3;FIS1;CALB2;FKBP1B;CXCR6;ADCY5
prerank,positive regulation of protein transport (GO:0051222),-0.3854753772272705,-1.471651892839836,0.036458333333333336,0.5419391300951595,1.0,26/67,21.38%,FRMD4A;IGF1;TREM2;PPIA;CD33;IL1A;ADAM8;PLK3;CHP1;TGFB2;TENM1;MYOM1;BMP6;ATP2C1;APBB1;TPR;IER3IP1;APBB3;EXOC1;OAZ1;RIPOR1;CEP290;ANG;PPID;MYH10;RACK1
prerank,positive regulation of biosynthetic process (GO:0009891),0.5423941388833251,1.4715652738488358,0.04666666666666667,0.36667977268388835,1.0,11/40,14.22%,PLCG2;CREB1;VIM;CD36;ZBTB20;SCX;MTPN;CREBL2;AKT1;SIRT4;TGFB1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4745309651800566,1.4714351682069848,0.030193236714975844,0.3660377843293024,1.0,16/86,6.95%,ARHGEF18;LYN;NOTCH2;RASGRP4;NGF;EPS8;DENND3;JAK2;RABL3;DENND1A;ERBIN;BCR;DLC1;ARHGDIB;GRB2;SHOC2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.45792715611030244,1.4708425551101767,0.008978675645342313,0.36665347210686683,1.0,30/140,8.95%,ARHGAP15;VAV3;TIAM1;ARHGEF18;CYRIB;SRGAP3;SRGAP2;TIAM2;RACGAP1;ARHGAP18;RABL3;ARHGAP30;SOS2;ARHGAP26;RAC2;OCRL;BCR;CDC42;TAGAP;CD2AP;DLC1;ARAP1;FGD4;ARHGDIB;DEPDC7;RAC1;FGD1;SOS1;FGD3;RHOA
prerank,positive regulation of endopeptidase activity (GO:0010950),0.58510275316992,1.4701717680396045,0.06231884057971015,0.3672420159058711,1.0,6/26,4.74%,LYN;FYN;PSME3;STAT3;PICALM;PSME2
prerank,regulation of MAP kinase activity (GO:0043405),0.4800000809490458,1.4701207985669584,0.024125452352231604,0.3663525693634544,1.0,25/92,14.83%,LRRK2;IL1B;LYN;FLT3;CD40;CD300A;RGS2;STK38;SORL1;ADRA2A;TSG101;PIK3R6;PAQR3;SNF8;DIRAS1;PTPN1;DUSP1;CDK12;PDGFD;RGS14;KIT;EZH2;TGFB1;PTPRJ;GSTP1
prerank,barbed-end actin filament capping (GO:0051016),0.6259752101019587,1.4698257227831613,0.07301587301587302,0.36511890632383676,1.0,5/18,8.86%,SVIL;EPS8;ADD3;CAPZB;CAPZA1
prerank,actin filament capping (GO:0051693),0.6259752101019587,1.4698257227831613,0.07301587301587302,0.36511890632383676,1.0,5/18,8.86%,SVIL;EPS8;ADD3;CAPZB;CAPZA1
prerank,neuron remodeling (GO:0016322),-0.6427674590631494,-1.4696654153214352,0.06310679611650485,0.5438735443855992,1.0,6/10,14.93%,C1QA;ADGRB3;FARP2;ANKS1A;C3;CX3CL1
prerank,positive regulation of metabolic process (GO:0009893),0.46947233135445865,1.4690301492047435,0.021764032073310423,0.3661117113636906,1.0,12/103,8.29%,CCR2;PLAC8;FFAR4;CAMK1D;SYK;JAK2;CD36;UCP2;IRF4;PRKAB2;THRA;ELOVL6
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6244061384427999,1.467910681094061,0.05993690851735016,0.3680878257223512,1.0,8/19,13.16%,KLF4;NFKB1;WFS1;MTPN;APP;MAP2K5;SLCO1C1;MAPK8
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.652748331401471,1.46748117009196,0.06771653543307087,0.36820945351262047,1.0,5/14,16.89%,KLF4;RHOA;MAP2K5;THBS1;STARD13
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5683631608853197,-1.467310516872795,0.08947368421052632,0.5469467296166254,1.0,10/14,37.14%,WNK1;ATP1B1;WNK2;CHP1;GLRX;WNK3;DMD;TESC;ACTN4;FXYD2
prerank,morphogenesis of an epithelium (GO:0002009),-0.4873325387426014,-1.4661980334798317,0.04304635761589404,0.54595909140227,1.0,6/25,11.66%,LRP6;ARHGAP12;FGFR2;KDM2B;TRAF3IP1;LAMA3
prerank,cellular response to sterol (GO:0036315),-0.5795776685217189,-1.4660901463362077,0.05764411027568922,0.5416194670264569,1.0,8/13,28.00%,LRP6;GRAMD1A;SMO;GPLD1;PTCH1;OSBPL7;MLC1;RORA
prerank,cardiac atrium morphogenesis (GO:0003209),0.6296442108081376,1.4659643236491995,0.06688417618270799,0.3712076789124957,1.0,3/16,8.16%,NOTCH2;BMPR2;ENG
prerank,receptor clustering (GO:0043113),0.5825586570440819,1.4655813877387156,0.05604719764011799,0.37121412131928117,1.0,6/27,6.98%,ITGB7;ITGA4;ITGAL;SYNJ2BP;ITGB2;FLNA
prerank,prostanoid metabolic process (GO:0006692),-0.5849642294429203,-1.4655439905650678,0.06153846153846154,0.5385852335405056,1.0,3/13,6.88%,HPGDS;PTGS1;PLAA
prerank,zymogen activation (GO:0031638),-0.44344679684603183,-1.4649719345506138,0.028985507246376812,0.5360211708671757,1.0,9/39,9.05%,LGMN;ASPH;VSIR;KLK3;PLAU;FURIN;MMP14;PGK1;TBC1D10A
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.44358589830936507,1.4641514436762388,0.005324813631522897,0.3738938251281892,1.0,36/214,10.92%,CD74;CD44;FFAR4;PTPRC;IL1B;LYN;NOTCH2;PTPN22;RAP1A;SYK;CCR1;CD36;RAPGEF2;PTPN6;GLIPR2;FBXW7;SYNJ2BP;PRXL2C;LMO3;TIRAP;PTEN;PTK2B;CIB1;EZR;EPHB2;DUSP6;ZDHHC17;OPRM1;ICAM1;BRAF;SPRED3;SMAD4;FN1;PTPN1;YWHAZ;DSTYK
prerank,cilium-dependent cell motility (GO:0060285),0.5971442183309498,1.4641413080308088,0.07131782945736434,0.37295627946494136,1.0,6/22,15.21%,DNAH2;DNAH8;RFX3;CCDC39;CFAP54;EFHC2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6486604359111917,1.4640875125426311,0.07547169811320754,0.3720647953834425,1.0,6/15,10.06%,IQGAP2;ACTR3;ACTR2;ARPC1B;ARPC2;ARPC4
prerank,negative regulation of programmed cell death (GO:0043069),0.43182131494917525,1.463916027594568,0.002028397565922921,0.3715502586868863,1.0,98/355,18.31%,CD74;CD44;FFAR4;GRK5;HCK;NOTCH2;CAPN13;NGF;BCL3;NGFR;MCL1;ITCH;PIM1;NFKB1;HSPA1A;RPS6KA3;LAPTM5;BIRC6;MALT1;TAF9;NFKBIA;NAA16;MRE11;CBL;SCX;IKBKB;DPEP1;GDNF;BIRC3;RAB7A;ARF4;SETX;PTK2B;ANXA4;ZFAND6;SERPINB9;WFS1;FLNA;CIB1;PAK2;TNFAIP8;AVEN;TM7SF3;IL6ST;IL6;HGF;NAA15;ANKLE2;PIDD1;BRAF;UBE2Z;ANXA1;IL31RA;CASP2;RIPK1;YWHAZ;DSTYK;PRKAA1;RPS6KA1;PSMD10;HYPK;SH3RF1;AREL1;HSPA9;CCND2;PRELID1;MAPK8;AKT1;DHCR24;API5;PRKAA2;YME1L1;DNAJC3;CITED2;HDAC3;GSTP1;MYD88;XIAP;RELA;PRDX5;THBS1;MED1;PROC;USP47;RPS6KB1;PPT1;HTATIP2;SEMA4D;NIBAN2;PSEN1;SIRT1;HSPD1;PLAUR;BAG3;HSPA5;HDAC1;AIFM2;HAX1
prerank,regulation of MAPK cascade (GO:0043408),0.45237358485187523,1.4621647082310758,0.008791208791208791,0.3748749781933843,1.0,34/157,15.33%,CD74;PTPRC;IL1B;IQGAP1;LYN;FLT3;PLCG2;RET;SYK;PAK1;LAPTM5;PTPN6;VRK2;TAOK3;ADRA2A;CAV2;STK4;PAK2;PHLPP1;IL6;MINK1;ZDHHC17;FN1;YWHAZ;DUSP1;PSMD10;KIT;LBH;ROCK1;FGFR3;PTPRJ;GSTP1;MAPK1;SPRED1
prerank,positive regulation of cell migration (GO:0030335),0.4375952809370037,1.4615315625178704,0.005175983436853002,0.3754900691521992,1.0,37/253,8.63%,CCR2;FGR;PTPRC;IL1B;NEDD9;DOCK5;TIAM1;PRKCE;TCAF2;PECAM1;PLCG2;ITGAX;RET;CCR1;PAK1;SEMA4A;SHTN1;STAT3;CLDN1;NIPBL;BMPR2;MYO1C;RAPGEF2;GLIPR2;LAMB1;CBLL1;PPP3CA;CARMIL1;ADRA2A;BCAR1;CXCL16;PTK2B;ADAM17;CIB1;ARHGEF39;EPHB2;HGF
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5408699915394521,1.4596717005706932,0.059722222222222225,0.3790602006279393,1.0,9/34,8.19%,NEDD9;DOCK5;CRK;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.7184426582430948,1.4595576863329272,0.07909604519774012,0.37840593203752465,1.0,3/10,7.87%,RARA;PPARG;RARG
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4524821709097407,1.459421698507513,0.014317180616740088,0.37777528965172447,1.0,38/149,13.04%,CARD11;IL1B;TRAF1;IL18RAP;CD40;NFKB1;STAT3;HSPA1A;CD36;PRKCH;MALT1;NFKBIA;EIF2AK2;IKBKB;TRIM62;RAB7B;RPS6KA5;TIRAP;UBE2N;CIB1;MTPN;TRIM25;CLOCK;CARD16;IL6;NFKBIB;PIDD1;RPS3;NLRC4;RIPK1;TRIM14;RNF31;TAB3;NLRP3;APP;MAP3K7;TLR2;BTK
prerank,pinocytosis (GO:0006907),0.689730702947506,1.459160276164384,0.0823327615780446,0.37750943726590025,1.0,5/10,6.58%,DOCK2;MAPKAPK3;MAPKAPK2;CARMIL1;RAB34
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.691015854152366,1.4581348123605273,0.08885017421602788,0.37907342029202457,1.0,3/11,5.32%,SP100;MAD2L2;HIPK2
prerank,embryonic hemopoiesis (GO:0035162),-0.5862908213492699,-1.4575399391709782,0.07829977628635347,0.5572627799461127,1.0,5/12,9.62%,TGFBR2;KITLG;TAL1;ATF4;THOC5
prerank,myeloid cell differentiation (GO:0030099),0.5139155475008652,1.4574508044750543,0.056833558863328824,0.37977666111651065,1.0,14/47,14.95%,LYN;RASGRP4;TET2;JAK2;SPI1;HIPK2;TIRAP;RPS14;KAT6A;SLC25A5;HSPA9;KIT;HCLS1;KMT2E
prerank,regulation of intracellular signal transduction (GO:1902531),0.42646833719056354,1.4571237522993976,0.0,0.37970599382011466,1.0,116/420,16.05%,ARHGAP15;LRRK2;VAV3;IL1B;MOB3B;TIAM1;ARHGEF18;DNA2;SRGAP3;SRGAP2;TRAF1;LYN;PTPN22;PLCG2;BCL3;RPL5;PIP4K2A;PAK1;TIAM2;RACGAP1;PRKAG2;ARHGAP18;CRK;ARHGAP30;RBBP8;SOS2;ARHGAP26;TAF13;TAF9;NFKBIA;RAC2;MRE11;OCRL;BCR;VRK2;CDC42;TAGAP;DLC1;ARAP1;TAOK3;TRAF4;BIRC3;RBBP4;HIPK2;FGD4;MAPK14;PTEN;ARHGDIB;HIPK1;STK4;PRKAB2;SGMS1;PDPK1;DEPDC7;ZFAND6;WRN;PAK2;TRAF3;PDE2A;DDIT4;EZR;PHLPP1;RAC1;FGD1;RPF2;SOS1;MINK1;FGD3;BRIP1;RHOA;KAT6A;CPNE1;SLC15A4;NEK8;CSNK2A2;CSNK2A1;PIDD1;ARHGEF6;ARHGAP21;PIP4K2B;DAXX;CYLD;PRKAR2A;PRKAG1;ING2;NET1;PRKAA1;TAF7;RPA3;GNAI1;CASTOR2;NF2;RPL11;PIP5K1A;PEX5L;AKT1;CHD4;LBH;PRKAA2;ARHGAP17;ARHGEF3;MAPKAP1;PPP2R5C;AURKB;USP7;RHOG;MAPK1;XIAP;PHF20;RELA;SPRED1;TAF1;RNF41;DYRK2;BRD7;PRR5
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6405907717644704,1.4566063960249098,0.07846410684474124,0.380078703524505,1.0,5/15,14.22%,DPP4;FAP;IL6;CLASP1;TGFB1
prerank,nerve growth factor signaling pathway (GO:0038180),0.7080671468113012,1.4564557923918162,0.08188153310104529,0.37946835853025496,1.0,3/10,3.14%,NGF;RAP1A;RAPGEF2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4824030974630238,1.4554942685920804,0.026004728132387706,0.3809455125954039,1.0,26/87,16.37%,GPR132;KLF4;PSME3;PSMB7;PSME2;PTEN;CDKN2C;AVEN;PSME4;ZFP36L2;PSMB8;PSMA5;PSMD9;PSMB3;DCUN1D3;PSMD6;PSMC4;PSMD10;PSMB1;WEE1;APC;RBL2;BRD7;USP47;PSMD12;RB1
prerank,cranial nerve development (GO:0021545),-0.6076126369694743,-1.4551736762041731,0.08466819221967964,0.561062410458427,1.0,2/11,1.02%,CHD7;SALL1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.6882224137389664,1.4539442329680599,0.10401459854014598,0.3837715915203758,1.0,3/10,4.62%,RACGAP1;RCC2;CDC42
prerank,lipoprotein transport (GO:0042953),0.6888932884170134,1.4536775081949318,0.08170515097690942,0.38346633051950857,1.0,6/10,13.94%,PPARG;CD36;ZDHHC17;UNC119B;UNC119;VMP1
prerank,melanosome transport (GO:0032402),-0.5296109365008822,-1.4519961156643468,0.0625,0.5630549755930876,1.0,8/18,23.52%,MLPH;BBS2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A;BLOC1S6
prerank,pigment granule transport (GO:0051904),-0.5296109365008822,-1.4519961156643468,0.0625,0.5630549755930876,1.0,8/18,23.52%,MLPH;BBS2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A;BLOC1S6
prerank,negative regulation of DNA binding (GO:0043392),0.5752330937169001,1.4515060601910694,0.059790732436472344,0.3880220125744064,1.0,9/28,14.75%,SP100;JAK2;MAD2L2;NFKBIA;SUMO1;CPNE1;TNKS;RSF1;ILRUN
prerank,negative regulation of hormone secretion (GO:0046888),0.7051914253594704,1.4507785243212283,0.0817391304347826,0.3889478843924979,1.0,2/10,1.63%,IL1B;RAB11FIP1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.44370640774787473,1.4504045208569005,0.013993541442411194,0.3889542410643708,1.0,43/175,15.29%,PID1;TRAF1;TNFSF13B;CD40;PSME3;JAK2;MAP3K14;ERBIN;NFKBIA;PSMB7;IKBKB;PSME2;BIRC3;STAT1;PTK2B;ADAM17;ZFAND6;NFE2L2;CIB1;TRAF3;PSME4;ZFP36L2;TANK;PSMB8;RPS3;PSMA5;PSMD9;RIPK1;CACTIN;PSMB3;FOXO3;PSMD6;PSMC4;ACOD1;PSMD10;PSMB1;AKT1;ADAMTS12;TNFRSF1B;GBP2;GBP3;TNFRSF4;RELA
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.6264909557732661,1.4500026171485896,0.07753164556962025,0.3890194472736857,1.0,7/17,18.46%,IL1B;PPP1R12A;IKBKB;F11R;ROCK1;PROC;VCL
prerank,response to fatty acid (GO:0070542),0.6281541985580449,1.4499667834664922,0.0878594249201278,0.3881567981300894,1.0,4/17,13.20%,PID1;CD36;FOXO3;PDK3
prerank,protein localization to synapse (GO:0035418),-0.5925597344225646,-1.4496166091724239,0.08872901678657075,0.5666384780576267,1.0,6/12,19.15%,NLGN1;PCLO;DLG4;NRXN2;NLGN2;NRXN1
prerank,myotube cell development (GO:0014904),-0.6316858191797854,-1.449611252693034,0.072992700729927,0.5620316611628493,1.0,2/10,0.72%,IGF1;SKI
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.46407817136225227,1.449529236227463,0.0193621867881549,0.38837256594111463,1.0,19/122,8.63%,CIITA;NIBAN1;IL1B;DNA2;GLI1;BCL3;KLF4;RPL5;NFKB1;JAK2;VIM;KAT7;IL33;FAF1;MTPN;YTHDF3;NOX1;IL6;HGF
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5455246506807165,1.4494203795969733,0.07252440725244072,0.38771300385269547,1.0,10/30,10.66%,TNIP3;CD40;IKBKB;BIRC3;UBE2D3;TRAF3;TLR3;TANK;IRF7;RIPK1
prerank,positive regulation of response to external stimulus (GO:0032103),0.4535652307389347,1.4493052360307577,0.018909899888765295,0.38700322981553215,1.0,28/128,14.65%,CCR2;IL1B;CD47;POLR3F;PLSCR1;DHX58;ANKRD17;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;OASL;PDCD4;PUM2;PDE2A;TLR3;IFI35;SLC15A4;USP15;RIPK1;ACOD1;APP;TLR2;GBP5;TGFB1;IL18
prerank,actin filament organization (GO:0007015),0.4447736482490814,1.448955765656331,0.020948180815876516,0.38693185287382587,1.0,38/151,15.51%,MYO1G;RND3;NEDD9;SVIL;LCP1;EPS8;TPM4;MAD2L2;MYO1C;MYO1E;CORO1A;SHROOM3;ABI1;RAC2;CDC42;CD2AP;CARMIL1;PPP1R9B;BCAR1;ELMO2;BIN3;MYO5B;FLNA;RHOBTB3;RAC1;RHOA;HIP1;ARPC4;CASS4;TMOD3;ARHGAP17;TRIOBP;MYO1F;ENAH;FHOD1;RHOG;ELMO1;SHROOM1
prerank,neuron development (GO:0048666),-0.3368191299998122,-1.4488148377714933,0.007874015748031496,0.5603359797129734,1.0,29/141,9.03%,OPHN1;PTPRM;ATP8A2;PPP1R9A;APOE;DTNBP1;MEF2C;CAMSAP1;WNK1;NTRK2;NLGN1;TENM4;MAP2;PLP1;ERCC6;HMGB1;TMEM108;TENM2;CNTN4;EPHA5;GPRIN3;RYK;RASGRF1;DCX;SRRM4;CDK5R1;SH3GL2;TBC1D23;GPM6A
prerank,intestinal lipid absorption (GO:0098856),0.7046777695207993,1.4487388023206482,0.08098591549295775,0.3865489701982305,1.0,3/11,5.82%,LDLR;CD36;CEL
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.46160640581631346,-1.4481820736061453,0.046296296296296294,0.5582269555033526,1.0,8/30,8.10%,ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;OSTC
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5728867656845908,-1.4478216031749325,0.07828282828282829,0.5550346867212549,1.0,3/13,2.95%,LARGE1;RENBP;NAGK
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6128406797936542,1.4475835638494525,0.061708860759493674,0.3885530134804181,1.0,6/17,14.37%,PTPN22;LAPTM5;PRNP;EZR;LGALS3;PTPRJ
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5187706048794821,1.4466457388261689,0.07133592736705577,0.3899771687517834,1.0,15/45,14.22%,IQGAP1;PIK3C2A;ERBIN;CBL;BCAR1;RPS6KA5;GRB2;PTK2B;ADAM17;PDPK1;SOS1;BRAF;PIK3CA;AKT1;TGFB1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5859627700293419,-1.4457945770190812,0.07888040712468193,0.557456415617915,1.0,9/12,32.31%,WNK1;ATP1B3;ATP1B1;WNK2;GLRX;WNK3;FXYD1;DMD;NOS1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6762690943783878,1.4443543968587735,0.09661016949152543,0.3949630963403738,1.0,5/11,9.68%,PARP8;PARP4;TIPARP;PARP14;PARP9
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4373593392268084,-1.4441397736681731,0.04059040590405904,0.5588366215238064,1.0,11/40,8.91%,P2RY12;FLT1;NTRK2;NTRK3;GNA15;FGF2;CD86;PLCG1;HTR2B;C5AR1;P2RY6
prerank,regulation of superoxide anion generation (GO:0032928),0.6450045391092812,1.443587425524735,0.07855973813420622,0.3959100064958953,1.0,6/14,18.44%,SYK;CD177;ITGB2;TGFB1;GSTP1;PRKCD
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.5894464968751805,1.4435616698339864,0.0943683409436834,0.39501332678499035,1.0,2/20,4.15%,SIK1;CRY1
prerank,regulation of innate immune response (GO:0045088),0.501482972343546,1.4431912222102299,0.03443708609271523,0.3950311130734627,1.0,21/57,16.77%,FGR;PTPN22;SAMHD1;POLR3F;PLSCR1;DHX58;PTPN6;BIRC3;TIRAP;IFI35;SLC15A4;PARP9;PTPN1;CACTIN;ACOD1;FCGR2B;GBP5;XIAP;LRP8;IRAK3;IFNAR2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.566338660483727,-1.4409134296196944,0.08068459657701711,0.565649183328494,1.0,2/13,0.41%,LGMN;ASPH
prerank,regulation of signal transduction (GO:0009966),0.4423848587486509,1.4394076934830147,0.007543103448275862,0.40393363311535185,1.0,42/190,13.67%,GRK3;LRRK2;GRK5;SP100;RASGRP4;GLI1;FYN;PLSCR1;CRK;CD36;RGS2;CD177;RSPO3;CDC42SE2;RGS3;LFNG;AXIN1;GDNF;SYNJ2BP;ZDHHC7;PRNP;CBFB;PLCB1;MTCH1;SIK2;PXN;ELF1;ZDHHC17;RGS12;GIT1;GSKIP;GRK6;PTPN1;FBXL17;APP;CASTOR2;RGS14;SNX3;LIFR;CSK;SREBF2;ITGA3
prerank,inositol phosphate metabolic process (GO:0043647),0.5184183681799236,1.439064332302352,0.05655172413793103,0.40382328964057274,1.0,12/46,8.66%,PLCG2;ITPKC;IP6K3;PLD4;OCRL;ITPK1;PTEN;INPP4A;IMPA1;PLCB1;PLCD4;SYNJ1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6176760334302607,1.4383832186537704,0.0853462157809984,0.40447517854549037,1.0,4/15,5.31%,TIAM1;RSPO3;GPC3;RNF213
prerank,fatty acid beta-oxidation (GO:0006635),-0.4003663482878755,-1.4380416364561885,0.03111111111111111,0.5709686915053291,1.0,26/51,28.87%,ABCD2;ECHS1;IVD;ABCD4;ECHDC1;ACAD10;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;ACADL;CPT2;ACADS;AMACR;GCDH;ACAT2;ACAD11;ACOX1;ACOT8;CROT;PPARD;DECR2;SLC27A2
prerank,regulation of T cell differentiation (GO:0045580),0.5446628844258172,1.4376568307723498,0.06406685236768803,0.40534815498485693,1.0,7/33,13.44%,CCR2;ZAP70;CBFB;CD2;PRELID1;METTL3;FANCA
prerank,negative regulation of immune effector process (GO:0002698),0.633623861535947,1.4376190643665363,0.10927152317880795,0.4044583163071988,1.0,6/13,12.85%,CD47;LILRB1;CD300A;RC3H1;SLAMF8;LGALS3
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5825609203180248,1.437291738089397,0.07462686567164178,0.4043618677905354,1.0,4/24,3.59%,CCR2;LYN;CCR1;CXCL10
prerank,RNA transport (GO:0050658),-0.37562269147487254,-1.4370258553528856,0.02577319587628866,0.5702760957411919,1.0,25/71,19.06%,TGFBR2;SRSF5;SRSF3;DDX39B;RBFOX1;RNPS1;CKAP5;SRSF7;NUP155;NUP188;KIF5C;RTRAF;THOC5;DHX38;NXF1;FLOT1;SIDT1;ZC3H11A;SRSF2;DDX39A;TPR;ATXN2;CASC3;SRSF1;HNRNPA2B1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6494820628971183,1.4363376554845555,0.09697933227344992,0.4059201578098101,1.0,2/13,2.49%,TESPA1;FOXJ1
prerank,peptide hormone secretion (GO:0030072),0.5684086459662381,1.4351319282810757,0.08784773060029283,0.40803213340612393,1.0,4/26,10.39%,FFAR4;CYB5R4;IL6;ANXA1
prerank,ether lipid metabolic process (GO:0046485),0.6258562982672167,1.4348592187152598,0.08881578947368421,0.40779269204118085,1.0,7/14,14.48%,AGPS;PAFAH1B1;FAR1;NCEH1;TMEM86B;PLA2G6;GNPAT
prerank,skeletal muscle organ development (GO:0060538),-0.47628333618160035,-1.4346088425250343,0.066006600660066,0.5748079339912746,1.0,8/26,13.25%,LARGE1;BASP1;MEF2C;CFLAR;IGSF8;FXR1;MYL6;DISP1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5605603222531264,1.4336277703369729,0.06808510638297872,0.4099997103696865,1.0,1/27,0.02%,CD74
prerank,peptidyl-asparagine modification (GO:0018196),-0.4521674672723487,-1.433521090838223,0.050473186119873815,0.5741428843835692,1.0,8/31,8.10%,ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;OSTC
prerank,toxin transport (GO:1901998),0.6819991449492573,1.4334121899011656,0.10283687943262411,0.40959197553860366,1.0,3/10,14.51%,ANTXR2;RAB40B;RAB29
prerank,receptor-mediated endocytosis (GO:0006898),0.4439280474526714,1.432335688433843,0.023516237402015677,0.4112587895259422,1.0,28/132,11.70%,GRK3;CLEC9A;HPX;LILRB1;LDLR;SYK;CD36;EPS15;SORL1;INPP5F;PICALM;HP;HPR;SCARB1;SNX1;ITGB2;CAV2;HSPG2;AP2A2;CXCL16;GRB2;PIKFYVE;SNX9;AP1G1;SCARB2;LMBRD1;AP2B1;FCGR2B
prerank,cellular response to retinoic acid (GO:0071300),0.5199455247752629,1.4321744376404149,0.07228915662650602,0.41072063797863984,1.0,5/42,6.45%,LYN;CREB1;RET;SETX;PTK2B
prerank,negative regulation of macrophage activation (GO:0043031),0.6354013410322025,1.4320040257647983,0.09546165884194054,0.41018498946179005,1.0,4/16,11.70%,PTPRC;LDLR;IL31RA;FCGR2B
prerank,negative regulation of phosphorylation (GO:0042326),0.4699585253455777,1.4318744448611525,0.037914691943127965,0.40956213889510135,1.0,16/85,9.59%,CBFA2T3;NIBAN1;LRRK2;PID1;LYN;STAP1;IBTK;PRKRIP1;PTEN;CDKN2C;PRNP;CIB1;PAQR3;EPHB2;GIT1;ANKLE2
prerank,cardiac cell development (GO:0055006),-0.6006746316936078,-1.430794870644204,0.07556675062972293,0.5795065327832077,1.0,3/11,14.27%,SLC8A1;VEGFA;CXADR
prerank,positive regulation of superoxide anion generation (GO:0032930),0.6519516063811212,1.4301467151193943,0.08818635607321132,0.41306513716081605,1.0,6/13,18.44%,SYK;CD177;ITGB2;TGFB1;GSTP1;PRKCD
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6766320938819099,1.4291397146124751,0.08231173380035026,0.41469781553067725,1.0,2/11,1.94%,LYN;SYK
prerank,regulation of catecholamine secretion (GO:0050433),-0.46386748377556963,-1.428792082481779,0.06948640483383686,0.5821699316413755,1.0,20/29,36.27%,PRKN;DTNBP1;SYT1;SYT9;SYT7;KCNA2;STX1A;SYT6;SYT8;KCNB1;SYT3;SYT12;SYT11;CHGA;SYT13;DRD2;SYT10;SYT5;SYT4;SYT17
prerank,regulation of T cell proliferation (GO:0042129),0.4916762497815017,1.4287741457405512,0.05699481865284974,0.414553035031851,1.0,11/61,13.54%,PTPRC;IL1B;LILRB1;SPN;CD276;GLMN;IL6ST;IL6;ANXA1;LGALS3;TNFRSF1B
prerank,phagosome-lysosome fusion (GO:0090385),0.6956145172727572,1.4285248237241266,0.09475465313028765,0.4142403084511417,1.0,6/10,13.26%,RAB7A;RAB7B;RAB39A;RAB34;PIKFYVE;ARL8B
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4567623209147372,-1.4279346108698947,0.054313099041533544,0.5808731435725834,1.0,7/28,11.81%,CAMSAP1;MAP2;MAP1B;CLASP2;MAP1A;MAPRE1;CAMSAP2
prerank,neutrophil mediated immunity (GO:0002446),0.42065607219146367,1.4277180673679495,0.0,0.4153111894936955,1.0,84/432,10.80%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;CDK13;RAP1A;ACE;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;NFKB1;SLC44A2;PTX3;ADGRE5;NFAM1;HSPA1A;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;OLR1;ERP44;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;GLIPR1;MAPK14;IRAK4;AP2A2;RAB6A;CYSTM1;ACTR2;ADAM17;OSTF1;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TSPAN14;TMEM179B;IL6;RHOA;DERA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;RAB44;TMC6;B2M;APAF1
prerank,carbohydrate transport (GO:0008643),0.67582008125543,1.4276536052439734,0.08186195826645265,0.41450597961061497,1.0,2/11,2.23%,SLC23A2;SLC23A1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6622107165124549,1.4269921652512727,0.09803921568627451,0.4152522910155942,1.0,4/11,6.11%,PTGIS;DLC1;FAP;DFFA
prerank,muscle cell development (GO:0055001),-0.4507361536146946,-1.426885477682383,0.06430868167202572,0.5799674089648381,1.0,8/30,14.27%,BIN1;IGF1;SLC8A1;NEBL;ANK2;NRAP;VEGFA;CXADR
prerank,regulation of transmembrane transport (GO:0034762),0.5347080381784436,1.4262885215280254,0.09558823529411764,0.4161419577995723,1.0,4/31,2.59%,FFAR4;PIM1;ACE2;NEDD4L
prerank,negative regulation of JUN kinase activity (GO:0043508),0.6662025530022845,1.425982220533702,0.11433756805807622,0.41606344877531865,1.0,3/10,14.83%,PTPN22;PDCD4;GSTP1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.503998663880557,1.425974776600679,0.045283018867924525,0.415137974535065,1.0,14/55,12.97%,GPR132;PSME3;PSMB7;PSME2;AVEN;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4659948391840204,1.425789254398684,0.036004645760743324,0.4147346942784251,1.0,32/94,17.53%,IL1B;MAP3K8;PSME3;NFKB1;NFKBIA;PSMB7;IKBKB;PSME2;PELI1;FBXW11;IRAK4;RPS6KA5;UBE2N;PLCB1;PSME4;IL1R2;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;MYD88;RELA;IRAK3;PSMD12;MAP3K3;TAB1
prerank,protein mannosylation (GO:0035268),-0.49578221524937094,-1.4256780858554057,0.06997084548104957,0.5797545442526219,1.0,12/22,31.64%,LARGE1;DPY19L4;RXYLT1;POMT1;DPM2;DPY19L3;FKRP;DPM3;TMTC1;POMT2;DPM1;SDF2L1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.6055900513071829,1.4251357545923036,0.1008,0.4154206060568579,1.0,2/17,4.59%,PTPRC;KAT7
prerank,cell part morphogenesis (GO:0032990),0.6423646355426813,1.4243699302120445,0.09415584415584416,0.4165565952853759,1.0,6/13,14.07%,PID1;FIS1;PACSIN2;DNM1L;PNPT1;MYH14
prerank,negative regulation of catabolic process (GO:0009895),0.5126783075127769,1.4241086099258735,0.06391478029294274,0.4162686672250775,1.0,15/47,18.97%,CBFA2T3;IL1B;MAD2L2;ADRA2A;ZDHHC7;FLNA;AZIN1;GIT1;PRKAA1;SNX3;SNX12;IRAK3;SF3B3;PIN1;PRKCG
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6426768493522839,1.4231042600865966,0.1016949152542373,0.41792213306943904,1.0,2/12,2.75%,PLCG2;CD36
prerank,regulation of immunoglobulin production (GO:0002637),0.5819650772000956,1.4219371587395868,0.09428129829984544,0.41991632766988846,1.0,7/23,17.48%,PTPRC;EPHB2;IL6;GPI;FCGR2B;TNFRSF4;SASH3
prerank,microvillus organization (GO:0032528),0.6494786933115252,1.4218386027425953,0.10526315789473684,0.41925114194553686,1.0,5/13,8.70%,FXYD5;RAP1A;RAPGEF2;EZR;MINK1
prerank,cell junction organization (GO:0034330),-0.3674760601863026,-1.4218091144391407,0.0335195530726257,0.5896015201180516,1.0,20/71,14.27%,OPHN1;APBB2;TJP1;MYO9A;C1QA;FBLIM1;PPFIA4;ILK;SEMA3E;SDK1;TJP2;CHRNA7;SMAD3;GRM5;PPFIBP1;PPFIBP2;NLGN2;AGRN;TGFB2;CXADR
prerank,photoreceptor cell development (GO:0042461),-0.5434830361823701,-1.421632059162049,0.07606263982102908,0.5860746793049838,1.0,5/14,20.21%,DCX;MYO7A;VEGFA;ARL3;CEP290
prerank,stress-activated MAPK cascade (GO:0051403),0.48570428594906484,1.4215965586767156,0.05189873417721519,0.4189641927110444,1.0,20/61,15.13%,MAP3K5;MAP3K8;NFKB1;SH2D3C;PTGER4;IKBKB;MAPK14;FBXW11;UBE2N;MINK1;ARHGEF6;MAP4K3;TAB3;MAP3K7;MAP2K3;MAP3K20;MAPK8;MAP3K13;GPS2;MAPK1
prerank,negative regulation of developmental growth (GO:0048640),-0.4580294279899948,-1.4211149755766366,0.05,0.5839501199049854,1.0,8/30,10.85%,DIP2B;DCC;ULK2;MAP2;FGF13;CDKL3;BBS2;WWC1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5290915686433877,1.421095651201627,0.08426966292134831,0.41926000145353526,1.0,10/36,13.20%,PTPRC;BCL3;JAK2;IL10RA;CRLF3;DOT1L;IL6;NLK;NF2;KIT
prerank,regulation of JUN kinase activity (GO:0043506),0.526051998261242,1.4209905390217776,0.09155937052932761,0.4185984980346969,1.0,12/33,17.33%,PTPN22;MAP3K5;PAK1;TAOK3;PDCD4;MAP3K4;RPS3;DVL3;MAP3K7;GSTP1;DVL2;TRAF2
prerank,secretory granule organization (GO:0033363),-0.6108656743639207,-1.420485112118785,0.0748792270531401,0.582034993552965,1.0,2/10,0.60%,ABCA1;DTNBP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5299576862406915,1.4199057390006689,0.07114093959731543,0.42045291606673296,1.0,7/39,9.15%,ITGA4;CD40;NDNF;PDPK1;NFE2L2;PDCD4;ICAM1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4433727482133706,1.419768024448976,0.020994475138121547,0.4198332718105439,1.0,22/140,10.60%,CCR2;FPR1;XCR1;FPR3;CCR1;CACNA1A;CD36;LPAR3;PTGER2;ACKR2;CCR9;NPTN;GPR35;PTGER4;TAC4;CCRL2;CYSLTR1;TACR1;CD52;SELENOT;PTGER3;FIS1
prerank,synaptic vesicle cycle (GO:0099504),-0.4425572432822186,-1.4197243540439985,0.0764525993883792,0.580781237719756,1.0,12/30,23.46%,NLGN1;PCLO;SLC17A6;SNAP25;SYT7;CDK5;STX1A;CPLX1;RIMS1;RAB3A;SLC32A1;CPLX2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.5096667462523778,-1.4194603241072274,0.075,0.5775764718354554,1.0,16/20,48.19%,ACVR1;BMPR1B;PTCH1;MDFI;LMX1B;AIDA;NBL1;GLI2;GREM1;LHX1;ACVRL1;FBXL15;SFRP1;SHH;NOG;WNT8B
prerank,regulation of insulin secretion (GO:0050796),0.4553450297133573,1.4176234692268233,0.04700352526439483,0.4245673308127105,1.0,16/101,12.63%,DPP4;ITPR1;IL1B;RAP1A;CACNA1A;SLC8B1;RFX3;ADRA2A;CLOCK;TM7SF3;IL6;PSMD9;CACNA2D2;GLUD1;REST;ADCY5
prerank,response to UV-A (GO:0070141),0.6266379430345592,1.4176172620507523,0.10465116279069768,0.42365599961538425,1.0,4/14,13.17%,MMP1;CERS1;CCND1;AKT1
prerank,dephosphorylation (GO:0016311),0.44653742371466276,1.4175609469197832,0.02346368715083799,0.42288777616582596,1.0,47/147,18.02%,PTPRC;DAPP1;PTPN22;DUSP16;PTPRE;PPP2R5A;PTPRU;PTPRO;PPP1R12A;SDHAF2;PTPN6;PTPN7;PPP3CA;PTPN12;FBXW11;PTEN;MTMR3;PXYLP1;PPP2R2A;PPP4R2;MTMR4;DUSP6;PPP4R1;PTPN1;PDP2;DUSP12;DUSP1;PPP2R3A;PPP1CB;PPM1D;SGPP2;TIMM50;PTPRJ;PPP2R5C;PTPRG;SGPP1;DUSP28;DUSP26;ILKAP;PPP2R5E;PPM1G;LHPP;MTMR2;PLPPR2;TAB1;PTPN4;PTPRA
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4737427239309877,1.4170051448996452,0.051470588235294115,0.4234545875064166,1.0,18/76,12.52%,LRRK2;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;WFS1;MYCBP2;FBXO4;TANK;DCUN1D3;RCHY1;PSMD10;FANCI
prerank,regulation of sodium ion transport (GO:0002028),-0.4427815929346519,-1.4167534579987409,0.06756756756756757,0.5830720890419452,1.0,16/34,22.16%,WNK1;AHCYL1;SLMAP;P2RX7;WNK2;P2RX4;SNTA1;SCN1B;PER1;NKAIN3;PKP2;FGF12;YWHAH;SCN3B;WNK3;SPTBN4
prerank,lipoprotein localization (GO:0044872),0.6566939161550349,1.4165002224504364,0.0963855421686747,0.4238760922520845,1.0,7/11,17.91%,PPARG;CD36;ZDHHC17;UNC119B;UNC119;VMP1;ZDHHC3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6127863238400194,1.4164206415341158,0.09609120521172639,0.4231707141075178,1.0,8/15,15.14%,NGF;NGFR;BCAR1;GRB2;DDIT4;SOS1;ZFYVE27;FRS2
prerank,extracellular transport (GO:0006858),0.6512529789651189,1.4157268147660076,0.10983606557377049,0.42406719281004457,1.0,4/13,9.20%,TSG101;ADCY10;CABYR;WWP2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6447317759562731,1.4157194166663452,0.12141652613827993,0.42317310771335287,1.0,4/12,8.62%,IL1B;STAP1;IL33;IL6
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5977565210898148,-1.4153954680112928,0.09276018099547512,0.5837644832163612,1.0,9/11,24.93%,CDK11B;SAFB2;SRPK1;SRPK2;DHX9;IWS1;PTCD2;SAFB;SRPK3
prerank,intestinal absorption (GO:0050892),0.6415336910226909,1.4153869235866583,0.0759493670886076,0.4231367526689543,1.0,4/13,7.55%,CD36;KCNQ1;ADRA2A;F11R
prerank,regulation of wound healing (GO:0061041),0.5184471139382814,1.4152139492416187,0.06002728512960437,0.4226745469833155,1.0,8/42,10.39%,PRKCE;CASK;CLDN1;CRK;ADRA2A;EPHB2;ARFGEF1;ANXA1
prerank,positive regulation of cell communication (GO:0010647),-0.455277438092328,-1.4150352948262341,0.056962025316455694,0.5809585704962961,1.0,9/28,18.82%,SYT1;WLS;DLG4;ILK;CLSTN2;CD80;SOX11;RIMS1;RIMS3
prerank,histone H2B ubiquitination (GO:0033523),0.6713390637885008,1.4148179032972779,0.12054329371816638,0.4227526379341198,1.0,4/10,5.34%,DTX3L;UBE2E1;WAC;RNF20
prerank,positive regulation of MAPK cascade (GO:0043410),0.4267899196043551,1.414676728106289,0.011566771819137749,0.4221909326208799,1.0,33/245,9.62%,CD74;LRRK2;CD44;FFAR4;PTPRC;IQGAP1;NOTCH2;FLT3;PTPN22;PLCG2;RAP1A;RET;CD40;CCR1;CD36;RAPGEF2;LAPTM5;GLIPR2;EIF2AK2;FBXW7;PRXL2C;TAOK3;ADRA2A;CAV2;TIRAP;PTK2B;PIK3R6;CIB1;IL6;OPRM1;ICAM1;DIRAS1;BRAF
prerank,regulation of vasoconstriction (GO:0019229),0.557588552718852,1.4143419745028822,0.07692307692307693,0.42218039387455497,1.0,4/27,4.25%,ACE;ACE2;BMPR2;ATP2B1
prerank,purine nucleotide catabolic process (GO:0006195),0.6525277865283323,1.4137974662695187,0.095,0.4226304623644794,1.0,2/13,2.68%,GDA;GPX1
prerank,cellular protein modification process (GO:0006464),0.4082592034939323,1.4135522222911932,0.0,0.42235641349205555,1.0,241/983,15.91%,GRK3;FGR;LRRK2;PTPRC;HLCS;ST3GAL1;ST8SIA4;GRK5;RARA;DAPP1;STK10;ST3GAL4;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;ZC3HAV1;PTPN22;SIK1;STK24;CDK13;VRK1;CREB1;FEM1C;DAPK1;DUSP16;ST8SIA1;FYN;DTL;PARP8;RET;MAP3K5;LMTK2;AKT3;TNC;PTPRE;PPP2R5A;PTPRU;PTPRO;SYK;PSME3;PIM1;PKN1;PAK1;PPP1R12A;STK17B;PRKAG2;JAK2;ASB5;CUL3;ERN1;SDHAF2;PRKCH;IP6K3;CUL5;BMPR2;NOTUM;FUT4;MAPKAPK2;BIRC6;STK38;ST8SIA6;UBE2E1;PTPN6;KLHL11;LAMB1;PTPN7;EIF2AK2;BCR;B4GALT5;PSMB7;GPC3;IKBKB;ZAP70;FBXW7;VRK2;PSME2;PPP3CA;PARP4;GMFG;TAOK3;SIK3;PTPN12;F13A1;HIPK2;DCAF5;UBE2D3;FBXW11;FBXL8;RPS6KA5;CEL;CDK14;DCUN1D1;PTEN;TIPARP;SHISA5;ARF4;MAP3K1;HIPK1;STK4;MTMR3;PTK2B;LGALS1;FBXW2;PDPK1;NEDD8;WFS1;ATG5;MKNK2;PARP14;ELOB;DYRK1A;PKN2;PAK2;UBXN7;PPP2R2A;FBXO4;ZDHHC6;PPP4R2;MTMR4;COP1;SIK2;PSME4;COQ8A;SERP2;ACVR2A;STK38L;DUSP6;IL6;MINK1;CSNK1G3;COPS3;SUMF2;TNKS;LATS1;WWP2;OXSR1;CSNK2A1;BRAF;FBN1;PARP9;TLK2;FBXO32;PSMB8;CAMKK2;PPP4R1;GRK6;PSMA5;PSMD9;FN1;ANXA1;MBTPS1;PTPN1;PDP2;KLHL5;SUMF1;YWHAZ;PRKG2;PRKAG1;DMPK;PTP4A2;PRSS23;NLK;PSMB3;UBE2S;LATS2;MAP4K3;DUSP12;DUSP1;DCUN1D3;PSMD6;PSMC4;PRKAA1;PPP2R3A;PIGS;APP;CCNT1;PIK3R4;PSMD10;PPP1CB;WIPI2;CDK12;B3GALT2;PPM1D;MORC3;MAP3K20;PSMB1;EIF2AK3;BTK;ATG10;UST;MAPK8;AKT1;PDK3;FBXL12;LIMK2;CSK;MARK3;DCAF10;TYK2;SLC35A1;HCST;KTN1;STK39;PRKAA2;SIRT4;ROCK1;TLK1;DNAJC3;LMTK3;FBXO30;TIMM50;TGFB1;HASPIN;PTPRJ;STT3B;TRIOBP;PPP2R5C;MAP3K13;AURKB;PTPRG;BRSK1;FBXO7;DUSP26;MAPK1;PMM2;PTAR1;TAF1;TBK1;MAML1;PIGH;THBS1;ILKAP;PPP2R5E;PPM1G;IRAK3;SEPHS1;DYRK2;PROC
prerank,neutrophil activation involved in immune response (GO:0002283),0.4156270476819353,1.4127895310846188,0.00101010101010101,0.42343396726359134,1.0,81/428,10.80%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;CDK13;RAP1A;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;SYK;NFKB1;SLC44A2;PTX3;ADGRE5;NFAM1;HSPA1A;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;OLR1;ERP44;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;GLIPR1;MAPK14;AP2A2;RAB6A;CYSTM1;ACTR2;OSTF1;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TSPAN14;TMEM179B;RHOA;DERA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;RAB44;TMC6;B2M;APAF1
prerank,myeloid cell development (GO:0061515),0.6088457223508387,1.4126707689147755,0.07934131736526946,0.4228430461622448,1.0,7/18,15.79%,FOXP1;ANXA2;NRROS;APP;TLR2;KIT;MED1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6260328200121987,1.4122915896789983,0.08576051779935275,0.4229006793460407,1.0,3/16,13.50%,CLDN1;CLDN12;CLDN14
prerank,positive regulation of protein ubiquitination (GO:0031398),0.47268053360330725,1.4122026469572324,0.037575757575757575,0.4222398946938841,1.0,21/80,15.20%,LRRK2;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;UBE2N;WFS1;MYCBP2;FBXO4;DCUN1D3;RCHY1;PSMD10;FANCI;RPS2;HDAC3;XIAP
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6181015281775419,1.4112836758032887,0.08387096774193549,0.42384502602580476,1.0,4/16,4.56%,SLAMF7;CORO1A;KIF5B;KLRK1
prerank,regulation of cellular catabolic process (GO:0031329),0.47727748933187947,1.4108249658395968,0.0599250936329588,0.4241448348680983,1.0,13/62,11.09%,ITPR1;LRRK2;DAPK1;PIP4K2A;DRAM1;DCAF12;MTMR3;PSAP;RMC1;MTMR4;DEPDC5;PIP4K2B;SCARB2
prerank,cellular response to cAMP (GO:0071320),0.5489521920625486,1.410623008640703,0.08645533141210375,0.4237485235052124,1.0,7/30,8.00%,RAP1A;RAPGEF2;KCNQ1;HCN4;AHR;PDE2A;EZR
prerank,negative regulation of neurogenesis (GO:0050768),0.5333889173962616,1.410319265821602,0.09182209469153516,0.4236724656170619,1.0,11/34,13.27%,IL1B;NGFR;RAPGEF2;SORL1;PTEN;IL6;RHOA;RTN4;B2M;REST;LRP4
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6045283929144978,1.4101380918420356,0.09394904458598727,0.4232621829400321,1.0,3/17,3.31%,KCNE3;GJA5;KCNQ1
prerank,response to cAMP (GO:0051591),0.5257576258253774,1.4100017071217692,0.08990318118948824,0.42274579159773396,1.0,8/37,8.00%,RAP1A;RAPGEF2;KCNQ1;HCN4;STAT1;AHR;PDE2A;EZR
prerank,negative regulation of blood coagulation (GO:0030195),-0.42738254105120893,-1.409421479476305,0.05185185185185185,0.5965091983536227,1.0,7/38,14.53%,APOE;SERPINE2;PLAU;CD34;PDGFA;SERPINE1;F8
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6439737265011314,1.4093546333103073,0.10221465076660988,0.42365519011243025,1.0,5/13,16.94%,ZC3HAV1;RC3H1;NUDT21;PNPT1;CNOT8
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.4476588002768031,-1.4093339357270942,0.07744107744107744,0.592916364120585,1.0,10/32,6.61%,CUX1;PTPRD;RAP2A;IL1RAPL1;TNIK;HECW1;ADGRB3;FBXW8;CDKL3;CAPRIN2
prerank,renal filtration (GO:0097205),0.6693361320582951,1.4087900645092282,0.10238907849829351,0.4242015026605865,1.0,5/10,13.67%,SULF2;MYO1E;TBC1D8B;TMEM63C;ITGA3
prerank,vasodilation (GO:0042311),-0.5650856538628203,-1.4087721303842904,0.10991957104557641,0.5910232105800248,1.0,4/13,21.89%,KCNMA1;ADRB1;SOD2;SOD1
prerank,digestive tract morphogenesis (GO:0048546),0.6374656389789355,1.4085473721962674,0.10310965630114566,0.42398311009818074,1.0,3/14,9.20%,GLI1;NIPBL;ID2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4129429488689027,1.4080862869853035,0.005055611729019211,0.42428382544669424,1.0,57/348,10.66%,CD74;NIBAN1;LRRK2;CD44;PTPRC;IL1B;IQGAP1;LYN;NGF;PECAM1;PLCG2;RAP1A;CD40;PAK1;SH2D3C;FGF5;FGF22;PRKAG2;JAK2;BMPR2;MAD2L2;RBPMS;RAPGEF2;NPTN;MRE11;IL6R;GDF1;AXIN1;CCND3;VEGFC;TRAF4;RPS6KA5;CCND1;STK4;PRNP;WDFY2;PTK2B;ADAM17;CIB1;PAK2;BMP3;ENG;RAC1;CACUL1;ACVR2A;IL6;HGF;RALB;LATS1;CREBL2;PGF;BRAF;SMAD4;CAMKK2;DAXX;SNX9;RIPK1
prerank,positive regulation of cell cycle process (GO:0090068),0.45463859477919405,1.4061290377127136,0.04431137724550898,0.4284145636026053,1.0,22/91,16.28%,IL1B;SVIL;CDC14A;PRKCE;RACGAP1;PLSCR1;CUL3;RCC2;FEN1;KIF23;CDC42;PKN2;RHOA;SPAST;DYNC1H1;CSPP1;ATRX;MAP3K20;AURKB;INO80;INSR;GPSM2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5237274909531149,1.4060280230329305,0.07670454545454546,0.42782430119603365,1.0,4/37,1.81%,JAML;ITGAL;ALCAM;NECTIN1
prerank,vesicle transport along actin filament (GO:0030050),0.5877302668487878,1.405788947277694,0.09763779527559055,0.42749805830696325,1.0,4/19,6.49%,MYO1G;MYO1C;MYO1E;MYO5B
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5713659661319128,1.4056702833019024,0.09968847352024922,0.4269773725781746,1.0,4/21,5.19%,NGF;NGFR;FYN;BIRC3
prerank,cellular response to leucine starvation (GO:1990253),-0.6006183476019558,-1.405399119666288,0.07462686567164178,0.5988245930033123,1.0,8/10,30.63%,SESN3;EIF2AK4;IMPACT;LARS1;SESN2;SESN1;RRAGD;MTOR
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6608189088642619,1.40390852724229,0.10309278350515463,0.4308936208580957,1.0,3/11,11.00%,MALT1;NFKBIZ;NFKBID
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5554957118864721,-1.4038072773161752,0.08205128205128205,0.600217812086256,1.0,6/13,20.21%,HEXB;ARSB;CSPG4;HEXA;BGN;HYAL1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4931100269842496,1.4037341539681227,0.0655307994757536,0.430402639207496,1.0,10/47,8.19%,NEDD9;DOCK5;CRK;RCC2;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,microvillus assembly (GO:0030033),0.6328954580391456,1.4033135531968133,0.1147011308562197,0.43061295286632784,1.0,5/14,8.70%,FXYD5;RAP1A;RAPGEF2;EZR;MINK1
prerank,cellular response to alkaloid (GO:0071312),-0.5245005218407056,-1.4030641376096478,0.08262108262108261,0.5991937251302984,1.0,5/17,11.73%,SLC8A1;RYR3;BLM;TGM2;CASP3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4296965800336412,1.4029434412316923,0.02516411378555799,0.43060799311857145,1.0,31/158,12.19%,CD74;CARD11;ALPK1;CD40;SLC44A2;MAP3K14;REL;ANKRD17;MALT1;IKBKB;TRIM62;BIRC3;TRAF3IP2;S100A4;PELI1;IRAK4;TIRAP;UBE2N;SHISA5;LGALS1;FLNA;TRIM25;ZDHHC13;CARD16;RHOA;ZDHHC17;RIPK1;TRIM14;RNF31;TAB3;MAP3K7
prerank,regulation of lysosomal lumen pH (GO:0035751),0.642782598590323,1.4028518495151658,0.1271860095389507,0.429985342651872,1.0,1/12,0.22%,LRRK2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.46698396772735806,1.40155414680967,0.05808080808080808,0.4326570146000521,1.0,20/76,14.19%,CBFA2T3;LRRK2;HSPA1A;LAPTM5;FBXW7;ANKIB1;SUMO1;AXIN1;ARIH1;PTEN;RNF217;HECTD1;ELOB;COP1;ARIH2;SUMO2;RCHY1;PSMD10;PABIR1;VCP
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4769912176759019,1.4014780622882925,0.06700379266750948,0.43197644060104007,1.0,20/59,17.53%,CARD11;BCL3;MAP3K14;REL;NFKBIA;IKBKB;BIRC3;TLR3;TANK;RIPK1;RNF31;TAB3;MAP3K7;TLR2;AKT1;ROCK1;RELA;TBK1;TRAF2;TAB1
prerank,nucleocytoplasmic transport (GO:0006913),0.5095346909825846,1.4012814101339923,0.08309859154929577,0.43164171705566984,1.0,15/40,20.41%,BACH2;XPO1;RSRC1;MALT1;SNRPD2;SNRPB;NUP98;RGS14;GEMIN7;NCBP1;HTATIP2;PHAX;DDX20;NEMF;SNUPN
prerank,ephrin receptor signaling pathway (GO:0048013),0.45967104946432574,1.4005702911668239,0.05568720379146919,0.4325237728114494,1.0,18/82,10.06%,VAV3;TIAM1;LYN;ACTR3;FYN;PAK1;CRK;CDC42;AP2A2;ACTR2;EFNA2;RAC1;EPHB2;ARPC1B;RHOA;GIT1;ARPC2;ARPC4
prerank,cellular response to zinc ion (GO:0071294),-0.5328374671533803,-1.400455628193487,0.09948979591836735,0.6042277981280009,1.0,13/15,42.18%,P2RX4;GLRA2;MT2A;MT3;ATP13A2;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.564241674356146,1.4002004731458235,0.09865470852017937,0.4325689750713956,1.0,11/26,18.32%,IQGAP1;STAT5B;PTPN12;PDPK1;ZFP36L2;ZPR1;MED1;DUSP22;KNSTRN;FOXC1;SYAP1
prerank,neutrophil degranulation (GO:0043312),0.41228224331449287,1.3996319023853543,0.0010121457489878543,0.43315444882404625,1.0,80/425,10.80%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;CDK13;RAP1A;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;NFKB1;SLC44A2;PTX3;ADGRE5;NFAM1;HSPA1A;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;OLR1;ERP44;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;GLIPR1;MAPK14;AP2A2;RAB6A;CYSTM1;ACTR2;OSTF1;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TSPAN14;TMEM179B;RHOA;DERA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;RAB44;TMC6;B2M;APAF1
prerank,secondary palate development (GO:0062009),-0.5549351372691513,-1.3990699692807134,0.11298076923076923,0.605006626765416,1.0,2/14,0.65%,TGFBR2;CHD7
prerank,cellular response to interleukin-1 (GO:0071347),0.43831631190148684,1.398790383334236,0.027472527472527472,0.4344202401837243,1.0,40/143,16.31%,IL1B;CD47;CD40;MAP3K8;PSME3;NFKB1;PTGIS;NFKBIA;PSMB7;IKBKB;PSME2;PELI1;RC3H1;FBXW11;IRAK4;RPS6KA5;UBE2N;PLCB1;PSME4;IL1R2;TANK;PSMB8;PSMA5;PSMD9;CACTIN;PSMB3;PSMD6;TAB3;PSMC4;ACOD1;MAP3K7;PSMD10;PSMB1;ADAMTS12;GBP2;GBP3;MYD88;RELA;IRAK3;PSMD12
prerank,chromatin organization (GO:0006325),0.4442691361511338,1.398578787493743,0.02857142857142857,0.4340482197912427,1.0,48/132,20.05%,JARID2;BAZ1A;PADI1;KDM6A;PAK1;BAZ2B;SPI1;INO80C;RBBP4;SMARCA5;FAM47E;SETD7;PHF19;SETDB2;EZH1;SETD5;SMARCE1;DAXX;TADA2A;SETD2;BAZ2A;ATRX;MYB;EZH2;SMARCC2;KAT2B;CHRAC1;HDAC3;RSF1;INO80;KDM4B;NPM3;HMGN1;RB1;BPTF;SIRT1;SUPT4H1;LRWD1;PADI2;SMARCD3;HCFC2;HDAC1;GATAD1;HP1BP3;EHMT1;PBRM1;SATB1;SUPV3L1
prerank,cell-matrix adhesion (GO:0007160),0.44976873262574013,1.3983507188522941,0.044548651817116064,0.43376689220459463,1.0,9/95,5.41%,ITGB7;ITGA4;ITGAL;CD44;TIAM1;RCC2;BCR;DLC1;ITGB2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.48076613379882854,1.3977789172948683,0.05481120584652863,0.43436508416859365,1.0,19/65,16.31%,GPR132;PSME3;PSMB7;PSME2;NABP1;AVEN;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;PABIR1;AURKB;USP47;PSMD12
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6324337445254695,1.3977437196451332,0.10526315789473684,0.43359656212153186,1.0,4/13,8.62%,PTPRC;JAK2;DOT1L;IL6
prerank,regulation of protein metabolic process (GO:0051246),0.5115377636419457,1.397562014221429,0.07953063885267275,0.4332409606977375,1.0,16/44,13.16%,ACE;KLF4;LDLR;NEDD4L;SPOP;FAF1;PARL;NEDD8;WFS1;GSAP;MTPN;TRAF3;SNF8;APP;MAP2K5;MAPK8
prerank,inositol phosphate catabolic process (GO:0071545),0.6480930929890597,1.3968409733435563,0.10606060606060606,0.4342397873724814,1.0,4/12,8.66%,OCRL;PTEN;IMPA1;SYNJ1
prerank,T cell differentiation (GO:0030217),0.5168297364435007,1.3966610366049141,0.07042253521126761,0.43380581254963646,1.0,11/40,13.51%,PTPRC;PTPN22;RABL3;SPI1;LFNG;ZAP70;ADAM17;ZFP36L2;ANXA1;KIT;FCER1G
prerank,transferrin transport (GO:0033572),-0.4274814436965355,-1.3965373827302539,0.055944055944055944,0.6100304020824564,1.0,13/33,13.26%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6AP1;ATP6V1D;TFRC;MCOLN1;ATP6V0D1;ATP6V0A1;ARHGAP1
prerank,regulation of lamellipodium assembly (GO:0010591),0.5186814298744605,1.3959514765753045,0.08591549295774648,0.4348328749477963,1.0,9/34,10.65%,ACTR3;WASF2;RAC2;CDC42;ACTR2;CAPZB;RAC1;ARPC2;PIK3CA
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.5167286383684221,-1.3956292169715745,0.1126005361930295,0.609398533885873,1.0,6/17,13.68%,BIN1;SERPINE2;TENM4;PTN;PTPRZ1;MDK
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5717788149874068,1.395158233498753,0.11059907834101383,0.4360279221038683,1.0,4/22,6.72%,AHNAK;HPCA;GPR35;CACNB1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4681427276055412,1.394585783498942,0.0713436385255648,0.43653537604077186,1.0,18/70,13.63%,ITGB7;ITGA4;ATRNL1;SRGAP2;NTNG2;SIPA1L3;SPI1;LAMB1;RAC1;PXN;RHOA;FN1;MEGF9;RILPL2;ITGA8;USH2A;METTL3;TBCD
prerank,actin filament-based transport (GO:0099515),0.5668564644654533,1.394505840361669,0.10138248847926268,0.4359172576657613,1.0,4/21,6.49%,MYO1G;MYO1C;MYO1E;MYO5B
prerank,actin nucleation (GO:0045010),0.5745640229141362,1.3939573894156494,0.10140405616224649,0.4364695815693994,1.0,6/21,10.06%,IQGAP2;ACTR3;ACTR2;ARPC1B;ARPC2;ARPC4
prerank,C-terminal protein amino acid modification (GO:0018410),-0.5889963251001046,-1.3939559636721468,0.12213740458015267,0.6111494634226015,1.0,8/11,19.60%,FOLH1;ATG12;GPLD1;TTL;ATG7;AGBL1;AGBL4;LCMT1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6117291180081004,1.3929442812031692,0.09208400646203554,0.43830573486821406,1.0,3/17,3.59%,CCR2;CCR1;CXCL10
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5813826131288288,-1.3920321921367673,0.08977556109725686,0.6139172216670675,1.0,2/10,2.08%,DLGAP1;DLGAP4
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.48454102621692485,1.3918495110864975,0.0663265306122449,0.4402198938153319,1.0,16/62,15.31%,LYN;NOTCH2;RASGRP4;NGF;JAK2;ERBIN;GPR35;GRB2;SHOC2;F11R;RAC1;NET1;LRRC59;ARHGEF3;LPAR6;RASGEF1A
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.45036582767103356,1.390379395316027,0.05853658536585366,0.4431718523556093,1.0,28/95,15.29%,IL1B;CYRIB;TNIP3;STAP1;LILRB1;NFKB1;VIM;CXCL10;MAPK14;TIRAP;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;FCGR2B;NLRP3;TLR2;MAPK8;TNFRSF1B;ADAM9;GSTP1;MYD88;RELA
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5639013574321585,1.3900398009524302,0.10207336523125997,0.4432178955552675,1.0,2/22,0.53%,LRRK2;SP100
prerank,granulocyte chemotaxis (GO:0071621),0.4868715215155604,1.3899220322811598,0.07908163265306123,0.442642117531342,1.0,10/55,13.51%,JAML;SYK;CXCL10;CKLF;ITGB2;GBF1;PIKFYVE;ANXA1;LGALS3;FCER1G
prerank,neutrophil chemotaxis (GO:0030593),0.4917752441950037,1.3898202447920007,0.08762886597938144,0.4420455208888364,1.0,9/53,13.51%,JAML;SYK;CXCL10;CKLF;ITGB2;GBF1;PIKFYVE;LGALS3;FCER1G
prerank,monosaccharide transmembrane transport (GO:0015749),0.6046783604366182,1.3887857517881246,0.1294851794071763,0.4439799454949759,1.0,2/16,2.23%,SLC23A2;SLC23A1
prerank,protein ADP-ribosylation (GO:0006471),0.5478607230495153,1.3886591640390153,0.10115606936416185,0.44346726113789553,1.0,14/28,21.67%,ZC3HAV1;PARP8;PARP4;TIPARP;ARF4;PARP14;TNKS;PARP9;SIRT4;PARP12;SIRT1;PARP11;SIRT3;PARP1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.6146437575466892,1.3881243262482537,0.12437810945273632,0.4440833087546934,1.0,6/16,11.02%,DTX3L;MAD2L2;SMCHD1;WRAP53;PARP9;KMT5B
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6588732327136512,1.388093420765423,0.13245033112582782,0.44329792141036795,1.0,5/11,16.74%,NEDD4L;PICALM;TAX1BP3;SNX33;GOPC
prerank,nuclear migration (GO:0007097),0.6188497917619975,1.387502720809043,0.11725293132328309,0.4439100267640007,1.0,4/13,11.89%,SYNE3;FBXW11;PAFAH1B1;DYNC1H1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.470319144166103,1.3874915465246154,0.049079754601226995,0.44309760003084864,1.0,21/72,13.17%,PSME3;MAP3K14;REL;MALT1;PSMB7;PSME2;BIRC3;FBXW11;TIRAP;PSME4;TLR3;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;PSMB1;AKT1
prerank,regulation of cytokinesis (GO:0032465),0.4616819558512581,1.3874347171704746,0.07779171894604768,0.44239630365875443,1.0,17/78,12.25%,SVIL;UVRAG;CDC14A;PRKCE;RACGAP1;CUL3;KIF20A;BIRC6;KIF23;CDC42;PKN2;RHOA;SPAST;GIT1;SETD2;CSPP1;PIK3R4
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6567458844602325,1.3872215965930328,0.1132404181184669,0.44214597745200107,1.0,3/10,10.19%,KYNU;ATP7A;KYAT1
prerank,"wound healing, spreading of cells (GO:0044319)",0.5679388867706399,1.3871349174795435,0.10182370820668693,0.4415246825264597,1.0,8/24,16.50%,CD44;LCP1;ADAM17;FLNA;RHOA;MRTFA;ITGA5;WNT7A
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6079043720396221,1.387104409932746,0.1070840197693575,0.44076253998880505,1.0,5/16,8.95%,ST3GAL4;FUT4;ITGB2;IL6;RHOA
prerank,positive regulation of protein modification process (GO:0031401),0.42150398774269965,1.3869562430632207,0.023305084745762712,0.4403079739003913,1.0,42/203,13.34%,CD74;NIBAN1;LRRK2;IL1B;LYN;PECAM1;ACE;CD40;PPP2R5A;PAK1;FGF5;FGF22;NPTN;AXIN1;DLC1;CCND3;VEGFC;UBE2N;CCND1;STK4;WDFY2;ADAM17;SVIP;CIB1;DYRK1A;ENG;RAC1;ACVR2A;HGF;RALB;PGF;ANKLE2;CAMKK2;DAXX;RIPK1;DVL3;APP;CLIP3;CCND2;ATG10;AKT1;LIMK2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4696868371176299,1.3863801705895735,0.05535499398315283,0.4409608026875505,1.0,28/70,18.39%,CYBB;LNPEP;PSME3;CD36;PSMB7;IKBKB;PSME2;MFSD6;TAP1;PSME4;PSMB8;NCF2;PSMA5;PSMD9;B2M;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;NCF1;FCER1G;SNAP23;PSMD12;CYBA;PDIA3;FCGR1A;TAPBP
prerank,macrophage migration (GO:1905517),0.6293735113266622,1.3863696432180055,0.12786885245901639,0.4401534595642111,1.0,2/13,5.36%,CCR2;CKLF
prerank,DNA double-strand break processing (GO:0000729),0.574796779408641,1.386211029860855,0.128125,0.43974001809985097,1.0,6/18,13.56%,DNA2;RBBP8;MRE11;UBE2N;EXD2;RNF138
prerank,negative regulation of MAPK cascade (GO:0043409),0.4543270170857519,1.3857230469972828,0.05596107055961071,0.4401363708407589,1.0,25/87,15.81%,PTPRC;IL1B;LYN;CD300A;RGS2;STK38;SORL1;SYNJ2BP;LMO3;PTEN;PAQR3;EZR;EPHB2;DUSP6;SPRED3;SMAD4;PTPN1;DUSP1;PSMD10;RGS14;PTPRJ;GSTP1;DUSP26;SPRED1;IRAK3
prerank,intracellular pH reduction (GO:0051452),-0.42348741224616615,-1.3856486377100008,0.06338028169014084,0.6324735326019958,1.0,14/33,16.18%,ATP6V1C1;ATP6V0B;SLC11A1;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;DMXL2;ATP6V0D1;ATP6V0A1;CLCN3;GPR89B;GPR89A
prerank,RNA interference (GO:0016246),-0.5071120667390522,-1.385486312948622,0.10526315789473684,0.6291214296753188,1.0,6/17,17.99%,AGO3;TSN;AGO1;DHX9;TSNAX;DROSHA
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5144687078268728,-1.3847996352628482,0.1099476439790576,0.6278625284954431,1.0,9/15,34.23%,ENTPD1;ENTPD5;AK1;ENTPD7;CMPK2;AK4;ENTPD3;ENTPD6;NME2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5952311654245706,-1.384432077767193,0.12672811059907835,0.6252116299919079,1.0,3/10,3.11%,PDE3B;RNF157;UBE2B
prerank,positive regulation of cellular respiration (GO:1901857),0.6489473472967099,1.3844236446752596,0.12903225806451613,0.44258994740827523,1.0,6/11,19.97%,IFNLR1;IFNAR1;PRELID1;VCP;PINK1;PARK7
prerank,oligosaccharide metabolic process (GO:0009311),0.49821287512437573,1.3841869155715023,0.08264462809917356,0.44234162519497083,1.0,5/46,3.54%,ST8SIA4;ST3GAL4;ST8SIA1;FUT4;ST8SIA6
prerank,positive regulation of RNA metabolic process (GO:0051254),0.5035099380988296,1.3837014989531027,0.09497964721845319,0.442805123776327,1.0,16/45,15.29%,IL1B;NFKB1;HSPA1A;ERN1;SETX;DYRK1A;RIOK1;IL6;RBM22;RIPK1;NMD3;ZPR1;HNRNPLL;PNPT1;TGFB1;RELA
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.5860525215852355,-1.3836688909201702,0.09610983981693363,0.6242219565899729,1.0,4/10,11.71%,COMT;SMOX;HNMT;ALDH7A1
prerank,Golgi organization (GO:0007030),0.4416202639321579,1.3828963456172865,0.037914691943127965,0.44405611525055305,1.0,34/112,17.55%,ATP8B4;LRRK2;VRK1;FAM174B;USP6NL;GOLPH3L;CDC42;PI4K2B;STX17;STX6;TMED10;GCC2;GBF1;STX5;BCAS3;ATL3;ARFGEF1;LMAN2L;ARHGAP21;FHDC1;YWHAZ;TRAPPC11;HTT;STX16;CLASP1;VMP1;RAB29;TMED7;VCPIP1;HACE1;TJAP1;PI4K2A;BET1;ATP8B2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6408193941721052,1.382365447117903,0.12871287128712872,0.44456091532977293,1.0,5/12,19.53%,UVRAG;SETX;FYCO1;INSR;JMJD4
prerank,regulation of cell killing (GO:0031341),0.6067805506035758,1.3819620995500927,0.10517529215358931,0.4447555963738946,1.0,8/16,18.68%,NOX1;RAC1;ICAM1;CR1L;MAPK8;DVL2;CYBA;FZD7
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5805353906564731,1.3818706208468763,0.13063063063063063,0.44413893662363463,1.0,4/19,5.91%,PRKCE;TNIP3;ITGB2;TIRAP
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.47638377610030375,1.3801516763827457,0.0922266139657444,0.44760874752570795,1.0,17/57,14.65%,LYN;FLT3;CD40;JAK2;STAT3;INPP5F;IL6R;PARP14;IL6ST;IL6;PARP9;IL31RA;NF2;KIT;HCLS1;FGFR3;IL18
prerank,regulation of stress fiber assembly (GO:0051492),0.4593146392152849,1.3799743401635776,0.06658595641646489,0.44729010814439085,1.0,18/74,8.95%,ARHGEF18;CD47;PAK1;WASF2;ARHGEF10L;PTGER4;CCDC88A;CDC42;DLC1;ARAP1;CARMIL1;PAK2;S100A10;PHLDB2;F11R;RAC1;PXN;RHOA
prerank,positive regulation of nervous system development (GO:0051962),-0.404284270336616,-1.3795496376368166,0.047244094488188976,0.6351583255557955,1.0,16/42,20.54%,CX3CR1;PTPRD;NUMB;IL1RAPL1;NLGN1;GRID2;TGM2;IL1RAP;NLGN2;SNW1;CLSTN2;NLGN3;SOX11;TRIM32;NRXN1;DLG5
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.549155578495964,-1.3794129909212947,0.10638297872340426,0.6317558864396502,1.0,9/13,40.08%,SYT1;SCAMP5;STX1A;CACNA1I;KCNB1;SYT10;SYT4;CACNA1H;HYAL3
prerank,regulation of monooxygenase activity (GO:0032768),0.5523094674287625,1.3794010302589594,0.10391566265060241,0.44796381033044474,1.0,3/23,4.77%,IL1B;NOSTRIN;GDNF
prerank,negative regulation of viral genome replication (GO:0045071),0.5034898614344288,1.378725175137823,0.08869814020028613,0.4489641952547925,1.0,8/40,7.16%,ZC3HAV1;OAS2;PLSCR1;EIF2AK2;SLPI;FAM111A;IFIH1;OASL
prerank,cell chemotaxis (GO:0060326),0.4736471209951822,1.3785385610843408,0.08194622279129321,0.44864482009155066,1.0,10/60,8.63%,CCR2;XCR1;CCR1;ACKR2;CCR9;BCAR1;ELMO2;CCRL2;ABCC1;HGF
prerank,mitochondrion distribution (GO:0048311),0.6271819187950454,1.378336812816621,0.13286713286713286,0.4483849228430519,1.0,3/12,12.87%,LRRK2;CLUH;DNM1L
prerank,regulation of protein phosphorylation (GO:0001932),0.411840823861192,1.3779576821399655,0.017616580310880828,0.4485460872216611,1.0,54/256,13.34%,CD74;FGR;NIBAN1;LRRK2;PID1;IL1B;LYN;PECAM1;FYN;CD40;PPP2R5A;PAK1;FGF5;FGF22;CCDC88C;NPTN;CCDC88A;AXIN1;IBTK;CCND3;VEGFC;ITGB2;PTEN;CCND1;STK4;PRNP;WDFY2;ADAM17;CIB1;MOB1B;PAQR3;ENG;RAC1;EPHB2;ACVR2A;HGF;RALB;PGF;CAMKK2;FN1;DAXX;RIPK1;CACTIN;DVL3;PPP1R15B;APP;NDUFS4;CLIP3;EIF2AK3;CCND2;AKT1;STAT2;NSD1;LIMK2
prerank,regulation of microtubule nucleation (GO:0010968),0.6735297261186818,1.3772901015802042,0.13846153846153847,0.4494055586668834,1.0,4/10,9.40%,PAK1;HSPA1A;MECP2;GIT1
prerank,positive regulation of coagulation (GO:0050820),0.6474690587859705,1.3769766023860064,0.11387900355871886,0.4486227127370567,1.0,1/10,0.58%,ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.6474690587859705,1.3769766023860064,0.11387900355871886,0.4486227127370567,1.0,1/10,0.58%,ST3GAL4
prerank,positive regulation of DNA repair (GO:0045739),-0.39120766393998696,-1.3766391701768823,0.05172413793103448,0.6375768352208063,1.0,16/46,14.35%,EYA4;SPIRE1;MGMT;SLF2;ERCC6;HMGB1;SLF1;XRCC1;FMN2;CEBPG;TMEM161A;ZCWPW1;TIGAR;PCNA;DHX9;NPAS2
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6053667224119541,1.3763123737043914,0.11666666666666667,0.44950081822050675,1.0,4/16,9.30%,FPR1;NDNF;CD36;GUCY1A1
prerank,mitochondrion morphogenesis (GO:0070584),0.6452087042180729,1.3762642312532152,0.11884550084889643,0.448831317488179,1.0,5/11,14.07%,PID1;FIS1;DNM1L;PNPT1;MYH14
prerank,regulation of cell junction assembly (GO:1901888),0.5413074499834301,1.3758546208507203,0.11301859799713877,0.44904208325257433,1.0,8/27,9.41%,PDLIM5;RAP1A;PRKCH;MYO1C;RAPGEF2;CBFB;F11R;SETD5
prerank,cellular response to organic substance (GO:0071310),0.43305708799615383,1.3750725924791098,0.049596309111880045,0.45024504456206277,1.0,19/116,9.32%,LRRK2;PID1;IL1B;FLT3;KLF4;STAT3;BMPR2;NCOA3;PTPN6;STAT5B;PTPN7;CERS1;PTPN12;ADRA2A;TIPARP;CIB1;ACVR2A;RHOA;NCOA2
prerank,ERBB signaling pathway (GO:0038127),0.4737942774352964,1.3749554063895573,0.07924528301886792,0.4497445175927149,1.0,20/64,15.13%,IQGAP1;PIK3C2A;NRG2;CUL5;ERBIN;CBL;PTPN12;BCAR1;RPS6KA5;GRB2;PTK2B;ADAM17;PDPK1;SOS1;BRAF;PIK3CA;AKT1;MVP;TGFB1;MAPK1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4034812471919438,-1.3743334701160113,0.0784313725490196,0.6421692818887422,1.0,14/44,15.01%,KCNMA1;WNK1;ATP1B3;KCNJ2;ATP1B1;ANK2;WNK2;KCNN2;KCNMB2;AKAP6;KCNJ6;KCNN3;KCNJ9;GABBR1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4947328357761094,1.373935638313756,0.09005376344086022,0.45163604049241574,1.0,13/43,15.29%,KLF4;NGFR;PPARG;STAT3;FOS;SPI1;KLF5;NR3C1;FOXO3;REST;TEAD1;TGFB1;RELA
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6421904950980022,1.3733057952259506,0.12607944732297063,0.4523992142237574,1.0,4/11,7.44%,LIMD1;STAT3;XPO5;PUM2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5936270866200603,1.3732872189612157,0.11961722488038277,0.45164259195949485,1.0,2/18,6.45%,CCR2;PTK2B
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5772422778814297,-1.3727535366103911,0.12155963302752294,0.6438053990339302,1.0,3/11,2.64%,BIN1;CACNB2;CACNA2D1
prerank,negative regulation of binding (GO:0051100),0.4515768990253632,1.372261662133674,0.05644171779141104,0.4535258578533481,1.0,22/81,15.26%,LRRK2;SP100;JAK2;IFIT2;SORL1;NFKBIA;SLPI;MITD1;SUMO1;CARD16;TMC8;PEX14;RALB;CPNE1;MAPK8;AKT1;IFIT1;ROCK1;RSF1;AURKB;ILRUN;DISC1
prerank,regulation of cellular component movement (GO:0051270),0.48200044127599945,1.372236786165487,0.08507853403141362,0.4527876912108207,1.0,12/49,8.95%,SP100;LYN;PKN1;NRG2;ARHGAP18;INPP5F;ARAP1;DIAPH1;ADAM17;MYCBP2;PKN2;RHOA
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3977307521922522,1.3721786077459481,0.002026342451874367,0.4521372744542068,1.0,99/476,15.29%,CD74;CIITA;NFE2;IL1B;RUNX2;RARA;SP100;SP3;RUNX3;GLI1;BCL3;KLF4;CREB1;RET;MAP3K5;PPARG;NFKB1;PITX3;ATF7IP;DTX3L;STAT3;EHF;NSD3;ELF4;FOS;MAD2L2;CRLF3;NAA16;MYRF;SCX;ATAD2;TBL1XR1;PICALM;IKBKB;MED30;RYBP;AXIN1;RFX3;WAC;DEAF1;MED13;STAT1;HIPK2;RNF20;IRF4;FBXW11;TRIM16;SEC14L2;AHR;TADA3;DYRK1A;PLCB1;AFAP1L2;CLOCK;CTCF;ELF1;IL6;KAT6A;ID2;CREBL2;NAA15;ZNF496;PARP9;IRF7;SMAD4;CAMKK2;PSMD9;NCOA1;IL31RA;ING2;FOXO3;MED12;DVL3;ETS2;REST;RPS6KA1;MED14;NFYA;TFAM;MAP2K3;TEAD1;MYB;AKT1;NSD1;LBH;NCF1;SMARCC2;CITED2;NFIL3;TGFB1;RSF1;MAZ;KMT2E;GPATCH3;SERTAD3;RHOG;KMT2A;CREBBP;RELA
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.45482673011665803,1.3717642765148683,0.07047387606318348,0.45240954681730144,1.0,18/76,12.51%,IL1B;PTPN22;BCL3;LAPTM5;SPI1;NFKBIA;EIF2AK2;PDCD4;EZR;TLR3;IFI35;RHOA;CPNE1;RPS3;CYLD;NLRP3;APP;TLR2
prerank,response to tumor necrosis factor (GO:0034612),0.4447081575690184,1.3716011566949762,0.06175771971496437,0.4520412741376389,1.0,25/91,17.83%,PID1;CD40;JAK2;ERBIN;IKBKB;CXCL16;ZFAND6;NFE2L2;CIB1;ZFP36L2;TANK;RPS3;RIPK1;CACTIN;MAP4K3;ACOD1;AKT1;ADAMTS12;ADAM9;GBP2;GBP3;RELA;AFF3;SIRT1;YBX3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4626619580507251,1.3709847436521831,0.05970149253731343,0.45281891199829805,1.0,24/75,17.18%,IL1B;LYN;HEG1;CD300A;PKIB;RGS2;STK38;SORL1;HEXIM1;PTEN;PAQR3;LATS1;PTPN1;PRKAR2A;LATS2;DUSP1;RGS14;AKT1;PTPRJ;GSTP1;IRAK3;APC;RB1;SIRT1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5458893830977871,-1.3705931954624093,0.15274463007159905,0.6480372802290884,1.0,3/13,7.61%,ATP1B3;ATP1B1;ATP1A2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.5333726492600227,-1.3703674348408164,0.11735941320293398,0.6450286970688462,1.0,9/14,38.44%,ENTPD1;ENTPD5;NUDT16;ENTPD7;NUDT1;ENTPD3;ENTPD6;NUDT18;ENTPD2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5588415688179056,1.3700691500393762,0.11624441132637854,0.4543578460009647,1.0,6/23,8.66%,OCRL;INPP5F;PTEN;MTMR3;MTMR4;SYNJ1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.48316633561074485,1.3691562875152263,0.0913978494623656,0.45594580164137155,1.0,15/49,14.65%,LYN;FLT3;CD40;JAK2;STAT3;IL6R;PARP14;IL6ST;IL6;PARP9;IL31RA;KIT;HCLS1;FGFR3;IL18
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.42554483200609244,1.3683512783601355,0.04515418502202643,0.4572790295952353,1.0,19/151,9.62%,CD74;CD44;FFAR4;PTPRC;NOTCH2;PTPN22;RAP1A;CCR1;CD36;RAPGEF2;GLIPR2;FBXW7;PRXL2C;TIRAP;PTK2B;CIB1;OPRM1;ICAM1;BRAF
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.5147678768150143,-1.3671653111788082,0.09090909090909091,0.6530811661927988,1.0,8/15,39.23%,SMOX;PAOX;DDC;ASMT;SAT2;MOXD1;SRM;AANAT
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4372922078359831,1.3666933916099873,0.06314580941446613,0.46072471398025533,1.0,27/114,13.54%,TRAF1;TNFSF13B;CD40;PSME3;JAK2;MAP3K14;NFKBIA;PSMB7;IKBKB;PSME2;BIRC3;STAT1;PTK2B;ADAM17;TRAF3;PSME4;PSMB8;PSMA5;PSMD9;RIPK1;PSMB3;FOXO3;PSMD6;PSMC4;PSMD10;PSMB1;TNFRSF1B
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.37287759369349016,-1.3663848864294768,0.02843601895734597,0.6520172454739831,1.0,10/57,3.96%,DLGAP1;MEF2C;GRIA4;LRRC7;NLGN1;DLGAP4;DLG2;DLG4;GRIA2;GRIA1
prerank,regulation of JNK cascade (GO:0046328),0.4358449528104029,1.3663674022488812,0.06257378984651712,0.4607407401421751,1.0,32/101,18.81%,IL1B;TRAF1;MARVELD3;MAP3K5;ITCH;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;PHLPP1;MBIP;MINK1;CYLD;RIPK1;FCGR2B;APP;SH3RF1;NCF1;HDAC3;GPS2;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7;PINK1
prerank,membrane lipid biosynthetic process (GO:0046467),0.4678940516510021,1.366084975953532,0.07279693486590039,0.4606380494426105,1.0,16/58,16.43%,CERS6;ST3GAL4;ACER3;ST8SIA6;CERS1;ELOVL5;SAMD8;SGMS1;SGMS2;ELOVL6;SPTSSB;SGPP2;SGPP1;FA2H;VAPA;HACD4
prerank,toll-like receptor signaling pathway (GO:0002224),0.44815084150569795,1.3654491664235857,0.06471306471306472,0.4614781089901183,1.0,23/84,13.04%,TNIP3;PLCG2;MAPKAPK3;CD36;RPS6KA3;MAPKAPK2;IKBKB;BIRC3;ITGB2;UBE2D3;IRAK4;TIRAP;MAP3K1;TRAF3;SFTPA1;SFTPA2;TLR3;RIPK1;TAB3;MAP3K7;PIK3R4;TLR2;BTK
prerank,cytoplasmic translational initiation (GO:0002183),-0.49092748262597374,-1.3653788980281634,0.10326086956521739,0.6515280999140595,1.0,8/17,15.06%,EIF4A1;DENR;EIF2S2;DHX29;EIF3M;EIF5;EIF4G1;EIF4H
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4773466478549979,1.3653282534383542,0.08311688311688312,0.4609901917226655,1.0,8/53,10.39%,XCR1;CCR1;LPAR3;HTR1D;HTR4;OPRM1;HRH1;ANXA1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.4962668223889324,1.3650675038240139,0.09403973509933775,0.4608823961714537,1.0,4/41,4.76%,ITPR1;PTPRC;PLCG2;IBTK
prerank,negative regulation of locomotion (GO:0040013),0.6279127975813208,1.3643280509177211,0.10683012259194395,0.46203472567344545,1.0,2/12,2.67%,CCDC125;CRK
prerank,regulation of microglial cell activation (GO:1903978),0.6083160251953361,1.3636881409243709,0.12618296529968454,0.4628370772005855,1.0,3/15,1.75%,PTPRC;STAP1;LDLR
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5917675965706868,1.3636279054235323,0.11587301587301588,0.46137717646850507,1.0,4/17,5.37%,STAT5A;STAT3;STAT5B;IL2RG
prerank,cellular response to interleukin-7 (GO:0098761),0.5917675965706868,1.3636279054235323,0.11587301587301588,0.46137717646850507,1.0,4/17,5.37%,STAT5A;STAT3;STAT5B;IL2RG
prerank,response to muramyl dipeptide (GO:0032495),0.6411186893048646,1.36346573508238,0.14160839160839161,0.46102701620374653,1.0,3/12,3.20%,PTPN22;VIM;ERBIN
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5104068426813937,1.3625621532121197,0.096,0.46257278969039384,1.0,8/41,11.98%,CD44;IL1B;CD47;PTPRU;AFDN;PIEZO1;ADAM19;MEGF10
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.41289118955883025,-1.3625164388929216,0.08362369337979095,0.6580420164038522,1.0,9/38,7.60%,CACNA1D;BIN1;CTNNA3;CACNB2;CACNA2D1;KCNJ2;CACNA1C;ANK2;JUP
prerank,axonal transport (GO:0098930),-0.4130958334285008,-1.3624789504636123,0.08417508417508418,0.6544074201134286,1.0,7/36,5.25%,DST;DTNBP1;TMEM108;KIF1B;KIF1A;AP3M2;HIF1A
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5205588305720722,1.362074891426426,0.11496062992125984,0.4630671767674209,1.0,4/30,3.33%,PTPRC;FLT3;ACE;PLD4
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3696985401830977,-1.3617706150495295,0.03571428571428571,0.6531123467711801,1.0,21/59,20.06%,PTPRM;CD84;CADM1;ROBO2;ROBO1;CNTN4;PLXNB2;HMCN1;PTPRT;SDK1;PVR;NECTIN4;IGSF11;KIRREL3;CNTN6;PLXNB3;PALLD;NECTIN2;NEXN;CELSR2;CDH4
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.503297125418035,1.36072881671334,0.10121457489878542,0.4657373347058861,1.0,11/39,16.27%,FXYD5;KLF4;MAD2L2;AKNA;MBP;MAP2K5;NF2;AKT1;TGFB1;ASS1;MYADM
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.4385576190906844,-1.3604029731875427,0.11071428571428571,0.6544095030857688,1.0,15/28,27.72%,LGMN;APOE;PTN;EIF2AK4;ZDHHC2;CHRNA7;SQSTM1;ADCY8;TYROBP;AKAP5;EPHA4;ADCY1;NSG1;ABL1;CALB1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4710820450172537,1.3600500026712585,0.09230769230769231,0.4668004611191507,1.0,9/51,8.70%,LRRK2;SRGAP2;NGF;PAK1;SHTN1;TAOK3;SNX1;ATP7A;MINK1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6024076712573558,1.3598442690747838,0.13376835236541598,0.4665343958417045,1.0,5/14,17.33%,MALT1;TIRAP;TLR3;MAP3K7;TRAF2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5590676605595621,1.3590890995430365,0.14219474497681608,0.46773214785888306,1.0,3/20,4.29%,PID1;PPP2R5A;PICALM
prerank,reverse cholesterol transport (GO:0043691),-0.5422936423595356,-1.3585940633394795,0.14092140921409213,0.6572643097717172,1.0,2/13,0.41%,ABCA1;APOE
prerank,regulation of immune effector process (GO:0002697),-0.40341742035588835,-1.3583154929581902,0.08303249097472924,0.6545984691792627,1.0,11/41,13.73%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,small GTPase mediated signal transduction (GO:0007264),0.4400935470475224,1.3582511526032008,0.06007067137809187,0.46919100796872487,1.0,25/103,11.32%,GRAP2;RIN2;TIAM1;ARHGEF18;TIAM2;SHTN1;CCDC88C;ARHGAP18;RASGRP2;ARHGAP30;RAPGEF2;CCDC88A;BCR;ADRA2A;MAPK14;GRB2;SHOC2;NUCB2;RAC1;GNB1;SOS1;RALB;RASSF1;RHEB;NTN1
prerank,RNA modification (GO:0009451),-0.37689166893853826,-1.358241240705217,0.0547945205479452,0.6512410317151993,1.0,36/54,36.26%,NSUN2;TRMT1;ANKRD16;JMJD6;QTRT1;ELP5;TYW5;NOP2;ADAR;NSUN3;CDKAL1;METTL1;DTWD2;SSB;THUMPD1;FTSJ3;NSUN5;WDR4;ADARB1;TRMT6;NSUN6;LCMT2;TRMT9B;NAT10;BCDIN3D;DTWD1;PUS7;QTRT2;FTSJ1;ALKBH1;CTU2;AARS2;THG1L;RBM15B;TRMT61A;CTU1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.49087573675791907,1.3580786253594046,0.11559888579387187,0.4688322645714627,1.0,15/46,15.33%,PTPRC;LYN;SYNJ2BP;LMO3;PTEN;EZR;EPHB2;DUSP6;SPRED3;SMAD4;PTPN1;RGS14;GSTP1;DUSP26;SPRED1
prerank,positive regulation of secretion by cell (GO:1903532),-0.35382200405156267,-1.3580227583226807,0.07253886010362694,0.6483854784085589,1.0,13/70,5.40%,FRMD4A;IGF1;DTNBP1;TREM2;CADPS;PPIA;CD33;IL1A;ATP6AP1;CLASP2;RAB9A;ADAM8;P2RX4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.39687482559193304,1.3578557384316443,0.005112474437627812,0.4685764054527823,1.0,71/390,10.06%,FGR;VAV3;NEDD9;TIAM1;CYBB;HCK;LYN;RASGRP4;NGF;FLT3;ACTR3;STAP1;NGFR;FYN;RET;LMTK2;SULF2;MAPKAPK3;SYK;PAK1;FGF5;FGF22;PIK3C2A;JAK2;STAT3;WASF2;KL;CRK;ATP6V0E1;GTF2F2;RAPGEF2;SLA;MAPKAPK2;ABI1;POLR2C;CBL;ZAP70;CDC42;CLNK;VEGFC;BCAR1;ELMO2;CAV2;STYK1;MAPK14;AP2A2;POLR1G;GRB2;SETX;PTK2B;ACTR2;EFNA2;SHOC2;PAK2;GIGYF2;PLCB1;DDIT4;RAC1;PXN;EPHB2;ARPC1B;SOS1;HGF;RHOA;ATP6V1H;GIT1;TRIM71;PGF;ARPC2;NCF2;ARPC4
prerank,positive regulation of protein secretion (GO:0050714),-0.3510899946420946,-1.357659761862063,0.025380710659898477,0.6460291533166544,1.0,24/69,21.35%,FRMD4A;IGF1;TREM2;WLS;PPIA;CD33;IL1A;ADAM8;TLR4;SOX4;NLGN2;TGFB2;MYOM1;BMP6;LRRC8A;APBB1;IER3IP1;APBB3;CAPN10;EXOC1;TCF7L2;ANG;PPID;MYH10
prerank,regulation of nervous system process (GO:0031644),-0.4742014930130005,-1.3571399127858956,0.11212121212121212,0.6443744895039177,1.0,5/18,13.27%,DLGAP1;DLGAP4;TMEM108;CHRNA7;HTR2C
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5906914524801415,1.3571207035179733,0.13183279742765272,0.469683000973344,1.0,3/17,4.56%,KLRD1;CD226;KLRK1
prerank,peripheral nervous system development (GO:0007422),0.5454990938275299,1.3568201541571423,0.12752721617418353,0.46970179372708776,1.0,3/23,4.77%,NGF;ADGRG6;GDNF
prerank,negative regulation of blood pressure (GO:0045776),0.6258698335368356,1.3561752101409703,0.1289198606271777,0.47049760830981663,1.0,2/13,5.35%,BMPR2;PRCP
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.49457469924262865,-1.355934261075898,0.1126005361930295,0.6451958127182938,1.0,5/18,11.36%,PRKN;SPIRE1;MFF;VPS35;RALA
prerank,energy reserve metabolic process (GO:0006112),0.5594929648526268,1.3553391047860497,0.12618296529968454,0.4719857131112968,1.0,3/19,9.08%,PID1;PRKAG2;UGP2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6484010088112471,1.3551620721975879,0.12412587412587413,0.4716527601765565,1.0,5/10,19.37%,JARID2;ATRX;MYB;SIRT1;DNMT1
prerank,regulation of cell migration (GO:0030334),0.3989775354579245,1.353995063637874,0.007070707070707071,0.47388353633005004,1.0,58/382,8.95%,CD74;FGR;IL1B;NEDD9;TIAM1;CYRIB;SRGAP3;SRGAP2;SGK3;TCAF2;PECAM1;STK24;ACE;NGFR;SLK;ITGAX;RET;NTNG2;PTPRU;CCR1;PAK1;SEMA4A;FGF5;FGF22;STAT3;DOCK10;CLDN1;MYO1C;RCC2;SORL1;LAMB1;DPEP1;CLIC4;CBLL1;PPP3CA;DLC1;TMSB10;CARMIL1;ADRA2A;BCAR1;RNF20;AFDN;PTEN;CXCL16;PTK2B;ADAM17;FLNA;CIB1;YTHDF3;LMNA;PLXND1;ENG;RAC1;ARHGEF39;EPHB2;HGF;MINK1;RHOA
prerank,mesoderm development (GO:0007498),0.5700600075303448,1.3535765383358815,0.12283464566929134,0.4741713282313581,1.0,4/18,13.04%,HCK;JAK2;IKZF3;BTK
prerank,peptidyl-arginine modification (GO:0018195),0.6054705042904214,1.3535040545518733,0.14102564102564102,0.47355557219103916,1.0,3/15,5.90%,PADI1;KRTCAP2;PRMT8
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5947553868651818,1.353428151444697,0.14006514657980457,0.4729735932896703,1.0,3/16,4.56%,KLRD1;CD226;KLRK1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6363310495736334,1.3533832653837503,0.1515650741350906,0.4723036162761074,1.0,3/11,9.91%,STK24;MAP3K5;GSKIP
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.6375509971047701,1.3532605302141676,0.14431239388794567,0.471835450649086,1.0,4/11,11.47%,RIN3;STAP1;SLAMF8;DUSP1
prerank,transcription by RNA polymerase III (GO:0006383),-0.43980010710433787,-1.35302956888682,0.10149253731343283,0.651747750003811,1.0,11/27,17.93%,IVNS1ABP;GTF3C3;CRCP;GTF3C4;ICE2;GTF3C2;POLR3H;SNAPC4;GTF3C5;SNAPC1;POLR2K
prerank,atrial septum morphogenesis (GO:0060413),0.6364560752977417,1.3529954231307944,0.14109347442680775,0.47172746537296384,1.0,2/10,2.93%,NOTCH2;BMPR2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5360738990352393,1.3524084786909412,0.10782865583456426,0.472398849434516,1.0,8/26,18.06%,FOXP1;CRY1;CRY2;CLOCK;CNOT2;STRN3;SIRT1;HDAC1
prerank,negative regulation of protein binding (GO:0032091),0.4489010117538399,1.3522800201319074,0.08596713021491782,0.47192956016228055,1.0,24/71,19.97%,ITGA4;LRRK2;IFIT2;SORL1;SLPI;MITD1;ATP2A3;CARD16;TMC8;PEX14;RALB;B2M;MAPK8;AKT1;IFIT1;ROCK1;AURKB;DISC1;TFIP11;PRKCD;PIN1;ACTB;STYX;PARK7
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6225421790928581,1.3516332823186916,0.11258278145695365,0.47282303320230945,1.0,4/13,6.65%,ITGA4;AKT3;ADAM17;PDPK1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6043745182614312,1.3512449090013787,0.12421383647798742,0.4730423123447136,1.0,6/14,20.45%,RAPGEF2;PKIB;PRKAR2A;HTT;SIRT1;PKIA
prerank,body fluid secretion (GO:0007589),-0.49985089238547586,-1.3508333502593997,0.1171875,0.655917758851734,1.0,4/15,16.02%,ERBB4;VEGFA;SLC22A4;GPAT4
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5408685324240914,1.350742946365305,0.12254160363086233,0.4736230822418682,1.0,3/24,4.29%,PID1;PPP2R5A;PICALM
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5451457375152107,1.350604347054406,0.12808641975308643,0.47321076226777736,1.0,7/24,7.55%,ARHGEF18;WASF2;DLC1;ARAP1;PAK2;PHLDB2;F11R
prerank,positive regulation of cell differentiation (GO:0045597),0.4018414456770238,1.3501129437436439,0.026096033402922755,0.47371220322609897,1.0,39/237,10.61%,FFAR4;IL1B;RUNX2;RIN2;TIAM1;NGF;RAP1A;CREB1;PPARG;NFKB1;CD36;PRKCH;RPS6KA3;BMPR2;RAPGEF2;CTNNA1;RIPOR2;GLIPR2;IL6R;CDC42;GDNF;BTG1;LMO3;MAPK14;WDFY2;PLCB1;MAPK12;ACVR2A;IL6ST;IL6;HGF;RHOA;CPNE1;ID2;CREBL2;OLFM1;SMAD4;NUDT21;CCDC71L
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.3234348544316843,-1.3496275766746522,0.007518796992481203,0.6567296572817234,1.0,26/124,9.03%,OPHN1;PTPRM;CSF1R;PPP1R9A;APOE;DTNBP1;CAMSAP1;NLGN1;MAP2;PLP1;ERCC6;ODF2;HMGB1;TMEM108;PKD2;CNTN4;WDPCP;LIMA1;CEP78;GPRIN3;RYK;RASGRF1;CDK5R1;SH3GL2;TBC1D23;GPM6A
prerank,C4-dicarboxylate transport (GO:0015740),0.5837482357701709,1.3491127545547088,0.16166666666666665,0.4755897858507799,1.0,5/14,11.50%,LRRC8D;SLC25A13;SLC25A30;SLC25A12;SLC25A18
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.45429587098334495,1.3484083006963015,0.07579462102689487,0.47666137150007787,1.0,18/75,14.09%,GRK5;RASGRP4;RGS2;RGS3;CRY1;PPP1R9B;ZDHHC7;CAMKMT;PLCB1;SYP;RGS12;GIT1;GRK6;NMT2;RGS14;PDE6B;ROCK1;PDE6H
prerank,maintenance of protein location in nucleus (GO:0051457),0.5598477973903797,1.3482802928405935,0.12738853503184713,0.47619287787152487,1.0,2/20,1.24%,SP100;BCL3
prerank,regulation of cytoplasmic transport (GO:1903649),0.6295340784081097,1.3479895572596576,0.1574539363484087,0.47618564266942465,1.0,1/11,0.22%,LRRK2
prerank,chromatin remodeling (GO:0006338),0.4368006793838757,1.3478762998823204,0.0660486674391657,0.4757162137188386,1.0,37/100,20.27%,JARID2;BAZ1A;KDM6A;PAK1;BAZ2B;GATAD2B;INO80C;RBBP4;SMARCA5;EZH1;SMARCE1;DAXX;TADA2A;MBD2;BAZ2A;ATRX;MYB;CHD4;SMARCC2;SRCAP;KAT2B;CHRAC1;RSF1;INO80;KDM4B;NPM3;RB1;BPTF;SIRT1;SMARCD3;HCFC2;HDAC1;GATAD1;ACTB;PBRM1;SATB1;HNRNPC
prerank,positive regulation of cellular catabolic process (GO:0031331),0.42435695381517824,1.3470242841383924,0.067853170189099,0.47692355285435395,1.0,34/132,14.67%,LRRK2;IL1B;ZC3HAV1;DAPK1;ITCH;MSN;PIK3C2A;DTX3L;PLEKHF1;LAPTM5;ZBTB20;ATF6;PRXL2C;ADRA2A;RC3H1;PTTG1IP;FAF1;SVIP;EZR;PTPN1;SNX9;TRIM14;FOXO3;PRKAA1;APP;SH3BP4;PFKFB3;ABCD1;TNFRSF1B;PRKAA2;ROCK1;PNPT1;PFKFB4;ADAM9
prerank,calcium ion transmembrane transport (GO:0070588),-0.3401058295811558,-1.3464075991953492,0.04371584699453552,0.6643627659929514,1.0,27/86,16.27%,CACNA1D;SLC8A1;RYR3;SLC24A3;GAS6;CACNA2D1;TRPV2;TRPM3;PKD2;CACNA1C;ATP2A2;TRPC4;P2RX7;P2RX4;AFG3L2;TRPC1;MCOLN1;MCOLN3;ATP2B3;TRPC7;TRPM2;SPG7;TRPV4;TRPC3;STOML2;MCOLN2;ATP2C1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.45348559781896414,-1.3461414069928563,0.10826210826210826,0.6617569413479663,1.0,7/22,11.81%,APOE;CAMSAP1;MAP2;MAP1B;MAP1A;CHRNA7;CAMSAP2
prerank,negative regulation of cell motility (GO:2000146),0.432340689863696,1.3454247501343088,0.060324825986078884,0.48026499829165403,1.0,14/108,5.92%,CD74;SRGAP3;SRGAP2;STK24;NGFR;PTPRU;CCDC125;CRK;DPEP1;CLIC4;DLC1;RNF20;AFDN;PTEN
prerank,B cell homeostasis (GO:0001782),0.6568850896788947,1.3448585927196555,0.14261460101867574,0.4809362255477688,1.0,5/10,10.04%,LYN;GAPT;DOCK10;DOCK11;CAMLG
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6376710130702526,1.3437376622892245,0.14821428571428572,0.4831898310687433,1.0,1/10,0.22%,LRRK2
prerank,positive regulation of TOR signaling (GO:0032008),-0.40050922483805246,-1.3432839719005092,0.07692307692307693,0.6684136587500168,1.0,14/40,15.21%,TREM2;RPTOR;FLCN;GAS6;FNIP1;GPR137B;KLHL22;LARS1;MIOS;NCKAP1L;LAMTOR5;SEC13;PIH1D1;RRAGC
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.4488963318985866,-1.3432142932487703,0.09428571428571429,0.6616878455427608,1.0,10/24,24.13%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3;ALDOA
prerank,canonical glycolysis (GO:0061621),-0.4488963318985866,-1.3432142932487703,0.09428571428571429,0.6616878455427608,1.0,10/24,24.13%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3;ALDOA
prerank,lipid droplet formation (GO:0140042),-0.5830123408401306,-1.3426051622441966,0.1187648456057007,0.6602847788900525,1.0,6/10,27.88%,CDS1;CDS2;AUP1;BSCL2;ZFYVE1;FITM2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4902632115927328,1.3424655865749162,0.12005457025920874,0.4857089079868729,1.0,12/39,17.18%,ITPKC;PIP4K2A;TTC7A;PIK3C2A;IP6K3;PI4K2B;PIP4K2B;PIK3CA;SMG1;EFR3A;PIK3R2;PI4K2A
prerank,positive regulation of cell population proliferation (GO:0008284),0.3942583311137843,1.3424263414103965,0.005060728744939271,0.485017447941006,1.0,74/423,15.88%,CD74;DPP4;PID1;PTPRC;IL1B;FOXP1;GRK5;RARA;TIAM1;HCK;LYN;CD47;GLI1;FLT3;CDK13;ITGAX;ACER3;TBC1D8;PIM1;PAK1;FGF5;FGF22;CUL3;PRKCH;PTPN6;LAMB1;SCX;IL6R;GDNF;VEGFC;RBPJ;ADRA2A;STAT1;PTEN;PTK2B;ADAM17;CIB1;MECP2;CNOT6;NOX1;DOT1L;CACUL1;IL6ST;IL6;ID2;PGF;CSNK2A1;RPRD1B;FN1;IL31RA;GLP2R;MCTS1;NAP1L1;SLC25A5;MEGF10;NDUFS4;PDGFD;CCND2;LIFR;AKT1;HCLS1;EZH2;GNAI2;TGFB1;COX17;FGFR3;IL18;MAZ;RHOG;RELA;RPS15A;THBS1;CDCA7L;RPS4X
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5587596716415214,1.3423989265447938,0.1482084690553746,0.4842863980678916,1.0,5/18,15.77%,SAMHD1;DERA;FUCA1;STT3B;BPGM
prerank,keratan sulfate biosynthetic process (GO:0018146),0.532008676244465,1.34237867923122,0.14220183486238533,0.48356414358239136,1.0,4/26,8.99%,ST3GAL1;ST3GAL4;B4GALT5;ACAN
prerank,central nervous system development (GO:0007417),-0.28832028268265525,-1.3416851007494466,0.0,0.6601457845905182,1.0,66/250,17.08%,PRKN;ZFHX3;ATXN1;TGFBR2;CX3CR1;WWP1;CHD7;MARCKS;C1QA;ADAM23;ROBO2;PKD2;TPP1;CNTN4;PLXNB2;SMO;NF1;MTF1;APOD;NFIB;AFF2;SPOCK1;CAPG;RAB3GAP1;GRIK1;DCX;JRKL;CDK5R1;NCOA6;POU6F1;SH3GL2;TBC1D23;AATK;LOXL3;ZFHX2;PTPRZ1;UFC1;CDK5;SHROOM2;PHF8;EPHA7;SERPINI1;DHX30;MEIS3;ROGDI;EIF2B5;SOX4;SETD1A;UFM1;C3;ADGRL3;RNF103;NPAS2;TAGLN3;POU3F3;TPPP;PAFAH1B2;ADGRL2;CNTNAP2;ADGRG1;CNTN6;SOX11;SCYL2;PHGDH;IER3IP1;HAPLN2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.5557409900625033,1.34163964190317,0.13924050632911392,0.48457956470747543,1.0,8/21,12.88%,PDZD8;MCUB;SLC8B1;MAIP1;ATP2A1;FIS1;LETM1;MICU3
prerank,adipose tissue development (GO:0060612),-0.5693844667514981,-1.3409493144183653,0.1411764705882353,0.659430773597013,1.0,8/11,33.12%,ARID5B;NAMPT;SH3PXD2B;PGRMC2;DYRK1B;SPTLC2;LRP5;DGAT2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5325393666570322,1.3407636652759323,0.15350223546944858,0.48607367630466247,1.0,5/23,6.72%,FYN;DIAPH1;PRNP;PTK2B;CACNB1
prerank,mitochondrial genome maintenance (GO:0000002),0.640578828977999,1.3405668676617815,0.1565217391304348,0.4857772750507736,1.0,2/11,2.00%,AKT3;LONP1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.33960347470848723,-1.340421746044811,0.04938271604938271,0.6578276236888765,1.0,29/84,14.05%,QKI;SON;DDX5;SRSF3;SFSWAP;RBFOX1;RNPS1;RBFOX2;SRPK1;KHDRBS3;SRSF7;TIA1;TRA2A;SRRM4;JMJD6;FXR1;NOVA1;RBFOX3;RBM5;RBM3;THRAP3;FXR2;NOVA2;PTBP1;RBM25;SRPK2;SNW1;KHDRBS2;WTAP
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5295303803555655,1.3402632837742097,0.13953488372093023,0.4857882751081092,1.0,5/26,4.77%,IL1B;RET;MCL1;HSPA1A;GDNF
prerank,regulation of neuron migration (GO:2001222),0.5350889748107832,1.3402245443665908,0.11561561561561562,0.4851331523581467,1.0,5/26,3.14%,SRGAP2;NTNG2;SHTN1;NIPBL;RAPGEF2
prerank,regulation of p38MAPK cascade (GO:1900744),0.4980749554259805,1.3401269650637087,0.13416320885200553,0.4846089999088861,1.0,12/35,13.44%,IL1B;PTPN22;SPI1;EZR;PHLPP1;MINK1;MAP3K4;RELL1;CYLD;DUSP1;EMC10;NCF1
prerank,polyol biosynthetic process (GO:0046173),0.572975329094079,1.3398428117332628,0.14057507987220447,0.48460593528503665,1.0,4/16,7.76%,ITPKC;ACER3;IP6K3;CYP27A1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6152095551806228,1.339247185060179,0.12947189097103917,0.4852594272385642,1.0,3/13,4.67%,LRRK2;CHMP4A;CHMP4B
prerank,regulation of intracellular pH (GO:0051453),0.4984814939879696,1.3389611653590299,0.11938202247191011,0.485196750232302,1.0,5/34,7.87%,LRRK2;SLC9A7;SLC4A7;SLC4A8;NOX1
prerank,protein monoubiquitination (GO:0006513),0.4990817357224747,1.3384109147120964,0.11310344827586206,0.48583931137742614,1.0,11/36,10.21%,DTL;DTX3L;CUL3;UBE2E1;PEX12;WAC;RNF20;UBE2D3;TRIM25;UBE2W;FANCL
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5939018838051404,1.3383497460989517,0.15544871794871795,0.4852392933598224,1.0,4/15,5.03%,SIK1;LDLR;FBXW7;SCARB1
prerank,cell-cell junction maintenance (GO:0045217),-0.5668014733701598,-1.3382149076334646,0.10772833723653395,0.6622656647081178,1.0,2/11,0.35%,CSF1R;TJP1
prerank,cellular response to lipid (GO:0071396),0.40561813427188476,1.337514933190532,0.04540540540540541,0.4866786625832735,1.0,39/191,15.29%,PID1;IL1B;MAP4K1;LYN;TNIP3;STAP1;CREB1;LILRB1;RET;NFKB1;MSN;VIM;NCOA3;CXCL10;MAPK14;SETX;PTK2B;AHR;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;NR3C1;CACTIN;ACOD1;NLRP3;GNAI1;ADCY5;MAPK8;NRIP1;PDK3;TNFRSF1B;ADAM9;GSTP1;MYD88;RELA
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.604533337217389,1.3374721744775975,0.13989637305699482,0.48602257916110453,1.0,5/13,5.41%,PPARG;LDLR;SYK;CD36;ITGB2
prerank,myeloid leukocyte differentiation (GO:0002573),0.45369618414524077,1.337198812059985,0.10165184243964422,0.4859560478060355,1.0,10/65,6.69%,CBFA2T3;FOXP1;RARA;PPARG;SPI1;MYH9;CDC42;MAPK14;DEK;EFNA2
prerank,regulation of aerobic respiration (GO:1903715),0.5974567346104624,1.337157866807038,0.1541038525963149,0.4852922058971594,1.0,6/15,18.81%,CBFA2T3;ATP7A;ABCD1;VCP;COX7A2;PINK1
prerank,chromatin assembly or disassembly (GO:0006333),0.6236390893669188,1.3367977774138498,0.15817223198594024,0.4854885303993784,1.0,2/11,5.29%,CHAF1A;RBBP4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.42911506354549667,1.3363665448814062,0.07879490150637311,0.4858905977195507,1.0,25/108,11.91%,NGF;DAPK1;NGFR;MAP3K5;PPARG;SYK;JAK2;LAPTM5;MALT1;ATP2A3;DLC1;BBC3;MTCH1;HIP1;PIDD1;RPS3;NLRC4;CASP2;FIS1;RIPK1;APAF1;GRAMD4;AIFM1;NLRP3;REST
prerank,purine-containing compound catabolic process (GO:0072523),0.6122825859324939,1.336235185855385,0.1306532663316583,0.4854859807031054,1.0,2/13,2.68%,GDA;GPX1
prerank,Golgi localization (GO:0051645),0.6271347185366831,1.3357329571808514,0.16695352839931152,0.48597250150317867,1.0,4/11,10.88%,UVRAG;CDC42;ARHGAP21;YWHAZ
prerank,response to sterol (GO:0036314),-0.5658086542034679,-1.3355947727337136,0.1431924882629108,0.6680220047095646,1.0,2/11,1.22%,TGFBR2;TGFBR1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5597762438189814,1.335244526752449,0.14084507042253522,0.4864310429895158,1.0,8/20,13.81%,MCUB;SLC8B1;MAIP1;PARL;LETM1;PMPCA;MICU3;YME1L1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.4971777704285632,-1.334820166151143,0.10803324099722991,0.6674348550794118,1.0,9/17,13.28%,BIN1;APOE;IGF1;NTRK2;RTN3;GGA3;CHRNA7;CLU;ABCA7
prerank,positive regulation of kinase activity (GO:0033674),0.42543124407126137,1.3334819366555877,0.06753554502369669,0.4901894364715476,1.0,18/107,11.05%,CD74;PTPRC;IQGAP1;FLT3;RAP1A;RET;LMTK2;PRKAG2;RAPGEF2;MRE11;TRAF4;PTK2B;CACUL1;EPHB2;DAXX;SNX9;DSTYK;PRKAG1
prerank,DNA replication (GO:0006260),0.4274101334597298,1.3333687683602646,0.08520710059171598,0.4897449491365521,1.0,33/105,18.20%,DNA2;BAZ1A;RBBP8;POLL;CDC45;MRE11;FEN1;FAM111A;KAT7;ORC5;MCM6;RBMS1;POLD4;WRN;ORC4;BRIP1;RECQL5;NAP1L1;RPA3;POLA2;MCM2;RNASEH2A;PCLAF;DONSON;MCMBP;ORC6;MCM9;POLG2;POLB;HUS1;POLD1;ORC2;RAD17
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5198958037463618,1.3330434431491405,0.11823361823361823,0.48979743262594333,1.0,3/27,2.59%,FXYD5;UTRN;NEDD4L
prerank,cell junction assembly (GO:0034329),-0.3282692466596007,-1.3329466483890273,0.03597122302158273,0.6703080640929016,1.0,23/100,16.10%,OPHN1;TJP1;MYO9A;ITGA6;PKP4;FLCN;NLGN1;FBLIM1;CDH11;NRXN2;ILK;RYK;SDK1;GPM6A;CDK5;TLN2;NLGN2;TRPV4;ADGRL3;SLITRK1;PKP2;KIRREL3;NLGN3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6388097871015753,1.332766893144242,0.15425531914893617,0.4897863550003597,1.0,3/10,8.82%,PTPN22;TIRAP;IFI35
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.36368065920533116,-1.3326302169560524,0.0625,0.6680951314803286,1.0,22/59,32.04%,ACACA;OSBPL1A;CH25H;ELOVL4;HOGA1;CBR4;HSD17B8;PER2;LIPH;ABCD3;MLYCD;OSBPL6;AMACR;OXSM;OSBPL7;NDUFAB1;ACOT8;OSBP;ALDH1A2;SLC27A2;OSBPL2;HSD17B10
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5741110764253972,1.3311471245520978,0.14733542319749215,0.4933987713488064,1.0,7/16,19.06%,LRRK2;GBF1;PPP1R15A;TAPT1;VAPA;HSPA5;UBAC2
prerank,regulation of mast cell activation (GO:0033003),0.630554345778632,1.3306551243703877,0.16725978647686832,0.4938707725391746,1.0,3/10,2.32%,CD226;LYN;PLSCR1
prerank,positive regulation of gene expression (GO:0010628),0.39011929911857424,1.3306351528498641,0.009072580645161291,0.49314698652728467,1.0,93/442,15.17%,CD74;CLEC9A;FGR;NIBAN1;PID1;IL1B;NGF;PTPN22;IFNGR1;PLCG2;BCL3;KLF4;STAP1;RPL5;LILRB1;ITGAX;MSN;FGF5;FGF22;PLSCR1;STAT3;VIM;NFAM1;HSPA1A;CD36;ERN1;MYO1C;TAF1A;RNF207;PTGER4;EIF2AK2;SCX;ATF2;RBPJ;IL33;ADRA2A;MAPK14;GLMN;SMARCA5;AFDN;UBR5;POLR1G;DEK;SETX;TADA3;SERPINB9;NFE2L2;DYRK1A;PDE2A;YTHDF3;EZR;MBIP;CTCF;EPHB2;TLR3;IL6;SNF8;RBM22;ID2;OLFM1;BRAF;RPS3;ADAM19;FN1;RIPK1;PRKAG1;MED26;PRKAA1;APP;TLR2;RPL11;EIF2AK3;ZPR1;HNRNPLL;MAPK8;AKT1;METTL3;TLE1;AGPAT1;TNRC6B;ROCK1;CITED2;KAT2B;TNRC6A;LARP4B;TGFB1;POLR1B;EIF3E;TENT4B;MAZ;MYD88;MAPK1;OCLN
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5758861654647255,1.330485155023492,0.1435483870967742,0.49279117649914833,1.0,4/16,8.26%,ST8SIA4;ST8SIA1;ST8SIA6;ST6GALNAC3
prerank,fat cell differentiation (GO:0045444),0.464446052346187,1.3304012171219983,0.1070063694267516,0.4922692283709143,1.0,5/57,1.96%,PID1;FFAR4;KLF4;PPARG;METRNL
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6235646411830436,1.3302103432730235,0.14285714285714285,0.4920598770087564,1.0,2/10,2.59%,PRKCE;NEDD4L
prerank,ventricular septum development (GO:0003281),-0.39423386653221365,-1.3302002254071221,0.10181818181818182,0.6731066014224653,1.0,12/37,13.74%,TGFBR2;SALL1;TGFBR1;ROBO2;ROBO1;SMAD7;MATR3;ACVR1;SLIT2;SLIT3;SOX4;TGFB2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4499847818064854,1.33007221746863,0.10755441741357234,0.49164467937550094,1.0,23/66,16.37%,KLF4;PSME3;ANKRD17;PTPN6;PSME2;CCND3;PTEN;CDKN2C;CCND1;ADAM17;PLCB1;ID2;ANXA1;DCUN1D3;CCND2;AKT1;WEE1;KMT2E;INO80;APC;RBL2;BRD7;RB1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5451416979106974,-1.3297872095773344,0.13123359580052493,0.6713914609374717,1.0,5/13,6.67%,PLXNA4;NRP1;NRP2;PLXNB2;PLXNA2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.394506430864221,1.3294990674413243,0.01859504132231405,0.49234104774316456,1.0,32/308,6.35%,CCR2;CLEC9A;PLAC8;FGR;FFAR4;IL1B;TIAM1;ITGAX;SYK;JAK2;NFAM1;FOXJ1;CD36;PRKCH;BMPR2;MAD2L2;SORL1;NCOA3;GLIPR2;PTGER4;EIF2AK2;UCP2;SCX;B4GALT5;GDNF;RFX3;IL33;ADRA2A;IRF4;GLMN;TRIM16;PRKAB2
prerank,glucose transmembrane transport (GO:1904659),-0.4707776391697966,-1.3285642783736695,0.13157894736842105,0.6725977127349744,1.0,8/18,32.64%,SORT1;SLC2A3;SLC2A9;SLC2A5;RAB4B;SLC2A8;PPARD;SLC45A1
prerank,membrane repolarization during action potential (GO:0086011),0.6108145696700874,1.3283765292736904,0.159369527145359,0.49441222841345944,1.0,2/13,3.31%,KCNE3;KCNQ1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3926020797918237,1.3283518085677912,0.006122448979591836,0.4937304113863258,1.0,77/348,15.17%,CD74;PID1;IL1B;NGF;PTPN22;IFNGR1;PLCG2;KLF4;STAP1;RPL5;LILRB1;ITGAX;ITCH;ANXA2;MSN;FGF5;ATF7IP;FGF22;PLSCR1;DTX3L;STAT3;HSPA1A;CD36;RNF207;LAPTM5;INPP5F;SCX;ATF2;RBPJ;IL33;MAPK14;AFDN;UBR5;TADA3;SERPINB9;WFS1;NFE2L2;MTPN;SETDB2;PDE2A;EZR;MBIP;CTCF;EPHB2;TLR3;IL6;SNF8;ID2;OLFM1;BRAF;TBC1D5;RPS3;ADAM19;FN1;PTPN1;PRKAG1;MED26;PRKAA1;APP;MAP2K5;TLR2;RPL11;EIF2AK3;ZPR1;MAPK8;AKT1;TLE1;TNRC6B;ROCK1;CITED2;TNRC6A;TGFB1;RAB29;MAZ;MYD88;MAPK1;OCLN
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4458029925899568,1.3280879460506194,0.11152882205513784,0.49366332222120896,1.0,29/73,22.13%,NGF;NGFR;PPARG;JAK2;LAPTM5;ATP2A3;DLC1;BBC3;MTCH1;HIP1;PIDD1;NLRC4;CASP2;RIPK1;APAF1;AIFM1;EIF2AK3;VCP;CASP12;TRAF2;HSPD1;BAD;MUL1;XDH;ANP32B;DIABLO;BID;CASP9;SENP1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.486578740002891,-1.3276983061955938,0.15384615384615385,0.6722380829732673,1.0,9/16,30.45%,AUTS2;ARHGAP24;RASGRF1;PIK3CG;ALS2;GABARAP;KBTBD7;CADM4;PIK3CB
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.519216906634721,1.327683956229901,0.14173228346456693,0.4939227787727232,1.0,7/24,14.22%,IL1B;SULF2;NOX1;IL6ST;IL6;EIF2AK3;TGFB1
prerank,regulation of interferon-beta production (GO:0032648),0.478301221729629,1.3276219950572332,0.1121751025991792,0.4933433478845996,1.0,13/46,12.51%,LILRB1;OAS2;POLR3F;DHX58;REL;POLR3A;IFIH1;TIRAP;TRAF3;TLR3;IRF7;CACTIN;TLR2
prerank,superoxide metabolic process (GO:0006801),0.5120509291757145,1.3269220282901453,0.12219101123595505,0.4944589871238878,1.0,7/29,13.44%,CYBB;ATP7A;NOX1;CYB5R4;NRROS;NCF2;NCF1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.4010401975083666,1.326346048529563,0.03164556962025317,0.4952267352352086,1.0,60/234,15.81%,CARD11;IL1B;TRAF1;PLCG2;IL18RAP;CAMK1D;PPARG;CD40;NFKB1;STAT3;NFAM1;HSPA1A;TRIM26;CD36;PRKCH;MALT1;NFKBIA;EIF2AK2;IKBKB;ATF2;TRIM62;RAB7B;HIPK2;RPS6KA5;TIRAP;PTEN;UBE2N;BUD31;CIB1;MTPN;TRIM25;CLOCK;CARD16;IL6;NFKBIB;PIDD1;RPS3;NLRC4;RIPK1;TRIM14;RNF31;TAB3;NLRP3;APP;MAP3K7;TLR2;BTK;AKT1;KIT;HCLS1;LPAR5;CRTC3;MAP3K13;IL18;MYD88;RELA;TAF1;DVL2;LRP8;IRAK3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6222780922996479,1.3259489819970303,0.1737649063032368,0.4954897756205046,1.0,1/12,0.38%,FOXP1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.49536455276711433,1.3252666187279756,0.12939521800281295,0.4965217499272696,1.0,6/38,3.17%,IL1B;CD47;KLF4;JAK2;CD36;PTGIS
prerank,positive regulation of interleukin-4 production (GO:0032753),0.562844140580663,1.3250645482858627,0.1423841059602649,0.496296221360807,1.0,5/17,13.51%,RARA;SYK;IRF4;NLRP3;FCER1G
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5649975688426564,1.3247428859587547,0.1527777777777778,0.49632066887800985,1.0,8/19,13.07%,KLF4;TAF9;IFIH1;CBFB;ELF1;PARP9;MAP2K5;LIFR
prerank,DNA packaging (GO:0006323),0.5813906783120784,1.324686876611903,0.15397350993377484,0.4957122571887517,1.0,4/16,11.18%,CHAF1A;RBBP4;KAT6A;AIFM1
prerank,copper ion homeostasis (GO:0055070),0.5709201052220481,1.3244646764949624,0.1492063492063492,0.4955443708152593,1.0,8/17,16.65%,PRNP;ARF1;ATP7A;ATOX1;APP;CUTC;XIAP;SLC31A1
prerank,positive regulation of innate immune response (GO:0045089),0.5038503561523495,1.3233525697828503,0.13069016152716592,0.49765831163757046,1.0,6/30,9.24%,POLR3F;PLSCR1;SPI1;TRIM62;IFI35;SLC15A4
prerank,cell cycle G1/S phase transition (GO:0044843),0.4507717498084325,1.3220924526791829,0.09102730819245773,0.5001286152217304,1.0,11/61,9.43%,GPR132;CUL3;CUL5;EIF4EBP1;CRLF3;CDKN2C;CCND1;CCNH;CACUL1;LATS1;TRIM71
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.5208250386519011,1.321919054563642,0.12759643916913946,0.4998370978353898,1.0,12/27,18.99%,LIMD1;STAT3;PUM2;IL6;RIPK1;EIF4ENIF1;TNRC6B;TGFB1;PUM1;AJUBA;DDX6;MAP2K1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5904189769578592,1.3206997486173087,0.1595197255574614,0.5022967116397206,1.0,2/14,1.13%,IL1B;PAEP
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4320310161670769,1.3206679711850913,0.08037825059101655,0.5016105132146713,1.0,18/94,11.18%,ITPR1;STK24;MAP3K5;MCL1;CUL3;ERN1;CUL5;ATP2A3;BBC3;HIPK2;CRIP1;ATP2A1;MSH6;PPP1R15A;GSKIP;CASP2;APAF1;AIFM1
prerank,negative regulation of cellular protein localization (GO:1903828),0.4989066893069173,1.3203097430559365,0.11624649859943978,0.5017765739832281,1.0,13/34,19.09%,NEDD4L;CTNNA1;RIPOR2;SPI1;PICALM;LATS1;LATS2;TAX1BP3;ILRUN;SNX33;GOPC;LZTFL1;ANKRD13A
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5077891014211879,-1.3199894606371556,0.15227272727272728,0.6953626260439579,1.0,10/15,32.35%,DERL2;HSP90B1;AUP1;NPLOC4;DERL1;HERPUD1;SEC61B;FAF2;TMEM129;SYVN1
prerank,postsynaptic membrane organization (GO:0001941),-0.48394780871472853,-1.3193891083572007,0.13196480938416422,0.694220532251785,1.0,8/17,19.15%,APOE;NLGN1;DLG4;NRXN2;NLGN2;NLGN3;LHFPL4;NRXN1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4419969197600905,1.3192286570253915,0.10476190476190476,0.5038770555946688,1.0,25/79,17.19%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;MFSD6;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;DYNC1I2;AP1M1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4698840333575574,1.3185177211462034,0.12185430463576159,0.5049549545815785,1.0,15/48,15.81%,PTPRC;SAMHD1;STAP1;PPARG;PARP14;YTHDF3;CARD16;IL6;CACTIN;OTUD4;STAT2;METTL3;GPS2;GSTP1;IRAK3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5333236290793785,1.3182803084643582,0.1537313432835821,0.5048272455643769,1.0,9/25,14.09%,CCDC88A;CBL;ARAP1;RBPJ;AFAP1L2;HIP1;RTN4;AKT1;PDE6H
prerank,cellular response to DNA damage stimulus (GO:0006974),0.38644705599969975,1.31812540052935,0.019427402862985686,0.504493424216259,1.0,87/336,16.48%,VAV3;FOXP1;UVRAG;LYN;SAMHD1;BCL3;DTL;MCL1;BCL6;PAK1;DTX3L;POLI;NIPBL;BTG2;RBBP8;MAPKAPK2;CHRNA4;TAF9;USP3;MRE11;FEN1;CRY1;FAM111A;SUMO1;ATF2;PARP4;TAOK3;WAC;MAPK14;UBR5;CCND1;GRB2;SETX;SETD7;CRIP1;CEP63;GNL1;MBD4;WRN;CIB1;USP45;MSH3;MAPK12;NABP1;DOT1L;PSME4;BACH1;MSH6;PPP1R15A;PIDD1;TLK2;TANK;IRF7;FANCC;RPS3;FANCL;CASP2;KMT5B;RECQL5;SUSD6;NUPR2;RAD54L;SPIDR;ERCC3;ERCC4;METTL3;FANCA;TNFRSF1B;PCLAF;SIRT4;VCP;XRCC2;BRSK1;XIAP;VCPIP1;TAF1;INO80;ENDOV;MCM9;DYRK2;APC;INIP;USP47;POLB;NSMCE4A;HUS1;UBA6
prerank,cotranslational protein targeting to membrane (GO:0006613),0.4240749104620613,1.3176652361538155,0.1024390243902439,0.5049220088494352,1.0,43/91,24.61%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;TRAM1;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPL34;RPLP0;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;RPS15A;RPS4X;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17;SSR2;RPL37;RPL36
prerank,positive regulation of type I interferon production (GO:0032481),0.4491310658050592,1.3164449710847608,0.10227272727272728,0.5072934141262418,1.0,22/73,17.38%,PTPN22;OAS2;POLR3F;NFKB1;DHX58;POLR3A;MRE11;LRRFIP1;STAT1;IFIH1;DDX41;TLR3;IRF7;SETD2;PQBP1;TLR2;MYD88;CREBBP;RELA;TBK1;IRF5;HSPD1
prerank,GPI anchor metabolic process (GO:0006505),-0.4424629404517134,-1.3163798307235877,0.12149532710280374,0.701690234454709,1.0,19/26,39.09%,PIGN;PIGG;PGAP2;PIGP;PIGB;PIGA;DPM2;GPLD1;PIGV;DPM3;PIGU;DPM1;PIGO;PGAP3;MPPE1;PIGZ;PIGW;PIGQ;PGAP1
prerank,microtubule nucleation (GO:0007020),-0.4729888611689759,-1.3158228628617978,0.10764872521246459,0.7002909761201944,1.0,9/20,24.05%,TUBGCP5;CLASP2;GOLGA2;CCDC57;TUBGCP6;TPPP;NDEL1;TUBGCP2;TPX2
prerank,actin filament bundle organization (GO:0061572),0.49147510675037476,1.3158161071903995,0.13212795549374132,0.5082202386951642,1.0,5/33,8.00%,NEDD9;LCP1;EPS8;PAWR;EZR
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.48970732869565253,1.3156366183676442,0.12534059945504086,0.5079786775932772,1.0,16/38,18.84%,PTPRC;NEDD9;ACE;PRNP;PTPN1;UNC119;APP;SH3BP5;CASS4;MVP;LRP8;RELN;EFNA1;LILRA5;FCGR1A;NCK2
prerank,regulation of apoptotic process (GO:0042981),0.38144715619558034,1.3153274159571327,0.003003003003003003,0.5080467452098865,1.0,166/676,17.38%,CD74;CD44;VAV3;FFAR4;GRK5;TIAM1;ARHGEF18;HCK;NOTCH2;CAPN13;NGF;FLT3;BCL3;LILRB1;DAPK1;NGFR;SLK;MAP3K5;MCL1;ITCH;BCL6;PIM1;TIAM2;NFKB1;STK17B;JAK2;HSPA1A;RPS6KA3;IFIT2;PHLDA1;SOS2;BIRC6;CXCL10;MALT1;TAF9;PTPN6;NFKBIA;NAA16;MRE11;CBL;BCL2L14;SCX;IKBKB;DPEP1;ATF6;RYBP;GDNF;BIRC3;BCAR1;STAT1;FGD4;DDX42;FAF1;ARF4;DFFA;STK4;SETX;PTK2B;LGALS1;ANXA4;ZFAND6;SERPINB9;WFS1;FLNA;WRN;IKZF3;CIB1;PAK2;PAWR;MTCH1;TNFAIP8;SAP18;RARG;TOX3;AVEN;PHLPP1;FGD1;IL6ST;DUSP6;SOS1;IL6;HGF;FGD3;LATS1;NAA15;ING3;OLFM1;HIP1;ANKLE2;PIDD1;BRAF;ARHGEF6;RPS3;NLRC4;RTN4;UBE2Z;DAXX;ANXA1;IL31RA;CASP2;CALHM2;RIPK1;USP42;APAF1;YWHAZ;DSTYK;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;PRKAA1;REST;RPS6KA1;HTT;PSMD10;HYPK;SH3RF1;CLIP3;NF2;AREL1;DNM1L;MAP3K20;ERCC3;HSPA9;CCND2;PRELID1;MAPK8;AKT1;DHCR24;API5;PRKAA2;YME1L1;DNAJC3;CITED2;ARHGEF3;HDAC3;RPS6KA2;VCP;GSTP1;MYD88;CASP6;XIAP;CREBBP;RELA;RNF122;PRDX5;THBS1;TRIM35;LRP8;MED1;PROC;APC;USP47;RPS6KB1;PPT1;DAPK3;IRF5;HTATIP2;SEMA4D;NIBAN2;PSEN1;RASSF2;SIRT1;TRAF2;HSPD1
prerank,cartilage development (GO:0051216),0.4673186207116295,1.3152756414644426,0.10655737704918032,0.5074216746509472,1.0,5/49,4.20%,CD44;RUNX2;RUNX3;SULF2;SCX
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6112320404042679,1.3149539091962947,0.1717171717171717,0.5074932815826007,1.0,4/11,8.63%,PAK1;BCAR1;RAC1;HGF
prerank,regulation of cell motility (GO:2000145),0.4121214978026633,1.3149355095624342,0.07452725250278086,0.5067936109262936,1.0,22/121,8.95%,CYRIB;SGK3;SLK;PKN1;FGF5;CCDC125;FGF22;NRG2;DOCK10;ARHGAP18;CRK;RCC2;INPP5F;TMSB10;DIAPH1;FLNA;PKN2;LMNA;PLXND1;RAC1;MINK1;RHOA
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.4484898134669906,-1.3146721637666365,0.125,0.7008427325526763,1.0,11/22,31.22%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;GTF2H5;UBA52;XPC;GTF2H4;DDB1;CHD1L
prerank,regulation of protein neddylation (GO:2000434),0.6315364801194837,1.3143429327093468,0.1614497528830313,0.5075587255302758,1.0,4/10,12.91%,RPL5;DCUN1D1;DCUN1D3;RPL11
prerank,negative regulation of T cell activation (GO:0050868),0.48988469621764513,1.3143419114848685,0.1154970760233918,0.5068188644822972,1.0,6/35,5.82%,PTPN22;LILRB1;LAPTM5;RIPOR2;SPN;GLMN
prerank,myelin assembly (GO:0032288),-0.5748623480119314,-1.3143281706393843,0.15137614678899083,0.6986478661532738,1.0,7/10,29.26%,TENM4;CD9;EPB41L3;TPPP;CNTNAP1;NCMAP;ABCA2
prerank,regulation of protein kinase C signaling (GO:0090036),0.5895225622077833,1.3129290782002425,0.16013071895424835,0.509777353974228,1.0,2/14,1.72%,DGKG;CD40
prerank,cardiolipin metabolic process (GO:0032048),-0.5287675485307355,-1.3124458476741536,0.16666666666666666,0.70202165455217,1.0,6/13,13.55%,PNPLA8;SLC27A1;PLA2G4A;HADHB;TAMM41;HADHA
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5690663964145206,-1.3122298947075048,0.15211970074812967,0.6994558629144378,1.0,3/10,14.16%,CACNB2;CACNA2D1;CALM1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.457804027292146,-1.3121722245444567,0.13157894736842105,0.6963733060570619,1.0,1/22,0.16%,LGMN
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4967396778332216,1.3117845744894423,0.15373352855051245,0.5120823569423466,1.0,12/33,14.95%,GLI1;PLCG2;ANKRD17;CCND3;CCND1;ADAM17;PLCB1;ANXA1;CCND2;AKT1;EZH2;KMT2E
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4345478323070332,-1.3115152536782004,0.12058823529411765,0.6954906936235398,1.0,10/25,24.13%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3;ALDOA
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4508552907815574,1.3111479509708202,0.1010230179028133,0.5130161521973277,1.0,25/62,20.61%,NFE2;LYN;SPI1;H3-3A;KMT2C;PTK2B;CBFB;PURB;RBM15;LGALS3;HSPA9;TNRC6B;KAT2B;TNRC6A;KMT2E;KMT2A;CREBBP;THBS1;FES;ASH2L;HDAC1;HOXA9;WDR5;RUNX1;ZBTB16
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.48896467849098796,-1.3096093997972966,0.14948453608247422,0.6988450336754187,1.0,8/17,19.79%,NRP1;ROBO1;FGF2;SLIT2;VEGFA;GPLD1;EFNB2;PIK3R3
prerank,cellular response to oxidative stress (GO:0034599),0.41446083037303105,1.3095656284551291,0.08284714119019837,0.516313880967016,1.0,29/118,15.36%,LRRK2;CYBB;DAPK1;LONP1;HSPA1A;FOS;GPX1;GSR;PRDX6;VRK2;SETX;NFE2L2;PXN;FANCC;CAMKK2;RPS3;NCF2;MGAT3;ERMP1;FOXO3;PRKAA1;MAPK8;AKT1;NCF1;PRKAA2;PNPT1;GSTP1;MAPK1;PRDX5
prerank,covalent chromatin modification (GO:0016569),0.5993483372314372,1.3093715999149762,0.17863105175292154,0.5160889331272814,1.0,7/14,19.97%,HLCS;SETD5;MBD2;AURKB;SIRT1;HDAC1;PARK7
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.4137433817344465,-1.3092743033605327,0.12627986348122866,0.6968319913876038,1.0,9/31,9.98%,OPHN1;PARD3B;MYO9A;RAP2A;LRRC7;DLG2;SCRIB;MTCL1;PARD3
prerank,cellular response to ketone (GO:1901655),0.49289525144522,1.3092043783641434,0.12430939226519337,0.5157738785850686,1.0,12/35,13.33%,MAP4K1;MSN;PTGER2;PTGER4;AHR;GNB1;NR3C1;ACOD1;GNAI1;ADCY5;KLF9;GNG2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.4246836943920895,1.3089873224894955,0.10684273709483794,0.5155762614317116,1.0,14/83,9.43%,GPR132;CUL3;CUL5;EIF4EBP1;CRLF3;CDC45;CDK14;CDKN2C;CCND1;CCNH;CACUL1;BACH1;LATS1;TRIM71
prerank,chondrocyte differentiation (GO:0002062),0.49701151163452384,1.3089643507177091,0.14595375722543352,0.5148865082182125,1.0,5/32,4.20%,RUNX2;RUNX3;SULF2;BMPR2;SCX
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.41040080145897095,1.3088617980554538,0.08934707903780069,0.5144210818714007,1.0,28/119,13.09%,PLCG2;ITPKC;PIP4K2A;TTC7A;PIK3C2A;IP6K3;MTMR14;OCRL;INPP5F;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;ARF1;MTMR4;SYNJ1;PITPNM1;PIKFYVE;PIGF;PIP4K2B;PIK3CA;CDIPT;PIK3R4;SMG1;PIP5K1A
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5559038569555602,-1.3088536292938668,0.1591928251121076,0.695130646940374,1.0,3/11,6.97%,PRKN;HIF1A;ATF4
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4282385979429905,-1.307620911496628,0.09695290858725762,0.6961930950407846,1.0,4/25,10.30%,PRKN;SLC8A1;CNNM2;CNNM4
prerank,positive regulation of phosphorylation (GO:0042327),0.39224530159832105,1.3073562669043808,0.040923399790136414,0.5175936544270925,1.0,52/240,14.29%,CD74;NIBAN1;LRRK2;IL1B;LYN;FLT3;PECAM1;RET;LMTK2;CD40;PAK1;FGF5;FGF22;NPTN;ZBTB20;MRE11;AXIN1;CCND3;PRXL2C;VEGFC;GLMN;CCND1;STK4;WDFY2;ADAM17;CIB1;ENG;RAC1;EPHB2;ACVR2A;HGF;RALB;PGF;CAMKK2;DAXX;RIPK1;DSTYK;PRKAA1;DVL3;APP;BTBD10;PFKFB3;CLIP3;CCND2;AKT1;KIT;LIMK2;PRKAA2;HDAC3;TGFB1;FGFR3;PFKFB4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4195880932667811,1.3072117241486878,0.09123649459783914,0.517232933674371,1.0,26/100,15.44%,CBFA2T3;LRRK2;XPO1;HSPA1A;TAF9;ANKIB1;SUMO1;RYBP;ARIH1;WAC;GLMN;RNF217;HECTD1;ELOB;COP1;ARIH2;TLK2;CAMLG;SUMO2;RCHY1;PSMD10;RPL11;PABIR1;VCP;USP7;TAF1
prerank,cellular response to UV-A (GO:0071492),0.617471519939347,1.3069584701949832,0.1721170395869191,0.5171431803027146,1.0,2/11,4.65%,MMP1;CERS1
prerank,positive regulation of protein metabolic process (GO:0051247),0.41637499089108787,1.306857459251803,0.08041958041958042,0.516660072042331,1.0,33/110,16.95%,IL1B;PAEP;KLF4;DTL;ITCH;ASB5;NEDD4L;SORL1;NFKBIA;GPC3;AXIN1;RAB7A;TIPARP;WFS1;MTPN;STX5;SNF8;WWP2;CSNK2A1;APP;MAP2K5;AREL1;MAPK8;AKT1;VCP;TGFB1;SLC6A9;IL18;RNF41;APC;HACE1;WNT7A;PSEN1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.47834200746948774,1.3064601178298414,0.15491009681881052,0.5169259969831815,1.0,9/40,14.99%,FGR;TIRAP;ADAM17;IL6;MBL2;RNASE6;TLR2;GBP2;MYD88
prerank,regulation of microtubule-based movement (GO:0060632),-0.5543912165817596,-1.3058959177753302,0.17607223476297967,0.6988837712623833,1.0,8/11,27.31%,MAP2;TTC21B;LAMP1;NEFH;HDAC6;IGBP1;CFAP298;HAP1
prerank,muscle organ development (GO:0007517),-0.3639963560678512,-1.3055332695066884,0.06493506493506493,0.697030832738074,1.0,10/54,8.58%,LARGE1;IGF1;MEF2C;SGCE;CAPN3;MRAS;MKX;FXR1;POU6F1;SPEG
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.44143490011435227,-1.305008324321037,0.13015873015873017,0.6956288776142028,1.0,8/25,16.73%,CACNB2;CAPN3;ANK2;PLCG1;TRPC1;AKAP6;CX3CL1;CEMIP
prerank,cytoplasmic translation (GO:0002181),0.416415252209777,1.3050021999376764,0.11070998796630566,0.5199897384529908,1.0,45/91,24.61%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL22L1;RPL13;ETF1;RWDD1;RPS3;RPS21;EIF4A2;RPL34;RPLP0;RPL19;RPL11;RPL30;TMA7;RPS2;RPL4;RPL7;DRG2;RPS15A;RPS4X;GSPT1;RPL32;RPSA;EIF2B3;RPS13;RPS6;RPL18A;RPS27;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17;RPL37;RPL36
prerank,protein catabolic process (GO:0030163),-0.35945958802912836,-1.3045420419705165,0.08144796380090498,0.6942394399467947,1.0,8/59,8.12%,PRKN;CTSD;APOE;CAPN3;LAMP2;TPP1;UCHL3;IDE
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.4099142570423093,1.3037554203460149,0.0880281690140845,0.5225505394976436,1.0,52/110,23.83%,RPL5;RPS10;RPL37A;RPL6;RPS18;HELZ2;RPS14;RPL35A;PPP2R2A;MAGOHB;RPL13;ETF1;DHX34;RPS3;RPS21;UPF2;DCP1A;RPL34;RPLP0;SMG1;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;EIF3E;RPS15A;NCBP1;RPS4X;PABPC1;SMG6;GSPT1;RPL32;RPSA;RPS13;UPF3B;RPS6;RPL18A;RPS27;RPLP2;UPF3A;RPL22;RPS7;RPS12;PPP2CA;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,calcium ion homeostasis (GO:0055074),0.4272804030420368,1.3037452353806578,0.09744779582366589,0.5218270763241847,1.0,16/95,12.61%,CCR2;CD40;CCR1;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;WFS1;ATP2A1;SLC30A1;DMPK;TMEM203;ATP13A3;SLC10A7;SLC24A4
prerank,activation of phospholipase C activity (GO:0007202),-0.41935756120201934,-1.3034021480609541,0.10932475884244373,0.69468406489922,1.0,8/29,8.91%,P2RY12;NTRK2;GNA15;CD86;PLCG1;HTR2B;C5AR1;P2RY6
prerank,dendrite self-avoidance (GO:0070593),0.5686244251883499,1.300854080937873,0.178743961352657,0.5287985256951038,1.0,3/16,6.70%,EMB;NPTN;IGSF9
prerank,regulation of protein kinase activity (GO:0045859),0.4193331576507618,1.3007522505959825,0.08761682242990654,0.5283608967669456,1.0,29/106,17.53%,FGR;PTPRC;IQGAP1;UVRAG;RAP1A;PRKAG2;RAPGEF2;TRAF4;PRKRIP1;PTK2B;PDPK1;PAK2;CACUL1;GSKIP;CAMKK2;DAXX;SNX9;DBNDD2;PRKAG1;TAF7;MAP2K3;AKT1;GSTP1;SPRED1;RELN;RB1;RASSF2;SIRT1;TAB1
prerank,positive regulation of cyclase activity (GO:0031281),-0.5038595075851523,-1.3005175358569854,0.1525,0.7015853242479064,1.0,3/14,4.00%,CACNA1D;CACNA1C;NF1
prerank,receptor recycling (GO:0001881),0.6222381784771293,1.2999797420485626,0.1732418524871355,0.5296484615952458,1.0,2/10,3.50%,LMTK2;SORL1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.45987043570998176,1.2999775511978393,0.13770053475935828,0.5288992795599876,1.0,8/47,7.72%,SIK1;FYN;NFKB1;RAPGEF2;PTGIS;CRY1;FBXW7;ERLIN1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.43477289050974105,1.2997870793236597,0.1357142857142857,0.5278599931807549,1.0,24/78,17.19%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;DYNC1I2;AP1M1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.43477289050974105,1.2997870793236597,0.1357142857142857,0.5278599931807549,1.0,24/78,17.19%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;DYNC1I2;AP1M1
prerank,activation of GTPase activity (GO:0090630),0.4175167237449654,1.2996349590574712,0.10623556581986143,0.5275208552420465,1.0,18/89,9.65%,RAP1GAP2;TIAM1;TBC1D1;TBC1D8;TIAM2;CCDC125;FOXJ1;SIPA1L3;TBC1D9;USP6NL;TBC1D10C;TBC1D2B;BCR;TBC1D8B;RABGAP1L;RABGAP1;BCAS3;TBC1D5
prerank,neuron differentiation (GO:0030182),-0.3033925764005382,-1.2995724543292724,0.011764705882352941,0.7014232257016905,1.0,35/165,17.13%,OPHN1;ATP8A2;MEF2C;LRP6;PTPRD;WNK1;TGFBR1;NTRK2;IL1RAPL1;TENM4;ERCC6;CTNNB1;TENM2;ATP2B2;SPOCK1;LDB1;EPHA5;NRBP2;RYK;CDK5R1;MYO7A;CDK5;SNPH;CASP3;VEGFA;ITM2C;SOX4;ERCC2;TGFB2;MANF;TENM1;HS6ST1;MYEF2;SOX11;VXN
prerank,activin receptor signaling pathway (GO:0032924),-0.4958428202147924,-1.297867202147985,0.15844155844155844,0.70397705030515,1.0,5/15,17.00%,TGFBR1;ACVR1;ACVR2B;SMAD3;ACVR1B
prerank,extracellular structure organization (GO:0043062),0.39272486431171966,1.2973994498875012,0.05353319057815846,0.5327188931786525,1.0,28/204,10.33%,ITGB7;ITGA4;ITGAL;CD44;CD47;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;ITGAD;ITGB2;HSPG2;TEX14;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;ADAM19;NCAN;FN1
prerank,synaptic vesicle recycling (GO:0036465),-0.40854705781719947,-1.2973788163543627,0.12258064516129032,0.7025770423350588,1.0,8/31,16.10%,OPHN1;SYT1;NLGN1;SYT7;CDK5;STX1A;NLGN2;NLGN3
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4722234429422255,1.2972625315976132,0.1392235609103079,0.5323206523571308,1.0,9/42,8.95%,NDNF;PTPRO;JAK2;RAC2;RSU1;RAC1;ATXN3;MINK1;RHOA
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.53482094071186,-1.2970229815863197,0.1731266149870801,0.6976726402129283,1.0,5/12,12.85%,IGF1;SPPL3;CAMTA1;AKAP6;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.53482094071186,-1.2970229815863197,0.1731266149870801,0.6976726402129283,1.0,5/12,12.85%,IGF1;SPPL3;CAMTA1;AKAP6;PTBP1
prerank,aerobic respiration (GO:0009060),-0.46691430471446116,-1.296962808302694,0.15126050420168066,0.6948412262396858,1.0,12/20,26.05%,UQCRC2;ME3;SDHB;OXA1L;SLC25A14;NDUFS7;MTFR1L;ATP5F1D;UQCRC1;UQCR10;NDUFS8;SURF1
prerank,regulation of phospholipase C activity (GO:1900274),-0.494552505182045,-1.2969318504686818,0.16049382716049382,0.691946595651577,1.0,5/15,13.91%,FLT1;NTRK3;FGF2;PLCG1;ESR1
prerank,actin filament polymerization (GO:0030041),0.5024124327044972,1.2968756926111142,0.15463917525773196,0.5325749908312485,1.0,7/29,11.45%,PSTPIP1;JAK2;PSTPIP2;MSRB1;DIAPH1;RAC1;TTC17
prerank,positive regulation of dendritic spine development (GO:0060999),-0.45012878504806203,-1.2965794578924146,0.10655737704918032,0.6902749709408968,1.0,4/20,6.61%,APOE;NLGN1;CAMK1;CAPRIN2
prerank,nucleosome organization (GO:0034728),0.45144985208310956,1.296189850214193,0.1395045632333768,0.5336676119087641,1.0,19/55,18.55%,NFE2;CHAF1A;H3-3A;SMARCA5;CTCF;ACTR6;SMARCE1;DAXX;ARID2;SETD2;NAP1L1;ATRX;SMARCC2;SRCAP;RSF1;INO80;BPTF;SMARCD3;BRD2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6290468912328379,1.2957901174483328,0.19400352733686066,0.5338872775286381,1.0,2/10,5.32%,SP100;HIPK2
prerank,heme biosynthetic process (GO:0006783),-0.44940240655522157,-1.2954464543481945,0.1415929203539823,0.6912685717208423,1.0,13/22,32.66%,ABCG2;FLVCR1;FECH;ALAS1;CPOX;COX10;FXN;SLC25A38;PGRMC1;ABCB10;HMBS;UROD;ATP5IF1
prerank,protein export from nucleus (GO:0006611),0.5133655202758299,1.2951709488404846,0.1688888888888889,0.5347661737897326,1.0,5/27,5.77%,XPO1;DUSP16;XPO5;XPO6;XPO4
prerank,external encapsulating structure organization (GO:0045229),0.39102698353108983,1.2946783828708248,0.05626326963906582,0.5353548475286269,1.0,27/205,10.33%,ITGB7;ITGA4;ITGAL;CD44;CD47;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;ITGAD;ITGB2;HSPG2;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;ADAM19;NCAN;FN1
prerank,histone ubiquitination (GO:0016574),0.5385439413363079,1.29443529027883,0.1588785046728972,0.535293590245048,1.0,6/21,7.93%,DTX3L;UBE2E1;WAC;RNF20;UBE2N;UBR2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5604332713499866,1.294150049081825,0.17560975609756097,0.5353239963353997,1.0,3/15,2.88%,NFKB1;CD36;PRKCH
prerank,regulation of hippo signaling (GO:0035330),0.5485678498726888,1.2933914275898284,0.1880064829821718,0.5366084993699884,1.0,7/17,13.42%,MOB3B;LIMD1;MAPK14;NEK8;MAP2K3;NF2;MARK3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4885523461614362,1.2925516482602117,0.1607898448519041,0.538085716805619,1.0,9/29,10.66%,CD40;IKBKB;BIRC3;UBE2D3;TRAF3;TLR3;TANK;IRF7;RIPK1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.6168010311708445,1.2916447699968387,0.21317157712305027,0.5398280073160406,1.0,3/10,21.15%,GNB1;PDE6B;SAG
prerank,synaptic membrane adhesion (GO:0099560),-0.5089695212658835,-1.2915425674838354,0.17857142857142858,0.7016549477233489,1.0,6/14,24.00%,PTPRD;GPC6;SLITRK1;PTPRF;GPC4;SLITRK3
prerank,response to cadmium ion (GO:0046686),0.5153083451250158,1.2914958252865802,0.16666666666666666,0.5394645705498476,1.0,8/26,15.13%,FOS;SUMO1;HAAO;DAXX;MAPK8;AKT1;NCF1;MAPK1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4172197471139023,1.2910795290851416,0.12792127921279212,0.5397849449233569,1.0,42/87,24.61%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPL34;RPLP0;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;RPS15A;RPS4X;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;SEC61A2;RPS25;RPL9;RPS16;RPL23;RPL17;RPL37;RPL36
prerank,cellular response to chemical stress (GO:0062197),0.4155038786347017,1.2910787406465754,0.08669833729216152,0.5390404075390094,1.0,24/96,15.36%,LRRK2;CYBB;LONP1;HSPA1A;GPX1;GSR;PRDX6;LRRC8D;VRK2;SETX;NFE2L2;NOX1;FANCC;NCF2;MGAT3;PIK3CA;ERMP1;FOXO3;PRKAA1;NCF1;PRKAA2;PNPT1;GSTP1;PRDX5
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5098064712592518,1.2904196552814275,0.170767004341534,0.5400606113470865,1.0,3/26,2.75%,IL1B;KLF4;CD36
prerank,regulation of protein secretion (GO:0050708),0.4087548445234317,1.2898223321922027,0.0984936268829664,0.5408778410284085,1.0,15/119,8.62%,DPP4;ITPR1;IL1B;RAP1A;DNAJC1;CACNA1A;SLC8B1;GOLPH3L;CD2AP;RFX3;ADRA2A;TMED10;CLOCK;EZR;IL6
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5092830168883478,1.289295634711027,0.18018018018018017,0.5415778162870666,1.0,8/25,14.19%,LONP1;CUL3;KLHL15;ATXN3;UBE2W;FBXL17;YME1L1;VCP
prerank,presynapse assembly (GO:0099054),-0.4794893368573096,-1.2891726877720262,0.14945652173913043,0.7067437436870762,1.0,5/16,3.60%,PTPRD;IL1RAPL1;NLGN1;PCLO;LRRTM3
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.398163067363942,-1.289056856138159,0.10437710437710437,0.7041169598767999,1.0,3/31,6.21%,TGFBR2;TGFBR1;FGFR2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4931707214781502,1.2887923045837424,0.15781922525107603,0.5421897318802048,1.0,11/33,14.09%,CCDC88A;CBL;FBXW7;ARAP1;ADRA2A;ADAM17;AFAP1L2;HIP1;AKT1;NCF1;PDE6H
prerank,protein O-linked mannosylation (GO:0035269),-0.4731295847823778,-1.2887576217013748,0.16897506925207756,0.7021904787708864,1.0,10/18,31.64%,LARGE1;RXYLT1;POMT1;DPM2;FKRP;DPM3;TMTC1;POMT2;DPM1;SDF2L1
prerank,V(D)J recombination (GO:0033151),-0.5516107758971569,-1.2885064569543188,0.17632241813602015,0.700161096595462,1.0,6/11,20.35%,HMGB1;DCAF1;HMGB2;LIG3;LIG1;TCF3
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5415602078806435,1.2884909157401936,0.1968,0.5422784404106633,1.0,3/17,6.35%,PPARG;PRKAG2;PRKAB2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.4689689296027858,-1.2884631300835543,0.16422287390029325,0.6973616330162814,1.0,6/18,13.68%,TENM4;PTN;NF1;DAAM2;PTPRZ1;MDK
prerank,iron ion transport (GO:0006826),-0.36291927870121576,-1.2880821797584052,0.09482758620689655,0.6958661441278255,1.0,16/47,13.26%,ATP6V1C1;ATP6V0B;SLC11A1;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6AP1;SLC11A2;ATP6V1D;TFRC;FTH1;MCOLN1;ATP6V0D1;ATP6V0A1;ARHGAP1
prerank,regulation of interleukin-4 production (GO:0032673),0.5218415621992626,1.2880489395398653,0.14814814814814814,0.5427568262084904,1.0,5/21,13.51%,RARA;SYK;IRF4;NLRP3;FCER1G
prerank,histone H4 deacetylation (GO:0070933),0.6069352649604051,1.287920746969564,0.2,0.5423407613262109,1.0,7/10,26.22%,HDAC9;REST;HDAC3;HDAC1;RCOR1;SIRT2;HDAC2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5427538297362351,1.2874505096912652,0.17404580152671756,0.5428027933625245,1.0,9/20,16.95%,NGFR;NFKB1;ADAM17;SPPL2A;MBTPS1;TGFB1;ADAM9;RELA;PSEN1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5542975316085823,1.287344055419887,0.19381107491856678,0.5423484304228827,1.0,4/16,9.43%,ZC3H12D;RC3H1;ZFP36L2;TRIM71
prerank,neurogenesis (GO:0022008),-0.3780413991188959,-1.2872923017638225,0.09025270758122744,0.69558720038935,1.0,11/43,17.13%,ERCC6;BTBD3;DAGLA;SPOCK1;RYK;METTL14;WDR62;FAT4;ROGDI;TGFB2;VXN
prerank,regulation of viral genome replication (GO:0045069),0.4374824709465295,1.2872731148636998,0.1203104786545925,0.5417909062362555,1.0,10/56,7.21%,ZC3HAV1;OAS2;PLSCR1;EIF2AK2;SLPI;FAM111A;STAU1;IFIH1;OASL;PKN2
prerank,negative regulation of nervous system development (GO:0051961),0.5583553705852274,1.2869981757533213,0.18196994991652754,0.5417887112326497,1.0,6/17,12.51%,IL1B;SORL1;IL6;B2M;REST;TLR2
prerank,organelle fusion (GO:0048284),-0.44631393128356367,-1.286854713316579,0.13262599469496023,0.6941739231189744,1.0,8/22,15.53%,AFG3L2;GDAP1;MFF;MIGA2;SPG7;USP30;BAX;MFN1
prerank,cellular senescence (GO:0090398),0.5042491504666082,1.2867113283058715,0.1511627906976744,0.5418243838564507,1.0,11/27,19.85%,SPI1;MAPK14;KAT6A;ID2;SIRT1;ECRG4;SMC6;PRKCD;SMC5;MAP2K1;TERF2
prerank,negative regulation of defense response (GO:0031348),0.42923278966057954,1.2864560132146738,0.1332533013205282,0.5417586823447377,1.0,9/77,4.32%,FFAR4;KLF4;PPARG;ITCH;METRNL;DHX58;PTGIS;PTGER4;SMPDL3B
prerank,prostaglandin biosynthetic process (GO:0001516),0.5506766344520215,1.2860392925757629,0.19001610305958133,0.5422136890694251,1.0,2/18,3.17%,CD74;PTGIS
prerank,positive regulation of protein catabolic process (GO:0045732),0.4238873307837272,1.2858461756263142,0.13366336633663367,0.5419739141786801,1.0,28/84,16.06%,IL1B;DTL;ITCH;MSN;ASB5;NEDD4L;SORL1;GPC3;AXIN1;ADRA2A;RAB7A;PTTG1IP;FAF1;TIPARP;EZR;STX5;SNF8;WWP2;CSNK2A1;SNX9;AREL1;TNFRSF1B;VCP;ADAM9;SNX33;RNF41;APC;HACE1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.48121617941010586,-1.2857529049135532,0.1678832116788321,0.694994527250463,1.0,11/17,32.35%,DERL2;HSP90B1;AUP1;NPLOC4;DERL1;HERPUD1;HM13;SEC61B;FAF2;TMEM129;SYVN1
prerank,positive regulation of catabolic process (GO:0009896),0.43422010368143643,1.285557094696404,0.1417624521072797,0.5420077970371565,1.0,20/65,16.06%,IL1B;DTL;ITCH;ASB5;NEDD4L;SORL1;GPC3;AXIN1;RAB7A;TIPARP;STX5;SNF8;WWP2;CSNK2A1;AREL1;VCP;ANGPTL3;RNF41;APC;HACE1
prerank,microtubule polymerization (GO:0046785),-0.41896290949573195,-1.285422024648116,0.13312693498452013,0.6932884358361907,1.0,11/29,20.30%,TUBGCP5;FGF13;CLASP2;CKAP5;GOLGA2;CCDC57;TRPV4;TUBGCP6;TPPP;NDEL1;TUBGCP2
prerank,protein-containing complex subunit organization (GO:0043933),0.4058778400786832,1.2850150129872626,0.10857142857142857,0.5427198233289158,1.0,24/109,16.20%,CD74;TRAF1;WIPF1;CD40;SKAP2;PICALM;CD2AP;PTK2B;ELOB;NUP98;PEX14;CAPZA1;FANCC;SNX9;TEAD1;DNM1L;FANCA;CLDN14;KMT2A;OCLN;SLC2A1;CREBBP;APC;SEH1L
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5468210026579582,1.2843813191983757,0.20446735395189003,0.5436351297000589,1.0,8/18,17.71%,AKT3;PIK3C2A;CIB1;HDAC9;ANXA1;MAP3K3;JCAD;HDAC7
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5454641920392443,1.2841138257206737,0.18354430379746836,0.5435862656933022,1.0,5/18,9.64%,LILRB3;LILRB1;FBXW7;TLR3;FBN1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5230799887424872,-1.2840538064440448,0.18204488778054864,0.6949109395479243,1.0,2/12,1.66%,BIN1;SERPINE2
prerank,positive regulation of MAP kinase activity (GO:0043406),0.43871269274347285,1.2839760103886937,0.13087674714104194,0.5432178465271841,1.0,17/66,14.22%,LRRK2;FLT3;MAP3K5;CD40;PAK1;TAOK3;ADRA2A;PIK3R6;DIRAS1;MAP3K4;RPS3;DVL3;MAP3K7;PDGFD;KIT;EZH2;TGFB1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.4796818687491318,-1.2835394646195175,0.15263157894736842,0.6938438692809491,1.0,8/16,15.43%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5PF;STOML2;ATP5F1D;ATP5MC3
prerank,stem cell differentiation (GO:0048863),0.4574212327387538,1.283137434712342,0.16642754662840745,0.5445829530097618,1.0,3/39,1.25%,PTPRC;JARID2;ACE
prerank,alpha-amino acid metabolic process (GO:1901605),0.4581491253335566,1.2827309397384594,0.15955983493810177,0.5448931912122938,1.0,12/45,17.45%,KMO;DPEP1;SLC25A13;ATP7A;KYAT1;SLC25A12;MTRR;GLUD1;ASS1;SRR;PYCR2;DDAH1
prerank,regulation of establishment of planar polarity (GO:0090175),0.4206786084993443,1.2827206994655012,0.1045828437132785,0.5441914487010776,1.0,29/88,19.83%,TIAM1;PSME3;CELSR1;PSMB7;CDC42;PSME2;AP2A2;RAC1;PSME4;RHOA;PSMB8;PSMA5;PSMD9;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD3;PSMF1
prerank,long-term synaptic potentiation (GO:0060291),0.522355244621668,1.2823844749487672,0.1781437125748503,0.5443430594662338,1.0,4/21,12.71%,CRHR2;NPTN;PTK2B;RGS14
prerank,mRNA polyadenylation (GO:0006378),0.5052279613684171,1.2822300804711422,0.16400580551523947,0.5433182043331986,1.0,15/26,19.38%,SSU72;FIP1L1;TUT1;SCAF8;TENT2;PAPOLG;MTPAP;APP;PNPT1;TENT4B;CPSF3;PAPOLA;PABPC1;CSTF3;WDR33
prerank,RNA polyadenylation (GO:0043631),0.5052279613684171,1.2822300804711422,0.16400580551523947,0.5433182043331986,1.0,15/26,19.38%,SSU72;FIP1L1;TUT1;SCAF8;TENT2;PAPOLG;MTPAP;APP;PNPT1;TENT4B;CPSF3;PAPOLA;PABPC1;CSTF3;WDR33
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.46709025978070207,-1.2822205770161963,0.16621983914209115,0.6956517572986951,1.0,6/18,23.19%,DERL2;UBC;TRIM13;RNF103;RNF139;UBA52
prerank,regulation of developmental growth (GO:0048638),0.4878508040968235,1.2804367590846557,0.17787114845938376,0.5474032268437669,1.0,11/29,16.27%,SPAAR;STAT5A;NIPBL;STAT5B;PLCB1;LATS1;OLFM1;LATS2;APP;FGFR3;INSR
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4978369924378684,-1.2802362746536282,0.18703241895261846,0.6994109998561752,1.0,3/14,5.04%,ATP1B3;ATP1B1;ANK2
prerank,regulation of phospholipid metabolic process (GO:1903725),0.6091944084240022,1.2801389287084175,0.19073083778966132,0.5474571077378837,1.0,4/10,8.05%,ABCA3;MTMR3;MTMR4;DNAJC19
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5316164770916266,1.280055301796272,0.1848341232227488,0.5469425778172701,1.0,3/20,4.29%,PID1;PPP2R5A;PICALM
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.47055916232779343,1.279985909035821,0.15818431911966988,0.5463792660630077,1.0,2/40,0.25%,LRRK2;PID1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5131960051999397,1.2799392270201992,0.17804154302670624,0.5457818654872418,1.0,3/25,2.75%,IL1B;KLF4;CD36
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5028571160952581,1.279833581136445,0.16666666666666666,0.5453137314063442,1.0,7/26,12.19%,ALPK1;ITCH;IFIH1;UBE2N;CYLD;TAB3;MAP3K7
prerank,determination of heart left/right asymmetry (GO:0061371),-0.37379813135207507,-1.27979243802098,0.1276595744680851,0.6981640798170503,1.0,4/43,3.99%,TGFBR2;MEF2C;PKD2;SMO
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.47092526527222117,1.2795084859009658,0.1664392905866303,0.5454173496753583,1.0,17/41,18.27%,NEDD9;ACE;STAP1;FYN;FBXW7;ADRA2A;PRNP;ADAM17;PTPN1;UNC119;CASS4;NCF1;LRP8;RELN;EFNA1;LILRA5;FCGR1A
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4885359528684256,-1.2791225992539486,0.1564102564102564,0.6976310758224021,1.0,5/15,7.63%,SKI;MAGI2;SMAD7;ACVR1;ACVR2B
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.40533009068286324,-1.279013454003387,0.12582781456953643,0.6952685904086007,1.0,9/32,16.73%,CAPN3;P2RX7;P2RX4;PLCG1;TRPC1;AKAP6;TRPC3;CX3CL1;CEMIP
prerank,protein localization to Golgi apparatus (GO:0034067),0.500235182438826,1.278924490188961,0.19068413391557495,0.5462230411775237,1.0,8/27,13.31%,SORL1;RAB6A;TMED10;GCC2;PAQR3;GBF1;VPS13A;GBP5
prerank,actin filament bundle assembly (GO:0051017),0.476513034044192,1.278821216973921,0.1601123595505618,0.5457692918354907,1.0,5/33,8.00%,NEDD9;LCP1;EPS8;PAWR;EZR
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.599447268010415,1.2787020612256317,0.199288256227758,0.5453651865515721,1.0,1/10,0.33%,IL1B
prerank,negative regulation of phagocytosis (GO:0050765),0.5517121291935944,1.2783172140265846,0.1853582554517134,0.5455871820760547,1.0,9/17,18.13%,CD47;PLSCR1;CD300A;DYSF;FCGR2B;TLR2;SNX3;CD300LF;APPL1
prerank,nervous system development (GO:0007399),-0.26294072630510856,-1.2782743302474644,0.0,0.6949157663776492,1.0,100/429,17.13%,NAV2;MERTK;OPHN1;NAV3;PRKN;RAPGEF5;ATXN1;WWP1;CHD7;MEF2C;EVL;ERBB4;MYLIP;MARCKS;TGFBR1;NELL1;ADAM23;NLGN1;ROBO2;FEZ2;ROBO1;ERCC6;FGF2;FGF13;GFRA1;CHRM3;PTN;PKD2;TPP1;RBFOX1;DLG4;CNTN4;CHRM2;SMO;NF1;MTF1;WDPCP;BTBD3;LIMK1;NRXN2;RBFOX2;DAGLA;SPOCK1;LDB1;CAPG;LSAMP;RYK;IGSF8;GRIK1;DCX;DPF2;SDK1;SRRM4;JRKL;EFNB3;SH3GL2;NAB2;GPM6A;FEZ1;RBFOX3;PTPRZ1;CDK5;WDR62;EFNA5;MOBP;RBM45;FAT4;VEGFA;SERPINI1;DHX30;ROGDI;NLGN2;SPG7;DPF3;MDK;CYP51A1;ATXN10;ADGRL3;RNF103;NPAS2;PPP2R5D;TAGLN3;MTR;NFASC;NINJ1;IRF2BPL;IGF2BP2;TENM1;SLITRK1;POU3F3;ADGRB1;CRMP1;KIRREL3;ADGRV1;NLGN3;CNTN6;CNTFR;ACVR1B;HAPLN2;VXN
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4524136455489074,1.2781926863049966,0.16531165311653118,0.5452209462271944,1.0,20/48,19.44%,AKT3;CD40;STAT5A;PIK3C2A;MAPK14;ADAM17;PDPK1;CIB1;HDAC9;ANXA1;MAP2K3;AKT1;TGFB1;THBS1;MAP3K3;SIRT1;JCAD;HDAC7;TMSB4X;FGFR1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5637175368933617,1.278177593066053,0.189792663476874,0.5445374584738378,1.0,3/16,5.35%,ACE;BMPR2;PRCP
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.46599954310280584,1.277984654103605,0.1518987341772152,0.5443949808481023,1.0,11/38,13.31%,POLR3F;PLSCR1;DHX58;ANKRD17;OASL;PUM2;IFI35;SLC15A4;USP15;ACOD1;GBP5
prerank,positive regulation of cell motility (GO:2000147),0.3865183151010172,1.2779712423144338,0.06296691568836713,0.5437195739284695,1.0,27/205,8.63%,FGR;IL1B;NEDD9;TIAM1;TCAF2;PECAM1;ITGAX;RET;CCR1;PAK1;SEMA4A;STAT3;CLDN1;MYO1C;LAMB1;CBLL1;PPP3CA;CARMIL1;ADRA2A;BCAR1;CXCL16;PTK2B;ADAM17;CIB1;ARHGEF39;EPHB2;HGF
prerank,mRNA destabilization (GO:0061157),0.46625012612636596,1.2776457012111304,0.14950634696755993,0.543874721651705,1.0,12/38,16.03%,ZC3H12D;MEX3D;RC3H1;GIGYF2;YTHDF3;ZFP36L2;TRIM71;TUT7;METTL3;ROCK1;CELF1;PUM1
prerank,intracellular sterol transport (GO:0032366),-0.5207735135692741,-1.2775398117531618,0.17369727047146402,0.6946576748649478,1.0,4/13,12.99%,ABCA1;ARV1;SERAC1;NPC1
prerank,Rac protein signal transduction (GO:0016601),0.5379415832474062,1.2769588647460126,0.17329093799682035,0.5449155427327345,1.0,7/18,16.06%,TIAM1;EPS8;RAC2;RAC1;RHOG;ELMO1;HACE1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5452575539465405,1.276475721805522,0.16563467492260062,0.5454820302273213,1.0,5/18,6.65%,ITGA4;AKT3;PPARG;ADAM17;PDPK1
prerank,cellular response to leucine (GO:0071233),-0.5634697372307409,-1.2763037879821102,0.1956043956043956,0.6935762155545714,1.0,5/10,8.48%,RPTOR;KLHL22;SESN3;LARS1;UBR1
prerank,response to leucine (GO:0043201),-0.5634697372307409,-1.2763037879821102,0.1956043956043956,0.6935762155545714,1.0,5/10,8.48%,RPTOR;KLHL22;SESN3;LARS1;UBR1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6089923315220611,1.2759259301961035,0.19601328903654486,0.5462139578391261,1.0,2/10,5.53%,RARA;IRF4
prerank,response to interleukin-6 (GO:0070741),0.6148859295066996,1.2754810675187755,0.21731448763250882,0.5466764790349854,1.0,3/10,3.17%,PID1;NFKB1;PTGIS
prerank,presynaptic endocytosis (GO:0140238),-0.4366886452662037,-1.2753437543967325,0.13690476190476192,0.694029772446262,1.0,7/24,16.10%,OPHN1;SYT1;NLGN1;CDK5;STX1A;NLGN2;NLGN3
prerank,aorta development (GO:0035904),-0.5049504525929451,-1.2750562458283243,0.16624040920716113,0.6922673806059305,1.0,4/14,3.41%,LRP1;ROBO2;ROBO1;PKD2
prerank,regulation of endocytic recycling (GO:2001135),0.6040687275225871,1.2750120742706044,0.20477815699658702,0.5471816753872352,1.0,3/11,4.34%,SORL1;INPP5F;EHD2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5592290529760013,1.2744475710116512,0.214168039538715,0.5479484933029352,1.0,8/15,21.96%,SAMHD1;YTHDF3;CACTIN;STAT2;METTL3;TTLL12;MUL1;PTPN2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.409026105251738,1.2731084886717716,0.13053892215568863,0.5506737638568568,1.0,26/98,17.14%,PID1;IFNLR1;KLF4;PPARG;ANXA2;ACE2;NFKBIA;INPP5F;MAPK14;GRB2;IFNAR1;TBC1D5;DHRS4;RIPK1;ACOD1;SLCO1C1;PRELID1;AKT1;AGPAT1;TGFB1;RAB29;THBS1;RNF41;INSR;WNT7A;CHCHD2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5052182407631971,1.273064997396249,0.19224806201550387,0.5500790873992896,1.0,11/26,19.84%,CBLB;CBL;FBXW7;ADRA2A;TSG101;ADAM17;APP;NCF1;ZFYVE28;NCK2;SOCS5
prerank,prostaglandin metabolic process (GO:0006693),0.5082292956785739,1.2728417815474107,0.18330849478390462,0.5499417327447731,1.0,2/26,3.17%,CD74;PTGIS
prerank,positive regulation of blood coagulation (GO:0030194),0.5466026445324725,1.2728052285597773,0.19781931464174454,0.5493238973117447,1.0,1/17,0.58%,ST3GAL4
prerank,positive regulation of GTPase activity (GO:0043547),0.38608845893435106,1.272639265453975,0.08783068783068783,0.5490111541846084,1.0,30/188,7.55%,RAP1GAP2;TIAM1;SRGAP2;TBC1D1;RAP1A;CD40;TBC1D8;TIAM2;CCDC125;DOCK10;FOXJ1;SIPA1L3;TBC1D9;RASGRP2;RAPGEF2;USP6NL;TBC1D10C;TBC1D2B;DOCK11;BCR;PICALM;ARAP1;RSU1;TBC1D8B;CAV2;AFDN;RABGAP1L;S100A10;RABGAP1;F11R
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4874380547167952,1.2725294555657325,0.17485549132947978,0.54859818339505,1.0,6/31,11.17%,PTPRC;MAD2L2;EPHB2;IL6;KMT5B;GPI
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5738078932947223,1.2721233655130244,0.2231404958677686,0.5489896814815508,1.0,2/13,10.04%,CYRIB;STX7
prerank,cellular response to peptide (GO:1901653),0.44159874530389204,1.272000925223419,0.1432225063938619,0.5485637693981056,1.0,10/56,6.93%,ITGA4;PTPN22;NGFR;FYN;VIM;CACNA1A;CD36;PRNP;CACNB1;ABCC1
prerank,regulation of dopamine secretion (GO:0014059),-0.42884101029654936,-1.271583945753129,0.1588235294117647,0.7010048933352229,1.0,6/25,9.18%,PRKN;DTNBP1;SYT1;SYT9;SYT7;KCNA2
prerank,sympathetic nervous system development (GO:0048485),-0.492488885379872,-1.2708884256744193,0.1956521739130435,0.7006903392651018,1.0,4/15,4.00%,NRP1;NRP2;CTNNB1;NF1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5329918540975335,-1.2701001867446757,0.1746031746031746,0.7006739525428414,1.0,2/11,4.91%,CD34;LGALS9
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5232880807210547,1.2695134573336069,0.19743178170144463,0.5537143738067153,1.0,8/21,16.46%,IL1B;MCL1;HSPA1A;GDNF;MAP2K5;AKT1;UNC5B;EYA3
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5232880807210547,1.2695134573336069,0.19743178170144463,0.5537143738067153,1.0,8/21,16.46%,IL1B;MCL1;HSPA1A;GDNF;MAP2K5;AKT1;UNC5B;EYA3
prerank,regulation of autophagosome assembly (GO:2000785),0.4755253619408694,1.2690367792867134,0.1957142857142857,0.554239625919845,1.0,8/33,10.36%,LRRK2;PIP4K2A;CHMP4A;CHMP4B;MTMR3;RALB;PIKFYVE;PIP4K2B
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.5476703454830371,-1.268509617232908,0.19331742243436753,0.7032435580339239,1.0,1/10,0.23%,DNMT3A
prerank,retinoic acid metabolic process (GO:0042573),-0.4920575124003265,-1.2682526288744507,0.2028985507246377,0.7013483300760031,1.0,11/14,50.82%,BCO2;SCPEP1;ALDH1A2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A1;UGT1A8;UGT1A7
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.48801386646377765,-1.2681668619812816,0.15873015873015872,0.6989556744432411,1.0,4/15,2.95%,LARGE1;RENBP;AMDHD2;NAGK
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5590738073311176,1.267916746327416,0.1977491961414791,0.556540266688385,1.0,2/15,1.70%,PRKCE;PPARG
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4327678872705956,1.26791286470277,0.13575757575757577,0.5558374506762777,1.0,25/67,18.39%,CYBB;PSME3;CD36;PSMB7;IKBKB;PSME2;TAP1;PSME4;PSMB8;NCF2;PSMA5;PSMD9;B2M;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;NCF1;SNAP23;PSMD12;CYBA;PDIA3;FCGR1A;TAPBP
prerank,mesoderm formation (GO:0001707),0.5330574268391064,1.2677451470230272,0.20662460567823343,0.5555731494471015,1.0,4/17,13.67%,BMPR2;SCX;ITGA8;ITGA3
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4781203563952816,-1.2676532253522996,0.16230366492146597,0.6979571055852575,1.0,7/16,17.61%,AUTS2;CTNNB1;CTR9;BCOR;SNW1;PIH1D1;BRCA1
prerank,regulation of protein sumoylation (GO:0033233),-0.46334721680023594,-1.2672996943901211,0.16358839050131926,0.6966834267296623,1.0,4/17,14.65%,CAPN3;CTNNB1;SAE1;PIAS4
prerank,response to interleukin-1 (GO:0070555),0.42247862510905587,1.2671673809005948,0.13054187192118227,0.5564296384662085,1.0,18/73,15.81%,IL1B;CD47;CD40;NFKB1;PTGIS;TAF9;RC3H1;TANK;ANXA1;CACTIN;ACOD1;APP;ADAMTS12;GBP2;GBP3;MYD88;RELA;IRAK3
prerank,positive regulation of programmed cell death (GO:0043068),0.37577231666824273,1.2670962041659113,0.06735751295336788,0.5559038920763469,1.0,55/272,13.16%,LRRK2;VAV3;TIAM1;ARHGEF18;NGF;LILRB1;DAPK1;NGFR;MAP3K5;SYK;BCL6;TIAM2;STK17B;IFIT2;LAPTM5;PHLDA1;SOS2;ATF6;RYBP;FGD4;FAF1;STK4;PAWR;MTCH1;TNFAIP8;SAP18;RARG;FGD1;DUSP6;SOS1;IL6;FGD3;LATS1;ING3;OLFM1;PIDD1;ARHGEF6;NLRC4;UBE2Z;CASP2;CALHM2;RIPK1;APAF1;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;REST;HTT;CLIP3;DNM1L;MAP3K20;ERCC3;MAPK8
prerank,positive regulation of lamellipodium organization (GO:1902745),0.47951756429518244,1.2670291663960713,0.14613180515759314,0.5553920936875145,1.0,9/32,10.65%,ACTR3;WASF2;RAC2;CDC42;CARMIL1;ACTR2;RAC1;ARPC2;PIK3CA
prerank,inorganic cation transmembrane transport (GO:0098662),-0.27374100928854744,-1.2668862692230065,0.0,0.6955143662760228,1.0,57/268,16.27%,CACNA1D;KCNK13;SLC8A1;RYR3;SLC24A3;KCNQ5;SLC11A1;KCND2;GAS6;SLC1A3;KCNQ3;SCN1A;ATP6V0C;TRPV2;ATP1B3;TRPM3;PKD2;KCNJ2;CACNA1C;ATP2A2;ATP1B1;TRPC4;P2RX7;SLC11A2;P2RX4;SLC6A15;SCN3A;SLC36A1;ATP5PO;SLC9A9;SLC9A6;KCNN2;ATP1A2;HPN;TRPC1;MCOLN1;KCNA2;ATP6V0D1;KCNK6;HCN1;MCOLN3;HCN2;SLC39A7;SCN1B;SLC25A14;SLC25A27;KCNN3;TRPC7;TRPM2;TRPV4;SLC6A8;TRPC3;KCNA1;SLC39A6;CCDC51;MCOLN2;ATP2C1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4296488895979383,1.2660494181901647,0.13325031133250312,0.5573311679854372,1.0,16/66,14.99%,FFAR4;FOXP1;JAK2;STAT3;CD36;MALT1;TRIM16;CARD16;IL6;GIT1;NLRC4;NLRP3;APP;GBP5;GSTP1;MYD88
prerank,cobalamin metabolic process (GO:0009235),0.5425346759409032,1.2651943540459705,0.1971383147853736,0.5589043259094555,1.0,5/17,13.52%,MMAB;ABCC1;MTRR;LMBRD1;MMAA
prerank,negative regulation of apoptotic process (GO:0043066),0.37051149299311575,1.2651167192862336,0.02125506072874494,0.5584044891948508,1.0,107/444,16.95%,CD74;CD44;FFAR4;GRK5;HCK;NOTCH2;CAPN13;NGF;BCL3;KLF4;NGFR;MCL1;ITCH;NDNF;PIM1;NFKB1;HSPA1A;GPX1;PRKCH;RPS6KA3;BIRC6;MALT1;TAF9;NFKBIA;NAA16;MRE11;CBL;SCX;IKBKB;DPEP1;GDNF;BIRC3;RNF213;ARF4;DFFA;SETX;PTK2B;ANXA4;ZFAND6;SERPINB9;WFS1;FLNA;CIB1;PAK2;TNFAIP8;TOX3;AVEN;CARD16;IL6ST;IL6;HGF;NAA15;CSNK2A2;CSNK2A1;ANKLE2;PIDD1;BRAF;UBE2Z;ANXA1;IL31RA;CASP2;PIK3CA;RIPK1;YWHAZ;DSTYK;PRKAA1;RPS6KA1;MAP2K5;PSMD10;HYPK;SH3RF1;AREL1;HSPA9;CCND2;PRELID1;MAPK8;AKT1;DHCR24;TLE1;HCLS1;API5;PRKAA2;YME1L1;DNAJC3;CITED2;HDAC3;GSTP1;UNC5B;MAZ;MYD88;MAPK1;XIAP;RELA;PRDX5;ITGA5;THBS1;MED1;PROC;USP47;RPS6KB1;PPT1;RB1;MAEA;HTATIP2;SEMA4D;NIBAN2;PSEN1
prerank,vascular transport (GO:0010232),-0.3248217501496137,-1.2645469523077102,0.041176470588235294,0.7004337835828889,1.0,17/81,12.90%,SLCO2B1;SLC24A3;LRP1;ABCC3;SLC1A3;ABCG2;SLC7A1;ATP8A1;SLC2A3;SLC27A1;ATP1A2;TFRC;SLC22A5;SLC7A2;SLC29A1;SLC7A8;SLC15A2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3704691361235196,1.264497767893728,0.03134479271991911,0.5593939179315169,1.0,75/417,14.22%,CIITA;CBFA2T3;JARID2;FOXP1;RUNX2;RARA;SP3;LIMD1;BCL3;KLF4;PPARG;SCML4;BCL6;ATF7IP;NIPBL;NAB1;CIART;SPI1;CRY1;MTA3;MBD1;SUMO1;KAT7;RFX3;RBPJ;DEAF1;HEXIM1;MBTD1;FBXW11;RPS6KA5;KLF10;AHR;ARID4A;PDCD4;SETDB2;MECP2;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;CTCF;PHF12;UIMC1;HDAC9;PEX14;CBFA2T2;KAT6A;RBAK;ID2;WWP2;SMARCE1;RCOR3;SMAD4;SBNO2;DAXX;NR3C1;RBM15;SPEN;EIF4A2;DEDD2;TAF7;REST;MBD2;L3MBTL2;MYB;LBH;TLE1;EZH2;SMARCC2;CITED2;HDAC3;NFIL3;TGFB1
prerank,negative regulation of T cell proliferation (GO:0042130),0.48785158188775524,1.2643923846280964,0.1800302571860817,0.5589686561018428,1.0,5/28,6.34%,LILRB1;SPN;RC3H1;GLMN;PRNP
prerank,regulation of tube diameter (GO:0035296),0.5813707802916384,1.2643619243400337,0.20068027210884354,0.5576401420059874,1.0,2/13,2.21%,ACE;ACE2
prerank,vascular process in circulatory system (GO:0003018),0.5813707802916384,1.2643619243400337,0.20068027210884354,0.5576401420059874,1.0,2/13,2.21%,ACE;ACE2
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.3622389235949205,-1.2643424425503542,0.1092436974789916,0.6985155513397393,1.0,7/47,12.35%,BIN1;TIMP2;SERPINE2;SPOCK1;TIMP3;SERPINE1;SERPINI1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5479923144872234,1.264341219317626,0.1984375,0.5569977436570386,1.0,5/17,11.82%,PTPRC;PPP1R12A;CD300A;PPP1R15A;PPP1R15B
prerank,negative regulation of cytokine production (GO:0001818),0.39361706221625514,1.264249074416547,0.09281767955801105,0.5565377396717662,1.0,35/163,12.11%,FFAR4;PTPRC;RARA;PTPN22;BCL3;KLF4;LILRB1;ITCH;FOXJ1;DHX58;LAPTM5;NPTN;PTPN6;PTGER4;ATP2B1;NLRX1;SRGN;IFIH1;RPS6KA5;PRNP;ANXA4;PDCD4;TRIM25;EZR;RAC1;HDAC9;IL6;FN1;ANXA1;CYLD;ADCY7;CACTIN;ACOD1;FCGR2B;MAP2K5
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4375470213001453,1.2637497865741363,0.14941022280471822,0.5571348044594272,1.0,15/55,15.86%,PID1;ACE2;RAC2;MAPK14;PARL;ARF4;GRB2;RAC1;PIKFYVE;DHRS4;RIPK1;ACOD1;PDK3;THBS1;RNF41
prerank,fatty acid catabolic process (GO:0009062),-0.3395331606249563,-1.2637456997209615,0.07368421052631578,0.6978041619267376,1.0,30/67,28.87%,ABCD2;PCCA;ECHS1;AIG1;PLA2G15;PECR;ABCD4;ECHDC1;ACAD10;ABHD3;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;ACADL;CPT2;ACADS;PHYH;ILVBL;PEX13;ACAT2;ACAD11;ACOX1;ACOT8;CROT;PPARD;SLC27A2
prerank,tRNA wobble uridine modification (GO:0002098),-0.4904554178778048,-1.2633687611738094,0.18251928020565553,0.6963370406822692,1.0,10/14,38.79%,ALKBH8;TRMU;ELP1;MTO1;GTPBP3;TRMT9B;CTU2;CTU1;MOCS3;KTI12
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4210101818377003,1.2631251790946365,0.13553113553113552,0.5581494702566392,1.0,20/73,14.23%,JARID2;GPX1;MYO1C;TAF1A;SPI1;H3-3A;RBBP4;GLMN;SMARCA5;POLR1G;DEK;PHF19;CGGBP1;MECP2;CTCF;TDG;PPM1D;EZH2;KAT2B;POLR1B
prerank,positive regulation of protein acetylation (GO:1901985),-0.5270255188375508,-1.2629804996008709,0.20518867924528303,0.6950599405388771,1.0,7/12,22.33%,DIP2B;CAMK1;TERF2IP;DDX3X;FAM161A;RAPGEF3;DIP2A
prerank,fatty acid biosynthetic process (GO:0006633),-0.3439994524462285,-1.2620271051317022,0.09947643979057591,0.6957383616532842,1.0,20/63,25.55%,ACACA;LTA4H;HACD2;LTC4S;ELOVL7;ABHD3;ELOVL4;CBR4;HSD17B8;FADS3;LIPH;ABCD3;ACOT7;ELOVL1;MLYCD;OXSM;TECR;NDUFAB1;ACSBG1;SCD
prerank,protein localization to lysosome (GO:0061462),0.48995990376332327,1.2619432868939144,0.18584070796460178,0.5606036242886971,1.0,8/28,12.47%,LAPTM5;SORL1;RAB7A;GCC2;RTN4;SCARB2;LMBRD1;SH3BP4
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5158883576519465,1.2619136116265193,0.19676945668135096,0.5599714610064385,1.0,8/22,19.10%,CYRIB;TMSB10;KANK3;ARFGEF1;MYADM;KANK1;PRKCD;TMSB4X
prerank,cellular response to oxygen-containing compound (GO:1901701),0.37470263773061724,1.2617077817648705,0.053180396246089674,0.5598463715698797,1.0,60/291,15.44%,PID1;IL1B;LYN;SPAAR;TNIP3;RAP1A;STAP1;CREB1;LILRB1;DAPK1;RET;NFKB1;VIM;FOS;RAPGEF2;KCNQ1;NCOA3;CXCL10;HCN4;DPEP1;CERS1;MAPK14;TIRAP;CAPN2;SETX;PTK2B;AHR;PDCD4;PDE2A;EZR;CARD16;PXN;GNB1;IL6;NFKBIB;RHOA;GIT1;CAMKK2;RPS3;SBNO2;CACTIN;ACOD1;NLRP3;SH3BP4;TLR2;MAPK8;AKT1;NRIP1;PDK3;GNG2;NCF1;TNFRSF1B;VCP;ADAM9;GSTP1;MYD88;MAPK1;RELA;PRDX5;TAF1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.39407584504332677,1.2617010867652019,0.1130820399113082,0.5591709480204238,1.0,36/136,17.18%,SP100;SIK1;KLF4;ITCH;PIM1;FOXJ1;MAD2L2;PTGIS;ERBIN;SPI1;NFKBIA;SUMO1;NFKBIE;PRNP;ANXA4;WFS1;FLNA;TRAF3;PEX14;ID2;WWP2;CYLD;CACTIN;ACOD1;NLRP3;MAP2K5;PSMD10;ZNF431;USP7;TNFRSF4;TAF1;BHLHE40;IRAK3;RB1;PROX1;SIRT1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4110288296160965,1.2615484325221318,0.14337349397590363,0.5588753834604884,1.0,20/87,15.49%,CD44;NDNF;FGF5;FGF22;KL;GTF2F2;POLR2C;CBL;GRB2;SETX;SHOC2;ZFP36L2;TRIM71;DSTYK;FLRT1;FGFR3;MAPK1;FRS2;SPRED1;NCBP1
prerank,regulation of TOR signaling (GO:0032006),-0.33896584811575464,-1.2614932442290918,0.1262135922330097,0.6950177570681163,1.0,21/67,18.14%,TREM2;GNA12;RPTOR;EPM2A;FLCN;GAS6;FNIP1;RFFL;LARS1;UBR1;MIOS;DGKQ;LAMTOR5;FBXO9;SEC13;TSC2;PIH1D1;RRAGC;AKT1S1;SMCR8;ITFG2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5337887013048758,1.2614759297748763,0.20611916264090177,0.5583596107364127,1.0,4/18,5.26%,LYN;FPR1;FPR3;BCAR1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4722137600138707,1.2611354800053984,0.17251461988304093,0.5585589067580392,1.0,15/37,19.97%,RPL5;TAF9;RYBP;WAC;HIPK2;CSNK2A2;CSNK2A1;TLK2;CAMLG;RPL11;USP7;TAF1;EIF3H;N4BP1;PARK7
prerank,regulation of mRNA catabolic process (GO:0061013),0.3967575558453227,1.2606730377419073,0.134009009009009,0.55905074730818,1.0,32/121,16.94%,ZC3HAV1;XPO1;PSME3;VIM;HSPA1A;MAPKAPK2;PSMB7;PSME2;RC3H1;DCP2;PUM2;YTHDF3;PSME4;ZFP36L2;PSMB8;PSMA5;IGF2BP3;PSMD9;YWHAZ;DCP1A;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;AKT1;PNPT1;PABPC1;PUM1;TNPO1;PSMD12;CNOT8
prerank,protein O-linked glycosylation (GO:0006493),0.4077871570741762,1.2603804507353504,0.11961722488038277,0.5590851370173938,1.0,8/96,4.27%,ST3GAL1;ST3GAL4;MUC3B;MUC3A;TET2;GXYLT1;ST8SIA6;B4GALT5
prerank,regulation of vesicle-mediated transport (GO:0060627),0.4085117894909114,1.26034671664882,0.13214285714285715,0.5584586657627976,1.0,10/91,5.03%,FGR;LRRK2;PTPRC;HCK;SYK;RAB3D;CD177;INPP5F;PICALM;SCARB1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.599312952416095,1.2600893634376982,0.20300751879699247,0.5584483156809452,1.0,1/10,1.25%,ACE
prerank,regulation of urine volume (GO:0035809),-0.5337542573284616,-1.259956679292877,0.18502202643171806,0.6974498813073344,1.0,7/10,45.91%,NPR3;ADCY6;HAS2;NPR1;TFAP2B;HYAL2;ADM
prerank,organonitrogen compound catabolic process (GO:1901565),-0.3535345633506088,-1.2597771046448007,0.1297071129707113,0.6955540872532551,1.0,18/57,14.45%,NPL;LTA4H;CAPN3;RENBP;AMDHD2;NAGK;PLA2G15;TPP1;ENPP2;PNPLA8;PLA2G4A;UCHL3;IDE;TRHDE;TXN2;RIDA;SGPL1;PDXDC1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.38798950666066595,-1.2590572690231818,0.12012987012987013,0.6954177475492263,1.0,7/35,4.00%,PTPRM;APOE;MEF2C;SPARC;FLT1;ATP5F1A;NF1
prerank,regulation of myotube differentiation (GO:0010830),0.5006696209772321,1.2590203430373903,0.20245398773006135,0.5604962790145265,1.0,9/24,19.28%,SIK1;MAPK14;HDAC9;PIEZO1;DMPK;HDAC3;MAML1;HDAC1;ATP11A
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5217578461919851,1.2588831163377177,0.19970193740685543,0.5601726295891775,1.0,3/22,5.23%,IL1B;PPP2R5A;ADRA2A
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4726594419953848,-1.2582734187176516,0.19363395225464192,0.6954833845557225,1.0,7/17,28.43%,MAFG;KLF7;AJAP1;CD24;SOX9;MAFF;CAV1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5533548265963822,1.258206313769974,0.20317460317460317,0.5612858044946464,1.0,5/17,13.17%,IL1B;SORL1;ADRA2A;PRKAA1;AKT1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5134220378467392,1.2579619986642627,0.19461077844311378,0.5612207566175631,1.0,7/22,13.44%,IL1B;SPI1;MINK1;MAP3K4;RELL1;EMC10;NCF1
prerank,regulation of mitochondrion organization (GO:0010821),0.44530494476348315,1.257491939145762,0.15053763440860216,0.561812987064875,1.0,11/47,13.63%,LRRK2;PID1;CYRIB;FBXW7;PARL;PDE2A;CSNK2A2;FIS1;DNM1L;STAT2;SREBF2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.49283407457699124,1.2571566879031115,0.1661721068249258,0.5619751511127694,1.0,13/27,19.10%,CD36;IRAK4;TIRAP;MAP3K1;TAB3;MAP3K7;TLR2;BTK;MYD88;IRAK3;HSPD1;TAB1;TLR1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.39932835955876816,1.2566368112529274,0.10998877665544332,0.5626306747860549,1.0,40/124,19.83%,TIAM1;PSME3;CELSR1;CCDC88C;PSMB7;CDC42;PSME2;PPP3CA;AP2A2;PLCB1;RAC1;PSME4;GNB1;RHOA;PSMB8;PSMA5;PSMD9;NLK;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;MAP3K7;PSMD10;PDE6B;PSMB1;GNG2;TNRC6B;TNRC6A;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD9;FZD3;PSMF1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5060932547227073,1.2560816795452552,0.18834080717488788,0.5634279218144863,1.0,8/26,12.51%,TREML4;PTPN22;TIRAP;TLR3;IFI35;SLC15A4;RTN4;TLR2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.39874610152245604,-1.2559191737434081,0.1602787456445993,0.7007048912410709,1.0,6/29,7.74%,APOE;SYNGR1;DLG4;ZDHHC2;RAB3GAP1;NETO1
prerank,amide biosynthetic process (GO:0043604),0.4451878710393379,1.2556682239484438,0.16666666666666666,0.5638592648344284,1.0,11/47,15.22%,CERS6;CERS1;SAMD8;SGMS1;SGMS2;ARG2;SPTSSB;PCSK5;ASL;ASS1;FA2H
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.42847973915415133,1.2555541170977114,0.14596670934699105,0.5634813550313947,1.0,20/59,15.88%,LRRK2;LMTK2;HIPK2;HIPK1;PDPK1;DYRK1A;TNKS;OXSR1;CSNK2A2;CSNK2A1;NLK;CAD;MAPK8;AKT1;STK39;ROCK1;MAPK1;TAF1;TBK1;DYRK2
prerank,rRNA catabolic process (GO:0016075),-0.45967271010778693,-1.2553260296059758,0.195822454308094,0.7003303369553081,1.0,6/16,19.77%,XRN1;TRIR;EXOSC9;EXOSC5;EXOSC10;EXOSC3
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4259087404928442,1.2549503143888245,0.15289765721331688,0.564329102598045,1.0,11/70,13.79%,PLBD1;SLC44A2;ABCA3;CEPT1;PCYT1A;CSNK2A2;CSNK2A1;SLC44A1;TMEM86B;SLC44A5;PLA2G6
prerank,positive regulation of protein kinase activity (GO:0045860),0.3875200719225122,1.2545081129938906,0.125,0.5647396374912952,1.0,28/148,11.05%,PTPRC;NEDD9;IQGAP1;RAP1A;ACE;PAK1;PRKAG2;RAPGEF2;CCDC88A;IL6R;AXIN1;TAOK3;TRAF4;ADRA2A;STK4;PRNP;PTK2B;CIB1;PAK2;CACUL1;MINK1;RALB;RHOA;DAXX;PTPN1;SNX9;UNC119;PRKAG1
prerank,apoptotic process (GO:0006915),0.377072134636365,1.2544278722663678,0.09110396570203644,0.5642594188581803,1.0,52/203,15.28%,IL1B;PRKCE;NOTCH2;PAEP;DAPK1;NGFR;PLSCR1;JAK2;IFIT2;NFKBIA;BCL2L14;DLC1;BBC3;ITGB2;FAP;STK4;PTK2B;AHR;ATP2A1;CIB1;PDCD4;DDX41;PAWR;KREMEN1;CD2;DDIT4;PPP1R15A;HIP1;PIDD1;ARHGEF6;RTN4;CSRNP1;CASP2;PIK3CA;RIPK1;APAF1;DMPK;AIFM1;NLRP3;APP;MAP3K7;TLR2;MCM2;ERCC3;AKT1;DHCR24;CASP7;CYFIP2;CASP12;MYD88;CASP6;ELMO1
prerank,arachidonic acid metabolic process (GO:0019369),-0.3783319776998831,-1.2542576365383864,0.14487632508833923,0.7011696838055191,1.0,6/35,7.25%,HPGDS;PTGS1;MGLL;DAGLA;PNPLA8;PLA2G4A
prerank,neutrophil activation (GO:0042119),0.5823109592386393,1.2541686225407493,0.22491349480968859,0.5643060953201307,1.0,5/12,19.49%,SYK;FCER1G;KMT2E;PRKCD;PREX1
prerank,heart looping (GO:0001947),-0.37733659675330167,-1.2540253238178913,0.11469534050179211,0.6994594657941571,1.0,4/40,3.99%,TGFBR2;MEF2C;PKD2;SMO
prerank,GTP metabolic process (GO:0046039),0.5538441776778928,1.253971943154838,0.19966722129783693,0.5641190183289919,1.0,1/15,0.22%,LRRK2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5694296453219075,1.253942909123217,0.21575342465753425,0.5635017685030635,1.0,1/13,0.22%,LRRK2
prerank,mRNA catabolic process (GO:0006402),0.4545527380985664,1.2538923638076636,0.1782312925170068,0.5629580996660173,1.0,14/44,14.60%,ZC3H12D;HSPA1A;ERN1;RC3H1;XRN2;DCP2;LSM5;ZFP36L2;DHX34;TUT7;METTL3;RNH1;PNPT1;MRTO4
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.44128518430829855,1.253761989605444,0.17158176943699732,0.5626173398156129,1.0,10/51,10.53%,PPARG;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ACVR2A;FBN1;SMAD4;LEMD2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3660513310484652,1.25348645227435,0.028311425682507583,0.5626681166692665,1.0,107/509,16.33%,CD74;CARD11;FGR;FFAR4;PTPRC;IL1B;IQGAP1;ALPK1;LYN;FLT3;PLCG2;FYN;RET;CD40;SLC44A2;FGF5;FGF22;JAK2;NRG2;MAP3K14;KL;DHX58;REL;RAPGEF2;LAPTM5;ANKRD17;MALT1;PTPN6;RAC2;EIF2AK2;CBL;IKBKB;TRIM62;BBC3;BIRC3;ADRA2A;TRAF3IP2;S100A4;PELI1;CAV2;HEXIM1;IRAK4;TIRAP;UBE2N;SHISA5;GRB2;LGALS1;PDPK1;FLNA;OASL;PDCD4;PUM2;TRIM25;ZDHHC13;CARD16;ENG;RAC1;TLR3;IL6;HGF;IFI35;RHOA;ZDHHC17;CPNE1;RNF13;USP15;HIP1;RPS3;RTN4;FN1;FIS1;PIK3CA;RIPK1;TRIM14;RNF31;RHEB;TAB3;APP;MAP3K7;TLR2;PDGFD;CASS4;DNM1L;KIT;NCF1;HCLS1;HCST;ROCK1;HDAC3;TGFB1;FGFR3;PTPRJ;IL18;UNC5B;MAZ;MYD88;RHOG;FRS2;RELA;MIER1;TBK1;THBS1;VAPA;PUM1;SEH1L;INSR;RELN
prerank,positive regulation of neuron migration (GO:2001224),0.5884694989460744,1.2530573152918711,0.20777027027027026,0.5631293615930865,1.0,3/11,3.14%,SHTN1;NIPBL;RAPGEF2
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5068668719168827,-1.252347931934089,0.1564102564102564,0.7023711000550701,1.0,3/12,8.94%,ABCD2;PPARGC1A;IRS1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5532887186657502,1.2522760198608318,0.21652892561983472,0.5644312056563696,1.0,4/15,11.91%,ZFP36L2;ANXA1;NR3C1;REST
prerank,peptidyl-lysine acetylation (GO:0018394),0.6039846679262847,1.252153915315027,0.23299319727891157,0.564031798717854,1.0,4/10,17.18%,KAT7;KAT2B;CREBBP;SIRT1
prerank,T cell mediated immunity (GO:0002456),0.562119768890532,1.2519804437046582,0.22056384742951907,0.5637884087254973,1.0,2/13,6.89%,MYO1G;GNL1
prerank,glucose homeostasis (GO:0042593),0.4175948726100679,1.2516024495608609,0.1446229913473424,0.5640554812355909,1.0,27/83,20.65%,NGFR;PPARG;STAT3;SLC8B1;CRY1;LRRC8D;ADRA2A;WFS1;CRY2;CYB5R4;IL6;SELENOT;PRKAA1;BACE2;PRKAA2;INSR;GCK;FOXK1;PIK3R2;SIRT1;PYGL;MBD5;BAD;RPS6;PARK7;ADIPOR1;STK11
prerank,actin polymerization or depolymerization (GO:0008154),0.44414107509191586,1.251419433481516,0.15176151761517614,0.5638209762884773,1.0,7/50,5.12%,SVIL;PSTPIP1;JAK2;PSTPIP2;MSRB1;ABI1;DIAPH1
prerank,MAPK cascade (GO:0000165),0.37552898507547333,1.251180159245707,0.06804123711340206,0.5637664889839734,1.0,69/295,15.33%,LRRK2;IL1B;RASGRP4;FLT3;FYN;RET;MAP3K5;MAP3K8;PSME3;PAK1;NFKB1;FGF5;FGF22;JAK2;NRG2;KL;CUL3;RAPGEF2;MAPKAPK2;RASA3;PTGER4;PTPN7;PSMB7;IKBKB;PSME2;GDNF;TAOK3;IL2RG;FBXW11;GRB2;SETX;CSF2RB;SHOC2;MAPK12;PAQR3;PSME4;DUSP6;ZFP36L2;SOS1;HGF;MINK1;ABHD17B;BRAF;PSMB8;CAMKK2;PSMA5;MBP;PSMD9;IL31RA;PIK3CA;PRKG2;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;PPP1CB;MAP3K20;PSMB1;MAPK8;KIT;MARK3;TGFB1;FGFR3;IL18;MAPK1;FRS2;RASGEF1A;SPRED1
prerank,cardiocyte differentiation (GO:0035051),0.5920751117928008,1.251055535993729,0.22333333333333333,0.5634213117296386,1.0,1/10,1.17%,SIK1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5004262217791376,1.2506706321989858,0.2039573820395738,0.5636804318776962,1.0,4/23,11.22%,SLC9A7;SLC12A7;SLC12A6;SLC12A9
prerank,N-glycan processing (GO:0006491),0.5247113076792136,1.2504229860536005,0.19448946515397084,0.5636570966162038,1.0,3/18,3.54%,ST8SIA4;ST8SIA1;ST8SIA6
prerank,negative regulation of axonogenesis (GO:0050771),-0.41024994669062187,-1.249780140056911,0.16825396825396827,0.7082782155201717,1.0,8/27,8.23%,DIP2B;DCC;ULK2;MAP2;FGF13;CDKL3;ARHGDIA;EFNB3
prerank,protein complex oligomerization (GO:0051259),0.4086061280078206,1.249485046079111,0.15119047619047618,0.5653133544175792,1.0,19/85,14.90%,CARD11;LRRC8C;CLDN1;UPB1;LRRC8D;RNF213;PRMT8;PDCD6IP;SPAST;ATL3;NLRC4;NUDT21;LETM1;DNM1L;YME1L1;PNPT1;CUTC;EHD1;ATL1
prerank,mitotic cell cycle phase transition (GO:0044772),0.3776024907199902,1.2493878051454754,0.09120171673819742,0.5648852837083919,1.0,45/204,15.04%,GPR132;EPS8;SDCCAG8;CNTRL;PPP1R12A;CUL3;CUL5;HAUS8;PHLDA1;EIF4EBP1;CRLF3;CCNJL;CHMP4B;CCND3;FBXW11;FBXL8;CDK14;CDKN2C;CCND1;CEP63;PAFAH1B1;PLCB1;HAUS1;PPP2R2A;CCNH;CACUL1;DCTN3;LATS1;SPAST;TRIM71;CEP250;UBE2S;FBXL17;LATS2;DYNC1H1;PPP1CB;CCND2;HAUS3;FBXL12;CLASP1;WEE1;USP37;BCAT1;BRSK1;ANAPC7
prerank,positive regulation by host of viral transcription (GO:0043923),-0.46955529819259967,-1.2487180246941827,0.18766066838046272,0.7093810658867401,1.0,11/15,34.31%,HPN;SMARCB1;SNW1;SP1;RRP1B;CHD1;TAF11;CTDP1;LEF1;TFAP4;SMARCA4
prerank,cellular response to growth factor stimulus (GO:0071363),0.3859360266273015,1.2482295838603383,0.10416666666666667,0.5672346702600525,1.0,45/151,18.32%,CD44;RUNX2;IQGAP1;RAP1A;KLF4;NDNF;ERN1;BMPR2;RAPGEF2;MAPKAPK2;STAT5B;PTPN12;BCAR1;MAPK14;SETX;PDPK1;CIB1;PDE2A;ACVR2A;ZFP36L2;HGF;SMAD4;ANXA1;NR3C1;DSTYK;MAP2K5;MAP2K3;ZPR1;AKT1;KIDINS220;ADAMTS12;TGFB1;EHD1;RELA;STMN2;MED1;DUSP22;RPS6KB1;WNT7A;RAB35;KNSTRN;NR4A1;FOXC1;APPL1;SYAP1
prerank,tetrapyrrole metabolic process (GO:0033013),0.5324353428851928,1.2481697322769625,0.2138364779874214,0.5667122272571011,1.0,5/18,13.52%,MMAB;ABCC1;MTRR;LMBRD1;MMAA
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5062938799276043,-1.248064060437806,0.1783132530120482,0.7090516120724711,1.0,8/12,31.80%,MTTP;P4HB;APOC4;APOC1;DGAT1;SOAT2;ACSL3;LPCAT3
prerank,regulation of microtubule depolymerization (GO:0031114),-0.4217485398153473,-1.2478822652274162,0.1742857142857143,0.7072375076478257,1.0,8/25,13.66%,NAV3;CAMSAP1;MAP1B;FGF13;CLASP2;MAP1A;CAMSAP2;TRPV4
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.4347645042136718,1.247876869342587,0.16579634464751958,0.5668019680972929,1.0,14/56,12.51%,ALPK1;PLCG2;MAPKAPK3;CD36;RPS6KA3;MAPKAPK2;IRAK4;TRAF3;SFTPA1;SFTPA2;TLR3;TAB3;MAP3K7;TLR2
prerank,positive regulation of DNA replication (GO:0045740),0.5520438579148991,1.246888318036528,0.22919937205651492,0.5686739444539274,1.0,4/16,5.79%,DNA2;GLI1;KAT7;FAF1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.4733702496734493,1.246673064848429,0.19220055710306408,0.5685673781929809,1.0,10/35,13.00%,LYN;STAT3;HSPA1A;SPI1;STAT5B;STAT1;MAPK14;ACVR2A;FOXO3;HSPA9
prerank,Golgi inheritance (GO:0048313),0.5889659257153282,1.246502013324087,0.21114864864864866,0.568366053210951,1.0,5/11,15.28%,VRK1;GBF1;STX5;YWHAZ;VCPIP1
prerank,calcium ion import (GO:0070509),-0.4005849759012411,-1.2461996603438195,0.17834394904458598,0.7101882805957241,1.0,7/28,6.81%,CACNA1D;SLC8A1;CACNB2;CACNA1C;ATP2A2;TRPC4;AFG3L2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.37716758239525,1.2460786746294652,0.1027542372881356,0.5688259799097918,1.0,35/199,14.22%,FFAR4;IL1B;PAEP;IFNGR1;MARVELD3;LNPEP;RAB11FIP1;PTPRO;SDHAF2;BMPR2;MAD2L2;RGS2;NPTN;ACOT11;SPI1;PTGER4;ATP2B1;RBPJ;SRGN;RPS6KA5;PTEN;ARHGDIB;ADAM17;HDAC9;SLAMF8;SPRED3;RHEB;FCGR2B;PGAM5;SLC6A4;USF3;LRP4;TIFAB;ROCK1;TGFB1
prerank,protein heterooligomerization (GO:0051291),-0.46730808733984264,-1.2456294773470264,0.20533333333333334,0.7096836557425172,1.0,8/17,22.55%,PKD2;MAT2A;CPSF6;CBR4;HSD17B8;TMEM120A;FARSA;GRIN2B
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5858877214845787,1.2454795150117497,0.23661485319516407,0.5696546053632112,1.0,2/10,2.59%,PRKCE;NEDD4L
prerank,eye photoreceptor cell development (GO:0042462),-0.48290183075190307,-1.245299105039563,0.19718309859154928,0.7082609914222675,1.0,3/15,20.21%,MYO7A;VEGFA;CEP290
prerank,BMP signaling pathway (GO:0030509),0.42891112575549,1.2451752138447096,0.16178343949044585,0.5697624491341913,1.0,10/62,9.94%,RUNX2;BMPR2;SCX;GDF1;HIVEP1;PDCD4;ENG;ACVR2A;USP15;SMAD4
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4537149116703846,1.2451391917180175,0.18319559228650137,0.5691847467067475,1.0,8/42,8.19%,RIN2;UTRN;CD36;PTK2B;PLEKHA2;CIB1;S100A10;RAC1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3856095325491264,1.2443970919160467,0.12184412733260154,0.57051843414572,1.0,42/148,16.37%,DNA2;RPL5;PIP4K2A;PRKAG2;RBBP8;TAF13;TAF9;MRE11;RBBP4;HIPK2;HEXIM1;MAPK14;HIPK1;PRKAB2;PDPK1;WRN;RPF2;BRIP1;KAT6A;CSNK2A2;CSNK2A1;PIP4K2B;DAXX;PRKAG1;ING2;PRKAA1;TAF7;RPA3;RPL11;AKT1;CHD4;PRKAA2;MAPKAP1;PPP2R5C;AURKB;USP7;PHF20;TAF1;DYRK2;BRD7;PRR5;HUS1
prerank,response to hydrogen peroxide (GO:0042542),0.4526534850824364,1.2443731780898133,0.18037135278514588,0.5698969422975148,1.0,12/45,11.32%,STK24;FYN;MAP3K5;GPX1;HP;SETX;NFE2L2;IL6;RPS3;ANXA1;RIPK1;NET1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5254114813620094,-1.2442450230941549,0.2323943661971831,0.70947392908472,1.0,3/10,1.35%,OPHN1;MYO9A;RAP2A
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4645916315655547,1.2438231123992416,0.19027777777777777,0.5707241012776441,1.0,12/34,16.20%,LYN;CD300A;SMPDL3B;RAB7B;TLR3;CACTIN;GRAMD4;ACOD1;OTUD4;GPS2;IRAK3;CD300LF
prerank,sensory perception of taste (GO:0050909),0.5981217762993187,1.2436148608370394,0.23519163763066203,0.5706197418517898,1.0,1/10,2.75%,CD36
prerank,plasma membrane tubulation (GO:0097320),0.5591759195214835,1.2434089554789511,0.21512605042016808,0.5704842902732102,1.0,6/13,15.67%,EHD2;CHMP4A;BIN3;SNX9;PACSIN2;SNX33
prerank,regulation of axon guidance (GO:1902667),-0.5348518118282006,-1.24327140384051,0.22014051522248243,0.7101566001280515,1.0,5/10,14.50%,NRP1;ZSWIM8;VEGFA;ZSWIM6;ZSWIM5
prerank,regulation of type I interferon production (GO:0032479),0.41130985069297,1.2429486836124393,0.15745192307692307,0.5710377534119375,1.0,24/84,15.48%,PTPN22;ITCH;POLR3F;NFKB1;DHX58;POLR3A;MRE11;LRRFIP1;NLRX1;IFIH1;TIRAP;DDX41;TRAF3;TRIM25;IRF7;CYLD;ACOD1;PQBP1;ILRUN;GPATCH3;MYD88;CREBBP;RELA;TBK1
prerank,regulation of cilium assembly (GO:1902017),0.4239597305982975,1.242916699695957,0.1759493670886076,0.5704713906549784,1.0,18/62,15.02%,TBC1D1;SDCCAG8;TBC1D8;USP6NL;TBC1D10C;CCDC88A;TBC1D2B;ATG5;RABGAP1;IFT140;TBC1D5;CYLD;TAPT1;TBC1D2;HTT;LIMK2;EVI5;DYNLT2B
prerank,clathrin coat assembly (GO:0048268),0.5454168987631236,1.2427769737858168,0.22488038277511962,0.5701700430986982,1.0,4/15,9.46%,PIK3C2A;EPS15;PICALM;HIP1
prerank,outer dynein arm assembly (GO:0036158),0.5372459303318485,1.2423557411022648,0.20868113522537562,0.5705763818129376,1.0,3/15,11.63%,DNAH8;DNAAF5;ODAD1
prerank,striated muscle cell differentiation (GO:0051146),-0.46736682884940417,-1.2423534491049766,0.19430051813471502,0.7108415633068741,1.0,4/16,4.54%,SKI;MEF2C;PLD3;SORT1
prerank,regulation of mRNA stability (GO:0043488),0.38665391437848085,1.2420947460860332,0.1211453744493392,0.5706494634898399,1.0,39/145,16.31%,TENT5A;XPO1;PSME3;FASTKD1;MEX3D;VIM;HSPA1A;MAPKAPK2;PSMB7;PSME2;GDNF;RC3H1;GIGYF2;DCP2;PUM2;YTHDF3;PSME4;ZFP36L2;PSMB8;PSMA5;IGF2BP3;PSMD9;YWHAZ;DCP1A;PSMB3;PSMD6;PSMC4;PSMD10;EIF4ENIF1;PSMB1;AKT1;METTL3;ROCK1;PAIP1;CELF1;PABPC1;PUM1;TNPO1;PSMD12
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5317610434095658,-1.241547209040976,0.2033898305084746,0.711076017142428,1.0,4/10,14.93%,CX3CR1;CTNNB1;VEGFA;CX3CL1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4376753586771231,1.2412774071938135,0.1668806161745828,0.5721169193483602,1.0,19/49,21.36%,NFE2;H3-3A;RAB7B;KMT2C;CBFB;CIB1;RBM15;TNRC6B;KAT2B;TNRC6A;KMT2E;KMT2A;THBS1;ASH2L;HDAC1;WDR5;RUNX1;MTURN;RBBP5
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.45876602012674106,-1.2411829978860094,0.19390581717451524,0.7097932429702167,1.0,8/17,15.43%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5PF;STOML2;ATP5F1D;ATP5MC3
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5087827262264155,1.241074281901943,0.2112676056338028,0.5719405389166459,1.0,7/21,12.85%,PTPN22;FOXJ1;LAPTM5;LST1;SAMSN1;FCGR2B;LGALS3
prerank,phospholipid homeostasis (GO:0055091),-0.5159570816297123,-1.2409608346675367,0.20863309352517986,0.7082032666834496,1.0,1/11,0.18%,ABCA1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5507453099826835,1.2405695887219264,0.22815533980582525,0.5725878544252576,1.0,4/15,7.77%,PRKCH;NCOA3;TRIM16;SULT2B1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4734273229196847,-1.2402949677673551,0.1865671641791045,0.7077907019876548,1.0,9/16,24.21%,DDX5;RBFOX2;EGLN2;PPARGC1B;ESR1;AR;NCOA4;ARID1A;SAFB
prerank,synaptic vesicle endocytosis (GO:0048488),-0.38372074652070365,-1.2402690710688535,0.1485148514851485,0.7055258115088181,1.0,9/33,13.30%,OPHN1;SYT1;NLGN1;ITSN1;DNM1;CDK5;STX1A;DNAJC6;NLGN2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6044380486727557,1.2402256680447006,0.24777183600713013,0.5727891966484104,1.0,4/10,12.53%,RUNX3;IRF4;CBFB;SH3RF1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.46771134741522524,-1.239649738908105,0.18181818181818182,0.7051962951421468,1.0,3/15,6.21%,TGFBR2;TGFBR1;FGFR2
prerank,regulation of interleukin-10 production (GO:0032653),0.4529751945534764,1.2391739902952916,0.18005540166204986,0.5748152363343122,1.0,7/44,8.62%,CD47;PLCG2;LILRB1;SYK;STAT3;IRF4;IL6
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.38195757334842356,1.2388899922106207,0.12691466083150985,0.5749333282469905,1.0,23/152,12.63%,GRK5;GNA14;CRHR2;FPR1;ADGRG5;ADGRG6;ADGRE5;WASF2;RXFP2;LPAR3;PTGER2;CXCL10;HTR1D;PTGER4;ADRA2A;PDE2A;PSAP;PTGER3;S1PR5;ADCY7;GLP2R;GNAI1;ADCY5
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5634031123999034,1.2388533377716042,0.23570190641247835,0.5743449719762588,1.0,3/12,3.04%,IQGAP1;PTPRO;MYO1E
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4205557811687032,1.2387292717281686,0.19066147859922178,0.5739957607366124,1.0,20/60,16.54%,RUNX2;NFKB1;ATF7IP;MED30;MED13;PTEN;CCND1;CBFB;MECP2;MED6;IL6;MED26;MED12;MED14;PPM1D;TNRC6B;TNRC6A;RELA;MED1;MED7
prerank,lamellipodium assembly (GO:0030032),0.49063217268683723,1.2387256612600142,0.2106038291605302,0.5733481780205969,1.0,6/26,9.69%,SRGAP2;PTPRO;CCDC88A;CARMIL1;RAC1;ARHGEF6
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4844263761425185,-1.2384925801374551,0.18611111111111112,0.7044053845439658,1.0,3/14,4.05%,SLCO2B1;ABCG2;BLVRB
prerank,heme catabolic process (GO:0042167),-0.4844263761425185,-1.2384925801374551,0.18611111111111112,0.7044053845439658,1.0,3/14,4.05%,SLCO2B1;ABCG2;BLVRB
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.47151302074686396,1.2384500775857843,0.2028169014084507,0.5733955580617889,1.0,11/31,18.81%,FBXW7;AXIN1;DCUN1D1;PTEN;UBE2N;UBE2S;DCUN1D3;RPS2;FZR1;PIN1;PINK1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.47310542038973713,-1.2384291296750545,0.1945945945945946,0.702262327855266,1.0,7/16,16.57%,PIGN;PIGG;PIGP;PIGB;PIGA;DPM2;PIGV
prerank,regulation of protein binding (GO:0043393),0.3900701431007528,1.237581172848598,0.13196814562002276,0.5749295745877407,1.0,29/114,15.44%,LRRK2;TIAM1;DTX3L;CRK;IFIT2;RAPGEF2;SORL1;SLPI;MITD1;HIPK2;PRMT8;STK4;CARD16;TMC8;PEX14;RALB;SNAPIN;B2M;APP;NMD3;RPL11;MAPK8;AKT1;MARK3;IFIT1;ROCK1;AURKB;DISC1;TAF1
prerank,positive regulation of phagocytosis (GO:0050766),0.4423965011126013,1.237536266312164,0.17918313570487485,0.5743878426016523,1.0,6/47,1.56%,PTPRC;IL1B;CD47;STAP1;DOCK2;CAMK1D
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.49149103850178927,1.2371924529372316,0.21839080459770116,0.5746214155210311,1.0,11/25,19.72%,PRPF6;DBR1;SRSF10;PRPF3;SRSF4;SLU7;DDX23;TXNL4A;SF3B3;SF3B1;SMNDC1
prerank,cellular component maintenance (GO:0043954),0.5760277536469566,1.2371379057433947,0.23076923076923078,0.5741119321492817,1.0,7/12,20.05%,FYN;CLDN1;PRNP;ITGA3;INSR;MTMR2;SUPV3L1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.47729475670502697,-1.2365768552747711,0.20947630922693267,0.7057982704484415,1.0,5/13,34.72%,SLC8A1;CALM1;CAV1;PDE4D;CALM2
prerank,negative regulation of cell activation (GO:0050866),-0.4838252956174757,-1.2364936180463617,0.19786096256684493,0.7037014727500319,1.0,3/14,8.53%,APOE;TREM2;PDGFA
prerank,detection of visible light (GO:0009584),0.5329906620996747,1.2361114837351206,0.24271844660194175,0.5761563712454254,1.0,3/16,14.72%,CEP250;PDE6B;GNA11
prerank,phasic smooth muscle contraction (GO:0014821),0.5924731475131,1.2357468474331514,0.2222222222222222,0.5764041135438236,1.0,4/10,13.68%,HTR1D;GDNF;PTGER3;TIFAB
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.36938133168097764,-1.235404156327169,0.152,0.7048138395697021,1.0,5/44,6.11%,TGFBR2;MEF2C;PKD2;SMO;ACVR1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.532146682745052,-1.2353452825657723,0.22758620689655173,0.7027173022995433,1.0,6/10,24.96%,IVD;ACADM;ACADL;ACADS;GCDH;ACAD11
prerank,epithelial cell development (GO:0002064),0.5213610126360408,1.2353278861395218,0.21316614420062696,0.576849296648062,1.0,7/20,21.18%,SIPA1L3;SLC4A7;PDZD7;RILPL2;WNT7A;WNT5B;DACT2
prerank,regulation of GTPase activity (GO:0043087),0.38029754167610386,1.2351978979362461,0.09795479009687837,0.5765283359377142,1.0,36/177,12.50%,ARHGAP15;LRRK2;VAV3;SRGAP2;RAP1A;CD40;DOCK10;CRK;RASGRP2;RAPGEF2;RCC2;USP6NL;DOCK11;OCRL;PICALM;KLRK1;ARAP1;RSU1;FGD4;CAV2;AFDN;S100A10;RABGAP1;F11R;PLXND1;FGD1;FGD3;BCAS3;ARFGEF1;SNX9;ADAP1;NET1;TBC1D2;DVL3;SH3BP4;PLXNC1
prerank,response to thyroid hormone (GO:0097066),-0.5033077214304161,-1.2351339457844834,0.2071611253196931,0.7011243237589198,1.0,4/13,8.19%,CTSB;LMO2;THRB;HPN
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5679157833233732,1.2348260061413845,0.22664359861591696,0.5767928702931276,1.0,2/11,2.59%,KCNE3;NEDD4L
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5695176483345022,1.2347004802159036,0.2247191011235955,0.5764918733245609,1.0,5/12,15.01%,IDH1;GLUD1;IREB2;SIRT4;ASS1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4046163693288692,-1.2344937725814218,0.17142857142857143,0.7008747445747039,1.0,5/26,7.74%,CACNA1D;ATP1B3;ATP1B1;ANK2;NETO1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.447272160230187,-1.2343414446376777,0.17681159420289855,0.6990151261250532,1.0,9/19,13.28%,BIN1;APOE;IGF1;NTRK2;RTN3;GGA3;CHRNA7;CLU;ABCA7
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4276346975934802,-1.2342559391408923,0.2,0.6969969843922916,1.0,8/21,18.88%,IGF1;FGF2;FOXJ2;P2RY6;GJA1;IGFBP5;ADAMTS1;FGF9
prerank,dendritic spine morphogenesis (GO:0060997),0.5500139603321796,1.234228723664749,0.2542372881355932,0.5770734707821659,1.0,4/15,8.44%,DOCK10;CDC42;PTEN;EPHB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5296295866438118,1.23398758596455,0.24193548387096775,0.5763852342371012,1.0,8/16,16.87%,RCC2;DLC1;PTEN;PHLDB2;BCAS3;THBS1;DUSP22;ARHGAP6
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5296295866438118,1.23398758596455,0.24193548387096775,0.5763852342371012,1.0,8/16,16.87%,RCC2;DLC1;PTEN;PHLDB2;BCAS3;THBS1;DUSP22;ARHGAP6
prerank,N-terminal protein amino acid modification (GO:0031365),-0.49187127382323403,-1.233431213093873,0.21164021164021163,0.6974068290033997,1.0,4/14,3.62%,METAP1D;NAA50;NAA40;METAP2
prerank,ESCRT complex disassembly (GO:1904896),-0.5369575894026116,-1.2332634486327765,0.21515892420537897,0.6935330040355131,1.0,6/10,27.54%,VPS4B;CHMP5;CHMP1B;CHMP7;CHMP2A;IST1
prerank,ESCRT III complex disassembly (GO:1904903),-0.5369575894026116,-1.2332634486327765,0.21515892420537897,0.6935330040355131,1.0,6/10,27.54%,VPS4B;CHMP5;CHMP1B;CHMP7;CHMP2A;IST1
prerank,mitochondrial fission (GO:0000266),-0.46258461121180694,-1.2325695169048398,0.20304568527918782,0.6937265978982013,1.0,5/16,14.28%,PRKN;GDAP1;MFF;DNM1;MTFR1L
prerank,negative regulation of response to external stimulus (GO:0032102),0.39829973501324445,1.231873724200223,0.14763552479815456,0.5811361700811183,1.0,13/105,5.92%,FFAR4;KLF4;CASK;PPARG;ITCH;METRNL;CRK;DHX58;PTGIS;PTGER4;INPP5F;SMPDL3B;PTEN
prerank,regulation of sensory perception of pain (GO:0051930),-0.5122726284644837,-1.231733412775171,0.20854271356783918,0.6941319240383224,1.0,4/11,19.93%,MGLL;ZFHX2;CCL3;TMEM100
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3594221866262802,1.2316278348560208,0.03621730382293763,0.5810887230561327,1.0,106/497,17.18%,CIITA;CBFA2T3;JARID2;FOXP1;RUNX2;RARA;SP3;LIMD1;BCL3;KLF4;DAPK1;PPARG;SCML4;BCL6;ATF7IP;NIPBL;NAB1;BTG2;CIART;BMPR2;SPI1;EIF2AK2;EIF2AK1;CRY1;MTA3;MBD1;SUMO1;KAT7;RFX3;RBPJ;DEAF1;HEXIM1;MBTD1;FBXW11;RPS6KA5;KLF10;AHR;ARID4A;PDCD4;GIGYF2;SETDB2;MECP2;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;CTCF;PHF12;UIMC1;MRPL13;HDAC9;PEX14;CBFA2T2;KAT6A;RBAK;ID2;WWP2;TRIM71;SMARCE1;RCOR3;SMAD4;RPS3;SBNO2;IGF2BP3;DAXX;NR3C1;RBM15;SPEN;S100A11;DEDD2;PAIP2;TAF7;REST;MBD2;L3MBTL2;EIF4ENIF1;MYB;EIF2AK3;LBH;TLE1;EZH2;SMARCC2;CITED2;HDAC3;NFIL3;TGFB1;SYNCRIP;RSF1;TNFRSF4;RELA;BHLHE40;PHC3;ZNF148;BRD7;USP47;RB1;DAPK3;PROX1;SCMH1;NIBAN2;CNOT8;CAPRIN1;FOXK1;SIRT1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4567104130134404,1.231617907318394,0.19859154929577466,0.5804623645185315,1.0,9/35,9.14%,IQGAP2;HCK;NOTCH2;STAP1;CDC42;ARHGDIB;PTK2B;F11R;BCAS3
prerank,carboxylic acid metabolic process (GO:0019752),0.46887300606889293,1.2313829608075477,0.21075581395348839,0.5804101916262748,1.0,9/33,15.17%,ST3GAL1;SLC23A2;SLC23A1;PTGIS;GLUD1;SIRT4;GNE;CSGALNACT1;SLC2A1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.37863110921096876,1.2310744557353719,0.11789924973204716,0.5805324560145613,1.0,36/172,13.62%,DGKG;PLCG2;PIP4K2A;SLC44A2;PLSCR1;PIK3C2A;AGPAT4;MTMR14;OCRL;INPP5F;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;CEPT1;ARF1;MTMR4;SYNJ1;PCYT1A;CPNE1;PITPNM1;PIKFYVE;FAR1;CSNK2A2;CSNK2A1;PIP4K2B;PIK3CA;CDIPT;SLC44A1;PIK3R4;SLC44A5;PIP5K1A;AGPAT1
prerank,adenine nucleotide transport (GO:0051503),0.5166759994827834,1.2310715218371397,0.21815286624203822,0.5798842841249217,1.0,4/17,11.96%,LRRC8C;LRRC8D;ABCC4;SLC25A5
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4053255366516843,-1.2309796945744242,0.14506172839506173,0.6941840997589589,1.0,8/25,17.38%,WNK1;ATP1B3;ATP1B1;ANK2;WNK2;TCAF1;GLRX;ACTN2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.48643281730256493,1.230415892032375,0.21014492753623187,0.5809233290085208,1.0,3/29,3.59%,CCR2;CCR1;CXCL10
prerank,heart contraction (GO:0060047),0.45429751982882105,1.2301128534731565,0.1891156462585034,0.5810524003795863,1.0,6/41,7.08%,ACE;TNNC1;GPX1;KCNQ1;MYL4;SGCD
prerank,cellular copper ion homeostasis (GO:0006878),0.5535588038327433,1.2297038676505898,0.2356902356902357,0.5814492745402857,1.0,6/14,16.65%,PRNP;ARF1;ATP7A;ATOX1;APP;SLC31A1
prerank,mRNA export from nucleus (GO:0006406),-0.2960269522473236,-1.2294149489171653,0.07317073170731707,0.6967721593862857,1.0,35/102,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;DDX19A;ZC3H11A;SEC13;IWS1;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;HNRNPA2B1;NUP37
prerank,negative regulation of signal transduction (GO:0009968),0.3651631726698249,1.2291547731637755,0.10377358490566038,0.5822263901443524,1.0,50/249,16.85%,LRRK2;PID1;PTPRC;IL1B;LYN;CD47;PIP4K2A;SULF2;PTPRE;HERC4;NOTUM;RGS2;CRY1;SMPDL3B;GPC3;FBXW7;APCDD1;PTPN12;TNS2;PTEN;DDIT4;CARD16;WWP2;CSNK2A2;CSNK2A1;PIP4K2B;PTPN1;CACTIN;NLK;NTN1;RGS14;OTUD4;AKT1;METTL3;TLE1;ADAMTS12;EZH2;TAX1BP3;CNMD;VCP;PTPRJ;GPS2;MAZ;TSPAN15;THBS1;IRAK3;RPS6KB1;RB1;MTMR2;NIBAN2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.4686099843751575,1.2291328234764973,0.2109704641350211,0.581631007113675,1.0,8/32,13.79%,CREB1;PRKAG2;ZBTB20;PRKAB2;CREBL2;AKT1;PRKAA2;SIRT4
prerank,cellular defense response (GO:0006968),0.45228820183045115,1.2283127776016465,0.20305980528511822,0.5830603045543715,1.0,9/40,15.73%,CD300C;LSP1;CCR9;SPN;PTK2B;NCF2;NCF1;RELA;ZNF148
prerank,regulation of cell population proliferation (GO:0042127),0.356788860864223,1.228118454960225,0.018018018018018018,0.5829304472945118,1.0,127/691,16.00%,DPP4;CBFA2T3;IL1B;GRK5;RARA;IFNLR1;TIAM1;SGK3;HCK;STAT4;LYN;CD47;GLI1;NGF;FLT3;CDK13;KLF4;ITGAX;ACER3;TBC1D8;STAT5A;PTPRU;BCL6;PAK1;ACE2;FGF5;FGF22;JAK2;STAT3;HSPA1A;CUL3;BTG2;BMPR2;RAPGEF2;FABP7;BIRC6;CXCL10;PTPN6;STAT5B;CCDC88A;ABI1;EIF2AK2;SCX;IL6R;GDNF;DLC1;VEGFC;BTG1;ADRA2A;PPP1R9B;RBBP4;STAT1;TNS2;KCNH1;GLMN;PTEN;CDKN2C;KLF10;PTK2B;ADAM17;CIB1;MECP2;CNOT6;SULT2B1;NOX1;RARG;LMNA;DOT1L;ENG;CACUL1;CTCF;IL6ST;IL6;IFI35;RHOA;OPRM1;ID2;TRIM71;PGF;CSNK2A1;RPRD1B;FN1;IL31RA;ARID2;GLP2R;MCTS1;S100A11;NAP1L1;REST;SLC25A5;APP;NUPR2;UTP20;SH3BP4;PDGFD;PPM1D;NF2;CCND2;LIFR;AKT1;KIT;STAT2;JUNB;HCLS1;EZH2;GNAI2;CD164;KAT2B;RPS6KA2;TGFB1;COX17;FGFR3;PTPRJ;PPP2R5C;MAZ;RHOG;XIAP;RELA;RPS15A;THBS1;CELF1;CDCA7L;DUSP22;RNF41;RPS4X;APC;BRD7
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5016045351898526,1.227654811636618,0.21580547112462006,0.5834347378683559,1.0,9/24,20.24%,PRKCH;NCOA3;TRIM16;CBFB;ROCK1;SGPP1;MED1;FOXC1;RUNX1
prerank,positive regulation of wound healing (GO:0090303),0.4598388389448213,1.2274967422924727,0.20874471086036672,0.5831876252453916,1.0,6/36,10.39%,ST3GAL4;PRKCE;CLDN1;ADRA2A;ARFGEF1;ANXA1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.40665215893749573,1.2273045104692748,0.17596034696406443,0.5830359851114004,1.0,17/78,14.19%,CBFA2T3;LRRK2;HSPA1A;ANKIB1;SUMO1;ARIH1;RNF217;HECTD1;NFE2L2;ELOB;COP1;ARIH2;SUMO2;RCHY1;PSMD10;PABIR1;VCP
prerank,synaptic vesicle exocytosis (GO:0016079),-0.361055597056313,-1.2271325844221455,0.13382899628252787,0.7017827584983131,1.0,17/40,23.52%,SYT1;PCLO;STX2;SNAP25;SYT7;CDK5;SNPH;STX1A;CPLX1;RIMS1;STX1B;RIMS3;RAB3A;SNAP29;CPLX2;SYT8;BLOC1S6
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.5506724357916817,1.2268446846641117,0.22330097087378642,0.5835417830059012,1.0,3/15,2.97%,RPL5;DTX3L;MAD2L2
prerank,positive regulation of histone modification (GO:0031058),0.46529003099487215,1.2266866284672495,0.21469740634005763,0.5832788557592562,1.0,7/33,11.13%,IL1B;NIPBL;RPS6KA5;UBE2N;FAM47E;TADA2A;ING2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5436071277346709,1.2262875923146823,0.2542955326460481,0.5836512528781871,1.0,6/15,16.01%,BTG2;EIF4ENIF1;TNRC6B;TNRC6A;TENT4B;PABPC1
prerank,cellular response to estrogen stimulus (GO:0071391),0.5385128157496069,1.226037812675037,0.23714759535655058,0.5836437206875297,1.0,3/14,9.14%,RARA;SERPINB9;BCAS3
prerank,carbohydrate catabolic process (GO:0016052),-0.37063448966067275,-1.225910587852622,0.15057915057915058,0.7034801557117272,1.0,14/38,24.13%,HK3;HK1;PFKL;NEU1;PGK1;MAN2B2;ENO2;PGAM1;PGAM4;PFKM;MAN2C1;ENO3;LDHA;ALDOA
prerank,response to glucagon (GO:0033762),0.5229653934922955,1.225800536986264,0.223950233281493,0.5835933974491059,1.0,6/19,12.63%,CYSLTR2;CREB1;CRY1;PRKAR2A;ADCY7;ADCY5
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.599745268381875,1.2255154707108404,0.26678765880217786,0.5836736595151351,1.0,4/10,11.00%,MALT1;NFKBIZ;RC3H1;NFKBID
prerank,regulation of cation channel activity (GO:2001257),-0.308727998912632,-1.2253032607105039,0.09032258064516129,0.7030546907968847,1.0,14/89,5.04%,MEF2C;GRIA4;FGF14;LRRC7;CACNB2;NLGN1;SLMAP;FGF13;DLG2;DLG4;GRIA2;GRIA1;PRKACA;ANK2
prerank,necroptotic process (GO:0070266),0.5297600330599515,1.224876237131671,0.2259083728278041,0.5846156732180413,1.0,7/16,15.46%,ITPK1;TLR3;CYLD;RIPK1;PGAM5;DNM1L;IPMK
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.49772861608491586,1.2245568701253469,0.2009273570324575,0.5847832437299164,1.0,6/22,17.18%,STAP1;PRKRIP1;CDKN2C;ANKLE2;ROCK1;SIRT1
prerank,negative regulation of cell communication (GO:0010648),0.5163871113097985,1.2245438125097285,0.23771790808240886,0.5841745614313131,1.0,3/21,10.52%,IL1B;OPRM1;PTPN1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.40474256886027093,1.2240955220825451,0.15494636471990464,0.5846620844832998,1.0,29/85,19.83%,TIAM1;PSME3;CELSR1;PSMB7;CDC42;PSME2;AP2A2;RAC1;PSME4;RHOA;PSMB8;PSMA5;PSMD9;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD3;PSMF1
prerank,histone mRNA catabolic process (GO:0071044),0.5407526363648953,1.2239889049106245,0.23089430894308943,0.5843252911807036,1.0,7/15,14.81%,DCP2;TUT1;ERI1;TENT2;MTPAP;TUT7;TENT4B
prerank,transport across blood-brain barrier (GO:0150104),-0.31346640937658393,-1.2239522975173973,0.07228915662650602,0.705111242788608,1.0,18/83,12.90%,SLCO2B1;SLC24A3;LRP1;ABCC3;SLC1A3;ABCG2;SLC7A1;ATP8A1;SLC2A3;FABP5;SLC27A1;ATP1A2;TFRC;SLC22A5;SLC7A2;SLC29A1;SLC7A8;SLC15A2
prerank,miRNA metabolic process (GO:0010586),0.5141494109697118,1.223804562574479,0.22992125984251968,0.584175489705257,1.0,6/20,14.81%,SND1;XPO5;DGCR8;TRIM71;TUT7;TENT4B
prerank,regulation of blood circulation (GO:1903522),0.4587965540238316,1.2237968826726697,0.22644163150492264,0.5835603551682264,1.0,5/34,11.05%,ACE;ACE2;KCNQ1;CELF2;DMPK
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4421520005212707,1.2237643814760384,0.19324324324324324,0.5830096041378229,1.0,10/44,8.95%,CD47;PAK1;ARHGEF10L;CCDC88A;CDC42;CARMIL1;S100A10;RAC1;PXN;RHOA
prerank,ERAD pathway (GO:0036503),-0.315427791802782,-1.2236945883568011,0.1,0.703793172374964,1.0,28/83,21.93%,PRKN;ECPAS;STUB1;ERLIN2;DERL2;CCDC47;HSP90B1;AUP1;NPLOC4;USP19;RNF121;DNAJB2;SGTB;DERL1;TRIM13;ANKZF1;RNF103;HERPUD1;TMUB2;RNF139;GET4;FAM8A1;UBQLN2;DNAJB9;UBE2G2;SEC61B;BRSK2;FBXO44
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.42540464191990845,1.223535745116807,0.2028985507246377,0.5829605266265995,1.0,18/54,14.83%,TRAF1;SYK;HSPA1A;LAPTM5;IKBKB;BIRC3;HIPK1;ADAM17;CARD16;SPATA2;SPPL2A;CPNE1;CYLD;RIPK1;RNF31;CLIP3;GPS2;GSTP1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.40337981619897867,1.2232956769011116,0.17747858017135862,0.5829505957726276,1.0,20/85,15.91%,CBFA2T3;LRRK2;HSPA1A;FBXW7;ANKIB1;SUMO1;ARIH1;RNF217;HECTD1;ELOB;COP1;ARIH2;ATXN3;SUMO2;RCHY1;PSMD10;PABIR1;VCP;TAF1;TMTC3
prerank,negative regulation of gene expression (GO:0010629),0.3616934779026621,1.2230824105925024,0.07921810699588477,0.5828301962565893,1.0,80/302,17.18%,FFAR4;JARID2;FOXP1;ZC3H12D;NOTCH2;PTPN22;KLF4;DAPK1;PTBP3;CCR1;NFKB1;HSPA1A;ERN1;BTG2;REL;NPTN;SPI1;PTGER4;EIF2AK2;ATP2B1;PICALM;FBXW7;H3-3A;RBBP4;SRGN;RPS6KA5;TIPARP;PHF19;PARP14;GIGYF2;SETDB2;DCP2;MECP2;ENG;LSM5;MRPL13;HDAC9;ZFP36L2;CPNE1;ID2;WWP2;OLFM1;TRIM71;PARP9;RPS3;IGF2BP3;PRKAA1;FCGR2B;PAIP2;REST;APP;PPM1D;EIF4ENIF1;EIF2AK3;METTL3;EZH2;RNH1;TNRC6B;PRKAA2;PNPT1;CITED2;KAT2B;TNRC6A;TGFB1;SYNCRIP;OCLN;TAF1;ZNF148;CELF1;SNX12;PTBP2;PPHLN1;RBL2;MYADM;RB1;DAPK3;CNOT8;PSEN1;CAPRIN1;SIRT1
prerank,cellular amino acid catabolic process (GO:0009063),0.40032794253302717,1.2228556272554836,0.17249698431845598,0.5827739009453599,1.0,23/87,18.37%,KMO;KYNU;HGD;HIBADH;HAAO;DLD;BCKDHA;KYAT1;MTRR;BCKDHB;GLUD1;CARNS1;ACAT1;OGDH;GCSH;HIBCH;AMT;BCAT1;SARDH;DDAH1;AUH;HMGCLL1;SHMT1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.37537027824844305,-1.2226711814301967,0.17343173431734318,0.7046514934694164,1.0,13/37,12.53%,SIRPA;TREM2;ABCD2;APPL2;PLD3;APOD;HIF1A;NLRC3;PYCARD;CUEDC2;CHID1;PER1;TLR4
prerank,cristae formation (GO:0042407),-0.38841083480245536,-1.2223809818050804,0.18789808917197454,0.7034527535596634,1.0,11/27,15.43%,ATP5F1A;ATP5PO;APOO;AFG3L2;ATP5MG;ATP5PD;CHCHD6;ATP5PF;SPG7;ATP5F1D;ATP5MC3
prerank,glycolytic process (GO:0006096),-0.3956369396813404,-1.2221138520827874,0.17218543046357615,0.7021300064458544,1.0,13/28,28.60%,HK3;HK1;PFKL;PGK1;ENO2;PGAM1;PGAM4;PFKM;ENO3;LDHA;ALDOA;PFKFB1;GAPDHS
prerank,negative regulation of cation channel activity (GO:2001258),0.48518576765445187,1.22201007915658,0.237741456166419,0.5842968887470016,1.0,5/26,14.60%,KCNE3;GPR35;EPHB2;FKBP1B;SLC6A9
prerank,negative regulation of interferon-gamma production (GO:0032689),0.49554014613220987,1.221710354253747,0.2015151515151515,0.5844259062913701,1.0,4/23,6.34%,RARA;LILRB1;LAPTM5;PRNP
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4012625744879296,-1.2216577876136103,0.17765042979942694,0.7013547788500791,1.0,16/27,36.27%,SYT1;SDF4;SYT9;SYT7;SYT6;RIMS1;RIMS3;SYT8;SYT3;SYT12;SYT11;SYT13;SYT10;SYT5;SYT4;SYT17
prerank,potassium ion homeostasis (GO:0055075),-0.4293746714127321,-1.2212476595231265,0.2318840579710145,0.700512780861315,1.0,5/23,7.61%,KCNMA1;ATP1B3;KCNJ2;ATP1B1;ATP1A2
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.39016575251167224,-1.2210262166058738,0.14935064935064934,0.6990436781431651,1.0,19/29,35.69%,BCL9;CTNNB1;TCF7L2;RUVBL1;TCF7L1;BCL9L;PYGO2;MEN1;PYGO1;MYC;KAT5;LEO1;TRRAP;AXIN2;CDC73;TLE3;LEF1;SMARCA4;TCF7
prerank,positive regulation of organelle assembly (GO:1902117),0.4446953083627654,1.2208261838528776,0.1903485254691689,0.586064576729115,1.0,11/44,12.06%,LCP1;PIP4K2A;CCDC88A;CNOT6;PDCD6IP;RALB;CNOT2;PIP4K2B;TAPT1;DYNC1H1;HTT
prerank,positive regulation of ossification (GO:0045778),-0.3618705433093443,-1.2208179867920173,0.1646586345381526,0.6974815175818011,1.0,14/39,16.72%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;TGFB2;BMPR1B;PKDCC;BMP6;ADGRV1;SOX11
prerank,JNK cascade (GO:0007254),0.44403776851060595,1.2206220187520587,0.22375690607734808,0.5859069715406093,1.0,14/40,17.53%,MAP3K5;SH2D3C;PTGER4;UBE2N;MINK1;ARHGEF6;MAP4K3;TAB3;MAP3K7;MAPK8;MAP3K13;GPS2;MAP2K4;TAB1
prerank,endodermal cell fate commitment (GO:0001711),-0.5417779416093074,-1.2205222898971957,0.23877068557919623,0.6962861233544028,1.0,5/10,31.87%,CTR9;RTF1;SOX2;LEO1;CDC73
prerank,response to chemokine (GO:1990868),0.5439788745686949,1.2204042818281446,0.2427843803056027,0.5858799266195645,1.0,7/13,18.10%,RIPOR2;RHOA;OXSR1;DUSP1;STK39;LRCH1;FOXC1
prerank,regulation of response to oxidative stress (GO:1902882),-0.5301247010338649,-1.220224773534339,0.21933962264150944,0.6950303654502678,1.0,1/11,0.12%,PRKN
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4781446152368493,-1.2198746614255163,0.20855614973262032,0.6940209783651374,1.0,4/15,7.61%,SLC8A1;ATP1B3;ATP1B1;ATP1A2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5081507069921165,-1.219770294563977,0.21372031662269128,0.692309399972613,1.0,3/11,19.05%,MEF2C;TGFB2;EFNB2
prerank,relaxation of cardiac muscle (GO:0055119),-0.4854636173290261,-1.219734106500846,0.2127659574468085,0.6903523753117353,1.0,5/13,7.61%,SLC8A1;KCNJ2;ATP1B1;P2RX4;ATP1A2
prerank,positive regulation of interferon-beta production (GO:0032728),0.468235558251444,1.2197077427040144,0.1977077363896848,0.5869956810474962,1.0,10/33,16.50%,OAS2;POLR3F;DHX58;POLR3A;IFIH1;TLR3;IRF7;TLR2;TBK1;IRF5
prerank,glycoprotein metabolic process (GO:0009100),0.41991326186192424,1.2193612345859253,0.17986577181208055,0.5872391992595787,1.0,6/53,4.46%,ST8SIA4;ST3GAL4;ST8SIA1;ST8SIA6;B4GALT5;ERP44
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5173794012047089,1.2193294830369732,0.2379421221864952,0.5866841105917866,1.0,2/17,5.11%,NOTCH2;RBPJ
prerank,icosanoid secretion (GO:0032309),0.5776471154656008,1.2181902817021375,0.2568493150684932,0.5890587087392841,1.0,3/12,11.60%,ACE;ANXA1;ABCC4
prerank,intracellular protein transmembrane transport (GO:0065002),0.44347767022846935,1.2181511892650227,0.20592193808882908,0.5885156985067955,1.0,11/42,11.18%,C2CD5;PEX16;PEX12;GRPEL2;RTN2;DNAJC19;TIMM21;PEX14;SEC63;TOMM40;AIFM1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.3359371138035119,-1.2177167145337147,0.14227642276422764,0.6946673140820114,1.0,13/54,15.01%,CACNA1D;KCNMA1;BIN1;KCNJ2;CD63;KCNN2;DPP10;KCNMB2;AKAP6;KCNJ6;KCNN3;KCNJ9;GABBR1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4331709011297171,-1.217168840461007,0.17582417582417584,0.6942488678193364,1.0,7/22,7.26%,FLT1;NTRK3;FGF2;FGFR2;PLAA;GNA13;PLCG1
prerank,sterol biosynthetic process (GO:0016126),0.46469075833112977,1.2171225749151535,0.22356495468277945,0.5906052013781639,1.0,11/33,18.93%,PRKAG2;HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.47899596765691127,-1.2170656299999976,0.22962962962962963,0.6924814552555191,1.0,6/14,18.84%,BFAR;TMEM33;BAX;DAB2IP;UFL1;DNAJB9
prerank,glycoprotein biosynthetic process (GO:0009101),0.40202841657794663,1.2170457845287879,0.17097170971709716,0.5901834542691238,1.0,11/79,8.28%,ST8SIA4;ST3GAL4;ST8SIA1;BMPR2;FUT4;ST8SIA6;B4GALT5;CHST12;ATP7A;XYLT1;SERP2
prerank,regulation of cell development (GO:0060284),0.453540326279818,1.2168567501916898,0.2073342736248237,0.5900613511891883,1.0,8/36,13.17%,IL1B;NOTCH2;ADGRA2;CLOCK;HDAC9;SLAMF8;RHEB;AKT1
prerank,proteolysis (GO:0006508),0.36547449929621095,1.2167685586950576,0.09538784067085954,0.5896560165907376,1.0,45/252,13.95%,DPP4;NAPSA;CAPN13;ACE;RET;LNPEP;LONP1;RSPRY1;ATG4C;TINAGL1;MALT1;MMP1;FAM111A;OLR1;PRCP;SRGN;RNPEPL1;FAP;PARL;CAPN2;FBXW2;ADAM17;NEDD8;CPQ;HGF;SPPL2A;ACAN;CPNE1;LACTB;ADAM19;MBTPS1;CASP2;SENP6;RNPEP;ERMP1;PSMD6;PSMC4;CAPN7;ATG4D;BACE2;CASP7;PCSK5;ADAMTS12;YME1L1;CAPN6
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.38380599974696034,1.216580488107812,0.15172413793103448,0.5895123852703906,1.0,18/118,8.62%,LRRK2;PID1;SP100;CYRIB;PDLIM5;BCL6;PAK1;NEDD4L;PDZD8;LFNG;ADGRA2;GDNF;RC3H1;CAPZB;PAK2;PHLDB2;PLXND1;IL6
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3492302232814204,1.2161669693362802,0.01,0.5899614206769456,1.0,233/1082,17.42%,CD74;CIITA;PLAC8;NFE2;PID1;IL1B;RUNX2;RARA;SP100;SP3;RUNX3;GLI1;TNIP3;HNF4G;ACTR3;BCL3;KLF4;CREB1;LILRB1;RET;MAP3K5;PPARG;IER2;CD40;PPP1R12A;NFKB1;PITX3;ATF7IP;TET2;FOSL2;PLSCR1;DTX3L;STAT3;EHF;NSD3;FOXJ1;ELF4;FOS;TCF20;RPS6KA3;BMPR2;MAD2L2;REL;AKNA;NCOA3;CXCL10;CRLF3;TAF9;SPI1;STAT5B;NFKBIA;NAA16;MYRF;SCX;ATAD2;TBL1XR1;PICALM;IKBKB;MED30;ZEB2;CAMTA2;KAT7;ATF6;RYBP;AXIN1;GDNF;ATF2;PPP3CA;IRF2;PRPF6;RFX3;RBPJ;IL33;WAC;HIVEP1;DEAF1;MED13;STAT1;HIPK2;RNF20;NUFIP1;KLF5;IRF4;FBXW11;HELZ2;RFX5;RPS6KA5;SMARCA5;ARF4;TRIM16;KMT2C;KLF10;CDC5L;SEC14L2;SETX;AHR;ACTR2;CREBRF;TADA3;NFE2L2;DYRK1A;PLCB1;AFAP1L2;THRA;CLOCK;MED6;ZBED4;RARG;TOX3;DOT1L;E2F2;ENG;GABPB1;GABPB2;CTCF;ACVR2A;ELOF1;ELF1;TLR3;IL6;HGF;SCAF8;KAT6A;TNKS;BCAS3;ID2;CREBL2;NAA15;NCOA2;E4F1;ZNF496;PARP9;IRF7;MEF2B;SMAD4;CAMKK2;SBNO2;RPRD1B;PSMD9;NCOA1;IL31RA;CSRNP1;NR3C1;RIPK1;PBX1;ING2;CCNT2;FOXO3;MED12;ZNF507;DVL3;TAF7;NLRP3;ETS2;REST;RPS6KA1;ATF6B;APP;MAP2K5;MED14;CCNT1;BCLAF3;NFYA;TFAM;TLR2;MAP2K3;TEAD1;ATRX;NFATC2IP;MYB;EIF2AK3;ZPR1;AKT1;NRIP1;NSD1;LBH;NCF1;JUNB;HCLS1;SREBF2;SMARCC2;CITED2;KAT2B;HDAC3;MRTFA;NFIL3;TGFB1;CRTC3;RSF1;FHOD1;IL18;GPS2;MAZ;KMT2E;GPATCH3;SERTAD3;RHOG;KMT2A;ASXL2;CREBBP;RELA;TBK1;DVL2;PHF5A;MAML1;INO80;ZMIZ2;MED1;ELF2;BRD7;HMGN1;ELL;WNT7A;IRF5;PAXBP1;BPTF;RAI1;HTATIP2;PROX1;NIBAN2;PSEN1;CREB3L4;CREB3;SMAD5;ELK4;FOXK1;PIK3R2;CHCHD2;SIRT1;SUPT4H1;ATF1;NR4A1;SS18
prerank,carbohydrate biosynthetic process (GO:0016051),0.5002618438074826,1.2159558724875177,0.24044585987261147,0.5898783233157857,1.0,3/21,3.54%,ST3GAL4;FUT4;ST8SIA6
prerank,glutamate receptor signaling pathway (GO:0007215),-0.37182941577469736,-1.2155658721061928,0.176,0.695013469708883,1.0,15/37,25.22%,GRIA4;GRIA2;DAGLA;GRID2;GRIK4;GRIK1;CDK5R1;CPEB4;GRM5;GRIA3;GRM7;GRIN2B;CLN3;HOMER3;KCNB1
prerank,cell differentiation in hindbrain (GO:0021533),-0.5176990031388287,-1.215397119702941,0.25806451612903225,0.6934131448396113,1.0,3/11,6.91%,OPHN1;GRID2;FAIM2
prerank,regulation of synapse assembly (GO:0051963),-0.3486363519808156,-1.2146916117440303,0.1646090534979424,0.6935773790071775,1.0,21/46,24.00%,MEF2C;PTPRD;IL1RAPL1;NLGN1;ROBO2;GRID2;VPS35;GPC6;IL1RAP;SLIT1;NLGN2;CLSTN2;EIF4G1;SLITRK1;NLGN3;LHFPL4;NRXN1;DLG5;CUX2;GPC4;SLITRK3
prerank,lytic vacuole organization (GO:0080171),-0.375206174933493,-1.2141929199198582,0.18,0.6930907227369435,1.0,9/32,8.04%,ABCA1;HPS4;GRN;ZKSCAN3;TPP1;ARSB;TPCN2;GAA;MYO7A
prerank,defense response to bacterium (GO:0042742),0.3892887107526984,1.2140022252275737,0.15294117647058825,0.5943532707825765,1.0,21/105,14.99%,FGR;OAS2;SYK;ANKRD17;SLPI;IL6R;SPN;TIRAP;ADAM17;TLR3;IL6;SLAMF8;NLRC4;MBL2;RNASE6;TLR2;RPL30;FCER1G;PLA2G6;GBP2;MYD88
prerank,ureteric bud development (GO:0001657),-0.4466337317252877,-1.2138224572075917,0.21957671957671956,0.6922204611246491,1.0,6/17,9.40%,SALL1;ROBO2;NPNT;PKD2;FGFR2;SLIT2
prerank,histone deubiquitination (GO:0016578),0.5113234584335755,1.213791401210867,0.23274478330658105,0.5942635338678453,1.0,6/18,14.87%,USP3;USP49;ATXN7;UIMC1;USP15;USP7
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.48650503485525004,1.2136516996472706,0.24142857142857144,0.5939886749908455,1.0,8/27,15.27%,ATAT1;KAT7;KAT6A;MORF4L1;MSL3;KAT2B;CREBBP;PHF20
prerank,stem cell development (GO:0048864),0.5338561297759293,1.2132638520627506,0.23283082077051925,0.5943882247934833,1.0,4/16,16.57%,PTPRC;TAPT1;WNT7A;KLHL12
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4739868615689228,1.2132467419089383,0.20644216691068815,0.5937915323641753,1.0,13/29,22.85%,SAMHD1;PTPN6;YTHDF3;PTPN1;CACTIN;STAT2;METTL3;IFNAR2;ABCE1;TTLL12;MUL1;PTPN2;UBE2K
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.5009417477912583,1.213206353495191,0.23802612481857766,0.5932626106397055,1.0,7/22,12.97%,PSMB7;NFE2L2;PSME4;PSMB8;PSMA5;PSMB3;PSMB1
prerank,neuropeptide signaling pathway (GO:0007218),0.4177518961742344,1.212611168764454,0.19573400250941028,0.5941867635159628,1.0,6/58,9.07%,CYSLTR2;LTB4R;RAPGEF2;SORL1;CYSLTR1;OPRM1
prerank,replication fork processing (GO:0031297),0.4434744248747212,1.2124837423044335,0.21552878179384202,0.5938649944784978,1.0,7/38,12.73%,DNA2;SAMHD1;MRE11;FAM111A;WRN;EXD2;ATRX
prerank,"phototransduction, visible light (GO:0007603)",0.5370355119486319,1.2122584185966492,0.26865671641791045,0.5938353654156469,1.0,4/14,21.15%,GNB1;PDE6B;GNA11;SAG
prerank,regulation of adenylate cyclase activity (GO:0045761),0.5016371280311779,1.2118275677350363,0.2227342549923195,0.5943870435962169,1.0,1/22,0.04%,CCR2
prerank,macromolecule catabolic process (GO:0009057),-0.3989136036311018,-1.211757816842079,0.20180722891566266,0.6961895382444107,1.0,6/26,8.12%,LGMN;CAPN3;SNX25;TPP1;UCHL3;IDE
prerank,lipoxygenase pathway (GO:0019372),0.5308519890446612,1.2117516133158384,0.2564935064935065,0.5939537390942587,1.0,2/14,2.68%,ALOX5AP;GPX1
prerank,cAMP-mediated signaling (GO:0019933),0.4866893552674186,1.211414951226227,0.23343373493975902,0.5942135928853565,1.0,5/24,7.50%,ADGRG6;RAPGEF2;PDE7A;AHR;PDE2A
prerank,positive regulation of integrin activation (GO:0033625),-0.503960442893121,-1.2111805315297999,0.22871046228710462,0.6959803058316333,1.0,4/11,16.71%,P2RY12;SKAP1;SRC;PLEK
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.526827817470307,-1.2111718005886458,0.24019607843137256,0.6939953238339831,1.0,5/10,22.55%,PRKN;OXA1L;HDAC6;MT3;ETFBKMT
prerank,tRNA 5'-leader removal (GO:0001682),-0.481254503213134,-1.2111449439426065,0.22797927461139897,0.6920776117160018,1.0,10/13,34.66%,POP1;RPP30;RPP14;SSB;RPP40;POP4;POP5;RPP21;POP7;RPP25L
prerank,hexose transmembrane transport (GO:0008645),-0.41385740281287575,-1.2104012438653364,0.22063037249283668,0.6921955012128279,1.0,8/21,32.64%,SLC2A3;SLC2A9;SLC2A5;SLC50A1;SLC2A8;SLC45A3;PPARD;SLC45A1
prerank,vacuolar acidification (GO:0007035),-0.4153049900202333,-1.2100228984610002,0.19873817034700317,0.6913661384855821,1.0,7/21,12.66%,SLC11A1;GRN;ATP6V0D2;TCIRG1;DMXL2;ATP6V0D1;ATP6V0A1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.507192080761027,1.2098711202286048,0.2283464566929134,0.5975626874348663,1.0,8/18,22.73%,GDNF;ATP7A;PDP2;ABL2;POR;PARK7;SIRT3;TNF
prerank,photoperiodism (GO:0009648),0.4687823955117065,1.209529392511568,0.22861356932153393,0.5978433007513573,1.0,11/28,15.59%,SIK1;CRY1;FBXL8;CRY2;CLOCK;ID2;FBXL17;PPP1CB;PDE6B;FBXL12;BHLHE40
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5628390593669623,1.2092490340853286,0.24620573355817876,0.5979173524049685,1.0,4/12,8.44%,B4GALT5;PTEN;MYCBP2;EPHB2
prerank,leukotriene metabolic process (GO:0006691),0.5035633082648389,1.2087872812765552,0.23667711598746083,0.5984549746975614,1.0,7/19,17.23%,ALOX5AP;MAPKAPK2;DPEP1;ABCC1;DPEP2;ABCC10;MGST3
prerank,positive regulation of cation channel activity (GO:2001259),0.4535917667470272,1.2086598423871395,0.23319615912208505,0.5981828843197795,1.0,1/40,0.04%,CCR2
prerank,regulation of defense response to virus (GO:0050688),0.5434631578162624,1.2081604448574523,0.25287356321839083,0.5988003909283857,1.0,3/14,7.46%,IFNLR1;ITCH;TRAF3
prerank,regulation of primary metabolic process (GO:0080090),0.3840966998062998,1.2074780188494758,0.15860517435320584,0.5999330048204328,1.0,37/126,16.94%,PPARG;LDLR;PSME3;TBL1XR1;PSMB7;PSME2;HELZ2;PRKAB2;AZIN1;PSAP;PSME4;ELOVL6;NFYC;ID2;NCOA2;LACTB;PSMB8;OPA3;PSMA5;PSMD9;NCOA1;IDI1;FDPS;PSMB3;PSMD6;PSMC4;NFYA;PSMD10;PSMB1;SREBF2;HDAC3;GPS2;CREBBP;MED1;PSMD12;MVD;MVK
prerank,cellular response to amyloid-beta (GO:1904646),0.45886737171356,1.2073450190673976,0.21678321678321677,0.5996456594065224,1.0,11/35,12.10%,ITGA4;NGFR;FYN;CACNA1A;CD36;PRNP;CACNB1;ABCC1;ICAM1;FCGR2B;APP
prerank,kinetochore organization (GO:0051383),-0.4840277724091747,-1.2073239196663965,0.23857868020304568,0.697737083409567,1.0,12/13,40.20%,POGZ;CENPE;CENPA;CENPF;DLGAP5;CENPT;NDC80;MIS12;CENPH;CDT1;CENPW;NUF2
prerank,phagosome acidification (GO:0090383),-0.3837332235468816,-1.206933889325775,0.18153846153846154,0.6969257072716744,1.0,9/26,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.45567667805556084,1.2068420184418192,0.23087431693989072,0.6002763141521665,1.0,8/33,11.43%,STAT3;HSPA1A;STAT5B;STAT1;RAB7B;MAPK14;ACVR2A;FOXO3
prerank,cytoplasmic microtubule organization (GO:0031122),-0.3337646354373465,-1.2062992410650664,0.11475409836065574,0.6967214409748704,1.0,19/54,15.44%,DST;CAMSAP1;NUMA1;TUBGCP5;VPS4B;CLIP1;PLK3;CLIP2;KATNAL1;FIGNL2;CEP126;FIGN;CAMSAP2;CHP1;TRPV4;HOOK1;CCDC88B;TUBGCP6;TPPP
prerank,RNA methylation (GO:0001510),-0.32103402018302124,-1.2060479590030062,0.14666666666666667,0.6954438369083256,1.0,30/60,26.25%,ALKBH8;NSUN2;METTL6;ZCCHC4;METTL14;DIMT1;NOP2;NSUN3;METTL2B;METTL2A;METTL1;TGS1;ZC3H13;WTAP;FTSJ3;METTL8;NSUN5;THUMPD2;TRMT10A;TRMT44;MTO1;TRMT6;TRMT12;NSUN6;LCMT2;TRMT112;GTPBP3;TRMT5;BCDIN3D;BUD23
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.37850673320726286,1.2057947314950526,0.15536105032822758,0.6023347919048714,1.0,28/146,13.13%,GPR132;SDCCAG8;DTL;CNTRL;PSME3;HAUS8;RCC2;PSMB7;PSME2;CCND1;CEP63;PAFAH1B1;MECP2;HAUS1;AVEN;PSME4;DCTN3;PSMB8;PSMA5;PSMD9;CEP250;PSMB3;PSMD6;PSMC4;DYNC1H1;PSMD10;PSMB1;HAUS3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5036414035910584,1.2055674365093512,0.22945736434108527,0.6022749646974515,1.0,8/20,19.45%,RUNX2;RBPJ;NFE2L2;SMAD4;RELA;CREB3;SMAD5;CARF
prerank,epidermal cell differentiation (GO:0009913),0.43070082445907193,1.2053571066881539,0.21171770972037285,0.6021986913424536,1.0,12/41,20.54%,GLI1;BCR;CLIC4;ANXA1;USH2A;ERCC3;PIP5K1A;ADAM9;MED1;HDAC1;SCEL;UGCG
prerank,regulation of histone methylation (GO:0031060),0.5454944192392629,1.205325936781865,0.2607944732297064,0.6016259608030129,1.0,2/13,5.98%,JARID2;FAM47E
prerank,mRNA transport (GO:0051028),-0.29278401130182524,-1.2052109146678436,0.10204081632653061,0.6960773082571328,1.0,34/101,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;KIF5C;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;HNRNPA2B1;NUP37
prerank,metanephric mesenchyme development (GO:0072075),-0.519226729724358,-1.2052000350457257,0.23024830699774265,0.6941567372745696,1.0,2/10,3.41%,BASP1;PKD2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.5316030736022088,1.2047510973299205,0.2465753424657534,0.6025261837897984,1.0,3/13,9.68%,PTGIS;NAXE;PARP9
prerank,amino sugar metabolic process (GO:0006040),0.5813386317350331,1.204350883912735,0.24518388791593695,0.6029320468968223,1.0,4/10,14.99%,ST3GAL1;GNE;SLC35A3;CSGALNACT1
prerank,regulation of filopodium assembly (GO:0051489),-0.3586874521579698,-1.2041722746811794,0.15547703180212014,0.6955463842034681,1.0,15/38,15.16%,NRP1;NLGN1;TENM2;MYO10;RHOQ;FXR1;GPM6A;PIK3R1;FXR2;RALA;DPYSL3;TRPM2;AGRN;PALM;TENM1
prerank,base-excision repair (GO:0006284),0.42622141929293755,1.2041618504875693,0.21467391304347827,0.6027955867803788,1.0,14/48,16.82%,DNA2;POLL;FEN1;APEX2;POLD4;MBD4;WRN;SMUG1;TDG;PARG;RPA3;USP47;POLB;POLD1
prerank,endoplasmic reticulum organization (GO:0007029),0.41023914054175875,1.2039361167973062,0.2119700748129676,0.6027531690839971,1.0,19/72,15.93%,LRRK2;SHTN1;TMCC1;CAV2;PRNP;TRAM2;TRAM1;STX5;ATL3;LMAN2L;RTN4;SPTSSB;APP;DNM1L;EIF2AK3;UBE2J2;ATL1;VCPIP1;VAPA
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5478506385072158,1.2033199694241952,0.2678260869565217,0.6037195002622405,1.0,3/13,6.32%,CBLB;CBL;TSG101
prerank,regulation of cell cycle (GO:0051726),0.3566837446465409,1.203079243984491,0.12748171368861025,0.6036967757131302,1.0,67/271,16.74%,PTPRC;GRK5;RARA;IQGAP1;RUNX3;CDC14A;NOTCH2;SIK1;LILRB1;DTL;STAT3;ERN1;ANKRD17;SND1;CRLF3;BIRC3;PPP1R9B;RBBP4;HIPK2;RNF20;FBXL8;FAP;CDKN2C;CCND1;LIN52;PDCD4;AFAP1L2;MAPK12;GBF1;PPP1R15A;ID2;E4F1;CSNK2A2;CSNK2A1;RASSF1;RPRD1B;LIN37;CYLD;FBXL17;DUSP1;DCUN1D3;TXLNG;NUPR2;LIN9;NF2;MAP3K20;DHCR24;FBXL12;METTL3;JUNB;PCLAF;PNPT1;CITED2;KAT2B;RPS6KA2;TGFB1;UHRF2;RRP8;XIAP;RPS15A;THBS1;APC;PUM1;RB1;DAPK3;MAEA;PROX1
prerank,artery morphogenesis (GO:0048844),-0.38231855077128785,-1.2024819069570691,0.17993079584775087,0.698581907233995,1.0,6/30,4.14%,NRP1;TGFBR1;LRP1;PKD2;NF1;SMAD7
prerank,peptidyl-threonine modification (GO:0018210),0.40264978012008124,1.2021225444435346,0.1949685534591195,0.6055413888626981,1.0,21/66,15.88%,LRRK2;LMTK2;HIPK2;HIPK1;PDPK1;DYRK1A;GALNT2;TNKS;OXSR1;CSNK2A2;CSNK2A1;NLK;CAD;MAPK8;AKT1;STK39;ROCK1;MAPK1;TAF1;TBK1;DYRK2
prerank,histone monoubiquitination (GO:0010390),0.4862605644988245,1.2021117522982099,0.23723723723723725,0.60494121170412,1.0,5/24,5.34%,DTX3L;UBE2E1;RYBP;WAC;RNF20
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.507157532129299,-1.201975899534483,0.2386634844868735,0.6982909955433448,1.0,2/11,2.21%,MERTK;GAS6
prerank,regulation of protein export from nucleus (GO:0046825),0.48665683305577884,1.2018792097345816,0.26497005988023953,0.6049429189567456,1.0,4/23,9.00%,IL1B;SP100;XPO4;RBM22
prerank,cellular calcium ion homeostasis (GO:0006874),0.3842036663269089,1.2017383125328147,0.16519823788546256,0.6047029753573084,1.0,25/133,12.88%,CCR2;CD40;CCR1;PDZD8;MCUB;NPTN;SLC8B1;ATP2B1;ATP2A3;MAIP1;CAV2;STIM2;WFS1;ATP2A1;SLC30A1;DMPK;CALB2;LETM1;TMEM203;FKBP1B;ATP13A3;SLC10A7;PACS2;SLC24A4;MICU3
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.42746843246899174,-1.201332448141442,0.2247191011235955,0.6984447684132014,1.0,6/19,13.68%,CSF1R;CMKLR1;CSF1;AKIRIN1;JAM3;MDK
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.43278220808278656,1.2010361331596162,0.21161825726141079,0.6059119146773219,1.0,11/45,14.99%,JAK2;STAT3;CD36;MALT1;TRIM16;IL6;NLRC4;NLRP3;APP;GBP5;MYD88
prerank,DNA geometric change (GO:0032392),0.4692922999877499,1.2010138279489582,0.23903177004538578,0.6053373323081118,1.0,6/24,11.19%,DNA2;MRE11;WRN;ASCC3;ANXA1;RECQL5
prerank,response to amino acid starvation (GO:1990928),-0.3134009337865887,-1.2004749315148193,0.12571428571428572,0.699084836359361,1.0,19/72,12.14%,LARP1;ATP6V1C1;RPTOR;ATP6V0B;FLCN;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;SESN3;EIF2AK4;IMPACT;ATF4;LARS1;ATP6V1D;MIOS;ATP6V0D1;LAMTOR5;PRKD1
prerank,chromatin assembly (GO:0031497),0.4498631697381609,1.1999814655123704,0.22925457102672292,0.6074015922815476,1.0,15/38,22.71%,CHAF1A;H3-3A;RBBP4;SMARCA5;CTCF;EZH1;DAXX;NAP1L1;ATRX;RSF1;SIRT1;BRD2;PRDM9;ANP32B;ASF1A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.39992694072977386,-1.1998823212710563,0.18235294117647058,0.6989051013706685,1.0,9/25,15.54%,CTNNA3;FGF13;CACNA1C;ATP2A2;ANK2;JUP;CALM1;CXADR;PKP2
prerank,protein localization to mitochondrion (GO:0070585),0.5640520939716394,1.1990805373530886,0.26750448833034113,0.6090333242373112,1.0,2/11,5.27%,LRRK2;MAIP1
prerank,negative regulation of cilium assembly (GO:1902018),-0.4850940740953409,-1.1989178733179937,0.25304136253041365,0.6996980918829585,1.0,7/12,28.32%,EVI5L;ODF2L;TCHP;CDK10;CEP97;TBC1D7;CCP110
prerank,phospholipid biosynthetic process (GO:0008654),0.451220171870523,1.1986959724262145,0.21448467966573817,0.6094372636806048,1.0,11/36,16.44%,AGPAT4;SAMD8;SGMS1;SGMS2;CPNE1;FAR1;IDI1;FDPS;PIP5K1A;GNPAT;MVD
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.4197615695750272,-1.1986060537341574,0.21568627450980393,0.6986778096250078,1.0,4/19,12.05%,APOE;CHRFAM7A;CHRNA7;SLC5A7
prerank,brain development (GO:0007420),-0.28707180890047873,-1.1984870625332675,0.09433962264150944,0.6971113087332499,1.0,37/136,16.84%,ZFHX3;ATXN1;TGFBR2;CX3CR1;ROBO2;CTNNA2;CNTN4;PLXNB2;NF1;APOD;NFIB;AFF2;RAB3GAP1;CDK5R1;BBS2;NCOA6;POU6F1;TBC1D23;AATK;ZFHX2;UFC1;SHROOM2;PHF8;EPHA7;MEIS3;ROGDI;SETD1A;UFM1;ADGRL3;VPS51;PAFAH1B2;ADGRL2;CNTNAP2;ADGRG1;SCYL2;PHGDH;IER3IP1
prerank,pre-replicative complex assembly (GO:0036388),0.41918035895880085,1.1983647129050736,0.22012578616352202,0.6097182590671858,1.0,16/64,12.97%,PSME3;PSMB7;PSME2;ORC5;MCM6;ORC4;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;MCM2;PSMB1
prerank,artery development (GO:0060840),-0.41034101965974706,-1.198243599187431,0.20909090909090908,0.695941683132712,1.0,8/23,7.63%,NRP1;TGFBR1;ROBO2;ROBO1;PKD2;NF1;SMAD7;ACVR2B
prerank,mismatch repair (GO:0006298),0.4745053262926462,1.19808621940902,0.24808575803981622,0.6098095945348765,1.0,11/27,16.82%,MLH1;POLD4;MSH3;MSH6;TDG;SETD2;RPA3;RNASEH2A;MCM9;PMS1;POLD1
prerank,sodium ion homeostasis (GO:0055078),-0.43029722668995485,-1.1979098379258941,0.23353293413173654,0.6949818147543565,1.0,4/21,7.61%,SLC8A1;ATP1B3;ATP1B1;ATP1A2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.581474386330501,1.1978335175815185,0.2793103448275862,0.6098550436981949,1.0,5/10,18.10%,PRKCH;NCOA3;TRIM16;MED1;FOXC1
prerank,phagosome maturation (GO:0090382),-0.35255529362262095,-1.197211428341424,0.18661971830985916,0.6951745913772276,1.0,13/35,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;RAB31;ATP6V1D;RAB32;MCOLN1;ATP6V0D1;MREG;ATP6V0A1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37921975821373954,1.19714692664533,0.18058690744920994,0.6110031581000579,1.0,40/129,20.12%,LRRK2;PSME3;NFKB1;CSNK1G1;TBL1XR1;PSMB7;GPC3;ZEB2;ADGRA2;RNF146;AXIN1;PSME2;UBR5;PSME4;CSNK1G3;TNKS;GSKIP;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;VCP;TGFB1;XIAP;LYPD6;USP47;PSMD12;DAPK3;LRRK1;KANK1;SMURF2;PIN1;FZD9;PSMF1;SCEL;USP8
prerank,synapse assembly (GO:0007416),-0.32119863504634166,-1.1971329058379538,0.12834224598930483,0.693507185413815,1.0,19/67,17.13%,NLGN1;FGF13;LRRTM3;PLXNB2;NRXN2;GABRG2;GRID2;RYK;SDK1;LGI2;GPM6A;CDK5;NLGN2;ADGRL3;GABRB3;SLITRK1;KIRREL3;NLGN3;GABRA2
prerank,DNA replication initiation (GO:0006270),0.4495161882980671,1.1969765784580944,0.2336578581363004,0.610822305850552,1.0,19/37,26.15%,CDC45;ORC5;MCM6;ORC4;RPA3;POLA2;MCM2;ORC6;LRWD1;ORC2;CDC34;NOC3L;POLE2;ORC1;DBF4;PRIM1;RPA1;MCM3;MCM7
prerank,protein homotetramerization (GO:0051289),-0.34088128515376726,-1.1969715436799437,0.15139442231075698,0.6920753979834352,1.0,13/49,13.21%,RYR3;ACACA;APPL2;PKD2;KCNJ2;ALDH9A1;GOLGA2;MCOLN1;HCN1;USP16;TRPM2;CBR4;AQP4
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4559925812583223,-1.1969579573842375,0.23017902813299232,0.6902683054053499,1.0,6/15,21.33%,AAK1;SMAP1;BMP2K;SCYL2;UBQLN2;SNAP91
prerank,potassium ion transport (GO:0006813),-0.2863928646312054,-1.1968599597968363,0.12878787878787878,0.6887292936667383,1.0,21/120,10.51%,KCNMA1;KCNK13;SLC24A3;KCNQ5;KCND2;SLC1A3;KCNQ3;ATP1B3;PKD2;KCNJ2;SLC9A9;SLC9A6;KCNN2;ATP1A2;KCNMB2;HPN;KCNA2;KCNJ6;KCNK6;HCN1;HCN2
prerank,regulation of lipid metabolic process (GO:0019216),0.39270994788676933,1.1967939348040846,0.1960542540073983,0.6106843448940206,1.0,23/88,16.94%,IL1B;PPARG;PRKAG2;TBL1XR1;HELZ2;PSAP;ELOVL6;NFYC;ID2;NCOA2;LACTB;OPA3;NCOA1;IDI1;FDPS;NFYA;SREBF2;HDAC3;GPS2;CREBBP;MED1;MVD;MVK
prerank,regulation of microtubule polymerization (GO:0031113),-0.34730396265735913,-1.1963959151215866,0.16981132075471697,0.6883278071625625,1.0,9/40,11.81%,NAV3;CAMSAP1;NUMA1;MAP2;CLIP1;CDK5R1;EML2;MAPRE1;CAMSAP2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.39661755979130464,1.1963693119879868,0.21046077210460773,0.6110958510377994,1.0,18/79,17.00%,CASK;SULF2;PPARG;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ACVR2A;SMAD4;PTPN1;LEMD2;ADAMTS12;CNMD;VWC2L;THBS1;NIBAN2;SMAD5
prerank,retrograde axonal transport (GO:0008090),-0.4520697578298343,-1.1960487594502809,0.25526315789473686,0.6874555688751129,1.0,5/16,8.13%,DST;DLG2;TMEM108;KIF1A;MAP1A
prerank,positive regulation of JUN kinase activity (GO:0043507),0.47959819401021775,1.1959880382311794,0.24188790560471976,0.6114256893930747,1.0,9/23,17.33%,MAP3K5;PAK1;TAOK3;MAP3K4;RPS3;DVL3;MAP3K7;DVL2;TRAF2
prerank,heterochromatin assembly (GO:0031507),0.5067185386181151,1.195882999477791,0.24545454545454545,0.6110755758323801,1.0,8/20,18.06%,H3-3A;SMCHD1;EZH1;MBD2;BAZ2A;RRP8;SIRT1;HDAC1
prerank,pre-miRNA processing (GO:0031054),-0.468379551532738,-1.194399407768591,0.23705722070844687,0.6905001539697928,1.0,5/14,18.78%,AGO3;AGO1;ADAR;DROSHA;LIN28B
prerank,positive regulation of leukocyte activation (GO:0002696),0.5073070907307843,1.1939647436896412,0.2687813021702838,0.615337152386965,1.0,3/18,7.78%,CD226;IL33;CD2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.40149066570882114,1.1931673652372001,0.21454993834771888,0.6167656538442686,1.0,15/67,11.37%,TBC1D1;SDCCAG8;TBC1D8;USP6NL;TBC1D10C;TBC1D2B;CDC42;CAPZB;ATG5;RABGAP1;IFT140;RAC1;TBC1D5;CYLD;TBC1D2
prerank,positive regulation of glucose import (GO:0046326),-0.41983101815558344,-1.1928260818352299,0.23006134969325154,0.6932076624363918,1.0,5/21,10.53%,IGF1;OSBPL8;RHOQ;IRS1;PIK3R1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.34039736731308645,-1.1924940729358673,0.1652542372881356,0.6923049994812399,1.0,5/53,0.75%,OPHN1;PRKN;APOE;TREM2;GNA12
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4612799870418428,-1.1924930476803532,0.23940149625935161,0.6904713512464369,1.0,3/15,1.56%,PRKN;IGF1;BCL2L1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5446865559621104,1.1922780862557485,0.2871452420701169,0.6185675950828731,1.0,6/12,16.30%,GMDS;UGP2;PARG;SLC35A3;CSGALNACT1;FUT8
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.37129177189846174,1.1922057921759093,0.17016574585635358,0.6181221924632457,1.0,47/152,20.12%,LRRK2;SULF2;PSME3;NFKB1;RSPO2;CSNK1G1;RSPO3;TBL1XR1;PSMB7;GPC3;ZEB2;ADGRA2;RNF146;AXIN1;PSME2;UBR5;PSME4;CSNK1G3;TNKS;CSNK2A1;GSKIP;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;TLR2;PSMB1;VCP;TGFB1;XIAP;DISC1;LYPD6;USP47;PSMD12;DAPK3;LRRK1;KANK1;SMURF2;WNT5B;PIN1;FZD9;PSMF1;SCEL;USP8
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4789694956423859,1.1918770483855619,0.23390894819466249,0.6183695988888646,1.0,2/24,5.18%,PID1;SLC25A13
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3957406730796908,1.1915658871938106,0.2159904534606205,0.6185803892187781,1.0,17/76,12.26%,KLF4;ITCH;FOXJ1;PTGIS;ERBIN;SPI1;NFKBIA;FAF1;ANXA4;TRAF3;NFKBIB;CYLD;CACTIN;ACOD1;NLRP3;MAP2K5;PSMD10
prerank,positive regulation of intracellular protein transport (GO:0090316),0.37151376290128757,1.1910482202331036,0.1762749445676275,0.6192998646140391,1.0,40/144,19.13%,IL1B;TCAF2;FYN;C2CD5;MYO1C;SORL1;RAC2;FBXW7;BBC3;ITGB2;UBE2D3;XPO4;UBR5;PRNP;FLNA;CIB1;ARIH2;RBM22;BCAS3;CSNK2A2;FIS1;YWHAZ;RNF31;ZPR1;MAPK8;HCLS1;SREBF2;HDAC3;UBE2J2;TGFB1;RAB29;PSEN1;TMEM30A;PIK3R2;BAG3;ATG13;PRKCD;PINK1;BAD;KIF20B
prerank,protein targeting to ER (GO:0045047),0.3795644265080595,1.1909709315399681,0.2109004739336493,0.6188915642475963,1.0,42/99,23.83%,RPL5;RPS10;CHMP4A;CHMP4B;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPL34;RPLP0;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;RPS15A;RPS4X;SPCS2;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,protein localization to cell junction (GO:1902414),0.47973431656828897,1.1907680257381423,0.26461538461538464,0.6187861377548345,1.0,4/22,1.81%,ARHGEF18;MARVELD3;HEG1;NECTIN1
prerank,positive regulation of apoptotic process (GO:0043065),0.35318125570963044,1.190729495562039,0.12873326467559218,0.6182752661312219,1.0,59/293,13.16%,VAV3;TIAM1;ARHGEF18;NGF;SIK1;LILRB1;DAPK1;NGFR;MAP3K5;BCL6;TIAM2;STK17B;IFIT2;PTGIS;PHLDA1;SOS2;ATF6;RYBP;DLC1;BTG1;FGD4;FAF1;FAP;STK4;PRNP;PAWR;MTCH1;TNFAIP8;SAP18;RARG;FGD1;DUSP6;SOS1;IL6;FGD3;LATS1;ING3;OLFM1;PIDD1;ARHGEF6;RPS3;NLRC4;UBE2Z;CASP2;CALHM2;RIPK1;APAF1;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;REST;HTT;CLIP3;DNM1L;MAP3K20;ERCC3;MAPK8
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5135760030026393,1.1907056197182646,0.250384024577573,0.6177105251673132,1.0,4/17,7.77%,FOXJ1;RFX3;BTG1;SULT2B1
prerank,positive regulation of transmembrane transport (GO:0034764),0.5411152711750569,1.1896825151536081,0.27168576104746317,0.6197404985023465,1.0,5/13,12.70%,C2CD5;ACSL5;AZIN1;BRAF;CLIP3
prerank,negative regulation of protein processing (GO:0010955),0.5520168175488697,1.1895342970044351,0.2802013422818792,0.619501159294935,1.0,2/12,6.34%,LRRK2;PRNP
prerank,neuron cell-cell adhesion (GO:0007158),-0.45581552734310204,-1.188766651266657,0.21608040201005024,0.6994477707322116,1.0,10/14,19.15%,NLGN1;NCAM2;CNTN4;NRXN2;CDK5R1;ASTN1;ASTN2;NLGN2;NLGN3;NRXN1
prerank,negative regulation of GTPase activity (GO:0034260),0.4848873589368447,1.1883927715851748,0.25892857142857145,0.621718316523714,1.0,8/22,13.88%,LRRK2;RCC2;KLRK1;F11R;BCAS3;ARFGEF1;SH3BP4;LRCH1
prerank,cellular protein-containing complex assembly (GO:0034622),0.3692230200859509,1.18838606045936,0.1756152125279642,0.6211146103607601,1.0,38/160,18.86%,TESPA1;TIAM1;UVRAG;STXBP6;LONP1;PIK3C2A;HSPA1A;EPS15;PICALM;CHMP4A;CHMP4B;AXIN1;NUP98;PXN;HIP1;SMAD4;RTN4;SNX9;IMMP2L;DNAJB12;AIFM1;SRP19;CCDC39;NUP153;POMP;TBCD;TGFB1;CENPC;AP2S1;TCP1;COX7A2;TRAF2;HSPD1;BBS10;CYBA;NUP93;NCK2;SHQ1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.49314408593601894,1.1882960691595739,0.250384024577573,0.620733586458106,1.0,4/22,6.89%,LYN;IFNGR1;PICALM;GSAP
prerank,microtubule-based transport (GO:0099111),0.5313664985002132,1.1882449080990727,0.2784184514003295,0.6202422039210946,1.0,4/13,17.13%,ADCY10;CABYR;HTT;DYNC1I2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4442825191068038,-1.188130307599958,0.23544973544973544,0.6993993670986838,1.0,10/15,36.94%,NLGN1;USP46;NLGN2;CNTNAP4;ADRA1A;CLN3;HAP1;DRD2;BAIAP3;SYN3
prerank,regulation of B cell differentiation (GO:0045577),0.5171002853336188,1.188127994085961,0.2661290322580645,0.6199361605793023,1.0,6/17,13.04%,SYK;IKZF3;ZFP36L2;ID2;SLAMF8;BTK
prerank,nuclear transport (GO:0051169),0.5084422175991775,1.1874600845927767,0.2672,0.6210674703589234,1.0,4/16,12.71%,XPO1;RSRC1;NUP98;RGS14
prerank,positive regulation of histone acetylation (GO:0035066),0.4887077058114884,1.1872892769488597,0.2389937106918239,0.6209006893806629,1.0,5/23,10.53%,IL1B;KAT7;RPS6KA5;SMAD4;TADA2A
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.5123601643028408,-1.1870524214160527,0.25120772946859904,0.7008081943357548,1.0,3/10,12.53%,VSIR;NCKAP1L;TLR4
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.48546588088252773,-1.1867237723580144,0.25961538461538464,0.699926866150792,1.0,6/12,18.03%,PIBF1;ERLIN2;WDTC1;APOC1;BRCA1;ACADL
prerank,negative regulation of autophagy (GO:0010507),0.410962303768622,1.186219175910432,0.23127463863337713,0.6229982048892106,1.0,12/54,13.17%,LRRK2;PTPN22;MCL1;STAT3;EIF4G3;IL10RA;HGF;TLK2;PIK3CA;TAB3;SMG1;AKT1
prerank,vesicle transport along microtubule (GO:0047496),0.47447498382007114,1.1858479628858505,0.25862068965517243,0.6233214660441028,1.0,8/23,14.70%,KIF5B;FBXW11;PAFAH1B1;KIF3B;DYNC1H1;HTT;KIF5A;FYCO1
prerank,actin crosslink formation (GO:0051764),0.5342664540731822,1.1856753879378785,0.2625418060200669,0.6231568850674953,1.0,3/12,6.98%,LCP1;EPS8;FLNA
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5558685557664035,1.1856024575963229,0.2733446519524618,0.6227236574689726,1.0,3/11,9.94%,RGS2;LMNA;SMAD4
prerank,regulation of hydrolase activity (GO:0051336),0.3962694771818018,1.185441433318646,0.22650602409638554,0.6225412958191503,1.0,15/71,11.09%,ARHGAP15;VAV3;CRK;OCRL;FGD4;FBXW11;WRN;PAFAH1B1;RABGAP1;PLXND1;FGD1;FGD3;TDG;ADAP1;SCARB2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.48113183004360394,-1.1852312166528955,0.26535626535626533,0.702568090778214,1.0,5/12,23.51%,SYT1;SYT7;RIMS1;RIMS3;SYT8
prerank,response to estradiol (GO:0032355),0.4500755313749244,1.185170572031326,0.24752475247524752,0.6225815211708775,1.0,7/31,14.22%,STAT3;NCOA3;STAT5B;ANXA1;NRIP1;STRN3;TGFB1
prerank,tRNA wobble base modification (GO:0002097),-0.46720546747638797,-1.185089044015103,0.2544987146529563,0.7011596581487217,1.0,10/14,38.79%,ALKBH8;MTO1;GTPBP3;TRMT9B;ALKBH1;CTU2;CTU1;MOCS3;ADAT2;KTI12
prerank,positive regulation of bone mineralization (GO:0030501),-0.35888917943805176,-1.184939852921116,0.20973782771535582,0.6997399743747903,1.0,12/35,15.97%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;BMPR1B;PKDCC;BMP6;ADGRV1
prerank,lipoprotein catabolic process (GO:0042159),-0.4946251949105037,-1.1844379511521004,0.2535885167464115,0.6992413465201475,1.0,4/11,7.31%,CTSD;APOE;ABHD17C;ABHD10
prerank,positive regulation of fat cell differentiation (GO:0045600),0.41931562451153126,1.1843730541183914,0.2313937753721245,0.6239762897909265,1.0,9/47,10.61%,CREB1;PPARG;METRNL;PIM1;LMO3;WDFY2;ID2;CREBL2;CCDC71L
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.42838754872794427,-1.1841969472616976,0.23714285714285716,0.6981430426155344,1.0,12/17,29.80%,SLC8A1;CACNA1C;PRKACA;ATP1B1;ATP1A2;GJA1;PKP2;RYR2;ATP1A1;ATP1A3;GJC1;GJD3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.43482692642392934,-1.1839644947062342,0.2388888888888889,0.6970714920119377,1.0,6/19,6.21%,MEF2C;ERBB4;TGFBR1;VGLL4;FGF2;FGFR2
prerank,regulation of DNA replication (GO:0006275),0.4277136695389847,1.1837028310844657,0.22077922077922077,0.6250640779613237,1.0,7/49,5.79%,DNA2;GLI1;ANKRD17;CCDC88A;KAT7;ORC5;FAF1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5386753538108452,1.1831915201123153,0.26588628762541805,0.6257487390397929,1.0,1/13,0.25%,PID1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.46426661065871433,1.182426082117325,0.2536873156342183,0.6270872727745893,1.0,7/27,14.27%,FGR;FLT3;PTK2B;PIK3R4;KIT;TGFB1;FGFR3
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.391361505747855,1.1814567330626615,0.220873786407767,0.6290640445078551,1.0,17/78,15.04%,PID1;PRKCE;PPP2R5A;PRKCH;KIF5B;PICALM;ZDHHC7;PDPK1;CIB1;EPHB2;STX7;CLIP3;LGALS3;AKT1;ITGA3;TGFB1;RHOG
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2898124016293819,-1.1813835628942957,0.147239263803681,0.7027012868222681,1.0,33/96,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;HNRNPA2B1;NUP37
prerank,positive regulation of protein localization to membrane (GO:1905477),0.38362875833319926,1.180870323842127,0.21602787456445993,0.630025226623272,1.0,20/98,13.67%,PRKCE;TCAF2;FYN;C2CD5;PRKCH;MYO1C;KIF5B;BBC3;ITGB2;PRNP;PDPK1;CIB1;EPHB2;FIS1;YWHAZ;CLIP3;LGALS3;MAPK8;AKT1;ITGA3
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4983026006317604,1.1803772157929324,0.26324237560192615,0.630644687262777,1.0,8/18,16.03%,DHX58;ANKRD17;BIRC3;OASL;PUM2;USP15;GPATCH3;PUM1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3994432514320489,-1.1798406877065473,0.25076452599388377,0.7055001613693261,1.0,11/24,34.72%,PKD2;PRKACA;AKAP6;CALM1;GSTO1;FKBP1A;PDE4D;DMD;NOS1;JPH3;CALM2
prerank,fluid transport (GO:0042044),-0.46690948798693177,-1.1796024901142401,0.24494949494949494,0.7043996882742765,1.0,3/12,27.23%,AQP4;SLC26A6;PDPN
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3945013724431985,1.179514513888161,0.23193916349809887,0.6321965343655939,1.0,24/72,19.44%,FGR;LYN;FLT3;JAK2;PTPN6;CBL;HGF;FN1;PIK3CA;PDGFD;KIT;NCF1;HCLS1;HCST;IL18;UNC5B;MAZ;INSR;SEMA4D;SIRT1;BECN1;HAX1;PIK3R5;FGFR1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3576406418332641,1.1793718331255831,0.17704918032786884,0.6319345312536131,1.0,70/168,23.83%,RPL5;RPS10;RPL37A;RPL6;RC3H1;RPS18;HELZ2;XRN2;PNLDC1;RPS14;RPL35A;DCP2;PPP2R2A;CNOT6;TUT1;MAGOHB;RPL13;ERI1;ETF1;TENT2;DHX34;RPS3;CNOT2;RPS21;UPF2;MTPAP;DCP1A;TUT7;RPL34;RPLP0;SMG1;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;MRTO4;EIF3E;TENT4B;RPS15A;NCBP1;RPS4X;PABPC1;SMG6;CNOT8;GSPT1;RPL32;RPSA;RPS13;UPF3B;TNKS1BP1;RPS6;RPL18A;RPS27;CNOT6L;RPLP2;UPF3A;PARN;RPL22;RPS7;RPS12;CNOT3;PPP2CA;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.47012931031649674,-1.179102360248566,0.25274725274725274,0.7041054114428299,1.0,6/13,17.65%,LGMN;EIF2AK4;ZDHHC2;CHRNA7;SQSTM1;ADCY8
prerank,negative regulation of endocytosis (GO:0045806),0.48044844553489063,1.1790210405249069,0.26625386996904027,0.6322669621337846,1.0,8/24,16.71%,LILRB1;CD300A;PICALM;RAC1;UNC119;LGALS3;SNX33;MTMR2
prerank,mitochondrion transport along microtubule (GO:0047497),0.5436215099378826,1.1789060089127514,0.2874354561101549,0.6319956773166286,1.0,2/13,9.33%,UXT;SPAST
prerank,intracellular protein transport (GO:0006886),0.349704855560044,1.1785822994759423,0.1282051282051282,0.632178721883985,1.0,61/304,14.84%,CD74;AP1S3;TBC1D1;XPO1;STX11;NGFR;RAB19;TBC1D8;SYK;STAT3;TBC1D9;C2CD5;RABL3;MYO1C;LAPTM5;SORL1;USP6NL;TBC1D10C;TBC1D2B;XPO5;XPO6;MAIP1;RAB7A;SNX1;TBC1D8B;PTTG1IP;XPO4;ARF4;STX17;RAB6A;RABGAP1L;KATNB1;RTN2;STX6;TMED10;RABGAP1;ARF1;STX5;STX12;SNF8;TBC1D5;SLU7;STX7;HIKESHI;SNX9;STAM;TBC1D2;NUP153;CLIP3;RPL11;EIF4ENIF1;AKT1;STX16;SGSM1;TLK1;TGFB1;EVI5;FAM53C;RAB29;SCFD2;EHD1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5732224272640833,1.1785581539919299,0.29948364888123924,0.6316216756045565,1.0,5/10,18.99%,LYN;RNF13;GSTP1;MAPK1;MAP2K1
prerank,response to amyloid-beta (GO:1904645),0.4313373428812826,1.1779550757605586,0.2442953020134228,0.6326038656918653,1.0,11/44,12.10%,ITGA4;NGFR;FYN;CACNA1A;CD36;PRNP;CACNB1;ABCC1;ICAM1;FCGR2B;APP
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.479613957002864,-1.177653162933622,0.2567237163814181,0.7066451888095096,1.0,6/12,38.72%,STARD3;AKR1B1;FDX1;TSPOAP1;STAR;CACNA1H
prerank,histone mRNA metabolic process (GO:0008334),0.46199875138187274,1.1774755111137518,0.2732474964234621,0.6332149925212164,1.0,10/27,15.49%,SNRPB;DCP2;TUT1;ERI1;TENT2;MTPAP;TUT7;TENT4B;CPSF3;NCBP1
prerank,positive regulation of cell aging (GO:0090343),0.556927760967838,1.177449526194695,0.281198003327787,0.632685668360033,1.0,4/11,17.18%,LMNA;ARG2;B2M;SIRT1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.30440751412409434,-1.1771743221787,0.14009661835748793,0.7061936238621779,1.0,15/75,13.66%,SLC8A1;CACNA2D1;TRPV2;ATP1B3;KCNJ2;SLC39A10;ATP1B1;SLC9A9;SLC9A6;ATP1A2;KCNJ6;HCN2;TRPM2;KCNJ9;TRPV4
prerank,RNA destabilization (GO:0050779),0.4969271034959002,1.177046683625678,0.2827476038338658,0.6331127620408176,1.0,8/18,19.51%,MEX3D;GIGYF2;YTHDF3;METTL3;ROCK1;CELF1;PUM1;FTO
prerank,metanephros development (GO:0001656),-0.3940628516687186,-1.1768946736806771,0.22522522522522523,0.7051569079855502,1.0,4/26,4.00%,BASP1;ROBO2;PKD2;NF1
prerank,DNA-dependent DNA replication (GO:0006261),0.37522341604731213,1.1768528043164144,0.21372328458942633,0.6329903088270352,1.0,33/128,17.75%,DNA2;BAZ1A;PSME3;CDC45;PSMB7;PSME2;ORC5;MCM6;POLD4;WRN;ORC4;PSME4;PSMB8;PSMA5;PSMD9;RECQL5;PSMB3;PSMD6;PSMC4;RPA3;POLA2;PSMD10;DDX23;MCM2;PSMB1;MCMBP;ORC6;POLG2;POLB;PSMD12;POLD1;LRWD1;ORC2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.44056787878221465,-1.1767891928505647,0.25065963060686014,0.7037124327116329,1.0,6/15,16.47%,WHRN;SCN1A;HPN;KCNA1;ADGRV1;TMEM120A
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.346835572236827,-1.1766218437454696,0.2,0.7024117163858348,1.0,12/40,15.97%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;BMPR1B;PKDCC;BMP6;ADGRV1
prerank,cellular response to BMP stimulus (GO:0071773),0.40154497490586705,1.176579918041824,0.24050632911392406,0.6330398829041477,1.0,13/66,15.34%,RUNX2;BMPR2;SCX;GDF1;HIVEP1;PDCD4;ENG;ACVR2A;USP15;SMAD4;ADAMTS12;TGFB1;USP9X
prerank,collagen fibril organization (GO:0030199),-0.3023263612700851,-1.176487233489512,0.16149068322981366,0.7010045476025779,1.0,34/88,30.36%,DST;P3H2;ITGA6;COL27A1;TGFBR1;NF1;P4HA1;COL15A1;LOXL3;LAMA3;P4HB;COL19A1;TGFB2;COL12A1;CRTAP;COL4A2;SERPINH1;ADAMTS2;COL23A1;PLOD3;PLEC;PLOD1;COLGALT1;CD151;COL11A2;COL26A1;ITGB4;COL6A2;COL24A1;COLGALT2;COL6A3;P3H4;COL4A6;P4HA3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4372895518014265,1.1757761652331105,0.24297752808988765,0.6345230767569435,1.0,13/35,18.79%,HEG1;CCDC125;CUL3;RIPOR2;DLC1;EPHB2;ITGA3;MAPKAP1;STMN3;KCTD13;ABL2;KANK1;SCAI
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5350707797844126,1.1755919766549752,0.26929392446633826,0.6343774556928772,1.0,2/14,2.97%,CD226;MAD2L2
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4985497945713596,1.175454484460049,0.2629179331306991,0.6340887354688998,1.0,8/19,19.97%,GPX1;NOX1;PXDN;MAOB;PRDX5;CYBA;CAT;PARK7
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.36440321885115895,-1.1754321534018501,0.20303030303030303,0.7023814917709958,1.0,19/31,36.27%,SYT1;SCAMP5;RAB3GAP1;SYT9;SYT7;STX1A;SYT6;CBARP;SYT8;CACNA1I;KCNB1;SYT3;SYT12;SYT11;SYT13;SYT10;SYT5;SYT4;SYT17
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.44702629665890353,1.1749304842948467,0.2600896860986547,0.6348042366240753,1.0,4/27,6.72%,AHNAK;HPCA;ADRA2A;CACNB1
prerank,regulation of kinase activity (GO:0043549),0.3793793059732622,1.1744662980707627,0.22327790973871733,0.6354943404029102,1.0,5/89,1.59%,CD74;FGR;FLT3;RET;LMTK2
prerank,negative regulation of histone modification (GO:0031057),0.5150362497393335,1.1742494760854962,0.27287319422150885,0.6354586854907773,1.0,1/14,0.35%,JARID2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.48696723985732004,-1.173569090202289,0.26433915211970077,0.706079527018847,1.0,3/12,5.32%,CTSB;LMO2;THRB
prerank,cellular response to cadmium ion (GO:0071276),0.4714250564141549,1.173529337270527,0.270516717325228,0.6366903319257405,1.0,7/24,15.13%,FOS;SUMO1;DAXX;MAPK8;AKT1;NCF1;MAPK1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3969074921153788,1.1729203748160169,0.2247596153846154,0.6376706104093689,1.0,20/74,16.31%,LIMD1;PSME3;PSMB7;PSME2;RBPJ;NFE2L2;ELOB;PSME4;BACH1;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;CITED2;CREBBP;PSMD12
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3827518981505684,1.1728748948536922,0.21666666666666667,0.6371852123780842,1.0,24/95,16.37%,SAMHD1;NIPBL;RBBP8;POLL;CDC45;MRE11;FEN1;MCM6;UBE2N;WRN;NABP1;MORF4L1;RECQL5;RPA3;EXD2;RAD54L;SPIDR;MCM2;ERCC4;RNF138;XRCC2;INO80;MCM9;HUS1
prerank,detection of calcium ion (GO:0005513),-0.4686182134570666,-1.1726350730711173,0.2731707317073171,0.7071717991281479,1.0,4/13,21.23%,SYT1;KCNMB2;CALM1;RYR2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.33913901425791526,1.1717713716975104,0.04909819639278557,0.6394534517359033,1.0,172/834,17.42%,CIITA;PLAC8;PID1;RUNX2;RARA;SP3;GLI1;TNIP3;HNF4G;ACTR3;CDK13;KLF4;CREB1;LILRB1;NGFR;PPARG;IER2;CD40;PPP1R12A;NFKB1;TET2;FOSL2;PLSCR1;STAT3;EHF;FOXJ1;ELF4;FOS;TCF20;RPS6KA3;BMPR2;REL;AKNA;NCOA3;CXCL10;CRLF3;TAF9;SPI1;STAT5B;NFKBIA;SCX;ATAD2;TBL1XR1;IKBKB;MED30;ZEB2;CAMTA2;KAT7;ATF6;GDNF;ATF2;PPP3CA;IRF2;PRPF6;RFX3;RBPJ;IL33;HIVEP1;MED13;STAT1;HIPK2;NUFIP1;KLF5;IRF4;HELZ2;RFX5;RPS6KA5;SMARCA5;ARF4;KMT2C;KLF10;CDC5L;SETX;AHR;ACTR2;CREBRF;NFE2L2;THRA;CLOCK;MED6;ZBED4;RARG;TOX3;DOT1L;PLXND1;E2F2;ENG;GABPB1;GABPB2;ACVR2A;ELF1;TLR3;IL6;HGF;KAT6A;TNKS;BCAS3;NCOA2;E4F1;IRF7;MEF2B;SMAD4;SBNO2;RPRD1B;NCOA1;CSRNP1;NR3C1;RIPK1;PBX1;CCNT2;FOXO3;MED12;ZNF507;DVL3;TAF7;NLRP3;REST;RPS6KA1;ATF6B;APP;MAP2K5;MED14;CCNT1;BCLAF3;TLR2;CDK12;TEAD1;ATRX;NFATC2IP;MYB;NRIP1;JUNB;HCLS1;SREBF2;CITED2;KAT2B;HDAC3;MRTFA;TGFB1;CRTC3;RSF1;FHOD1;IL18;GPS2;KMT2A;ASXL2;CREBBP;RELA;TBK1;DVL2;MAML1;INO80;ZMIZ2;MED1;ELL;WNT7A;IRF5;PAXBP1;BPTF;HTATIP2;PROX1;CREB3L4;CREB3;SMAD5;ELK4;PIK3R2;CHCHD2;SIRT1;SUPT4H1;ATF1;NR4A1;SS18
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4135178815898899,1.1717413042546394,0.2456839309428951,0.6389118884500581,1.0,12/51,14.99%,JAK2;STAT3;CD36;MALT1;TRIM16;TMED10;IL6;NLRC4;NLRP3;APP;GBP5;MYD88
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4005126573046693,1.1704685879702774,0.2571428571428571,0.6415041696286914,1.0,21/59,16.54%,RUNX2;NFKB1;MED30;MED13;PTEN;CCND1;SETX;CBFB;MECP2;THRA;MED6;IL6;MED26;MED12;MED14;PPM1D;TNRC6B;TNRC6A;RELA;MED1;MED7
prerank,peptide catabolic process (GO:0043171),0.4818145603121812,1.170332037668672,0.27586206896551724,0.6412580720055289,1.0,4/23,7.40%,ACE;LNPEP;DPEP1;CPQ
prerank,regulation of calcium ion transport (GO:0051924),-0.32122875542553686,-1.1698112320929517,0.15555555555555556,0.7136160517301919,1.0,9/54,5.40%,CACNA1D;CD84;CACNB2;CACNA2D1;CD33;CTNNB1;PKD2;ANK2;P2RX4
prerank,dendritic cell differentiation (GO:0097028),0.4717127180192906,1.169805744405837,0.27675840978593275,0.6420102756802692,1.0,3/22,1.35%,LYN;FLT3;LILRB1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5134503347500121,1.1695797107493304,0.2863849765258216,0.6419715290692309,1.0,2/16,4.20%,VIM;SCX
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.4502087871180136,-1.1693610634332106,0.26785714285714285,0.7131978376808044,1.0,7/15,14.18%,CSTF2;RTRAF;FAM98B;TSEN2;TSEN34;ZBTB8OS;RTCB
prerank,purine ribonucleotide transport (GO:0015868),0.4919125764300528,1.169071469198556,0.2770700636942675,0.6426512840660901,1.0,3/16,11.60%,LRRC8C;LRRC8D;ABCC4
prerank,regulation of ossification (GO:0030278),-0.356912092194057,-1.1690704182843148,0.20912547528517111,0.7122706266241575,1.0,9/36,7.87%,MEF2C;LRP6;ANKH;ENPP1;PTN;ACVR1;BMP2K;NBR1;S1PR1
prerank,regulation of gene expression (GO:0010468),0.33699157347131903,1.1687836431694085,0.036036036036036036,0.6427819385755122,1.0,186/903,16.39%,CD74;PID1;PTPRC;IL1B;FOXP1;MBNL1;AHNAK;SP3;RUNX3;LYN;NOTCH2;LIMD1;NGF;KDM6A;PTPN22;IFNGR1;PLCG2;KLF4;STAP1;RPL5;LILRB1;PTBP3;ITGAX;CCR1;BCL6;SAP30;NFKB1;MSN;PITX3;ACE2;FGF5;FGF22;PLSCR1;STAT3;NSD3;HSPA1A;TRIM26;GPX1;CD36;NAB1;REL;RNF207;PRX;SPI1;SCX;PICALM;FBXW7;MBNL3;KAT7;RYBP;GDNF;ATF2;NFKBIZ;IRF2;RFX3;RPL6;RBPJ;BTG1;IL33;RNF20;RC3H1;MAPK14;CD276;RPS6KA5;GLMN;AFDN;TIPARP;UBR5;AHR;PHF19;CRIP1;TADA3;SERPINB9;CGGBP1;CREM;SRSF10;NFE2L2;PARP14;SETDB2;MECP2;PUM2;TRAF3;PDE2A;CLOCK;TOB2;EZR;ENG;MBIP;CTCF;PHF12;EPHB2;NFYC;TLR3;ZBTB11;IL6;BACH1;NKAPL;AFF1;SNF8;CPNE1;RBAK;ASCC1;ID2;WWP2;CREBL2;NCOA2;OLFM1;TRIM71;BRAF;PARP9;METTL4;RPS3;SBNO2;ADAM19;IGF2BP3;BNC2;FN1;DAXX;NR3C1;YTHDC1;NUDT21;TDG;TRIM14;NFKBID;CACTIN;PRKAG1;ING2;SRRT;NLK;MED26;PRKAA1;ZNF507;REST;APP;BAZ2A;NFYA;TRIM17;PQBP1;MSL3;TLR2;ATRX;ICOSLG;RPL11;MYB;EIF2AK3;ZPR1;HNRNPLL;MAPK8;AKT1;NSD1;TLE1;HCLS1;EZH2;TNRC6B;RBM38;PRKAA2;ROCK1;CITED2;TNRC6A;NFIL3;TGFB1;ZNF431;MAZ;MYD88;SERTAD3;MAPK1;OCLN;CREBBP;RELA;MARF1;TAF1;DVL2;BHLHE40;ZNF148;CELF1;SNX12;MED1;PTBP2;FOXN2;RBL2;PUM1;AFF3;MYADM;INSR;RB1;DAPK3
prerank,estrogen metabolic process (GO:0008210),0.5122206806735157,1.1686498330370971,0.30218068535825543,0.6425149291053686,1.0,4/15,17.80%,HSD17B14;HSD17B7;HSD17B11;HSD17B2
prerank,acylglycerol catabolic process (GO:0046464),-0.367463293767257,-1.1685351538622655,0.23728813559322035,0.7120723361511282,1.0,4/30,6.30%,ABHD12;MGLL;DAGLA;FABP5
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.4434201894511556,-1.1683983738885235,0.23351648351648352,0.7107421193786263,1.0,6/16,13.96%,APOE;TREM2;LRP1;CLU;ABCA7;CYP51A1
prerank,mononuclear cell differentiation (GO:1903131),0.47060076835077724,1.168158289235426,0.27314814814814814,0.6431922150152041,1.0,5/24,4.25%,LYN;FLT3;LILRB1;PPARG;MYH9
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.47139936469283145,1.1672807991692138,0.26857142857142857,0.6447921571854406,1.0,7/25,11.43%,STAT3;HSPA1A;STAT5B;STAT1;MAPK14;ACVR2A;FOXO3
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.45966756074129583,-1.1671337571101024,0.2727272727272727,0.7126530959625048,1.0,3/15,2.19%,TREM2;OSBPL11;OSBPL8
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.43713381148016894,-1.167055100957419,0.25839793281653745,0.711152625201053,1.0,10/16,27.20%,ACACA;CBR4;HSD17B8;MLYCD;DIP2A;GCDH;PPCS;ACSS1;SCD;FASN
prerank,regulation of autophagy (GO:0010506),0.3511649474619591,1.166204876899431,0.1829787234042553,0.6468231529906051,1.0,44/216,13.81%,ITPR1;LRRK2;PTPN22;DAPK1;PIP4K2A;DRAM1;MCL1;PRKAG2;PIK3C2A;STAT3;PLEKHF1;ATP6V0E1;ERN1;EIF4G3;IL10RA;FBXW7;ATF6;DCAF12;MTMR3;PRKAB2;SVIP;PSAP;RMC1;MTMR4;HGF;ATP6V1H;CSNK2A2;DEPDC5;TLK2;EXOC7;PIP4K2B;TRIM14;PRKAG1;RHEB;FOXO3;TAB3;PRKAA1;SH3BP4;DNM1L;MAPK8;AKT1;SREBF2;PRKAA2;ROCK1
prerank,midbody abscission (GO:0061952),0.507842414241962,1.165885246573853,0.29541864139020535,0.6470701504930715,1.0,5/17,8.00%,KIF20A;MITD1;CHMP4A;CHMP4B;PDCD6IP
prerank,sulfur compound catabolic process (GO:0044273),-0.34248695041017085,-1.1657840009685851,0.20863309352517986,0.7131057082927273,1.0,7/38,11.41%,HEXB;GALNS;GNS;ARSB;TXN2;CSPG4;HEXA
prerank,axon extension (GO:0048675),-0.39281831067125894,-1.1656299226079454,0.24923076923076923,0.7117784955546186,1.0,14/23,20.68%,ULK2;NRP1;AUTS2;NRP2;MAP1B;SLC9A6;SLIT2;CDK5;SLIT1;SLIT3;NLGN3;HSP90AB1;SEMA5B;CYFIP1
prerank,negative regulation of cell migration (GO:0030336),0.36853686227616567,1.1654824265769126,0.20782122905027933,0.6474677119778844,1.0,17/137,8.19%,CD74;SRGAP3;SRGAP2;STK24;MARVELD3;NGFR;PTPRU;DPEP1;CLIC4;DLC1;RNF20;AFDN;PTEN;ARHGDIB;PHLDB2;ENG;RAC1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4949335489523976,1.1654628534021425,0.2703125,0.6469016453356173,1.0,5/18,12.90%,ZFP36L2;ANXA1;NR3C1;REST;KLF9
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.47917649010968066,1.1653872234943101,0.2689335394126739,0.6464789226451821,1.0,6/22,15.79%,MED30;MED13;MED12;PSMC4;MED14;MED1
prerank,calcium ion transport (GO:0006816),-0.2856717707899493,-1.1650523236411368,0.12727272727272726,0.7116265839309467,1.0,34/113,16.59%,CACNA1D;SLC8A1;RYR3;SLC24A3;CACNB2;GAS6;CACNA2D1;TRPV2;TRPM3;PKD2;CDH23;CACNA1C;PSEN2;ATP2A2;TRPC4;P2RX7;ANK2;ATP2B2;P2RX4;TRPC1;MCOLN1;CRACR2A;CHRNA7;MCOLN3;CRACR2B;SELENOK;SLC3A2;TRPC7;TRPM2;TRPV4;TRPC3;MCOLN2;ATP2C1;CAMK2A
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.37564408033384256,1.1642599169400034,0.2290167865707434,0.6488356495285641,1.0,17/95,13.15%,IL1B;ST3GAL1;ST3GAL4;EXT1;B4GALT5;GPC3;HSPG2;CHST12;PXYLP1;XYLT1;ACAN;NCAN;GALNT5;SDC3;SLC10A7;CHST15;UST
prerank,DNA metabolic process (GO:0006259),0.3466392965263824,1.1642504667307039,0.17309697601668406,0.6482388635916856,1.0,80/270,20.38%,SP100;UVRAG;DNA2;SAMHD1;LONP1;POLI;BTG2;RBBP8;POLL;CHRNA4;CDC45;USP3;MRE11;FEN1;SUMO1;PARP4;DNTT;ORC5;MCM6;UBE2N;POLD4;MBD4;WRN;USP45;MSH3;NABP1;ORC4;DOT1L;PSME4;SMUG1;BACH1;MSH6;FANCC;FANCL;TDG;KMT5B;RECQL5;DFFB;PARG;RPA3;POLA2;DDX23;EXD2;RAD54L;MCM2;ERCC3;ERCC4;FANCA;RNASEH2A;RNASEH1;VCP;XRCC2;USP7;UHRF2;ORC6;STN1;INO80;ENDOV;INIP;POLB;NSMCE4A;KPNA2;HUS1;POLD1;LRWD1;LTO1;ORC2;RAD17;RAD21;PRIMPOL;SETMAR;FANCG;DNMT1;DNASE1L1;TERF2;PARK7;APEX1;SUPV3L1;PDS5B;XPA
prerank,acylglycerol metabolic process (GO:0006639),-0.3466706451114813,-1.163919744802067,0.21223021582733814,0.7132194244739186,1.0,4/37,2.13%,APOE;ABHD12;DGKZ;MGLL
prerank,endomembrane system organization (GO:0010256),0.3547489531934364,1.1637657042835008,0.20810514786418402,0.6488805193959751,1.0,39/178,16.11%,ATP8B4;LRRK2;FAM174B;PLEKHF1;DYSF;USP6NL;GOLPH3L;TMCC1;LEMD3;CDC42;SRGN;CAV2;PI4K2B;STX17;TMED10;GBF1;SYP;BCAS3;ATL3;ARFGEF1;LMAN2L;ARHGAP21;LEMD2;DMPK;TRAPPC11;SPTSSB;HTT;DNM1L;EIF2AK3;SYNGR2;CLASP1;VMP1;RAB29;ATL1;TMED7;SNX33;VAPA;HACE1;TJAP1
prerank,positive regulation of signal transduction (GO:0009967),0.3493846880920878,1.1635222669930856,0.17395833333333333,0.648907114302609,1.0,48/238,16.50%,CD74;LRRK2;PTPRC;IL1B;CD226;GLI1;SULF2;JAK2;STAT3;ERN1;MYO1C;PTGIS;RSPO2;RSPO3;SORL1;NPTN;RBPJ;LMO3;CAV2;PTEN;TRIM16;PTK2B;RAB34;FLNA;TSPAN14;IL6ST;IL6;CSNK2A1;RPS3;DSTYK;HTT;TLR2;TUBD1;AGPAT1;CITED2;KAT2B;PDE6H;TXNDC15;GPS2;ASXL2;DISC1;CREBBP;POGLUT1;MAML1;ITGA5;TSPAN5;RELN;WNT7A
prerank,regulation of ion transport (GO:0043269),-0.30464135934891245,-1.1629344915075523,0.18536585365853658,0.7144828096140915,1.0,18/76,14.39%,PRKN;DTNBP1;WNK1;SYT1;KCNJ2;P2RX7;P2RX4;SYT9;ITGB3;SYT7;KCNA2;KCNJ6;SNX6;CA2;PER1;KCNJ9;SYT6;NKAIN3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.4559323508705188,1.162860012585434,0.27002967359050445,0.6500561024380918,1.0,5/27,3.83%,PPARG;NFKB1;CD36;PRKCH;NFKBIA
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5051156865868804,1.1628084750456886,0.2898550724637681,0.649576585856224,1.0,4/18,10.75%,LRRK2;RAP1A;SLC4A8;SNAPIN
prerank,eye development (GO:0001654),0.40326149544645595,1.162699385725093,0.24770642201834864,0.6492205834057513,1.0,9/54,10.95%,MAB21L2;SIPA1L3;NIPBL;COL5A2;ATF6;HIPK2;HIPK1;FBN1;PBX1
prerank,telomere organization (GO:0032200),0.4242115379843209,1.1624030338499778,0.2613480055020633,0.649338393019414,1.0,13/43,17.55%,SP100;DNA2;MRE11;H3-3A;POLD4;WRN;DOT1L;RPA3;ERCC4;STN1;HUS1;POLD1;LTO1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.5185455716496137,1.1621373774615478,0.298811544991511,0.6494027323742696,1.0,5/14,15.49%,ERN1;FIP1L1;TUT1;NUDT21;NCBP1
prerank,regulation of presynapse assembly (GO:1905606),-0.41363052750028423,-1.1617843962390446,0.2658959537572254,0.7144594724300601,1.0,6/18,15.29%,PTPRD;IL1RAPL1;VPS35;GPC6;EIF4G1;SLITRK1
prerank,regulation of presynapse organization (GO:0099174),-0.41363052750028423,-1.1617843962390446,0.2658959537572254,0.7144594724300601,1.0,6/18,15.29%,PTPRD;IL1RAPL1;VPS35;GPC6;EIF4G1;SLITRK1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.4384683992523119,1.1614350328636027,0.2782485875706215,0.6505523773708368,1.0,13/36,18.78%,DNA2;CDC45;CDC5L;CEP63;CLOCK;DOT1L;BRIP1;MAP3K20;DONSON;HUS1;RAD17;CHEK2;SETMAR
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5217366214382585,1.161161309180973,0.2825719120135364,0.6506686016384918,1.0,2/13,7.45%,SORL1;GCC2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.35074655725744663,1.1611410854102686,0.18305439330543932,0.6501027166900943,1.0,64/248,18.77%,LRRK2;LIMD1;GLI1;PTPRU;PTPRO;PSME3;NFKB1;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;CSNK1G1;TBL1XR1;PSMB7;GPC3;ZEB2;ADGRA2;RNF146;AXIN1;PSME2;CDK14;UBR5;TMEM131L;STK4;KREMEN1;PSME4;CSNK1G3;TNKS;LATS1;GSKIP;PSMB8;PSMA5;PSMD9;CYLD;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;VCP;TGFB1;INVS;XIAP;DVL2;APC;LYPD6;USP47;IGFBP6;PSMD12;DAPK3;KLHL12;PSEN1;LRRK1;KANK1;HDAC1;SMURF2;PIN1;FZD7;STK3
prerank,positive regulation of RNA splicing (GO:0033120),0.45273833971878946,1.1601245700324763,0.2878787878787879,0.6521326025349974,1.0,10/29,15.49%,HSPA1A;ERN1;PRDX6;SETX;DYRK1A;NUP98;RBM22;ZPR1;HNRNPLL;NCBP1
prerank,connective tissue development (GO:0061448),0.4351348575168451,1.1599711050213992,0.27712609970674484,0.651904852033567,1.0,4/35,7.74%,CD44;SULF2;SCX;ATP7A
prerank,mitotic cytokinetic process (GO:1902410),0.4843931783110203,1.1599348723220506,0.299079754601227,0.6513969929031935,1.0,6/20,8.95%,KIF20A;MITD1;CHMP4A;CHMP4B;PDCD6IP;RHOA
prerank,peptidyl-amino acid modification (GO:0018193),-0.507226384506943,-1.15974225634531,0.2916666666666667,0.7188727714276024,1.0,2/10,3.62%,METAP1D;METAP2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4561140630305309,1.1594762297920995,0.28075253256150506,0.6519731259478013,1.0,8/26,19.97%,PLCG2;CD36;ABCB7;PIKFYVE;ABCD1;CYBA;MMP8;PARK7
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.35631595631766766,1.1583775992762333,0.20022246941045607,0.654231953881868,1.0,41/166,18.06%,RARA;NOTCH2;HNF4G;PPARG;GTF2F2;TAF1A;TAF13;TAF9;GTF2E2;POLR2C;TBL1XR1;RBPJ;SMARCA5;POLR1G;THRA;RARG;CCNH;GTF2A1;E2F2;HDAC9;NR3C1;MED26;TAF7;TFAM;TEAD1;ERCC3;KAT2B;HDAC3;POLR1B;RSF1;MAZ;CREBBP;TAF1;MAML1;MED1;TFB1M;MED7;TAF1C;NR4A1;HDAC7;HDAC1
prerank,negative regulation of cell growth (GO:0030308),-0.28093260329978254,-1.1578462710656028,0.17117117117117117,0.7225908283286612,1.0,39/121,21.87%,APBB2;DIP2B;DCC;ULK2;FLCN;VGLL4;MAP2;FGF13;ENPP1;NDRG3;IP6K2;ADAM15;CDKL3;CAPRIN2;PRDM11;RERG;SLIT2;DNAJB2;SMAD3;DCBLD2;GJA1;SLIT3;TCHP;TGFB2;APBB1;CGRRF1;ACVR1B;SPHK2;DDX3X;ING1;SESN2;HYAL1;NDUFA13;MT3;PPP2R1A;RACK1;GNG4;CCDC85B;DACT3
prerank,cellular response to drug (GO:0035690),0.45809964856881963,1.1577606330096146,0.2708333333333333,0.655283268567267,1.0,7/25,11.91%,IL1B;KCNQ1;DPEP1;CERS1;RBM22;SLAMF8;REST
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.44068116796658124,-1.1577085972684258,0.2727272727272727,0.7195676460471173,1.0,5/15,15.45%,DTNBP1;AP3M2;AP3B1;AP3B2;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.44068116796658124,-1.1577085972684258,0.2727272727272727,0.7195676460471173,1.0,5/15,15.45%,DTNBP1;AP3M2;AP3B1;AP3B2;BLOC1S5
prerank,positive regulation of chemotaxis (GO:0050921),-0.33664798246256306,-1.157605468910982,0.18725099601593626,0.7181788163898921,1.0,9/43,5.40%,LGMN;TREM2;P2RY12;NRP1;NTRK3;FGF2;AIF1;PTN;P2RX4
prerank,ATP transport (GO:0015867),0.5595193354384447,1.1575194638593318,0.3175438596491228,0.6552988854246146,1.0,2/10,11.96%,CD47;SLC25A5
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.37210590746705924,1.1573596308528313,0.24224343675417662,0.6551036659618289,1.0,30/100,19.44%,FGR;LYN;FLT3;PIP4K2A;JAK2;PTPN6;CBL;PTEN;HGF;FN1;PIP4K2B;PIK3CA;PDGFD;PIP5K1A;KIT;NCF1;HCLS1;HCST;PPP2R5C;IL18;UNC5B;MAZ;MAPK1;INSR;SEMA4D;SIRT1;BECN1;HAX1;PIK3R5;FGFR1
prerank,actin filament network formation (GO:0051639),0.5400588599287923,1.1573203258036717,0.31561461794019935,0.654583656984313,1.0,4/11,16.34%,LCP1;CARMIL1;FHOD1;PLS1
prerank,neuronal action potential (GO:0019228),-0.40947411942976225,-1.156959920054651,0.2553191489361702,0.7182871801733138,1.0,5/22,14.97%,SCN1A;SCN3A;KCNMB2;KCNA2;KCNA1
prerank,regulation of chromosome segregation (GO:0051983),0.5040087143551633,1.1565547166729222,0.2861788617886179,0.6559334304219625,1.0,8/16,18.88%,IHO1;PUM2;CSNK2A2;CSNK2A1;AURKB;PUM1;SMC6;SMC5
prerank,negative regulation of macroautophagy (GO:0016242),0.45924498225233185,1.1558673468043,0.27492877492877493,0.6570677077301683,1.0,7/26,13.17%,LRRK2;CHMP4A;CHMP4B;CLEC16A;PIK3CA;SMG1;AKT1
prerank,negative regulation of histone methylation (GO:0031061),0.5588903966815789,1.1552367179028078,0.2900355871886121,0.658044201391988,1.0,1/10,0.35%,JARID2
prerank,positive regulation of response to wounding (GO:1903036),0.4599868078888737,1.1548330731314302,0.28735632183908044,0.6584087224855011,1.0,9/24,20.75%,PRKCE;CLDN1;ADRA2A;ARFGEF1;ANXA1;OCLN;KANK1;PTK2;INSL3
prerank,positive regulation of transferase activity (GO:0051347),0.35887830366745416,1.1547843501867325,0.22937853107344633,0.6579340318461209,1.0,30/142,16.27%,CD74;FLT3;KLF4;RET;LMTK2;DTX3L;PKIB;SORL1;MRE11;FBXW7;AXIN1;DCUN1D1;UBE2N;EPHB2;PARM1;WRAP53;TNKS;MAP3K4;CHTF18;DSTYK;DCUN1D3;KIT;RPS2;TGFB1;FGFR3;AURKB;MAPK1;TCP1;POLG2;INSR
prerank,positive regulation of vacuole organization (GO:0044090),0.5407500962311376,1.1545334238008849,0.31314878892733566,0.6579727968802473,1.0,4/10,10.36%,PIP4K2A;ANXA2;RALB;PIP4K2B
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.43373517080870067,1.1543981172922184,0.2679296346414073,0.6576985393970892,1.0,5/39,11.00%,FFAR4;TM7SF3;SELENOT;PSMD9;GLUD1
prerank,arachidonic acid secretion (GO:0050482),0.5617886759322283,1.1542154395539137,0.32521739130434785,0.6569774962055808,1.0,2/10,10.39%,ACE;ANXA1
prerank,arachidonate transport (GO:1903963),0.5617886759322283,1.1542154395539137,0.32521739130434785,0.6569774962055808,1.0,2/10,10.39%,ACE;ANXA1
prerank,eye morphogenesis (GO:0048592),0.47531995763713175,1.1536471292071222,0.3,0.6578690542127742,1.0,5/19,9.64%,STAT3;NIPBL;COL5A2;RARG;FBN1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.429288548762844,-1.1536122518027114,0.296,0.7264574952061252,1.0,7/16,31.56%,IGF1;IGFBP5;IGFBP2;IGFBP4;ZFAND2B;IGFBP3;BMP5
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4462713788309106,1.1532656997845676,0.2921511627906977,0.658288987489414,1.0,12/29,21.54%,DTX3L;FBXW7;AXIN1;DCUN1D1;UBE2N;DCUN1D3;RPS2;PIN1;PINK1;PARK7;FEM1B;ARRDC4
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3650638787193958,-1.1530044413929668,0.2604166666666667,0.7264321686826101,1.0,10/32,20.34%,CAPN3;PKD2;PLCG1;TRPC1;P2RY6;AKAP6;CALM1;CX3CL1;CEMIP;GSTO1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.42971839081748914,-1.1529767450151536,0.276536312849162,0.7247967898173027,1.0,10/17,44.93%,LPCAT1;PLA2G4A;SERAC1;LPGAT1;PLA2G3;CRLS1;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,synapse organization (GO:0050808),-0.278776393550545,-1.152772959604319,0.11475409836065574,0.7236909562448318,1.0,28/125,16.10%,APBB2;CX3CR1;C1QB;PTPRD;C1QA;CACNB2;NLGN1;C1QC;NRXN2;PPFIA4;RYK;SEMA3E;SDK1;C5AR1;GPM6A;CHRNA7;GPC6;CDK5;GRM5;PPFIBP1;PPFIBP2;NLGN2;AGRN;ADGRL3;CX3CL1;SLITRK1;KIRREL3;NLGN3
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.36029822537575185,1.1527403044927644,0.20610687022900764,0.6589940768408589,1.0,37/161,16.57%,LIMD1;GLI1;PTPRU;PTPRO;PSME3;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;PSMB7;AXIN1;PSME2;TMEM131L;STK4;KREMEN1;PSME4;LATS1;PSMB8;PSMA5;PSMD9;CYLD;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;INVS;DVL2;APC;IGFBP6;PSMD12;KLHL12
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.41881691481743577,1.152595955294765,0.27310924369747897,0.6587550757866599,1.0,7/39,7.28%,MYO1G;MYO1C;MYO1E;KIF5B;FBXW11;MYO5B;PAFAH1B1
prerank,protein K48-linked ubiquitination (GO:0070936),0.39995221278979454,1.152533918155864,0.2632978723404255,0.6583049689792214,1.0,11/54,8.24%,ITCH;DTX3L;NEDD4L;CUL3;UBE2E1;RNF146;PELI1;UBE2D3;UBR5;FBXO38;ARIH2
prerank,insulin secretion (GO:0030073),-0.4130901177179134,-1.1524878009412702,0.26744186046511625,0.7227702586469109,1.0,4/19,7.30%,PTPRN2;RAB11FIP2;RAB11FIP5;SNX19
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.43633181555281286,-1.1522812524032955,0.29023746701846964,0.7216839477461712,1.0,6/15,24.18%,NEK6;TPR;CDC16;CENPE;TACC3;ANAPC1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.34277803825617204,-1.1522299915466279,0.20136518771331058,0.7201394806849191,1.0,12/40,15.46%,TIMP2;NELL1;SNRNP70;CTSA;CST3;TIMP3;FMN2;RIC1;CYP51A1;DAB2IP;PTPN3;ADGRB1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3868051889368998,1.152051440844829,0.24155193992490614,0.6589352197849141,1.0,22/72,17.51%,ARHGEF18;EPS8;HEG1;CCDC125;CUL3;GPR35;RIPOR2;BCR;DLC1;ARHGDIB;F11R;RAC1;NET1;ITGA3;ARHGEF3;LPAR6;KCTD13;STARD13;ARHGEF28;ABL2;GPR65;KANK1
prerank,response to muscle stretch (GO:0035994),-0.44128387532426194,-1.1520180597999345,0.26229508196721313,0.7190143648439751,1.0,2/15,3.16%,SLC8A1;CTNNB1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.4144342131877689,-1.15200846447834,0.2448377581120944,0.7173621079319965,1.0,2/21,0.92%,PRKN;ABCD2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4132239645995641,-1.1516781803579639,0.25925925925925924,0.7166754997592568,1.0,6/19,13.16%,TREM2;CORO2B;CCT2;DKC1;CHP1;CCT8
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.46294439812128685,1.15167331067947,0.2684887459807074,0.6593841015410278,1.0,9/24,18.81%,PSME3;GPX1;PSME2;PTK2B;LATS1;EFNA1;USP14;CTSC;PINK1
prerank,nuclear pore complex assembly (GO:0051292),0.5517773433707542,1.1514811717735243,0.31497418244406195,0.6592511013652292,1.0,4/10,18.20%,NUP98;RTN4;NUP153;NUP93
prerank,ceramide metabolic process (GO:0006672),0.3992696621009445,1.1509417321502908,0.2733423545331529,0.6600413717860653,1.0,7/49,8.26%,CERS6;ACER3;CERS1;SAMD8;SGMS1;SGMS2;ST6GALNAC3
prerank,neuron projection morphogenesis (GO:0048812),0.3628204621350816,1.1508395952541357,0.23370786516853934,0.6597137742834165,1.0,18/137,9.09%,LRRK2;ALCAM;IQGAP1;SRGAP2;NGF;LMTK2;NTNG2;PAK1;SHTN1;DOCK10;CDC42;TAOK3;PTEN;ATP7A;EPHB2;MINK1;ZDHHC17;CPNE1
prerank,extracellular matrix assembly (GO:0085029),0.46678159354781756,1.1506509741119715,0.3059360730593607,0.6596089492215024,1.0,4/23,8.31%,NTNG2;LAMB1;ATP7A;PXDN
prerank,exit from mitosis (GO:0010458),0.538659436880166,1.1502341077729286,0.2857142857142857,0.6600859675628835,1.0,5/12,13.92%,EPS8;CHMP4B;SPAST;UBE2S;CLASP1
prerank,programmed necrotic cell death (GO:0097300),0.49043893932474225,1.1502330486567918,0.2819314641744548,0.6594867700166267,1.0,7/18,15.46%,ITPK1;TLR3;CYLD;RIPK1;PGAM5;DNM1L;IPMK
prerank,positive regulation of developmental process (GO:0051094),-0.2588585351750349,-1.1500633392893673,0.08823529411764706,0.7197677284619929,1.0,36/164,16.07%,PRKN;RREB1;BASP1;APOE;NLGN1;NUMA1;SPIRE1;CAMK1;PTN;GRIP1;DLG4;CLASP2;TMEM119;ENPP2;ACVR1;ADGRL1;TFRC;MFF;RBM19;RIF1;VPS35;SHLD2;CFL1;RALA;PHLDB1;PA2G4;VEGFA;GJA1;MDK;BMPR1B;SRC;DAB2IP;HMCES;SOX5;AR;CPEB3
prerank,protein kinase A signaling (GO:0010737),0.531280391807808,1.1496610397513516,0.29930795847750863,0.6603853591108275,1.0,2/12,8.00%,LCP1;EZR
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.46453971973923724,-1.1493514767858566,0.31645569620253167,0.7200535012487643,1.0,5/13,12.21%,CACNB2;CACNA1C;ANK2;KCNN2;GJA1
prerank,regulation of interleukin-13 production (GO:0032656),0.5296911887452895,1.149046529320562,0.32348111658456485,0.6614151276685124,1.0,2/13,5.53%,RARA;IRF4
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.47217718900383754,1.1489893580032582,0.30165912518853694,0.6609734263876864,1.0,10/22,18.95%,CDK13;KAT7;SCAF8;CCNT2;CCNT1;CDK12;HMGN1;ELL;SUPT4H1;BRD4
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.42066434636395894,-1.1486308101842468,0.2784090909090909,0.7204604020548737,1.0,5/18,7.71%,GNA15;CHRM3;CHRM2;RGS10;CDK5R1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4737514523454129,1.1485615012266417,0.3016845329249617,0.6614623648495194,1.0,6/22,11.67%,LYN;PTPN22;RAB7B;TIRAP;IFI35;ACOD1
prerank,ion homeostasis (GO:0050801),0.4486206275870672,1.1484141731093729,0.3062409288824383,0.6612520945211757,1.0,5/30,7.52%,NEDD4L;SLC30A4;HCN4;SLC4A7;SLC4A8
prerank,negative regulation of innate immune response (GO:0045824),0.43130225227927116,1.1483194367700054,0.28133704735376047,0.6609035692843903,1.0,11/34,15.81%,SAMHD1;DHX58;YTHDF3;USP15;SLAMF8;FAM3A;CACTIN;ACOD1;STAT2;METTL3;IRAK3
prerank,regulation of protein processing (GO:0070613),0.47419932719795543,1.148202360796189,0.28328173374613,0.6605853575225324,1.0,3/21,10.13%,LRRK2;PRNP;NLRC4
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3964458796943999,-1.1480073846648673,0.2605042016806723,0.7205788078683675,1.0,7/24,11.81%,NAV3;CAMSAP1;FGF13;CLASP2;LIMA1;PLEKHH2;CAMSAP2
prerank,melanosome organization (GO:0032438),-0.37180481951114147,-1.147950425345495,0.2672955974842767,0.7190723171778036,1.0,7/26,15.45%,DTNBP1;HPS4;RAB32;AP3B1;SHROOM2;LYST;BLOC1S5
prerank,glycosphingolipid metabolic process (GO:0006687),-0.33579925829640456,-1.1478835259011693,0.19767441860465115,0.7176499096869602,1.0,10/42,11.41%,HEXB;LARGE1;CERK;B3GALNT1;CTSA;GALC;NEU1;ST6GALNAC6;ST6GALNAC5;HEXA
prerank,cellular metal ion homeostasis (GO:0006875),0.375237547943173,1.1473096374393426,0.2542955326460481,0.6622599346375732,1.0,17/102,12.61%,CCR2;CD40;CCR1;NEDD4L;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;ATP2A1;SLC30A1;DMPK;LETM1;TMEM203;ATP13A3;SLC10A7;SLC24A4
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.30508078105142206,-1.1466679463884182,0.24870466321243523,0.7195611766782187,1.0,29/72,24.76%,GTF2H2;ERCC6;COPS4;POLD3;TCEA1;GTF2H1;UBC;XRCC1;POLR2A;COPS7A;ERCC2;COPS2;PCNA;LIG3;PPIE;ISY1;POLR2K;RFC3;LIG1;GTF2H3;COPS7B;XAB2;CDK7;POLR2H;GTF2H5;POLR2J;UBA52;COPS6;ERCC1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3014004645064292,-1.1465037086316967,0.22395833333333334,0.7183978878772784,1.0,16/72,12.13%,NAV3;PRKN;APOE;TREM2;CAMSAP1;MAP2;FGF13;CLASP2;LIMA1;PFN1;PLEKHH2;SLIT2;EML2;MAPRE1;CAMSAP2;CLU
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4569599424464141,1.1462721210793367,0.29515418502202645,0.6643570320366344,1.0,11/25,19.85%,CDK13;HEXIM1;RECQL5;NELFA;CDK12;EAF1;ELL;SUPT4H1;BRD4;RNF168;LARP7
prerank,regulation of embryonic development (GO:0045995),0.43646674679595576,1.1462136014818833,0.2825788751714678,0.6639208483903923,1.0,10/34,16.85%,RACGAP1;NIPBL;B4GALT5;PHLDB2;PLCB1;TDG;CLASP1;POGLUT1;INSR;NIBAN2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4433613750974322,1.1461039342394812,0.2872340425531915,0.6635947861969982,1.0,11/30,21.30%,HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR;SQLE
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.45269160423140853,1.1458003911901222,0.29806259314456035,0.6637528075356447,1.0,7/27,7.55%,ARHGEF18;WASF2;DLC1;ARAP1;PAK2;PHLDB2;F11R
prerank,regulation of actin filament polymerization (GO:0030833),0.38756343517490316,1.1457855144763454,0.2827417380660955,0.6631770110068906,1.0,12/69,10.62%,CYRIB;HCK;PRKCE;ARHGAP18;CARMIL1;PTK2B;KANK3;MTPN;LATS1;ARFGEF1;SNX9;VASP
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.49561293982139576,-1.1457783278465974,0.28878281622911695,0.7189005473095305,1.0,4/10,28.15%,TSN;TSNAX;DROSHA;MRPL44
prerank,histone H3 acetylation (GO:0043966),0.4257154729379229,1.1457536424855999,0.2847222222222222,0.6626630275692608,1.0,11/40,13.97%,TAF9;SPI1;KAT7;TRIM16;TADA3;MBIP;KAT6A;TADA2A;JADE3;MAP3K7;KAT2B
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4480422378360303,-1.1457403854669095,0.26246719160104987,0.7173709612320617,1.0,9/14,31.43%,SEC23B;TBC1D20;SEC23A;SEC13;SAR1A;SEC24A;SEC24D;SEC31B;SEC24B
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3572568848611742,1.145560543240778,0.2536806342015855,0.6625669732932917,1.0,33/138,18.06%,RARA;NOTCH2;HNF4G;PPARG;GTF2F2;TAF13;TAF9;GTF2E2;POLR2C;TBL1XR1;RBPJ;THRA;RARG;CCNH;GTF2A1;E2F2;HDAC9;NR3C1;MED26;TAF7;TEAD1;ERCC3;KAT2B;HDAC3;MAZ;CREBBP;TAF1;MAML1;MED1;MED7;NR4A1;HDAC7;HDAC1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5571367071882832,1.145270452809561,0.3140495867768595,0.6620750034027462,1.0,4/10,16.27%,KLF4;MBP;MAP2K5;MYADM
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5571367071882832,1.145270452809561,0.3140495867768595,0.6620750034027462,1.0,4/10,16.27%,KLF4;MBP;MAP2K5;MYADM
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3279430893738431,1.1450790754846216,0.024,0.6619316475566391,1.0,252/1645,13.63%,CD74;CIITA;CBFA2T3;BCL11A;TRPS1;NFE2;ZBTB46;IL1B;BACH2;JARID2;FOXP1;RUNX2;HIVEP2;RARA;SP100;SP3;BAZ1A;RUNX3;STAT4;LIMD1;TOX4;GLI1;HNF4G;BCL3;KLF4;UXT;CREB1;RET;MAP3K5;PPARG;MED13L;ETV6;STAT5A;SCML4;BCL6;SAP30;PKN1;POLR3F;NFKB1;PITX3;ATF7IP;FOSL2;DTX3L;STAT3;BAZ2B;EHF;NSD3;FOXJ1;ELF4;RFX7;NIPBL;FOS;KDM7A;CRK;NAB1;TCF20;RPS6KA3;CIART;MAD2L2;REL;RBBP8;ZBTB20;CRLF3;CDC45;SPI1;STAT5B;NAA16;MYRF;CRY1;SCX;ATAD2;TBL1XR1;MTA3;PICALM;IKBKB;MED30;ZEB2;MBD1;SUMO1;PGBD1;CAMTA2;KAT7;ATF6;LRRFIP1;KLF8;RYBP;AXIN1;ATF2;IRF2;RFX3;RPL6;ZNF319;RBPJ;BTG1;WAC;HIVEP1;DEAF1;MED13;STAT1;HIPK2;RNF20;KLF5;IRF4;HEXIM1;MBTD1;MAPK14;FBXW11;BBX;RFX5;RPS6KA5;SMARCA5;CDK14;KLF13;FAM47E;TSHZ1;TRIM16;DEK;KLF10;CDC5L;SEC14L2;ELOA;AHR;ANXA4;CREBRF;PHF19;TADA3;ARID4A;CBFB;CREM;SRSF10;IKZF3;NFE2L2;PDCD4;DYRK1A;KDM3B;SETDB2;PURB;HTATSF1;MECP2;PLCB1;AFAP1L2;THRA;CRY2;CLOCK;ZFP3;SAP18;MED6;GATAD2A;CCNH;TOX3;E2F2;ENG;CTCF;PHF12;UIMC1;NFYC;HDAC9;ELF1;ZBTB11;IL6;PEX14;CBFA2T2;BRIP1;BACH1;NFE2L1;ZNF182;SNF8;KAT6A;RBAK;ASCC1;ID2;WWP2;CREBL2;NAA15;EPC2;NCOA2;E4F1;SETD5;PKNOX1;SMARCE1;ZNF496;ZFX;PARP9;IRF7;METTL4;MEF2B;RCOR3;SMAD4;CAMKK2;SBNO2;CNOT2;PSMD9;BNC2;NCOA1;DAXX;IL31RA;CSRNP1;NR3C1;TADA2A;GMEB2;SP140;RBM15;SPEN;PBX1;ING2;CCNT2;SRRT;NLK;MED26;FOXO3;MED12;IKZF5;DEDD2;DVL3;TAF7;ZNF260;ETS2;REST;RPS6KA1;ZNF418;MBD2;ATF6B;NUPR2;BAZ2A;MED14;CCNT1;NFYA;LIN9;TFAM;PQBP1;MSL3;MAP2K3;TEAD1;RGS14;ATRX;L3MBTL2;KLF9;CCNL1;MYB;IFRD1;AKT1;KIT;STAT2;NSD1;CHD4;LBH;NCF1;TLE1;JUNB;HCLS1;EZH2;SREBF2
prerank,membrane raft organization (GO:0031579),0.5116835466549996,1.1448694330324685,0.3076923076923077,0.6618935376861493,1.0,6/15,16.32%,ANXA2;S100A10;NAXE;FA2H;MYADM;PPT1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4642092762474101,1.1448119299420232,0.29204892966360857,0.6614394741417313,1.0,9/22,16.58%,NGF;RAP1A;RAPGEF2;CIB1;AKT1;KIDINS220;EHD1;STMN2;RAB35
prerank,regulation of glycolytic process (GO:0006110),0.38610805329979464,1.1447260712843965,0.2773809523809524,0.6610697094376038,1.0,18/68,16.98%,CBFA2T3;NUP210;PRKAG2;ZBTB20;PRXL2C;NUP98;GIT1;PRKAG1;PRKAA1;APP;NUP153;PFKFB3;PRKAA2;PFKFB4;SEH1L;INSR;PSEN1;GCK
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4967074152232003,1.1444781314350136,0.33783783783783783,0.6610972497110212,1.0,2/14,2.48%,LRRK2;HSPA1A
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.4064983492296804,-1.144003406271489,0.26541554959785524,0.7209001458141934,1.0,4/21,4.38%,NAV3;CAMSAP1;FGF13;CLASP2
prerank,skeletal system development (GO:0001501),0.3549323478750069,1.1436439351121201,0.2346368715083799,0.6625698182422463,1.0,25/148,14.27%,TRPS1;CD44;EXT1;SULF2;ANKRD11;RPS6KA3;NOTUM;PTGER4;DEAF1;PAPSS1;ATP7A;BMP3;XYLT1;PAPSS2;RPL13;ACAN;FBN1;TLL1;NCAN;ETS2;SLC10A7;EIF2AK3;PCSK5;CNMD;FGFR3
prerank,axon guidance (GO:0007411),-0.2557815551145553,-1.1429776755979302,0.08928571428571429,0.7222172674742073,1.0,46/201,13.15%,OPHN1;PTPRM;DCC;PLXNA4;EVL;RHOH;NRP1;EPHA6;ROBO2;NRP2;FEZ2;ROBO1;CHN1;GFRA1;GAB1;CNTN4;PLXNB2;SMO;NFIB;SPTAN1;SEMA3D;EPHA5;SPTB;RYK;SEMA3E;PLXNA2;PLCG1;CDK5R1;KIF5C;EFNB3;SEMA6D;ARHGAP35;FEZ1;SLIT2;KLF7;PIK3R1;EFNA5;LAMA3;EPHA7;VEGFA;TUBB3;SCN1B;SLIT1;SLIT3;RAP1GAP;DOK1
prerank,cognition (GO:0050890),0.4166217561965634,1.1428660001132196,0.296448087431694,0.6640672133459722,1.0,11/42,12.10%,ST3GAL4;NIPBL;CHRNA4;DGCR2;PTCHD1;RP9;SETD5;MGAT3;MAGT1;SLC1A4;APP
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4471520601678433,1.1422400961788088,0.2936746987951807,0.6650176795157613,1.0,10/27,15.59%,SIK1;CRY1;FBXL8;CRY2;ID2;FBXL17;PPP1CB;PDE6B;FBXL12;BHLHE40
prerank,microtubule anchoring at centrosome (GO:0034454),0.5444375575515179,1.1417790377046646,0.33274021352313166,0.6655765274150492,1.0,2/10,7.38%,CCDC120;NIN
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3554635999857044,1.1416729649980653,0.22941822173435786,0.6652527559101281,1.0,38/150,17.53%,NIBAN1;LRRK2;PID1;PTPRC;LYN;PRKAG2;PTPN6;IBTK;PRKRIP1;PTEN;PRNP;PDPK1;SAMSN1;CIB1;PAK2;DDIT4;PAQR3;ENG;EPHB2;SPRED3;GSKIP;PMEPA1;DBNDD2;CACTIN;TAF7;PPP1R15B;AKT1;MVP;DNAJC3;TGFB1;GSTP1;OCLN;SPRED1;MYADM;RB1;SEMA4D;RASSF2;TAB1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.3920953101142043,-1.1414752240366777,0.2656716417910448,0.7249646498386056,1.0,14/22,36.28%,ATF4;SMARCB1;UTP15;PWP1;PHF8;PIH1D1;DDX11;WDR43;LYAR;IPPK;WDR75;MTOR;SMARCA4;NCL
prerank,regulation of mitochondrial fission (GO:0090140),0.44635588464277853,1.1411801436488858,0.30923076923076925,0.6658863030949539,1.0,2/24,0.59%,LRRK2;CYRIB
prerank,protein import into peroxisome matrix (GO:0016558),0.5185478273759211,1.1409819002992232,0.2978723404255319,0.6658220866314842,1.0,4/12,13.11%,PEX16;PEX12;PEX14;PEX5L
prerank,endothelial cell proliferation (GO:0001935),0.48998865026599814,1.140958551493622,0.3018575851393189,0.6652866309727785,1.0,2/17,2.93%,ERN1;BMPR2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.506187419222008,1.140957337196784,0.2833607907742998,0.6647028322852568,1.0,5/14,15.90%,FASTKD1;FOXO3;TFAM;PNPT1;TFB1M
prerank,RNA export from nucleus (GO:0006405),-0.2787326266478793,-1.1409166980379037,0.19078947368421054,0.7248888261750733,1.0,34/100,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;RAN;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;HNRNPA2B1;NUP37
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4036033632533581,1.1406191061755309,0.26052631578947366,0.664951169535751,1.0,10/51,8.95%,CD47;PAK1;ARHGEF10L;CCDC88A;CDC42;CARMIL1;S100A10;RAC1;PXN;RHOA
prerank,protein polyubiquitination (GO:0000209),0.338587153764053,1.140504072077468,0.17967145790554415,0.6646384615263424,1.0,82/297,18.61%,TRAF1;DTL;LNPEP;ITCH;PSME3;DTX3L;NEDD4L;CUL3;UBE2E1;PSMB7;FBXW7;ANKIB1;RNF146;PSME2;TRIM62;ARIH1;TRAF3IP2;RNF213;RNF20;PELI1;RC3H1;UBE2QL1;UBE2D3;SPOP;FBXW11;FBXL8;UBE2N;RNF217;UBR5;FBXO38;FBXW2;HECTD1;CBFB;TRAF3;FBXO4;UBR2;PSME4;ARIH2;TNKS;WWP2;TRIM71;UBE2W;FBXO32;PSMB8;PSMA5;PSMD9;TRIM14;HERC6;RNF31;PSMB3;UBE2S;FBXL17;PSMD6;PSMC4;LONRF1;TPP2;PSMD10;UBE2G1;AREL1;PSMB1;FBXL12;HECTD2;FBXO30;UBE2J2;FBXO7;ANAPC7;RNF166;TAF1;RNF41;HACE1;FBXL16;PSMD12;TRIM36;RNF144A;UBE2Q2;TRAF2;RNF19B;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4730326407602332,1.1404635999872894,0.30793650793650795,0.6641665273347244,1.0,4/21,6.98%,KCNE3;GJA5;KCNQ1;FLNA
prerank,glutathione metabolic process (GO:0006749),0.4185271083791142,1.1404373763538576,0.273972602739726,0.6636515716282717,1.0,6/38,6.35%,GPX1;GSR;ETHE1;DPEP1;GSTA3;GSS
prerank,regulation of DNA binding (GO:0051101),0.42052755527359614,1.1404294360205365,0.32172701949860727,0.6630866976392753,1.0,13/44,14.75%,SP100;NGF;BCL3;PPARG;JAK2;NFKBIA;SUMO1;DOT1L;CPNE1;MAPK8;TGFB1;RSF1;ILRUN
prerank,gene silencing by miRNA (GO:0035195),0.43734270924706053,1.140088536318555,0.31004366812227074,0.6633800205718745,1.0,10/32,16.94%,LIMD1;XPO5;PUM2;CNOT6;TRIM71;TNRC6B;TNRC6A;PUM1;AJUBA;CNOT8
prerank,negative regulation of cholesterol transport (GO:0032375),0.5514866823499631,1.1400561695732356,0.3238255033557047,0.6628811195799222,1.0,2/10,13.63%,NFKB1;SREBF2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.4099321769966565,1.139932169689341,0.29831387808041504,0.662589372390682,1.0,13/50,12.97%,PSME3;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,negative regulation of type I interferon production (GO:0032480),0.41736340332885946,1.1398419313913493,0.29261363636363635,0.6622667015051185,1.0,13/40,15.48%,LILRB1;ITCH;DHX58;REL;NLRX1;IFIH1;TRIM25;CYLD;CACTIN;ACOD1;ILRUN;GPATCH3;TBK1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4852225697210421,1.1392201075398203,0.30782029950083195,0.6631992582628509,1.0,7/17,18.31%,HCK;STAP1;CDC42;BCAS3;HCLS1;FES;HAX1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.37917678296370155,-1.1390810116829326,0.29289940828402367,0.7284977047673565,1.0,10/25,21.48%,ITGA6;NRP1;KCTD20;ILK;NCKAP1L;PTGES3;SRC;AR;ANG;MIF
prerank,regulation of protein kinase A signaling (GO:0010738),0.47101444212808885,1.1390649849362084,0.30923076923076925,0.6630187114961761,1.0,1/20,0.22%,LRRK2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3039257920262075,-1.1387530659791507,0.1989247311827957,0.7277856131178518,1.0,15/75,10.39%,OPHN1;DCC;MEF2C;MAP2;MAP1B;CTNNA2;CNTN4;BTBD3;FGFR2;RYK;AFG3L2;MAP1A;PARD3;CDK5;KLF7
prerank,positive regulation of bone resorption (GO:0045780),-0.47769130128072235,-1.1383161301111844,0.3231850117096019,0.7273755208936864,1.0,4/11,5.34%,SPP1;TNFRSF11A;ATP6AP1;ADAM8
prerank,cellular response to insulin stimulus (GO:0032869),-0.27103079236805133,-1.1382979984918977,0.16806722689075632,0.725795157419035,1.0,26/124,12.66%,PDE3B;BCAR3;ATP6V1C1;ATP6V0B;ATP6V0D2;CPEB2;ATP6V0C;TCIRG1;ENPP1;ATP6V1B2;GAB1;ATP6AP1;CPEB1;GOT1;RAB31;RHOQ;SLC27A1;ATP6V1D;PCK2;IDE;IRS1;ATP6V0D1;PIK3R1;MYO5A;NAMPT;ATP6V0A1
prerank,macrophage activation involved in immune response (GO:0002281),0.5128549857260167,1.138234784451887,0.3211314475873544,0.6645464537619079,1.0,5/13,10.00%,PLCG2;SYK;DYSF;IFI35;SBNO2
prerank,regulation of cholesterol esterification (GO:0010872),-0.49348922428221476,-1.1379307728076682,0.3231850117096019,0.7252664278169602,1.0,5/10,32.49%,APOE;APOC1;LAMTOR1;ABCA2;STARD4
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5215265314742424,1.137898758505933,0.3250883392226148,0.6648306009597649,1.0,5/13,16.01%,BTG2;EIF4ENIF1;TNRC6B;TNRC6A;PABPC1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4864223793515178,-1.1378662091918499,0.3192488262910798,0.7238291920928331,1.0,6/11,16.52%,NSUN2;CPSF6;AKAP8L;DHX9;IWS1;TPR
prerank,negative regulation of protein modification process (GO:0031400),0.37174500445087666,1.1373380285073509,0.2490974729241877,0.6656585201936204,1.0,17/79,14.22%,NIBAN1;LRRK2;PID1;LYN;IBTK;PTEN;PRNP;CIB1;PAQR3;EPHB2;PPP1R15A;CACTIN;PRKAA1;PPP1R15B;CDYL;PRKAA2;TGFB1
prerank,histone modification (GO:0016570),0.3699712108375633,1.1371566726641211,0.26030624263839813,0.6655537635109042,1.0,32/109,20.01%,HLCS;PADI1;NSD3;USP3;TBL1XR1;MTA3;RPS6KA5;PRMT8;UBE2N;ATXN7;HDAC9;KAT6A;RCOR3;MORF4L1;BAZ2A;MSL3;NSD1;EZH2;AURKB;CREBBP;PHF20;MIER1;NTMT1;EYA3;SIRT1;PADI2;HDAC1;PRKCD;MIDEAS;EHMT1;PARK7;RCOR1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4638992827638495,-1.1369586131715346,0.30412371134020616,0.7247224190091927,1.0,6/13,15.74%,PLPP1;PGR;NR3C2;CALCOCO1;ESR1;AR
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.34482969295035104,-1.1369159082473694,0.27741935483870966,0.7232002590967355,1.0,9/35,8.32%,PLXNA4;NRP1;NRP2;PLXNB2;SEMA3D;ARHGDIA;SEMA3E;PLXNA2;SEMA6D
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3566001294837907,-1.1367018077909066,0.2687074829931973,0.7221890000032204,1.0,8/32,11.81%,NAV3;CAMSAP1;MAP2;FGF13;CLASP2;EML2;MAPRE1;CAMSAP2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.48458571478847967,-1.136601129057001,0.32057416267942584,0.7208700229332189,1.0,6/10,15.43%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5F1D;ATP5MC3
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.43635915144678494,-1.1362752140759331,0.291005291005291,0.7201932625729462,1.0,7/14,34.91%,DAGLA;ALDH9A1;SLC5A7;CHAT;NOS1;MOXD1;ACHE
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4720046990488416,1.1358722505957783,0.32601880877742945,0.6682404180894731,1.0,10/19,21.92%,STAT1;IFIH1;TLR3;IRF7;SETD2;TBK1;IRF5;HSPD1;RIPK2;TLR8
prerank,cholesterol biosynthetic process (GO:0006695),0.43768172658960025,1.1354880881776797,0.3040847201210287,0.668605320737871,1.0,11/31,21.30%,HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR;SQLE
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4837286174844667,-1.1350249035816755,0.3194103194103194,0.7221668917608587,1.0,7/10,38.91%,HTR2B;PLPP1;PARD3;PICK1;DGKH;DGKD;GAP43
prerank,DNA alkylation (GO:0006305),0.4761112192240214,1.1347912005104597,0.3195084485407066,0.6692189487320663,1.0,10/19,19.46%,ATF7IP;FOS;GATAD2A;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;DNMT1;EHMT1
prerank,DNA methylation or demethylation (GO:0044728),0.4761112192240214,1.1347912005104597,0.3195084485407066,0.6692189487320663,1.0,10/19,19.46%,ATF7IP;FOS;GATAD2A;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;DNMT1;EHMT1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3794786299925501,-1.1343708155085799,0.26936026936026936,0.7224607860170363,1.0,13/24,19.65%,GRN;CTNNB1;NF1;ATF4;CDK5R1;BACE1;CDK5;EPHA7;SRPK2;TGFB2;BAX;CCL3;TYROBP
prerank,positive regulation of interleukin-10 production (GO:0032733),0.44589699254320786,1.1342180006229707,0.3039647577092511,0.6700560018305669,1.0,5/30,8.62%,PLCG2;SYK;STAT3;IRF4;IL6
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3493195337234781,1.1339280731550645,0.24239130434782608,0.670195102034422,1.0,13/159,5.41%,JAML;ITGAL;ALCAM;EMB;PECAM1;NECTIN1;PCDHB11;CLDN1;SELL;CD177;NPTN;CLDN12;ITGB2
prerank,nitric oxide metabolic process (GO:0046209),0.499081125584101,1.1337118694789847,0.3183279742765273,0.6701422888931043,1.0,4/14,19.18%,CYB5B;ARG2;AKT1;CYB5R3
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.42747122855051056,-1.1336382717094444,0.28717948717948716,0.723002735048466,1.0,6/16,18.03%,APPL2;ERLIN2;WDTC1;APOC1;BRCA1;ACADL
prerank,action potential (GO:0001508),0.4093776482302046,1.1327192834857895,0.3063660477453581,0.6720856969906573,1.0,4/44,3.56%,KCNE3;GNA14;KCNQ1;CHRNA4
prerank,epithelial cell morphogenesis (GO:0003382),0.48446932087237904,1.132453553028461,0.31155015197568386,0.6721563045047757,1.0,4/17,13.96%,SIPA1L3;CCDC88C;RILPL2;CNMD
prerank,pyruvate metabolic process (GO:0006090),-0.3226094473961473,-1.1320460678261828,0.2398190045248869,0.7259814015713651,1.0,19/52,24.13%,HK3;HK1;ME3;PFKL;PGK1;PCK2;LDHB;ENO2;VDAC1;HOGA1;DLAT;PDHB;PGAM1;PGAM4;PFKM;ENO3;PDHA1;LDHA;ALDOA
prerank,regulation of RNA metabolic process (GO:0051252),0.38827129178613395,1.1319763395768767,0.2765685019206146,0.6727882477739608,1.0,17/59,15.87%,MBNL1;AHNAK;PTBP3;OAS2;PRX;MBNL3;RC3H1;OASL;METTL4;IGF2BP3;PQBP1;HNRNPLL;TNFRSF1B;RBM38;CELF1;MED1;PTBP2
prerank,peptidyl-proline modification (GO:0018208),-0.37880655947223274,-1.1318683702540016,0.2857142857142857,0.7249462369273548,1.0,8/25,20.70%,P3H2;FKBP5;PPIA;CWC27;PPIE;OGFOD1;FKBP7;PPID
prerank,regulation of myoblast fusion (GO:1901739),0.5327028629050052,1.1315816221688604,0.3174872665534805,0.6732039976514179,1.0,3/11,5.65%,RIPOR2;EHD2;MAPK14
prerank,regulation of fibroblast proliferation (GO:0048145),0.40623163276171576,1.1315436720005236,0.2868525896414343,0.6727224230383192,1.0,2/45,2.92%,CD74;CD300A
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.37010188999063676,-1.1313098262964023,0.267515923566879,0.7248820962899254,1.0,7/29,10.37%,NAPA;COPA;RAB6B;GOLGA5;VTI1B;GOSR2;COPE
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.41402801310697057,1.1311520901716763,0.3058510638297872,0.6730945647223918,1.0,8/43,8.63%,FFAR4;RUNX2;BMPR2;IL6R;ACVR2A;IL6ST;IL6;HGF
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4703798664367434,1.130741411256266,0.3293943870014771,0.6735484444346141,1.0,5/21,12.91%,RPL5;MAD2L2;PTEN;UBE2S;RPL11
prerank,fibrinolysis (GO:0042730),-0.44844320994194864,-1.1301462907773274,0.3052109181141439,0.7267603570519106,1.0,3/13,21.44%,PLAU;SERPINE1;PLAT
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34606092219886664,1.1300295000499434,0.23390557939914164,0.6747912116199108,1.0,49/190,17.85%,ITPR1;CYRIB;LYN;LIMD1;DGKG;TNIP3;MCL1;SPI1;CD2AP;NLRX1;STAT1;MAPK14;PTEN;CIB1;PDE2A;DDIT4;UBR2;PHLPP1;IFI35;CPNE1;DEPDC5;TANK;CYLD;RIPK1;CACTIN;DUSP1;PRKAA1;NLRP3;PSMD10;SH3BP4;MAP2K3;AKT1;MARK3;CARD19;TLE1;PRKAA2;PTPRJ;PPP2R5C;GSTP1;RELA;SPRED1;THBS1;MYADM;AJUBA;PIK3R2;SIRT1;PLAUR;HDAC7;CGNL1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.45830513154054475,1.1295805060226265,0.30873493975903615,0.6753422136930821,1.0,1/24,0.16%,TRPS1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.4652647935958129,1.128982491981139,0.323397913561848,0.6761661607997518,1.0,5/22,15.80%,DUSP16;DUSP6;DUSP1;PPM1D;PPM1G
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.3422803415908311,-1.1287262739766726,0.2593856655290102,0.729308779555397,1.0,12/37,20.95%,IFT74;DYNLL2;IFT172;DYNLL1;TRAF3IP1;IFT80;IFT20;DYNC2H1;TTC21B;KIF3A;CLUAP1;IFT27
prerank,visual system development (GO:0150063),0.4199998394530174,1.1286066054358577,0.3013888888888889,0.6765106356473611,1.0,5/37,6.12%,MAB21L2;SIPA1L3;ATF6;HIPK2;HIPK1
prerank,organic substance transport (GO:0071702),-0.2671358727933935,-1.128366676221893,0.16071428571428573,0.7287038696482244,1.0,30/121,20.24%,SLCO2B1;ABCA1;LRP1B;ABCD2;MFSD12;SCAMP1;ABCG2;FLVCR1;ATP8A1;SCAMP2;PLEKHA8;SCAMP5;HSP90B1;SLC22A5;CHKA;SPNS2;TOM1;DISP1;ABCA7;SLC22A4;TXNIP;CHMP1B;VPS33B;ARRDC2;ABCD3;KIF3A;SLC50A1;ABCB9;CEP290;CHMP2A
prerank,neuromuscular process controlling balance (GO:0050885),-0.4539166144957398,-1.12836146520142,0.32075471698113206,0.7271433427132423,1.0,4/12,8.04%,CDH23;TPP1;PCDH15;MYO7A
prerank,response to endoplasmic reticulum stress (GO:0034976),0.35927704369977265,1.12823813495455,0.27017543859649124,0.6768741689546015,1.0,18/107,13.10%,ITPR1;NIBAN1;MAP3K5;ERN1;ERP44;ATF6;ATP2A3;BBC3;WFS1;ATP2A1;PPP1R15A;MBTPS1;DNAJB12;AIFM1;PPP1R15B;ATF6B;EIF2AK3;ATG10
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4706159017291867,1.1276616816081069,0.33126934984520123,0.6777646721498661,1.0,7/19,15.17%,PRKCH;MYO1C;IKBKB;CBFB;F11R;ROCK1;OCLN
prerank,cortical cytoskeleton organization (GO:0030865),0.40866092770763274,1.127611780730652,0.292749658002736,0.6773067860719668,1.0,8/41,8.95%,RND3;LCP1;RAC2;IKBKB;RHOBTB3;EZR;RAC1;RHOA
prerank,cardiac ventricle development (GO:0003231),0.474610898250737,1.127578776805257,0.3265625,0.6768028138152149,1.0,4/20,8.16%,GJA5;HECTD1;PDE2A;ENG
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4442966904578476,1.127490296548458,0.3119402985074627,0.6764350983946995,1.0,4/26,7.74%,IL1B;GDNF;SCARB1;ATP7A
prerank,response to purine-containing compound (GO:0014074),-0.4183618163516857,-1.127344263668442,0.2892561983471074,0.7284601889157448,1.0,6/17,14.64%,P2RX7;P2RX4;P2RY6;DGKQ;TRPM2;TRPC3
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.40746660303332155,1.1270026966892752,0.29178082191780824,0.6771085233323166,1.0,11/43,14.37%,EPS15;CBLB;CBL;CDC42;RAB7A;TSG101;GRB2;EPS15L1;STAM;MVP;PTPRJ
prerank,cyclooxygenase pathway (GO:0019371),-0.4878722581362212,-1.126756388141477,0.3130630630630631,0.7284635810416853,1.0,2/10,0.82%,HPGDS;PTGS1
prerank,positive regulation of isotype switching (GO:0045830),0.500030633662964,1.1267343280655209,0.3424,0.6772384583655217,1.0,4/15,14.22%,CD40;MAD2L2;KMT5B;TGFB1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3917617783443507,1.1265300760526957,0.3002610966057441,0.6771643324434827,1.0,19/56,16.58%,RACGAP1;KIF20A;MITD1;KIF23;CHMP4B;BIN3;PDCD6IP;DCTN3;RHOA;SPAST;SNX9;UNC119;ROCK1;AURKB;EFHC2;SNX33;APC;TRIM36;RAB35
prerank,neuron projection extension (GO:1990138),-0.3500116768197239,-1.1263853652162172,0.22996515679442509,0.7279484365333206,1.0,13/32,10.31%,ULK2;NRP1;AUTS2;NRP2;MAP1B;TMEM108;CTNNB1;CDKL3;EIF2AK4;IMPACT;SLC9A6;SH3GL2;CDK5
prerank,regulation of cholesterol storage (GO:0010885),-0.427522108702688,-1.1262282834506985,0.2849740932642487,0.7268832879504259,1.0,4/15,4.30%,ABCA1;TREM2;TTC39B;MSR1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.41250424828924176,1.1261657793555446,0.28777923784494086,0.6775002067543713,1.0,4/39,2.59%,FXYD5;PRKCE;UTRN;NEDD4L
prerank,positive chemotaxis (GO:0050918),-0.4166899101660836,-1.1256375349008156,0.3170731707317073,0.7269984832095863,1.0,9/17,21.05%,NRP1;SCRIB;SCG2;VEGFA;TSC2;CX3CL1;PLXNB3;ANGPT1;FGF10
prerank,cellular response to amino acid starvation (GO:0034198),-0.29305436742755053,-1.1254749248052458,0.23655913978494625,0.7259442040118519,1.0,18/71,12.14%,ATP6V1C1;RPTOR;ATP6V0B;FLCN;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;SESN3;EIF2AK4;IMPACT;ATF4;LARS1;ATP6V1D;MIOS;ATP6V0D1;LAMTOR5;PRKD1
prerank,cellular response to misfolded protein (GO:0071218),0.4713440982082139,1.1253720429961729,0.3081761006289308,0.6789903095328121,1.0,6/20,14.19%,CUL3;KLHL15;ATXN3;UBE2W;DNAJB12;VCP
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4639178060846084,-1.1252286286018782,0.31218274111675126,0.725140655034233,1.0,5/11,21.75%,RASA1;NOVA1;NOVA2;IGF2BP2;PCBP4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.44708699292014387,1.1248866605270083,0.3253012048192771,0.679684087096294,1.0,7/28,11.02%,DTX3L;MAD2L2;SMCHD1;ACTR2;WRAP53;PARP9;KMT5B
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3794461768645133,-1.1245081607484324,0.2886297376093295,0.7257610666421017,1.0,5/21,14.27%,SLC8A1;MEF2C;ACVR1;VEGFA;CXADR
prerank,negative regulation of transmembrane transport (GO:0034763),0.5421415387746098,1.1242917064366436,0.354014598540146,0.6806483821332286,1.0,1/10,0.33%,IL1B
prerank,protein processing (GO:0016485),-0.2725827236582972,-1.1242194486995238,0.17142857142857143,0.7250107695197925,1.0,36/102,25.04%,LGMN;VSIR;MMP16;KLK3;METAP2;PSEN2;SPCS3;FURIN;SPPL3;LONP2;MMP14;AFG3L2;SEC11C;CASP4;PCSK1;BACE1;PCSK7;SPG7;STOML2;HTRA2;ZMPSTE24;HM13;PSENEN;SPRTN;AEBP1;TMEM208;ECE1;FXN;PTCH1;CLN3;CPE;PCSK2;EEF1AKMT4-ECE2;CTSH;APH1A;TYSND1
prerank,spinal cord development (GO:0021510),-0.46688234572746956,-1.1242036768520587,0.328537170263789,0.723538095002936,1.0,5/12,16.72%,PKD2;NF1;LOXL3;SOX4;SOX11
prerank,regulation of anoikis (GO:2000209),0.47493670164859475,1.1241734553868512,0.2985553772070626,0.6803551630571731,1.0,5/19,15.60%,SIK1;MCL1;PIK3CA;TLE1;ITGA5
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4401893717633051,1.12399050028436,0.2875,0.6802432700247487,1.0,8/29,13.79%,CREB1;LDLR;ZBTB20;SCARB1;ELOVL5;CREBL2;AKT1;SIRT4
prerank,reticulophagy (GO:0061709),-0.46241352224862087,-1.1238492053237186,0.33410672853828305,0.7230398139969769,1.0,6/12,25.50%,ULK2;UFC1;UFM1;UFL1;ATG2A;UBA5
prerank,bone morphogenesis (GO:0060349),-0.4303744494465353,-1.1238458090101309,0.27543424317617865,0.7215346950468838,1.0,3/14,6.21%,SKI;LRP6;FGFR2
prerank,negative regulation of JNK cascade (GO:0046329),0.43452504314676726,1.123775751910838,0.3181148748159057,0.6802219036461387,1.0,9/31,14.83%,PTPN22;MARVELD3;ITCH;TAOK3;PDCD4;CYLD;HDAC3;GPS2;GSTP1
prerank,regulation of bone mineralization (GO:0030500),-0.31016165422695735,-1.1235459791683535,0.24766355140186916,0.7209040395420429,1.0,14/55,7.87%,SLC8A1;MEF2C;NELL1;ANKH;ENPP1;PTN;BCOR;TMEM119;P2RX7;ACVR1;BMP2K;NBR1;ACVR2B;S1PR1
prerank,regulation of dendrite development (GO:0050773),-0.34041082452877003,-1.1235081347935116,0.26666666666666666,0.7195160954570458,1.0,8/37,4.17%,CSMD3;DCC;RAP2A;TNIK;HECW1;PTN;ADGRB3;MARK1
prerank,cholesterol efflux (GO:0033344),-0.39956505144143367,-1.1232088426482956,0.30029154518950435,0.7188200503729171,1.0,2/20,0.41%,ABCA1;APOE
prerank,heterochromatin organization (GO:0070828),0.5057511214213107,1.1230895776847276,0.3426356589147287,0.6814886645478955,1.0,6/14,18.90%,SMCHD1;SETD7;SETDB2;EZH1;SIRT1;HP1BP3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.4120570455554859,-1.1226323988688778,0.3126760563380282,0.7189960099124476,1.0,8/17,22.29%,TREM2;PPIA;P4HB;HTRA2;MAPK7;SOD2;SOD1;BAG5
prerank,negative regulation of neuron death (GO:1901215),-0.2802709474301718,-1.1224970926208047,0.19653179190751446,0.7179062398555717,1.0,21/93,10.59%,PRKN;LGMN;APOE;MEF2C;NTRK2;GRN;CSF1;RASA1;CD34;PPARGC1A;ADAM8;NRBP2;ATF4;KDM2B;SNX6;CPEB4;VPS35;PTPRZ1;CDK5;MSH2;SET
prerank,DNA repair (GO:0006281),0.3306300702394544,1.1220456307913018,0.22130299896587383,0.6837124073019745,1.0,85/284,20.38%,UVRAG;DNA2;MLH1;DTX3L;POLI;BTG2;MAD2L2;RBBP8;POLL;CHRNA4;USP3;MRE11;FEN1;FAM111A;SUMO1;PARP4;APEX2;SMARCA5;UBE2N;POLD4;SETX;MBD4;WRN;CIB1;USP45;MSH3;NABP1;DOT1L;PSME4;SMUG1;UIMC1;ATXN3;ASCC3;BRIP1;BACH1;MSH6;ASCC1;PARP9;FANCC;FANCL;TDG;SETD2;KMT5B;RECQL5;RPA3;XRCC4;EXD2;FANCI;RAD54L;ERCC3;MAPK8;ERCC4;FANCA;RNASEH2A;VCP;XRCC2;VCPIP1;INO80;ENDOV;INIP;KDM4B;USP47;POLB;NSMCE4A;KPNA2;HUS1;EYA3;MDC1;PMS1;POLD1;SIRT1;RAD17;RAD21;CHEK2;PRIMPOL;FANCG;ALKBH2;WDR33;TNKS1BP1;FTO;RNF168;PARK7;APEX1;PDS5B;XPA
prerank,cellular component assembly (GO:0022607),0.3341013189369106,1.121965070248155,0.23197492163009403,0.6833167773829791,1.0,51/253,16.50%,CD74;NEDD9;TRAF1;WIPF1;LCP1;EPS8;CD40;FOXJ1;CHAF1A;SKAP2;RAC2;PICALM;ABCA3;CDC42;CD2AP;RBBP4;PTK2B;FLNA;ELOB;PAWR;YTHDF3;EZR;RAC1;PEX14;CAPZA1;RHOA;FANCC;STX7;RTN4;SNX9;VASP;YWHAZ;TEAD1;DNM1L;FANCA;CLDN14;VMP1;TGFB1;BSN;RHOG;KMT2A;ZFYVE27;OCLN;SLC2A1;CREBBP;VCPIP1;SHROOM1;APC;STAG3;PLS1;WNT7A
prerank,regulation of protein acetylation (GO:1901983),-0.4737577778246338,-1.1217630872048157,0.34057971014492755,0.7185583386446975,1.0,6/12,27.14%,CAMK1;TERF2IP;DDX3X;FAM161A;RAPGEF3;KAT5
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4916338478844506,1.1216978016173176,0.33001658374792703,0.6834022558486281,1.0,6/15,18.13%,STAT3;IL17RA;IL6;GBP5;MYD88;APPL1
prerank,bone development (GO:0060348),0.41365912550561973,1.1215346747174375,0.3140495867768595,0.6832429509678956,1.0,4/39,3.91%,PTPRC;SULF2;NOTUM;PTGER4
prerank,positive regulation of binding (GO:0051099),0.37116516289177814,1.121354399484862,0.2696078431372549,0.6831133150158613,1.0,25/84,18.77%,LRRK2;RARA;TIAM1;NGF;PPARG;DTX3L;RAPGEF2;HIPK2;STK4;RALB;PARP9;B2M;APP;NMD3;RPL11;MARK3;TAF1;NCBP1;DPH3;PSEN1;PLAUR;MMP8;FOXC1;PIN1;STK3
prerank,membrane repolarization (GO:0086009),0.49798853979044266,1.1213194090459098,0.3294314381270903,0.6826087503097157,1.0,2/15,3.31%,KCNE3;KCNQ1
prerank,ruffle organization (GO:0031529),-0.4207198695965355,-1.1210804984095057,0.2994652406417112,0.7189886519927657,1.0,3/16,4.50%,CSF1R;AIF1;LIMA1
prerank,regulation of angiogenesis (GO:0045765),0.33944843467685476,1.120890113235161,0.2668112798264642,0.6831196822947352,1.0,25/192,9.48%,CCR2;IL1B;SP100;KLF4;ITGAX;PPARG;CD40;PTGIS;CXCL10;ADGRA2;ATF2;SYNJ2BP;VEGFC;BTG1;STAT1;HIPK2;HSPG2;HIPK1;PIK3R6;PDPK1;MECP2;PLXND1;IL6;NAXE;PGF
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5103502783360087,1.120779808222109,0.33825944170771755,0.6816888690958843,1.0,5/12,18.61%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5103502783360087,1.120779808222109,0.33825944170771755,0.6816888690958843,1.0,5/12,18.61%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5103502783360087,1.120779808222109,0.33825944170771755,0.6816888690958843,1.0,5/12,18.61%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4591312305638934,1.1206318835919806,0.3074626865671642,0.6809018396956121,1.0,8/23,15.65%,ZEB2;HIPK2;ADAM17;SMAD4;ING2;CITED2;CREBBP;THBS1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4591312305638934,1.1206318835919806,0.3074626865671642,0.6809018396956121,1.0,8/23,15.65%,ZEB2;HIPK2;ADAM17;SMAD4;ING2;CITED2;CREBBP;THBS1
prerank,regulation of stem cell differentiation (GO:2000736),0.36936230192051545,1.120371789189918,0.27887981330221706,0.6809844598574027,1.0,23/89,16.31%,ITCH;PSME3;EIF2AK2;PSMB7;PSME2;GDNF;CBFB;PSME4;ZFP36L2;PSMB8;PSMA5;PSMD9;NUDT21;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3;KMT2A;OCIAD1;PSMD12
prerank,regulation of T cell migration (GO:2000404),0.47757606384058726,1.1202281475885663,0.34455128205128205,0.6808026863249524,1.0,6/18,13.88%,CXCL10;RIPOR2;SPN;RHOA;APP;LRCH1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3891355127983336,1.1199425117325899,0.30904522613065327,0.6809310610339768,1.0,14/61,12.97%,PSME3;PRKAG2;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,selective autophagy (GO:0061912),-0.31095848543235943,-1.119890493401459,0.24166666666666667,0.7208824931775016,1.0,13/56,14.33%,PRKN;WDFY3;ULK2;UBC;DYNLL2;NBR1;AUP1;DYNLL1;UFC1;MAP1LC3B;UFM1;USP30;SQSTM1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4268400646203896,1.119884073224618,0.3411420204978038,0.6805157862198012,1.0,13/30,19.97%,TAF9;RYBP;WAC;SVIP;TLK2;CAMLG;RPL11;USP7;EIF3H;USP14;N4BP1;STYX;PARK7
prerank,cellular response to nutrient levels (GO:0031669),0.38765492070749374,1.1189730219134746,0.3170103092783505,0.682173338794996,1.0,12/62,13.78%,LRRK2;STK24;BMPR2;KLF10;WRN;CLEC16A;RALB;PRKAA1;NUPR2;WIPI2;SREBF2;PRKAA2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.44877957110991157,1.11891608567372,0.32125984251968503,0.6817327943779532,1.0,2/21,2.48%,LRRK2;HSPA1A
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.39242727813807843,-1.1186370635614193,0.30578512396694213,0.7229237907916798,1.0,6/20,13.70%,CHRM3;CHRM2;RGS10;CDK5R1;CHRNA7;AGRN
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4086624132981194,-1.1186057559433003,0.303125,0.7215293752937547,1.0,9/22,21.23%,PKD2;ATP1B1;ANK2;P2RY6;AKAP6;CALM1;STAC2;GSTO1;RYR2
prerank,amino acid transmembrane transport (GO:0003333),-0.329892259627537,-1.1185760490019612,0.2835249042145594,0.7201281383639296,1.0,8/45,6.03%,SLC38A6;MFSD12;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SFXN1
prerank,carnitine metabolic process (GO:0009437),-0.45577818056855945,-1.1184738378412162,0.3033419023136247,0.7189077810466671,1.0,8/12,32.51%,ALDH9A1;ACADM;ACADL;CPT2;CPT1C;CROT;BBOX1;TMLHE
prerank,bile acid metabolic process (GO:0008206),-0.3643678508218244,-1.118233906139011,0.2908496732026144,0.7181501910884824,1.0,13/27,34.28%,OSBPL1A;CH25H;NPC1;GBA2;OSBPL6;AMACR;OSBPL7;ACOT8;OSBP;SLC27A2;OSBPL2;HSD17B10;CYP7B1
prerank,L-amino acid transport (GO:0015807),-0.3716967285079522,-1.118139402132062,0.2865853658536585,0.7169554459536925,1.0,8/28,12.67%,SLC1A3;SLC7A1;SLC36A4;SLC36A1;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4070144510387431,1.1180838899396017,0.31763122476446837,0.683261203052519,1.0,2/46,0.22%,CCR2;LRRK2
prerank,regulation of cell differentiation (GO:0045595),0.34577596958008067,1.1174733662839582,0.2643171806167401,0.684220556029888,1.0,14/148,7.31%,TRPS1;RUNX2;TIAM1;RUNX3;NGF;SIK1;KLF4;BCL6;RPS6KA3;EIF2AK2;GDNF;CBFB;PURB;PHLDB2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5027897935924612,1.117221323402501,0.3316582914572864,0.6842501247754542,1.0,3/13,5.11%,GLI1;PIM1;RBPJ
prerank,chromatin disassembly (GO:0031498),0.496506690368517,1.1167297739091453,0.34105960264900664,0.684358755091046,1.0,4/14,13.76%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,nucleosome disassembly (GO:0006337),0.496506690368517,1.1167297739091453,0.34105960264900664,0.684358755091046,1.0,4/14,13.76%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,nitric oxide biosynthetic process (GO:0006809),0.4990931641236998,1.1164245174547345,0.361247947454844,0.6845261865692156,1.0,4/13,19.18%,CYB5B;ARG2;AKT1;CYB5R3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.32074969619973454,1.1164114020146736,0.052,0.6839929167155178,1.0,291/1667,15.84%,CIITA;PLAC8;BCL11A;TRPS1;NFE2;ZBTB46;PID1;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP100;SP3;BAZ1A;RUNX3;STAT4;TOX4;GLI1;TNIP3;HNF4G;ACTR3;CDK13;KLF4;UXT;CREB1;LILRB1;PPARG;IER2;CD40;MED13L;ETV6;STAT5A;BCL6;SAP30;PKN1;PPP1R12A;NFKB1;PITX3;TET2;FOSL2;PLSCR1;STAT3;BAZ2B;EHF;FOXJ1;ELF4;RFX7;NIPBL;NEDD4L;FOS;KDM7A;CRK;TCF20;RPS6KA3;BMPR2;MAD2L2;REL;RBBP8;AKNA;NCOA3;CXCL10;ZBTB20;CRLF3;TAF9;SPI1;STAT5B;NFKBIA;CRY1;SCX;ATAD2;TBL1XR1;MTA3;GATAD2B;IKBKB;MED30;ZEB2;SUMO1;PGBD1;CAMTA2;KAT7;ATF6;LRRFIP1;KLF8;GDNF;ATF2;PPP3CA;IRF2;PRPF6;RFX3;ZNF319;RBPJ;IL33;KCNIP3;HIVEP1;DEAF1;MED13;STAT1;HIPK2;NUFIP1;KLF5;UBE2D3;IRF4;HEXIM1;MAPK14;HELZ2;BBX;RFX5;RPS6KA5;SMARCA5;PTEN;KLF13;TSHZ1;ARF4;CCND1;DEK;KMT2C;KLF10;CDC5L;ELOA;SETX;AHR;ACTR2;RPS14;ANXA4;CREBRF;BUD31;TADA3;SSU72;CGGBP1;WFS1;ARID4A;CBFB;CREM;IKZF3;NFE2L2;KDM3B;PURB;HTATSF1;MECP2;PDE2A;THRA;CRY2;CLOCK;ZFP3;SAP18;MED6;ZBED4;GATAD2A;RARG;CCNH;TOX3;EZR;DOT1L;E2F2;ENG;GABPB1;GABPB2;CTCF;PHF12;NFYC;ACVR2A;HDAC9;ELF1;TLR3;IL6;HGF;BRIP1;BACH1;NFE2L1;ZNF182;SNF8;KAT6A;TNKS;BCAS3;RBAK;ID2;WWP2;EZH1;EPC2;NCOA2;E4F1;PKNOX1;SMARCE1;ZNF496;ZFX;PARP9;IRF7;MEF2B;RCOR3;SMAD4;SBNO2;CNOT2;RPRD1B;NCOA1;LIN37;CSRNP1;NR3C1;TADA2A;RIPK1;GMEB2;SP140;SPEN;PBX1;CCNT2;MED26;FOXO3;MED12;IKZF5;ZNF507;DVL3;TAF7;ZNF260;NLRP3;ETS2;REST;RPS6KA1;ZNF418;MBD2;ATF6B;APP;MAP2K5;NUPR2;MED14;CCNT1;BCLAF3;NFYA;PSMD10;LIN9;TLR2;CDK12;TEAD1;ATRX;PPM1D;NFATC2IP;KLF9;CCNL1;MYB;IFRD1;NRIP1;KIT;STAT2;NSD1;CHD4;JUNB;HCLS1;EZH2;SREBF2;TNRC6B;SMARCC2;SRCAP;CITED2;KAT2B;TNRC6A;HDAC3;MRTFA;NFIL3;TGFB1;CRTC3;ZNF431;SLTM;RSF1;FHOD1;IL18;GPS2;ZNF436;MAFK;AURKB;SP4;MAZ;KMT2A;HOMEZ;DUSP26;ASXL2;CREBBP;PHF20;RELA;ZBTB25;USP9X;MIER1;TAF1;TBK1;DVL2;HSF5;MAML1;BHLHE40;INO80;ZNF148;ZMIZ2;MED1;DUSP22
prerank,protein tetramerization (GO:0051262),-0.302490491860102,-1.1161597202692088,0.2347417840375587,0.7208926457428617,1.0,16/67,13.60%,RYR3;ACACA;APPL2;PKD2;KCNJ2;ALDH9A1;GOLGA2;MCOLN1;CPSF6;OXA1L;HCN1;USP16;TRPM2;CBR4;AQP4;HSD17B8
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.38197258616714463,1.1158985370136243,0.2937420178799489,0.6847496252860363,1.0,16/65,14.37%,EPS15;CCDC88A;CBL;CDC42;ARAP1;PTPN12;TSG101;GRB2;AFAP1L2;HIP1;EPS15L1;STAM;AKT1;MVP;PDE6H;PTPRJ
prerank,pyroptosis (GO:0070269),-0.4327930422428397,-1.1155707480732606,0.32439678284182305,0.7211366410708199,1.0,3/15,14.03%,TREM2;CASP4;DHX9
prerank,peptide cross-linking (GO:0018149),0.43788121870272195,1.1153868064715469,0.30383480825958703,0.6854828106997992,1.0,4/25,10.39%,NDNF;F13A1;FN1;ANXA1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.35365022894693027,1.1150914765000757,0.28390804597701147,0.6856363924393443,1.0,16/110,13.33%,ADGRG5;ADGRG6;ADGRE5;RXFP2;LPAR3;PTGER2;RAPGEF2;CXCL10;PTGER4;ADRA2A;GNB1;PTGER3;S1PR5;ADCY7;ADCY5;GNG2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4705088405595076,1.114784913313816,0.3441358024691358,0.6858621629110975,1.0,5/19,14.37%,PTPRC;PRNP;FIS1;FKBP1B;PTPRJ
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.45009134186973593,1.1138963625344016,0.3136094674556213,0.6875566194026758,1.0,6/24,13.11%,FFAR4;RAPGEF2;PDE2A;PRKAR2A;GNAI1;PEX5L
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5211594307757734,1.1138449184416988,0.36869565217391304,0.6871040321521088,1.0,2/11,2.90%,ITPKC;IP6K3
prerank,positive regulation of neurogenesis (GO:0050769),-0.2957669386943234,-1.113702075958062,0.245,0.7248554210199403,1.0,16/68,6.67%,CX3CR1;PLXNA4;CUX1;PTPRD;NTRK2;NUMB;IL1RAPL1;ROBO2;ROBO1;CTNNB1;PLXNB2;FBXW8;CDKL3;ARHGDIA;CAPRIN2;PLXNA2
prerank,pulmonary valve morphogenesis (GO:0003184),0.47253074099282477,1.1133824887431234,0.33751962323390894,0.6877016621832697,1.0,2/17,2.90%,NOTCH2;GJA5
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.36851646384403375,1.113175349979882,0.31425091352009743,0.6876944150026602,1.0,16/74,15.33%,IL1B;TIAM1;SDHAF2;MAD2L2;GLIPR2;PTEN;PHLDB2;IL6;OLFM1;SPRED3;SMAD4;USF3;EZH2;CLASP1;TGFB1;SPRED1
prerank,lipid transport (GO:0006869),-0.27625819793411427,-1.113168888264443,0.2185430463576159,0.7248947412222783,1.0,13/97,7.17%,SLCO2B1;ABCA1;APOE;ABCD2;PITPNC1;OSBPL8;ABCC3;ATP8A1;PRELID2;PLEKHA8;FABP5;ATP8B1;SLC27A1
prerank,negative regulation of hydrolase activity (GO:0051346),0.3928923027513704,1.1127930402585284,0.3157199471598415,0.6880856128223691,1.0,11/49,14.42%,LRRK2;PTX3;RCC2;KLRK1;F11R;BCAS3;ARFGEF1;GPATCH2;SH3BP4;LRCH1;ZCCHC9
prerank,negative regulation of anoikis (GO:2000811),0.5002289469161839,1.1126307265378237,0.34517766497461927,0.687915050754767,1.0,6/14,22.11%,MCL1;PIK3CA;TLE1;ITGA5;PTK2;BCL2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.47077607834982393,1.1124809990839246,0.33876221498371334,0.6877177609623414,1.0,5/18,13.79%,FFAR4;ADRA2A;PSMD9;REST;SIRT4
prerank,neuromuscular junction development (GO:0007528),0.44471957818808033,1.1124697691001326,0.3078055964653903,0.6871789597784637,1.0,2/24,6.72%,LRRK2;CACNB1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.44856884410389203,1.1118171750972692,0.33483483483483484,0.6882172667499193,1.0,2/25,3.56%,LRRK2;CHRNA4
prerank,positive regulation of exosomal secretion (GO:1903543),0.5006784262490367,1.111419272436779,0.3306188925081433,0.6886154035801608,1.0,5/15,11.11%,RAB7A;TSG101;PDCD6IP;SNF8;STAM
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.3487962617658088,-1.1112213379698694,0.27899686520376177,0.7289527481330947,1.0,9/33,12.13%,PRKN;IGF1;FLCN;BCL2L1;SLC35F6;TFRC;MPV17L;VAT1;CLU
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.37937313438687315,1.1111922487708434,0.3140794223826715,0.6886172353724752,1.0,17/70,13.40%,ITCH;PSME3;EIF2AK2;PSMB7;PSME2;CBFB;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3
prerank,positive regulation of viral genome replication (GO:0045070),-0.35340978330436557,-1.1107893516027456,0.2829581993569132,0.7287210689743381,1.0,19/29,34.20%,LARP1;PPIA;SRPK1;ADAR;SRPK2;PPIE;VAPB;DDX3X;PPID;ADARB1;RAD23A;CNOT7;PDE12;CD28;DDB1;CCL5;PPIH;TOP2B;HACD3
prerank,DNA replication checkpoint signaling (GO:0000076),0.486853125823329,1.110772861972219,0.3300970873786408,0.6890926382089652,1.0,2/16,3.73%,DNA2;CDC45
prerank,regulation of cell cycle process (GO:0010564),0.3560682546673502,1.1106864913674814,0.2923433874709977,0.6887373536855058,1.0,20/104,12.25%,UVRAG;CDK13;RACGAP1;KIF20A;BIRC6;SND1;CDC42;CAV2;IHO1;E4F1;GIT1;CSNK2A2;CSNK2A1;RPRD1B;CEP250;SETD2;DCUN1D3;TXLNG;DYNC1H1;PIK3R4
prerank,positive regulation of synapse assembly (GO:0051965),-0.3641276232029785,-1.110546789686155,0.3053691275167785,0.7279190901857288,1.0,13/27,23.47%,PTPRD;IL1RAPL1;NLGN1;GRID2;IL1RAP;NLGN2;AGRN;CLSTN2;NLGN3;NRXN1;DLG5;VSTM5;CUX2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3767449017350604,1.1101754929981031,0.30759951749095293,0.689466585162169,1.0,18/73,13.40%,ITCH;PSME3;SPI1;EIF2AK2;PSMB7;PSME2;CBFB;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3
prerank,hyaluronan metabolic process (GO:0030212),0.45280279720757,1.1097884382326486,0.3216995447647951,0.6898181569086355,1.0,2/23,0.33%,CD44;IL1B
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.40313561851093793,-1.109617965739528,0.33066666666666666,0.7291718155613197,1.0,3/18,5.25%,PRKN;PPIA;HIF1A
prerank,regulation of complement activation (GO:0030449),-0.3348391887374157,-1.1093813722455825,0.2517482517482518,0.728319123216744,1.0,11/40,13.73%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5176334718719209,1.1093788896458237,0.3702479338842975,0.6902975161188479,1.0,6/12,21.67%,PARP8;TIPARP;TNKS;PARP12;PARP11;PARP1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.32612246712779697,1.1093268433682026,0.23282051282051283,0.6898725970256359,1.0,57/306,14.11%,ZAR1;ST3GAL4;DNA2;EXT1;BCL3;RPL5;RBBP8;POLL;CDC45;RPS10;POLR3A;MRE11;FEN1;POLR2C;SCX;FAM111A;B4GALT5;KAT7;RPL37A;MRPL55;RPL6;ORC5;MRPL18;MCM6;RBMS1;RPS18;RPS14;WRN;RPL35A;ORC4;RPL13;MRPL13;NFKBIB;BRIP1;CREBL2;EEF1G;RPS3;IGF2BP3;RPS21;FARSB;RECQL5;NAP1L1;RPA3;RPL34;RPLP0;BAZ2A;POLA2;RPL19;RPL11;MCM2;RPL30;RNASEH2A;PCLAF;RPS2;RPL4;DONSON;RPL7
prerank,nucleosome assembly (GO:0006334),0.43020494050565133,1.10916196967287,0.319364161849711,0.6897192806178288,1.0,13/31,22.71%,CHAF1A;H3-3A;RBBP4;SMARCA5;DAXX;NAP1L1;ATRX;RSF1;BRD2;HAT1;CABIN1;ANP32B;ASF1A
prerank,amino acid import across plasma membrane (GO:0089718),-0.373223741037697,-1.1090293508277789,0.2857142857142857,0.7278890777116005,1.0,7/24,14.59%,SLC1A3;SLC7A1;SLC36A1;SLC7A2;SLC7A8;SLC3A2;SLC22A4
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.33106611641639316,-1.108714501891789,0.28113879003558717,0.7273205992557292,1.0,9/39,12.57%,ABCA1;TANGO2;RAB3C;PREB;SCG2;ARFGAP3;OLFM2;TANGO6;MTTP
prerank,endoderm formation (GO:0001706),0.41122381784545303,1.1083643012320985,0.3244005641748942,0.6911554805290414,1.0,6/35,11.47%,ITGA4;LAMB1;ITGB2;FN1;SETD2;DUSP1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5097090825435447,1.1082835264676956,0.36650082918739635,0.6907964936618969,1.0,5/13,18.20%,JAK2;RBPMS;SMAD4;TGFB1;NUP93
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.32998265736377325,1.1076540515472706,0.2611862643080125,0.6918152034689734,1.0,46/260,13.29%,FXYD5;SRGAP2;CDC14A;ATAT1;ACTR3;RAP1A;PTPRO;SHTN1;FOXJ1;EXOC6;RAPGEF2;CCDC88A;OCRL;EHD2;RP2;CD2AP;RFX3;CARMIL1;PPP1R9B;FGD4;ARF4;ACTR2;FLNA;IFT140;EZR;GBF1;RAC1;FGD1;MINK1;FGD3;KIF24;ARHGEF6;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;PTPDC1;NTN1;ABCC4;IQCB1;CFAP54;PIP5K1A;KIT;CFAP70
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.47682318598459367,1.107391397102796,0.34359805510534847,0.69193163458659,1.0,4/17,9.28%,RET;SYK;CIB1;PIEZO1
prerank,vasculature development (GO:0001944),0.48626141176213694,1.1071693553865742,0.3465818759936407,0.6919404392808775,1.0,3/16,10.65%,BMPR2;FBXW7;PIK3CA
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.4334938889420235,-1.1070185224700906,0.3502673796791444,0.7306504049172036,1.0,5/14,7.65%,OPHN1;MYO9A;RAP2A;PATJ;SCRIB
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.3933933465838233,1.1067545259198444,0.3468869123252859,0.692385083336886,1.0,13/53,12.97%,PSME3;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,transepithelial transport (GO:0070633),0.48490477858217357,1.1064716930372458,0.33983739837398375,0.69253705813954,1.0,3/15,6.93%,SLC23A2;SLC23A1;ABCC1
prerank,P-body assembly (GO:0033962),0.508993215989262,1.1063097730744236,0.3383084577114428,0.692395465868152,1.0,6/12,20.36%,LIMD1;RC3H1;DYNC1H1;EIF4ENIF1;DDX6;EDC3
prerank,mesenchymal cell differentiation (GO:0048762),-0.30240985938202136,-1.105955772959214,0.2742616033755274,0.7321685095643479,1.0,10/51,10.02%,MEF2C;LRP6;TGFBR1;DDX5;CTNNB1;HIF1A;FGFR2;HTR2B;LOXL3;HNRNPAB
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.426188765637985,-1.1058979096019188,0.33246753246753247,0.7308781750540836,1.0,2/16,5.33%,PRKN;PDK1
prerank,cell-substrate junction assembly (GO:0007044),-0.33984423004213404,-1.1055288436650659,0.2847682119205298,0.7305118031742858,1.0,11/33,19.48%,DST;ITGA6;PTPRK;PEAK1;LAMA3;TESK2;SRC;WHAMM;CTTN;ACTN2;THSD1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.4223158862884673,1.1042049701106795,0.3245997088791849,0.6971044444567089,1.0,9/31,16.37%,KLF4;PTEN;CDKN2C;DCUN1D3;WEE1;APC;RBL2;BRD7;RB1
prerank,relaxation of muscle (GO:0090075),-0.43968318038274457,-1.104166516507807,0.33687002652519893,0.7328316615036583,1.0,5/13,7.61%,SLC8A1;KCNJ2;ATP1B1;P2RX4;ATP1A2
prerank,respiratory system development (GO:0060541),-0.34584421660057074,-1.103701136692582,0.2676923076923077,0.7327097618629423,1.0,7/32,13.25%,BASP1;CHD7;FGF2;FGFR2;LOXL3;VEGFA;DISP1
prerank,regulation of protein ubiquitination (GO:0031396),0.35513889873078186,1.103527252430623,0.3108265424912689,0.6982232692457335,1.0,27/108,15.38%,LRRK2;HSPA1A;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;UBE2N;WFS1;MYCBP2;FBXO4;RPS3;CAMLG;DAXX;RCHY1;PSMD10;USP4;FANCI;AKT1;HDAC3;PRMT3;XIAP;SVBP
prerank,protein deacetylation (GO:0006476),0.4029869842905238,1.1033749577393517,0.33689839572192515,0.6980492745733767,1.0,18/41,21.55%,TBL1XR1;MTA3;FLNA;HDAC9;RCOR3;MORF4L1;BAZ2A;MSL3;SIRT4;HDAC3;MIER1;SIRT1;HDAC7;HDAC1;MIDEAS;RCOR1;SIRT3;HDAC5
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.36733545715410615,1.1030760468056053,0.3215130023640662,0.6982249591203223,1.0,20/88,13.29%,PSME3;CUL5;PSMB7;FBXW7;PSME2;FBXW11;FBXL8;FBXO38;FBXO4;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;FBXL17;PSMD6;PSMC4;PSMD10;PSMB1;FBXL12
prerank,positive regulation of ATP metabolic process (GO:1903580),0.42125318564584335,1.1026988681370493,0.3208053691275168,0.6986387199595564,1.0,13/32,19.10%,PID1;ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;VCP;PFKFB4;INSR;PSEN1;PINK1;TMSB4X
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5251611328985235,1.1026438423016427,0.36177474402730375,0.6982114071923592,1.0,5/12,13.59%,SMCHD1;YTHDC1;RBM15;METTL3;CDYL
prerank,negative regulation of bone mineralization (GO:0030502),0.5058309704350638,1.1025903217113109,0.3482587064676617,0.6977935992151109,1.0,3/13,6.45%,CCR1;SRGN;PTK2B
prerank,regulation of lipid storage (GO:0010883),0.445719763003502,1.1022991942551803,0.3521341463414634,0.6979641189442478,1.0,4/22,8.62%,NFKB1;NFKBIA;FBXW7;IL6
prerank,"phagocytosis, engulfment (GO:0006911)",0.4100903266387321,1.102087084525903,0.33714285714285713,0.6979591698529652,1.0,14/36,18.27%,CD36;RAC2;MYH9;CDC42;ITGB2;XKR4;RAC1;FCGR2B;MEGF10;RHOG;ELMO1;THBS1;GULP1;FCGR1A
prerank,negative regulation of signaling (GO:0023057),0.44088839109146016,1.1019713967809845,0.33086053412462907,0.6976728661729336,1.0,3/25,10.52%,IL1B;OPRM1;PTPN1
prerank,monocarboxylic acid transport (GO:0015718),-0.31299558680668516,-1.1018365183041599,0.2936170212765957,0.7364524615505528,1.0,7/51,7.17%,SLCO2B1;SLC16A6;ABCC3;ABCG2;ABCB4;ATP8B1;SLC27A1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4210189794760871,-1.101668176902549,0.33766233766233766,0.7354542687557384,1.0,6/16,17.68%,MEF2C;SNCAIP;FLOT1;CPLX1;CAMK2A;RIMS1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5303073293058969,1.1015564131309026,0.36787564766839376,0.6981633422103942,1.0,4/10,13.44%,FBXW7;ADRA2A;ADAM17;NCF1
prerank,amino acid transport (GO:0006865),-0.3180181416705599,-1.1015496256961606,0.28174603174603174,0.7343562254866438,1.0,10/49,12.67%,SLC38A6;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC6A15;SLC36A1;SLC7A2;SLC7A8;SLC3A2
prerank,cellular response to virus (GO:0098586),0.4286948464398524,1.101499902102505,0.33575581395348836,0.6977233137796678,1.0,6/30,8.62%,CXCL10;IFIH1;MAPK14;ARF1;GBF1;IL6
prerank,innate immune response in mucosa (GO:0002227),-0.47515038894420436,-1.1012565216053811,0.35933806146572106,0.7337284673489926,1.0,5/10,44.08%,RNASE3;CAMP;LTF;DEFA6;RPL39
prerank,TOR signaling (GO:0031929),0.4459968304529329,1.1011584492049193,0.34593023255813954,0.6979992578418535,1.0,13/26,21.55%,CARD11;EIF4EBP1;CCDC88A;SMG1;AKT1;MAPKAP1;PRR5;RPS6KB1;SYAP1;PINK1;RPS6;RICTOR;TIPRL
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3743825344308409,-1.1004810705955173,0.3476923076923077,0.734540157813152,1.0,4/24,8.94%,IGF1;ENPP1;PPP1R3B;IRS1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.40131965286733456,1.1004471395323359,0.340080971659919,0.6992707023988444,1.0,7/45,9.94%,BMPR2;RBPMS;GDF1;BMP3;ENG;ACVR2A;SMAD4
prerank,inner ear morphogenesis (GO:0042472),-0.38791865298705763,-1.1003844940755396,0.32670454545454547,0.7334225301691597,1.0,4/22,8.19%,CHD7;MYO6;FGFR2;HPN
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5037599451738309,1.099935228142576,0.35962145110410093,0.6999079888917066,1.0,6/13,19.18%,PRPF6;SRSF10;PRPF3;USP4;AAR2;DDX20
prerank,regulation of intracellular transport (GO:0032386),0.40329920169276257,1.0998263934644852,0.33643617021276595,0.6996111586275685,1.0,8/38,15.02%,LRRK2;LCP1;INPP5F;RINT1;PTPN1;DYNC1H1;GRIPAP1;DYNLT2B
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3174917808458729,1.0996443581517295,0.161,0.6995007966421906,1.0,158/807,17.21%,CIITA;CBFA2T3;BCL11A;TRPS1;JARID2;FOXP1;RUNX2;RARA;SP100;SP3;RUNX3;LIMD1;BCL3;KLF4;UXT;CREB1;PPARG;ETV6;SCML4;BCL6;SAP30;NFKB1;ATF7IP;STAT3;FOXJ1;NIPBL;NEDD4L;NAB1;CIART;MAD2L2;SPI1;CRY1;TBL1XR1;MTA3;GATAD2B;ZEB2;MBD1;SUMO1;KAT7;LRRFIP1;KLF8;IRF2;RFX3;RBPJ;IL33;KCNIP3;HIVEP1;DEAF1;STAT1;UBE2D3;HEXIM1;MBTD1;FBXW11;RPS6KA5;CCND1;KLF10;AHR;RPS14;CGGBP1;WFS1;ARID4A;CBFB;FLNA;CREM;PDCD4;SETDB2;MECP2;PDE2A;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;RARG;EZR;CTCF;PHF12;UIMC1;HDAC9;PEX14;CBFA2T2;BACH1;KAT6A;RBAK;ID2;WWP2;EZH1;E4F1;SMARCE1;PARP9;IRF7;RCOR3;SMAD4;SBNO2;CNOT2;DAXX;LIN37;NR3C1;RBM15;SPEN;FOXO3;IKZF5;DEDD2;TAF7;ETS2;REST;MBD2;MAP2K5;NUPR2;PSMD10;L3MBTL2;MYB;NRIP1;NSD1;LBH;TLE1;EZH2;SREBF2;SMARCC2;CITED2;HDAC3;NFIL3;TGFB1;ZNF431;RSF1;GPS2;ZNF436;MAFK;AURKB;MAZ;DUSP26;TNFRSF4;CREBBP;RELA;USP9X;PRDX5;MIER1;TAF1;BHLHE40;PHC3;ZNF148;MED1;DUSP22;BRD7;USP47;RB1;BPTF;NCOA5;SEMA4D;PROX1;SCMH1;NIBAN2;PSEN1;ELK4;FOXK1;SIRT1;SUPT4H1
prerank,regulation of adaptive immune response (GO:0002819),0.4656260413833897,1.099516087391684,0.3731117824773414,0.6992762464878614,1.0,8/18,17.48%,AHR;SAMSN1;IL6ST;IRF7;ADCY7;FCGR2B;SIRT1;SASH3
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.26642044471015747,-1.0994406712875342,0.24390243902439024,0.7345424965654602,1.0,21/107,10.34%,OPHN1;DLGAP1;CX3CR1;MEF2C;DGKZ;SNCAIP;SYT1;NLGN1;DLGAP4;ABR;TMEM108;DLG4;USP46;NRG3;GRID2;GRIK4;GRIK1;ATP1A2;CHRNA7;CDK5;GRM5
prerank,regulation of acrosome reaction (GO:0060046),0.5327612130441279,1.0993199075926108,0.37347294938917974,0.69920759478548,1.0,1/10,7.50%,PLCB1
prerank,ketone body metabolic process (GO:1902224),-0.4676833123194335,-1.0993083889418218,0.3316582914572864,0.7334845242226892,1.0,2/10,4.02%,OXCT1;HMGCL
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3406624209660878,1.0991977189955993,0.30954994511525796,0.6989424060670012,1.0,38/166,18.13%,NIBAN1;IL1B;DNA2;GLI1;BCL3;KLF4;RPL5;LDLR;VIM;CD36;ZEB2;KAT7;SCARB1;ELOVL5;FAF1;ATP7A;YTHDF3;IL6;HGF;NMD3;AKT1;METTL3;LARP4B;SLC6A9;EIF3E;ASS1;STN1;THBS1;RPS4X;DYRK2;RPS6KB1;INSR;GCK;SIRT1;DDAH1;ATAD5;MMP8;APPL1
prerank,dopaminergic neuron differentiation (GO:0071542),0.45382888560307144,1.0991698454435688,0.3353658536585366,0.6984478751683363,1.0,2/19,2.15%,CDNF;PITX3
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4386529757898907,-1.0990776545909697,0.3226600985221675,0.7327008327199109,1.0,5/13,21.59%,MAP1A;ABCA7;HSP90AB1;TYROBP;TMEM35A
prerank,activation of protein kinase B activity (GO:0032148),-0.3465711264887579,-1.099037785857928,0.31974921630094044,0.7314083912041429,1.0,5/29,2.77%,IGF1;NTRK3;OSBPL8;GAS6;PPIA
prerank,regulation of RNA splicing (GO:0043484),0.3709229625888789,1.0986593206034074,0.31907090464547677,0.6991907137661362,1.0,20/69,15.87%,MBNL1;AHNAK;PTBP3;HSPA1A;ERN1;PRX;MBNL3;SETX;SRSF10;DYRK1A;RBM22;METTL4;YTHDC1;PQBP1;ZPR1;HNRNPLL;RBM38;CELF1;RBM39;PTBP2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.35478314874013395,1.0983822208564282,0.3042959427207637,0.6993272268783518,1.0,21/101,14.22%,LRRK2;IL1B;FLT3;CD40;RAPGEF2;CCND3;ADRA2A;CCND1;PIK3R6;ADAM17;CIB1;RALB;RHOA;DIRAS1;PSMD10;PDGFD;CCND2;AKT1;KIT;EZH2;TGFB1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3524522641047123,-1.0979995927309085,0.31125827814569534,0.7328065056306827,1.0,12/30,22.18%,HEXB;CHST11;ARSB;CHST9;CHPF2;CSPG4;HEXA;DSE;CHST3;BGN;HYAL1;CHSY1
prerank,positive regulation of organelle organization (GO:0010638),0.42058988057072055,1.0979821469129505,0.3524355300859599,0.6997678268812403,1.0,7/32,10.39%,UVRAG;ANXA2;C2CD5;KATNBL1;SYNJ1;ATL3;ANXA1
prerank,skin development (GO:0043588),0.36592683459932873,1.0968661193768783,0.32665832290362956,0.7019704953795338,1.0,12/65,15.79%,CLDN1;COL5A2;BCR;CLIC4;ATP7A;ANXA1;PIP5K1A;DHCR24;ITGA3;ADAM9;FA2H;MED1
prerank,DNA methylation (GO:0006306),0.45112398981470003,1.096847188514967,0.364741641337386,0.7014605285387713,1.0,11/23,19.46%,ATF7IP;FOS;GATAD2A;METTL4;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;DNMT1;EHMT1
prerank,ncRNA metabolic process (GO:0034660),0.4090092047730984,1.0968366569728687,0.3492286115007013,0.7009277176451792,1.0,10/37,22.58%,XPO5;DGCR8;EXD1;TRIM71;TUT7;TENT4B;DTD1;PARN;TARBP2;ZCCHC8
prerank,microglial cell activation (GO:0001774),-0.37450728582296006,-1.0965011232375415,0.34036144578313254,0.7356835667807957,1.0,5/21,3.16%,CX3CR1;TREM2;C1QA;GRN;AIF1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4215860420695233,1.0963088147204838,0.35959885386819485,0.7016997091241122,1.0,9/31,14.20%,PEX16;PEX12;GRPEL2;DNAJC19;TIMM21;PEX14;TOMM40;AIFM1;TIMM50
prerank,monoacylglycerol metabolic process (GO:0046462),-0.4416331300081118,-1.0962164256435172,0.343980343980344,0.7350875895672729,1.0,3/13,7.25%,ABHD12;MGLL;PLA2G4A
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4544047076198883,-1.0959583624233902,0.35323383084577115,0.7343766986694514,1.0,2/12,0.70%,APOE;TREM2
prerank,regulation of catabolic process (GO:0009894),0.47179184430605803,1.095953239775269,0.36923076923076925,0.701970562500727,1.0,5/18,8.95%,NEDD4L;ZDHHC7;FAF1;FAP;SNF8
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5290654668338566,1.0957218953651287,0.3577371048252912,0.7020160075462376,1.0,3/10,12.38%,MMGT1;EMC9;EMC10
prerank,smooth muscle cell differentiation (GO:0051145),-0.43828936701770466,-1.0952768672766302,0.340153452685422,0.7348402061904946,1.0,1/12,0.72%,MEF2C
prerank,double-strand break repair (GO:0006302),0.3365884622639859,1.0949957333263756,0.3088888888888889,0.7032278252298586,1.0,45/158,19.65%,DNA2;SAMHD1;DTX3L;MAD2L2;RBBP8;POLL;MRE11;FEN1;SUMO1;DNTT;SMARCA5;UBE2N;SETX;WRN;CIB1;NABP1;UIMC1;BRIP1;PARP9;MORF4L1;RECQL5;RPA3;XRCC4;EXD2;SPIDR;MAPK8;ERCC4;RNF138;VCP;XRCC2;INO80;MCM9;KDM4B;POLB;KPNA2;HUS1;EYA3;MDC1;SMC6;RAD21;CHEK2;SETMAR;SMC5;TNKS1BP1;RNF168
prerank,maintenance of protein localization in organelle (GO:0072595),0.4519680041833189,1.0949713855479362,0.35772357723577236,0.7027247843925941,1.0,7/19,21.25%,BCL3;TAPT1;MORC3;AKT1;HSPA5;PINK1;TAF3
prerank,negative regulation of protein polymerization (GO:0032272),0.43244724481130403,1.094965317711356,0.3475783475783476,0.7021833016721373,1.0,10/27,18.44%,CYRIB;DYRK1A;KANK3;ARFGEF1;CLIP3;TBCD;STMN2;MYADM;KANK1;PRKCD
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.4490066750330979,1.0944708216702175,0.36163522012578614,0.7028839826770593,1.0,1/21,0.54%,PLA1A
prerank,protein-DNA complex assembly (GO:0065004),0.3533630740901578,1.0944018931091013,0.32903981264637,0.7025140394290097,1.0,25/116,12.97%,PSME3;CHAF1A;PSMB7;PSME2;H3-3A;ORC5;MCM6;SMARCA5;ORC4;CCNH;PSME4;PSMB8;PSMA5;PSMD9;DAXX;PSMB3;PSMD6;PSMC4;NAP1L1;RPA3;PSMD10;ATRX;MCM2;PSMB1;ERCC3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3372068168665257,1.0943819953204148,0.30472103004291845,0.7020021910551804,1.0,41/186,16.57%,LIMD1;GLI1;PTPRU;PTPRO;PSME3;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;PSMB7;APCDD1;AXIN1;PSME2;RNF213;TMEM131L;STK4;KREMEN1;PSME4;LATS1;PSMB8;PSMA5;PSMD9;CYLD;NLK;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;TAX1BP3;INVS;DVL2;APC;IGFBP6;PSMD12;KLHL12
prerank,protein modification process (GO:0036211),0.36806024613259875,1.0940422551317361,0.3382352941176471,0.7022804829908253,1.0,12/76,11.47%,ST3GAL1;ST8SIA4;STK38;PARP4;UBE2D3;FBXW2;NEDD8;PPP4R2;CSNK1G3;WWP2;UBE2S;DUSP12
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.36459016760621593,1.09401802184729,0.3391304347826087,0.7017813512630764,1.0,22/69,18.69%,GTF2F2;TAF13;TAF9;GTF2E2;POLR2C;NABP1;GTF2A1;RPRD2;SNAPC3;RPRD1B;INTS2;CCNT2;SRRT;INTS11;INTS14;CCNT1;INTS4;NCBP1;ELL;INTS6;POU2F2;PHAX
prerank,tRNA 5'-end processing (GO:0099116),-0.41201258779295263,-1.093963191072883,0.34203655352480417,0.7369422793540443,1.0,11/15,34.66%,POP1;RPP30;RPP14;SSB;RPP40;POP4;POP5;HSD17B10;RPP21;POP7;RPP25L
prerank,pore complex assembly (GO:0046931),0.467771836215479,1.0933592488197599,0.362095531587057,0.7028435616488887,1.0,7/19,18.89%,AFDN;NUP98;TSPAN33;RTN4;NUP153;NUP93;BAD
prerank,negative regulation of cell cycle (GO:0045786),0.37107030664348645,1.0930776045419899,0.3399503722084367,0.7029956627003845,1.0,19/73,18.81%,RUNX3;LILRB1;BTG2;BTG1;HEXIM1;PTEN;PDCD4;LATS1;LATS2;DUSP1;NUPR2;RPS6KA2;TGFB1;TRIM35;APC;RB1;NR4A1;FOXC1;HPGD
prerank,regulation of cell adhesion (GO:0030155),0.341659843821481,1.0927725450814247,0.32840909090909093,0.703195873855168,1.0,30/129,17.65%,CYTIP;LYN;RET;PPP1R12A;RIPOR2;RAC2;CBLL1;PPP3CA;SPN;RSU1;ARHGDIB;PTK2B;TGFBI;PLXND1;EPHB2;ATXN3;MINK1;DUSP1;PPP1CB;PLXNC1;ROCK1;CD164;PTPRJ;IL18;DUSP26;MYADM;FES;SEMA4D;ABL2;EFNA1
prerank,myoblast differentiation (GO:0045445),0.49030732687909934,1.092737277647016,0.3652597402597403,0.7027357736939208,1.0,4/14,11.91%,MBNL1;PLEKHM3;MAPK12;REST
prerank,lipid oxidation (GO:0034440),-0.4351864881784955,-1.0927339622812762,0.35396039603960394,0.7387916370293042,1.0,3/12,25.51%,PPARGC1A;ADIPOR2;ACOX1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.4398023310452888,1.0927061859037441,0.34831460674157305,0.7022616029057033,1.0,10/23,16.95%,NFKB1;ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,cellular response to glucose starvation (GO:0042149),0.3974722326924831,1.0926976628989182,0.3592896174863388,0.7017352729468243,1.0,14/41,17.99%,SIK1;PRKAG2;MTMR3;SIK2;PRKAG1;FOXO3;PRKAA1;PIK3R4;EIF2AK3;PRKAA2;BRSK1;RRP8;BECN1;HSPA5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.43917562907228,1.092451460426178,0.35650887573964496,0.7017873643345292,1.0,7/24,16.09%,JAK2;IL10RA;CRLF3;PTK2B;IL6;KIT;OCIAD1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4232296922418309,1.092201123018573,0.35703703703703704,0.7018735521295644,1.0,7/29,14.27%,FGR;FLT3;PTK2B;PIK3R4;KIT;TGFB1;FGFR3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.2884328334375971,-1.0921296918761902,0.26521739130434785,0.7390211879317494,1.0,26/69,25.21%,ECPAS;STUB1;ERLIN2;DERL2;HSP90B1;AUP1;NPLOC4;USP19;RNF121;DNAJB2;SGTB;DERL1;TRIM13;ANKZF1;RNF103;HERPUD1;TMUB2;FAM8A1;UBQLN2;DNAJB9;UBE2G2;SEC61B;FBXO44;UBE4A;UBE4B;FBXO17
prerank,regulation of cell aging (GO:0090342),-0.45040201632461846,-1.0919474772324758,0.358974358974359,0.7381393193102072,1.0,3/11,8.07%,NUAK1;NEK6;NEK4
prerank,polarized epithelial cell differentiation (GO:0030859),-0.4422706820460576,-1.0919099729227164,0.3438320209973753,0.736839813711109,1.0,3/13,1.35%,OPHN1;MYO9A;RAP2A
prerank,apical protein localization (GO:0045176),0.5236308908686793,1.0917502983257243,0.35547576301615796,0.7024423800071621,1.0,6/10,19.21%,CELSR1;SHROOM3;INSC;GOPC;MAL;ACTB
prerank,epithelial cell-cell adhesion (GO:0090136),-0.467934907400629,-1.0917172920720701,0.3713527851458886,0.7359654027671919,1.0,2/11,7.60%,ITGB5;JUP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4743418826043589,-1.0914984766989815,0.3865336658354115,0.7338001815279995,1.0,4/10,12.15%,MYLIP;AP2A1;CLTA;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4743418826043589,-1.0914984766989815,0.3865336658354115,0.7338001815279995,1.0,4/10,12.15%,MYLIP;AP2A1;CLTA;AP2M1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5200722884979256,1.091332907674455,0.3503521126760563,0.7028854528019532,1.0,5/10,18.36%,RAPGEF2;ZEB2;ATP7A;APPL1;CTNS
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.38165085990141073,1.0913241065088863,0.3549222797927461,0.70235216819121,1.0,9/48,8.19%,NEDD9;DOCK5;CRK;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4708982632735335,-1.091252808543177,0.3615023474178404,0.7331568205567786,1.0,6/10,38.64%,BMPR1B;PKDCC;SOX5;SOX9;SOX6;ACVRL1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.46439316816034915,1.0909008256457557,0.35104669887278583,0.7028859920573857,1.0,9/18,23.52%,MSN;EZR;SNX3;MAPK1;SNX12;MTMR2;MAP2K1;RAB21;CHMP3
prerank,regulation of protein polymerization (GO:0032271),-0.3330528274812917,-1.0901922058163724,0.314878892733564,0.7346737079859427,1.0,16/35,28.64%,CAMSAP1;COTL1;MAP2;RASA1;PFN1;FCHSD2;CAMSAP2;PFN2;TPPP;CTTN;GBA2;MAPRE3;ABITRAM;HSP90AA1;ABL1;DBN1
prerank,macroautophagy (GO:0016236),0.3441515821254828,1.0901678823131555,0.31823461091753774,0.7041904033274555,1.0,38/118,19.01%,UVRAG;PIP4K2A;PRKAG2;VPS37C;MTMR14;CHMP4A;CHMP4B;STX17;MTMR3;TSG101;PRKAB2;ATG5;SNF8;CSNK2A2;CSNK2A1;TBC1D5;TOMM40;PIP4K2B;PRKAG1;STAM;PRKAA1;PGAM5;PIK3R4;WIPI2;ATG10;ARL8B;PRKAA2;VCP;ILRUN;RB1CC1;FUNDC1;AMBRA1;BECN1;ATG13;STAM2;SNX14;PINK1;VPS37B
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5000628224884452,1.0894948990016922,0.37110016420361247,0.7052979487235174,1.0,4/13,14.83%,JAK2;IL33;TLR2;GSTP1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.39705957975975575,1.0892790408709156,0.3283173734610123,0.705267367267902,1.0,8/40,14.22%,IL1B;TIAM1;GLIPR2;IL6;OLFM1;SMAD4;EZH2;TGFB1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.4233800828635871,1.0883654166627768,0.3590504451038576,0.7069875803717538,1.0,8/24,16.85%,BMPR2;DFFA;MSH3;MSH6;RPS3;ERCC4;KMT2A;NIBAN2
prerank,regulation of NMDA receptor activity (GO:2000310),0.4180956989231306,1.0881312920117319,0.34859675036927623,0.7070197523093726,1.0,5/32,9.07%,CCR2;DAPK1;PTK2B;EPHB2;OPRM1
prerank,positive regulation of DNA binding (GO:0043388),-0.34142136468358253,-1.0875349085321275,0.33993399339933994,0.740685349510761,1.0,4/31,2.97%,PRKN;IGF1;SKI;HMGB1
prerank,regulation of biomineral tissue development (GO:0070167),-0.3596770179823531,-1.0872489680589408,0.3322784810126582,0.7400231975865088,1.0,6/26,7.87%,GAS6;ANKH;ENPP1;BMP2K;NBR1;S1PR1
prerank,regulation of protein localization to nucleus (GO:1900180),0.3986137968482441,1.0868743188600472,0.363265306122449,0.7096168761339863,1.0,12/43,14.75%,NGFR;DTX3L;CTNNA1;KAT7;LATS1;PARP9;LATS2;EIF2AK3;AKT1;LIMK2;TGFB1;ILRUN
prerank,positive regulation of neuron death (GO:1901216),0.3919545136104782,1.0868718025414383,0.36988110964332893,0.7090708942140845,1.0,11/46,11.91%,FYN;MAP3K5;FOS;PICALM;ITGB2;PRNP;DDIT4;DAXX;FOXO3;FCGR2B;REST
prerank,protein-DNA complex disassembly (GO:0032986),0.4719966854290289,1.0868448785883453,0.3566775244299674,0.7085857839749813,1.0,4/16,13.76%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,positive regulation of hydrolase activity (GO:0051345),0.3421768632537313,1.0865975242165362,0.33,0.708631226057753,1.0,25/137,11.72%,SRGAP2;RAP1A;CD40;DOCK10;RASGRP2;RAPGEF2;USP6NL;DOCK11;PICALM;ARAP1;RSU1;CAV2;AFDN;WRN;S100A10;F11R;PSAP;MAPK12;RHOA;BCAS3;RPS3;SNX9;NET1;TBC1D2;DVL3
prerank,regulation of focal adhesion assembly (GO:0051893),0.3845468274005259,1.0862805497774473,0.36578947368421055,0.7088379499021136,1.0,19/54,18.46%,SLK;RCC2;DLC1;PTEN;S100A10;PHLDB2;RAC1;RHOA;BCAS3;ROCK1;CLASP1;PTPRJ;COL16A1;THBS1;DUSP22;DAPK3;ARHGAP6;PTPRA;VCL
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.41979316537778044,-1.0862245898285983,0.36639118457300274,0.7416234092386415,1.0,6/16,9.54%,IGF1;MEF2C;ERBB4;FGF2;FGFR2;AKAP6
prerank,regulation of exocytosis (GO:0017157),-0.30870076390455337,-1.0859697350243578,0.28308823529411764,0.7409695714744687,1.0,8/46,5.26%,SYT1;IL1RAPL1;CADPS;RAB3C;STXBP5L;ATP6AP1;CLASP2;RAB9A
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.455811720729083,-1.0859070594907085,0.3722627737226277,0.7397647673665366,1.0,6/11,13.98%,IGF1;GHR;GIGYF1;IRS1;PIK3R1;TSC2
prerank,ERBB2 signaling pathway (GO:0038128),0.41519454983204246,1.0846460458958793,0.35694050991501414,0.7124109316482237,1.0,7/31,10.65%,NRG2;CUL5;ERBIN;PTPN12;GRB2;SOS1;PIK3CA
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3882562787289547,-1.0840998550672092,0.3277777777777778,0.7434544238915387,1.0,9/18,19.15%,NLGN1;DLG4;CHRNA7;NLGN2;PRKCZ;NLGN3;RIMS1;STX1B;NRXN1
prerank,gonad development (GO:0008406),-0.32065764070437597,-1.084093460649956,0.29296875,0.7420965381984158,1.0,18/41,33.12%,BASP1;SALL1;KITLG;MSH2;TGFB2;AR;NCOA4;NR2F2;FGF9;SOX9;WNT4;INHBA;MEA1;BIK;WNT5A;MKKS;WNT2B;MAMLD1
prerank,negative regulation of bone remodeling (GO:0046851),-0.4634876625550267,-1.0839966315848162,0.39847715736040606,0.7409867968699748,1.0,3/11,4.93%,GPR137B;TMEM119;P2RX7
prerank,snRNA transcription (GO:0009301),0.35942516397198904,1.0835861698521347,0.34895191122071517,0.7145062129937808,1.0,22/70,18.69%,GTF2F2;TAF13;TAF9;GTF2E2;POLR2C;NABP1;GTF2A1;RPRD2;SNAPC3;RPRD1B;INTS2;CCNT2;SRRT;INTS11;INTS14;CCNT1;INTS4;NCBP1;ELL;INTS6;POU2F2;PHAX
prerank,protein secretion (GO:0009306),-0.2964573641753014,-1.0834571237097523,0.3089430894308943,0.741120866872968,1.0,11/56,12.57%,ABCA1;TANGO2;WLS;RAB3C;PREB;SNX19;SCG2;ARFGAP3;OLFM2;TANGO6;MTTP
prerank,dendritic spine organization (GO:0097061),0.4314837409394018,1.0832858701210148,0.35893854748603354,0.7146925822901695,1.0,11/26,16.71%,FYN;DOCK10;CDC42;PTEN;PRNP;ARF1;EPHB2;ITGA3;INSR;WNT7A;MTMR2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.38198745595686306,1.08316059819358,0.3418693982074264,0.7139064415416255,1.0,10/51,10.53%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,mitotic nuclear membrane organization (GO:0101024),0.38198745595686306,1.08316059819358,0.3418693982074264,0.7139064415416255,1.0,10/51,10.53%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,thymus development (GO:0048538),-0.42459449031530944,-1.0830837482410198,0.36164383561643837,0.740732430247914,1.0,9/13,48.98%,TGFBR1;FGF10;SOD1;EPHB3;HES1;ZBTB1;SHH;FADD;RIPK3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.42730330798289495,1.0830124725540902,0.3781763826606876,0.7136982122612018,1.0,4/26,13.17%,ACER3;CYB5B;ARG2;AKT1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4390712625499204,1.0827753053897329,0.3716417910447761,0.7137203273933014,1.0,9/23,20.42%,SPI1;IFI35;CPNE1;CYLD;NLRP3;RELA;HDAC7;TMSB4X;ADIPOR1
prerank,signal transduction in response to DNA damage (GO:0042770),0.3832672038660691,1.0826310501184035,0.3523936170212766,0.7135423430691362,1.0,20/49,23.16%,BCL3;MAD2L2;MAPK14;CDC5L;GRB2;CEP63;CLOCK;DOT1L;BRIP1;ATRX;MAP3K20;DONSON;HUS1;RAD17;CHEK2;TIPRL;BID;CASP9;BATF;STK33
prerank,cGMP metabolic process (GO:0046068),0.5144312036720428,1.082539431204921,0.3811881188118812,0.7132394974191572,1.0,5/12,24.92%,PDE2A;GUCY1A1;NPR2;NPPC;PDE9A
prerank,translesion synthesis (GO:0019985),0.39383068202800336,1.0824225215546877,0.367911479944675,0.7129828636980056,1.0,10/42,14.19%,DTL;POLI;MAD2L2;POLDIP2;POLD4;TRIM25;RPA3;RCHY1;PCLAF;VCP
prerank,mitochondrion localization (GO:0051646),0.4621875495024219,1.0822847433549452,0.36774193548387096,0.7127868104473181,1.0,2/19,6.98%,LRRK2;ATP2A1
prerank,gland development (GO:0048732),-0.2988069878926808,-1.0822580693812784,0.32558139534883723,0.7417136550096749,1.0,20/59,29.16%,SALL1;TGFBR1;PKD2;NF1;FGFR2;ARID5B;CEBPG;ARHGAP35;PHF2;PRKCSH;MDK;DKK3;FGF10;SOD1;HOXD3;SOX9;SOX2;WNT4;CAV1;NOTCH4
prerank,negative regulation of cell population proliferation (GO:0008285),0.31982076726024095,1.081999382952123,0.3018292682926829,0.7129549417655261,1.0,56/351,14.47%,CBFA2T3;IL1B;IFNLR1;RUNX3;LYN;NGF;MARVELD3;KLF4;PPARG;PTPRU;PAK1;JAK2;HSPA1A;BTG2;CD300A;BMPR2;RAPGEF2;FABP7;PTPN6;ABI1;EIF2AK2;DLC1;BTG1;RBBP4;TNS2;GLMN;FAP;PTEN;CDKN2C;KLF10;PTK2B;CIB1;SULT2B1;RARG;LMNA;CTCF;IL6;IFI35;OPRM1;ARID2;B2M;S100A11;REST;APP;NUPR2;UTP20;SH3BP4;PPM1D;NF2;MORC3;CD164;KAT2B;RPS6KA2;TGFB1;PTPRJ;PPP2R5C
prerank,regulation of BMP signaling pathway (GO:0030510),0.36319226358739654,1.0816365555775427,0.3415841584158416,0.7132817967448053,1.0,14/73,15.20%,PPARG;BMPR2;SORL1;LEMD3;RBPJ;HIPK2;UBE2D3;ENG;ACVR2A;SMAD4;LEMD2;ITGA3;VWC2L;XIAP
prerank,negative regulation of calcium ion transport (GO:0051926),0.4726784112713246,1.0815920532106214,0.37796610169491524,0.7128351340138559,1.0,3/15,8.42%,LILRB1;ADRA2A;SLC30A1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.35040687809814586,1.0815205347488617,0.3447880870561283,0.7124719426684859,1.0,15/107,12.61%,CCR2;CD40;CCR1;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;ATP2A1;SLC30A1;DMPK;TMEM203;ATP13A3;SLC10A7;SLC24A4
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5113680192870763,1.081500325847778,0.3830155979202773,0.7119711821094541,1.0,6/11,22.71%,H3-3A;RBBP4;ATRX;HAT1;CABIN1;ASF1A
prerank,regulation of lipid catabolic process (GO:0050994),0.46857829040269505,1.0813324084657965,0.36900958466453676,0.7118276123801812,1.0,5/19,15.06%,IL1B;ADRA2A;PRKAA1;ABCD1;ANGPTL3
prerank,protein polymerization (GO:0051258),0.37598075756812316,1.0807735305557051,0.3715046604527297,0.7126974011192385,1.0,11/56,11.45%,PSTPIP1;JAK2;PSTPIP2;MSRB1;CHMP4A;CHMP4B;DIAPH1;TPPP3;RAC1;UBE2S;TTC17
prerank,positive regulation of protein export from nucleus (GO:0046827),0.47688734136194844,1.0807540529401667,0.38682432432432434,0.7121983731704659,1.0,3/15,9.00%,IL1B;XPO4;RBM22
prerank,transcription by RNA polymerase II (GO:0006366),0.31872022195931754,1.0804643890762222,0.3139896373056995,0.7123439851316099,1.0,73/305,17.38%,RARA;NOTCH2;HNF4G;CDK13;PPARG;NFKB1;GTF2F2;TAF1A;TAF13;TAF9;GTF2E2;POLR2C;TBL1XR1;MBD1;RBPJ;DEAF1;KLF13;SNRPB;DEK;ELOA;SETX;SSU72;CBFB;ELOB;NABP1;THRA;FIP1L1;RARG;CCNH;GTF2A1;E2F2;HDAC9;ELOF1;SCAF8;RPRD2;SNAPC3;PKNOX1;RPRD1B;NR3C1;NUDT21;GMEB2;INTS2;SETD2;CCNT2;SRRT;MED26;NELFA;TAF7;INTS11;INTS14;CCNT1;NFYA;CDK12;TEAD1;ERCC3;EAF1;KAT2B;INTS4;HDAC3;MAZ;CREBBP;CPSF3;TAF1;PAPOLA;NCBP1;MAML1;MED1;ELL;MED7;INTS6;TAF1C;SUPT4H1;NR4A1
prerank,sphingolipid biosynthetic process (GO:0030148),0.3590961254545436,1.080417416202529,0.3454317897371715,0.7119155433943968,1.0,15/71,16.43%,CERS6;ST8SIA1;ACER3;CERS1;ELOVL5;SAMD8;SGMS1;SGMS2;ELOVL6;SPTSSB;SGPP2;SGPP1;FA2H;VAPA;HACD4
prerank,negative regulation of interleukin-2 production (GO:0032703),0.456798830483298,1.0802081018511314,0.36577708006279436,0.711878327622267,1.0,4/18,8.00%,PTPRC;LAPTM5;PRNP;EZR
prerank,telomere maintenance (GO:0000723),0.3818430900238099,1.0798363798382697,0.36449864498644985,0.7122442769647669,1.0,16/50,20.00%,SP100;DNA2;MRE11;TEP1;POLD4;WRN;RPA3;ERCC4;STN1;HUS1;POLD1;LTO1;SMC6;SMC5;TERF2;APEX1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4340074804431719,1.0796806271345283,0.37091988130563797,0.7120680745830744,1.0,4/22,11.69%,LRRK2;ID2;TRIM71;NAP1L1
prerank,lysosome organization (GO:0007040),-0.32776820224743924,-1.079360752978844,0.3188405797101449,0.7485882080393716,1.0,9/36,8.04%,ABCA1;HPS4;GRN;ZKSCAN3;TPP1;ARSB;TPCN2;GAA;MYO7A
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.44337388112069537,-1.0792493972009856,0.3578199052132701,0.7475290276187984,1.0,9/11,36.28%,SMARCB1;PWP1;PIH1D1;DDX11;NOP53;IPPK;MTOR;SMARCA4;NCL
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.44431889516635276,-1.079042948140451,0.3681592039800995,0.7467514577831574,1.0,6/11,55.57%,RTP4;PKD1L3;PKD2L1;LPO;RTP2;TAS1R3
prerank,protein targeting to membrane (GO:0006612),0.35874808540648473,1.0790289272862876,0.32889963724304716,0.7131878133711157,1.0,17/83,13.44%,VPS37C;MYO1C;PEX16;CHMP4A;CHMP4B;PEX12;ZDHHC7;TRAM1;ZDHHC6;ZDHHC23;PEX14;SEC63;PIKFYVE;FIS1;SRP19;ABCD1;NCF1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3993362711389663,1.0789412346572167,0.3485254691689008,0.7128635416901701,1.0,4/39,2.59%,FXYD5;TCAF2;UTRN;NEDD4L
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5249480695942006,1.0789245295439598,0.3848797250859107,0.7123644085239392,1.0,3/10,12.51%,JAK2;IL33;TLR2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.440056068834383,1.078792943256747,0.3726993865030675,0.7121984260244969,1.0,2/22,1.57%,NOTCH2;CASK
prerank,regulation of gene silencing by miRNA (GO:0060964),0.36838138839644385,1.0784226695241654,0.37182741116751267,0.712575994131512,1.0,15/62,16.81%,LIMD1;PPARG;NUP210;STAT3;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;TGFB1;PUM1;SEH1L;AJUBA
prerank,regulation of endothelial cell migration (GO:0010594),-0.28104839681169574,-1.0783969549117673,0.28402366863905326,0.7471675169883961,1.0,18/85,9.40%,PTPRM;ANXA3;APOE;SASH1;SPARC;NRP1;GRN;GLUL;NRP2;ETS1;FGF2;PTN;NF1;RHOB;PIK3CG;ITGB3;AAMP;SLIT2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.43208258091217266,-1.077786860817908,0.344578313253012,0.7475783460509544,1.0,5/12,34.72%,CALM1;CAV1;PDE4D;GJD3;CALM2
prerank,respiratory electron transport chain (GO:0022904),0.4871179451027334,1.0776994722808508,0.38387096774193546,0.7137534298631553,1.0,4/14,11.50%,GPD2;SLC25A13;SLC25A12;SLC25A18
prerank,translational elongation (GO:0006414),-0.26590883656271713,-1.0776234277823011,0.26973684210526316,0.7466807201948047,1.0,46/101,29.97%,EEF2K;GFM2;MRPL24;MRPS9;DAP3;EEF1A1;MRPS21;MRPL1;MRPS5;LTN1;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;GTPBP2;MRPL3;MRPL32;MRPL47;EEF1D;RACK1;MRPS30;MRPL17;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;EEF1B2;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.41272174565091285,1.0776199008379546,0.37517433751743373,0.7134036964227927,1.0,6/33,9.15%,NDNF;CAST;PDPK1;WFS1;NFE2L2;ICAM1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.4941149014205187,1.0774613588372928,0.3810264385692068,0.7132336812638075,1.0,2/14,1.75%,PTPRC;LDLR
prerank,t-circle formation (GO:0090656),0.504867159101009,1.0774388745915255,0.36769759450171824,0.7116809005356955,1.0,2/10,7.02%,DNA2;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.504867159101009,1.0774388745915255,0.36769759450171824,0.7116809005356955,1.0,2/10,7.02%,DNA2;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),0.504867159101009,1.0774388745915255,0.36769759450171824,0.7116809005356955,1.0,2/10,7.02%,DNA2;WRN
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.46856283204757687,-1.076868263162201,0.3681710213776722,0.7474184766379074,1.0,3/10,8.53%,TGFBR2;FGFR2;PDGFA
prerank,positive regulation of T cell differentiation (GO:0045582),0.4038105894792984,1.076711254663056,0.36894586894586895,0.7128790979880819,1.0,3/36,4.42%,TESPA1;BCL6;ZAP70
prerank,glucan catabolic process (GO:0009251),-0.40857739523165026,-1.0761927699519778,0.3669250645994832,0.748055662237181,1.0,7/15,22.67%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,placenta development (GO:0001890),0.5008585316565305,1.075972278022306,0.3986013986013986,0.7141203048008836,1.0,2/12,10.02%,PPARG;ADAM19
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5049338433180893,1.0756999143648123,0.3898305084745763,0.7136974578327564,1.0,1/10,10.54%,CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5049338433180893,1.0756999143648123,0.3898305084745763,0.7136974578327564,1.0,1/10,10.54%,CEP250
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3390971801915427,-1.0750071392935097,0.3438485804416404,0.749968288698009,1.0,7/33,9.57%,WNK1;AHCYL1;CHRM3;KCNJ2;P2RX7;AKAP6;KCNJ6
prerank,positive regulation of protein binding (GO:0032092),0.3767113493248311,1.0749969258206316,0.3633986928104575,0.7148681784015379,1.0,12/56,13.42%,LRRK2;TIAM1;DTX3L;RAPGEF2;HIPK2;STK4;RALB;B2M;APP;NMD3;RPL11;MARK3
prerank,regulation of cell death (GO:0010941),0.34668910803719627,1.074785045312696,0.33833718244803695,0.7148218287666238,1.0,11/94,7.09%,LRRK2;SRGAP2;ACER3;HSPA1A;CD36;NOA1;CHMP4B;HP;HPR;FAF1;ATG5
prerank,cellular response to organonitrogen compound (GO:0071417),-0.2706899641506739,-1.0746202703211776,0.32116788321167883,0.7497648429608698,1.0,24/99,10.51%,RYR3;MEF2C;P2RY12;LARP1;RPTOR;CTNNB1;PKD2;GABRG2;CPEB1;P2RX7;P2RX4;GABRB1;IMPACT;LARS1;IPO5;JUP;HSP90B1;GLRA2;P2RY6;SLIT2;AKAP6;CPEB4;HCN1;HCN2
prerank,chemical synaptic transmission (GO:0007268),-0.23242033743430404,-1.0743493890274454,0.23333333333333334,0.7492038872672866,1.0,60/284,16.10%,APOE;DLGAP1;LRP6;GRIA4;SYT1;PTPRN2;CACNB2;NLGN1;CAMK1;KCND2;SLC1A3;PLP1;KCNQ3;CHRM3;DLG2;NAPA;DLG4;CHRM2;KIF1B;GRIA2;GRIA1;PRKACA;GABRG3;NRXN2;GABRG2;SLC17A6;GRID2;GRIK4;SNAP25;GLRA3;GABRB1;GRIK1;HTR2B;GLRA2;FCHSD2;NOVA1;GABRA4;GAD2;CHRFAM7A;CHRNA7;RIT2;CDK5;GRM5;CAMK4;SNPH;STX1A;SLC5A7;PRKAR1A;HTR2C;NLGN2;SST;CALM1;ERC1;GIPC1;LIN7A;KCNA1;GABRB3;HTR7;CPLX1;NLGN3
prerank,excitatory postsynaptic potential (GO:0060079),0.45324274788523927,1.0739916575865067,0.3915094339622642,0.7162444353264944,1.0,1/19,0.22%,LRRK2
prerank,protein glycosylation (GO:0006486),0.33692217241567873,1.0739368956177293,0.3317972350230415,0.7158357533069747,1.0,14/125,10.28%,ST3GAL1;ST8SIA4;ST3GAL4;ST8SIA1;TET2;KRTCAP2;FUT4;ST8SIA6;B4GALT5;GALNT2;SERP2;GALNT10;MGAT3;MAGT1
prerank,regulation of secretion (GO:0051046),0.47105335178840074,1.0738550808174019,0.3888888888888889,0.7154952971134714,1.0,2/13,3.31%,OAS2;KCNQ1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.46100350071779683,1.073719942315755,0.38028169014084506,0.7152875061137571,1.0,4/17,15.20%,CASK;ZDHHC17;ITGA3;XIAP
prerank,neural crest cell differentiation (GO:0014033),-0.38784817616202927,-1.0736954608253577,0.34177215189873417,0.7497635917127363,1.0,3/18,7.38%,MEF2C;LRP6;HTR2B
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5010600526879316,1.0736688821088258,0.40069686411149824,0.7148708135017475,1.0,2/12,7.38%,CCDC120;NIN
prerank,mitochondrion disassembly (GO:0061726),-0.33163469357477415,-1.0736660265086941,0.3401360544217687,0.7485017222270469,1.0,12/34,21.91%,PRKN;ULK2;MAP1LC3B;ATG12;USP30;SQSTM1;ATG9A;FUNDC2;ATG7;WDR45;ATG2A;GABARAP
prerank,sodium ion transmembrane transport (GO:0035725),-0.2859687283215418,-1.0733124906810756,0.3248407643312102,0.7481379091117233,1.0,15/84,13.79%,SLC8A1;SLC24A3;SCN1A;ATP1B3;PKD2;ATP1B1;SLC6A15;SCN3A;SLC9A9;SLC9A6;ATP1A2;HCN1;HCN2;SCN1B;SLC6A8
prerank,cellular response to organic cyclic compound (GO:0071407),0.3371500720801181,1.0732661943672712,0.33,0.7153050543510575,1.0,29/141,15.79%,LRRK2;IL1B;RAP1A;MSN;RAPGEF2;KCNQ1;NCOA3;CTNNA1;HCN4;GABRB2;DIAPH1;TIPARP;AHR;PDE2A;EZR;GNB1;HRH1;NR3C1;GNAI1;ADCY5;SPIDR;NRIP1;GNG2;CASP7;TGFB1;IL18;CASP6;TAF1;MED1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3531742636235383,1.0731313522764245,0.36228287841191065,0.7150986122148444,1.0,15/73,14.22%,CD44;NGF;PAK1;SH2D3C;MAD2L2;AXIN1;STK4;IL6;LATS1;CREBL2;BRAF;APP;AKT1;HCLS1;TGFB1
prerank,bicarbonate transport (GO:0015701),0.4273978422609417,1.0729332808106462,0.39212827988338195,0.7150738339822834,1.0,5/25,13.59%,SLC4A7;SLC4A8;CYB5R4;CYB5R1;SLC26A7
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.3582263875030801,-1.0727907416009335,0.34782608695652173,0.7481566132646976,1.0,4/23,9.54%,IGF1;MEF2C;MMP14;AKAP6
prerank,anterior/posterior pattern specification (GO:0009952),-0.2960607937542998,-1.0725532488206926,0.29310344827586204,0.7474360297707512,1.0,4/53,1.74%,BASP1;SKI;TGFBR1;WLS
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.4241303366488096,-1.0724609402555885,0.3439153439153439,0.7463345236570522,1.0,3/14,8.94%,ABCD2;LONP2;IRS1
prerank,positive regulation of growth (GO:0045927),0.3662561566319531,1.072435696389142,0.35279187817258884,0.715741427905549,1.0,20/64,16.27%,RPS6KA3;CDC42;H3-3A;CXCL16;ADAM17;WFS1;CIB1;MTPN;PLCB1;DDX49;CSNK2A1;RPS6KA1;PSMD10;ZPR1;PABIR1;AKT1;NCBP1;INO80;USP47;INSR
prerank,bile acid and bile salt transport (GO:0015721),-0.36379161419117323,-1.072332207245727,0.34277620396600567,0.7453730071061043,1.0,3/24,7.06%,SLCO2B1;ABCC3;ATP8B1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3960056513143684,-1.0720066559182722,0.3785900783289817,0.7449075088542016,1.0,7/16,22.67%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,negative regulation of cell adhesion (GO:0007162),0.3586788428770876,1.071735390149507,0.3650190114068441,0.7169483248906303,1.0,16/72,14.22%,PTPRC;PTPRO;RIPOR2;CBLL1;SPN;ARHGDIB;TGFBI;PLXND1;EPHB2;RHOA;DUSP1;PLXNC1;NF2;TBCD;CD164;TGFB1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.311804094380878,1.071483287107752,0.278,0.7170167609376498,1.0,120/572,18.14%,CIITA;BCL11A;TRPS1;FOXP1;RARA;SP100;RUNX3;KLF4;UXT;PPARG;ETV6;BCL6;SAP30;NFKB1;STAT3;HSPA1A;FOXJ1;NIPBL;NEDD4L;MAD2L2;SPI1;CRY1;TBL1XR1;MTA3;GATAD2B;ZEB2;SUMO1;LRRFIP1;KLF8;IRF2;RBPJ;IL33;KCNIP3;HIVEP1;DEAF1;STAT1;UBE2D3;HEXIM1;CCND1;KLF10;RPS14;CGGBP1;WFS1;CBFB;CREM;MECP2;PDE2A;THRA;CRY2;GATAD2A;RARG;EZR;CTCF;PHF12;HDAC9;BACH1;ID2;WWP2;EZH1;E4F1;PARP9;IRF7;SMAD4;CNOT2;LIN37;NR3C1;SPEN;FOXO3;IKZF5;TAF7;ETS2;REST;MBD2;MAP2K5;NUPR2;PSMD10;ATRX;MYB;NRIP1;NSD1;EZH2;SREBF2;CITED2;HDAC3;NFIL3;ZNF431;GPS2;ZNF436;MAFK;AURKB;MAZ;DUSP26;CREBBP;RELA;USP9X;MIER1;TAF1;BHLHE40;ZNF148;MED1;DUSP22;RB1;BPTF;NCOA5;SEMA4D;PROX1;PSEN1;ELK4;SIRT1;SUPT4H1;MCPH1;NFATC3;EFNA1;ORC2;BAG3;HCFC2;HDAC1;SMURF2;FOXC1;CBX8
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4769912645283429,1.0706886591936968,0.38688524590163936,0.7184526499140326,1.0,5/14,12.26%,NFKBIA;NFKBIE;FAF1;NFKBIB;PSMD10
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.46298793677272904,-1.0706261619362754,0.35374149659863946,0.7473868051984425,1.0,6/10,21.27%,CAMK1;SMARCB1;PIH1D1;BRCA1;SPHK2;RAPGEF3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4049821389581543,1.0705283327297115,0.39628040057224606,0.7182993604295094,1.0,4/30,9.32%,FOXP1;PKN1;H3-3A;NCOA2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3468993708178497,-1.0705099137292584,0.321875,0.7463563464699562,1.0,9/26,18.86%,PRKN;ASAP3;LIMK1;PFN1;PFN2;CX3CL1;PLEK;RDX;SYNPO2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.40337772281315487,-1.0703424625199776,0.3696808510638298,0.7454520268488412,1.0,5/15,17.90%,LGMN;MVB12B;FER;PTPN18;RHBDF2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4968175676420912,1.070117532030329,0.3922480620155039,0.7187351016496031,1.0,3/12,12.95%,CDC45;MCM6;MCM2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.48634488832285305,1.0690734094018033,0.3785211267605634,0.720698177931836,1.0,5/13,17.81%,SPI1;FAM47E;ELOF1;ZMIZ2;PADI2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.44754544309555,-1.0690500366051252,0.3879093198992443,0.7477913664836227,1.0,3/12,0.72%,PRKG1;DOCK4;MEF2C
prerank,axon development (GO:0061564),-0.2765494420045746,-1.068961290221236,0.30319148936170215,0.7466902439990775,1.0,25/78,20.01%,RTN4RL1;DCC;MAP1B;PLP1;CTNNA2;CNTN4;FGFR2;NREP;RYK;AFG3L2;CDK5R1;MAP1A;ARHGAP35;PARD3;CDK5;KLF7;CAMSAP2;MTR;SLITRK1;ADGRB1;APBB1;NEFH;RAB3A;PLPPR4;GRM7
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3676700331955007,1.0689451430191972,0.3602941176470588,0.7204773380510039,1.0,23/63,20.90%,SP100;TRAF1;PSME3;BIRC6;BCL2L14;PAK2;TMC8;CYLD;RIPK1;DEDD2;HTT;SH3RF1;LGALS3;GSTP1;RELA;THBS1;TRAF2;DEPTOR;FGFR1;PARK7;FEM1B;ITGAV;PHIP
prerank,extracellular matrix organization (GO:0030198),0.3203890377894694,1.068512599336204,0.3340270551508845,0.720989904543972,1.0,31/276,10.33%,ITGB7;ITGA4;ITGAL;CD44;CD47;LCP1;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;SCX;ITGAD;ITGB2;HSPG2;CAPN2;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;TLL1;ADAM19;NCAN;FN1
prerank,cilium movement (GO:0003341),0.3783218082922216,1.0683640008522934,0.353099730458221,0.7208161991507138,1.0,9/48,13.29%,DNAH9;ADCY10;DNAAF5;CABYR;CFAP61;ODAD1;CCDC39;CFAP54;CFAP70
prerank,positive regulation of cell adhesion (GO:0045785),0.3591644634897245,1.0679992407154046,0.37880633373934225,0.7211684349059624,1.0,10/74,8.19%,CD47;RET;NDNF;SYK;JAK2;PPP3CA;RSU1;AFDN;CIB1;RAC1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5025495208134606,1.0678480114989004,0.41402337228714525,0.7210095275530322,1.0,5/12,21.94%,DIAPH1;PTK2B;FKBP1B;ANXA6;UBASH3B
prerank,embryonic limb morphogenesis (GO:0030326),-0.3239377800242838,-1.0677535739737258,0.31226765799256506,0.7486339173545428,1.0,6/34,4.23%,SKI;LRP6;SALL1;CTNNB1;CACNA1C;WDPCP
prerank,cellular response to starvation (GO:0009267),0.3339384229278016,1.0677020593498818,0.3511111111111111,0.7208471897242817,1.0,39/147,17.99%,LRRK2;SIK1;STK24;MAP3K5;PRKAG2;ATP6V0E1;BMPR2;EIF2AK2;ATF2;KLF10;MTMR3;WRN;ATG5;CLEC16A;SIK2;RALB;ATP6V1H;DEPDC5;PRKAG1;RHEB;FOXO3;PRKAA1;NUPR2;PIK3R4;WIPI2;CASTOR2;EIF2AK3;MAPK8;SREBF2;PRKAA2;BRSK1;RRP8;MAPK1;SEH1L;XPR1;SIRT1;ATP6V1E1;BECN1;HSPA5
prerank,regulation of ruffle assembly (GO:1900027),-0.36068887569169206,-1.0675623398971898,0.3524355300859599,0.7478356983918659,1.0,6/23,5.75%,P2RY12;EVL;NLGN1;ARHGAP24;P2RX4;PFN1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.3118246945964099,-1.0674672739346074,0.34814814814814815,0.7467777824742494,1.0,10/42,17.99%,TREM2;SLC11A1;PYCARD;OPTN;SERPINE1;TLR4;HMGB2;ADGRB1;MR1;DROSHA
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4014253786575812,1.0672062822473687,0.3595505617977528,0.7215275442968815,1.0,6/35,7.50%,ADGRG6;CD36;RAPGEF2;PDE7A;AHR;PDE2A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.35096000403199695,1.0671879707102994,0.3705080545229244,0.7210451681848471,1.0,16/80,12.06%,ACTR3;EPS8;WASF2;RIPOR2;CCDC88A;RAC2;DOCK11;CDC42;ARAP1;ACTR2;RAC1;BCAS3;ARPC2;PIK3CA;TAPT1;HTT
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.2853189676619267,-1.0671231136751766,0.3348623853211009,0.7464740164346273,1.0,17/65,13.20%,KCND2;CPEB2;FAM162A;STUB1;CPEB1;HIF1A;ADAM8;PGK1;EGLN3;FMN2;EGLN2;HYOU1;CPEB4;HMOX1;VEGFA;TIGAR;P4HB
prerank,receptor catabolic process (GO:0032801),-0.352369907184953,-1.0671174010711317,0.37797619047619047,0.7451783871910101,1.0,7/24,12.15%,LGMN;MYLIP;AP2A1;SNX25;CLTA;ZNRF3;AP2M1
prerank,negative regulation of immune system process (GO:0002683),0.46424584359157756,1.0669875907289694,0.40062111801242234,0.7209760622014298,1.0,1/16,0.76%,LYN
prerank,nucleoside catabolic process (GO:0009164),0.5022459325433591,1.0667754135105934,0.3936348408710218,0.7209560315671006,1.0,3/11,13.21%,UPB1;DERA;NT5C3A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.4246962704826093,-1.0667550216266188,0.3740648379052369,0.74488912396868,1.0,11/13,44.97%,ANAPC15;TPR;LCMT1;GEN1;NDC80;CDK5RAP2;MAD2L1;XRCC3;PCID2;DYNC1LI1;CCNB1
prerank,response to estrogen (GO:0043627),0.40717392911751354,1.0664664013976648,0.3684210526315789,0.7212186983355734,1.0,4/31,9.14%,RARA;SERPINB9;TRIM25;BCAS3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.30174156347746983,-1.0663891597230981,0.3319672131147541,0.7445299371429134,1.0,24/47,30.12%,ATP5F1A;ATP5PO;APOO;AFG3L2;TMEM11;TIMM9;ATP5MG;ATP5PD;CHCHD6;ATP5PF;SPG7;ATP5F1D;ATP5MC3;TIMM10B;AGK;NDUFA13;ATP5MF;TIMM13;SAMM50;TIMM8B;ROMO1;TIMM29;APOOL;UQCC3
prerank,positive regulation of hormone secretion (GO:0046887),-0.3933390842431679,-1.0663383485484392,0.36768802228412256,0.7433789636354453,1.0,9/17,39.80%,SPP1;VAMP8;SOX11;HFE;PLA2G3;C1QTNF3;GRP;TFR2;HCAR2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.35673001508583646,1.0660662219476569,0.38154613466334164,0.7216546873455487,1.0,9/75,7.39%,CCR2;KLF4;PPARG;CXCL10;ATF2;SYNJ2BP;STAT1;HSPG2;MECP2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.4604382432123257,1.0658845060905706,0.3971518987341772,0.721550328272972,1.0,3/16,5.88%,MAD2L2;SMCHD1;KLHL15
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.46757402700320355,1.0658051071425179,0.3784219001610306,0.7212114501106909,1.0,6/15,18.68%,MRE11;ATF2;HUS1;MDC1;RAD17;CHEK2
prerank,pentose-phosphate shunt (GO:0006098),0.49920379496376155,1.0655470876788993,0.40165289256198344,0.7212998310429295,1.0,5/11,15.36%,TALDO1;RPE;DERA;RBKS;H6PD
prerank,regulation of water loss via skin (GO:0033561),0.4646421236853824,1.065286094034774,0.37720706260032105,0.7208464550015148,1.0,3/15,20.54%,CLDN1;FA2H;UGCG
prerank,establishment of skin barrier (GO:0061436),0.4646421236853824,1.065286094034774,0.37720706260032105,0.7208464550015148,1.0,3/15,20.54%,CLDN1;FA2H;UGCG
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5199375855148445,1.0652696639250314,0.4056437389770723,0.7203593947891728,1.0,2/10,3.50%,HSPA1A;SORL1
prerank,regulation of viral release from host cell (GO:1902186),0.4373544952334444,1.0651138770661837,0.3652694610778443,0.720207066721719,1.0,4/21,7.47%,TRIM26;TRIM62;TSG101;TRIM25
prerank,protein localization to membrane (GO:0072657),0.3259026162341869,1.0645924795358468,0.3776824034334764,0.7209996871660876,1.0,22/187,8.37%,ITGB7;ITGA4;ITGAL;RAP1A;SYNE3;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;IKBKB;EHD2;SYNJ2BP;KCNIP3;ITGB2;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14
prerank,blood vessel morphogenesis (GO:0048514),-0.29083377058164983,-1.0637703133342338,0.34439834024896265,0.7491819720807105,1.0,7/54,4.43%,TGFBR2;NRP1;TGFBR1;FLT1;NF1;SMAD7;RASA1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.32833059716898616,-1.0636843077526552,0.3400673400673401,0.7480780898291803,1.0,12/35,16.60%,DDX5;RBFOX2;PLPP1;PGR;EGLN2;NR3C2;PPARGC1B;CALCOCO1;ESR1;SRC;AR;NCOA4
prerank,thyroid hormone generation (GO:0006590),0.5086245753356256,1.0632207778547875,0.375,0.7237488229630692,1.0,1/10,7.40%,CPQ
prerank,UV protection (GO:0009650),0.5140683314116548,1.0630834969659646,0.4074074074074074,0.7235508792083732,1.0,2/10,4.13%,GPX1;FEN1
prerank,mitotic cytokinesis (GO:0000281),0.379898736638067,1.0626680620734674,0.39620081411126185,0.723999761593141,1.0,16/47,17.64%,RACGAP1;KIF20A;MITD1;KIF23;CHMP4B;PDCD6IP;SPAST;SNX9;UNC119;ROCK1;EFHC2;SNX33;APC;TRIM36;RAB35;CNTROB
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4526417378535279,1.0626257579176246,0.36910569105691055,0.7235776457449932,1.0,7/17,16.74%,CCND3;CCND1;ADAM17;PSMD10;CCND2;AKT1;PROX1
prerank,cell-cell junction organization (GO:0045216),-0.2697039929031585,-1.0625535216243525,0.27741935483870966,0.7497568676332604,1.0,18/79,14.27%,CSF1R;TJP1;CADM1;PKP4;FLCN;CADM2;CDH11;SDK1;JUP;TJP2;SMAD3;PVR;NECTIN4;TLN2;NLGN2;TRPV4;TGFB2;CXADR
prerank,regulation of protein transport (GO:0051223),0.4105059277071068,1.0622874744563182,0.37163120567375885,0.7238487311829891,1.0,11/27,23.14%,LCP1;DNAJC1;WWP2;PTPN1;SNX3;SNX12;NDFIP2;LLGL2;HSPA8;TNF;SCFD1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.39626002852839526,-1.061466831838754,0.38202247191011235,0.7514228247210472,1.0,4/17,3.16%,IGF1;DOCK4;NRP1;AIF1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.284521326169913,-1.0612893308664122,0.32432432432432434,0.7506208787042203,1.0,8/65,5.48%,LDLRAD4;TGFBR2;SKI;TGFBR1;SNX25;SMAD7;STUB1;UBC
prerank,regulation of epithelial cell migration (GO:0010632),0.3771077113892337,1.0610798961692183,0.39304123711340205,0.7262144465609417,1.0,6/51,3.77%,DOCK5;PRKCE;PLCG2;MARVELD3;BMPR2;GLIPR2
prerank,protein sumoylation (GO:0016925),0.3741995173707621,1.0608348604023468,0.36947791164658633,0.7262846951726466,1.0,5/49,7.27%,BCL11A;NUP210;SUMO1;IFIH1;NUP98
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2922014130538987,-1.0605331172037773,0.3508771929824561,0.7513195764730902,1.0,17/52,14.05%,DDX5;RBFOX1;RNPS1;RBFOX2;KHDRBS3;SRRM4;FXR1;NOVA1;RBFOX3;RBM5;THRAP3;FXR2;NOVA2;PTBP1;RBM25;KHDRBS2;WTAP
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3359548729613605,1.0605319517056742,0.38497652582159625,0.7264803600650549,1.0,21/108,13.67%,LRRK2;TIAM1;SULF2;NOTUM;RSPO2;RSPO3;GPC3;APCDD1;AXIN1;CDK14;CBFB;KREMEN1;CSNK2A1;GSKIP;NLK;APP;TLR2;SNX3;TLE1;TAX1BP3;ITGA3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3850888571070426,1.0604848153091115,0.37640449438202245,0.7260550917269849,1.0,10/38,14.21%,LRRK2;RAC2;FBXW7;UBE2D3;PARL;ARIH2;CSNK2A2;RNF31;SREBF2;UBE2J2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5140092095563463,1.0603582342929292,0.4054982817869416,0.7258335724243092,1.0,1/10,0.80%,PRKCE
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.36541659230328294,1.060223645696207,0.36753246753246754,0.7256498044258874,1.0,15/57,18.68%,DTL;MRE11;ATF2;TAOK3;WAC;CCND1;UIMC1;RINT1;DONSON;BRSK1;HUS1;MDC1;RAD17;FZR1;CHEK2
prerank,Rho protein signal transduction (GO:0007266),0.37034196861551316,1.0599708209066572,0.389945652173913,0.7257381898221713,1.0,13/53,15.04%,EPS8;NGFR;CELSR1;SHTN1;CDC42;ADRA2A;ARHGDIB;RHOA;NTN1;TAX1BP3;ROCK1;ARHGEF3;RHOG
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.34340134419329693,1.0598407448048988,0.3948896631823461,0.7255145072166683,1.0,25/101,16.50%,NIBAN1;BCL3;KLF4;RPL5;MSN;VIM;NFKBIA;PTTG1IP;FBXW11;FAF1;YTHDF3;EZR;IL6;ATG10;AKT1;METTL3;CYFIP2;LARP4B;TGFB1;EIF3E;THBS1;RPS4X;RPS6KB1;AURKAIP1;WNT7A
prerank,anion transmembrane transport (GO:0098656),0.3601686257265923,1.0597735681781255,0.37593984962406013,0.7251431924829097,1.0,15/67,14.80%,LRRC8C;SLC23A2;SLC23A1;LRRC8D;SLC25A13;LRRC8B;SLC25A30;ABCC1;SLC25A12;SLC6A5;SLC25A18;SLC25A5;SLC35A1;SLC6A9;SLC35A3
prerank,positive regulation of filopodium assembly (GO:0051491),-0.3593576636697545,-1.0595946268197762,0.3798219584569733,0.7525685331304428,1.0,11/24,15.16%,NRP1;NLGN1;TENM2;RHOQ;GPM6A;PIK3R1;RALA;DPYSL3;AGRN;PALM;TENM1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4198623046186527,1.0593347215095408,0.3881278538812785,0.7256214716461342,1.0,10/26,14.95%,ANKRD17;CCND3;CCND1;ADAM17;PLCB1;ANXA1;MTBP;CCND2;AKT1;KMT2E
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3493670835718394,1.0592386190297043,0.3939393939393939,0.725328073941431,1.0,17/86,15.65%,JAK2;BMPR2;RBPMS;ZEB2;GDF1;RBPJ;HIPK2;ADAM17;BMP3;ENG;ACVR2A;SMAD4;ING2;CITED2;TGFB1;CREBBP;THBS1
prerank,negative regulation of metabolic process (GO:0009892),0.3732271997799196,1.059211830656351,0.3825136612021858,0.7248724149623564,1.0,9/54,11.73%,IL1B;LNPEP;ACOT11;RBPJ;ZDHHC7;ADAM17;FIS1;RHEB;PGAM5
prerank,cellular protein localization (GO:0034613),0.3156529873061825,1.0589729801697203,0.3609100310237849,0.7248972407606815,1.0,36/285,10.56%,CD74;LRRK2;TBC1D1;STX11;NGFR;RAB19;TBC1D8;PTPRU;CELSR1;FOXJ1;TBC1D9;NIPBL;RABL3;LAPTM5;CD177;USP6NL;TBC1D10C;TBC1D2B;SNX1;TBC1D8B;ARF4;STX17;RAB6A;RABGAP1L;FLNA;STX6;TMED10;RABGAP1;ARF1;STX5;STX12;TBC1D5;SLU7;STX7;CEP250;SNX9
prerank,sensory organ development (GO:0007423),0.3697752596875609,1.0585311638326742,0.376984126984127,0.725475937300574,1.0,6/51,6.12%,MAB21L2;SIPA1L3;ATF6;HIPK2;SMCHD1;HIPK1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3566767175138481,-1.0585034283971997,0.3864306784660767,0.7542619129582375,1.0,13/23,29.26%,TIMM9;BAX;COX18;TIMM10B;AGK;NDUFA13;TIMM13;SAMM50;TIMM8B;HSP90AA1;BMF;ROMO1;TIMM29
prerank,regulation of mononuclear cell migration (GO:0071675),0.4199109164370458,1.0583318029742532,0.4017467248908297,0.7254094709260948,1.0,3/23,2.13%,STK10;LYN;MSN
prerank,positive regulation of immune system process (GO:0002684),-0.3945797480588101,-1.0583276949233813,0.384,0.7534361961489027,1.0,4/16,13.74%,LGALS9;NCKAP1L;VEGFA;TGFB2
prerank,response to reactive oxygen species (GO:0000302),0.36966739531470033,1.0582270585519584,0.37451235370611186,0.7251215713979317,1.0,15/54,15.36%,STK24;FYN;FOS;GPX1;HP;PXN;CAMKK2;RPS3;MAPK8;AKT1;NCF1;ADAM9;GSTP1;MAPK1;PRDX5
prerank,protein heterotetramerization (GO:0051290),-0.4248520065702206,-1.057965978301845,0.39709443099273606,0.7531370246240974,1.0,6/13,22.55%,PKD2;CPSF6;CBR4;HSD17B8;FARSA;GRIN2B
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4895358161140993,1.057908405523372,0.42857142857142855,0.7253325248913114,1.0,3/12,10.52%,ERN1;ATF6;PTPN1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.43535741373996134,1.0578405158271906,0.3952,0.7249658878434693,1.0,6/21,15.79%,MED30;MED13;SETX;MED12;MED14;MED1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3782342975120576,1.0578252110361452,0.38235294117647056,0.7244835483544892,1.0,8/51,9.48%,CCR2;CCR1;CXCL10;IL6R;VEGFC;ADAM17;IL6;PGF
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.41797355196264807,1.0577526877208376,0.3536231884057971,0.7241429882129988,1.0,4/26,9.64%,RARA;LILRB3;TLR3;FBN1
prerank,regulation of autophagosome maturation (GO:1901096),0.49415188145184946,1.0577379926665251,0.4262295081967213,0.7236590847327806,1.0,2/13,7.32%,UVRAG;CLEC16A
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3625775492552313,1.0577359290926938,0.3974358974358974,0.7231445686240138,1.0,22/66,19.97%,NGFR;DTX3L;KAT7;UBR5;FLNA;RBM22;PARP9;NMD3;EIF2AK3;ZPR1;AKT1;LIMK2;HCLS1;HDAC3;TGFB1;TCP1;PSEN1;PIK3R2;BAG3;PRKCD;LARP7;PARK7
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.466252198757804,1.0576101253010164,0.38287560581583197,0.7229265755360764,1.0,2/16,2.85%,TET2;UPB1
prerank,response to light stimulus (GO:0009416),0.3644198433033039,1.0566331053834077,0.3729456384323641,0.7247466420892708,1.0,13/55,14.86%,DTL;CRY1;CRY2;CLOCK;MSH6;COPS3;GPR88;MAP4K3;ERCC3;MAPK8;ERCC4;PCLAF;BRSK1
prerank,regulation of chromosome organization (GO:0033044),-0.35665214352768704,-1.056471702641113,0.3644578313253012,0.7558039196762112,1.0,5/22,11.58%,WAPL;YLPM1;UPF1;TERF2IP;XRCC5
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.3699043454848093,-1.056013584348571,0.3628808864265928,0.7558069298734691,1.0,7/20,12.11%,IGF1;NRP1;LRP1;PLAU;PDGFA;SLIT2;SERPINE1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.34093324135960107,1.0560098522947425,0.3736654804270463,0.7257227480388989,1.0,19/93,14.22%,CD44;NGF;PAK1;SH2D3C;MAD2L2;AXIN1;PTEN;STK4;DDIT4;PAQR3;IL6;LATS1;CREBL2;BRAF;APP;AKT1;NSD1;HCLS1;TGFB1
prerank,negative regulation of response to wounding (GO:1903035),0.4420129786946048,1.0552033311097146,0.3978328173374613,0.7271564993995481,1.0,4/19,9.40%,CASK;CRK;INPP5F;GIT1
prerank,neuron projection organization (GO:0106027),-0.3950815558062854,-1.054777776714503,0.38227146814404434,0.757927059045799,1.0,4/15,9.50%,LGMN;ABCD2;MAP1A;CHRNA7
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.49798707092358985,1.05432045549624,0.4200988467874794,0.7287094363634732,1.0,3/11,10.39%,LYN;RAPGEF2;ANXA1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.34480610509948717,-1.0540236438673216,0.3663663663663664,0.7587507932708576,1.0,11/25,19.49%,EVL;ARHGAP24;EVI5L;SLIT2;ODF2L;RAP1GAP;TCHP;PFN2;CDK10;PLXNB3;CEP97
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.31205067618413956,-1.0537671546131655,0.35580524344569286,0.7581777485508272,1.0,7/39,6.52%,MAML2;ROBO2;MAML3;ROBO1;AAK1;EPN2;BMP2K
prerank,regulation of actomyosin structure organization (GO:0110020),0.48875381733213846,1.0535022782795789,0.4135090609555189,0.730107121567455,1.0,7/13,21.31%,PTGER4;CDC42;RAC1;ROCK1;FHOD1;ALMS1;WAS
prerank,neurotransmitter transport (GO:0006836),-0.2694801425792867,-1.0534721278827535,0.3411764705882353,0.7576221406958047,1.0,25/73,22.61%,SYT1;PTPRN2;GLUL;SLC1A3;NRXN2;PPFIA4;SLC6A15;SLC17A6;SNAP25;ATP1A2;GAD2;SNPH;STX1A;SLC29A1;SLC5A7;LIN7A;CPLX1;GABRA2;RIMS1;RAB3A;NRXN1;GAD1;SYN2;PDZD11;SLC32A1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2917298747352044,-1.0531968518532853,0.3470319634703196,0.7570890397467456,1.0,20/52,22.10%,PREB;TPP1;ATP6V0D1;HYOU1;GOSR2;ARFGAP1;SRPRB;PARP16;TATDN2;DNAJB11;GFPT1;PDIA6;EXTL3;CXXC1;VAPB;DNAJB9;FKBP14;DDX11;HDGF;PDIA5
prerank,nuclear membrane reassembly (GO:0031468),0.3679987349968051,1.0530658056054876,0.3790931989924433,0.730676604417846,1.0,10/54,10.53%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,entry into host (GO:0044409),0.4752341129703396,1.0527247495929932,0.4083333333333333,0.7309297432763687,1.0,3/13,6.44%,CBL;CBLL1;GRB2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.42914326548541126,1.0526562689302785,0.40188383045525905,0.7305971547875713,1.0,4/20,15.65%,SULF2;NPTN;DSTYK;THBS1
prerank,positive regulation of vascular permeability (GO:0043117),-0.4220192467225684,-1.0525852365244899,0.40153452685422,0.7574400268306892,1.0,6/12,18.26%,TJP1;TJP2;VEGFA;TRPV4;BMP6;ANGPT1
prerank,regulation of cellular response to stress (GO:0080135),-0.2535010196077649,-1.0524320449578175,0.3103448275862069,0.7565662961734954,1.0,35/115,19.43%,PRKN;NUAK1;RPTOR;NEK6;NUP54;ATF3;NUP133;CORO2B;BAG4;NUP155;BAG1;ATF4;NUP188;NEK4;DNAJC2;USP19;RANBP2;PTGES3;NPM1;SEC13;NPAS2;NUP85;EIF4G1;MANF;HSBP1;MBTPS2;NUP42;TPR;CAMK2A;NUP35;ADCY8;AKT1S1;HSP90AB1;CRYAB;NUP37
prerank,steroid catabolic process (GO:0006706),0.5024402509831051,1.0523979123607259,0.40273037542662116,0.7306656033193288,1.0,2/10,12.84%,HSD17B14;HSD17B11
prerank,negative regulation of cell death (GO:0060548),0.34460533777158525,1.0521693850254779,0.37841043890865955,0.7306450037663053,1.0,10/88,8.09%,LRRK2;SRGAP2;FYN;HSPA1A;SORL1;CHMP4A;CHMP4B;WFS1;ATG5;TM7SF3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.43028125719633914,1.0521558263809057,0.3953488372093023,0.7301524844614996,1.0,6/18,19.19%,PTBP3;KAT2B;TGFB1;PTBP2;SHQ1;RPS13
prerank,regulation of protein catabolic process (GO:0042176),0.3394325320662096,1.0520871569789365,0.38600723763570566,0.7297805077250491,1.0,31/99,18.97%,DTL;ITCH;ASB5;NEDD4L;MAD2L2;SORL1;GPC3;AXIN1;RAB7A;FAF1;TIPARP;FLNA;AZIN1;STX5;SNF8;WWP2;CSNK2A1;SNX3;AREL1;VCP;SNX12;IRAK3;RNF41;APC;HACE1;SF3B3;SMURF2;FZR1;PIN1;CHEK2;PRKCG
prerank,positive regulation of lipid catabolic process (GO:0050996),0.460077513481508,1.0516965316768616,0.39351851851851855,0.7302205881485476,1.0,1/19,0.33%,IL1B
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4562165336047713,1.0516600043775333,0.4204724409448819,0.7297927753052447,1.0,4/16,12.78%,BCL3;INPP5F;PARP14;NF2
prerank,positive regulation of lipid localization (GO:1905954),-0.44460851607266705,-1.0515102956247644,0.4188235294117647,0.7579280436786987,1.0,4/11,13.73%,LRP1;IKBKE;VSTM2A;C3
prerank,regulation of oxidoreductase activity (GO:0051341),0.47606825020111937,1.0514442755109201,0.42671009771986973,0.7297834200956017,1.0,5/13,17.11%,HP;ATP7A;SLAMF8;SIRT4;ABL2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4739400420713573,1.051114141258106,0.4114671163575042,0.7300594770371707,1.0,7/14,20.27%,MAPKAPK2;MAPK14;TIRAP;MYD88;BOLL;YBX3;HNRNPC
prerank,positive regulation of cellular component organization (GO:0051130),-0.2550690001875641,-1.0506610726381305,0.30708661417322836,0.7590495393253395,1.0,27/107,15.74%,APOE;PLEKHM2;FNIP2;TREM2;TGFBR1;LRP1;CAMK1;SLF2;FNIP1;FRMPD4;ABCB4;SLF1;TAL1;LMAN1;ADGRL1;TFRC;TMED9;FLOT1;VEGFA;CLU;TGFB2;WARS1;BAX;DAB2IP;PIH1D1;TPPP;AR
prerank,organic hydroxy compound transport (GO:0015850),-0.31445842426572196,-1.0502499756069041,0.367003367003367,0.758891912928904,1.0,3/36,7.06%,SLCO2B1;ABCC3;ATP8B1
prerank,substrate-dependent cell migration (GO:0006929),0.47257695424471075,1.050244054459365,0.40854700854700854,0.7316136102675058,1.0,4/14,5.00%,PTPRC;SHTN1;CD2AP;VEGFC
prerank,cell projection organization (GO:0030030),-0.33422735890112476,-1.0499240536053984,0.3980263157894737,0.7585067186661639,1.0,11/30,17.46%,P2RY12;RHOH;PARVG;RHOQ;CAPG;PDGFA;NCKAP1L;PARVA;RHOU;PLEK;NEFH
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.35058045227837054,1.049331973441685,0.3842364532019704,0.7332638161876068,1.0,27/70,22.11%,NGF;MCL1;JAK2;IL6R;HIPK1;PDPK1;CIB1;SIVA1;TLR3;DAXX;CASP2;RIPK1;DEDD2;TNFRSF1B;TGFB1;FGFR3;RNF41;TRAF2;BAG3;APPL1;BAD;ITGAV;DIABLO;BID;GSK3B;CASP9;BCL2
prerank,plasma membrane invagination (GO:0099024),0.40115764246060037,1.0489626672355536,0.4059259259259259,0.7335950451122801,1.0,12/29,18.27%,CD36;MYH9;CDC42;ITGB2;RHOA;SNX9;FCGR2B;AURKB;ELMO1;SNX33;GULP1;FCGR1A
prerank,positive regulation of leukocyte migration (GO:0002687),-0.34240258281749913,-1.0489112253668185,0.35313531353135313,0.7599530172384272,1.0,8/27,13.68%,AIF1;PTN;CSF1;ADAM8;NCKAP1L;VEGFA;JAM3;MDK
prerank,basement membrane organization (GO:0071711),0.4830589681694451,1.0487413784681667,0.3967479674796748,0.7336040628972121,1.0,3/14,8.31%,NTNG2;LAMB1;PXDN
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2875788140965515,-1.048650958348219,0.3562231759656652,0.7593976861839473,1.0,11/57,15.27%,PRKN;TREM2;SPIRE1;FAM162A;PPARGC1A;PYCARD;MFF;VPS35;RALA;BAX;HTRA2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.394716037464488,1.0483819436818054,0.40404040404040403,0.7339513944522115,1.0,10/35,16.82%,POLL;FEN1;POLD4;MBD4;SMUG1;TDG;PARG;RPA3;POLB;POLD1
prerank,regulation of heart contraction (GO:0008016),0.3457180678344463,1.0480532269457663,0.39903264812575573,0.73421353853612,1.0,8/90,4.80%,ITPR1;ACE2;GJA5;RNF207;KCNQ1;HCN4;ATP2B1;ATP2A3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.45625247443160616,-1.0479982576030829,0.3957845433255269,0.7599400321088082,1.0,4/10,28.92%,SAE1;PIAS4;HDAC4;UBA2
prerank,protein K63-linked ubiquitination (GO:0070534),0.3856828445336061,1.0478717733683365,0.40440165061898214,0.7341297693469058,1.0,11/41,12.38%,TRAF1;ITCH;TRAF3IP2;PELI1;UBE2N;HECTD1;TRAF3;ARIH2;WWP2;UBE2S;UBE2G1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2700669522959209,-1.0474452655205826,0.3448275862068966,0.7601390166507935,1.0,13/88,8.34%,PTPRM;APOE;SPARC;NRP1;TGFBR1;NRP2;FGF2;ATP5F1A;NF1;HIF1A;HTR2B;ITGB3;SCG2
prerank,recombinational repair (GO:0000725),0.3494915015906913,1.0472849134824909,0.39015151515151514,0.7350323890026226,1.0,19/77,16.37%,SAMHD1;RBBP8;POLL;MRE11;FEN1;UBE2N;WRN;NABP1;MORF4L1;RECQL5;RPA3;EXD2;SPIDR;ERCC4;RNF138;XRCC2;INO80;MCM9;HUS1
prerank,hepaticobiliary system development (GO:0061008),-0.3636644573352265,-1.0472667232853725,0.36033519553072624,0.7593970682422956,1.0,6/20,13.66%,PKD2;NF1;ARID5B;CEBPG;PHF2;PRKCSH
prerank,positive regulation of cellular process (GO:0048522),0.3049273577641499,1.0472075204670592,0.342713567839196,0.7346987983064781,1.0,105/565,16.27%,DPP4;IL1B;GRK5;RARA;TIAM1;HCK;LYN;CD47;GLI1;FLT3;CDK13;DOCK2;ITGAX;CAMK1D;ACER3;TBC1D8;PAK1;FGF5;FGF22;CUL3;CD36;RPS6KA3;ANKRD17;PTPN6;MYRF;SCX;IL6R;CDC42;GDNF;PPP3CA;HP;HPR;VEGFC;H3-3A;ADRA2A;IL2RG;FAF1;PTEN;CCND1;CXCL16;PTK2B;ADAM17;CIB1;MTPN;MECP2;CNOT6;NOX1;LMNA;DOT1L;RAC1;CACUL1;IL6ST;IL6;DDX49;PGF;CSNK2A1;RPRD1B;FN1;IL31RA;GLP2R;MCTS1;PRKAA1;FKBP1B;NAP1L1;FCGR2B;DYNC1H1;RPS6KA1;SLC25A5;CSPP1;PSMD10;TLR2;PDGFD;CCND2;LIFR;PABIR1;MAPK8;AKT1;FCER1G;TNFRSF1B;HCLS1;EZH2;AGPAT1;GNAI2;PRKAA2;CITED2;TGFB1;COX17;FGFR3;PTPRJ;MAZ;RHOG;DUSP26;RELA;RPS15A;NCBP1;DVL2;INO80;THBS1;CELF1;CDCA7L;RPS4X;APC;USP47;NSMCE4A;INSR
prerank,positive regulation of receptor internalization (GO:0002092),-0.35549414530698903,-1.046195358091213,0.3850574712643678,0.7610726274953472,1.0,8/22,28.54%,MAGI2;CD63;VEGFA;SCYL2;ANGPT1;ARRB2;PICK1;EGF
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.49906958142020075,1.0460484299710848,0.4067796610169492,0.7369252527605702,1.0,1/11,0.26%,CD44
prerank,positive regulation of transport (GO:0051050),0.34672181480309244,1.045416987500068,0.4213759213759214,0.7378965407289709,1.0,10/85,5.37%,IL1B;CD47;DOCK2;CAMK1D;ANXA2;NEDD4L;C2CD5;GPC3;CBLL1;IL2RG
prerank,negative regulation of response to stimulus (GO:0048585),0.36299387652897613,1.045060839686826,0.3969658659924147,0.7382168392080135,1.0,9/60,12.11%,LYN;KLF4;CASK;AKT3;ADRA2A;WFS1;PTPN1;FCGR2B;MAP2K5
prerank,macrophage differentiation (GO:0030225),-0.4122721332537706,-1.0447467535519985,0.40669856459330145,0.7637269386186893,1.0,2/13,3.39%,CSF1R;CSF1
prerank,Rap protein signal transduction (GO:0032486),0.5025007177494667,1.043954027477765,0.42237061769616024,0.74043125181426,1.0,2/10,3.14%,RAP1A;RAPGEF2
prerank,lamellipodium organization (GO:0097581),0.4046520380037405,1.0438123388131966,0.4046920821114369,0.7402655713522354,1.0,7/29,13.20%,PTPRO;CCDC88A;CARMIL1;SNX1;RAC1;ARHGEF6;KIT
prerank,cellular response to metal ion (GO:0071248),0.32811378830993304,1.0437979731867575,0.3900226757369615,0.7397836466246607,1.0,23/123,13.78%,LRRK2;IQGAP1;PLCG2;ALOX5AP;FOS;HPCA;RASGRP2;DPEP1;SUMO1;CLIC4;KCNH1;PRNP;CPNE1;BRAF;DAXX;B2M;ADCY7;PRKAA1;CPNE2;MAPK8;AKT1;NCF1;PRKAA2
prerank,phosphate ion homeostasis (GO:0055062),-0.440371654577396,-1.043729152144585,0.40399002493765584,0.7653024962789414,1.0,1/10,3.14%,ENPP1
prerank,homeostasis of number of cells (GO:0048872),-0.42656739025883195,-1.0433992479103982,0.42431761786600497,0.7648856282096987,1.0,6/12,36.48%,CX3CR1;NAPEPLD;OCIAD2;LPCAT3;UBAP2L;CCN3
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3964563234440468,1.0431947693748826,0.41679160419790107,0.7406779327103069,1.0,6/29,13.76%,PAK1;AXIN1;CBFB;LATS1;CNOT2;STRN3
prerank,negative regulation of lipid storage (GO:0010888),-0.37658115256607455,-1.042700066795439,0.42058823529411765,0.7655667593773637,1.0,4/19,3.76%,ABCA1;TREM2;OSBPL8;TTC39B
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.44368547165777616,1.0426510498757773,0.39968895800933124,0.7414160743981785,1.0,4/18,8.29%,ACSL5;ELOVL5;HSD17B12;ELOVL6
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.41756618089175346,-1.0425524941187851,0.41866028708133973,0.7647179063872461,1.0,8/13,31.66%,ENTPD1;ENPP1;ENTPD5;ITPA;ENTPD7;ENPP3;ENTPD3;ENTPD6
prerank,positive regulation of axonogenesis (GO:0050772),0.37830434680118846,1.0424286071702895,0.4152777777777778,0.7413980100052634,1.0,5/43,2.36%,TIAM1;NGF;NGFR;TIAM2;SHTN1
prerank,sphingosine biosynthetic process (GO:0046512),0.489863546530228,1.0421371120643639,0.41889483065953653,0.7410653010546103,1.0,1/11,1.59%,ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.489863546530228,1.0421371120643639,0.41889483065953653,0.7410653010546103,1.0,1/11,1.59%,ACER3
prerank,regulation of axonogenesis (GO:0050770),0.3706572973005848,1.041957212252192,0.40992167101827676,0.7409789485902991,1.0,12/51,13.27%,TIAM1;NGF;NGFR;PAK1;TIAM2;PTEN;PAK2;PLXND1;RHOA;RTN4;PLXNC1;LRP4
prerank,response to amino acid (GO:0043200),-0.3243980157540498,-1.0416850019957151,0.3929712460063898,0.7658493176102094,1.0,12/31,19.38%,RPTOR;CPEB1;GLRA3;LARS1;IPO5;GLRA2;CPEB4;LAMTOR5;RRAGC;CPEB3;NSMF;SESN2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.46130694343957174,1.041499247786859,0.40634920634920635,0.7414298277326933,1.0,5/14,11.82%,PPP3CA;PPTC7;PPP2R2A;DUSP1;PPP1R15B
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.47377870495566626,1.041416718806661,0.42833607907743,0.7410770483256903,1.0,4/13,19.10%,MAD2L2;TAF1;PSEN1;TMSB4X
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.4098980625177322,-1.0412455812550279,0.39572192513368987,0.7657791504360201,1.0,6/13,18.23%,UBA3;SAE1;NAE1;UBA7;UBA1;ATG7
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.354701599670945,-1.041183831421827,0.396011396011396,0.7647195369858778,1.0,8/23,24.01%,COPS4;UBC;COPS7A;COPS2;COPS7B;UBA52;XPC;COPS6
prerank,protein deubiquitination (GO:0016579),0.3146532622328411,1.0409249170940003,0.3985200845665962,0.7417262923632195,1.0,69/242,18.09%,TNIP3;PSME3;NFKBIA;USP3;PSMB7;INO80C;PSME2;OTULINL;IL33;BIRC3;EIF3F;IFIH1;OTUD1;PTEN;USP49;NEDD8;TADA3;ATXN7;USP45;TRAF3;JOSD1;PSME4;SPATA2;UIMC1;ATXN3;USP32;USP48;USP31;RHOA;USP15;PSMB8;SMAD4;PSMA5;PSMD9;CYLD;RIPK1;USP42;STAM;PSMB3;PSMD6;PSMC4;NLRP3;USP40;MAP3K7;PSMD10;USP4;SNX3;OTUD4;PSMB1;KAT2B;VCP;USP37;USP7;ASXL2;VCPIP1;USP9X;INO80;APC;USP47;POLB;PSMD12;WDR20;FOXK1;TRAF2;TAB1;USP14;BECN1;USP38;SMURF2
prerank,autophagy of mitochondrion (GO:0000422),-0.3107038355901103,-1.0404850496082167,0.4134275618374558,0.7653638403866632,1.0,12/38,21.91%,PRKN;ULK2;MAP1LC3B;ATG12;USP30;SQSTM1;ATG9A;FUNDC2;ATG7;WDR45;ATG2A;GABARAP
prerank,oligosaccharide biosynthetic process (GO:0009312),0.435542270993463,1.0401484646418155,0.416260162601626,0.7430232047875613,1.0,2/20,3.36%,ST3GAL4;FUT4
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.4405188989829627,-1.0400174529567774,0.40654205607476634,0.7653727266789623,1.0,8/11,31.65%,TGFBR2;FGFR2;PDGFA;SOX9;MYC;WNT5A;LRP5;CTNNBIP1
prerank,regulation of mitochondrial translation (GO:0070129),-0.36198203830410397,-1.0398789888995625,0.407202216066482,0.7645026627819449,1.0,10/21,30.78%,RMND1;RCC1L;NSUN3;C1QBP;MTG1;SHMT2;FASTKD3;MPV17L2;COA3;ALKBH1
prerank,acidic amino acid transport (GO:0015800),0.43719655883945685,1.039843775882239,0.39461172741679873,0.7432008360851677,1.0,4/17,11.50%,LRRC8D;SLC25A13;SLC25A12;SLC25A18
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.43864019815289274,1.0395527423094724,0.4174454828660436,0.7434009817434573,1.0,4/19,12.33%,RFX3;ADCY10;CABYR;CCDC39
prerank,sterol transport (GO:0015918),0.4427629330342176,1.0395048925512138,0.4168012924071082,0.7429929169781717,1.0,2/19,2.75%,LDLR;CD36
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.47610965325873783,1.0394479572499227,0.4304635761589404,0.7426136596049993,1.0,6/13,19.85%,HEXIM1;RECQL5;NELFA;SUPT4H1;RNF168;LARP7
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.42729837579133584,1.0394323767940734,0.4143070044709389,0.7421413190823462,1.0,5/21,18.20%,JAK2;RBPMS;SMAD4;TGFB1;NUP93
prerank,erythrocyte differentiation (GO:0030218),0.37727432832948155,1.0392472300674267,0.41025641025641024,0.7420644487811553,1.0,12/44,16.73%,LYN;JAK2;HIPK2;RPS14;ID2;SLC25A5;HSPA9;KIT;HCLS1;KMT2E;MED1;ACIN1
prerank,regulation of cell projection organization (GO:0031344),-0.40725957255300066,-1.038684497429954,0.4186046511627907,0.7664943071661071,1.0,2/13,0.70%,MYO9A;TREM2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4921819349614399,1.0385865174144775,0.42016806722689076,0.7431506870491459,1.0,2/11,3.48%,FYN;ABCB7
prerank,cellular macromolecule catabolic process (GO:0044265),0.3661671293249752,1.0382889316717088,0.41939711664482304,0.743316378278151,1.0,18/49,21.12%,DENND3;SND1;XRN2;RNASEH2C;RIPK1;RNASE6;DFFB;UBE2G1;RNASEH2A;RNASEH1;PNPT1;STT3B;NCBP1;SIDT2;CHEK2;DNASE1L1;SUPV3L1;NGLY1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.44040241123653906,1.0382117738999883,0.4272300469483568,0.7429766485970354,1.0,3/18,11.70%,ERN1;ATXN3;FCGR2B
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.374640841340215,-1.0381132779298632,0.41642228739002934,0.7667784979692644,1.0,12/20,33.12%,ACACA;CBR4;HSD17B8;GCDH;DGAT1;ACSL4;SCD;ACSL3;FASN;FITM2;FAR2;DGAT2
prerank,sodium ion transport (GO:0006814),-0.2676336139040798,-1.0380243602994135,0.3464052287581699,0.7658016648202386,1.0,14/85,12.12%,SLC8A1;SLC24A3;FGF13;SCN1A;ATP1B3;PKD2;ATP1B1;SGK1;SLC6A15;SCN3A;ATP1A2;HCN1;HCN2;SCN1B
prerank,calcineurin-mediated signaling (GO:0097720),0.49505685602215077,1.0378402280804662,0.4331103678929766,0.7427756734987914,1.0,5/10,24.96%,PPP3CA;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.49505685602215077,1.0378402280804662,0.4331103678929766,0.7427756734987914,1.0,5/10,24.96%,PPP3CA;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,protein transport (GO:0015031),0.30709030335701576,1.0378067908484705,0.39143730886850153,0.7423335901133082,1.0,65/332,15.67%,CD74;NEURL1B;TBC1D1;STX11;NGFR;RAB19;LMTK2;PPARG;TBC1D8;TBC1D9;RABL3;ATP6V0E1;CD36;RAB3D;LAPTM5;IL10RA;USP6NL;TBC1D10C;GOLPH3L;TBC1D2B;MYH9;COPG2;RAB7A;SNX1;TBC1D8B;ARF4;STX17;RAB6A;RABGAP1L;RAB34;STX6;TMED10;GCC2;RABGAP1;ARF1;STX5;STX12;ZDHHC17;ATP6V1H;TBC1D5;UNC119B;SLU7;STX7;LMAN2L;HIKESHI;SNX9;KIF3B;UNC119;TBC1D2;SLC10A7;TMEM167A;STX16;SGSM1;TLK1;VMP1;CANX;EVI5;RAB29;SCFD2;ABCG1;EHD1;TMED7;SVBP;CALCRL;SNX33
prerank,actomyosin structure organization (GO:0031032),-0.26435997507235875,-1.0375423888819415,0.37566137566137564,0.7659133793167594,1.0,5/75,3.20%,ITGB5;EPB41L2;TJP1;CAPN3;EPB41L4B
prerank,central nervous system neuron development (GO:0021954),0.46670488418563566,1.0374118146410958,0.43023255813953487,0.7427655460400554,1.0,4/15,7.74%,RAPGEF2;B4GALT5;PTEN;ATP7A
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3767310618984873,-1.0374033009971955,0.391812865497076,0.7650395987966891,1.0,12/18,44.29%,TGFBR2;ACVR1;TGFB2;MDM4;SOX9;BMP2;BMP4;ACVRL1;HEY1;TBX2;HEYL;ISL1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.42875213543862556,1.0371876800035877,0.4356589147286822,0.7427933263715077,1.0,2/20,0.65%,IL1B;PSTPIP1
prerank,lung epithelium development (GO:0060428),0.5012032729216517,1.036973267573582,0.4270650263620387,0.7427786875967225,1.0,1/10,2.49%,FOXJ1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.39020374100789135,-1.0368368514528543,0.4327956989247312,0.765298072728124,1.0,5/16,18.22%,BCL2L1;TMEM161A;CLU;FBH1;TRIM32
prerank,regulation of cell morphogenesis (GO:0022604),0.3984591028559101,1.036690453660833,0.4056737588652482,0.7429266444215561,1.0,4/30,6.69%,CD44;NTNG2;PDZD8;CAPZB
prerank,anterograde axonal transport (GO:0008089),-0.3083130335214546,-1.0364907605256826,0.37666666666666665,0.7649976290842794,1.0,10/37,15.45%,DTNBP1;DLG2;KIF1B;KIF1A;AP3M2;KIF5C;MAP1A;AP3B1;AP3B2;BLOC1S5
prerank,aggrephagy (GO:0035973),-0.3431536615491063,-1.0363272791862055,0.40173410404624277,0.764183438925571,1.0,5/27,8.44%,PRKN;WDFY3;UBC;DYNLL2;DYNLL1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.34198807392117425,-1.0346782814775144,0.3818770226537217,0.7674160549547636,1.0,6/25,17.67%,MEF2C;NLGN1;CACNG2;NLGN2;NLGN3;PRRT1
prerank,regulation of viral transcription (GO:0046782),0.3815845114478632,1.034590365186927,0.4435028248587571,0.7473953792718003,1.0,13/39,19.85%,GTF2F2;POLR2C;TRIM62;HEXIM1;TRIM14;NELFA;CCNT1;RSF1;IFITM3;SUPT4H1;MDFIC;MID2;LARP7
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.37717961527216387,-1.0345298629498099,0.41899441340782123,0.766582686185642,1.0,8/20,18.03%,APOE;TTC39B;ARV1;DGKQ;FMO5;MBTPS2;RAN;ACADL
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.36374814198338457,1.034015985019845,0.4258064516129032,0.7482275620473761,1.0,12/52,16.34%,PRKCE;PRKCH;KIF5B;PDPK1;CIB1;EPHB2;CLIP3;LGALS3;AKT1;ITGA3;RHOG;PLS1
prerank,regulation of telomerase activity (GO:0051972),0.3710620610066922,1.0338668148520869,0.42105263157894735,0.748071526623094,1.0,13/45,16.35%,KLF4;PKIB;CERS1;PARP4;PARM1;WRAP53;TNKS;MAP3K4;ERCC4;AURKB;MAPK1;TCP1;SMG6
prerank,histone acetylation (GO:0016573),0.35414999334727315,1.0338018799290687,0.400990099009901,0.7477195165962033,1.0,17/69,15.27%,TAF9;SPI1;KAT7;ATF2;TRIM16;TADA3;MBIP;KAT6A;ING3;TADA2A;MORF4L1;JADE3;MAP3K7;MSL3;KAT2B;CREBBP;PHF20
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.4408833880227333,-1.0336824675570166,0.39285714285714285,0.7676464755768712,1.0,2/10,1.53%,DIP2B;FLCN
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.48904730467943314,1.0336201908837186,0.43463497453310695,0.7476008046271808,1.0,2/10,10.33%,LILRB1;FN1
prerank,regulation of platelet activation (GO:0010543),0.4189309342259458,1.033498136528127,0.4218512898330804,0.7473856562767731,1.0,2/21,1.94%,LYN;SYK
prerank,negative regulation of chemotaxis (GO:0050922),-0.3204192274324151,-1.0330298134202265,0.4057507987220447,0.7682246706654637,1.0,7/31,9.40%,ROBO2;ROBO1;AIF1;SEMA3D;SEMA3E;SEMA6D;SLIT2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4502749537213187,1.0329640966230085,0.41233766233766234,0.7481762426763203,1.0,6/15,15.67%,IL1B;ADRA2A;SNX9;TNFRSF1B;ADAM9;SNX33
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.31922713386385865,-1.03291537221569,0.3931034482758621,0.7673453607862962,1.0,6/34,9.97%,FLCN;TRIO;ANKRD26;ENPP1;RUNX1T1;SMAD3
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3667514113939704,1.0328869814491322,0.414021164021164,0.7478448269390385,1.0,10/50,12.51%,IL1B;LAPTM5;EIF2AK2;PDCD4;TLR3;IFI35;RHOA;RPS3;APP;TLR2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4283332542168724,-1.032715361711852,0.431924882629108,0.766656580994713,1.0,6/11,44.29%,SOX4;TGFB2;JAG1;BMP4;HEY2;ISL1
prerank,regulation of neuroinflammatory response (GO:0150077),0.4304438439096461,1.0326417442258895,0.42966360856269115,0.7479137250329899,1.0,5/19,14.65%,IL1B;IL33;IL6;TNFRSF1B;IL18
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3422234348652369,1.0324969347871047,0.3997613365155131,0.7477206608087216,1.0,18/80,16.12%,NIBAN1;IFNGR1;BCL3;RPL5;VIM;PICALM;GSAP;YTHDF3;IL6;METTL3;PLA2G6;LARP4B;EIF3E;ABCG1;RELA;THBS1;RPS4X;RPS6KB1
prerank,cation transport (GO:0006812),-0.23408755664042466,-1.0324377280969408,0.34782608695652173,0.7661913587454026,1.0,26/167,13.02%,KCNMA1;SLC8A1;SLC7A6;FGF13;SCN1A;TRPM3;KCNJ2;SLC7A1;ANO10;ATP1B1;SLC36A4;SGK1;SLC11A2;SCN3A;SLC36A1;KCNN2;ATP1A2;KCNMB2;MCOLN1;KCNA2;KCNJ6;KCNK6;SLC7A8;CHP1;SLC3A2;TRPM2
prerank,regulation of regulated secretory pathway (GO:1903305),0.38883568337406316,1.0324105640477381,0.4281524926686217,0.74740989731054,1.0,3/34,4.17%,LRRK2;RAB3D;UNC13D
prerank,Ras protein signal transduction (GO:0007265),0.321686723384057,1.0323132619020747,0.40497737556561086,0.7471253031520083,1.0,20/137,8.95%,GRAP2;TIAM1;RAP1A;EPS8;NGFR;CELSR1;SHTN1;RASGRP2;RAPGEF2;RAC2;ADRA2A;MAPK14;ARHGDIB;GRB2;SHOC2;RAC1;GNB1;SOS1;RALB;RHOA
prerank,protein insertion into ER membrane (GO:0045048),0.38389826389428466,1.0323041954807899,0.407557354925776,0.7466393445362661,1.0,11/37,15.93%,MMGT1;PRNP;TRAM2;TRAM1;EMC9;STX5;CAMLG;APP;EMC10;UBE2J2;VAPA
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3705768007221049,1.0320380206323871,0.42536327608982827,0.7467656615616707,1.0,7/46,9.20%,FOXP1;PPARG;IL6R;STAT1;NOX1;IL6;ID2
prerank,negative regulation of protein metabolic process (GO:0051248),0.3685107433024869,1.0319565175704768,0.43391188251001334,0.7464462559074153,1.0,8/48,7.13%,LDLR;NFKB1;PTX3;MAD2L2;EIF2AK1;PRNP;FLNA;AZIN1
prerank,regulation of neuron death (GO:1901214),0.3394334664270803,1.0317412921302525,0.42016806722689076,0.7464624030536791,1.0,19/82,14.51%,LRRK2;FYN;MAP3K5;FOS;SORL1;PICALM;CHMP4A;CHMP4B;ITGB2;PRNP;DDIT4;DAXX;FCGR2B;REST;BTBD10;AKT1;DHCR24;TNFRSF1B;RAB29
prerank,membrane organization (GO:0061024),0.3087997465944009,1.0315360950566685,0.42083333333333334,0.7464224882971258,1.0,51/227,16.32%,ACTR3;STX11;FNBP1;LDLR;PIK3C2A;EPS15;REPS1;KIF20A;DYSF;CCDC88A;OCRL;CBL;PICALM;TMCC1;MITD1;LEMD3;CHMP4A;CHMP4B;AP2A2;GRB2;ACTR2;MTCH1;PDCD6IP;SYP;SYNJ1;SPAST;HIP1;ARPC2;EPS15L1;ARPC4;LEMD2;SNX9;ATP10B;DMPK;SCARB2;STAM;AP2B1;TOR1AIP1;AGFG1;SNX3;PACSIN2;DNM1L;SYNGR2;TIMM50;SNAP23;DVL2;AP2S1;VAPA;HACE1;MYADM;PPT1
prerank,actin filament depolymerization (GO:0030042),-0.4363596382621472,-1.0312538175835582,0.4322429906542056,0.7680491687313483,1.0,3/11,22.18%,MICAL3;CFL1;GSN
prerank,positive regulation of myoblast differentiation (GO:0045663),0.45326755660863094,1.0306219203172033,0.45893719806763283,0.7480471619939018,1.0,4/16,7.50%,RIPOR2;BTG1;MAPK14;PLCB1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.40820925746202963,1.0305103865781071,0.42589928057553955,0.7477864144047075,1.0,7/26,15.81%,ITCH;DHX58;CARD16;CACTIN;ACOD1;ILRUN;IRAK3
prerank,phospholipid transport (GO:0015914),0.361565281381379,1.0304350821025168,0.4300653594771242,0.7474471864304931,1.0,18/52,19.75%,ATP8B4;LDLR;ABCA3;SCARB1;PITPNB;ABCC1;PITPNM1;ATP10B;SCARB2;PRELID1;ATP11C;ABCG1;TMEM30A;PITPNA;ATP8B2;ATP11A;ATP11B;PRELID3A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.42765894869210835,-1.0303627794810246,0.423963133640553,0.7691504918427721,1.0,6/11,18.00%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4573646380786452,1.0299286261862413,0.43427620632279534,0.7481830777268117,1.0,6/16,14.37%,PIK3C2A;BCAR1;PTPN1;PDGFD;RGS14;PTPRJ
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.38922071904085903,1.0297347139556636,0.4177396280400572,0.7481064672663577,1.0,9/33,16.37%,KLF4;PTEN;CDKN2C;DCUN1D3;WEE1;APC;RBL2;BRD7;RB1
prerank,protein ubiquitination (GO:0016567),0.30051890466946396,1.029297802518606,0.42249240121580545,0.7486250623754517,1.0,111/471,17.33%,DTL;LNPEP;ITCH;PSME3;DTX3L;ASB5;NEDD4L;TRIM26;CUL3;CUL5;BIRC6;UBE2E1;RNF38;TRIM7;CBL;PSMB7;FBXW7;ANKIB1;RNF146;CBLL1;PSME2;TRIM62;PEX12;ARIH1;WAC;RNF213;RNF20;PELI1;RC3H1;UBE2QL1;UBE2D3;SPOP;FBXW11;FBXL8;UBE2N;RNF217;UBR5;HLTF;FBXW2;NEDD8;CBFB;NFE2L2;ELOB;MYCBP2;TRIM25;FBXO4;UBR2;PCNP;PSME4;ARIH2;PEX14;RNF141;TNKS;WWP2;RNF13;TRIM71;UBE2W;FBXO32;PSMB8;PSMA5;UBE2Z;FANCL;PSMD9;TRIM14;HERC6;RNF31;PSMB3;UBE2S;FBXL17;PSMD6;PSMC4;LONRF1;KLHL8;TPP2;RCHY1;PSMD10;TRIM17;UBE2G1;SH3RF1;AREL1;PSMB1;FBXL12;RNF138;HECTD2;FBXO30;VCP;UBE2J2;USP7;UHRF2;FBXO7;ANAPC7;KCTD13;VCPIP1;RNF166;RNF122;USP9X;TAF1;TRIM35;RNF41;HACE1;FBXL16;PSMD12;TRIM36;UBR3;UBA6;KLHL12;MSL2;SIRT1;RNF144A;UBE2Q2;TRAF2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3950749084061875,-1.029103682730165,0.40782122905027934,0.7712824297387213,1.0,2/15,1.61%,CD84;GRN
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.36960624186332924,1.0290349401472543,0.43087248322147653,0.7487041544181515,1.0,12/43,18.47%,DTL;MRE11;TAOK3;NABP1;UIMC1;RINT1;PABIR1;DONSON;BRSK1;HUS1;RAD17;FZR1
prerank,regulation of acute inflammatory response (GO:0002673),0.43646292587074464,1.0287471161848483,0.4267716535433071,0.7488878964188268,1.0,4/18,14.83%,IL6ST;IL6;NLRP3;GSTP1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.33165886294889535,-1.0284555664376231,0.4121212121212121,0.7717393379972397,1.0,6/27,7.60%,CTNNA3;FGF13;CACNA1C;ATP2A2;ANK2;JUP
prerank,rRNA modification (GO:0000154),-0.3599838928980858,-1.0282947212888582,0.42265193370165743,0.7709571636047582,1.0,9/21,26.25%,ZCCHC4;DIMT1;NSUN3;DKC1;THUMPD1;FTSJ3;TRMT112;NAT10;BUD23
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4653687757845679,1.0281785557407606,0.4391891891891892,0.7496901119184186,1.0,3/12,14.22%,STAT3;IL6;TGFB1
prerank,sensory perception (GO:0007600),0.36806088653477925,1.027713514928776,0.4167776298268975,0.7502457981151206,1.0,2/45,3.56%,CCR2;CHRNA4
prerank,cellular respiration (GO:0045333),-0.30975843787895196,-1.0276203436528855,0.3896551724137931,0.7714755733280756,1.0,16/41,26.05%,UQCRC2;ME3;PPARGC1A;SDHB;OXA1L;SLC25A14;NDUFS7;MTFR1L;ATP5F1D;COX10;NDUFA5;UQCRC1;UQCR10;LYRM7;NDUFS8;SURF1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.355217721754823,-1.0269073584405768,0.4265536723163842,0.7722640421796709,1.0,8/22,19.79%,NRP1;ROBO1;FGF2;SLIT2;VEGFA;GPLD1;EFNB2;PIK3R3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.39370905867324835,1.026845917553228,0.43216783216783217,0.7518555614846542,1.0,13/33,21.02%,SNRPB;SETX;SSU72;FIP1L1;SCAF8;NUDT21;MAZ;CPSF3;PAPOLA;NCBP1;CSTF3;WDR33;SLBP
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.37353101837155767,-1.02612729097723,0.41543026706231456,0.7731346122131193,1.0,10/19,24.73%,CTC1;XRN1;SRC;TEN1;TERF1;EXOSC10;HNRNPU;TINF2;PINX1;NAT10
prerank,AMP metabolic process (GO:0046033),-0.4044528809808179,-1.025975231062144,0.417910447761194,0.7723248764754882,1.0,6/13,30.73%,ADSS2;AK3;AMPD2;NUDT2;ADSS1;AK4
prerank,modulation by symbiont of host process (GO:0044003),-0.43442881625856367,-1.025950779914406,0.407158836689038,0.7712058972732921,1.0,3/10,7.23%,UBC;PGK1;HGS
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.34346538729937676,1.0259219414177112,0.44556962025316454,0.7534885982934934,1.0,16/72,15.49%,FGF5;FGF22;KL;GTF2F2;POLR2C;CBL;GRB2;SETX;SHOC2;TRIM71;FLRT1;FGFR3;MAPK1;FRS2;SPRED1;NCBP1
prerank,regulation of gluconeogenesis (GO:0006111),0.4020456111102929,1.0258973544649113,0.4476744186046512,0.7530326991215407,1.0,8/27,23.34%,SIK1;CRY1;USP7;GCK;SIRT1;CLK2;PTPN2;SELENOS
prerank,regulation of centriole replication (GO:0046599),-0.3771359305084391,-1.0257252024116466,0.42857142857142855,0.7706033878384658,1.0,12/18,33.56%,TRIM37;NPM1;RBM14;CEP76;BRCA1;SPICE1;PLK2;CDK5RAP2;CEP295NL;CENPJ;STIL;PLK4
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.47656516256615744,1.0256343005971515,0.4494195688225539,0.7531091122725792,1.0,6/11,21.32%,LYN;TIRAP;ACOD1;CYBA;TLR1;TNFAIP3
prerank,cellular response to interleukin-4 (GO:0071353),-0.43837114742972955,-1.025620867595525,0.44362745098039214,0.7696523093719063,1.0,5/10,35.69%,STAT6;JAK3;SHPK;LEF1;TCF7
prerank,regulation of macroautophagy (GO:0016241),-0.24941697277617403,-1.0256150146775547,0.3769230769230769,0.7684746128737598,1.0,34/105,18.04%,LARP1;SCOC;ATP6V1C1;RPTOR;EPM2A;ATP6V0B;SNX5;ATP6V0D2;ATP6V0C;ATP6V1B2;PRKACA;SESN3;NRBP2;ATP6V1D;CDK5R1;CAPNS1;SNX6;ATP6V0D1;VPS35;CDK5;LAMTOR5;CASP3;ATP6V0A1;TRIM13;TSC2;SNX32;UCHL1;RRAGC;PAFAH1B2;GPSM1;UBQLN2;EXOC1;HDAC6;SMCR8
prerank,wound healing (GO:0042060),0.3514301741525073,1.0256077678322706,0.424968474148802,0.75265876227769,1.0,8/62,5.35%,JAML;PAK1;CLDN1;DYSF;MYH9;PPP3CA;SCARB1;PRCP
prerank,phospholipid translocation (GO:0045332),0.4041250737693438,1.0253257176045785,0.4329268292682927,0.7528141366252835,1.0,2/28,2.32%,ATP8B4;PLSCR1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4022550159743685,1.0251731272322067,0.4294573643410853,0.7526849679132518,1.0,3/24,6.84%,LRRK2;HSPA1A;WFS1
prerank,somite development (GO:0061053),-0.43235634673924095,-1.025154343539515,0.424390243902439,0.7684577125680082,1.0,5/11,27.18%,SMO;LOXL3;SOX11;PTCH1;MTHFD1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2785240436084686,-1.0249479074789747,0.4,0.7654428885304684,1.0,16/61,16.04%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;LMAN1;CTSZ;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,vesicle coating (GO:0006901),-0.2785240436084686,-1.0249479074789747,0.4,0.7654428885304684,1.0,16/61,16.04%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;LMAN1;CTSZ;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,COPII vesicle coating (GO:0048208),-0.2785240436084686,-1.0249479074789747,0.4,0.7654428885304684,1.0,16/61,16.04%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;LMAN1;CTSZ;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4277284113456864,-1.0248742078405655,0.4201474201474201,0.7644661357436828,1.0,4/11,20.24%,APOE;PORCN;ATG7;WDR45
prerank,response to histamine (GO:0034776),0.49619644642087024,1.0247579587193232,0.4652777777777778,0.7531729490465324,1.0,3/10,9.67%,GABRB2;DIAPH1;HRH1
prerank,calcium import into the mitochondrion (GO:0036444),0.49244634922395264,1.024326661927431,0.45166959578207383,0.753665606270302,1.0,4/10,18.73%,MCUB;MAIP1;MICU3;MICU2
prerank,glycerophospholipid catabolic process (GO:0046475),-0.33823541072936203,-1.0242554747869927,0.4012539184952978,0.7648476919283743,1.0,6/27,7.25%,ABHD12;PLA2G15;GDE1;ENPP2;PNPLA8;PLA2G4A
prerank,regulation of store-operated calcium entry (GO:2001256),-0.4350731020330504,-1.02398716051679,0.4489311163895487,0.7644199018273574,1.0,1/10,0.17%,CD84
prerank,negative regulation of organelle assembly (GO:1902116),0.3790180151141759,1.0238348974488882,0.43134535367545074,0.7542801645616062,1.0,7/35,13.97%,LRRK2;CHMP4A;CHMP4B;SMAD4;MDM1;LIMK2;KAT2B
prerank,organic anion transport (GO:0015711),0.3405624407663491,1.0236772379294798,0.4245398773006135,0.7541277259264128,1.0,16/76,17.24%,LRRC8C;SLC23A1;SLC4A7;LRRC8D;SLCO1B1;SLC4A8;CYB5R4;CYB5R1;ABCC4;SLCO1C1;SLC26A7;SLC35A1;SLC35A3;SLCO4C1;SLC52A1;SLCO3A1
prerank,metal ion export (GO:0070839),0.3879572562407666,1.0235128616330076,0.4117647058823529,0.7540027655361794,1.0,3/31,7.74%,KCNE3;KCNQ1;ATP7A
prerank,positive regulation of catalytic activity (GO:0043085),0.3735537943347758,1.0233869655982435,0.4315352697095436,0.7537649628309109,1.0,11/37,17.11%,MAPK14;WRN;CIB1;MSH3;ATP7A;MSH6;BCAS3;XRCC4;MAPK8;PSEN1;ABL2
prerank,response to iron ion (GO:0010039),-0.4143455264296231,-1.0233488579294052,0.4375,0.7649442305548625,1.0,5/12,22.03%,HIF1A;SLC11A2;BMP6;FXN;HFE
prerank,triglyceride metabolic process (GO:0006641),-0.2948124843621838,-1.0231652288958346,0.4090909090909091,0.7642115622138981,1.0,13/48,25.38%,APOE;AGMO;FABP5;GPAM;GK5;GPAT4;APOC1;LIPH;LPGAT1;LMF1;PLAAT3;DGAT1;FABP4
prerank,negative regulation by host of viral process (GO:0044793),-0.44726032166898516,-1.0230357791470972,0.4430992736077482,0.7633953870133827,1.0,2/10,5.14%,PRKN;EIF2AK4
prerank,import into cell (GO:0098657),0.37907790098539135,1.0228437240360306,0.43156424581005587,0.7545166495426483,1.0,5/41,4.52%,NEURL1B;LRRC8C;IL10RA;LRRC8D;SLC12A7
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2285395490111552,-1.0218448457329257,0.40816326530612246,0.76537747260598,1.0,48/224,16.10%,DLGAP1;LRP6;GRIA4;SYT1;CACNB2;NLGN1;CAMK1;KCND2;SLC1A3;PLP1;KCNQ3;CHRM3;DLG2;DLG4;CHRM2;GRIA2;GRIA1;PRKACA;GABRG3;NRXN2;GABRG2;GRIK4;SNAP25;GLRA3;GABRB1;GRIK1;HTR2B;GLRA2;NOVA1;GABRA4;GAD2;CHRFAM7A;CHRNA7;RIT2;CDK5;GRM5;CAMK4;PRKAR1A;HTR2C;NLGN2;SST;CALM1;GIPC1;KCNA1;GABRB3;HTR7;CPLX1;NLGN3
prerank,negative chemotaxis (GO:0050919),-0.315898886761077,-1.0218067424884578,0.40559440559440557,0.7643242019040162,1.0,10/33,12.71%,ROBO1;SEMA3D;SEMA3E;ITGB3;SEMA6D;PDGFA;SLIT2;EPHA7;SLIT1;SLIT3
prerank,long-term memory (GO:0007616),-0.36117150166538947,-1.021537367039431,0.4331395348837209,0.7638809403207222,1.0,7/19,16.16%,APOE;EIF2AK4;SGK1;RASGRF1;CAMK4;CPEB3;PJA2
prerank,positive regulation of myelination (GO:0031643),0.4746254402815992,1.0212951119257732,0.4713804713804714,0.7575391054947089,1.0,2/11,4.08%,ITGAX;MYRF
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.44517169940163814,1.0210443650588168,0.4552980132450331,0.7576171959848625,1.0,4/16,12.95%,MCM6;WRN;RECQL5;MCM2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.36112908252558,1.0209111671997337,0.43346508563899866,0.7574319766881642,1.0,18/56,18.95%,DTL;CUL3;ANKRD17;RCC2;CCND3;CCND1;ADAM17;MECP2;PLCB1;ANXA1;CCND2;AKT1;KMT2E;ANAPC7;RB1;ANAPC11;ANAPC4;BRD4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3637171525903367,1.0205867832574702,0.41948051948051945,0.7577061469739685,1.0,14/48,19.21%,MYO1C;TAF1A;ATAD2;SMARCA5;POLR1G;DEK;ELOF1;KAT2B;POLR1B;ZMIZ2;TAF1C;PADI2;SF3B1;ACTB
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4054717920279325,1.0203536142351166,0.44585091420534456,0.7577475538895658,1.0,5/25,9.94%,BMPR2;RBPJ;ENG;ACVR2A;SMAD4
prerank,zinc ion homeostasis (GO:0055069),-0.3382500185102435,-1.02001073047236,0.4380664652567976,0.766685368502548,1.0,6/28,16.45%,PRKN;SLC39A10;SLC39A7;SLC30A9;SLC39A6;MT2A
prerank,amino sugar biosynthetic process (GO:0046349),-0.41173490690900505,-1.0197890342874658,0.43155452436194897,0.7661129975562883,1.0,6/12,18.00%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,regulation of osteoblast differentiation (GO:0045667),0.3380118007834397,1.019776161235224,0.4429771908763505,0.7585690002404254,1.0,10/82,8.63%,FFAR4;RUNX2;LIMD1;PPARG;BMPR2;IL6R;ACVR2A;IL6ST;IL6;HGF
prerank,regulation of secretion by cell (GO:1903530),-0.2845091614008698,-1.019217138699095,0.40444444444444444,0.766421392753099,1.0,16/54,18.87%,MEF2C;SNCAIP;SYT1;RAB3C;STXBP5L;RIC1;RALA;DISP1;SCG5;VAMP8;CPLX1;CAMK2A;RIMS1;RHBDF2;VAMP3;RAB3A
prerank,neuron maturation (GO:0042551),-0.3683343839831249,-1.0191576238339544,0.4180327868852459,0.7654269561540402,1.0,7/18,14.93%,C1QA;ADGRB3;SRRM4;FARP2;ANKS1A;C3;CX3CL1
prerank,negative regulation of angiogenesis (GO:0016525),0.3356280218914005,1.0191159339209286,0.4352078239608802,0.7596154866576628,1.0,11/84,9.45%,CCR2;KLF4;PPARG;CXCL10;ATF2;SYNJ2BP;STAT1;HSPG2;MECP2;E2F2;NAXE
prerank,positive regulation of cellular protein localization (GO:1903829),0.3480743106328002,1.0189464017157752,0.4308641975308642,0.7594923262596905,1.0,17/69,15.92%,NGFR;FYN;DTX3L;CCDC88A;KAT7;PARP9;RTN4;CEP250;CENPQ;PRKAA1;EIF2AK3;AKT1;LIMK2;PRKAA2;TGFB1;SNX33;APC
prerank,response to exogenous dsRNA (GO:0043330),0.43580185343563915,1.0189015012119185,0.44462025316455694,0.7590827443541396,1.0,6/18,15.81%,IFIH1;TLR3;RALB;PQBP1;IFIT1;IRAK3
prerank,regulation of cardiac conduction (GO:1903779),0.3592090038657804,1.018883239380915,0.4559386973180077,0.7586162968895716,1.0,6/54,6.98%,ITPR1;ACE2;GJA5;ATP2B1;ATP2A3;ATP2A1
prerank,negative regulation of viral transcription (GO:0032897),0.4607873421547378,1.0188672515567172,0.4465195246179966,0.7581379404339678,1.0,6/13,19.85%,TRIM62;HEXIM1;TRIM14;IFITM3;MID2;LARP7
prerank,protein methylation (GO:0006479),0.371291793627922,1.0184603862829342,0.44506258692628653,0.7585690063994754,1.0,13/40,19.46%,NSD3;PRMT8;SNRPB;RAB6A;CAMKMT;ETF1;NSD1;EZH2;PRMT3;EEF1AKMT1;NTMT1;GSPT1;EHMT1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4465144947778173,-1.0176365717705735,0.4755244755244755,0.768324538661481,1.0,3/10,7.23%,LRP1;APOD;HGS
prerank,glucose import (GO:0046323),-0.3876086810481927,-1.0173322033606496,0.43882978723404253,0.7679530730824812,1.0,3/13,7.17%,SORT1;SLC2A3;SLC27A1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.46525903364168564,1.016826628190284,0.44329896907216493,0.7618169067579417,1.0,1/12,1.70%,PPARG
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4241543126691311,1.0167601858559383,0.4236760124610592,0.7614663740245642,1.0,4/20,9.42%,RBPJ;PDCD4;ENG;OLFM1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3026959645038444,-1.0157960976826905,0.4148148148148148,0.7708458013623004,1.0,8/39,9.10%,P2RY12;PPIA;PLPP3;ILK;MEGF11;PIK3CG;ITGB3;TJP2
prerank,regulation of glucose metabolic process (GO:0010906),-0.3196095337471341,-1.0156621367851373,0.40942028985507245,0.7700331505047281,1.0,4/34,9.25%,PRKN;PDK1;IRS1;DGKQ
prerank,2-oxoglutarate metabolic process (GO:0006103),0.47040737467677013,1.0153481907768234,0.4583333333333333,0.7642009496941115,1.0,3/13,12.50%,TAT;IDH1;OGDH
prerank,myeloid dendritic cell activation (GO:0001773),-0.42500751389073305,-1.0150250271063046,0.454320987654321,0.7704783218233404,1.0,4/12,10.74%,TGFBR2;HMGB1;PYCARD;CAMK4
prerank,cellular response to acid chemical (GO:0071229),-0.3242114777058844,-1.0148976962123262,0.4194528875379939,0.7696334995072407,1.0,12/27,19.38%,RPTOR;CPEB1;LARS1;IPO5;GLRA2;CPEB4;LAMTOR5;VEGFA;RRAGC;CPEB3;NSMF;SESN2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4581646910268019,1.0145464423860797,0.4429530201342282,0.7655483446371957,1.0,4/12,13.17%,PLCB1;SLAMF8;DUSP1;AKT1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4018568795632169,1.0145082364755067,0.4560862865947612,0.7651277251878581,1.0,5/24,6.68%,JARID2;SPI1;H3-3A;RBBP4;PHF19
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.336687548232926,1.013999381198736,0.46318289786223277,0.765769061225167,1.0,20/86,16.31%,LIMD1;PSME3;HSPA1A;PSMB7;PSME2;NFE2L2;ELOB;PSME4;BACH1;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;CREBBP;INO80;PSMD12
prerank,phospholipid dephosphorylation (GO:0046839),0.37839250315371387,1.0139189770203676,0.4458161865569273,0.7654564307587487,1.0,10/37,17.30%,OCRL;INPP5F;PTEN;MTMR3;MTMR4;SYNJ1;SGPP2;SGPP1;MTMR2;PLPPR2
prerank,eosinophil migration (GO:0072677),-0.3966628505660124,-1.0138640486755837,0.46113989637305697,0.7702238471620771,1.0,6/14,31.86%,SCG2;CCL13;CX3CL1;CCL3;CCL2;CCL5
prerank,eosinophil chemotaxis (GO:0048245),-0.3966628505660124,-1.0138640486755837,0.46113989637305697,0.7702238471620771,1.0,6/14,31.86%,SCG2;CCL13;CX3CL1;CCL3;CCL2;CCL5
prerank,circulatory system development (GO:0072359),-0.24383564982180728,-1.0133024793048797,0.421875,0.7705671582502933,1.0,16/118,8.16%,ADAP2;TGFBR2;MEF2C;ERBB4;SALL1;TGFBR1;NTRK3;TCF25;PKD2;CACNA1C;NF1;BCOR;ACVR1;NXN;NCOA6;POU6F1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.414662925385987,1.0131758524666772,0.43823529411764706,0.7666716021810602,1.0,9/25,20.76%,RIN3;PICALM;RAC1;UNC119;APP;MTMR2;PSEN1;ANKRD13A;ITGAV
prerank,insulin receptor signaling pathway (GO:0008286),-0.271361775198108,-1.012513553929807,0.3869346733668342,0.7715051078516929,1.0,17/69,12.66%,BCAR3;ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;GAB1;ATP6AP1;RHOQ;ATP6V1D;IDE;IRS1;ATP6V0D1;PIK3R1;NAMPT;ATP6V0A1
prerank,positive regulation of chromosome organization (GO:2001252),0.4427861917144087,1.012238690233384,0.45806451612903226,0.7683764909591898,1.0,4/15,18.32%,MRE11;FEN1;ATRX;RAD21
prerank,positive regulation of cellular component movement (GO:0051272),-0.3421996458958526,-1.0120869796973415,0.4114114114114114,0.7713963744292259,1.0,6/24,11.94%,CSF1R;TGFBR1;ETS1;CFAP20;CCDC25;VEGFA
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4357961889650619,-1.012021420974503,0.4642857142857143,0.7704137920240351,1.0,2/10,4.09%,EPB41L4B;IQSEC1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.38617746018401305,1.0117504928457677,0.4611032531824611,0.7690035121169958,1.0,5/34,3.90%,GJA5;RNF207;RGS2;KCNQ1;HCN4
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.43696903759225614,1.0113651126613346,0.4510108864696734,0.7693882933990284,1.0,4/18,7.39%,DTL;RCC2;CCND1;MECP2
prerank,inner dynein arm assembly (GO:0036159),0.46548958483444336,1.0110141761139446,0.4507042253521127,0.769699995048812,1.0,3/11,19.26%,DNAAF5;CCDC39;CFAP73
prerank,embryonic organ development (GO:0048568),-0.27865343897904304,-1.0109747711768917,0.41743119266055045,0.7720557762232743,1.0,12/61,14.89%,TGFBR2;SALL1;KITLG;TAL1;FGFR2;RPL10;ATF4;PDGFA;TBC1D23;GLI3;TGFB2;PKDCC
prerank,regulation of platelet aggregation (GO:0090330),0.43478237043757084,1.0100370947008197,0.475,0.7714820235719612,1.0,3/17,7.55%,LYN;SYK;F11R
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3948383965586725,1.0099263298069598,0.47938931297709925,0.7712180006232944,1.0,9/26,19.97%,LRRK2;FYN;NFE2L2;REST;AKT1;FBXO7;SIRT1;PINK1;PARK7
prerank,Notch signaling pathway (GO:0007219),0.3529060834917657,1.0098568904134793,0.4616368286445013,0.7708701514344166,1.0,8/59,8.06%,NOTCH2;ITCH;DTX3L;RBPJ;STAT1;GMDS;ADAM17;PLXND1
prerank,negative regulation of hippo signaling (GO:0035331),0.4603553089978563,1.0096247532509584,0.44867549668874174,0.7708996629434802,1.0,5/12,16.81%,LIMD1;MAPK14;MAP2K3;MARK3;AJUBA
prerank,retinal metabolic process (GO:0042574),-0.4319583902753463,-1.0095491943332582,0.4578313253012048,0.7746853205123815,1.0,8/12,49.40%,BCO2;RDH13;DHRS13;RDH11;ABCA4;CYP1B1;ALDH1A3;ALDH8A1
prerank,glutathione derivative metabolic process (GO:1901685),-0.3577569840296489,-1.0094574681909976,0.44235924932975873,0.772624155398664,1.0,2/20,6.13%,HPGDS;AKR1A1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3577569840296489,-1.0094574681909976,0.44235924932975873,0.772624155398664,1.0,2/20,6.13%,HPGDS;AKR1A1
prerank,response to UV (GO:0009411),0.32984666010364544,1.009433449922523,0.43937575030012005,0.7708313877573055,1.0,34/95,22.09%,BCL3;DTL;GPX1;FEN1;CCND1;WRN;MSH6;MAP3K4;MAP4K3;DCUN1D3;ERCC3;MAPK8;AKT1;ERCC4;METTL3;PCLAF;AURKB;BRSK1;CREBBP;RELA;TAF1;INO80;USP47;POLD1;PRKCD;PRIMPOL;CAT;N4BP1;RHBDD1;XPA;POLK;PARP1;CASP9;SDE2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3373434371552994,1.009353888485779,0.4585365853658537,0.7705046661848032,1.0,18/84,13.17%,FOXP1;RIN2;AKT3;CD40;STAT5A;BMPR2;SCARB1;BCAR1;MAPK14;PTK2B;ADAM17;PDPK1;RAC1;BCAS3;GPI;EMC10;MAP2K3;AKT1
prerank,protein autoprocessing (GO:0016540),0.42667612891004164,1.0088422119593337,0.4562798092209857,0.771158473718773,1.0,3/17,9.62%,MYRF;FAM111A;PIDD1
prerank,regulation of axon extension (GO:0030516),-0.3003850108241575,-1.0088378366451385,0.423841059602649,0.7730305566140216,1.0,6/37,7.70%,APOE;DIP2B;MAP2;LIMK1;CDKL3;GOLGA4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2976926487342436,1.0085441973784282,0.46830265848670755,0.771350311036506,1.0,80/341,16.56%,FEM1C;DTL;ITCH;PSME3;RNF149;DTX3L;VPS37C;NEDD4L;CUL3;BIRC6;UBE2E1;CBL;TBL1XR1;PSMB7;FBXW7;ANKIB1;RNF146;PSME2;KCTD2;ARIH1;RNF213;RNF20;PELI1;RC3H1;UBE2D3;SPOP;FBXW11;FAF1;KLHL15;RNF217;TSG101;NEDD8;NFE2L2;TRIM25;CLOCK;COP1;PCNP;PSME4;ARIH2;RNF130;ATXN3;COPS3;WWP2;RNF13;TRIM71;UBE2W;PSMB8;KCTD5;PSMA5;PSMD9;PSMB3;UBE2S;FBXL17;PSMD6;PSMC4;KLHL8;RCHY1;PSMD10;UBE2G1;AREL1;PSMB1;UBAP1;VCP;RNF150;PPP2R5C;AURKB;FBXO7;ANAPC7;KCTD13;UBXN11;RMND5B;RNF166;RNF122;USP9X;TAF1;HACE1;PSMD12;UBR3;UBA6;MAEA
prerank,icosanoid metabolic process (GO:0006690),0.36245922441830514,1.0083319071051702,0.45187165775401067,0.7713820107011528,1.0,6/40,6.93%,ALOX5AP;GPX1;PTGIS;MAPKAPK2;DPEP1;ABCC1
prerank,protein targeting to lysosome (GO:0006622),0.4198495168810067,1.008222057277723,0.44753086419753085,0.771105797556417,1.0,5/20,11.09%,LAPTM5;SORL1;RAB7A;GCC2;SCARB2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4176739357744258,1.007889956354166,0.45648854961832064,0.7713239052552431,1.0,4/19,7.84%,BCL3;HIPK2;HIPK1;DDIT4
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3982587178589543,1.0073430491960813,0.4452662721893491,0.7721300686952076,1.0,3/26,4.27%,ST3GAL4;ST8SIA6;B4GALT5
prerank,inhibitory synapse assembly (GO:1904862),-0.4134123881604744,-1.0071928462074637,0.44976076555023925,0.7761221984213287,1.0,5/11,17.13%,FGF13;GABRG2;LGI2;GABRB3;GABRA2
prerank,cellular glucan metabolic process (GO:0006073),0.4654485365816603,1.006489519119194,0.47027972027972026,0.7735685110842779,1.0,2/11,9.08%,PRKAG2;UGP2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.408887119136116,1.006117532467574,0.4573529411764706,0.7739238626641534,1.0,4/21,14.28%,GLI1;RAB34;TUBD1;TXNDC15
prerank,mitochondrial translational termination (GO:0070126),-0.25596035881582874,-1.0060085295878296,0.4157303370786517,0.7781326520221885,1.0,49/88,35.84%,GFM2;MRPL24;MRPS9;DAP3;MRRF;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;MRPL3;MRPL32;MRPL47;MRPS30;MRPL17;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23
prerank,keratinocyte differentiation (GO:0030216),0.3860716369247039,1.005791949684899,0.4640804597701149,0.7741259645291685,1.0,8/29,20.54%,BCR;CLIC4;ANXA1;PIP5K1A;ADAM9;MED1;SCEL;UGCG
prerank,serine family amino acid catabolic process (GO:0009071),0.474613851724728,1.0056701744784662,0.4506065857885615,0.7739098575879024,1.0,4/10,18.37%,DLD;GCSH;AMT;SHMT1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.34888252417183957,1.005539253940416,0.45695364238410596,0.7736862739673458,1.0,9/54,7.39%,AKT3;PPARG;CD40;STAT5A;PRCP;MAPK14;ADAM17;PDPK1;MECP2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.38109639529415135,1.0055243505681466,0.4444444444444444,0.7732148678850655,1.0,7/32,14.86%,DTL;MRE11;TAOK3;UIMC1;RINT1;DONSON;BRSK1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.49618747207132236,1.005418731947087,0.47833935018050544,0.772959742881315,1.0,2/10,5.34%,TAF9;NUFIP1
prerank,glycerolipid catabolic process (GO:0046503),-0.3589427705888699,-1.005231244430448,0.43956043956043955,0.7789603768915244,1.0,4/19,7.25%,ABHD12;MGLL;GDE1;PLA2G4A
prerank,cellular response to reactive oxygen species (GO:0034614),0.34648336825186987,1.0051937790590908,0.45534591194968554,0.7729546768387242,1.0,17/59,15.36%,MAP3K5;FOS;SETX;NFE2L2;PXN;IL6;CAMKK2;RPS3;ANXA1;RIPK1;NET1;MAPK8;AKT1;NCF1;MAPK1;RELA;PRDX5
prerank,regulation of metal ion transport (GO:0010959),-0.37798765535655976,-1.0045377479013118,0.44021739130434784,0.7796376657919016,1.0,2/16,5.04%,CACNA2D1;ANK2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3366504386740179,1.004404849054209,0.4542168674698795,0.7742980383991337,1.0,10/76,10.38%,GNA14;FPR1;LTB4R;FPR3;GPR35;ADRA2A;TACR1;OPRM1;HRH1;PTGER3
prerank,liver development (GO:0001889),-0.3139672073945832,-1.0042846932317055,0.4197952218430034,0.7791455645357271,1.0,7/32,13.66%,PKD2;NF1;PCK2;ARID5B;CEBPG;PHF2;PRKCSH
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.37069835939539114,-1.0038454666156227,0.45843828715365237,0.7791229710282582,1.0,7/18,18.22%,SKI;NF1;NLRC3;FTH1;MED25;DAB2IP;TRIM32
prerank,cellular response to fluid shear stress (GO:0071498),0.4626044928170001,1.0037914029323818,0.44605475040257647,0.7751833826942668,1.0,6/12,15.01%,KLF4;NFE2L2;MAP2K5;SREBF2;HDAC3;ASS1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.37240322460324726,1.0036531300092595,0.44951590594744123,0.7749991291298476,1.0,10/37,15.76%,SND1;XRN2;RNASEH2C;RNASE6;DFFB;RNASEH2A;RNASEH1;PNPT1;NCBP1;SIDT2
prerank,protein localization to chromosome (GO:0034502),-0.31093807763981945,-1.0034386847947094,0.43333333333333335,0.7790766276633393,1.0,17/34,24.04%,WAPL;SLF2;TPP1;SLF1;IFFO1;TERF2IP;MSH2;XRCC5;ESR1;MRNIP;TNKS2;CHMP7;CENPA;BOD1;PARP3;TINF2;PINX1
prerank,cardiac myofibril assembly (GO:0055003),-0.382353377562396,-1.0033510439379416,0.45187165775401067,0.7781505184530907,1.0,8/15,41.43%,NEBL;NRAP;FHOD3;MEF2A;NEB;PDGFRB;OBSL1;MYL2
prerank,cell differentiation in spinal cord (GO:0021515),-0.4391075303178503,-1.0032960366284376,0.4719626168224299,0.7771573500219925,1.0,6/10,38.08%,MDGA2;SOX4;SOX13;ZC4H2;SOX6;LHX1
prerank,intracellular lipid transport (GO:0032365),-0.3509217775770096,-1.0030172374767106,0.42363112391930835,0.7767998820632819,1.0,6/21,8.46%,ABCD2;ACACA;PLEKHA8;ABCD4;ARV1;SLC25A20
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3698488626885671,-1.0027789294999758,0.4359673024523161,0.7763531810469894,1.0,8/17,18.85%,RPF1;WDR12;C1D;LAS1L;PES1;FTSJ3;RRP15;EXOSC10
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.38179805989446614,-1.0027212754958421,0.4725274725274725,0.7753905788217862,1.0,7/16,18.33%,PSIP1;SFSWAP;SNRNP200;PRPF39;CWC15;SNRPC;SRSF1
prerank,alanine transport (GO:0032328),-0.4312900076419938,-1.0021320091091246,0.46952595936794583,0.7758959981020005,1.0,2/10,5.88%,SLC36A4;SLC36A1
prerank,glycine metabolic process (GO:0006544),0.4578486936381197,1.0016892406061129,0.4698996655518395,0.7789689914098686,1.0,5/12,19.33%,DLD;GCSH;AMT;SHMT1;GLYAT
prerank,mesenchyme development (GO:0060485),-0.3839796706400393,-1.001229192545119,0.43544303797468353,0.777060054179543,1.0,3/15,6.21%,TGFBR1;PKD2;FGFR2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.42924799141640135,1.0011488901895447,0.4649122807017544,0.7796598384637555,1.0,4/16,11.11%,CHMP4A;CHMP4B;SNF8;STAM
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.36755935179302107,1.0010185040033657,0.4636118598382749,0.7794891097988157,1.0,7/43,9.20%,FOXP1;ERN1;IL6R;STAT1;NOX1;IL6;ID2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.47731599223599985,1.0009016148940202,0.47202797202797203,0.7792569357362404,1.0,4/12,13.80%,IFIH1;RALB;PQBP1;IFIT1
prerank,protein modification by small protein removal (GO:0070646),0.3011694726640601,1.0003546716761202,0.48484848484848486,0.7799950418240227,1.0,70/252,18.09%,TNIP3;PSME3;NFKBIA;USP3;PSMB7;INO80C;PSME2;OTULINL;IL33;BIRC3;EIF3F;IFIH1;OTUD1;PTEN;USP49;NEDD8;TADA3;ATXN7;USP45;TRAF3;JOSD1;PSME4;UIMC1;ATXN3;USP32;USP48;USP31;RHOA;COPS3;USP15;PSMB8;SMAD4;PSMA5;PSMD9;CYLD;RIPK1;USP42;SENP6;STAM;PSMB3;PSMD6;PSMC4;NLRP3;USP40;MAP3K7;PSMD10;USP4;SNX3;OTUD4;PSMB1;KAT2B;VCP;USP37;USP7;ASXL2;VCPIP1;USP9X;INO80;APC;USP47;POLB;PSMD12;WDR20;FOXK1;TRAF2;TAB1;USP14;BECN1;USP38;SMURF2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3737794076655371,1.0000306392813332,0.471004243281471,0.780229874569883,1.0,12/34,18.93%,ERN1;MAPKAPK2;VEGFC;MAPK14;PGF;ANXA1;PIK3CA;MAP2K3;RELA;NR4A1;FOXC1;SEMA6A
prerank,regulation of translation (GO:0006417),0.30724669688268424,0.9999223995214654,0.4644396551724138,0.7799797206732422,1.0,43/173,18.37%,NIBAN1;BCL3;RPL5;DAPK1;VIM;RPS6KA3;BTG2;EIF4G3;EIF2AK2;MTPN;GIGYF2;YTHDF3;MRPL13;IL6;ETF1;TRIM71;RPS3;IGF2BP3;FOXO3;EIF4A2;PAIP2;RPS6KA1;APP;EIF4ENIF1;EIF2AK3;METTL3;MTRF1;LARP4B;SYNCRIP;PAIP1;EIF3E;NCBP1;THBS1;RPS4X;RPS6KB1;DAPK3;EIF1;CNOT8;CAPRIN1;EIF3H;DDX6;GSPT1;SHMT1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4122485962804827,0.999918959262866,0.4607250755287009,0.7794832205068309,1.0,9/24,18.39%,ACE;MFSD6;TAP1;B2M;FCER1G;CANX;SEC24C;PDIA3;TAPBP
prerank,cell projection assembly (GO:0030031),-0.35000310299278786,-0.9991867357425105,0.46407185628742514,0.7811339363893623,1.0,11/22,22.18%,RHOH;PARVG;RHOQ;CAPG;PDGFA;NCKAP1L;PARVA;RHOU;NEFH;CYFIP1;GSN
prerank,homocysteine metabolic process (GO:0050667),0.47175940910679753,0.9991018797769913,0.47957371225577267,0.7808902934852779,1.0,2/11,10.45%,DPEP1;MTRR
prerank,intracellular cholesterol transport (GO:0032367),-0.392616217383962,-0.9980886714093152,0.48677248677248675,0.7828042437862988,1.0,2/15,0.76%,ABCA1;LRP6
prerank,mitochondrial translation (GO:0032543),-0.2456092286989487,-0.9980459503130265,0.4267515923566879,0.7818026078551585,1.0,50/104,31.52%,GFM2;MRPL24;MRPS9;DAP3;MRRF;LARS2;MRPS21;MRPL1;MRPS5;OXA1L;NDUFA7;MRPL45;MRPS31;MRPS17;GATB;MRPL10;MRPL43;GATC;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;MRPL3;MRPL32;MRPL47;MRPS30;MRPL17;EARS2;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;QRSL1;MRPS18C;MRPL44;MTIF2;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;HARS1;MRPS35;MRPS28
prerank,platelet degranulation (GO:0002576),0.3173732167516156,0.9979591068879621,0.48878923766816146,0.783048040609037,1.0,18/118,12.51%,CYRIB;PHACTR2;LYN;PECAM1;CD36;TOR4A;VEGFC;F13A1;SRGN;NHLRC2;FLNA;PSAP;HGF;FN1;CYB5R1;ABCC4;APP;TLN1
prerank,endocytic recycling (GO:0032456),0.3541420731484539,0.9977859739376825,0.4700520833333333,0.7829559397360587,1.0,9/50,8.95%,LMTK2;EPS15;DENND1A;EHD2;RAB7A;VPS53;DENND1B;STX6;SNF8
prerank,regulation of mitochondrial fusion (GO:0010635),0.46678541620518615,0.9975966777229945,0.4565972222222222,0.7828754604920931,1.0,2/11,7.68%,PID1;ZDHHC6
prerank,central nervous system myelination (GO:0022010),0.4773061814379562,0.9970662656034158,0.4610169491525424,0.7836233962941893,1.0,3/11,5.92%,MYRF;B4GALT5;PTEN
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4460268363968806,0.9970499890473782,0.47019867549668876,0.783158379389545,1.0,4/13,17.60%,PPARG;REST;RELA;NFATC3
prerank,primary alcohol metabolic process (GO:0034308),-0.32808450788860866,-0.9969661989781152,0.4212121212121212,0.7834173460065244,1.0,4/25,8.62%,IGF1;GDE1;PECR;DHRS3
prerank,histone lysine demethylation (GO:0070076),0.40247157803006617,0.9969375376145528,0.4559505409582689,0.7828916834313084,1.0,3/25,7.21%,KDM6A;KDM7A;KDM3B
prerank,positive regulation of cell projection organization (GO:0031346),0.3167608993539178,0.9966251129136496,0.49303944315545245,0.783067689037284,1.0,30/115,17.11%,TIAM1;LYN;NGF;RAP1A;NGFR;CAMK1D;RET;NDNF;TIAM2;RAPGEF2;NPTN;CARMIL1;SETX;PTK2B;PLXND1;CBFA2T2;RHOA;SCARB2;DVL3;PLXNC1;SNX3;KIDINS220;MAP3K13;STMN2;DVL2;RETREG3;RELN;FES;CAPRIN1;ABL2
prerank,membrane lipid metabolic process (GO:0006643),-0.344692222739536,-0.9963893738917964,0.44919786096256686,0.7838542352703187,1.0,10/22,22.14%,ST3GAL6;CERK;AGMO;ARV1;B4GALT4;SERINC1;AGK;SPHK2;TECR;ST6GALNAC4
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.41382797398658505,0.9963577752992903,0.4556390977443609,0.7831855019060624,1.0,10/21,22.77%,SLK;RHOA;ROCK1;CLASP1;DAPK3;PTPRA;VCL;PTK2;LIMCH1;CORO1C
prerank,pulmonary valve development (GO:0003177),0.41572413144181397,0.9959662233224078,0.456656346749226,0.7836208195995836,1.0,2/18,2.93%,NOTCH2;BMPR2
prerank,cellular response to alcohol (GO:0097306),0.3601786371661255,0.9957505546231777,0.48517520215633425,0.7836070737658567,1.0,12/42,13.33%,MAP4K1;PTGER2;CTNNA1;PTGER4;AHR;GNB1;ADCY7;GNAI1;ADCY5;SPIDR;KLF9;GNG2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4045573378304417,0.995639004739358,0.47878787878787876,0.7833612899440593,1.0,5/23,9.47%,ACSL5;ELOVL5;HSD17B12;ELOVL6;FAR1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4708949613488641,0.9956245187566611,0.476027397260274,0.7828928094190665,1.0,4/11,19.34%,GPX1;PXDN;PRDX5;CAT
prerank,cellular response to catecholamine stimulus (GO:0071870),0.3935941784697384,0.9955186168813702,0.4613050075872534,0.7826439883457461,1.0,3/23,8.39%,LRRK2;KCNQ1;GNB1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3259003761166422,0.9954867009212658,0.4863582443653618,0.7822082942758076,1.0,19/92,14.67%,FOXP1;RIN2;DOCK5;PRKCE;PLCG2;BMPR2;GLIPR2;SCARB1;BCAR1;PTK2B;RAC1;BCAS3;RTN4;GPI;EMC10;CAPN7;AKT1;CLASP1;ADAM9
prerank,lipid translocation (GO:0034204),0.4032427742772465,0.9944733196024859,0.45412130637636083,0.7840516291332311,1.0,1/21,0.05%,ATP8B4
prerank,regulation of amyloid fibril formation (GO:1905906),-0.38281451099642766,-0.9944718022845188,0.43869209809264303,0.7877854867432663,1.0,4/15,12.13%,APOE;TREM2;CHRNA7;CLU
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3007113393549642,-0.9943587885038888,0.4362934362934363,0.7869516628810641,1.0,7/33,10.53%,IGF1;NYAP2;NF1;HTR2B;PIK3CG;IRS1;PIK3R1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.24815652172052605,-0.994307462607926,0.47305389221556887,0.785968735721477,1.0,22/84,16.07%,BIN1;APOE;IGF1;LARP1;NTRK2;SAMD4A;RTN3;LSM14A;FXR1;GGA3;CHRNA7;CNOT10;PAIP2B;FXR2;RPL13A;CLU;RIDA;TOB1;ABCA7;IGF2BP2;RNF139;CPEB3
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.48553443748634834,0.9927164254770204,0.483704974271012,0.787575810448242,1.0,3/10,11.58%,ATF7IP;THRA;PSMC4
prerank,lipid homeostasis (GO:0055088),-0.27277631071315983,-0.9926935564431197,0.4472573839662447,0.789059800186434,1.0,7/57,5.91%,ABCA1;APOE;TREM2;USF2;ABCB4;PNPLA8;NR1D2
prerank,neuron projection development (GO:0031175),0.30600380764233037,0.9921896568751686,0.5065502183406113,0.7882999633249383,1.0,22/168,8.70%,LRRK2;SRGAP2;LYN;CDNF;NGF;PAK1;SHTN1;DOCK10;BTG2;FRY;RAPGEF2;LAMB1;CDC42;GDNF;TAOK3;PPP1R9B;PTEN;FRYL;ATP7A;EPHB2;IL6;MINK1
prerank,RNA splicing (GO:0008380),0.32238075581602627,0.9920263894318355,0.4857792946530148,0.7881478533864333,1.0,30/95,20.94%,MBNL1;RSRC1;RNPC3;SNRPD2;PRPF6;PPP1R9B;SNRPB;DBR1;SRSF10;MAGOHB;PRPF3;RP9;SRSF4;DHX8;SLU7;DDX23;SNRPA1;CDK12;SYNCRIP;NCBP1;TXNL4A;SF3B3;SF3B2;SF3B1;PDCD7;SMNDC1;HNRNPC;LUC7L3;PRPF18;NONO
prerank,cellular iron ion homeostasis (GO:0006879),-0.2718286929469814,-0.9917342854499556,0.4558139534883721,0.7903787924419932,1.0,13/55,10.86%,FRRS1;SLC11A1;ABCG2;ATP6AP1;FLVCR1;SLC22A17;SLC11A2;TFRC;FTH1;ATP6V0D1;CAND1;FTL;HMOX1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3811388781724721,0.991653991955563,0.4622222222222222,0.7885076487284943,1.0,11/29,23.69%,DHX37;RPS14;UTP6;RPS21;UTP20;RRP36;TBL3;NOP9;HEATR1;DCAF13;RPS16
prerank,ganglioside metabolic process (GO:0001573),0.41853342992211556,0.9915157998887211,0.49516129032258066,0.788312616219501,1.0,4/20,8.26%,ST8SIA4;GM2A;ST8SIA6;ST6GALNAC3
prerank,regulation of potassium ion transport (GO:0043266),-0.3222727621075815,-0.9914390364149381,0.42517006802721086,0.7900406025645509,1.0,5/31,7.56%,CACNA1D;CD63;ANK2;KCNN2;DPP10
prerank,ovarian follicle development (GO:0001541),-0.3915700254587321,-0.9905756770751923,0.4214659685863874,0.7911661733261379,1.0,6/13,29.40%,VEGFA;EIF2B5;EIF2B4;ANG;SOD1;INHBA
prerank,protein localization to plasma membrane (GO:0072659),0.3097256810848276,0.9904685588287242,0.49944994499449946,0.7902050245066186,1.0,33/129,17.91%,RAP1A;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;CCDC88A;IKBKB;EHD2;KCNIP3;AFDN;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14;TSPAN33;PACS2;PACS1;RAB40B;PIP5K1A;ROCK1;EFR3A;EHD1;ZFYVE27;TSPAN15;TSPAN5;MYADM;TSPAN17;EHD3;ZDHHC3
prerank,UV-damage excision repair (GO:0070914),-0.4008007899054087,-0.9903245324251695,0.49257425742574257,0.7907020011753705,1.0,6/12,28.18%,POLD3;ACTR5;POLA1;XPC;ERCC1;DDB1
prerank,vesicle organization (GO:0016050),0.35571321536405653,0.990267401184439,0.47368421052631576,0.7901246898502213,1.0,6/46,5.50%,PLEKHF1;EPS15;CORO1A;SRGN;CAV2;PI4K2B
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.32831347996194177,-0.9898343385855851,0.46647230320699706,0.7909049265332428,1.0,4/24,3.16%,MEF2C;CAMK1;CTNNA2;CTNNB1
prerank,spliceosomal snRNP assembly (GO:0000387),0.3711602815998361,0.9897539181219217,0.4959785522788204,0.7907655905009289,1.0,9/38,15.57%,SNRPD2;PRPF6;SNRPB;SRSF10;COIL;PRPF3;USP4;GEMIN7;AAR2
prerank,sarcomere organization (GO:0045214),-0.31899196847575406,-0.9894960757840344,0.4392523364485981,0.7906486674382722,1.0,15/27,56.60%,CAPN3;ACTN2;FHOD3;CSRP2;TNNT3;MYPN;TTN;CSRP1;TNNT2;MYH6;SIX4;MYOM2;SYNPO2L;MYOZ2;TNNT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.46795197427866175,0.9892597691252797,0.47332185886402756,0.7903497008899852,1.0,4/11,11.96%,SLC25A16;PANK1;PANK4;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.46795197427866175,0.9892597691252797,0.47332185886402756,0.7903497008899852,1.0,4/11,11.96%,SLC25A16;PANK1;PANK4;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.46795197427866175,0.9892597691252797,0.47332185886402756,0.7903497008899852,1.0,4/11,11.96%,SLC25A16;PANK1;PANK4;ACAT1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3408583082149049,-0.9890146769769427,0.4491017964071856,0.7907675671115562,1.0,5/21,14.93%,CX3CR1;CTNNB1;VEGFA;MDK;CX3CL1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3173975584083828,-0.9888628167693729,0.49404761904761907,0.7900649746243301,1.0,4/27,3.75%,APOE;TREM2;LRP1;ABCB4
prerank,glycogen catabolic process (GO:0005980),-0.369037276237196,-0.9884091554802792,0.4753246753246753,0.790089580362506,1.0,7/15,22.67%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,peptide biosynthetic process (GO:0043043),0.30241306647892885,0.9883693033677743,0.512568306010929,0.7919101411604049,1.0,52/153,23.83%,ZAR1;RPL5;RPS10;RPL37A;MRPL55;RPL6;MRPL18;RPS18;RPS14;GGTA1;RPL35A;RPL13;MRPL13;RPS3;IGF2BP3;RPS21;FARSB;CARNS1;RPL34;RPLP0;RPL19;RPL11;RPL30;PCSK5;RPS2;RPL4;RPL7;RPS15A;MRPS6;RPS4X;MRPS33;HARS2;GSPT1;RPL32;RPSA;RPS13;MRPS15;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;MRPS12;RPL10A;MRPS18A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,global genome nucleotide-excision repair (GO:0070911),-0.32442780553886863,-0.9883039869517609,0.4658753709198813,0.7892364736290748,1.0,11/26,28.18%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;GTF2H5;UBA52;XPC;ERCC1;GTF2H4;DDB1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.46069869713336686,0.9879390731985931,0.4874551971326165,0.7923610890543651,1.0,4/12,12.10%,CXCL10;SPN;RHOA;APP
prerank,cell-cell junction assembly (GO:0007043),-0.26021745181198075,-0.9876854400242423,0.4696969696969697,0.7897390443551313,1.0,20/63,21.50%,TJP1;PKP4;FLCN;CD9;CTNNB1;CDH11;SMAD7;PATJ;JUP;EPB41L3;GJA1;JAM3;TLN2;TRPV4;PKP2;RHOC;ARVCF;CDH22;CLDN11;CNTNAP1
prerank,regulation of interleukin-1 production (GO:0032652),0.43371463402502125,0.9876583538887594,0.4859375,0.7925192069095489,1.0,3/15,10.39%,FOXP1;TMED10;ANXA1
prerank,neutral amino acid transport (GO:0015804),-0.3204532080551687,-0.9875853734189997,0.47761194029850745,0.7888730918782338,1.0,6/28,12.67%,SLC38A6;SLC36A4;SLC6A15;SLC36A1;SLC7A8;SLC3A2
prerank,protein N-linked glycosylation (GO:0006487),-0.25807538648166456,-0.9873062040309026,0.4520547945205479,0.7884708194254272,1.0,19/66,17.23%,MAN1C1;ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;MPDU1;OSTC;MGAT4C;ENTPD5;ALG2;ALG9;MGAT4A;ALG10B;DPM2;GFPT1;ALG1
prerank,regulation of vasculature development (GO:1901342),0.3889660304713181,0.9872699209932121,0.4635958395245171,0.7928768645556207,1.0,4/26,8.62%,SP100;ADGRA2;PLXND1;IL6
prerank,nucleus organization (GO:0006997),-0.28151676225990613,-0.9872362538860276,0.45267489711934156,0.7875434653285295,1.0,9/47,6.89%,BIN1;NUMA1;IRAG2;VPS4B;NUP54;CHMP5;NUP133;SUN1;NUP155
prerank,protein oxidation (GO:0018158),-0.408348518163153,-0.9871427217296563,0.4744525547445255,0.7867368971952026,1.0,4/11,22.36%,LOXL3;TMX3;PRDX3;CHCHD4
prerank,inorganic ion transmembrane transport (GO:0098660),-0.39437808969992455,-0.9867871928446871,0.4578005115089514,0.7864985576400517,1.0,6/12,41.44%,PKD2;ABCC9;ABCC8;PKD2L1;CACNA1H;P2RX3
prerank,water-soluble vitamin metabolic process (GO:0006767),0.33292332209525677,0.9865580132884492,0.48860759493670886,0.7939998827338536,1.0,16/68,19.18%,HLCS;SLC23A2;SLC23A1;MMAB;ABCC1;TPK1;MTRR;LMBRD1;ACP5;MMAA;PCCB;SLC2A1;SLC52A1;SHMT1;MTHFD1L;CYB5R3
prerank,brain morphogenesis (GO:0048854),0.4591972766118183,0.9860264265903649,0.49263502454991814,0.7946999211794755,1.0,4/12,12.05%,FBXW11;PTEN;PAFAH1B1;SLC6A4
prerank,negative regulation of cellular process (GO:0048523),0.288085571098767,0.9856618420485999,0.5246231155778894,0.7950323247202239,1.0,75/521,13.00%,CBFA2T3;IL1B;IFNLR1;SP100;SRGAP2;RUNX3;LYN;NGF;KLF4;LILRB1;CASK;PTPRU;BCL6;PLSCR1;JAK2;HSPA1A;BTG2;BMPR2;RAPGEF2;FABP7;DYSF;CRLF3;RIPOR2;PTPN6;ABI1;EIF2AK2;MYH9;CHMP4B;CBLL1;DLC1;BTG1;PPP1R9B;SPN;RBBP4;TNS2;GLMN;PTEN;ARHGDIB;CDKN2C;OSGIN2;KLF10;PTK2B;WFS1;ATG5;CIB1;PDCD4;SULT2B1;RARG;TGFBI;LMNA;UBR2;PLXND1;CTCF;EPHB2;IL6;IFI35;OPRM1;SMAD4;RTN4;ARID2;DUSP1;DCUN1D3;S100A11;FCGR2B;REST;APP;NUPR2;UTP20;SH3BP4;PLXNC1;TLR2;SNX3;PPM1D;NF2;EIF2AK3
prerank,positive regulation of cellular senescence (GO:2000774),0.4692069647219592,0.9851715099552902,0.48211243611584326,0.7956349671164615,1.0,3/10,17.18%,ARG2;B2M;SIRT1
prerank,negative regulation of ossification (GO:0030279),0.3964261405975393,0.9849743342766701,0.48878923766816146,0.7955618801072976,1.0,4/23,6.45%,CCR1;RBPJ;SRGN;PTK2B
prerank,inorganic anion transport (GO:0015698),-0.2701609865514405,-0.9846902001537516,0.462882096069869,0.7906730598139198,1.0,19/53,30.05%,SLC11A1;TTYH3;CLCN6;ENPP1;ANO10;CLCN4;SLC26A11;SLC25A11;SLC25A14;ANO8;CLCN2;SLC26A8;SLC4A10;SLC26A6;SLC25A10;CLCN1;CLIC5;FXYD1;ENPP3
prerank,motile cilium assembly (GO:0044458),0.4548432819044951,0.9845293864948022,0.5051369863013698,0.7960332744798049,1.0,2/12,12.33%,SPATA6;CCDC39
prerank,protein-containing complex assembly (GO:0065003),0.29389343836179355,0.9845116695060151,0.5067218200620476,0.7955735683918045,1.0,27/259,10.98%,CD74;LRRK2;TIAM1;TRAF1;WIPF1;CD40;TRAPPC5;CLDN1;CUL3;SKAP2;PICALM;AXIN1;CD2AP;AFDN;PTK2B;ELOB;TMED10;STX5;PEX14;CAPZA1;FANCC;TSPAN33;FN1;SNX9;RIPK1;DNAJB12;TRAPPC2L
prerank,striated muscle tissue development (GO:0014706),0.3877431449649502,0.9843743406297096,0.4978165938864629,0.7953706696741554,1.0,3/29,7.08%,SVIL;BMPR2;SGCD
prerank,diterpenoid metabolic process (GO:0016101),-0.27286963904238093,-0.9841690261077171,0.4826086956521739,0.7909645329939656,1.0,8/55,15.75%,APOE;LRP1;BCO2;PECR;DHRS3;GPC6;AGRN;AKR1B1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.45077872500677807,0.9836073715798841,0.5072697899838449,0.7965920046125338,1.0,3/13,12.68%,SPAAR;DEPDC5;CASTOR2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.46857544069504775,0.9835565175813087,0.5026642984014209,0.7961927343519971,1.0,5/11,19.50%,BIRC3;PELI1;RIPK1;YBX3;FZD9
prerank,response to nutrient levels (GO:0031667),-0.3687269359817776,-0.983102056652217,0.5173410404624278,0.7926869058666812,1.0,4/17,14.52%,RPTOR;CD68;ATF4;EIF4G1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.3182617438957918,-0.9829287423799994,0.46540880503144655,0.7920315274918346,1.0,18/30,39.09%,PIGN;PIGG;PGAP2;PIGP;PIGB;PIGA;DPM2;PIGV;DPM3;PIGU;DPM1;PIGO;PGAP3;MPPE1;PIGZ;PIGW;PIGQ;PGAP1
prerank,regulation of organelle organization (GO:0033043),0.32610160401968535,0.982916943540595,0.48495788206979545,0.7971394291210646,1.0,26/80,20.82%,MSN;USP6NL;ZEB2;CLIC4;DIAPH1;PARL;CAPN2;PAK2;CLEC16A;PDE2A;F11R;EZR;STX5;FIS1;SCARB2;DNM1L;CAPN6;STMN3;MAPK1;EHD3;TBC1D25;PINK1;AKAP9;PTK2;MUL1;ARMH3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3603672979081072,0.9827009398907107,0.49173553719008267,0.7971180810362438,1.0,3/36,5.03%,IL1B;NOSTRIN;SCARB1
prerank,negative regulation of translation (GO:0017148),0.32141824826908105,0.9826925108293764,0.48854041013269,0.796640114331198,1.0,25/87,18.37%,DAPK1;MEX3D;BTG2;EIF4EBP1;EIF2AK2;GIGYF2;YTHDF3;MRPL13;TRIM71;RPS3;IGF2BP3;PAIP2;EIF4ENIF1;EIF2AK3;METTL3;ROCK1;SYNCRIP;EIF3E;CELF1;PUM1;DAPK3;CNOT8;CAPRIN1;DDX6;SHMT1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.30725936992101854,-0.9824246872596536,0.46534653465346537,0.7922154045578966,1.0,5/36,2.97%,PTPRM;APOE;MEF2C;FGF2;HMGB1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3701254202867003,0.9821661220619246,0.49022346368715086,0.797378666752994,1.0,13/31,20.03%,HSPA1A;ERN1;TM7SF3;ATXN3;UBE2W;DAXX;PTPN1;DNAJB12;HSPA9;BAG3;HSPA5;DNAJB14;RHBDD1
prerank,cytoskeleton organization (GO:0007010),0.31142618483508044,0.982028125812613,0.4977168949771689,0.79720476984451,1.0,16/114,8.95%,RND3;NEDD9;LIMD1;CNN2;SYNE3;SIPA1L3;PDZD8;RAC2;DIAPH1;FGD4;CAPZB;RHOBTB3;RAC1;FGD1;FGD3;RHOA
prerank,mitochondrial translational elongation (GO:0070125),-0.24827734192062026,-0.9817592659917321,0.480225988700565,0.7927583882087438,1.0,51/88,37.78%,GFM2;MRPL24;MRPS9;DAP3;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;MRPL3;MRPL32;MRPL47;MRPS30;MRPL17;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23;MRPS2;MRPL14;MRPL36
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3440305678502868,0.981569572205726,0.5089514066496164,0.7977337353357299,1.0,14/52,16.34%,PRKCE;PRKCH;KIF5B;PDPK1;CIB1;EPHB2;GNAI1;CLIP3;LGALS3;AKT1;ITGA3;RHOG;GPSM2;PLS1
prerank,histone H2A monoubiquitination (GO:0035518),-0.36092875566646343,-0.9814007597425476,0.4540540540540541,0.7926210674697143,1.0,4/17,8.09%,BCOR;TRIM37;PCGF6;KDM2B
prerank,mammary gland epithelium development (GO:0061180),-0.3828924619055558,-0.9810402616236807,0.48157248157248156,0.7924194327352284,1.0,2/14,0.93%,CSF1R;ERBB4
prerank,positive regulation of peptidase activity (GO:0010952),0.40543931621564483,0.9807943140740862,0.48036253776435045,0.7989884765766943,1.0,6/20,14.19%,PSME3;PSME2;MAPK12;TANK;PRELID1;VCP
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3074970947339994,0.9807227704684481,0.49426605504587157,0.7986480829256787,1.0,26/129,14.86%,SDCCAG8;CNTRL;PPP1R12A;HAUS8;PHLDA1;FBXW11;FBXL8;CDK14;CEP63;PAFAH1B1;PLCB1;HAUS1;PPP2R2A;CCNH;DCTN3;BACH1;LATS1;CEP250;FBXL17;DYNC1H1;PPP1CB;HAUS3;FBXL12;CLASP1;WEE1;BRSK1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.38357093464257064,0.9806923772178249,0.5065693430656935,0.798218743268702,1.0,10/27,18.56%,ZC3H12D;ERN1;NHP2;RNASE1;KHNYN;RNASE6;RNASEH1;CPSF3;NYNRIN;CSTF3
prerank,organelle organization (GO:0006996),0.2873915669462578,0.9802372030446,0.5589430894308943,0.7987395476388841,1.0,65/388,13.94%,ATP8B4;LRRK2;NEDD9;LIMD1;FAM174B;CNN2;SYNE3;TSGA10IP;LONP1;SIPA1L3;PLEKHF1;PDZD8;EPS15;USP6NL;GOLPH3L;TMCC1;ABCA3;PEX16;CDC42;CHMP4A;CHMP4B;PEX12;DIAPH1;RAB7A;FGD4;CAV2;PI4K2B;STX17;HPS3;CLUH;PITPNB;RAB34;CAPZB;ATXN7;TMED10;ATP7A;YTHDF3;PDCD6IP;GBF1;GABPB1;FGD1;PEX14;FGD3;BCAS3;PIKFYVE;ATL3;ARFGEF1;STX7;LMAN2L;ARHGAP21;CFAP61;STRIP2;TTC17;TRAPPC11;SPTSSB;HTT;TFAM;PACSIN2;DNM1L;EIF2AK3;ABCD1;SIRT4;YME1L1;CLASP1;VMP1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.32637974426194966,0.9801115052867994,0.49403341288782815,0.798523921236447,1.0,14/80,12.11%,UVRAG;RACGAP1;GOLPH3L;COPG2;KIF23;ARF4;RAB6A;PITPNB;TMED10;GBF1;RINT1;KIF3B;HTT;KDELR1
prerank,myelin maintenance (GO:0043217),0.47255718094375343,0.9798807558052297,0.494195688225539,0.7985284787914129,1.0,4/10,13.07%,PRX;MYRF;PTEN;ABCD1
prerank,steroid hormone biosynthetic process (GO:0120178),0.37168327628677295,0.979607823019064,0.4727540500736377,0.798618465117206,1.0,5/29,17.80%,HSD17B14;HSD17B7;HSD17B11;MED1;HSD17B2
prerank,signal peptide processing (GO:0006465),-0.4079233218120064,-0.9794189925637001,0.4919908466819222,0.7955299954475297,1.0,4/11,7.28%,SPCS3;FURIN;SPPL3;SEC11C
prerank,positive regulation of signaling (GO:0023056),-0.2894671947543509,-0.9793657459335627,0.4847457627118644,0.79456896852291,1.0,12/37,20.71%,SYT1;WLS;DLG4;ILK;SCRIB;CLSTN2;CD80;SOX11;RIMS1;VAMP3;RIMS3;ECE1
prerank,heart trabecula morphogenesis (GO:0061384),0.41898959010703896,0.9792234472368839,0.47619047619047616,0.7989743817654762,1.0,3/18,8.16%,ADGRG6;RBPJ;ENG
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.34150381913119104,-0.9786281103233739,0.47863247863247865,0.7952814617929961,1.0,6/20,17.99%,AGO3;TSN;AGO1;ZC3H7B;TSNAX;DROSHA
prerank,regulation of ATP biosynthetic process (GO:2001169),0.42482022394375124,0.9784709681726408,0.5118483412322274,0.8001584003442702,1.0,1/16,0.25%,PID1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3224577876630091,0.9780105702738442,0.5073349633251834,0.80071312325116,1.0,7/75,6.65%,ITGA4;AKT3;STAT5A;BMPR2;VEGFC;ADAM17;PDPK1
prerank,in utero embryonic development (GO:0001701),-0.32672836592408727,-0.9779112266524312,0.4782608695652174,0.7960955003587447,1.0,6/25,12.58%,CHD7;TGFBR1;FLCN;FGFR2;VEGFA;HINFP
prerank,regulation of histone acetylation (GO:0035065),0.3665282924023864,0.977503753578011,0.48801128349788436,0.8013474360786521,1.0,8/33,16.00%,IL1B;SPI1;RPS6KA5;SETD5;TADA2A;TAF7;KMT2A;BRD7
prerank,bile acid biosynthetic process (GO:0006699),-0.33074360545037174,-0.9774023525812265,0.4968944099378882,0.7963332514917482,1.0,11/24,34.28%,OSBPL1A;CH25H;OSBPL6;AMACR;OSBPL7;ACOT8;OSBP;SLC27A2;OSBPL2;HSD17B10;CYP7B1
prerank,myoblast fusion (GO:0007520),-0.40707578253049537,-0.9773912542872528,0.5012165450121655,0.7952675882945348,1.0,4/12,15.75%,CD9;ADGRB3;JAM2;ADAMTS5
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.39470354299407767,-0.9773124182024391,0.48872180451127817,0.7943831300718304,1.0,5/12,42.54%,TLR4;SOX9;TLR9;INAVA;NOD2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3757840672016554,0.9773055977034757,0.5021156558533145,0.8012792447702874,1.0,2/31,1.70%,LIMD1;PPARG
prerank,base conversion or substitution editing (GO:0016553),-0.4192563698461326,-0.9771903923336612,0.4953051643192488,0.793608193361275,1.0,4/11,26.72%,ADARB2;ADAR;ADARB1;NUDT16
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.37380117778944977,0.9767210025066183,0.4934876989869754,0.8020906649618572,1.0,10/32,16.87%,CASK;RCC2;DLC1;PTEN;PHLDB2;BCAS3;NF2;THBS1;DUSP22;ARHGAP6
prerank,histone H3-K4 methylation (GO:0051568),0.38394663989054423,0.9764394895987942,0.48516320474777447,0.8022403001890467,1.0,9/26,21.36%,KDM6A;TET2;KMT2C;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3622302417928688,0.9761964726475874,0.49441340782122906,0.8022597708477632,1.0,10/36,14.83%,PTPN22;MARVELD3;ITCH;TAOK3;EZR;CYLD;DUSP1;HDAC3;GPS2;GSTP1
prerank,regulation of interferon-alpha production (GO:0032647),0.3868607314650076,0.975363971972338,0.5052473763118441,0.8035948177040844,1.0,10/23,21.92%,STAT1;IFIH1;TLR3;IRF7;SETD2;TBK1;IRF5;HSPD1;RIPK2;TLR8
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.3349578625108609,-0.9748674215371699,0.4956521739130435,0.7985154847801116,1.0,6/21,13.68%,CSF1R;CMKLR1;CSF1;MTUS1;AKIRIN1;MDK
prerank,protein palmitoylation (GO:0018345),0.3761176672355354,0.9747806921483908,0.497134670487106,0.8044809222680143,1.0,7/30,12.70%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17;CLIP3
prerank,positive regulation of exocytosis (GO:0045921),0.3702896300965045,0.9745550340490532,0.5070621468926554,0.8045008113242208,1.0,8/35,13.92%,RAB3D;UNC13D;RAB7A;TSG101;PDCD6IP;SNF8;STAM;CLASP1
prerank,xenobiotic transport (GO:0042908),-0.36237805170267157,-0.9745467688427266,0.47668393782383417,0.7982586334353619,1.0,6/17,17.09%,ABCC3;ABCG2;GJA1;SLC15A2;SLC22A4;ABCC5
prerank,stress fiber assembly (GO:0043149),0.4203523846716933,0.9743466733733972,0.5112540192926045,0.8039509758101466,1.0,7/15,17.46%,PDLIM1;CUL3;RHOA;FHDC1;KCTD13;PHACTR1;FAM171A1
prerank,contractile actin filament bundle assembly (GO:0030038),0.4203523846716933,0.9743466733733972,0.5112540192926045,0.8039509758101466,1.0,7/15,17.46%,PDLIM1;CUL3;RHOA;FHDC1;KCTD13;PHACTR1;FAM171A1
prerank,adherens junction organization (GO:0034332),-0.2746955629903569,-0.974113546089577,0.49159663865546216,0.798294788149523,1.0,10/48,12.62%,TJP1;CADM1;CTNNB1;CADM2;CDH11;SMAD7;JUP;PVR;NECTIN4;JAM3
prerank,anion transport (GO:0006820),0.3699533978725868,0.97408129640998,0.484149855907781,0.8040141167124797,1.0,4/33,5.67%,LRRC8C;LRRC8D;LRRC8B;SLCO1B1
prerank,sodium-independent organic anion transport (GO:0043252),-0.42807547064519463,-0.9740605883779406,0.4725,0.7973402825907421,1.0,1/10,0.11%,SLCO2B1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.38607318745099045,-0.9740447714237754,0.4881889763779528,0.7963013234663855,1.0,10/14,43.93%,TGFBR1;EFEMP1;SOX9;CHADL;GREM1;PTHLH;RFLNB;RFLNA;WNT9A;SNAI2
prerank,angiogenesis involved in wound healing (GO:0060055),0.4484656020527507,0.9740435600144031,0.48282097649186256,0.803592637857313,1.0,2/11,5.35%,NDNF;PRCP
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.38718206855568765,-0.9737362759329465,0.4936061381074169,0.7960502382673098,1.0,6/13,29.86%,GLUL;GOT1;MTHFS;GAD1;ACOT8;DDO
prerank,mRNA stabilization (GO:0048255),0.35727514490892925,0.9737082231198086,0.5199468085106383,0.8038496190531982,1.0,12/40,17.83%,TENT5A;MAPKAPK2;GDNF;MAPK14;TIRAP;EIF4ENIF1;SYNCRIP;PAIP1;MYD88;PABPC1;BOLL;YBX3
prerank,protein K48-linked deubiquitination (GO:0071108),-0.33271573826221057,-0.9736563629118979,0.4868804664723032,0.7951756619780775,1.0,9/23,20.01%,MINDY2;OTUD5;USP20;OTUD7A;MINDY1;OTUD7B;OTUB1;OTUD3;USP5
prerank,regulation of telomere capping (GO:1904353),0.3960662223688324,0.9727926752534718,0.5155763239875389,0.8053737223331812,1.0,7/23,16.35%,PKIB;TNKS;MAP3K4;AURKB;USP7;MAPK1;SMG6
prerank,positive regulation of cell junction assembly (GO:1901890),-0.26704689467951226,-0.9722974000355682,0.49295774647887325,0.7974696189907715,1.0,22/56,28.43%,PTPRD;NRP1;IL1RAPL1;NLGN1;GRID2;PPM1F;IL1RAP;FLOT1;VEGFA;NLGN2;CLSTN2;CNTNAP2;NLGN3;NRXN1;DLG5;CUX2;KDR;TSC1;NPHP4;NPHP1;ABL1;CAV1
prerank,development of primary male sexual characteristics (GO:0046546),-0.30023283614684726,-0.9721406518740142,0.46503496503496505,0.7967878673192311,1.0,15/34,33.12%,LHFPL2;KITLG;MSH2;TGFB2;AR;NCOA4;FGF9;SOX9;WNT4;INHBA;MEA1;BIK;WNT5A;WNT2B;MAMLD1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.41223634797130754,0.9720324018604048,0.5111821086261981,0.806548821308395,1.0,6/20,10.66%,BIRC3;PELI1;PDCD6IP;SPATA2;CYLD;RIPK1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3664277800111331,-0.9719073819264615,0.49214659685863876,0.7963151672794284,1.0,3/16,7.38%,APOE;HIF1A;HTR2B
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4088161364161409,0.9718541818611242,0.5047021943573667,0.8064425224717077,1.0,6/20,16.00%,IL1B;RPS6KA5;TADA2A;PRKAA1;PRKAA2;BRD7
prerank,negative regulation of lymphocyte migration (GO:2000402),0.46572772989035555,0.971838372141404,0.5017123287671232,0.8059890500824043,1.0,5/10,22.06%,RIPOR2;AKT1;LRCH1;PADI2;MIA3
prerank,endodermal cell differentiation (GO:0035987),0.37494426133247916,0.9717259469818122,0.5296735905044511,0.8057451244853209,1.0,5/31,10.80%,ITGA4;LAMB1;ITGB2;FN1;SETD2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4218257595992312,0.9717214699402158,0.5024,0.8052614949789598,1.0,4/16,12.35%,CDK13;RSRC1;SLU7;PQBP1
prerank,telomere maintenance via recombination (GO:0000722),0.43982785846459377,0.9716772375229132,0.48743718592964824,0.8048620752463762,1.0,4/11,18.88%,TEP1;ERCC4;SMC6;SMC5
prerank,regulation of double-strand break repair (GO:2000779),-0.28452824283598943,-0.9715687375766007,0.5076335877862596,0.7961383847350432,1.0,9/39,10.75%,SPIRE1;MGMT;SLF2;SLF1;RNF169;FMN2;ZCWPW1;TERF2IP;SHLD2
prerank,regulation of fibroblast migration (GO:0010762),-0.3417318340105346,-0.9707996165369471,0.45045045045045046,0.7969857975672423,1.0,4/20,3.66%,GNA12;APPL2;FGF2;RFFL
prerank,cellular response to ionizing radiation (GO:0071479),0.3415140228954328,0.9707037792666323,0.48741721854304637,0.8065223276140733,1.0,13/47,17.18%,NIPBL;MAPK14;GRB2;WRN;CLOCK;TLK2;TANK;NET1;SPIDR;MAP3K20;INO80;HUS1;SIRT1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.2958409641004262,0.9705399057140244,0.5444801714898178,0.8063896161624938,1.0,51/182,20.24%,FOXP1;NOTCH2;PTPN22;RIN3;KLF4;LDLR;CCR1;NFKB1;REL;SPI1;PICALM;FBXW7;TIPARP;PARP14;SETDB2;MECP2;ENG;CPNE1;ID2;WWP2;OLFM1;PARP9;PRKAA1;REST;APP;TNRC6B;PRKAA2;CITED2;TNRC6A;TGFB1;OCLN;TAF1;ZNF148;CELF1;SNX12;RBL2;MYADM;RB1;MTMR2;PSEN1;SIRT1;MMP8;HDAC1;PINK1;MAP2K1;ANKRD13A;DNMT1;TERF2;NDFIP2;PARK7;RUNX1
prerank,ribosomal large subunit assembly (GO:0000027),0.383248246862098,0.9700302534842937,0.48254931714719274,0.8070191733588362,1.0,5/24,12.91%,RPL5;RPL6;RPF2;RPLP0;RPL11
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3068805605662533,0.9699862274226868,0.5023255813953489,0.8066220906378999,1.0,29/128,18.13%,RUNX2;ARHGEF18;FOS;BMPR2;CBL;SCX;GDF1;HIVEP1;PDCD4;ZFYVE9;F11R;ENG;PXN;ACVR2A;RHOA;USP15;NRROS;SMAD4;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;SMAD5;SIRT1;SMURF2;APPL1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2987652928314685,0.9696235756296947,0.528322440087146,0.8068838373729563,1.0,26/170,12.32%,PTPRC;FOXP1;KDM6A;LDLR;TRIM26;GDNF;NFKBIZ;MTMR3;AHR;CRIP1;CGGBP1;ARF1;MTMR4;TOB2;CTCF;NKAPL;AFF1;IGF2BP3;TRIM14;NFKBID;CACTIN;SCARB2;ZNF507;REST;APP;TRIM17
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.4094874690784616,-0.9696049855491039,0.4715261958997722,0.7989749300995593,1.0,6/10,27.24%,GALNT3;GALNT13;GALNT16;POGLUT2;MGAT5B;POGLUT3
prerank,multivesicular body organization (GO:0036257),0.3744461116395788,0.969584637165126,0.5196078431372549,0.8064775956850144,1.0,7/31,11.11%,VPS37C;CHMP4A;CHMP4B;TSG101;PDCD6IP;SNF8;STAM
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.44470095266094123,0.9694848559664468,0.5093696763202725,0.8061873157186744,1.0,3/12,8.44%,MYCBP2;PAFAH1B1;EPHB2
prerank,negative regulation of defense response to virus (GO:0050687),0.46792238691725396,0.9692123608764075,0.49913344887348354,0.8063012663625556,1.0,4/10,22.55%,ITCH;ILRUN;MUL1;TARBP2
prerank,multivesicular body assembly (GO:0036258),0.3749257060206881,0.9690217381430825,0.5210084033613446,0.8062335967868631,1.0,7/30,11.11%,VPS37C;CHMP4A;CHMP4B;TSG101;PDCD6IP;SNF8;STAM
prerank,acylglycerol biosynthetic process (GO:0046463),-0.328477596758856,-0.9689634585183408,0.4696132596685083,0.7994900546498408,1.0,9/23,26.77%,PLA2G15;AGMO;PLA2G4A;GPAM;GPAT4;LPGAT1;ANG;DGAT1;AWAT2
prerank,maintenance of blood-brain barrier (GO:0035633),0.38335155707475693,0.9686181352995237,0.5,0.8066124582704777,1.0,10/30,19.21%,PECAM1;CLDN1;CLDN12;F11R;IL6;MBP;OCLN;TJP3;VCL;ACTB
prerank,skeletal system morphogenesis (GO:0048705),-0.2850346353508121,-0.9682987167493018,0.536,0.8001360246574345,1.0,3/42,1.22%,SKI;LRP6;TGFBR1
prerank,smoothened signaling pathway (GO:0007224),0.3738283719241031,0.9671279865368241,0.5109170305676856,0.8093587370691239,1.0,4/32,7.95%,GLI1;HIPK2;HIPK1;PTCHD1
prerank,positive regulation of protein deacetylation (GO:0090312),0.42763297777780884,0.9669122769451531,0.5158597662771286,0.8093208266898697,1.0,3/14,11.13%,NIPBL;DYRK1A;ING2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.450580423018187,0.9667828741879815,0.5121951219512195,0.8091013199391307,1.0,1/12,1.25%,VRK1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3226069425022326,0.966598104324504,0.5270108043217286,0.8089855543297851,1.0,20/74,17.33%,IL1B;MCL1;PSME3;HSPA1A;GPX1;BIRC6;GDNF;ICAM1;RIPK1;HTT;MAP2K5;SH3RF1;LGALS3;AKT1;GSTP1;UNC5B;RELA;THBS1;EYA3;TRAF2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3519165702113566,0.9665941310115523,0.5085865257595773,0.8084980168567525,1.0,12/48,15.83%,SLC25A16;PANK1;ADCY10;PANK4;PAPSS1;PAPSS2;GUCY1A1;ADCY7;ACAT1;ADCY5;ADSL;GMPS
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.45212098330996586,0.9664232118388473,0.515702479338843,0.8084087481188869,1.0,4/11,17.59%,TPK1;NT5C3A;DCK;ERH
prerank,erythrocyte development (GO:0048821),-0.42466495196736337,-0.9660276987885709,0.5052910052910053,0.804826058380169,1.0,7/10,41.95%,ALAS1;NCKAP1L;LYAR;ABCB10;ZBTB7A;SH2B3;DMTN
prerank,positive regulation of chromatin organization (GO:1905269),0.4414518944851638,0.9660046590869936,0.5032051282051282,0.8088553359643694,1.0,5/12,15.44%,H3-3A;UBE2N;DAXX;ATRX;MIER1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3117201765801283,-0.9658747257759966,0.4955223880597015,0.8041308942476937,1.0,13/29,31.37%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;CDK7;GTF2H5;UBA52;XPC;GTF2H4;DDB1;CHD1L;MNAT1
prerank,axonemal dynein complex assembly (GO:0070286),0.3694069626439263,0.9657674128783561,0.513595166163142,0.8089023791586782,1.0,4/28,12.33%,DNAH8;DNAAF5;ODAD1;CCDC39
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.39491442428066353,-0.965712771194484,0.48514851485148514,0.8034280776831828,1.0,4/12,15.61%,DPYD;DPYSL3;UMPS;CRMP1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.39996107065758935,0.9656261086770707,0.5062111801242236,0.8087122821324512,1.0,7/20,16.74%,CCND3;CCND1;ADAM17;PSMD10;CCND2;AKT1;PROX1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.46003354363231896,0.9655442245095611,0.5134228187919463,0.8083933962881132,1.0,2/11,5.03%,LDLR;SCARB1
prerank,lymphocyte chemotaxis (GO:0048247),-0.3036643551278893,-0.9651204038909332,0.4962962962962963,0.8038213181748767,1.0,9/34,17.36%,GAS6;ADAM8;PIK3CG;CH25H;CCL13;GPR183;CX3CL1;CCL14;CCL3
prerank,coenzyme A metabolic process (GO:0015936),0.4333565323171261,0.9647708478179635,0.4958263772954925,0.8095739954381694,1.0,4/14,11.96%,SLC25A16;PANK1;PANK4;ACAT1
prerank,mRNA modification (GO:0016556),0.3939170601203228,0.9646124631503964,0.5129770992366413,0.8094187624239528,1.0,10/22,21.47%,VIRMA;CBLL1;CMTR1;PUS3;METTL3;TRMT10C;PUS1;TRMT61B;PCIF1;TRUB2
prerank,negative regulation of interferon-beta production (GO:0032688),0.45707213009638004,0.9645884662025515,0.49910873440285203,0.8089917045873344,1.0,2/10,3.07%,LILRB1;REL
prerank,secondary alcohol metabolic process (GO:1902652),-0.2794708209461988,-0.9645049146787015,0.4944649446494465,0.8043665241507073,1.0,5/42,10.36%,ABCA1;APOE;OSBPL1A;STARD3;CH25H
prerank,negative regulation of proteolysis (GO:0045861),0.36234837442756673,0.9643393060823736,0.5041899441340782,0.8090535296155535,1.0,3/34,6.34%,LRRK2;DNAJC1;PRNP
prerank,modification-dependent protein catabolic process (GO:0019941),0.2926330701335782,0.9641198650313795,0.5580645161290323,0.8090695983770178,1.0,49/193,18.81%,FEM1C;DTL;ITCH;LONP1;RNF149;DTX3L;NEDD4L;CUL3;BIRC6;UBE2E1;CBL;ANKIB1;RNF146;ARIH1;RNF213;RNF20;RC3H1;KLHL15;RNF217;NEDD8;TRIM25;ARIH2;RNF130;ATXN3;COPS3;RNF13;PSMD9;UBE2S;KLHL8;RCHY1;UBE2G1;AREL1;RNF150;AURKB;FBXO7;ANAPC7;RNF166;TAF1;HACE1;UBR3;UBA6;RNF144A;RNF19B;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4;PINK1
prerank,proteasomal protein catabolic process (GO:0010498),0.29177541042882854,0.9639526169128079,0.5688367129135539,0.8089132452648066,1.0,47/201,16.56%,FEM1C;ITCH;PSME3;NEDD4L;CUL3;TBL1XR1;PSMB7;FBXW7;PSME2;KCTD2;PELI1;UBE2D3;SPOP;FBXW11;FAF1;NFE2L2;CLOCK;COP1;PCNP;PSME4;ATXN3;WWP2;TRIM71;UBE2W;PSMB8;KCTD5;PSMA5;PSMD9;DNAJB12;PSMB3;FBXL17;PSMD6;PSMC4;PSMD10;UBE2G1;AREL1;PSMB1;VCP;PPP2R5C;KCTD13;UBXN11;RMND5B;RNF122;RNF41;HACE1;PSMD12;MAEA
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.22091071565962866,-0.963949405478696,0.5365853658536586,0.804773704234013,1.0,40/173,16.84%,TGFA;GAS6;NAPA;COPA;PREB;MCFD2;GRIA1;PROS1;GOLT1A;ANK2;SPTAN1;TBC1D20;CAPZA2;ERGIC3;GOLGA2;NRBP2;DYNLL2;SPTB;LMAN1;CTSZ;SEC23A;VTI1B;DYNLL1;HYOU1;GOSR2;DCTN5;ARFGAP1;ARFGAP3;COPE;ZW10;TMED9;TEX261;SEC13;BCAP31;CNIH1;F8;TMED4;TRAPPC4;WHAMM;IER3IP1
prerank,organophosphate biosynthetic process (GO:0090407),0.35294555131593675,0.9635328086107479,0.5281980742778541,0.8094012478474281,1.0,9/37,18.15%,ITPKC;AGPAT4;IP6K3;TPK1;PIP5K1A;GNPAT;IPMK;GK;MOCS1
prerank,sphingolipid metabolic process (GO:0006665),0.3043400929054927,0.9635247655262723,0.5486111111111112,0.8089250950114837,1.0,25/108,16.43%,CERS6;CERKL;ACER3;GM2A;ESYT3;CERS1;ELOVL5;ESYT1;SAMD8;SGMS1;SGMS2;PSAP;ST6GALNAC3;ELOVL6;SUMF2;SUMF1;SPTSSB;ESYT2;SGPP2;TEX2;SGPP1;FA2H;VAPA;PPT1;HACD4
prerank,metal ion transport (GO:0030001),0.31908560496495403,0.9634784880997789,0.5100354191263282,0.8085376616887291,1.0,12/86,10.59%,ITPR1;FYN;CCR1;CACNA1A;CHRNA4;ATP2A3;MMGT1;ATP2A1;KCNN4;SLC30A1;MAGT1;NIPA2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.4434840830436828,0.9632864078524511,0.5155709342560554,0.8084796864582682,1.0,2/11,8.24%,ETV6;ARIH2
prerank,histone deacetylation (GO:0016575),0.34995277873968333,0.9630704605983813,0.5094339622641509,0.80848286810875,1.0,15/43,20.01%,TBL1XR1;MTA3;HDAC9;RCOR3;MORF4L1;REST;BAZ2A;MSL3;HDAC3;MIER1;ELK4;SIRT1;HDAC1;MIDEAS;RCOR1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4029483142950625,-0.9627955989752376,0.5025380710659898,0.8066032151891305,1.0,8/11,45.10%,UQCRC2;UQCRC1;UQCR10;UQCC3;CYC1;UQCRQ;UQCR11;UQCRH
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4150014755124387,-0.9626678993012858,0.5066371681415929,0.8058896383431864,1.0,5/10,18.59%,GABRG3;GABRG2;GABRA4;GABRA2;GABRA5
prerank,detection of mechanical stimulus (GO:0050982),-0.3518766274683576,-0.9625891512505586,0.4861878453038674,0.805031132993934,1.0,3/19,7.60%,CTNNB1;PKD2;JUP
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.39895693241993474,-0.9625608427815304,0.47911547911547914,0.8040269275985621,1.0,6/11,23.66%,SMARCAL1;BLM;LIG3;FBH1;FBXO5;TIMELESS
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.3172822497439598,-0.9625004259622392,0.5641025641025641,0.8031046269376587,1.0,6/26,13.66%,NAV3;NUMA1;CLIP1;CDK5R1;MAPRE1;TRPV4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.29306567209119966,-0.9624666881668411,0.5055350553505535,0.8021324310370993,1.0,5/37,5.03%,IGF1;PRKG1;MEF2C;FGF2;FOXJ2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4218099082332952,0.9623855662426052,0.5119236883942766,0.8094915742094859,1.0,2/15,5.11%,PPARG;ELOVL5
prerank,regulation of nuclear division (GO:0051783),0.4077033182215027,0.9623258186243705,0.49698795180722893,0.8091358389926127,1.0,2/20,5.44%,CDK13;CAV2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.44928498847743414,0.9623159139192199,0.5404040404040404,0.8086657539920669,1.0,5/12,19.85%,HEXIM1;RECQL5;NELFA;RNF168;LARP7
prerank,long-chain fatty acid import into cell (GO:0044539),0.46025232136041283,0.962228907110728,0.5282051282051282,0.8083641181430731,1.0,5/10,22.21%,CD36;SLC2A1;RPS6KB1;ACSL1;SLC27A4
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3771372869660275,-0.962174130755385,0.5084269662921348,0.8018032316449867,1.0,6/13,28.72%,SYNGR1;RAB3GAP1;RAB3A;CLN3;SLC4A10;SLC8A2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3757690776447028,0.9621541072186836,0.5043352601156069,0.8080353797314064,1.0,7/30,17.35%,GPR35;F11R;RAC1;NET1;ARHGEF3;LPAR6;GPR65
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3679190161576966,0.9620868301159613,0.517193947730399,0.8076903287947195,1.0,7/32,12.62%,SLC44A2;CEPT1;PCYT1A;CSNK2A2;CSNK2A1;SLC44A1;SLC44A5
prerank,negative regulation of neuron projection development (GO:0010977),0.33160853343123514,0.9618538411513485,0.5038560411311054,0.8077076884530094,1.0,16/56,18.51%,BCL11A;NGFR;PTPRO;PTEN;CIB1;PAQR3;CBFA2T2;RHOA;RTN4;LRP4;RAB29;STMN2;DENND5A;KANK1;EFNA1;SEMA3A
prerank,establishment of epithelial cell polarity (GO:0090162),0.39806422469121167,0.9615348125068225,0.5165876777251185,0.8079407826302075,1.0,6/19,8.95%,MSN;SIPA1L3;CDC42;EZR;CYTH3;RHOA
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3208906504639744,0.9613408301594945,0.5397196261682243,0.8079019796972551,1.0,23/84,18.61%,PSME3;CUL3;UBE2E1;PSMB7;PSME2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;UBE2S;PSMD6;PSMC4;PSMD10;PSMB1;AURKB;ANAPC7;PSMD12;RB1;ECRG4;ANAPC11;FZR1;ANAPC4
prerank,regulation of cellular protein localization (GO:1903827),0.34356343417612656,0.9611564056739095,0.5191780821917809,0.8078138140176497,1.0,13/45,15.28%,LCP1;GPC3;TRIM46;GBF1;RALB;PTPN1;SETD2;PRKAA1;DVL3;SPIDR;PRKAA2;VCP;VCPIP1
prerank,genitalia development (GO:0048806),-0.3909352786613056,-0.9609962234950946,0.5025380710659898,0.8037295566718438,1.0,1/12,0.65%,CHD7
prerank,COPII-coated vesicle budding (GO:0090114),-0.2588994352675952,-0.960319681518,0.538860103626943,0.8044655132582921,1.0,17/68,16.04%,TGFA;NAPA;PREB;MCFD2;GRIA1;SEC23B;TBC1D20;GOLGA2;LMAN1;CTSZ;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,ceramide catabolic process (GO:0046514),-0.3750206347236066,-0.9602084300914229,0.5253807106598984,0.8036714553905985,1.0,2/14,6.06%,HEXB;NEU1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.318427966541639,0.9601757753311732,0.5357142857142857,0.8094058538278599,1.0,18/78,16.74%,CCNJL;CCND3;HEXIM1;PTEN;CDKN2C;CCND1;ADAM17;CCNH;LATS1;CCNT2;LATS2;CCNT1;PSMD10;CCND2;AKT1;CDK5R2;APC;PROX1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.3501624114068347,-0.9600878447508491,0.5148247978436657,0.8029567776319834,1.0,7/18,13.59%,FLCN;APOD;SUFU;OTUD7B;MFHAS1;CHP1;UFM1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.29373423843387725,0.9590852660691145,0.5472901168969182,0.8113027864632001,1.0,32/185,13.13%,CDC14A;SDCCAG8;CNTRL;PSME3;CUL3;HAUS8;UBE2E1;PTPN6;PSMB7;PSME2;PPP1R9B;CEP63;MAD2L1BP;PAFAH1B1;HAUS1;PSME4;ZFP36L2;DCTN3;ID2;PSMB8;PSMA5;PSMD9;CEP250;PSMB3;UBE2S;PSMD6;PSMC4;DYNC1H1;PSMD10;PSMB1;ERCC3;HAUS3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.32916911935729054,0.9588078688852035,0.5324189526184538,0.811446864278695,1.0,18/64,20.19%,SLK;CASK;UTRN;CD36;PTK2B;PLEKHA2;CIB1;MINK1;RHOA;NF2;ROCK1;CLASP1;THBS1;DAPK3;PTPRA;VCL;NEXMIF;PTK2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.4325830806270491,0.9583930446706261,0.5115131578947368,0.8118045614719152,1.0,4/13,9.16%,NFKBIA;NFKBIE;FLNA;LATS1
prerank,"transcription, DNA-templated (GO:0006351)",0.2855455039824874,0.9583776942794153,0.56957928802589,0.8113475330018982,1.0,36/207,12.31%,BCL3;NFKB1;GTF2F2;TAF1A;TAF13;TAF9;GTF2E2;POLR3A;POLR2C;SCX;MBD1;DEAF1;SMARCA5;KLF13;DEK;ELOA;SETX;CBFB;ELOB;THRA;CCNH;GTF2A1;NFKBIB;CREBL2;SNAPC3;PKNOX1;GMEB2;CCNT2;NELFA;FOXO3;TAF7;GTF3C6;BAZ2A;CCNT1;NFYA;TFAM
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.4011563749983782,0.9582237550262839,0.5121212121212121,0.811207203668507,1.0,7/20,16.94%,LIMD1;CNOT6;TNRC6B;TNRC6A;CELF1;AJUBA;CNOT8
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3635226084854121,0.9580085420469956,0.514726507713885,0.8111595191800463,1.0,9/34,17.10%,FGR;FLT3;PTK2B;PIK3R4;KIT;TGFB1;FGFR3;AMBRA1;PIK3R2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.38397119016836023,0.958006224998824,0.5253456221198156,0.8106805903795976,1.0,10/26,15.81%,CD36;SMPDL3B;BIRC3;TLR3;IRF7;CACTIN;TLR2;OTUD4;GPS2;IRAK3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3637250450838375,0.9575865193345944,0.5056980056980057,0.8111093201796801,1.0,10/30,18.81%,RAC2;FBXW7;UBE2D3;ARIH2;CSNK2A2;RNF31;SREBF2;UBE2J2;ATG13;PINK1
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.3659750617030957,-0.9570925060153794,0.5184135977337111,0.8094398385575334,1.0,9/16,38.85%,RMI1;FANCM;SLX4;HFM1;CENPX;TOP2B;MUS81;MSH4;EME1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.40263811907294866,0.9565805995130777,0.527190332326284,0.8128097779121203,1.0,4/19,4.87%,FOXJ1;ERBIN;CLIC4;SYNJ2BP
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.4142632087912569,-0.9565670269283478,0.4963680387409201,0.8096886031438559,1.0,5/10,27.18%,MTHFD2L;MTHFS;DHFR;SHMT2;MTHFD1
prerank,L-glutamate transmembrane transport (GO:0015813),0.4480970266768439,0.9560259098251399,0.4929328621908127,0.8135241394925675,1.0,3/10,11.50%,SLC25A13;SLC25A12;SLC25A18
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.4606349733639223,0.9555984239195962,0.5297297297297298,0.8139699108313402,1.0,2/10,3.16%,ST3GAL1;GNPDA1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.411853503560489,-0.95543526571198,0.5180995475113123,0.8115072986795516,1.0,2/10,3.75%,APOE;ABCB4
prerank,regulation of phospholipase activity (GO:0010517),0.4547820157633373,0.955195963809935,0.5316901408450704,0.8143808913288452,1.0,5/10,19.44%,RGS2;PDPK1;FGFR3;ANGPTL3;FGFR1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.3800873749988181,-0.9550583950670646,0.5302663438256658,0.8113920837358932,1.0,6/13,18.00%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,negative regulation of catalytic activity (GO:0043086),0.3845416347162821,0.9547029597506664,0.5084485407066052,0.8149802877834332,1.0,6/24,17.18%,PPP1R12A;APBA3;HP;PARP9;IFIT1;SIRT1
prerank,response to organonitrogen compound (GO:0010243),0.3568400183941942,0.9546765050192761,0.5184659090909091,0.8145559482377893,1.0,8/38,16.50%,HLCS;KYNU;KAT7;IL6;DNAJB12;VCP;IRAK3;IRF5
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.33940608376591125,0.9543966467584023,0.5211459754433834,0.8146692640885527,1.0,9/42,12.80%,MAD2L2;SMCHD1;KLHL15;ACTR2;PPP4R2;WRAP53;ARID2;SETD2;SPIDR
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.37426901717479066,-0.9531427001899121,0.5040214477211796,0.8150960895403095,1.0,7/14,24.04%,TPP1;NABP2;TERF2IP;XRCC5;TNKS2;TINF2;PINX1
prerank,positive regulation of neuron projection development (GO:0010976),0.31394929127664567,0.9529556449693105,0.5525672371638142,0.8172656576985577,1.0,20/85,17.11%,LYN;RAP1A;CAMK1D;RET;NDNF;RAPGEF2;NPTN;SETX;PTK2B;CBFA2T2;SCARB2;SNX3;KIDINS220;STMN2;LRP8;RETREG3;RELN;FES;CAPRIN1;ABL2
prerank,Golgi ribbon formation (GO:0090161),0.44005068004657233,0.9528534951174772,0.5459272097053726,0.8169832368936333,1.0,4/13,13.82%,STX6;GCC2;FHDC1;STX16
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.374659610043683,-0.9528349279349775,0.5295629820051414,0.8147807949920729,1.0,3/14,3.41%,AUTS2;CTNNB1;CTR9
prerank,mRNA methylation (GO:0080009),0.4150751445906983,0.9527527151547706,0.5265625,0.8167029172362259,1.0,5/15,14.38%,VIRMA;CBLL1;CMTR1;METTL3;TRMT10C
prerank,positive regulation of telomerase activity (GO:0051973),0.3594979955920139,0.9526636965254117,0.5455840455840456,0.8164146951152421,1.0,9/33,15.82%,KLF4;PKIB;PARM1;WRAP53;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,regulation of integrin activation (GO:0033623),-0.3610057975251247,-0.9523351830119087,0.5089514066496164,0.8149615965569064,1.0,6/15,16.71%,FBLIM1;FARP2;JAM3;SKAP1;SRC;PLEK
prerank,female gonad development (GO:0008585),-0.3439125321139429,-0.9519000080837298,0.5340909090909091,0.8149084609275083,1.0,6/19,21.89%,VEGFA;EIF2B5;EIF2B4;NR2F2;ANG;SOD1
prerank,response to insulin (GO:0032868),-0.24191957088517063,-0.9512144500296509,0.5493827160493827,0.8156550831176094,1.0,13/80,11.86%,PDE3B;CPEB2;ENPP1;SORT1;CPEB1;GOT1;RAB31;RHOQ;SLC27A1;PCK2;IRS1;PIK3R1;MYO5A
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.44461808514363677,0.9506766137687397,0.527027027027027,0.820187293545669,1.0,3/12,8.81%,CHMP4A;CHMP4B;SEC63
prerank,skeletal muscle contraction (GO:0003009),0.396001261658945,0.9506653828174352,0.5258358662613982,0.8197187384861208,1.0,1/19,1.85%,TNNC1
prerank,peptide metabolic process (GO:0006518),0.31643871377554394,0.9505892499648131,0.5470085470085471,0.8193992956905896,1.0,18/75,18.36%,ACE;LNPEP;GPX1;GSR;ETHE1;DPEP1;PARL;GSTA3;CPQ;MGAT3;BACE2;PCSK5;GSTP1;MIPEP;PSEN1;SPCS2;ANPEP;CTNS
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3193994882633275,0.9503498028476446,0.5442708333333334,0.81942411622064,1.0,17/62,17.21%,CDK13;GTF2F2;POLR2C;ELOA;ELOB;CCNH;ELOF1;SETD2;CCNT2;NELFA;CCNT1;CDK12;ERCC3;EAF1;NCBP1;ELL;SUPT4H1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4683814055803997,0.9500769428581601,0.5166374781085814,0.819482923642945,1.0,6/10,24.13%,HSPA1A;CITED2;BAG3;NCK1;HIF1AN;SIRT2
prerank,nitrogen compound transport (GO:0071705),-0.218868522280132,-0.9497729482586049,0.64,0.8182890263901902,1.0,28/141,16.77%,LRP1B;SEC14L1;SLC11A1;SCAMP1;SLC7A6;ABCG2;SLC7A1;FLVCR1;SCAMP2;SCAMP5;SLC7A7;SLC6A15;SLC36A1;HSP90B1;SLC22A5;SLC7A2;SLC7A8;SLC5A7;TOM1;SLC3A2;SLC15A2;SLC6A8;SLC22A4;SLC25A47;TXNIP;CHMP1B;VPS33B;ARRDC2
prerank,T cell proliferation (GO:0042098),0.4370390140917878,0.9496499863289394,0.5327868852459017,0.8199138607358684,1.0,3/13,9.27%,LILRB1;MSN;CTPS1
prerank,nucleic acid-templated transcription (GO:0097659),0.34061746580678337,0.9493141109583287,0.538881309686221,0.820142189485295,1.0,7/42,12.13%,BCL3;POLR3A;POLR2C;SCX;NFKBIB;CREBL2;BAZ2A
prerank,translational termination (GO:0006415),-0.23855535807667397,-0.9491795990752584,0.5925925925925926,0.8187573829789125,1.0,52/95,35.84%,GFM2;MRPL24;MRPS9;DAP3;MRRF;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;MRPL3;MRPL32;MRPL47;MRPS30;MRPL17;N6AMT1;MRPL50;MRPS14;TRMT112;MRPL51;MRPL16;MRPL11;GSPT2;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23
prerank,nuclear export (GO:0051168),-0.23971036206522767,-0.9482997592032772,0.5491329479768786,0.8198832813913185,1.0,23/80,18.33%,ATXN1;SRSF5;SRSF3;DDX39B;STRADA;RNPS1;SRSF7;NUP155;NUP188;THOC5;DHX38;NXF1;NUTF2;CHP1;ZC3H11A;SRSF2;DDX39A;NUP42;TPR;RAN;RANBP3L;CASC3;SRSF1
prerank,protein acylation (GO:0043543),0.3540587587026179,0.9482780945015986,0.5290858725761773,0.8218531884938606,1.0,8/38,9.06%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;CLOCK;ZDHHC23;ZDHHC17;KAT6A
prerank,keratan sulfate metabolic process (GO:0042339),0.36135973924757936,0.9482452292755986,0.5222381635581061,0.8214347348115939,1.0,3/31,4.27%,ST3GAL1;ST3GAL4;B4GALT5
prerank,cellular protein metabolic process (GO:0044267),0.277751293258108,0.9481657306439517,0.6192893401015228,0.8211079970168914,1.0,66/396,14.11%,NAPSA;ST3GAL1;ST8SIA4;ZAR1;RPL5;DENND3;TNC;MSRB1;NOTUM;STK38;RPS10;MMP1;LAMB1;GPC3;ABCA3;RPL37A;PARP4;MRPL55;RPL6;MRPL18;UBE2D3;RPS18;PARL;SHISA5;LGALS1;RPS14;FBXW2;ADAM17;NEDD8;WFS1;CSF2RB;RPL35A;SFTPA1;SFTPA2;PPP4R2;RPL13;MRPL13;IL6;CSNK1G3;WWP2;FBN1;RPS3;IGF2BP3;RPS21;FN1;FARSB;MBTPS1;RIPK1;PRSS23;UBE2S;DUSP12;RPL34;RPLP0;APP;UBE2G1;RPL19;RPL11;RPL30;PCSK5;SLC35A1;KTN1;YME1L1;DNAJC3;RPS2;RPL4;RPL7
prerank,limb morphogenesis (GO:0035108),0.4048007899936813,0.9471794207680506,0.5367647058823529,0.8227651405570554,1.0,2/20,2.57%,MBNL1;NIPBL
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.38355824746456596,-0.9469673495406026,0.5276381909547738,0.8220770122277826,1.0,9/12,40.20%,RMDN1;MAD1L1;CENPE;BOD1;NDC80;MIS12;CDT1;KIF2C;NUF2
prerank,response to glucocorticoid (GO:0051384),0.3728946910709481,0.946872155315625,0.5199409158050221,0.8229502316071458,1.0,6/26,14.67%,ZFP36L2;IL6;ANXA1;NR3C1;REST;ADAM9
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.35839708890717636,-0.9468626625045061,0.5168831168831168,0.8212546944495336,1.0,6/16,14.96%,FLCN;GPR137B;KLHL22;LARS1;LAMTOR5;PIH1D1
prerank,protein modification by small protein conjugation (GO:0032446),0.2762682480586924,0.9466465698831014,0.6401630988786952,0.822932552367297,1.0,75/361,17.32%,BCL11A;NUP210;ITCH;DTX3L;ASB5;NEDD4L;TRIM26;CUL3;CUL5;BIRC6;UBE2E1;RNF38;TRIM7;CBL;FBXW7;SUMO1;CBLL1;TRIM62;PEX12;ARIH1;WAC;RNF213;RNF20;UBE2D3;IFIH1;FBXW11;DCUN1D1;UBE2N;HLTF;NEDD8;NFE2L2;ELOB;MYCBP2;NUP98;FBXO4;UBR2;PCNP;ARIH2;PEX14;WWP2;UBE2W;FBXO32;UBE2Z;SUMO2;TRIM14;UBE2S;FBXL17;DCUN1D3;KLHL8;RCHY1;TRIM17;UBE2G1;NUP153;AREL1;ATG10;RNF138;VCP;UBE2J2;USP7;UHRF2;FBXO7;ANAPC7;KCTD13;VCPIP1;USP9X;TRIM35;RNF41;HACE1;SEH1L;UBR3;UBA6;MSL2;SIRT1;RNF144A;UBE2Q2
prerank,focal adhesion assembly (GO:0048041),0.3884069685610342,0.946544492171623,0.5384615384615384,0.8226838752296962,1.0,3/21,4.86%,RCC2;BCR;DLC1
prerank,antibacterial humoral response (GO:0019731),0.4149762741350178,0.946195525084748,0.5395799676898223,0.8229304894174854,1.0,3/16,13.79%,SLPI;RNASE6;PLA2G6
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.40774369487785506,0.9459944712113524,0.5135135135135135,0.8228778912850636,1.0,2/17,5.23%,RAPGEF2;ADRA2A
prerank,monocyte chemotaxis (GO:0002548),0.3557077038476976,0.945861146776445,0.5532212885154062,0.8227013139216435,1.0,5/32,12.85%,PTPRO;IL6R;IL6;ANXA1;LGALS3
prerank,B cell activation involved in immune response (GO:0002312),0.4236740810761731,0.9458210101258056,0.5235690235690236,0.8223008699508239,1.0,3/13,11.70%,GAPT;MSH6;FCGR2B
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.4182901234422809,0.9456354982390245,0.5201863354037267,0.8221958020566635,1.0,2/16,5.03%,LDLR;SCARB1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.269301022099859,-0.9455402662189331,0.5581395348837209,0.8234632644906101,1.0,16/49,19.60%,LDLRAD4;TREM2;HMGB1;NLRC3;IMPACT;PYDC1;TRAF3IP1;RPL13A;CLU;JAM3;PRKCZ;SRC;HDAC6;DDX3X;CRYAB;LCMT1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3594166330615428,0.9453895670440033,0.5280575539568345,0.8222454905579094,1.0,3/31,5.92%,LRRK2;PDLIM5;PTEN
prerank,positive regulation of telomere capping (GO:1904355),0.4073730753156103,0.9449282854177303,0.5205930807248764,0.8227604912918306,1.0,5/17,15.13%,PKIB;TNKS;MAP3K4;AURKB;MAPK1
prerank,protein import into nucleus (GO:0006606),-0.2504886268013198,-0.944920957770235,0.5522388059701493,0.8239141643433437,1.0,21/66,17.53%,E2F3;APPL2;KPNA6;NUP54;NUP133;NUP155;IPO5;NUP188;TNPO2;PPP1R10;IPO13;RANBP2;NUTF2;SEC13;TSC2;NUP85;FAM53A;TPR;RAN;IPO7;NUP35
prerank,plasma membrane repair (GO:0001778),0.42135112948602743,0.9448525858854099,0.5408496732026143,0.8224317898857858,1.0,5/13,19.87%,DYSF;MYH9;ARL8B;MYOF;ANXA6
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4060002663194816,0.9446934634978064,0.5251677852348994,0.8223141246569516,1.0,3/17,7.48%,WASF2;GMFG;ARF1
prerank,regulation of Golgi organization (GO:1903358),0.4094216782350085,0.9446107296343332,0.5351437699680511,0.8220237669628072,1.0,7/17,20.82%,USP6NL;STX5;MAPK1;EHD3;MAP2K1;AKAP9;ARMH3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.36046189751175683,-0.9441190671732785,0.5101522842639594,0.8249010994441945,1.0,3/14,7.11%,GAS6;RFFL;PYDC1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.41028328157400096,0.9440383961759411,0.5244865718799369,0.8227307087496143,1.0,6/18,17.65%,IFNGR1;PICALM;GSAP;ABCG1;RELA;EFNA1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3926915672661008,0.9437000820792542,0.5529753265602322,0.8224816841083203,1.0,9/20,16.95%,ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,positive regulation of glycolytic process (GO:0045821),0.3926915672661008,0.9437000820792542,0.5529753265602322,0.8224816841083203,1.0,9/20,16.95%,ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3041464646949683,-0.9436869980678092,0.5282392026578073,0.8249427279018577,1.0,10/30,19.92%,BCL2L1;CFLAR;RFFL;FAIM2;HMOX1;SERPINE1;TRADD;BRCA1;DDX3X;TNFSF10
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4470241980996821,0.9435828270294235,0.5165217391304348,0.8222509251058419,1.0,3/10,12.78%,INPP5F;PARP14;NF2
prerank,positive regulation of cell growth (GO:0030307),0.30442616909848547,0.9434876309759499,0.5589622641509434,0.8219834257576327,1.0,24/96,16.72%,NGF;SHTN1;NEDD4L;RPS6KA3;CDC42;H3-3A;CXCL16;ADAM17;CIB1;MTPN;DDX49;CSNK2A1;NTN1;RPS6KA1;PSMD10;PABIR1;AKT1;ITSN2;MAP3K13;ZFYVE27;NCBP1;INO80;USP47;SEMA4D
prerank,defense response to protozoan (GO:0042832),0.4281134914171285,0.9433165439292397,0.5431034482758621,0.8218982888196971,1.0,4/12,14.99%,CD40;IRF4;GBP2;MYD88
prerank,cellular response to glucose stimulus (GO:0071333),-0.3023195339025714,-0.9426327389707281,0.5363321799307958,0.8263953244401911,1.0,6/30,7.43%,PTPRN2;RAB11FIP2;GAS6;RAB11FIP5;PRKACA;PCK2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2826616372612671,-0.9425812333813534,0.5547445255474452,0.8254672833086871,1.0,8/40,14.25%,PRKN;IGF1;BCL2L1;FAM162A;PYCARD;MFF;CLU;BAX
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.38319037633234854,0.9424982400996845,0.5477611940298508,0.823173501857738,1.0,4/24,9.15%,NDNF;PDPK1;NFE2L2;ICAM1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3976541699912997,0.9422696320735913,0.5555555555555556,0.8231841741914769,1.0,3/17,7.52%,RAB3D;UNC13D;SLC4A8
prerank,positive regulation of cartilage development (GO:0061036),0.4036560487943516,0.941862385531897,0.5518867924528302,0.8235859917976949,1.0,3/17,10.83%,BMPR2;SCX;TAPT1
prerank,maturation of SSU-rRNA (GO:0030490),0.34937563079253203,0.941808190320306,0.5267605633802817,0.8232170134709711,1.0,16/34,27.36%,DHX37;RPS14;UTP6;RIOK1;NOL11;RRP36;TSR3;DDX52;HEATR1;DCAF13;RPS16;WDR46;NOB1;RIOK2;WDR3;TSR1
prerank,mitotic DNA replication (GO:1902969),0.46183977183859853,0.9414653993953395,0.5467128027681661,0.8234765853092747,1.0,3/10,12.95%,CDC45;MCM6;MCM2
prerank,regulation of membrane repolarization (GO:0060306),0.4374021778269108,0.9411425746313503,0.5547826086956522,0.8236886298035243,1.0,2/13,3.31%,NEDD4L;KCNQ1
prerank,osteoclast differentiation (GO:0030316),0.3884101910360465,0.9410125348966168,0.5525525525525525,0.823481975094337,1.0,5/22,10.00%,FOXP1;ANXA2;MAPK14;EFNA2;SBNO2
prerank,snRNA 3'-end processing (GO:0034472),-0.33151230251872466,-0.9406057521265,0.536986301369863,0.8293439122358292,1.0,7/19,20.85%,INTS6L;INTS8;EXOSC9;EXOSC5;INTS1;EXOSC3;INTS7
prerank,cellular response to hormone stimulus (GO:0032870),0.31526939966629147,0.9402726901582583,0.5618686868686869,0.8246020972730048,1.0,10/69,10.43%,RARA;STAT3;NCOA3;STAT5B;ADRA2A;SERPINB9;BCAS3;NCOA2;NCOA1;NR3C1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3717002357687784,0.9401761755266838,0.546242774566474,0.8243365105188349,1.0,7/26,16.71%,LRRK2;PTEN;PTK2B;APP;RELN;WNT7A;MTMR2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.34394643007918935,0.9399325168510634,0.5509641873278237,0.8243838073435067,1.0,11/42,18.71%,DTL;POLI;POLD4;WRN;TRIM25;RPA3;PCLAF;VCP;POLD1;SIRT1;PRIMPOL
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3891603516917999,0.9397401387383423,0.5214814814814814,0.8243110301318741,1.0,3/20,7.72%,SIK1;FBXW7;ERLIN1
prerank,female gamete generation (GO:0007292),0.3717178275345438,0.9392128240899773,0.5592972181551976,0.8249299134274525,1.0,9/29,20.96%,DIAPH2;IHO1;TOB2;METTL3;USP9X;MARF1;MCM9;PRDM9;PARN
prerank,negative regulation of reproductive process (GO:2000242),0.40472338986739387,0.9389402116571937,0.5457364341085271,0.8250186568086241,1.0,3/17,11.47%,PAEP;ARHGDIB;DUSP1
prerank,mitochondrion organization (GO:0007005),0.28826491640882773,0.9387442017952278,0.6074561403508771,0.8249479317291958,1.0,51/165,21.94%,LRRK2;PID1;AKT3;LONP1;IFIT2;CAV2;CLUH;ATP2A1;ATP7A;DNAJC19;GABPB1;TOMM40;FIS1;IMMP2L;AIFM1;TFAM;DNM1L;SIRT4;YME1L1;PNPT1;MYH14;TIMM50;RAB29;FBXO7;TFB1M;POLG2;AIP;COX7A2;CHCHD2;HSPD1;VPS13D;AIFM2;HAX1;PINK1;FANCG;NRF1;NIPSNAP2;MTFR1;PARK7;SUPV3L1;HIGD2A;TRAK1;MUL1;SIRT3;DNAJA3;TRAK2;BNIP3L;TOMM22;PARP1;BID;RHOT1
prerank,translation (GO:0006412),0.2801509060333562,0.9386751343850545,0.6139978791092259,0.8246229088523445,1.0,59/208,21.92%,ZAR1;RPL5;NOA1;MRPL57;RPS10;FARS2;RPL37A;MRPL55;VARS1;RPL6;MRPL18;RPS18;DARS2;RPS14;RPL35A;RPL22L1;RPL13;MRPL13;ETF1;RWDD1;EEF1G;RPS3;IGF2BP3;RPS21;FARSB;RPL34;RPLP0;PTCD3;RPL19;RPL11;RPL30;TMA7;RPS2;RPL4;RPL7;DRG2;RPS15A;MRPS6;RPS4X;MRPS33;HARS2;GSPT1;RPL32;TUFM;RPSA;ABCE1;RPS13;MRPS15;RPS6;RPL18A;RPS27;RPLP2;EEFSEC;RPL22;RPS7;AARS1;RPS12;MRPS12;TARS1
prerank,lipid phosphorylation (GO:0046834),0.4502356563708965,0.9382101617319831,0.551433389544688,0.8251588732319675,1.0,1/10,1.04%,DGKG
prerank,muscle contraction (GO:0006936),0.2968768268009798,0.938079569558476,0.5926339285714286,0.8249582854625566,1.0,8/126,3.90%,LTB4R;TNNC1;UTRN;TPM4;VIM;DYSF;MYL4;HCN4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.430872359392396,0.9378849307945392,0.5403087478559176,0.8248763197597038,1.0,6/13,27.74%,SORL1;TMEM30A;CD81;EDEM2;SAR1B;SEC16A
prerank,ion transport (GO:0006811),-0.23089461240122797,-0.937806773361304,0.6590909090909091,0.835229190274319,1.0,19/111,12.90%,SLC8A1;SLC24A3;WNK1;SLC1A3;TRPM3;ANO10;SLC25A26;SLC36A1;SLC17A6;SLC9A9;GABRB1;SLC9A6;KCNN2;MCOLN1;CHRNA7;VDAC1;SLC26A11;KCNN3;SLC15A2
prerank,positive regulation of histone methylation (GO:0031062),0.3727765863842446,0.9367948452604513,0.5509893455098934,0.8266658843725362,1.0,9/24,19.63%,JARID2;FAM47E;PHF19;SMAD4;MYB;KMT2A;SIRT1;DNMT1;WDR5
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3147807834345899,0.936602356052608,0.5660130718954248,0.8266001672233337,1.0,17/64,17.21%,CDK13;GTF2F2;POLR2C;ELOA;ELOB;CCNH;ELOF1;SETD2;CCNT2;NELFA;CCNT1;CDK12;ERCC3;EAF1;NCBP1;ELL;SUPT4H1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.31198958068255644,0.9365719390406878,0.5621156211562116,0.8261988090809148,1.0,13/72,13.36%,DNA2;MRE11;FEN1;XRN2;POLD4;IHO1;RNASE1;RNASE6;DCP1A;RPA3;EXD2;ERCC3;ERCC4
prerank,sulfur compound biosynthetic process (GO:0044272),0.29909929781668476,0.936460198973294,0.5533642691415314,0.825967386635879,1.0,23/104,18.67%,ST3GAL1;ST3GAL4;B4GALT5;GSTA3;GSS;GGTA1;CHST12;TPK1;PAPSS1;PAPSS2;ACAN;NCAN;SLC10A7;CHST15;UST;GSTP1;CSGALNACT1;CHSY3;GLCE;MGST3;GGCT;VCAN;DSEL
prerank,positive regulation of developmental growth (GO:0048639),0.33054529768569807,0.9364073779825925,0.5607843137254902,0.82561761022967,1.0,11/49,16.72%,NGF;SHTN1;NEDD4L;PLCB1;NTN1;ITSN2;MAP3K13;ZFYVE27;INSR;PPIB;SEMA4D
prerank,ear morphogenesis (GO:0042471),-0.3372600250242549,-0.936017680822952,0.5498575498575499,0.8386074264726664,1.0,3/20,6.21%,CHD7;MYO6;FGFR2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4495428105619703,0.9356831824060107,0.5456053067993366,0.8266595128962408,1.0,2/10,2.92%,STAP1;CD300A
prerank,cellular response to calcium ion (GO:0071277),0.31634595072708616,0.9351520843556748,0.5752212389380531,0.8273048918008769,1.0,12/67,12.44%,IQGAP1;PLCG2;ALOX5AP;HPCA;RASGRP2;DPEP1;CLIC4;KCNH1;CPNE1;BRAF;PRKAA1;CPNE2
prerank,regulation of chemotaxis (GO:0050920),-0.2979982432236531,-0.9345586220856428,0.569620253164557,0.8411978498781265,1.0,9/30,14.50%,TREM2;P2RY12;AIF1;P2RX4;ZSWIM8;PPM1F;ZSWIM6;GPR183;ZSWIM5
prerank,transition metal ion transport (GO:0000041),-0.2892225024303252,-0.9344212409221527,0.5753424657534246,0.8404737745612889,1.0,12/35,17.82%,SLC11A1;TRPC4;SLC11A2;TFRC;FTH1;TRPC1;TRPC7;SLC30A9;TRPC3;ATP2C1;SLC31A2;CP
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3693857246068027,0.9343087673693234,0.5437589670014347,0.8286349750249375,1.0,3/27,3.76%,PTPN22;FOXJ1;PTPN6
prerank,regulation of cellular component biogenesis (GO:0044087),0.3462346725526743,0.9337664677879112,0.576437587657784,0.8292904275321704,1.0,6/39,9.16%,RAP1A;MSN;CD36;RAPGEF2;EZR;LATS1
prerank,positive regulation of translational initiation (GO:0045948),-0.3359788653615146,-0.9334028042332574,0.5751295336787565,0.8420034482794151,1.0,10/18,32.38%,LARP1;CDC123;EIF2B5;DDX3X;HABP4;UHMK1;YTHDF2;MTOR;CCL5;RPS6KB2
prerank,regulation of neuron projection development (GO:0010975),0.288764380775261,0.9333581873565008,0.6124721603563474,0.8296653502645003,1.0,20/163,8.64%,LRRK2;LYN;PDLIM5;RAP1A;CAMK1D;RET;NTNG2;NDNF;PTPRO;PAK1;RAPGEF2;NPTN;CCDC88A;PTEN;SETX;PTK2B;CIB1;PAK2;PAQR3;CBFA2T2
prerank,regulation of osteoclast differentiation (GO:0045670),0.3564926333599604,0.9333271002025193,0.5584045584045584,0.8292458891672672,1.0,4/33,9.64%,LILRB3;CCR1;TLR3;FBN1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3279539819341212,0.9331855984567508,0.5896774193548387,0.8290512696433016,1.0,12/57,15.06%,HTR1D;HTR4;ADRA2A;FLNA;PDE2A;PSAP;OPRM1;ADCY7;GNAI1;ADCY5;GNAI2;GRM8
prerank,positive regulation of secretion (GO:0051047),-0.3972590196722747,-0.9326768754536485,0.5583126550868487,0.8426679935177156,1.0,7/11,53.80%,GPLD1;ACSL3;NPR1;AQP1;ABCB11;SCIN;TRH
prerank,negative regulation of axon extension (GO:0030517),-0.29970877129805096,-0.9325828964159764,0.5859872611464968,0.8418213697092023,1.0,6/30,8.32%,DIP2B;MAP2;CDKL3;SEMA3D;SEMA3E;SEMA6D
prerank,limb development (GO:0060173),-0.2933555142475762,-0.9322625010526976,0.5769230769230769,0.8415110847812837,1.0,6/28,14.26%,CHD7;SALL1;IQCE;ZNRF3;GLI3;BMPR1B
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4264555408530714,0.9322586077603283,0.5695142378559463,0.8304645336030388,1.0,2/13,2.01%,METRNL;PIM1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.37603105023173533,0.9322149241624712,0.5541984732824428,0.8300765397056423,1.0,5/24,16.85%,IL1B;PTPN1;CNMD;ITGA5;NIBAN2
prerank,muscle cell differentiation (GO:0042692),-0.2884100694715404,-0.9313091475836973,0.5833333333333334,0.8428034660867499,1.0,4/32,9.44%,MEF2C;NEBL;SPEG;NRAP
prerank,positive regulation of angiogenesis (GO:0045766),0.29489149781423935,0.9312157897955873,0.5940023068050749,0.8317268856118638,1.0,11/108,6.65%,IL1B;KLF4;ITGAX;CD40;PTGIS;VEGFC;BTG1;HIPK2;HIPK1;PIK3R6;PDPK1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3656367598698981,-0.9311490063087768,0.5256410256410257,0.8421417539908624,1.0,4/13,14.84%,IGF1;GOLGA2;CHP1;ALG10B
prerank,negative regulation of protein transport (GO:0051224),-0.30342931300505305,-0.9307109722208314,0.5660377358490566,0.8422288230256314,1.0,6/25,17.90%,APOE;ERP29;PPM1F;CYP51A1;PKDCC;RHBDF2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3933309461996179,0.9300843700802596,0.5625942684766214,0.8336411280520831,1.0,4/21,7.39%,DTL;RCC2;CCND1;MECP2
prerank,positive regulation of embryonic development (GO:0040019),0.38852289184228256,0.9298938662226782,0.5465288035450517,0.8335651917887797,1.0,3/19,7.50%,SCX;B4GALT5;PLCB1
prerank,purine nucleotide metabolic process (GO:0006163),0.37529114118605056,0.929737641289032,0.5671191553544495,0.8334044338990271,1.0,2/24,2.68%,GDA;GPX1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.4349884392302191,0.9295315764057122,0.5562913907284768,0.8333677549732135,1.0,3/12,17.99%,TAPT1;KDELR1;HSPA5
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.43590331720746645,0.9294628425008806,0.5359019264448336,0.833048412930678,1.0,2/11,6.96%,RUNX3;CBFB
prerank,establishment of protein localization to membrane (GO:0090150),0.31872531431482176,0.929421900247933,0.593198992443325,0.8326537132834064,1.0,10/66,9.62%,SYNE3;VPS37C;MYO1C;ZDHHC7;AFDN;ZDHHC6;ZDHHC23;SEC63;PIKFYVE;BRAF
prerank,regulation of postsynapse organization (GO:0099175),0.3652025180103058,0.929381555792825,0.5660919540229885,0.8322509919525166,1.0,2/28,1.08%,LRRK2;PDLIM5
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2893872172072952,-0.9289184556187916,0.5751633986928104,0.8456338944593885,1.0,11/32,16.85%,FHIT;CDIP1;DDX5;USP28;PYCARD;MSH2;MYBBP1A;SNW1;PPP1R13B;JMY;AEN
prerank,cell cycle G2/M phase transition (GO:0044839),0.2902930368110264,0.9287792186588247,0.6036655211912944,0.8329533461418979,1.0,25/130,14.86%,SDCCAG8;CNTRL;PPP1R12A;HAUS8;PHLDA1;FBXW11;FBXL8;CDK14;CEP63;PAFAH1B1;PLCB1;HAUS1;PPP2R2A;CCNH;DCTN3;LATS1;CEP250;FBXL17;DYNC1H1;PPP1CB;HAUS3;FBXL12;CLASP1;WEE1;BRSK1
prerank,supramolecular fiber organization (GO:0097435),0.2729546365076904,0.9285573199961211,0.6441717791411042,0.8329441062231,1.0,61/334,15.53%,MYO1G;RND3;SLK;TPM4;VIM;CCDC88C;CD36;MAD2L2;MYO1C;MYO1E;COL5A2;SORL1;CORO1A;SHROOM3;CCDC88A;RAC2;SCX;CDC42;CD2AP;H3-3A;CARMIL1;PPP1R9B;BCAR1;ELMO2;HSPG2;BIN3;KATNA1;MYO5B;KATNB1;TPPP3;CIB1;ATP7A;TGFBI;RHOBTB3;RAC1;PXDN;TSPAN14;KIF24;RHOA;SPAST;HIP1;TLL1;TSPAN33;RIPK1;B2M;DYNC1H1;APP;CLIP3;TMOD3;TCHH;ARHGAP17;TRIOBP;MYO1F;STMN3;RHOG;ELMO1;COL16A1;USP9X;TSPAN15;SHROOM1;STMN2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4039958950916582,0.928454049081024,0.554160125588697,0.8326749641762516,1.0,2/17,4.20%,VIM;SCX
prerank,cytosolic transport (GO:0016482),0.2974462276403695,0.928106615262189,0.5868055555555556,0.8329459432298583,1.0,23/108,14.51%,LMTK2;EPS15;LAPTM5;TBC1D10C;RAB7A;SNX1;VPS53;RAB6A;TMEM87A;STX6;GCC2;RHOBTB3;GBF1;STX5;SNF8;PIKFYVE;TBC1D5;VPS13A;AP1G1;ANKFY1;STX16;EVI5;RAB29
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3582668181787137,0.9280807535412835,0.5459940652818991,0.8325273051197755,1.0,7/29,17.33%,RET;PAK2;CYLD;RIPK1;DEDD2;THBS1;TRAF2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2942673779271753,0.9280789413504915,0.6075514874141876,0.8320579239025682,1.0,8/113,5.00%,JAML;NOTCH2;AKT3;STAT5A;CLDN1;BMPR2;LAMB1;VEGFC
prerank,positive regulation of heart contraction (GO:0045823),0.3895305509133172,0.927692858431265,0.5543478260869565,0.8323979819722208,1.0,2/19,3.31%,RGS2;KCNQ1
prerank,negative regulation of RNA splicing (GO:0033119),0.3878672750824058,0.927517318791596,0.5303030303030303,0.8322833943769237,1.0,4/19,9.18%,PTBP3;SRSF10;SAP18;SRSF4
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.396339080038544,-0.9274978204757008,0.5503875968992248,0.8480720810643402,1.0,3/10,7.74%,SYNGR1;DLG4;NETO1
prerank,amyloid-beta metabolic process (GO:0050435),0.41224323272724306,0.9274487466962964,0.5564387917329093,0.8319458687004629,1.0,5/16,16.95%,ACE;DYRK1A;MGAT3;BACE2;PSEN1
prerank,polyamine metabolic process (GO:0006595),-0.37164855239628625,-0.9274261962754644,0.5498721227621484,0.8472031687681065,1.0,6/13,31.48%,SMOX;HDAC6;PAOX;ODC1;SAT2;DHPS
prerank,ncRNA 3'-end processing (GO:0043628),-0.3665195368714297,-0.9272866031410342,0.5699745547073791,0.8464904502731402,1.0,5/14,12.45%,INTS6L;TRNT1;INTS8;PTCD1;SSB
prerank,regulation of proteolysis (GO:0030162),0.3304624802144741,0.9272447954452889,0.5767741935483871,0.8318861389850223,1.0,8/48,7.46%,ITCH;DNAJC1;SPOP;FBXW11;PARL;NEDD8;GSAP;TRAF3
prerank,regulation of glucose import (GO:0046324),0.355726439982769,0.9270740405845708,0.5533428165007113,0.8317709133821187,1.0,8/30,18.13%,PID1;PRKAG2;RTN2;CREBL2;AKT1;OCLN;INSR;APPL1
prerank,regulation of striated muscle contraction (GO:0006942),0.36587657892606196,0.9264823656051968,0.5401974612129761,0.8325263818159742,1.0,3/27,3.90%,GJA5;RNF207;HCN4
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2780095773465756,-0.9262437947637835,0.6015037593984962,0.8479954553606806,1.0,15/39,28.18%,GTF2H2;POLD3;GTF2H1;UBC;ERCC2;PCNA;RFC3;GTF2H3;OGG1;GTF2H5;UBA52;ERCC1;RFC2;GTF2H4;DDB1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.42298954030536684,0.9262116923132131,0.5501672240802675,0.832594805460885,1.0,2/13,6.96%,RUNX3;CBFB
prerank,membrane assembly (GO:0071709),0.35329680561456206,0.9255973403686998,0.5793103448275863,0.8334044233394797,1.0,7/34,9.33%,ANXA2;PICALM;CHMP4B;CEL;PTEN;S100A10;SPAST
prerank,protein destabilization (GO:0031648),-0.2872928196843682,-0.9253769615308786,0.5615141955835962,0.8490015067187359,1.0,6/32,8.06%,PRKN;CAPN3;SENP2;FBXL3;BTRC;GGA3
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3328370834983519,0.9250836081398355,0.5859788359788359,0.8339908145592492,1.0,7/44,10.62%,HCK;PRKCE;CARMIL1;PTK2B;ARPC4;SNX9;VASP
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.34290572853493223,0.9250553973206769,0.5825242718446602,0.8335764253493885,1.0,10/39,14.37%,EPS15;CBL;CDC42;PTPN12;TSG101;GRB2;EPS15L1;STAM;MVP;PTPRJ
prerank,regulation of mitotic cell cycle (GO:0007346),0.28629452343709966,0.9249123965522733,0.6292735042735043,0.8333974297578405,1.0,42/171,18.61%,IQGAP1;SIK1;CDK13;PSME3;BTG2;EIF4EBP1;UBE2E1;PSMB7;PSME2;BTG1;RNF20;CAV2;PKN2;AFAP1L2;GBF1;PSME4;PSMB8;PSMA5;PSMD9;CYLD;PSMB3;UBE2S;PSMD6;PSMC4;APP;PSMD10;PSMB1;ERCC3;TGFB1;ANAPC7;TRIM35;RPS6KB1;PSMD12;RB1;DAPK3;MAEA;SIRT1;FOXC1;ANAPC11;FZR1;PIN1;ANAPC4
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3398298850856323,0.9245717766958506,0.5512995896032832,0.8335948645644624,1.0,2/34,2.62%,IL1B;CUL3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3613912066590468,0.9245648455102344,0.5741556534508077,0.8331372606945074,1.0,10/28,18.36%,CD47;PRKAG2;JAK2;PRKAB2;RAC1;TNFRSF1B;PRKAA2;MED1;SIRT1;CTNS
prerank,import into nucleus (GO:0051170),0.31105649787260164,0.9242351174775296,0.595,0.8333530468804795,1.0,17/73,18.20%,BACH2;SYK;STAT3;SNRPD2;PTTG1IP;SNRPB;HIKESHI;NUP153;EIF4ENIF1;AKT1;FAM53C;GEMIN7;TNPO1;KPNB1;HTATIP2;APPL1;NUP93
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3296826870397138,-0.9241374836717923,0.5633423180592992,0.8510868111347569,1.0,9/17,30.46%,ALG8;MPDU1;ALG2;ALG9;ALG1;ALG6;ALG3;DOLPP1;DOLK
prerank,regulation of actin nucleation (GO:0051125),0.4314325507004858,0.9237226045839901,0.5679442508710801,0.8339782263728583,1.0,2/12,7.48%,CORO1A;ARF1
prerank,protein localization to organelle (GO:0033365),0.2892606804904226,0.9235987373321294,0.6266816143497758,0.8337688307693651,1.0,30/133,17.61%,LRRK2;SORL1;RAB6A;PRNP;TRAM2;TRAM1;GCC2;IFT140;LMNA;PAQR3;GBF1;STX5;PPP1R15A;PIKFYVE;LAMP5;CEP250;DCP1A;LMBRD1;TOR1AIP1;APP;PACSIN2;RPL11;GBP5;UBE2J2;GBP2;EHD1;VAPA;RAB35;TMEM30A;TSPAN17
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.39394832400661595,0.9233808430372876,0.5599393019726859,0.8337492070535001,1.0,4/19,10.02%,PTPRU;MAD2L2;AFDN;ADAM19
prerank,protein import (GO:0017038),-0.23482695199418013,-0.9231827338523267,0.654320987654321,0.8523765747505367,1.0,23/84,17.51%,APOE;ABCD2;E2F3;APPL2;LAMP2;NUP133;NUP155;IPO5;NUP188;GDAP1;TNPO2;PPP1R10;IPO13;NUTF2;CLU;SEC13;TSC2;NUP85;FAM53A;TPR;RAN;ABCD3;IPO7
prerank,protein localization to condensed chromosome (GO:1903083),-0.3811346664750584,-0.9229692147160703,0.5657276995305164,0.8518187228084196,1.0,7/12,34.39%,IK;BUB3;ZW10;KNL1;SPDL1;MIS12;CDK1
prerank,negative regulation of insulin secretion (GO:0046676),-0.3444009971361085,-0.9229329321076983,0.5494791666666666,0.8508604720390903,1.0,3/17,10.39%,PRKN;IRS1;KLF7
prerank,positive regulation of vasculature development (GO:1904018),0.29750492609995155,0.9223729933887038,0.6151990349819059,0.835360373170804,1.0,10/94,6.65%,IL1B;ITGAX;CD40;PTGIS;VEGFC;BTG1;HIPK2;HIPK1;PIK3R6;PDPK1
prerank,visual perception (GO:0007601),0.3031520221316983,0.9222910343615156,0.6038882138517618,0.8350581196358087,1.0,11/84,11.36%,CRYBG3;RP2;ATF6;WFS1;ATXN7;DNAJC19;OPA3;KIFC3;CEP250;UNC119;IMPG2
prerank,modulation by host of symbiont process (GO:0051851),-0.28948029890127036,-0.922194713216181,0.5555555555555556,0.8515803959839998,1.0,17/31,34.31%,CX3CR1;TARDBP;HPN;SMARCB1;SNW1;CCL3;SP1;HMGA2;NAPEPLD;RRP1B;CHD1;TAF11;CTDP1;CCL5;LEF1;TFAP4;SMARCA4
prerank,sterol metabolic process (GO:0016125),-0.2502025434037216,-0.9215959046150032,0.6513761467889908,0.8519784138128883,1.0,6/60,7.51%,ABCA1;APOE;OSBPL1A;LIPA;ARV1;STARD3
prerank,protein localization to vacuole (GO:0072665),0.42378986722211714,0.921533223295633,0.5661375661375662,0.8361369337066183,1.0,3/13,12.47%,RTN4;LMBRD1;SH3BP4
prerank,urogenital system development (GO:0001655),0.4332602177010928,0.9212705940302622,0.5818815331010453,0.8362105805880733,1.0,2/11,10.39%,EPHB2;ANXA1
prerank,regulation of endocytosis (GO:0030100),0.3147601279208006,0.9211804753117925,0.5933075933075933,0.8359355977035161,1.0,18/61,17.11%,LILRB1;NEDD4L;CD177;PICALM;GPC3;CBLL1;HIP1;PTPN1;CLIP3;PACSIN2;LGALS3;ROCK1;STON1;AP2S1;SNX33;SNX12;MTMR2;ABL2
prerank,early endosome to late endosome transport (GO:0045022),0.38021768356633767,0.9210633668449011,0.5714285714285714,0.8356909246846131,1.0,3/20,8.95%,LMTK2;RAB7A;SNF8
prerank,regulation of phosphorylation (GO:0042325),0.28950480241073695,0.9207469313496848,0.6217440543601359,0.835852430903682,1.0,30/120,18.68%,LYN;STAP1;NUP210;PRKAG2;CCDC88C;CCDC88A;IKBKB;PRKRIP1;GLMN;CDKN2C;NUP98;ANKLE2;SLAMF8;FN1;PRKAG1;APP;NDUFS4;BTBD10;NUP153;STAT2;ROCK1;THBS1;SEH1L;PSEN1;GCK;SIRT1;RAD17;NUP93;PIN1;FZD7
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3645293176579771,0.9206942405791411,0.5524781341107872,0.8354954209874906,1.0,10/25,17.21%,KAT7;HTATSF1;SCAF8;SETD5;CCNT2;CCNT1;EAF1;HMGN1;ELL;SUPT4H1
prerank,glutamate metabolic process (GO:0006536),-0.3302060395643129,-0.9203400247458978,0.5906593406593407,0.8540357848482749,1.0,12/19,25.91%,GLUL;GOT1;GCLC;MTHFS;ALDH18A1;GCLM;GAD1;ALDH5A1;OAT;GLS;PRODH;FPGS
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3469023296650549,0.9200514441016682,0.5702005730659025,0.8362769570886716,1.0,4/32,10.75%,LRRK2;MCTP2;SLC30A1;SNAPIN
prerank,regulation of protein modification process (GO:0031399),0.32741853068368415,0.9198862039153852,0.5961538461538461,0.8361351938008832,1.0,17/50,20.90%,LYN;CCDC88C;RABL3;CCDC88A;SPRED3;FN1;PARG;NDUFS4;ATG10;STAT2;KAT2B;SPRED1;PPIB;PIN1;PUM3;PTK2;PHIP
prerank,embryonic appendage morphogenesis (GO:0035113),0.4298057390192659,0.9196269717700489,0.5598086124401914,0.8361742034930446,1.0,1/12,0.58%,MBNL1
prerank,regulation of cell growth (GO:0001558),0.277647553749247,0.9193826414606519,0.6563169164882227,0.836213169598958,1.0,44/204,17.57%,SGK3;ITCH;BCL6;HSPA1A;RASGRP2;RPS6KA3;BMPR2;MAD2L2;CRLF3;CDC42;H3-3A;BTG1;PPP1R9B;BCAR1;CDKN2C;OSGIN2;CXCL16;ADAM17;CIB1;MTPN;TMC8;DDX49;CSNK2A1;SMAD4;RTN4;IL17RB;NET1;DCUN1D3;RPS6KA1;PSMD10;SH3BP4;PABIR1;AKT1;TGFB1;PTPRJ;SERTAD3;NCBP1;INO80;USP47;PPT1;RB1;ST7L;SIRT1;NUBP1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.2817248506392041,-0.9193224688744173,0.5952380952380952,0.8554808392770029,1.0,4/33,4.21%,PRKG1;MEF2C;AIF1;APOD
prerank,sphingolipid catabolic process (GO:0030149),0.4030235066869492,0.9191466283467535,0.5834683954619124,0.8362382568537908,1.0,2/15,5.04%,ACER3;SMPDL3A
prerank,nucleotide-excision repair (GO:0006289),-0.22814687454114113,-0.9188625901551568,0.6942675159235668,0.8555235030962813,1.0,36/101,24.76%,GTF2H2;ERCC6;COPS4;POLD3;MMS19;TCEA1;GTF2H1;UBC;XRCC1;POLR2A;COPS7A;ERCC2;COPS2;PCNA;SLC30A9;LIG3;POLA1;PPIE;ISY1;POLR2K;RFC3;LIG1;GTF2H3;OGG1;COPS7B;XAB2;CDK7;POLR2H;GTF2H5;SLX4;POLR2J;RAD23A;UBA52;XPC;COPS6;ERCC1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35892879933035804,0.9186622795482803,0.5745296671490593,0.8367196274779917,1.0,11/28,18.44%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,engulfment of apoptotic cell (GO:0043652),0.4060418544107643,0.91865194063509,0.5796387520525451,0.8362739747113621,1.0,6/15,15.65%,RAC2;XKR4;RAC1;MEGF10;RHOG;THBS1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3701850850947641,-0.9186416513237485,0.5863746958637469,0.8550054618540719,1.0,2/13,3.14%,TPST2;ENPP1
prerank,actin cytoskeleton reorganization (GO:0031532),0.31622814765496204,0.9181217950315578,0.6015228426395939,0.8368603140028171,1.0,14/63,13.20%,NEDD9;PAK1;MYH9;BCAR1;GRB2;FLNA;EZR;MINK1;RHOA;ANXA1;PTPN1;CASS4;PIP5K1A;KIT
prerank,cellular response to hydroxyurea (GO:0072711),-0.3975425601205504,-0.9181005826596519,0.5671981776765376,0.8552715673352131,1.0,5/10,23.66%,BLM;RTF2;NSMCE3;DDX11;TIMELESS
prerank,spliceosomal complex assembly (GO:0000245),0.3290263474783314,0.9180873326059733,0.5912806539509536,0.8364620147321528,1.0,16/46,20.53%,CRNKL1;SNRPD2;PRPF6;SETX;SRSF10;CELF2;YTHDC1;DDX23;SF3A1;NCBP1;TXNL4A;CELF1;SF3B1;SF3A2;LUC7L3;LUC7L
prerank,cell junction maintenance (GO:0034331),0.40727253552214304,0.9179333048069438,0.538971807628524,0.8363020161916689,1.0,2/14,3.32%,CLDN1;CD177
prerank,neuron migration (GO:0001764),0.32859523427138027,0.9177719634432795,0.5864864864864865,0.8361603973929643,1.0,9/48,8.19%,SDCCAG8;NDNF;CELSR1;NAV1;RAPGEF2;CEP85L;PAFAH1B1;DDIT4;RAC1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.36445472437463994,-0.9177375214712923,0.5601023017902813,0.8550828845444159,1.0,7/13,27.11%,ALG8;MPDU1;ALG2;ALG9;ALG1;ALG6;ALG3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.40579209517739123,0.9176885365682291,0.5728314238952537,0.8358557634725304,1.0,4/14,10.65%,MYO1C;VEGFC;PGF;PIK3CA
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3790100273361288,-0.9176258554049711,0.5751173708920188,0.8542886430645636,1.0,5/12,12.14%,CTBP1;AKAP8;AKAP8L;VEGFA;PRKD1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.3475518716103955,0.9171594114424201,0.5925394548063128,0.8364891894298215,1.0,2/34,3.56%,LRRK2;CHRNA4
prerank,positive regulation of phosphatase activity (GO:0010922),-0.31364566945172534,-0.9170170389343323,0.5800604229607251,0.8547593205847145,1.0,7/21,18.44%,MEF2C;MAGI2;MTMR9;CALM1;GPLD1;PLEK;HSP90AB1
prerank,protein alkylation (GO:0008213),0.376776114341834,0.9169361158945051,0.5957446808510638,0.8364798578243733,1.0,7/22,18.24%,PRMT8;SNRPB;CAMKMT;ETF1;PRMT3;EEF1AKMT1;GSPT1
prerank,regulation of necroptotic process (GO:0060544),0.3706758528528241,0.9168908443330525,0.5599393019726859,0.8361161171700211,1.0,6/23,10.66%,BIRC3;PELI1;PDCD6IP;SPATA2;CYLD;RIPK1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.37240300206646104,0.916607194300196,0.5724743777452416,0.8362164599776992,1.0,5/21,14.22%,CCR1;SRGN;PTK2B;ROCK1;TGFB1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3981156528872737,-0.916417864697636,0.5638051044083526,0.855139101243988,1.0,4/10,20.86%,CTBP1;SET;BRCA1;THAP7
prerank,protein homotrimerization (GO:0070207),0.41210989626241884,0.9161406747926643,0.5611745513866232,0.8362349520179913,1.0,3/14,13.83%,ALOX5AP;SLC1A5;PNPT1
prerank,protein trimerization (GO:0070206),0.41210989626241884,0.9161406747926643,0.5611745513866232,0.8362349520179913,1.0,3/14,13.83%,ALOX5AP;SLC1A5;PNPT1
prerank,cellular response to interferon-beta (GO:0035458),0.40699814869505235,0.9159313751387008,0.5767284991568297,0.8361835047881738,1.0,7/14,25.03%,STAT1;ACOD1;PNPT1;AIM2;CDC34;UBE2K;IRF1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4132669171680117,0.9159256728829298,0.5570698466780238,0.8357303804471243,1.0,1/14,1.95%,CCR1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3632457924228957,0.9158056673193395,0.5686567164179105,0.835524040116256,1.0,10/27,16.95%,NTNG2;CCDC88A;PTEN;FCGR2B;AKT1;BRSK1;FBXO7;EFHC2;DISC1;PSEN1
prerank,positive regulation of autophagy (GO:0010508),0.3026297418638087,0.9154668124568563,0.6111786148238153,0.8357236034064218,1.0,18/81,15.48%,LRRK2;DAPK1;PIK3C2A;PLEKHF1;ATF6;WAC;SVIP;CAMKK2;TRIM14;FOXO3;PRKAA1;HTT;MAP3K7;SH3BP4;PRKAA2;ROCK1;FBXO7;TBK1
prerank,protein localization to cell periphery (GO:1990778),0.2858909877641988,0.9151873961463093,0.6127232142857143,0.8358402121191292,1.0,32/133,17.91%,RAP1A;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;IKBKB;EHD2;KCNIP3;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14;TSPAN33;PACS2;PACS1;RAB40B;PIP5K1A;ROCK1;EFR3A;RAB29;EHD1;ZFYVE27;TSPAN15;TSPAN5;MYADM;TSPAN17;EHD3;ZDHHC3
prerank,cellular component disassembly (GO:0022411),0.32315785487404314,0.9151793868111144,0.5861182519280206,0.8353915644475,1.0,4/53,6.14%,CD44;LCP1;MMP1;CAPN2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4127240886040135,0.9149384420543323,0.5667244367417678,0.835412449908424,1.0,3/13,10.70%,MBD4;SMUG1;TDG
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2833447235414383,0.9145825310971871,0.64293659621802,0.8356816502174765,1.0,38/150,20.31%,FLT3;FYN;RET;FGF5;FGF22;NRG2;KL;RAC2;GRB2;PDPK1;ENG;RAC1;HGF;CPNE1;HIP1;RTN4;PIK3CA;CASS4;KIT;HCLS1;TGFB1;FGFR3;PTPRJ;IL18;MAZ;RHOG;FRS2;THBS1;INSR;PIK3R2;HAX1;PINK1;PIK3R5;FGFR1;PARK7;PTK2;TSPYL5;STRN
prerank,protein kinase B signaling (GO:0043491),0.3668434896457371,0.914307593921659,0.5731523378582202,0.8357756101770772,1.0,3/23,6.44%,IL1B;PTEN;SETX
prerank,blood vessel diameter maintenance (GO:0097746),0.34675056489013945,0.914250706228036,0.5682451253481894,0.8354274316170037,1.0,2/34,2.21%,ACE;ACE2
prerank,pseudouridine synthesis (GO:0001522),0.4147900091748074,0.9136292010988368,0.5716694772344013,0.836198040613911,1.0,5/13,21.47%,NHP2;PUS3;PUS1;PUS7L;TRUB2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3292691738822147,0.9133348495806238,0.5760111576011158,0.836338499361825,1.0,13/46,18.44%,IL1B;XPO4;UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.3778016872687347,-0.9132576948287173,0.5839598997493735,0.8617663641077973,1.0,2/12,3.39%,CSF1R;CSF1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.31776156549468476,0.9129712724861461,0.5858064516129032,0.836601539779064,1.0,10/57,11.91%,DAPK1;FYN;MAP3K5;SYK;MALT1;NLRC4;FIS1;GRAMD4;NLRP3;REST
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3863327738287389,0.9128307813240443,0.5411184210526315,0.8364117793870256,1.0,6/17,15.49%,VIRMA;RNF20;ZC3H3;NUDT21;CCNT1;NCBP1
prerank,regulation of hormone secretion (GO:0046883),-0.3543729605914499,-0.9127574921955279,0.5840220385674931,0.8618780392589865,1.0,4/15,18.70%,SNX6;SCG5;SOX11;VAMP3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.41527822921392,0.9122926626225096,0.576068376068376,0.8370640900710238,1.0,2/12,4.16%,CBLB;CBL
prerank,negative regulation of kinase activity (GO:0033673),0.3146594199489573,0.9120153727061532,0.6025157232704402,0.8371596520407587,1.0,15/62,18.57%,PTPRC;PPP2R5A;PRKAG2;PRKRIP1;PDPK1;PAK2;GSKIP;DBNDD2;TAF7;AKT1;GSTP1;SPRED1;RB1;TAB1;DEPTOR
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.38351353807857297,-0.9119946340796463,0.5727923627684964,0.8627271418599257,1.0,3/11,14.84%,TREM2;AKAP6;ALG10B
prerank,positive regulation of lipid storage (GO:0010884),-0.327025868110723,-0.9118887247112112,0.5681159420289855,0.8619033496226437,1.0,6/21,13.73%,OSBPL11;MSR1;IKBKE;VSTM2A;APOC4;C3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3711591205840096,0.911684297136416,0.5742424242424242,0.8373949932098419,1.0,10/22,22.73%,IKBKB;CRY2;PPP1R15A;FKBP1B;LGALS3;ROCK1;PTPA;TIPRL;GSK3B;TNF
prerank,Golgi to lysosome transport (GO:0090160),0.4221141496001386,0.9116587059491523,0.5721476510067114,0.8369751029517761,1.0,4/11,17.87%,LAPTM5;AP1G1;ANKFY1;EHD3
prerank,synaptic vesicle transport (GO:0048489),0.427617399698928,0.9114236949261363,0.5960854092526691,0.8369862831018487,1.0,4/11,14.64%,KIF5B;SYNJ1;SNAPIN;KIF5A
prerank,regulation of feeding behavior (GO:0060259),0.4318611587503733,0.9113698440979353,0.5701906412478336,0.8366230476363958,1.0,1/11,2.37%,STAT3
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.40908483997990597,0.9105498907527613,0.5723684210526315,0.837785244427358,1.0,2/12,6.13%,WAC;CCND1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4129613094302449,0.9105164360345858,0.5530434782608695,0.8373904865197559,1.0,4/13,15.49%,FIP1L1;TUT1;NUDT21;NCBP1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.39016498494391405,0.9103853681294297,0.5572998430141287,0.8371898363965331,1.0,4/18,8.00%,MSN;PTTG1IP;FAF1;EZR
prerank,protein deneddylation (GO:0000338),-0.3988652999227539,-0.909875330975441,0.585812356979405,0.8656407124754902,1.0,5/10,24.01%,COPS4;COPS7A;COPS2;COPS7B;COPS6
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3421906445543741,-0.9098316630998887,0.6016713091922006,0.8647077303259436,1.0,8/18,31.95%,KIF1B;FCHSD2;SLC5A7;ERC1;DTNA;TSPOAP1;STAC3;CHAT
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3785862514436821,-0.9094054387923407,0.562962962962963,0.8646643839411849,1.0,6/11,24.42%,TRIM37;CENATAC;NPM1;RBM14;BRCA1;CCNF
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3318733293200764,0.9094033775954744,0.5796703296703297,0.8386778540850006,1.0,4/41,3.76%,RARA;PTPN22;LILRB1;PTPN6
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3694828157906861,0.90927715177041,0.5739549839228296,0.8384680488579147,1.0,3/21,8.21%,EXT1;SULF2;XYLT1
prerank,regulation of cellular component organization (GO:0051128),0.28426684955698917,0.9092585284207771,0.6281464530892449,0.8380439916219183,1.0,34/135,18.81%,SGK3;RAP1A;ITCH;CD36;RASGRP2;MAD2L2;RAPGEF2;CD177;PICALM;BCAR1;TMC8;STK38L;LATS1;SETD5;HIP1;METTL4;PTPN1;IL17RB;NET1;PACSIN2;SLITRK4;ROCK1;STON1;AP2S1;SNX12;IRAK3;SEMA4D;ABL2;TRAF2;BBS10;NUBP1;NCLN;ARHGEF11;PINK1
prerank,acylglycerol homeostasis (GO:0055090),-0.32001179109254774,-0.9092200047362343,0.6096866096866097,0.8640792406134514,1.0,3/20,13.38%,APOE;PNPLA8;APOC4
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.39155182980716746,0.9090547320648051,0.5878489326765188,0.8379771298686105,1.0,4/17,11.66%,PPARG;PTEN;PDCD4;TAFA5
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.4227274547635536,0.908968329307038,0.5952782462057336,0.8376744528274365,1.0,1/11,1.21%,PLCG2
prerank,negative regulation of ion transport (GO:0043271),0.36845082376386035,0.9088555915793284,0.5913818722139673,0.8374445642624628,1.0,3/24,6.45%,LILRB1;ADRA2A;PTK2B
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3486782238205323,0.9088062507674661,0.5817174515235457,0.8370722507170945,1.0,12/32,18.58%,PPP2R5A;CD300A;DLC1;PPP1R15A;ANKLE2;PPP1R15B;TGFB1;DUSP26;PPP1R7;PTPA;PRKCD;PIN1
prerank,cellular glucose homeostasis (GO:0001678),0.33254860909256895,0.908695252552753,0.6010928961748634,0.8368402401691375,1.0,11/41,17.18%,NGFR;ERN1;ZBTB20;LRRC8D;PRKAA1;PDK3;PRKAA2;GCK;FOXK1;PIK3R2;SIRT1
prerank,organophosphate ester transport (GO:0015748),0.3694088138195538,0.9086255241365079,0.5800604229607251,0.8365302041847268,1.0,6/24,13.14%,LDLR;ABCA3;SCARB1;PITPNB;PITPNM1;PRELID1
prerank,regulation of pH (GO:0006885),0.43458422166848093,0.9084760997177969,0.5847457627118644,0.8363737395313998,1.0,1/11,2.03%,SLC9A7
prerank,negative regulation of cellular catabolic process (GO:0031330),0.31128410909247584,0.908235886992536,0.6166666666666667,0.8363851556233491,1.0,12/63,13.81%,PTPN22;MCL1;STAT3;EIF4G3;IL10RA;SORL1;HP;HGF;TLK2;TAB3;AKT1;ROCK1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3288623226862568,0.90807494887114,0.5799457994579946,0.8362521156643095,1.0,4/43,3.76%,RARA;PTPN22;LILRB1;PTPN6
prerank,regulation of neuroblast proliferation (GO:1902692),0.3984394691747028,0.9075572779709395,0.5993537964458805,0.8367941811804811,1.0,1/15,0.22%,LRRK2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3814097492848191,-0.9074586318588648,0.5793450881612091,0.8671498518560042,1.0,7/10,28.22%,ABCD2;NR1H2;LPGAT1;MID1IP1;MLXIPL;SLC45A3;NR1H3
prerank,proteoglycan biosynthetic process (GO:0030166),0.34289860147722173,0.9069050018790749,0.5806451612903226,0.8376651483772397,1.0,5/31,8.21%,EXT1;BMPR2;CHST12;PXYLP1;XYLT1
prerank,diacylglycerol metabolic process (GO:0046339),-0.31120533976189807,-0.9068565625260628,0.5969696969696969,0.8675704209152795,1.0,5/23,9.66%,DGKZ;PLA2G15;DAGLA;DGKQ;GPAM
prerank,regulation of exosomal secretion (GO:1903541),-0.3269367524552098,-0.9067883421320073,0.6086956521739131,0.866651807567847,1.0,3/19,7.23%,PRKN;VPS4B;HGS
prerank,nuclear membrane disassembly (GO:0051081),0.4070344834453355,0.9064614274237204,0.5986509274873525,0.8380977019238489,1.0,1/14,1.25%,VRK1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3838822551224102,0.9062896666199792,0.5714285714285714,0.8379828444605434,1.0,5/19,14.83%,FFAR4;CARD16;GIT1;NLRP3;GSTP1
prerank,positive regulation of telomere maintenance (GO:0032206),0.34911541754726594,0.9058832403353262,0.5872781065088757,0.8382771546852834,1.0,7/31,15.13%,PKIB;MRE11;TNKS;MAP3K4;ATRX;AURKB;MAPK1
prerank,cellular amide metabolic process (GO:0043603),-0.2245987845384939,-0.9058745047259055,0.72,0.8678016636062986,1.0,44/102,29.41%,CERK;PCCA;MCCC1;PLA2G15;ST6GAL1;PLPP3;MTHFD2L;ATF4;PANK2;PLPP1;ACSF2;MTHFS;AASDHPPT;ABHD4;ACOT9;SGPL1;NLN;GPAT4;ACOT7;AEBP1;ORMDL3;MLYCD;NAPEPLD;ABCB9;PPP2R1A;OXSM;ACOT6;PDZD11;PLAAT3;CPE;DHFR;SMPD3;ORMDL1;ACOT8;SHMT2;FPGS;ALDH1L1;MTHFD1;SMPD1;SLC46A1;SMPD2;ACSL6;ABCA2;CPD
prerank,negative regulation of protein secretion (GO:0050709),0.33254093456775613,0.9057127732901032,0.5913528591352859,0.8381526545755348,1.0,7/38,13.79%,IL1B;RAB11FIP1;ADRA2A;OPRM1;PSMD9;REST;SIRT4
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3126740464934726,-0.9055175666081031,0.6081081081081081,0.8676052162827256,1.0,1/20,0.42%,IGF1
prerank,protein localization to cell-cell junction (GO:0150105),0.4062774296795535,0.9053594054293439,0.5893155258764607,0.8383966199218148,1.0,3/15,7.55%,ARHGEF18;PAK2;F11R
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4199569056770013,0.9052692860137691,0.5885245901639344,0.8381090531091383,1.0,2/12,9.79%,KAT7;METTL4
prerank,embryonic digit morphogenesis (GO:0042733),-0.32083259017996335,-0.9047130183056858,0.5867768595041323,0.8685048370713507,1.0,3/18,11.76%,SALL1;WDPCP;GLI3
prerank,peptidyl-methionine modification (GO:0018206),-0.3723539759674088,-0.9044714308491586,0.5970149253731343,0.8680326110623825,1.0,2/12,3.62%,METAP1D;METAP2
prerank,iron ion homeostasis (GO:0055072),-0.2442422661320325,-0.9039015829618641,0.6682464454976303,0.8683843003057471,1.0,13/58,10.86%,FRRS1;SLC11A1;ABCG2;ATP6AP1;FLVCR1;SLC22A17;SLC11A2;TFRC;FTH1;ATP6V0D1;CAND1;FTL;HMOX1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3854794103999286,0.9038795698273726,0.5818759936406995,0.8403903486493062,1.0,7/18,21.96%,HSPA1A;ACAA2;SLC25A5;FZD9;MUL1;BID;GSK3B
prerank,cortical actin cytoskeleton organization (GO:0030866),0.37355978475181306,0.903696751994905,0.5677321156773212,0.8402762321210265,1.0,5/20,17.99%,LCP1;IKBKB;ROCK1;FHOD1;FMNL1
prerank,embryonic digestive tract development (GO:0048566),-0.32296349194993956,-0.9029766538578272,0.6020671834625323,0.8694910054557861,1.0,6/18,16.72%,SALL1;FGFR2;GLI3;TGFB2;PKDCC;SOX11
prerank,organelle fission (GO:0048285),-0.2980720783328821,-0.902560594886725,0.5929203539823009,0.8694742183103529,1.0,4/24,9.43%,PRKN;GDAP1;MFF;DNM1
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.26888010707228804,-0.9013829569417476,0.6254681647940075,0.871144647765405,1.0,10/41,15.01%,KCNMA1;KCNJ2;ANK2;KCNN2;KCNMB2;AKAP6;KCNJ6;KCNN3;KCNJ9;GABBR1
prerank,glycolipid metabolic process (GO:0006664),0.32059969910647057,0.9012111205080646,0.5966057441253264,0.8446412269189902,1.0,11/47,12.57%,ST3GAL4;GM2A;ST8SIA6;ESYT3;ESYT1;PSAP;ST6GALNAC3;SUMF2;FUCA1;SUMF1;ESYT2
prerank,glycolipid biosynthetic process (GO:0009247),0.3293343670845494,0.9011414047519983,0.589041095890411,0.844316637518343,1.0,3/38,3.54%,ST3GAL4;ST8SIA1;ST8SIA6
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.29810126893579525,-0.9008875348671056,0.5888157894736842,0.8712743677287597,1.0,8/28,15.91%,PRKN;TREM2;CLU;PSMC2;ECSCR;CCDC22;DAB2IP;RNF139
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3507112041423957,-0.9008824574689536,0.5883777239709443,0.8702541291789132,1.0,6/15,25.12%,ACACA;PMVK;MLYCD;DIP2A;PPCS;ACSS1
prerank,chloride transport (GO:0006821),-0.2387185816591438,-0.900865778342972,0.7034883720930233,0.869269093106488,1.0,17/74,18.59%,SLC1A3;TTYH3;CLCN6;GABRG3;ANO10;GABRG2;CLCN4;GLRA3;GABRB1;GLRA2;GABRA4;CLCN3;GABRB3;LRRC8A;GABRA2;ANO8;GABRA5
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.36796765925395974,0.9004353385201953,0.5787831513260531,0.8452356346341143,1.0,8/21,16.98%,TALDO1;RPE;DERA;GPI;RBKS;PGM2L1;H6PD;GCK
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.29804329288854076,-0.9003373372923815,0.6172106824925816,0.8695436417976782,1.0,10/26,23.38%,EPHA5;KLF7;EFNA5;C2CD2L;GPLD1;ADCY8;STXBP4;PIM3;BRSK2;CDK16
prerank,extracellular matrix disassembly (GO:0022617),0.317041109163423,0.8995319388376475,0.6062176165803109,0.8465350212019402,1.0,4/53,6.14%,CD44;LCP1;MMP1;CAPN2
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3202931665143492,-0.8995235970287766,0.6080691642651297,0.8704290651416934,1.0,8/18,27.34%,APOE;PSEN2;BACE1;PSENEN;TMCC2;CLN3;APH1A;NSG1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2895100198373901,0.8992794129823735,0.6486161251504212,0.8465702614896929,1.0,15/104,10.53%,PPARG;HSPA1A;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ADAM17;PDPK1;MTMR4;ACVR2A;SPRED3;SMAD4;PMEPA1;LEMD2
prerank,fatty acid transport (GO:0015908),0.38542038844168663,0.8984167072481857,0.586038961038961,0.8477595949859379,1.0,2/17,2.75%,PPARG;CD36
prerank,positive regulation of nuclear division (GO:0051785),0.352528863872177,0.8983864866006236,0.5744360902255639,0.8473653097200741,1.0,1/25,0.33%,IL1B
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3823305245267645,0.8983694975537713,0.5847076461769115,0.8469431606413812,1.0,6/18,16.33%,CAMK1D;RPS6KA5;LPAR5;CRTC3;LRP8;RELN
prerank,regulation of fat cell differentiation (GO:0045598),0.3017530108788175,0.8983237909985972,0.6253101736972705,0.8465780124453944,1.0,13/74,15.16%,CREB1;PPARG;LMO3;WDFY2;ZFP36L2;IL6;ID2;CREBL2;CCDC71L;AKT1;TGFB1;GPS2;ASXL2
prerank,Golgi to endosome transport (GO:0006895),-0.3349428778146209,-0.8981897428128606,0.6005434782608695,0.8725243145162539,1.0,5/16,11.27%,AP2A1;SORT1;DOP1B;MON2;AP1AR
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4106023099599069,0.8976585638286987,0.5876288659793815,0.8474054259022012,1.0,1/12,2.37%,STAT3
prerank,DNA catabolic process (GO:0006308),0.43348637877404733,0.897205179832282,0.6006825938566553,0.8478328198076597,1.0,4/11,19.58%,XRN2;DFFB;SETMAR;DNASE1L1
prerank,positive regulation of viral transcription (GO:0050434),0.3537060055621498,0.897066872185395,0.6046852122986823,0.8476595172228907,1.0,7/25,18.82%,GTF2F2;POLR2C;NELFA;CCNT1;RSF1;SUPT4H1;MDFIC
prerank,spindle assembly (GO:0051225),-0.23645230009116672,-0.8970611063621219,0.64,0.8740576764553316,1.0,20/67,20.30%,STARD9;NUMA1;TUBGCP5;NEK6;PIBF1;GOLGA8B;CLASP2;NEK7;GOLGA2;LSM14A;MAPRE1;BCCIP;TUBGCP6;HAUS4;SMC1A;RAB11A;SPICE1;HAUS5;MAP9;TUBGCP2
prerank,response to zinc ion (GO:0010043),0.35734687869653836,0.8969229360967524,0.5911047345767575,0.8474981116329844,1.0,3/25,6.73%,SLC30A4;HAAO;CRIP1
prerank,post-translational protein modification (GO:0043687),0.26410674149628216,0.8967787399655168,0.7311608961303462,0.8473060218359981,1.0,55/332,14.06%,FEM1C;DTL;TNC;PSME3;ASB5;CUL3;CUL5;NOTUM;KLHL11;LAMB1;PSMB7;GPC3;FBXW7;PSME2;DCAF5;FBXW11;FBXL8;DCUN1D1;SHISA5;LGALS1;FBXW2;NEDD8;WFS1;ATG5;ELOB;UBXN7;FBXO4;COP1;PSME4;IL6;COPS3;SUMF2;FBN1;FBXO32;PSMB8;PSMA5;PSMD9;FN1;MBTPS1;KLHL5;SUMF1;PTP4A2;PRSS23;PSMB3;DCUN1D3;PSMD6;PSMC4;APP;PSMD10;PSMB1;FBXL12;DCAF10;KTN1;DNAJC3;FBXO30
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3754149739766689,0.8964041180109837,0.5909774436090226,0.8475544189718549,1.0,6/19,24.96%,PPP3CA;HRH1;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3199281015559172,0.8963083435334005,0.6174142480211082,0.847280129450365,1.0,10/45,12.10%,MEX3D;RC3H1;MTPN;PUM2;TRIM71;PARP9;YTHDC1;NUDT21;FOXO3;APP
prerank,protein targeting (GO:0006605),0.28139822215328153,0.8962759709732361,0.6532258064516129,0.8468924634915846,1.0,16/118,10.60%,AP1S3;VPS37C;MYO1C;SORL1;PEX16;PEX12;ZDHHC7;KATNB1;ZFAND6;ZDHHC6;DNAJC19;ZDHHC23;SEC63;PIKFYVE;TOMM40;FIS1
prerank,response to interferon-beta (GO:0035456),0.3706005611774011,0.8959418763494528,0.6019417475728155,0.847089187085638,1.0,10/22,22.85%,PLSCR1;STAT1;ACOD1;PNPT1;IFITM3;IFNAR2;AIM2;CDC34;UBE2K;BST2
prerank,cellular response to oxygen levels (GO:0071453),-0.3840032294328804,-0.895846924837328,0.6412776412776413,0.8758335646998145,1.0,3/10,9.87%,ATP6AP1;ATP6V0D1;CPEB4
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3701562290473671,-0.8949534960556556,0.6109725685785536,0.8757505398361691,1.0,5/11,34.72%,PKD2;CALM1;GSTO1;FKBP1A;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3701562290473671,-0.8949534960556556,0.6109725685785536,0.8757505398361691,1.0,5/11,34.72%,PKD2;CALM1;GSTO1;FKBP1A;CALM2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.38041296155514104,-0.8949165652899733,0.5740740740740741,0.8748128028574482,1.0,1/11,0.12%,PRKN
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3055317751016685,-0.8947621119615597,0.6089743589743589,0.8741691081747968,1.0,12/24,24.73%,CTC1;XRN1;SRC;TEN1;TERF1;TNKS2;EXOSC10;SLX4;HNRNPU;TINF2;PINX1;NAT10
prerank,protein autoubiquitination (GO:0051865),0.3078916190150982,0.8946702211939793,0.6245210727969349,0.8490817861340432,1.0,17/61,17.80%,ITCH;DTX3L;CUL3;RNF146;RNF213;UBE2D3;RNF141;WWP2;RNF13;TRIM71;TRIM17;SH3RF1;UHRF2;RNF122;RNF41;TRAF2;RNF19B
prerank,regulation of lymphocyte activation (GO:0051249),-0.3666270995022539,-0.8940687372116195,0.6004618937644342,0.8747696587726872,1.0,1/12,0.27%,PAG1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.27528930453210926,-0.8937501135391297,0.6501766784452296,0.8745408850005273,1.0,10/36,17.99%,CACNA1D;CACNB2;P2RX7;ANK2;P2RX4;CRACR2A;TRPC3;CAMK2A;CCL3;SPHK2
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3610539162958879,-0.8934647075806587,0.6240409207161125,0.8742001555256159,1.0,8/13,54.14%,ADRA1B;ADRA1A;CAV1;SMTNL2;AVPR2;TBXA2R;OXTR;AVPR1A
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.28191785418584003,-0.8930373624930875,0.6124260355029586,0.8741973075018363,1.0,8/28,18.77%,COTL1;RASA1;PFN1;FCHSD2;ARHGAP35;PFN2;CTTN;GBA2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.38057235892574176,0.8928818286285871,0.6018662519440124,0.8521079632019374,1.0,5/20,15.92%,HEXIM1;PTEN;LATS1;LATS2;APC
prerank,cellular response to nitrogen compound (GO:1901699),-0.31650475257132393,-0.892391280696529,0.5847457627118644,0.8746505468445265,1.0,7/20,24.68%,EPG5;BLM;RTF2;NSMCE3;DDX11;TIMELESS;PDE12
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.24693659527440479,-0.8919599509669597,0.6652892561983471,0.8735860870359466,1.0,33/56,33.66%,NDUFAF6;NDUFAF2;OXA1L;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;FOXRED1;NDUFA5;NDUFB5;NDUFAF7;NDUFB9;NDUFB7;ACAD9;NDUFA13;TIMMDC1;NDUFAF1;BCS1L;NDUFB8;NDUFAB1;NDUFB6;NDUFS8;NDUFB10;TMEM126A;NDUFAF4;NDUFS3;NDUFS6;NDUFA11;NDUFAF8;NDUFB11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.24693659527440479,-0.8919599509669597,0.6652892561983471,0.8735860870359466,1.0,33/56,33.66%,NDUFAF6;NDUFAF2;OXA1L;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;FOXRED1;NDUFA5;NDUFB5;NDUFAF7;NDUFB9;NDUFB7;ACAD9;NDUFA13;TIMMDC1;NDUFAF1;BCS1L;NDUFB8;NDUFAB1;NDUFB6;NDUFS8;NDUFB10;TMEM126A;NDUFAF4;NDUFS3;NDUFS6;NDUFA11;NDUFAF8;NDUFB11
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3123315162791005,-0.8917933181509807,0.6116207951070336,0.8729688685640898,1.0,11/21,28.54%,IGF1;LGALS9;HTR2B;KARS1;MT3;FGF10;CTSH;SOX9;KDR;MYC;EGF
prerank,hippo signaling (GO:0035329),-0.2925830425792228,-0.8914622571325468,0.6,0.8727642622289259,1.0,7/26,11.73%,TJP1;AMOTL1;TJP2;SAV1;WWC1;FAT4;CASP3
prerank,generation of neurons (GO:0048699),0.27116007827604677,0.8913997873218801,0.7009857612267251,0.8544683612014906,1.0,15/190,8.19%,IL1B;RUNX2;RUNX3;SDCCAG8;IER2;NDNF;CELSR1;RACGAP1;NAV1;RAPGEF2;CEP85L;MTPN;PAFAH1B1;DDIT4;RAC1
prerank,phosphatidylserine metabolic process (GO:0006658),0.3401858217278272,0.8912972887694989,0.5971014492753624,0.8542161542477382,1.0,2/32,2.32%,PLA1A;PLSCR1
prerank,autophagy of peroxisome (GO:0030242),-0.364080553887482,-0.8909257973033564,0.6172839506172839,0.8729732009681859,1.0,4/12,14.33%,NBR1;MAP1LC3B;USP30;SQSTM1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3533672135010428,0.8898379964827129,0.6039755351681957,0.8564850126398494,1.0,8/23,22.85%,PRKAG2;AXIN1;APP;TGFB1;MAPK1;TNKS1BP1;RIPK2;UBE2K
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2691933343759791,-0.8895655172784139,0.6451612903225806,0.8751959861498169,1.0,14/37,28.18%,GTF2H2;POLD3;GTF2H1;UBC;ERCC2;PCNA;RFC3;GTF2H3;GTF2H5;UBA52;ERCC1;RFC2;GTF2H4;DDB1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3283481964076642,0.8893217723040228,0.6330532212885154,0.8570342428374643,1.0,5/40,6.93%,SLC23A2;SLC23A1;SLC38A10;SLC25A30;ABCC1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3438306156104562,-0.8890418771285019,0.5885416666666666,0.8754525367844345,1.0,8/15,38.39%,PIBF1;CEP83;CCDC14;NEDD1;CEP192;STIL;CEP131;SPAG5
prerank,positive regulation of nervous system process (GO:0031646),0.3718239133291483,0.8882062505612854,0.5990853658536586,0.8587475305554935,1.0,2/18,4.08%,ITGAX;MYRF
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3113257545184017,0.8876560050790182,0.64629388816645,0.8593668606313417,1.0,8/56,10.08%,BMPR2;RBPMS;GDF1;BMP3;ENG;ACVR2A;SMAD4;PMEPA1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.33714495301416647,0.8875999932960165,0.6217765042979942,0.8590176137451863,1.0,4/33,5.92%,SP100;MARVELD3;SYNJ2BP;PTEN
prerank,positive regulation of protein polymerization (GO:0032273),0.2999611634202859,0.887541376793152,0.6461159062885327,0.8586660987054652,1.0,10/65,10.62%,HCK;PRKCE;PAK1;CARMIL1;PTK2B;TPPP3;RAC1;RPS3;SNX9;VASP
prerank,organic cation transport (GO:0015695),-0.3064515612317317,-0.8874337673585703,0.6140845070422535,0.8781285991452095,1.0,5/20,14.59%,SEC14L1;SLC25A26;SLC22A5;SLC5A7;SLC22A4
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.37401850342530757,0.8874170784660123,0.6058732612055642,0.8584458465004651,1.0,2/18,3.22%,PTPN22;LAPTM5
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3140729690518686,0.8869017947337552,0.6443850267379679,0.8590139066569272,1.0,8/48,10.49%,BCL3;MCL1;HIPK2;HIPK1;CRIP1;DDIT4;MSH6;CASP2
prerank,androgen metabolic process (GO:0008209),0.37604132969088067,0.8867078054058557,0.6173228346456693,0.8589270890732038,1.0,4/18,15.79%,HSD17B7;DHRS9;HSD17B11;MED1
prerank,cellular response to hypoxia (GO:0071456),0.2839965761454139,0.8862824695215196,0.6944127708095781,0.859319874101832,1.0,21/126,12.97%,LIMD1;NDNF;PSME3;PTGIS;PSMB7;PSME2;HIPK2;ELOB;LMNA;CARD16;PSME4;BACH1;ACAA2;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2623390697761379,0.8862645336109533,0.741701244813278,0.8588969806887,1.0,77/314,18.61%,FEM1C;ITCH;PSME3;NEDD4L;CUL3;CUL5;UBE2E1;TBL1XR1;PSMB7;FBXW7;PSME2;KCTD2;PELI1;UBE2D3;SPOP;DCAF12;FBXW11;FBXL8;FAF1;KLHL15;FBXO38;WFS1;NFE2L2;TRIM25;FBXO4;ERLIN1;CLOCK;UBR2;COP1;PCNP;PSME4;ATXN3;WWP2;TRIM71;UBE2W;PSMB8;KCTD5;PSMA5;PSMD9;DNAJB12;PSMB3;UBE2S;FBXL17;PSMD6;PSMC4;FOXRED2;PSMD10;UBE2G1;AREL1;PSMB1;FBXL12;VCP;UBE2J2;STT3B;PPP2R5C;AURKB;ANAPC7;KCTD13;UBXN11;RMND5B;RNF122;TAF1;HACE1;FBXL16;PSMD12;RB1;UBR3;MAEA;MAN1B1;SIRT1;ECRG4;HSPA5;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.366603546261969,0.8859701395036966,0.6212121212121212,0.8590340727756959,1.0,7/21,16.95%,MYH9;ADAM17;SPPL2A;ADAM19;BACE2;ADAM9;PSEN1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.3756246234224019,-0.885830887105478,0.6098765432098765,0.8807925523524224,1.0,4/11,19.77%,DKC1;EXOSC5;EXOSC10;EXOSC3
prerank,glial cell differentiation (GO:0010001),0.34284599616959005,0.885815611722062,0.6118518518518519,0.8588643057519263,1.0,3/28,4.08%,ADGRG6;STAT3;MYRF
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.321919602973744,-0.8857335325605422,0.6305555555555555,0.8799996976302775,1.0,7/18,17.78%,ZDHHC2;MMP14;VTI1B;CDK5;VAMP8;AR;STX8
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3325448786542561,-0.8853891911599079,0.6266318537859008,0.879713179223214,1.0,5/15,17.61%,STOX2;RAI2;USP22;TGFB2;BRCA1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.24844129300547707,-0.8852972511076881,0.7172995780590717,0.8788821935067912,1.0,22/54,26.22%,CNOT4;CRADD;PLK3;CNOT10;SOX4;PCNA;BAX;TFDP2;TFDP1;CNOT11;ARID3A;PCBP4;CNOT7;GADD45A;MDM4;CARM1;E2F1;CDKN1A;MDM2;RGCC;PLK2;RPL26
prerank,regulation of myoblast differentiation (GO:0045661),0.34072734862762055,0.8852573548315298,0.6235795454545454,0.8594934337132485,1.0,4/32,7.50%,RIPOR2;BTG1;MAPK14;PLCB1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2750340516852152,0.8847589690237335,0.6829268292682927,0.8600020719834833,1.0,29/151,16.43%,CERS6;ST3GAL4;ACER3;SLC44A2;B4GALT5;CERS1;ELOVL5;GSTA3;SAMD8;SGMS1;SGMS2;CEPT1;ELOVL6;PCYT1A;CSNK2A2;CSNK2A1;ARG2;SLC44A1;SPTSSB;SLC44A5;SGPP2;PCSK5;ASL;GSTP1;SGPP1;ASS1;FA2H;VAPA;HACD4
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26244035993128456,-0.8846871082159703,0.7148936170212766,0.8792338553010853,1.0,9/46,11.75%,PLD1;DGKZ;LPCAT1;SLC27A1;PLA2G4A;DGKQ;GPAM;DDHD2;ABHD4
prerank,nucleic acid metabolic process (GO:0090304),0.2984328463075686,0.8842235294916214,0.6511627906976745,0.8605642728263528,1.0,7/69,7.02%,DNA2;GTF2F2;FEN1;POLR2C;DNTT;XRN2;WRN
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.4073515536157279,0.8839460893964753,0.6080843585237259,0.8606570703328333,1.0,3/11,8.00%,MSN;SORL1;EZR
prerank,protein deacylation (GO:0035601),0.35645294668781935,0.8839249139798921,0.624813153961136,0.8602418572714742,1.0,13/23,25.47%,NOTUM;ABHD17B;HDAC3;PPT1;SIRT1;ABHD17A;HDAC7;HDAC1;SIRT3;HDAC5;SIRT2;LYPLA1;SIN3A
prerank,transition metal ion homeostasis (GO:0055076),0.348854413218003,0.8837181865222663,0.6262924667651403,0.8601800217396889,1.0,9/28,15.20%,ABCB7;PICALM;HEPH;TMC8;B2M;HMOX2;IREB2;CUTC;XIAP
prerank,regulation of axon regeneration (GO:0048679),0.40750823270652103,0.8836986165001468,0.5888157894736842,0.859766548393783,1.0,2/12,4.12%,STK24;INPP5F
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2887676296536308,0.8832905450396322,0.6493349455864571,0.8601241261084487,1.0,12/88,12.10%,AP1S3;STXBP6;EXOC6;EPS15;SORL1;AP1S2;RP2;ARF1;GBF1;VPS13A;AP1G1;APP
prerank,copper ion transport (GO:0006825),0.4120243808982701,0.8832634390042072,0.6078098471986417,0.8597174022636299,1.0,5/11,16.65%,ATP7A;ATOX1;COX17;CUTC;SLC31A1
prerank,histone methylation (GO:0016571),0.3419860339317338,0.8831796521298202,0.611271676300578,0.8594168180679567,1.0,7/26,19.46%,NSD3;PRMT8;NSD1;EZH2;CREBBP;NTMT1;EHMT1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.38489227985615226,0.882884905075247,0.6019417475728155,0.8595051709305251,1.0,1/16,1.38%,NGFR
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3616763590574577,0.8821562761217572,0.6184419713831478,0.8599815064874526,1.0,8/20,17.97%,HIBADH;DLD;BCKDHA;BCKDHB;ACAT1;HIBCH;BCAT1;AUH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3616763590574577,0.8821562761217572,0.6184419713831478,0.8599815064874526,1.0,8/20,17.97%,HIBADH;DLD;BCKDHA;BCKDHB;ACAT1;HIBCH;BCAT1;AUH
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3206785089703299,0.8813380928758098,0.6287671232876713,0.8611075851116741,1.0,7/40,12.26%,MCL1;ARMT1;CRY1;UBE2N;ING2;PARG;SMG1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.42769721659684934,0.881228864820185,0.6087689713322091,0.8608649955963881,1.0,2/10,13.21%,UPB1;NT5C3A
prerank,aortic valve morphogenesis (GO:0003180),-0.2757421465103178,-0.8805700005027921,0.6785714285714286,0.8876147619646232,1.0,4/30,12.71%,ROBO2;ROBO1;SLIT2;SLIT3
prerank,negative regulation of DNA recombination (GO:0045910),0.31845531803503113,0.880540603317705,0.6380697050938338,0.8617400679845265,1.0,8/43,12.73%,MAD2L2;POLR2C;SMCHD1;KLHL15;MSH3;MSH6;DAXX;ATRX
prerank,gene expression (GO:0010467),0.25742163515420263,0.8802311646051759,0.7658486707566462,0.8619165990546762,1.0,87/348,20.33%,ZAR1;BCL3;RPL5;NUP210;RBPMS;SORL1;RPS10;POLR3A;POLR2C;SCX;RPL37A;MRPL55;RPL6;MRPL18;NUFIP1;RBMS1;RPS18;XRN2;SETX;RPS14;RPL35A;THOC3;NUP98;RBMS2;FIP1L1;GALNT2;MAGOHB;TSPAN14;RPL13;MRPL13;NFKBIB;SRSF4;CREBL2;DHX8;SLU7;RPS3;TSPAN33;IGF2BP3;RPS21;CELF2;FARSB;UPF2;YTHDC1;DEDD2;RPL34;RPLP0;BAZ2A;SMG1;AGFG1;NUP153;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;SYNCRIP;RPS15A;CPSF3;TSPAN15;NCBP1;MRPS6;RBM39;RPS4X;MRPS33;TSPAN5;SEH1L;SMG6;TFIP11;HARS2;HSPD1;TSPAN17;NUP93;GSPT1;RPL32;RPSA;ANGPT2;DDX20;RPS13;MRPS15;UPF3B;WDR33;CDC40;RPS6;RPL18A;RPS27;RPLP2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.416332022980323,0.8800187560921504,0.6046099290780141,0.8618725122141112,1.0,2/10,6.34%,RC3H1;PRNP
prerank,regulation of protein-containing complex assembly (GO:0043254),0.2785768543440115,0.8796721176182989,0.6697674418604651,0.8620550382694765,1.0,27/110,18.00%,HCK;SYK;ATF7IP;CD36;SORL1;MMP1;EIF2AK2;SUMO1;CDC42;FAF1;TIRAP;SVIP;TMC8;RALB;LATS1;RPS3;SPIDR;LGALS3;VCP;TGFB1;RB1;AJUBA;TFIP11;TRAF2;BBS10;HSPA5;NCLN
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.35682743801439354,-0.8792110025451294,0.6197530864197531,0.8896955987812416,1.0,4/12,15.22%,SNX5;IRS1;PRKCZ;GKAP1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.31282243983048097,0.8791698440613982,0.6571428571428571,0.8625965652880304,1.0,14/52,18.89%,RAC2;FBXW7;BBC3;UBE2D3;ARIH2;CSNK2A2;YWHAZ;RNF31;MAPK8;SREBF2;UBE2J2;ATG13;PINK1;BAD
prerank,positive regulation of DNA recombination (GO:0045911),-0.28473052308688895,-0.8791238664755788,0.6609686609686609,0.8888593035857714,1.0,10/27,17.36%,ERCC6;MMS19;TFRC;FUS;ZCWPW1;RIF1;SHLD2;ERCC2;HMCES;MRNIP
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3969820390496665,0.8788481509101408,0.6171617161716172,0.8627717557885282,1.0,4/14,17.59%,UPB1;CAD;NT5C3A;ERH
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.37693007984674337,0.8780664827251303,0.6210691823899371,0.8638115605023897,1.0,7/17,15.56%,RBPJ;STAT1;PLXND1;PBX1;KAT2B;CREBBP;MAML1
prerank,regulation of nervous system development (GO:0051960),-0.26329329585545663,-0.8779038106538588,0.6787003610108303,0.8906330826984782,1.0,10/37,16.91%,CX3CR1;TENM4;CTNNB1;PTN;PTPRZ1;HMGB2;BHLHE41;CX3CL1;PER2;NSUN5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.29348164273989885,0.8778800352174243,0.6513994910941476,0.8637125415475355,1.0,5/62,7.11%,LRRK2;MCL1;HSPA1A;PTTG1IP;NFE2L2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.29856364545629865,-0.8775440249289903,0.6538461538461539,0.890431382015707,1.0,7/23,16.72%,BCL9;SMAD7;NREP;SMAD3;TRIM33;DKK3;SOX11
prerank,regulation of histone modification (GO:0031056),-0.34791634637818036,-0.8775374653505208,0.6107226107226107,0.8894277660104741,1.0,4/13,11.54%,FLCN;HPF1;AKAP8;AKAP8L
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.35390067206109654,0.8775352202621348,0.6024653312788906,0.8639019365536538,1.0,7/22,15.67%,IL1B;ADRA2A;SNX9;TNFRSF1B;ROCK1;ADAM9;SNX33
prerank,RNA processing (GO:0006396),0.2700131707854643,0.8774511269777889,0.7186147186147186,0.8636160599585709,1.0,51/176,20.94%,MBNL1;RSRC1;RBPMS;RNPC3;SNRPD2;PRPF6;PPP1R9B;NUFIP1;RBMS1;XRN2;SNRPB;SETX;RBMS2;TUT1;LSM5;MAGOHB;PRPF3;TENT2;RP9;SRSF4;DHX8;SLU7;CELF2;NUDT21;MTPAP;TUT7;DEDD2;DDX23;SNRPA1;CDK12;SF3A1;METTL3;SYNCRIP;TENT4B;NCBP1;CELF1;RBM39;AURKAIP1;TFIP11;SF3B3;SUPT4H1;CSTF3;SF3B2;SF3B1;DDX20;PDCD7;SF3A2;HNRNPC;LUC7L3;PRPF18;NONO
prerank,renal water homeostasis (GO:0003091),-0.2943158154146801,-0.8772088956491704,0.6470588235294118,0.8891532430858042,1.0,8/23,17.70%,RAB11FIP2;ADCY9;PRKACA;PRKAR1A;ADCY3;AQP4;ADCY8;RAB11A
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3716493642250138,0.8768139111046483,0.6217948717948718,0.8643719828945197,1.0,2/20,2.48%,LONP1;HSPA1A
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3491388491593132,0.876550150223916,0.6423357664233577,0.8644103234416034,1.0,9/28,16.55%,PAK1;HSPA1A;MECP2;RAC1;GIT1;RPS3;CLASP1;OCLN;FES
prerank,chemical homeostasis (GO:0048878),0.3035203237183641,0.8763150342611582,0.6556543837357052,0.8643967847829408,1.0,7/61,7.52%,PPARG;NEDD4L;ZBTB20;SLC4A7;FBXW7;ACOX3;SLC4A8
prerank,protein localization to cilium (GO:0061512),-0.27352846770263717,-0.8762161210029303,0.6534653465346535,0.8903522542822117,1.0,12/32,26.67%,ATP6V1D;ZNF423;IFT20;ARL6;TTC21B;RABEP1;ARL3;TULP2;TULP3;TCTN2;TUB;NPHP4
prerank,ncRNA catabolic process (GO:0034661),-0.2827102613054214,-0.8761540123457662,0.6319018404907976,0.8894627403283464,1.0,9/28,19.77%,XRN1;POP1;TRIR;EXOSC9;EXOSC5;DIS3L2;LIN28B;EXOSC10;EXOSC3
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.27538080252827757,-0.8761119586743938,0.6643109540636042,0.8885310754730081,1.0,7/33,11.94%,TJP1;GLUL;FGF2;EPN1;EPN2;JAK1;VEGFA
prerank,digestive tract development (GO:0048565),0.3309798208294774,0.8760412611655404,0.634453781512605,0.8644433622012552,1.0,5/33,13.36%,GLI1;NIPBL;CCDC39;KIT;PCSK5
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3518467743196628,0.876016634960848,0.6452554744525547,0.8640341835456853,1.0,4/26,7.72%,PRKAG2;ELOVL5;PRKAB2;ERLIN1
prerank,positive regulation of macroautophagy (GO:0016239),0.31258127905242894,0.8759524930543767,0.6469038208168643,0.8636953053829125,1.0,15/48,18.81%,UVRAG;PIP4K2A;WAC;RALB;PIP4K2B;SLC25A5;HTT;MAP3K7;PRKAA2;FYCO1;TBK1;SIRT1;VPS13D;BAG3;PINK1
prerank,regulation of DNA recombination (GO:0000018),0.33329693375809727,0.8758751762391612,0.6260623229461756,0.8633650578954906,1.0,7/32,16.30%,MRE11;MSH3;PPP4R2;MSH6;SETD2;SPIDR;KPNA2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3141486619339356,0.8755682923966178,0.632,0.8634632631770833,1.0,11/45,19.50%,BCL6;BTG2;BTG1;NABP1;ZFP36L2;TGFB1;WEE1;TRIM35;AURKAIP1;FOXC1;FZD3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3621344750681327,-0.8752473812736545,0.643979057591623,0.8894073429562965,1.0,9/12,41.43%,IFI27;TPR;UHMK1;PTPN14;NEDD4;RBM4;BMP4;AAAS;SIRT7
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.32894330798427723,0.8746092873627759,0.6557610241820768,0.8648894632704415,1.0,8/36,15.71%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;PHC3
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3163954597912881,-0.8743737557735928,0.6381766381766382,0.8903303354604893,1.0,3/20,6.10%,CHRM3;CHRM2;SETD3
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.25976807479333575,-0.8740899452828935,0.6736842105263158,0.8899628077134288,1.0,8/41,16.72%,TGFBR2;MEF2C;SMAD7;FGFR2;SOX4;TGFB2;PKP2;SOX11
prerank,regulation of interleukin-17 production (GO:0032660),-0.2782810466428879,-0.874071476829323,0.6711864406779661,0.8889850397352006,1.0,5/31,12.53%,VSIR;LY9;SLAMF6;NCKAP1L;TLR4
prerank,regulation of viral life cycle (GO:1903900),-0.303678309064638,-0.8740659801585093,0.6371681415929203,0.887981744293145,1.0,4/21,4.37%,HS3ST5;PPIA;KPNA6;TRIM5
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.35248505491949,-0.8740362266033308,0.6293532338308457,0.8870557779148691,1.0,2/12,8.94%,IGF1;IRS1
prerank,regulation of blood coagulation (GO:0030193),0.33896829063120887,0.8740128062486486,0.6221889055472264,0.8655466578848313,1.0,3/27,8.44%,ST3GAL4;FAP;EPHB2
prerank,sphingosine metabolic process (GO:0006670),0.3699498011873916,0.8737057178397247,0.622257053291536,0.8656900342645643,1.0,4/17,15.01%,ACER3;NAAA;SGPP2;SGPP1
prerank,positive regulation of endocytosis (GO:0045807),0.31720109425561005,0.8732830882511313,0.6397849462365591,0.8660437739952791,1.0,10/45,13.72%,STAP1;NEDD4L;CBL;GPC3;CDC42;CBLL1;HIP1;B2M;CLIP3;ANKFY1
prerank,protein neddylation (GO:0045116),0.3994467987234219,0.873253722479874,0.6310679611650486,0.865654030775274,1.0,3/13,11.52%,DCUN1D1;NEDD8;DCUN1D3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2839825445541147,-0.8727896266333904,0.6573426573426573,0.888919699876328,1.0,6/27,12.28%,PLA2G15;PNPLA8;SLC27A1;ABHD4;CHKA;PCYT2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.34286124883443325,0.8726635342274487,0.6253602305475504,0.8663146150360845,1.0,7/28,16.85%,LFNG;FBXW7;WWP2;AKT1;METTL3;TSPAN15;NIBAN2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.34816335507776425,-0.8725224737850836,0.6115288220551378,0.8884648260190289,1.0,3/13,5.75%,P2RY12;NLGN1;PFN1
prerank,leukotriene biosynthetic process (GO:0019370),0.38604684630272473,0.8723755676874904,0.6167471819645732,0.8663995965165461,1.0,2/14,6.71%,ALOX5AP;GGTA1
prerank,protein localization to phagophore assembly site (GO:0034497),0.41466891398093475,0.8721594917258758,0.6313131313131313,0.8663449544648752,1.0,5/11,21.64%,STX17;PACS2;WIPI2;ATG13;TRAPPC8
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3523920030190039,0.872078500901143,0.6340740740740741,0.8660284261256717,1.0,5/24,12.19%,ITCH;UBE2N;CYLD;TAB3;MAP3K7
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3760441348966386,0.8717323253861146,0.6090225563909775,0.8661988068809414,1.0,4/17,12.38%,MMGT1;EMC9;CAMLG;EMC10
prerank,regulation of cellular localization (GO:0060341),0.311660663606108,0.8714144212950947,0.6320754716981132,0.8663247992382016,1.0,7/46,12.63%,LRRK2;LYN;UNC13D;TRIM46;DVL3;DYNC1H1;ADCY5
prerank,sulfate transport (GO:0008272),0.39396742240074495,0.8713822623877725,0.6220735785953178,0.865937352288027,1.0,2/14,5.59%,RACGAP1;SLC25A30
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2978402090408921,0.8711888719537438,0.6565272496831432,0.8658322492300332,1.0,13/60,16.10%,KLF4;PKIB;FBXO4;HGF;PARM1;WRAP53;TNKS;MAP3K4;CHTF18;AURKB;MAPK1;TCP1;POLG2
prerank,protein prenylation (GO:0018342),-0.38153226318288685,-0.8711583775479838,0.6359223300970874,0.8904990235977922,1.0,5/10,30.56%,PGGT1B;FNTB;CHML;RCE1;FNTA
prerank,atrioventricular valve development (GO:0003171),0.38662586554493117,0.8707628208834264,0.6353135313531353,0.8662015352840142,1.0,2/14,2.93%,GJA5;BMPR2
prerank,DNA damage checkpoint signaling (GO:0000077),0.3445458809461293,0.8707414884911332,0.6383601756954612,0.8657967978983854,1.0,10/28,18.68%,CDC5L;CEP63;CLOCK;DOT1L;BRIP1;MAP3K20;DONSON;HUS1;RAD17;CHEK2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2737872992854035,0.8706563299704279,0.70662100456621,0.8655047735514595,1.0,10/117,9.86%,HLCS;KYNU;PPARG;ME2;CD36;ACOT11;ACOT2;NAAA;MSMO1;DLD
prerank,response to X-ray (GO:0010165),0.384947937016755,0.8700602333723909,0.601010101010101,0.8661565528455304,1.0,3/14,12.21%,NIPBL;ANXA1;XRCC4
prerank,ribosomal subunit export from nucleus (GO:0000054),0.39223647950151447,0.8698333411659294,0.6045751633986928,0.8661432971258606,1.0,1/13,1.09%,XPO1
prerank,protein import into mitochondrial matrix (GO:0030150),0.3761707535925976,0.8697852616527493,0.6302250803858521,0.8657839669825642,1.0,5/18,14.20%,GRPEL2;DNAJC19;TIMM21;TOMM40;TIMM50
prerank,positive regulation of protein maturation (GO:1903319),-0.3639308975418213,-0.86925079446427,0.631336405529954,0.8936586023614829,1.0,3/11,14.70%,ADAM8;SOX4;CCBE1
prerank,histone H3-K9 demethylation (GO:0033169),0.40495461831081253,0.869232454455581,0.6306620209059234,0.8663486270114797,1.0,2/11,7.21%,KDM7A;KDM3B
prerank,regulation of muscle cell differentiation (GO:0051147),0.3280098013001916,0.868782300479409,0.6657223796033994,0.8667214271293772,1.0,7/31,11.98%,CTNNA1;CDC42;MAPK14;MAPK12;HDAC9;ID2;MEGF10
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4127473983194303,0.868715548571585,0.6260720411663808,0.866410405000058,1.0,1/10,3.69%,GPR35
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.2931399756370509,0.8686135740465137,0.6683804627249358,0.8661543707829923,1.0,7/66,5.44%,RUNX3;MARVELD3;CASK;FBXW7;SYNJ2BP;STAT1;CAV2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.30817777498509097,-0.8682728205777258,0.6575342465753424,0.8948636922394037,1.0,5/19,13.74%,TGFBR2;ACVR1;SLIT3;SOX4;TGFB2
prerank,regulation of neurogenesis (GO:0050767),0.302912658949753,0.8681670494418956,0.6649417852522639,0.8665481419092347,1.0,9/55,12.71%,IL1B;SORL1;IL6;OPRM1;B2M;SPEN;NAP1L1;REST;RGS14
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3882873331944744,0.8681157873765603,0.6222596964586846,0.866203493822249,1.0,1/12,1.34%,STX11
prerank,response to hexose (GO:0009746),-0.2919555650840927,-0.8680650190076301,0.6676470588235294,0.8942963680972648,1.0,6/25,18.05%,PFKL;EIF2B5;EIF2B4;SLC2A5;GPLD1;TCF7L2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.31485488230760117,0.8679032629974589,0.6357243319268636,0.8661530297452796,1.0,14/42,20.27%,GATAD2B;RBBP4;SMARCA5;ACTR6;SMARCE1;MBD2;CHD4;SMARCC2;SRCAP;INO80;HDAC1;ACTB;PBRM1;HNRNPC
prerank,regulation of intracellular protein transport (GO:0033157),0.3294139980588938,0.8675919947503932,0.6400560224089635,0.8662764791028539,1.0,6/32,14.51%,LCP1;GCC2;BCAS3;PTPN1;TGFB1;RAB29
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3250813660524168,0.8673513497066014,0.6394557823129252,0.8663029783404941,1.0,9/35,13.12%,PPP1R12A;CD300A;CRY2;PPP1R15A;PPP1R2;FKBP1B;PPP1R15B;HTT;PPP6R2
prerank,cardiac muscle contraction (GO:0060048),0.32654217929887597,0.8673063920352913,0.6439499304589708,0.8659449033136495,1.0,3/34,3.70%,TNNC1;KCNQ1;MYL4
prerank,cellular response to unfolded protein (GO:0034620),0.34055424051619104,0.8672569968874354,0.6221264367816092,0.8655877051813384,1.0,10/26,20.03%,HSPA1A;ERN1;TM7SF3;DAXX;PTPN1;HSPA9;HSPD1;BAG3;HSPA5;RHBDD1
prerank,primary miRNA processing (GO:0031053),0.41370454449175337,0.8670846567643985,0.6333907056798623,0.8654588210584613,1.0,3/10,13.40%,DGCR8;SRRT;METTL3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.385499381024111,0.866904961253779,0.6456310679611651,0.8653509197349507,1.0,6/15,18.67%,CHST12;NCAN;UST;CSGALNACT1;VCAN;DSEL
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3715644090823204,-0.8666809425712951,0.6325,0.8963045602074463,1.0,5/11,28.43%,ATP6AP1;ATP6V0D1;ATG7;FAS;CAV1
prerank,pancreas development (GO:0031016),0.400463852821758,0.866611316951244,0.6088379705400983,0.8654647430952991,1.0,3/12,16.74%,SELENOT;CCDC39;PROX1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.27778652353802163,-0.8664736422450906,0.6700680272108843,0.8957265932433899,1.0,11/30,24.30%,FHIT;DDX5;MYO6;PYCARD;MYBBP1A;PPP1R13B;JMY;SESN2;ACER2;MDM4;HINT1
prerank,negative regulation of protein kinase activity (GO:0006469),0.2826090599226411,0.8658139733888139,0.6682408500590319,0.8664751200755604,1.0,17/88,15.33%,PTPRC;PTPRO;PRKAG2;SORL1;PRKRIP1;PDPK1;PAK2;GSKIP;PTPN1;DBNDD2;TAF7;SH3BP5;AKT1;MVP;GSTP1;DUSP26;SPRED1
prerank,response to laminar fluid shear stress (GO:0034616),0.4171344333539813,0.8656861393980001,0.6483333333333333,0.8662576937675845,1.0,5/10,15.01%,KLF4;NFE2L2;MAP2K5;SREBF2;ASS1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.33551771956692183,0.8656256199513329,0.6657381615598886,0.8659278232879577,1.0,8/33,11.32%,MAP3K5;SETX;NFE2L2;IL6;RPS3;ANXA1;RIPK1;NET1
prerank,negative regulation of cartilage development (GO:0061037),-0.351093729857949,-0.8654637121184627,0.6275510204081632,0.8969582527383757,1.0,8/13,43.93%,TGFBR1;EFEMP1;SOX9;CHADL;GREM1;PTHLH;WNT9A;SNAI2
prerank,amyloid fibril formation (GO:1990000),0.30396214629117335,0.8653756118056126,0.6779431664411367,0.8659163352648284,1.0,13/51,16.13%,CD36;SORL1;H3-3A;HSPG2;TGFBI;TSPAN14;TSPAN33;RIPK1;B2M;APP;USP9X;TSPAN15;TSPAN5
prerank,glucose metabolic process (GO:0006006),-0.2408797726457075,-0.8650203478354097,0.7397260273972602,0.8968421297669799,1.0,14/58,16.19%,APOD;GOT1;PPARGC1A;AKR1A1;PGK1;ATF4;GAA;PCK2;CRTC2;ENO2;SLC25A11;BRAT1;PER2;PGAM1
prerank,regulation of isotype switching (GO:0045191),0.39283550959550523,0.864989408626071,0.6432078559738135,0.8661568325545903,1.0,3/14,11.02%,MAD2L2;SLC15A4;KMT5B
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.38833201433266923,0.8649007672554241,0.6173469387755102,0.8658624839365453,1.0,1/13,0.53%,SP100
prerank,negative regulation of cell projection organization (GO:0031345),0.30456630218432656,0.8648630268511358,0.6316489361702128,0.8654874007864446,1.0,8/48,8.64%,FYN;PTPRO;RAPGEF2;PTEN;PRNP;CIB1;PAQR3;CBFA2T2
prerank,cilium organization (GO:0044782),0.2603207645306893,0.8647454282966474,0.7585470085470085,0.8652676017164241,1.0,34/210,15.26%,CDC14A;ATAT1;ACTR3;TSGA10IP;FOXJ1;EXOC6;OCRL;EHD2;RP2;RFX3;ARF4;ACTR2;FLNA;IFT140;GBF1;KIF24;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;CFAP61;PTPDC1;TTC17;ABCC4;IQCB1;CFAP54;CFAP70;TXNDC15;NUDCD3;EHD1;DYNLT2B;DISC1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3517838291127191,0.8644908832927896,0.6163793103448276,0.8653187123583522,1.0,5/22,13.81%,RGS2;MTPN;IL6ST;SMAD4;ROCK1
prerank,regulation of neuron projection arborization (GO:0150011),-0.33660424116672494,-0.8641504547735117,0.6338383838383839,0.8976797320225804,1.0,3/15,3.73%,MYO9A;GRIP1;DLG4
prerank,regulation of neutrophil migration (GO:1902622),0.4123602601697832,0.8640526034406061,0.6204506065857885,0.8656706597974536,1.0,4/10,15.04%,RAC2;RAC1;SLAMF8;RHOG
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.24068768200057378,-0.8638026926195997,0.7244444444444444,0.8973978734058032,1.0,19/53,26.35%,EYA4;DDX5;ERCC6;FXR1;CEBPG;TMEM161A;FXR2;TIGAR;PCNA;DHX9;NPAS2;BRCA1;FBH1;HMGA2;FGF10;RNF8;CCAR2;BABAM2;MYC
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.36403084057008883,-0.8637441471028755,0.6511056511056511,0.8965078336655409,1.0,1/11,0.72%,MEF2C
prerank,neural crest cell migration (GO:0001755),-0.26433196932872016,-0.8635463073235239,0.6950354609929078,0.8959130455855836,1.0,6/36,8.32%,ERBB4;NRP1;SEMA3D;SEMA3E;HTR2B;SEMA6D
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.3965310922337713,0.8634829544418454,0.6688851913477537,0.8662689019552451,1.0,2/12,5.50%,CELSR1;ZDHHC7
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.32135637775247977,0.8634046913183797,0.6502242152466368,0.8659839844297369,1.0,6/33,9.32%,PKN1;AXIN1;H3-3A;CBFB;LATS1;NCOA2
prerank,cochlea morphogenesis (GO:0090103),0.4239264872389583,0.8633695940114323,0.6573913043478261,0.8656034218458969,1.0,2/10,13.68%,MYO3B;TIFAB
prerank,regulation of Notch signaling pathway (GO:0008593),0.2865785620310887,0.8632274996492993,0.6807228915662651,0.8654311691039991,1.0,18/76,16.85%,STAT3;LFNG;FBXW7;SYNJ2BP;RBPJ;TSPAN14;IL6ST;WWP2;AKT1;METTL3;SREBF2;KAT2B;CREBBP;TSPAN15;POGLUT1;MAML1;TSPAN5;NIBAN2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.323054539338816,0.8625948299510648,0.6685082872928176,0.8661362588613272,1.0,7/36,10.51%,TRAF1;BCL2L14;SGMS1;CSNK2A2;CSNK2A1;RPS3;CYLD
prerank,clathrin-dependent endocytosis (GO:0072583),0.3421311012077524,0.8621947931128047,0.6421052631578947,0.8664544506027047,1.0,9/26,17.85%,INPP5F;PICALM;AP2A2;LMBRD1;AP2B1;ITSN2;CANX;AP2S1;GPR107
prerank,neuron fate commitment (GO:0048663),-0.3366130910262387,-0.861916309929382,0.6466346153846154,0.8983307390773972,1.0,1/14,1.22%,TGFBR1
prerank,establishment of vesicle localization (GO:0051650),0.3646745721360189,0.8618145784388592,0.6368,0.8667204175171453,1.0,5/18,14.64%,KIF5B;SYNJ1;SNAPIN;LIMK2;KIF5A
prerank,cellular response to glucagon stimulus (GO:0071377),0.37712136773580135,0.8614986607972279,0.6442307692307693,0.8668642332498084,1.0,4/17,12.63%,CYSLTR2;PRKAR2A;ADCY7;ADCY5
prerank,positive regulation of protein import (GO:1904591),0.33273763950621016,0.8614665123005102,0.6390870185449358,0.8664748189738543,1.0,11/30,18.44%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.4038562317181384,0.8614553648009876,0.6472602739726028,0.8660556123183955,1.0,3/11,7.55%,RAPGEF2;AFDN;F11R
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4064296681510796,0.8612006034131462,0.6310344827586207,0.8660713137127807,1.0,1/11,1.24%,BCL3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3534865513123596,0.8611238574411657,0.6342943854324734,0.8657738678823108,1.0,3/21,8.44%,CYRIB;CD2AP;EPHB2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.304831825065945,-0.8609927829150346,0.6788732394366197,0.8992584310449617,1.0,13/20,42.70%,FKBP5;PPIA;CWC27;PPIE;PPID;FKBP1A;PPIF;PPIH;PPIL6;NKTR;PPIG;PPIL3;PPIC
prerank,cellular response to dsRNA (GO:0071359),0.3872708054734628,0.8606770276119938,0.6462809917355372,0.8661589334884551,1.0,4/15,13.80%,IFIH1;RALB;PQBP1;IFIT1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3347843164013075,0.8605947100573197,0.643609022556391,0.8658627488530669,1.0,9/25,23.61%,EXT1;B3GALT2;CSGALNACT1;HS2ST1;NDST2;EXT2;B3GALT5;B3GNT2;NDST4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3098880774985904,-0.8605908178477187,0.651595744680851,0.899123661915883,1.0,9/19,24.58%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2;NANS;GNPNAT1;MPI
prerank,sister chromatid segregation (GO:0000819),-0.2700203880241877,-0.860362732911203,0.7084639498432602,0.8986191430045284,1.0,20/31,40.87%,KLHL22;ZW10;SMC1A;RAN;KIF18A;CENPK;NCAPG2;NDC80;NSL1;CDCA8;DSN1;KIFC1;MIS12;TOP2B;SPAG5;SGO1;ZWINT;PLK1;TUBG1;KIF18B
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.39268931669512236,0.8601008582443195,0.6410714285714286,0.8663126206648809,1.0,5/13,12.02%,WFS1;PPP1R15A;PTPN1;PPP1R15B;ATF6B
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.30529812311493426,-0.8598708946178168,0.6807909604519774,0.8986549404723189,1.0,8/19,27.88%,MTHFD2L;MTHFS;DHFR;SHMT2;FPGS;ALDH1L1;MTHFD1;SLC46A1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.33715297470496863,0.8598348862415041,0.6578947368421053,0.8663567435218412,1.0,3/30,3.31%,KCNE3;NEDD4L;KCNQ1
prerank,regulation of translational initiation (GO:0006446),-0.23077049226326532,-0.859258491437905,0.7391304347826086,0.8989243909876085,1.0,19/63,19.24%,LARP1;ATF3;EIF2AK4;CDC123;KLHL25;IMPACT;ATF4;EIF5;PAIP2B;EIF2B5;NPM1;EIF4G1;EIF4H;GLE1;TPR;DDX3X;HABP4;EIF3B;UHMK1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2869618906415341,0.8591107302058298,0.7019464720194647,0.86724158115695,1.0,11/76,11.89%,HCK;PRKCE;STAP1;CDC42;CARMIL1;PTK2B;KATNBL1;BCAS3;SNX9;VASP;DYNC1H1
prerank,positive regulation of ion transport (GO:0043270),0.3135491223937271,0.8589159444345134,0.6684420772303595,0.8671458856681973,1.0,7/48,6.84%,CCR1;KIF5B;ATP2B1;GDNF;ADRA2A;STIM2;WFS1
prerank,glycerophospholipid metabolic process (GO:0006650),0.28901730340497267,0.8588036353721625,0.7163636363636363,0.8669090498332854,1.0,11/75,9.48%,PLA1A;IP6K3;PRDX6;ABCA3;GPCPD1;PAFAH1B1;PLCB1;SYNJ1;CPNE1;FAR1;PIGF
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3252777783179347,0.8586898724370156,0.6930555555555555,0.8666679479373854,1.0,9/33,16.78%,NGF;CACNA1A;BCR;CEL;SLC4A8;GRID1;LRP8;RELN;LRRC4
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.29313482074830943,-0.8585215926650794,0.6614420062695925,0.8994808580005761,1.0,13/24,32.66%,ABCG2;FLVCR1;FECH;ALAS1;CPOX;COX10;FXN;SLC25A38;PGRMC1;ABCB10;HMBS;UROD;ATP5IF1
prerank,cardiac muscle cell development (GO:0055013),0.35694358629845413,0.8585206113707764,0.6318181818181818,0.8665261557826123,1.0,1/20,1.08%,PDLIM5
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25774201699762767,0.8579638531257755,0.7847439916405433,0.8670921235079879,1.0,67/241,20.27%,RSRC1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;BUD31;SRSF10;BUD13;DDX41;DNAJC8;FIP1L1;RBM10;LSM5;MAGOHB;DDX46;PRPF3;SF3B6;RBM22;SRSF4;DHX8;SLU7;YTHDC1;NUDT21;RBM15;SPEN;CACTIN;SRRT;FRG1;PQBP1;DDX23;SNRPA1;SF3A1;METTL3;SYNCRIP;AQR;U2SURP;GEMIN7;CPSF3;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;PABPC1;PPWD1;SYF2;TFIP11;SF3B3;CWF19L1;RBM41;CSTF3;SF3B2;SF3B1;UPF3B;WDR33;PDCD7;CDC40;SMNDC1;SF3A2;HNRNPC
prerank,positive regulation of macrophage activation (GO:0043032),0.3703031652134551,0.8578440151015831,0.6567656765676567,0.8668552926866399,1.0,5/17,18.03%,STAP1;IL33;THBS1;HSPD1;MMP8
prerank,axonal fasciculation (GO:0007413),-0.3488361660720931,-0.857769737046028,0.618925831202046,0.9000924275704498,1.0,3/12,9.05%,CNTN4;CDK5R1;ARHGAP35
prerank,regulation of receptor recycling (GO:0001919),0.3689353784661412,0.8577457751942208,0.635483870967742,0.8665967191551678,1.0,2/16,4.12%,ANXA2;INPP5F
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3337128544539684,0.8572813745853874,0.6690647482014388,0.8670194878410555,1.0,4/32,13.26%,CXCL10;FAM3A;RNASE6;RPL30
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3034975633060382,0.8569590853627607,0.6635883905013192,0.8671942894149467,1.0,9/50,15.26%,GLI1;HERC4;GPC3;RAB34;FBXL17;TUBD1;VCP;TXNDC15;CREBBP
prerank,carbohydrate derivative transport (GO:1901264),0.3651156322196981,0.8560668786335222,0.6388467374810318,0.8683765398437804,1.0,4/18,14.77%,SCARB1;SLC15A4;SLC10A7;ABCG1
prerank,sodium ion import across plasma membrane (GO:0098719),0.36957819041494455,0.8560461998808616,0.6301369863013698,0.867981112298106,1.0,2/17,3.90%,SLC9A7;HCN4
prerank,inositol lipid-mediated signaling (GO:0048017),0.3062710046919447,0.8559177354105064,0.7082262210796915,0.8677769399133233,1.0,9/50,10.65%,NGF;PIK3C2A;INPP5F;KCNH1;PLCB1;PLCD4;EZR;RHOA;PIK3CA
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.334910521717518,-0.8550647405916262,0.6666666666666666,0.9048520073172388,1.0,3/15,7.36%,KCNJ2;ATP1B1;KCNN2
prerank,protein maturation (GO:0051604),-0.21557553313109837,-0.8548017318589678,0.8201438848920863,0.9044209532188741,1.0,31/95,25.09%,NAA50;MMP16;NAA40;MMS19;METAP2;PSEN2;STUB1;FURIN;LONP2;MMP14;AFG3L2;PCSK1;BACE1;PCSK7;DNAJB11;CIAO1;PSENEN;LMF2;AEBP1;LMF1;ECE1;PTCH1;CLN3;CPE;PCSK2;EEF1AKMT4-ECE2;NAA10;APH1A;BOLA2;TYSND1;NDUFAB1
prerank,cellular response to inorganic substance (GO:0071241),0.35270762596272376,0.8544397637505801,0.6721556886227545,0.8699766689820626,1.0,4/21,12.80%,DPEP1;ADCY10;ATRX;SPIDR
prerank,folic acid metabolic process (GO:0046655),-0.3097252180734527,-0.8533237257047878,0.6890756302521008,0.9065129358049995,1.0,8/18,27.88%,MTHFD2L;MTHFS;DHFR;SHMT2;FPGS;ALDH1L1;MTHFD1;SLC46A1
prerank,tRNA aminoacylation (GO:0043039),-0.26448737587002324,-0.8528865220571542,0.7226277372262774,0.906433213144821,1.0,16/37,26.71%,YARS1;LARS1;NARS1;WARS2;LARS2;WARS1;GATB;GATC;IARS1;DARS1;KARS1;PPA2;FARSA;RARS1;CARS1;QRSL1
prerank,RNA metabolic process (GO:0016070),0.2681406282641418,0.852365818742441,0.7236693091732729,0.8732698946012346,1.0,27/127,15.83%,FASTKD1;RBPMS;GTF2F2;SND1;POLR2C;NUFIP1;RBMS1;XRN2;RNASEH2C;SETX;RBMS2;RNASE1;TENT2;DHX8;CELF2;PAPOLG;RNASE6;DEDD2;METTL3;RNASEH2A;RNASEH1;PNPT1;SYNCRIP;PAPOLA;NCBP1;SIDT2;RBM39
prerank,positive regulation of synaptic transmission (GO:0050806),0.28608852527828066,0.8522726880104371,0.7224938875305623,0.8730026708988282,1.0,3/72,3.56%,CCR2;CRHR2;NPTN
prerank,regulation of actin filament-based movement (GO:1903115),-0.3651993560653508,-0.85184704646252,0.6707317073170732,0.9076892492519569,1.0,6/10,45.33%,ANK2;PDPN;PDE4D;MYBPC3;PLN;STC1
prerank,regulation of cellular response to heat (GO:1900034),-0.216089953900906,-0.8518086610702119,0.8087431693989071,0.9067857792107613,1.0,30/77,27.55%,RPTOR;NUP54;CD34;NUP133;BAG4;NUP155;BAG1;NUP188;DNAJC2;RANBP2;PTGES3;SEC13;NUP85;HSBP1;NUP42;TPR;CAMK2A;NUP35;AKT1S1;HSP90AB1;CRYAB;NUP37;HSPH1;BAG5;POM121;CCAR2;DNAJB6;MLST8;HSP90AA1;DNAJB1
prerank,autophagy of nucleus (GO:0044804),-0.31061499320953295,-0.8514845541025224,0.6851851851851852,0.9064622958742474,1.0,6/16,20.63%,ULK2;ATG12;ATG9A;ATG7;WDR45;ATG2A
prerank,myofibril assembly (GO:0030239),-0.24761597928036824,-0.8514808663885107,0.7786561264822134,0.905479507526789,1.0,6/42,21.92%,CAPN3;CFLAR;TMOD1;ACTN2;TMOD2;FHOD3
prerank,myelination in peripheral nervous system (GO:0022011),0.38419419226546536,0.8509306894364035,0.6371100164203612,0.8749269179851392,1.0,2/13,3.41%,ADGRG6;PRX
prerank,mitotic spindle assembly (GO:0090307),0.3102073638978489,0.8508269381791299,0.6517615176151762,0.8746894527600648,1.0,10/42,16.04%,RACGAP1;KIF23;FLNA;RHOA;STAG1;KIF3B;STAG2;CLASP1;AURKB;KPNB1
prerank,oligodendrocyte differentiation (GO:0048709),-0.30321792405954157,-0.8507817226738229,0.6602209944751382,0.9059256613141178,1.0,8/19,24.20%,PTPRZ1;CDK5;EIF2B5;EIF2B4;TPPP;NSUN5;SOX13;SOX9
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.32092751534354386,0.8506582646034452,0.6731843575418994,0.8745346983563117,1.0,6/35,10.77%,CBL;PICALM;ARF1;RAC1;HIP1;B2M
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.315034065215331,0.8506453425749977,0.6461748633879781,0.8741124451183045,1.0,9/36,14.05%,PPP3CA;PLCB1;GNB1;NLK;MAP3K7;PDE6B;GNG2;TNRC6B;TNRC6A
prerank,defense response to fungus (GO:0050832),0.36803612503069183,0.8503854642081501,0.6420545746388443,0.8741313525141869,1.0,2/17,9.84%,PLCG2;FAM3A
prerank,protein stabilization (GO:0050821),0.2612267660938119,0.8503380620492014,0.7684782608695652,0.8737781825742389,1.0,42/168,18.81%,CREB1;RPL5;ATF7IP;HSPA1A;RABL3;TAF9;NAA16;FBXW7;SUMO1;PTEN;STK4;WFS1;FLNA;CCNH;STX12;CREBL2;NAA15;HIP1;CAMLG;RTN4;NLK;TSPAN1;DVL3;HYPK;MORC3;RPL11;USP7;USP9X;TAF1;TCP1;PPIB;RASSF2;HSPD1;EFNA1;BAG3;NCLN;ATP1B2;PRKCD;PIN1;CHEK2;STK3;PINK1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.282746183429435,0.8495133917835188,0.7090909090909091,0.8747973268059701,1.0,22/80,16.79%,TBC1D10C;RAB7A;RAB7B;SNX1;VPS53;RAB6A;TMEM87A;STX6;GCC2;RHOBTB3;GBF1;STX5;PIKFYVE;TBC1D5;SNX3;ANKFY1;STX16;EVI5;RAB29;SNX12;DENND5A;RAB9B
prerank,phosphatidic acid metabolic process (GO:0046473),-0.246463112670059,-0.8491533301388451,0.7521739130434782,0.9081693738322658,1.0,9/48,11.75%,PLD1;DGKZ;LPCAT1;SLC27A1;PLA2G4A;DGKQ;GPAM;DDHD2;ABHD4
prerank,phosphate ion transport (GO:0006817),-0.31293252904884705,-0.8485671227904446,0.7080103359173127,0.9084335182663602,1.0,4/16,12.25%,SLC37A2;SLC25A3;SLC25A11;SLC25A14
prerank,positive regulation of protein processing (GO:0010954),-0.310026225538093,-0.8482520010168866,0.7086834733893558,0.9080988828339049,1.0,3/19,8.19%,PLGRKT;ADAM8;HPN
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3142955265698947,0.8481346272681383,0.6730506155950753,0.8767957126967671,1.0,8/38,17.33%,SP100;GPX1;TMC8;ICAM1;RIPK1;LGALS3;THBS1;TRAF2
prerank,negative regulation of leukocyte migration (GO:0002686),0.4128792641743843,0.8480516823913278,0.6666666666666666,0.8764957321532992,1.0,2/10,9.78%,CD300A;SLAMF8
prerank,negative regulation of wound healing (GO:0061045),0.3275818847639933,0.8478768876936968,0.6714082503556188,0.8763559642995582,1.0,4/28,7.31%,CASK;CRK;PTEN;PHLDB2
prerank,neuron projection fasciculation (GO:0106030),-0.3588313745483047,-0.8476228381070506,0.6400966183574879,0.908359196502475,1.0,3/10,9.05%,CNTN4;CDK5R1;ARHGAP35
prerank,regulation of chromatin organization (GO:1902275),0.3763151599050082,0.8473039674319877,0.6610455311973018,0.8769838321342105,1.0,5/14,13.91%,SETD5;TLK2;METTL4;PARG;TLK1
prerank,substantia nigra development (GO:0021762),-0.2520505067565276,-0.8472046784803637,0.7534722222222222,0.9082517047529078,1.0,11/37,19.33%,BASP1;PLP1;DYNLL1;CKB;ATP5PF;CALM1;CCDC14;INA;NDRG2;FGF9;YWHAH
prerank,negative regulation of interleukin-1 production (GO:0032692),0.34373243484748994,0.8466541606838504,0.6430678466076696,0.8776763595795999,1.0,5/23,14.83%,FFAR4;CARD16;GIT1;NLRP3;GSTP1
prerank,protein homooligomerization (GO:0051260),0.27138963763029833,0.8463092399322149,0.7261072261072261,0.8778778050554147,1.0,17/114,14.90%,CARD11;SAMHD1;ALOX5AP;UPB1;RNF213;PRMT8;PDCD6IP;SPAST;SLC1A5;ATL3;NLRC4;B2M;LETM1;GBP5;PNPT1;EHD1;ATL1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2927092141218258,-0.8461865135860994,0.6712707182320442,0.9094344812615369,1.0,2/21,3.16%,LRP6;CTNNB1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2775000174318063,0.8461442582551244,0.731535756154748,0.877748003021302,1.0,19/86,16.95%,HCK;PRKCE;PAK1;GPX1;CARMIL1;PTK2B;KATNB1;RAC1;RPS3;SNX9;VASP;APP;CLASP1;OCLN;STMN2;RB1;FES;PROX1;PSEN1
prerank,aminoglycan biosynthetic process (GO:0006023),0.295015339654672,0.8458889626756156,0.6957671957671958,0.8777669801842745,1.0,8/49,12.68%,EXT1;GPC3;HSPG2;PXYLP1;XYLT1;GALNT5;SDC3;B3GALT2
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.3108362033634289,-0.8456633496431628,0.675,0.9095441489538392,1.0,5/17,20.31%,SORT1;FURIN;NR1H2;APOC1;LMF1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2526401488571027,0.8453991781243111,0.8029045643153527,0.8781724330179482,1.0,71/264,20.41%,CDK13;RSRC1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;BUD31;SRSF10;BUD13;DDX41;DNAJC8;FIP1L1;RBM10;LSM5;MAGOHB;DDX46;COIL;PRPF3;SF3B6;RBM22;SRSF4;DHX8;SLU7;YTHDC1;NUDT21;RBM15;SPEN;CACTIN;SRRT;FRG1;PQBP1;DDX23;SNRPA1;SF3A1;METTL3;SYNCRIP;AQR;U2SURP;GEMIN7;CPSF3;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;PABPC1;PPWD1;SYF2;TFIP11;SF3B3;CWF19L1;RBM41;CSTF3;SF3B2;SF3B1;DDX20;UPF3B;WDR33;PDCD7;CDC40;SMNDC1;SF3A2;HNRNPC;SNUPN
prerank,regulation of activated T cell proliferation (GO:0046006),0.31754155803842526,0.845165232081705,0.6757142857142857,0.8781650318557452,1.0,6/30,14.65%,IL27RA;RC3H1;PRNP;RPS3;ICOSLG;IL18
prerank,ncRNA export from nucleus (GO:0097064),-0.2585764459232378,-0.8451409040489725,0.7265917602996255,0.9096491552630325,1.0,14/36,19.43%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;NPM1;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,regulation of neuron differentiation (GO:0045664),0.2808372030217624,0.8449101155267801,0.7397094430992736,0.8781753902418156,1.0,3/76,1.01%,LRRK2;TIAM1;NGF
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.339196150114126,-0.844909366479848,0.6692307692307692,0.9091264786792768,1.0,4/13,15.22%,SNX5;IRS1;PRKCZ;GKAP1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.25193027597894835,-0.8448815180701394,0.7581967213114754,0.9081966460541534,1.0,5/41,7.25%,PTGS1;MGLL;DAGLA;PNPLA8;PLA2G4A
prerank,icosanoid biosynthetic process (GO:0046456),-0.3779982211583505,-0.8448540271318954,0.6683168316831684,0.9072677215915053,1.0,3/10,7.25%,LTA4H;LTC4S;PLA2G4A
prerank,positive regulation of cell development (GO:0010720),-0.2699332846938256,-0.844821499856612,0.7368421052631579,0.9063474100216095,1.0,8/31,19.65%,CX3CR1;NUMB;ATP6AP1;TGM2;SNW1;SOX11;TRIM32;TYROBP
prerank,regulation of macrophage differentiation (GO:0045649),-0.31841527535600467,-0.8447066626783759,0.6790450928381963,0.9056259676006588,1.0,2/15,3.39%,C1QC;CSF1
prerank,apoptotic cell clearance (GO:0043277),0.33086260207689994,0.8447006252364749,0.6714905933429812,0.8780965286731857,1.0,9/30,15.65%,RARA;RAC2;SCARB1;XKR4;RAC1;ANXA1;MEGF10;RHOG;THBS1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.26627118743837086,-0.843858664650777,0.6996466431095406,0.9054049144549242,1.0,13/32,19.43%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,tRNA export from nucleus (GO:0006409),-0.26627118743837086,-0.843858664650777,0.6996466431095406,0.9054049144549242,1.0,13/32,19.43%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,regulation of vacuole organization (GO:0044088),0.35111219815173966,0.8436845789524937,0.6527131782945736,0.8794571987998333,1.0,4/20,11.09%,ANXA2;MTMR3;PIKFYVE;SCARB2
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3353758300969816,-0.8433935132632655,0.6579634464751958,0.9053873868539731,1.0,6/14,29.68%,RMND1;RCC1L;C1QBP;FASTKD3;MPV17L2;COA3
prerank,regulation of osteoblast proliferation (GO:0033688),-0.3137895672774553,-0.843276037999017,0.6730245231607629,0.9046328390454758,1.0,3/17,6.21%,NELL1;TMEM119;FGFR2
prerank,diol biosynthetic process (GO:0034312),0.3640340949205323,0.8431532855760152,0.6672131147540984,0.8799942402344063,1.0,1/15,1.59%,ACER3
prerank,regulation of G0 to G1 transition (GO:0070316),0.3149600854989128,0.8421220018262622,0.6862745098039216,0.8813412977420458,1.0,8/38,15.71%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;PHC3
prerank,negative regulation of nuclear division (GO:0051784),-0.35021300562672125,-0.8417207907131651,0.6620370370370371,0.9067396459605915,1.0,6/11,42.78%,TOM1L1;FBXO5;TOM1L2;BMP4;CHEK1;BMP7
prerank,regulation of cholesterol transport (GO:0032374),-0.2928293963103884,-0.8416966949908221,0.6853333333333333,0.9058257123560329,1.0,7/20,19.90%,LRP1;ABCB4;TTC39B;ARV1;NR1H2;APOC1;OSBPL6
prerank,mitochondrial protein processing (GO:0034982),0.39741786014194735,0.8415489342277092,0.6677577741407529,0.8819191738605099,1.0,5/11,19.63%,IMMP2L;PMPCA;YME1L1;MIPEP;IMMP1L
prerank,histone H2A ubiquitination (GO:0033522),0.3607109191039624,0.8413395347403622,0.6591276252019386,0.8818366842511125,1.0,3/17,7.93%,DTX3L;RYBP;UBR2
prerank,positive regulation of dendrite development (GO:1900006),-0.3645742927208984,-0.8409702417885471,0.6583541147132169,0.9062499335468506,1.0,2/10,14.55%,PTN;DAB2IP
prerank,cilium assembly (GO:0060271),0.2492395466986404,0.8409660781675392,0.8307372793354102,0.8820491193521647,1.0,53/297,17.90%,CDC14A;ATAT1;ACTR3;SDCCAG8;CNTRL;FOXJ1;EXOC6;HAUS8;TBC1D32;OCRL;EHD2;RP2;SPATA6;RFX3;ARF4;ACTR2;CEP63;FLNA;PAFAH1B1;HAUS1;IFT140;GBF1;DCTN3;KIF24;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;PTPDC1;ABCC4;DYNC1H1;CCDC39;IQCB1;CFAP54;HAUS3;CFAP70;CLASP1;TXNDC15;NUDCD3;EHD1;DYNLT2B;DISC1;EXOC2;TNPO1;DYNC1I2;CEP135;BBS10;ASAP1;EHD3;CC2D2A;LZTFL1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3379188102245436,-0.8407118843994643,0.6532438478747203,0.9057910350099255,1.0,3/11,32.83%,TGFB2;DDC;MOXD1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2612856039756138,-0.8405627362983371,0.73,0.905123965238657,1.0,2/36,0.83%,OPHN1;FHIT
prerank,triglyceride catabolic process (GO:0019433),0.3519416997887839,0.8401923182402133,0.6752655538694993,0.8829641958038562,1.0,1/19,3.29%,FABP7
prerank,autophagosome assembly (GO:0000045),0.29433923840598136,0.8397885180118191,0.7137254901960784,0.883272081962075,1.0,17/52,21.87%,RAB19;RAB7A;STX17;ATG5;STX12;PACS2;WIPI2;VMP1;RB1CC1;AMBRA1;BECN1;ATG13;RAB43;ULK1;GABARAPL1;TRAPPC8;SMURF1
prerank,heart morphogenesis (GO:0003007),-0.2380573831309477,-0.839545506268134,0.8026315789473685,0.9061885090498474,1.0,7/50,13.74%,CHD7;TGFBR1;FLRT2;ACVR1;HTR2B;VEGFA;TGFB2
prerank,positive regulation of cell cycle (GO:0045787),0.28499539768508103,0.8395300087967146,0.7166882276843467,0.8833039039038765,1.0,15/62,16.74%,RARA;ANKRD17;EIF4EBP1;CCND3;CCND1;ADAM17;PKN2;APP;PSMD10;CCND2;AKT1;CITED2;RPS15A;RPS6KB1;PROX1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.35599137897613464,-0.8393371360471619,0.6778042959427207,0.905624616753836,1.0,3/10,12.14%,ENPP1;IMPACT;CHP1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3230499253415734,0.8392063424353411,0.6822157434402333,0.883456831123283,1.0,7/29,17.65%,SDHAF2;MAD2L2;PTEN;SPRED3;USF3;SPRED1;EFNA1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3163428795770122,0.8390280646559232,0.6994459833795014,0.8833213755271794,1.0,6/36,10.78%,GOLPH3L;RAB7A;AFDN;RAB34;GCC2;RILPL2
prerank,histone lysine methylation (GO:0034968),0.3162213316885651,0.8386809841351418,0.6733238231098431,0.883505989502952,1.0,10/33,21.36%,KDM6A;SETDB2;DOT1L;EZH2;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,negative regulation of cellular metabolic process (GO:0031324),0.311994995573734,0.8385813915763661,0.6815020862308763,0.8832462583128111,1.0,3/37,2.15%,RIN3;NFKB1;PTX3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.3250919668085097,-0.8379363373663945,0.7018970189701897,0.9074920621215395,1.0,8/14,37.68%,PPARGC1A;IRS1;GPLD1;SLC45A3;DDB1;IRS2;ARPP19;PMAIP1
prerank,postreplication repair (GO:0006301),0.2996841442638514,0.837928565723864,0.6881720430107527,0.8839476005127598,1.0,11/45,19.38%,DTL;POLI;UBE2N;POLD4;TRIM25;RPA3;PCLAF;VCP;POLD1;PRIMPOL;WDR33
prerank,response to growth factor (GO:0070848),0.3016888473609886,0.8373630596950482,0.7001321003963011,0.8845327939986456,1.0,7/41,13.17%,KLF4;BMPR2;STAT5B;CIB1;ACVR2A;MAP2K5;AKT1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3253959363862778,0.8372768513441171,0.7118881118881119,0.8842465357017048,1.0,9/28,21.34%,ITCH;UBE2N;CYLD;TAB3;MAP3K7;RELA;TAB1;TNFAIP3;RIPK2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.34419889098970985,0.8367059118550036,0.7108626198083067,0.8847835969431898,1.0,3/21,4.47%,PPARG;NFKBIA;ABCA3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.38319065076701986,0.8366767316575922,0.6609880749574105,0.8844051709738464,1.0,6/13,22.73%,ITGB2;IL6;RHOA;RELA;NFAT5;TNF
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.33813481464670514,-0.8365566359039247,0.7081339712918661,0.9093012993629015,1.0,4/13,19.65%,GAS6;LAMP1;TICAM1;TYROBP
prerank,triglyceride biosynthetic process (GO:0019432),-0.30915250122147303,-0.8363656002228892,0.6844919786096256,0.9086979728086083,1.0,5/18,18.27%,AGMO;PCK2;GPAM;GPAT4;LPGAT1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3149130843381539,0.8362279338776212,0.686046511627907,0.8847404626773204,1.0,8/33,16.89%,KLF4;PPARG;MECP2;RHOA;MAP2K5;TGFB1;THBS1;STARD13
prerank,proteoglycan metabolic process (GO:0006029),0.3297714032971078,0.8359446609490516,0.6757164404223228,0.8847879818817632,1.0,7/26,14.99%,SULF2;BMPR2;CHST12;XYLT1;ADAMTS12;CNMD;CSGALNACT1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.36282447400082557,0.8358288000107603,0.691437802907916,0.8845618112143298,1.0,1/15,1.35%,LILRB1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.27754926154018256,0.835730059131255,0.7292682926829268,0.8843070983377285,1.0,23/77,16.37%,MCL1;PSME3;HSPA1A;GPX1;BIRC6;HGF;ACAA2;CSNK2A2;CSNK2A1;RIPK1;SLC25A5;HTT;PSMD10;SH3RF1;LGALS3;PRELID1;AKT1;CAAP1;GSTP1;MAZ;RELA;THBS1;RB1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.39078714918815394,0.835562830311988,0.6605042016806723,0.8841778714354175,1.0,5/12,18.67%,CHST12;NCAN;UST;VCAN;DSEL
prerank,error-prone translesion synthesis (GO:0042276),0.340786424091299,0.834796652925644,0.6837209302325581,0.8850905892016427,1.0,2/21,2.97%,POLI;MAD2L2
prerank,renal system development (GO:0072001),0.29435550255903925,0.8347907247027779,0.7277486910994765,0.8846641447969513,1.0,7/52,13.36%,ACE;SULF2;STAT1;WFS1;ITGA8;LRP4;PCSK5
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.27985713139665624,-0.8345831529012553,0.660377358490566,0.9111926558669976,1.0,10/24,29.77%,CFAP20;TTLL11;TTLL5;GGCX;AGBL4;CEP41;TTLL1;NAA10;TTLL3;NAA80
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3207626318102463,-0.8343563722312343,0.6684782608695652,0.9106632091948679,1.0,6/15,35.07%,DAGLA;GRM5;GRM7;HOMER3;HOMER2;GRM4
prerank,maturation of LSU-rRNA (GO:0000470),-0.27446982955752613,-0.8339856060190717,0.7067448680351907,0.9104135501849814,1.0,9/26,17.40%,MRPL1;RPF1;NOP2;WDR12;LAS1L;PES1;FTSJ3;SNU13;RRP15
prerank,regulation of protein localization to membrane (GO:1905475),-0.27249701859036946,-0.8338041841406972,0.7507987220447284,0.909822389985186,1.0,12/28,23.78%,PRKN;ZDHHC2;MMP14;VTI1B;GPC6;CDK5;VAMP8;AR;STX8;GSN;CLN3;GPC4
prerank,ncRNA transcription (GO:0098781),0.37580814402122353,0.8334534220466717,0.6643952299829642,0.886561052345719,1.0,2/13,9.39%,POLR1G;SNAPC3
prerank,negative regulation of cellular component organization (GO:0051129),0.2777309734474438,0.8332962461813526,0.7244389027431422,0.8863760165456995,1.0,8/74,8.09%,LILRB1;HSPA1A;SORL1;CDC42;CARMIL1;FAP;SVIP;TMC8
prerank,DNA conformation change (GO:0071103),-0.30643839300711656,-0.8328753361799602,0.6873385012919897,0.9106713654013411,1.0,9/17,33.91%,HMGB1;TOP1;HMGB2;TOP1MT;NAA10;ABL1;HHEX;TOP2B;HMGB3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2441051562200921,0.832671718746986,0.8537590113285273,0.8870433004453053,1.0,68/366,16.39%,SP3;RUNX3;LIMD1;SAP30;PITX3;STAT3;NSD3;RABL3;NAB1;ANKRD17;SPI1;CCDC88A;KAT7;RYBP;ATF2;IRF2;RFX3;RPL6;BTG1;ORC5;RNF20;RPS6KA5;AHR;PHF19;CREM;SRSF10;MTPN;CLOCK;ENG;PHF12;NFYC;ZBTB11;BACH1;RBAK;ASCC1;CREBL2;NCOA2;SBNO2;BNC2;DAXX;NR3C1;ING2;SRRT;NLK;FOXO3;REST;APP;BAZ2A;NFYA;PQBP1;MSL3;ATRX;MYB;NSD1;HCLS1;EZH2;NFIL3;ZNF431;USP37;SERTAD3;CREBBP;RELA;DVL2;BHLHE40;FOXN2;INSR;RB1;DAPK3
prerank,negative regulation of transport (GO:0051051),0.2925642350813637,0.8325408864136609,0.7315789473684211,0.8868261425990638,1.0,13/51,16.71%,LILRB1;PLSCR1;DYSF;RAB7A;PTEN;WWP2;FCGR2B;TLR2;SNX3;LGALS3;SNX33;SNX12;MTMR2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.3340450658944738,0.8323985094993195,0.702416918429003,0.8866300794860993,1.0,2/23,4.77%,ITGAX;GDNF
prerank,mRNA splice site selection (GO:0006376),-0.25989194386065173,-0.8323184227837002,0.7222222222222222,0.9107530291091968,1.0,4/30,3.29%,SRSF5;LUC7L2;PSIP1;SFSWAP
prerank,proton transmembrane transport (GO:1902600),-0.2536855232371666,-0.8322424166659995,0.7785977859778598,0.9099428952119005,1.0,7/36,12.43%,ATP6V0C;SLC36A1;ATP5PO;ATP1A2;ATP6V0D1;SLC25A14;SLC25A27
prerank,nucleotide metabolic process (GO:0009117),-0.28279516433938107,-0.8320953703181355,0.7109634551495017,0.909264472250344,1.0,9/23,30.73%,FHIT;DCTD;AK1;NMNAT2;CMPK2;RNASEH2B;GUK1;ENPP3;AK4
prerank,negative regulation of T cell differentiation (GO:0045581),0.40110029084475607,0.831879792195804,0.6837748344370861,0.8870831730153205,1.0,1/10,2.49%,FOXJ1
prerank,regulation of cell cycle phase transition (GO:1901987),0.2741629134139727,0.8316956874881977,0.7456242707117853,0.8869725626140179,1.0,22/91,18.61%,PSME3;UBE2E1;PSMB7;FBXW7;PSME2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;UBE2S;PSMD6;PSMC4;PSMD10;PSMB1;ERCC3;ANAPC7;TAF1;PSMD12;ANAPC11;FZR1;ANAPC4
prerank,rRNA transcription (GO:0009303),-0.3161938511923663,-0.8314152104624056,0.7032085561497327,0.9096586098956496,1.0,6/17,20.55%,GTF3C3;GTF3C4;GTF3C2;GTF3C5;ANG;TCOF1
prerank,organelle assembly (GO:0070925),0.2435525920829423,0.8313021391718822,0.8709349593495935,0.8872587198487228,1.0,64/385,15.26%,CDC14A;LIMD1;ATAT1;ACTR3;RAB19;VPS37C;FOXJ1;EXOC6;HAUS8;CORO1A;OCRL;EHD2;ABCA3;RP2;CHMP4A;CHMP4B;RFX3;RAB7A;RC3H1;ARF4;TSG101;DHX37;ACTR2;CEP63;FLNA;ATG5;HAUS1;IFT140;YTHDF3;PDCD6IP;GBF1;STX12;KIF24;SNF8;TNKS;EXOC7;UNC119B;RPS3;STX7;CEP250;KIF3B;RILPL2;FHDC1;STAM;PTPDC1;ABCC4;DYNC1H1;PACS2;IQCB1;WIPI2;CFAP54;EIF4ENIF1;HAUS3;CFAP70;TMOD3;VMP1;HDAC3;TXNDC15;NUDCD3;RB1CC1;EHD1;CENPC;DYNLT2B;DISC1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3046270667048275,0.8309488162381202,0.7277628032345014,0.8874282748442236,1.0,9/38,14.83%,TNIP3;NLRX1;STAT1;TANK;RIPK1;CACTIN;CARD19;TLE1;GSTP1
prerank,positive regulation of reproductive process (GO:2000243),-0.25549770291903984,-0.8302947070775697,0.7579617834394905,0.910931081917751,1.0,1/31,0.19%,LHFPL2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.3925270285289362,0.8300429839998722,0.6649122807017543,0.8885224594624036,1.0,5/11,19.55%,SYNJ2BP;E2F2;THBS1;SEMA6A;KLF2
prerank,protein import into peroxisome membrane (GO:0045046),0.3355552067505219,0.8297316415203225,0.6994134897360704,0.8886292534462874,1.0,5/22,13.07%,PEX16;PEX12;PEX14;FIS1;ABCD1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.33146301428589053,0.8297163942299342,0.6849925705794948,0.8882151950743506,1.0,7/22,18.12%,ABCB7;GLRX5;LYRM4;HSPA9;NUBP2;NUBP1;NFU1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.2889514431838316,-0.8289543550150087,0.6946778711484594,0.9125596737588956,1.0,8/20,19.40%,ATP2A2;CCDC47;TGM2;SELENOK;BCAP31;BAX;HERPUD1;RAP1GDS1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.30109613375285793,0.8287084512193408,0.6957708049113234,0.8895120115763544,1.0,10/39,20.04%,CASK;PTPRO;RCC2;RHOA;NF2;TBCD;THBS1;KANK1;FZD7;NEXMIF
prerank,negative regulation of receptor internalization (GO:0002091),0.38858005722687533,0.8281416482402442,0.6802030456852792,0.8900383232367653,1.0,1/12,1.22%,RIN3
prerank,mitochondrial gene expression (GO:0140053),-0.23952659166676576,-0.8279767407951687,0.8007380073800738,0.913403820579201,1.0,19/42,26.71%,GFM2;LARS2;MRPS21;NDUFA7;MRPS17;GATB;GATC;POLRMT;MRPS7;MRPL2;MRPS24;MRPS18B;SLC25A33;MRPL47;MRPS14;MRPL51;MRPL16;TEFM;QRSL1
prerank,cellular response to estradiol stimulus (GO:0071392),0.346991755779837,0.8274341705447211,0.6719242902208202,0.890830880477623,1.0,5/18,22.92%,NCOA3;NRIP1;LCOR;CCDC62;FAM210B
prerank,cellular response to heat (GO:0034605),0.3117026446149826,0.826883421690744,0.7015130674002751,0.8913217417929901,1.0,10/35,18.63%,HSPA1A;SUMO1;ATXN3;SLU7;DAXX;HIKESHI;VCP;THBS1;BAG3;CLPB
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.32916096363921477,0.8265777345210102,0.7246376811594203,0.8914118937320981,1.0,10/29,18.44%,CYRIB;CORO1A;KANK3;ARFGEF1;SMAD4;PIK3CA;CLASP1;MYADM;KANK1;PRKCD
prerank,carnitine shuttle (GO:0006853),0.37825538355233923,0.8265582582367373,0.662751677852349,0.8910112016166502,1.0,3/11,13.78%,PRKAG2;PRKAB2;PRKAA2
prerank,zinc ion transmembrane transport (GO:0071577),0.33243182990344844,0.8258379094124679,0.6718266253869969,0.8918051189732632,1.0,5/22,17.41%,SLC30A4;SLC30A1;SLC39A11;SLC39A13;SLC39A12
prerank,response to ketone (GO:1901654),-0.27778132596046057,-0.8258336767625958,0.7017045454545454,0.9165120087230441,1.0,5/24,13.74%,ABCB4;SLIT2;SLIT3;CATSPER2;TGFB2
prerank,gastrulation (GO:0007369),0.3657536087885447,0.8249871555599224,0.6772046589018302,0.892831110350062,1.0,2/15,11.21%,GPC3;LMBRD1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.31439640871285496,0.8249014342952599,0.6927453769559033,0.8925425835137638,1.0,6/31,16.74%,TNNC1;RBPJ;ENG;SMAD4;TGFB1;PROX1
prerank,cellular response to hexose stimulus (GO:0071331),0.3339279483524117,0.8247607901034525,0.6967455621301775,0.89234102776697,1.0,5/23,13.78%,ERN1;ZBTB20;PRKAA1;PDK3;PRKAA2
prerank,negative regulation of double-strand break repair (GO:2000780),0.31496695230948296,0.8247528498601331,0.7065693430656934,0.89192015803696,1.0,4/30,6.03%,MAD2L2;SMCHD1;KLHL15;UBR5
prerank,cholesterol metabolic process (GO:0008203),0.2762175241762884,0.8246506346401682,0.7206632653061225,0.8916488526061578,1.0,17/68,17.23%,CEL;HSD17B7;CYP27A1;SULT2B1;ACAA2;MSMO1;IDI1;FDPS;NSDHL;ABCA5;DHCR24;SOAT1;ABCG1;ANGPTL3;MVD;MVK;SCAP
prerank,dermatan sulfate metabolic process (GO:0030205),0.38032725726725014,0.824613258763194,0.6578512396694215,0.8912883604605165,1.0,5/13,18.67%,CHST12;NCAN;UST;VCAN;DSEL
prerank,response to calcium ion (GO:0051592),0.26514257362017457,0.8245712317922903,0.7715617715617715,0.8909349474975776,1.0,10/102,5.68%,IQGAP1;PLCG2;ALOX5AP;HPCA;RASGRP2;DPEP1;CLIC4;PPP3CA;SLC25A13;KCNH1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.28277321468683736,0.824561823471692,0.7650602409638554,0.890521340744991,1.0,10/69,10.65%,NGF;PIK3C2A;INPP5F;KCNH1;PTEN;PLCB1;PLCD4;EZR;RHOA;PIK3CA
prerank,regulation of protein kinase B signaling (GO:0051896),0.25290935898549277,0.8245281296287229,0.8177874186550976,0.8901441508934338,1.0,48/193,20.85%,FLT3;FYN;RET;FGF5;FGF22;NRG2;KL;RAC2;PTEN;GRB2;PDPK1;CIB1;PHLPP1;ENG;RAC1;HGF;CPNE1;HIP1;RTN4;PIK3CA;CASS4;AKT1;KIT;HCLS1;TGFB1;FGFR3;PTPRJ;PPP2R5C;IL18;MAZ;RHOG;FRS2;THBS1;RNF41;INSR;PIK3R2;SIRT1;HAX1;PINK1;PIK3R5;FGFR1;PARK7;PTK2;TSPYL5;STRN;MUL1;XDH;RICTOR
prerank,regulation of centrosome duplication (GO:0010824),-0.2722182073790569,-0.8237642182662047,0.7722419928825622,0.9194471326677998,1.0,19/30,37.38%,VPS4B;CHMP5;CENATAC;NPM1;CHMP1B;CEP76;SPICE1;CHMP2A;CCNF;NAT10;GEN1;PLK2;CEP295NL;CENPJ;STIL;CEP131;CHMP1A;FBXW5;CHMP4C
prerank,Golgi to plasma membrane transport (GO:0006893),0.2924442554701109,0.8234071611085066,0.7260458839406208,0.8915711001215442,1.0,5/47,7.45%,STXBP6;EXOC6;GOLPH3L;RAB34;GCC2
prerank,positive regulation of proteolysis (GO:0045862),0.28800151076375696,0.8227978640749843,0.7593582887700535,0.8921974044024438,1.0,17/55,20.62%,IL1B;ADRA2A;FBXW11;MAPK12;TANK;NLRC4;SNX9;TNFRSF1B;CYFIP2;ADAM9;SNX33;AURKAIP1;CTSC;PINK1;BAD;RHBDD1;SH3D19
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3763497099823684,0.8227875903964952,0.6543624161073825,0.8917806306565746,1.0,4/12,14.77%,PPARG;NFKBIA;ABCA5;ABCG1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3902790745253316,0.8227518971376623,0.6837455830388692,0.8914078750129097,1.0,4/11,18.99%,IL6;RIPK1;TGFB1;MAP2K1
prerank,smooth muscle tissue development (GO:0048745),-0.34702892728109036,-0.8226983131110246,0.719626168224299,0.920464871406347,1.0,2/10,4.00%,SMO;NF1
prerank,rRNA processing (GO:0006364),0.2504387765552928,0.8226747128493784,0.8148558758314856,0.8911135655647813,1.0,36/172,15.90%,RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;NHP2;UTP6;RIOK1;RPL13;ERI1;NSA2;DDX49;NOC4L;MPHOSPH6;NOL11;MAK16;RPL34;RPLP0;UTP20;RPL19;RPL11;RPL30;NOP58;RRP36;RPS2;RPL4;RPL7;UTP18;MRTO4;DDX10;TBL3;TSR3;TFB1M
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.37859454101202694,0.8225433214315023,0.6655683690280065,0.8908985462680438,1.0,5/12,16.04%,SEC14L2;MBTPS1;SREBF2;H6PD;KPNB1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.36020347883081427,0.8214724947836538,0.66553480475382,0.8922391579457707,1.0,2/14,6.98%,CD177;FLNA
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3252516539226341,-0.8212511864941896,0.7036082474226805,0.9221964510811431,1.0,2/13,8.94%,IGF1;IRS1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2741524752623276,-0.8208280376193569,0.7555555555555555,0.9220288685387891,1.0,10/24,27.71%,POLD3;UBC;XRCC1;PCNA;LIG3;RFC3;LIG1;UBA52;RFC2;POLE
prerank,regulated exocytosis (GO:0045055),0.2521768893460797,0.8204319100803562,0.823721436343852,0.8935756054319084,1.0,26/173,14.59%,CYRIB;PHACTR2;LYN;PECAM1;RAB11FIP1;CD36;TOR4A;MYH9;VEGFC;F13A1;SRGN;NHLRC2;FLNA;TMED10;PSAP;HGF;FN1;SNAPIN;CYB5R1;ABCC4;APP;TLN1;SYNGR2;ARHGAP17;TGFB1;TAGLN2
prerank,snRNA metabolic process (GO:0016073),0.3437229478429717,0.81933402631998,0.6782477341389728,0.894998261333079,1.0,5/17,16.67%,TUT1;INTS2;INTS11;INTS4;INTS6
prerank,peptidyl-lysine modification (GO:0018205),0.2641663652541415,0.819263924407126,0.7825059101654847,0.8946842921840856,1.0,14/99,14.65%,BCL11A;NUP210;SUMO1;IFIH1;NUP98;ATP7A;HDAC9;SUMO2;SENP6;NUP153;SIRT4;GCSH;KAT2B;EEF1AKMT1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.2816467347004589,0.8191872831851318,0.7146496815286624,0.8943940314470642,1.0,15/61,17.18%,MRE11;SMCHD1;UBE2N;WRN;MECP2;UIMC1;HGF;WRAP53;RPS3;ATRX;OTUD4;USP7;USP9X;EYA3;SIRT1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.33655935611844434,0.8191454322280598,0.706060606060606,0.894036731429436,1.0,4/21,15.22%,NUDT19;CEL;LDHD;FAAH
prerank,regulation of dendrite extension (GO:1903859),-0.2969684594964727,-0.818884034450842,0.7436619718309859,0.9246716900691464,1.0,3/18,6.88%,SYT1;RNF157;PLAA
prerank,fatty acid metabolic process (GO:0006631),0.2601333404029869,0.8186682007057624,0.7839080459770115,0.8944294711904492,1.0,9/115,5.82%,PPARG;ALOX5AP;GPX1;CD36;ACOT11;ACSL5;NUDT19;ACOT2;CEL
prerank,regulation of receptor internalization (GO:0002090),-0.25053352776849985,-0.8184916959096944,0.78125,0.9244593943264549,1.0,10/35,18.26%,MAGI2;DLG4;CD63;FLOT1;VEGFA;ANKRD13D;SCYL2;ATXN2;ANKRD13B;ANGPT1
prerank,cholesterol homeostasis (GO:0042632),-0.2216109348933461,-0.8184820547454441,0.8325991189427313,0.9235154547426904,1.0,8/64,13.45%,ABCA1;APOE;TTC39B;LIMA1;CNBP;MTTP;NPC1;NR1H2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2832367059562777,0.8183657264079721,0.7331606217616581,0.894501779643913,1.0,7/58,8.43%,UVRAG;POLL;MRE11;SUMO1;DNTT;UBE2N;UIMC1
prerank,cellular protein catabolic process (GO:0044257),0.2827108143368539,0.8182850315201009,0.741421568627451,0.8942088279065392,1.0,13/59,13.81%,DENND3;LONP1;RSPRY1;MALT1;RAB7A;FAP;AP2A2;CAPN2;RIPK1;AP2B1;UBE2G1;ADAMTS12;YME1L1
prerank,regulation of tissue remodeling (GO:0034103),-0.2994265236568966,-0.8179519705086057,0.7122905027932961,0.9235591760658365,1.0,4/18,19.27%,CST3;SYT7;MDK;LEPR
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.35840240737736856,0.8178281873004962,0.6831683168316832,0.8945427829198036,1.0,1/14,1.61%,SULF2
prerank,cellular response to radiation (GO:0071478),0.2979739947876951,0.8177126139808062,0.7148817802503477,0.8943139161526323,1.0,10/40,17.18%,MAPK14;GRB2;CLOCK;TANK;GPR88;NET1;SPIDR;INO80;HUS1;SIRT1
prerank,apoptotic nuclear changes (GO:0030262),0.32661511799394416,0.8176179849768865,0.7113095238095238,0.8940462320550547,1.0,6/24,16.73%,DFFA;DEDD2;DFFB;EXOG;KPNB1;ACIN1
prerank,tRNA transport (GO:0051031),-0.25189008868896273,-0.8174187421110245,0.7333333333333333,0.9235943362650674,1.0,13/35,19.43%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,response to ionizing radiation (GO:0010212),0.2773067567240476,0.8172313040708026,0.7777777777777778,0.8942703421821636,1.0,23/70,21.08%,MAPK14;GRB2;NABP1;CLOCK;COP1;UIMC1;TANK;ANXA1;NET1;DCUN1D3;PRKAA1;XRCC4;SPIDR;BRSK1;INO80;INIP;HUS1;EYA3;SIRT1;TNKS1BP1;RNF168;STK11;CLK2
prerank,zinc ion transport (GO:0006829),0.3339096907588798,0.816200015687125,0.69377990430622,0.8955952658987772,1.0,3/21,8.93%,SLC30A4;SLC30A1;SLC39A11
prerank,negative regulation of mRNA processing (GO:0050686),-0.3140111362605955,-0.8150194974153766,0.7154046997389034,0.9271219220651569,1.0,8/15,26.23%,SFSWAP;RNPS1;SRSF7;PTBP1;PCBP4;C1QBP;SRSF12;BARD1
prerank,regulation of DNA repair (GO:0006282),0.2967740571886573,0.8148455170953928,0.7269129287598944,0.8974066567660735,1.0,9/44,11.81%,KAT7;SMCHD1;UBE2N;UBR5;DEK;UIMC1;WRAP53;RPS3;PARG
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2984501983049466,0.8147514199114129,0.7063711911357341,0.8971294506411346,1.0,8/37,15.33%,PRKAG2;AXIN1;DDIT4;SPRED3;APP;TGFB1;MAPK1;SPRED1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3143155377588181,0.8146196929856213,0.7210982658959537,0.8969322971743374,1.0,7/29,16.03%,DGCR8;PUM2;TRIM71;SRRT;TUT7;METTL3;PUM1
prerank,protein depolymerization (GO:0051261),-0.26183727435542076,-0.8146081256609774,0.772189349112426,0.9269103003915207,1.0,8/27,23.22%,MICAL3;VPS4B;CKAP5;CFL1;KIF18A;GSN;NCKAP5L;NCKAP5
prerank,platelet aggregation (GO:0070527),-0.25094846710042673,-0.8142485185795616,0.7694915254237288,0.9266231207118701,1.0,11/33,24.48%,P2RY12;PPIA;ILK;PIK3CG;ITGB3;GNAS;PLEK;RAP2B;FIBP;TYRO3;ACTG1
prerank,T cell homeostasis (GO:0043029),-0.34930042989754256,-0.8142232062752455,0.714987714987715,0.9257102151509501,1.0,5/10,27.19%,NCKAP1L;JAK3;PPP2R3C;ZC3H8;FAS
prerank,mRNA processing (GO:0006397),0.2410755728229387,0.8139447129512938,0.8619979402677652,0.8976097211326027,1.0,75/287,19.72%,RSRC1;ERN1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;CMTR1;BUD31;SRSF10;BUD13;THOC3;DDX41;DNAJC8;FIP1L1;CCNH;RBM10;LSM5;MAGOHB;DDX46;PRPF3;SF3B6;RBM22;RPRD2;SRSF4;DHX8;SLU7;RPRD1B;YTHDC1;NUDT21;RBM15;SPEN;CACTIN;SRRT;FRG1;PQBP1;DDX23;SNRPA1;SF3A1;ERCC3;METTL3;SYNCRIP;AQR;U2SURP;GEMIN7;CPSF3;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;CELF1;PABPC1;PPWD1;AURKAIP1;SYF2;TFIP11;SF3B3;SUPT4H1;CWF19L1;RBM41;CSTF3;SF3B2;SF3B1;UPF3B;WDR33;PDCD7;CDC40;SMNDC1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3140082245359187,0.8139430892551002,0.6997206703910615,0.897181460610667,1.0,6/29,16.01%,TENT5A;GDNF;DHX34;EIF4ENIF1;PAIP1;PABPC1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.3833430265913726,0.8137129119355998,0.6894736842105263,0.8971277860235425,1.0,1/10,5.06%,CARMIL1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.3765320854865463,0.8130348409528967,0.6972789115646258,0.8978316373984725,1.0,4/12,13.81%,PICALM;PRNP;TMED10;ROCK1
prerank,axoneme assembly (GO:0035082),-0.252574731952713,-0.8129900450949354,0.7533333333333333,0.9270522498913389,1.0,23/31,47.09%,CFAP74;DCX;DNAI4;LRGUK;SPAG16;SPEF1;TTLL3;CFAP46;CCDC40;RSPH9;JHY;DNAJB13;CFAP206;DRC1;SPAG17;GAS8;TTC12;DNAAF2;RSPH1;RP1;RSPH4A;DNAAF1;CCDC65
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.27366626558953394,-0.8129323471884559,0.767515923566879,0.9262091809190421,1.0,6/26,13.73%,IGF1;OSBPL8;RHOQ;IRS1;PIK3R1;C3
prerank,gliogenesis (GO:0042063),-0.31744373462660314,-0.812789610139836,0.7393483709273183,0.9255244715004172,1.0,4/15,13.74%,CD9;NFIB;METTL14;TGFB2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.33120416237430234,-0.8127739747976537,0.7311557788944724,0.924605957414111,1.0,1/13,0.40%,TGFBR2
prerank,protein insertion into membrane (GO:0051205),0.3098507128015077,0.8125098072332735,0.7329545454545454,0.898268073471682,1.0,8/32,15.93%,MAIP1;PRNP;TRAM2;TRAM1;STX5;APP;UBE2J2;VAPA
prerank,endochondral bone morphogenesis (GO:0060350),-0.34323478689324544,-0.8124453087753919,0.6700507614213198,0.9242431981913083,1.0,5/11,14.26%,MEF2C;INPPL1;TMEM119;TRPV4;BMPR1B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3597613080753144,0.8122109294629337,0.7004909983633388,0.898321928608575,1.0,5/15,14.84%,RIPOR2;EHD2;MAPK14;ADAM9;EHD1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.33439714938597787,0.8120898819083106,0.7198142414860681,0.8976819722363222,1.0,4/22,12.70%,ZDHHC7;ZDHHC6;ZDHHC23;CLIP3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.33439714938597787,0.8120898819083106,0.7198142414860681,0.8976819722363222,1.0,4/22,12.70%,ZDHHC7;ZDHHC6;ZDHHC23;CLIP3
prerank,regulation of coagulation (GO:0050818),-0.3445383878374956,-0.8115271153701952,0.719047619047619,0.9248903204951481,1.0,1/11,1.65%,HS3ST5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3199841927666164,0.8112015410935076,0.6995581737849779,0.8987333410060413,1.0,7/25,19.97%,MAD2L2;DOT1L;NSD1;TGFB1;RB1;NIBAN2;PARK7
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.23770053841459726,-0.8106253807483358,0.7873134328358209,0.9255664721513978,1.0,17/42,24.62%,YARS1;LARS1;NARS1;WARS2;LARS2;NARS2;WARS1;TARS3;IARS1;DARS1;TARS2;KARS1;PPA2;FARSA;EARS2;RARS1;CARS1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.31241790907722244,-0.8100067195537772,0.7176470588235294,0.9257267234344304,1.0,1/15,0.41%,APOE
prerank,positive regulation of heart rate (GO:0010460),-0.29582975122373806,-0.8093870506257234,0.7138888888888889,0.9258960485208221,1.0,6/17,22.39%,ATP2A2;ADRA1B;ADRB1;SCN3B;RYR2;ADRA1A
prerank,regulation of cellular protein catabolic process (GO:1903362),0.3515260243253318,0.8093855074502405,0.7149606299212599,0.9013250444307984,1.0,4/18,8.00%,MSN;PTTG1IP;FAF1;EZR
prerank,fatty acid transmembrane transport (GO:1902001),0.33730290623101494,0.8092297424518671,0.709726443768997,0.9011538535091453,1.0,6/19,15.17%,PRKAG2;CD36;PRKAB2;ABCD1;PRKAA2;SLC2A1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3144481484104549,-0.8085897211714131,0.7069408740359897,0.9263520219838459,1.0,7/14,24.31%,SFSWAP;RNPS1;SRSF7;PTBP1;PCBP4;C1QBP;SRSF12
prerank,positive regulation of dendrite extension (GO:1903861),-0.2969727701498064,-0.8085427106951899,0.7430167597765364,0.9254684273934652,1.0,3/17,6.88%,SYT1;RNF157;PLAA
prerank,aminoglycan catabolic process (GO:0006026),0.3172676487290873,0.8085174010255839,0.7153284671532847,0.90190363038528,1.0,9/28,22.76%,GPC3;HSPG2;FUCA1;SDC3;CTBS;GPC1;NAGLU;IDS;HPSE
prerank,protein polyglutamylation (GO:0018095),-0.3385879373502801,-0.808425261474305,0.712082262210797,0.924734528935438,1.0,5/11,22.19%,CFAP20;TTLL11;TTLL5;CEP41;TTLL1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2728717018325253,0.8083634682485397,0.7573891625615764,0.9017243032801215,1.0,8/72,10.49%,SP100;BCL3;BTG2;HIPK2;CNOT6;PIDD1;CNOT2;CASP2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.28186594179073204,0.8078772694451993,0.7373868046571799,0.9021131435391413,1.0,8/54,11.57%,EXT1;GPC3;HSPG2;PXYLP1;XYLT1;FUCA1;GALNT5;SDC3
prerank,positive regulation of potassium ion transport (GO:0043268),0.2949911326312268,0.8075924672276944,0.7747875354107648,0.9021229723549303,1.0,6/38,8.39%,KCNQ1;KIF5B;ADRA2A;FLNA;KCNN4;GNB1
prerank,positive regulation of tissue remodeling (GO:0034105),0.381107889787538,0.8071470879179281,0.7258620689655172,0.9024188766102564,1.0,2/10,14.65%,ROCK1;IL18
prerank,protein K11-linked ubiquitination (GO:0070979),-0.25966082265462287,-0.8069980006334143,0.8017492711370262,0.9263555660259871,1.0,2/27,3.11%,PRKN;UBE2B
prerank,potassium ion transmembrane transport (GO:0071805),0.25410307589611264,0.8068105627552021,0.8085351787773933,0.9025562149059368,1.0,9/135,5.68%,KCNE3;KCNG4;KCNA6;SLC9A7;KCNK7;KCNQ1;HCN4;SLC12A7;KCNH1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.27673521370305,-0.8061362447117769,0.7681564245810056,0.9269152268637462,1.0,2/20,1.56%,DCC;BCL2L1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.26737808524528556,-0.8055926704292649,0.7374631268436578,0.9269338295537005,1.0,6/26,13.56%,LGMN;TAL1;USP2;CCDC57;PPP1R10;USP22
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.296352858535236,-0.8055859532201108,0.7564469914040115,0.9260002005660005,1.0,7/18,23.76%,ATF4;UTP15;PHF8;MAF1;POLR2K;WDR43;LYAR
prerank,determination of left/right symmetry (GO:0007368),0.3014812305617376,0.8049673017691582,0.7384823848238482,0.9051117677327604,1.0,5/37,13.95%,FOXJ1;RFX3;KIF3B;CCDC39;CITED2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2826136799653727,0.8046574334218456,0.7708609271523179,0.9051851020745453,1.0,9/50,14.76%,CCNJL;CCND3;CDKN2C;CCND1;CCNH;CCNT2;CCNT1;CCND2;CDK5R2
prerank,sensory perception of chemical stimulus (GO:0007606),0.34955248760048213,0.8045474693896579,0.7292006525285482,0.9049356623772732,1.0,3/15,16.44%,CD36;SLC24A4;UBR3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3521488072558599,0.8043112068127518,0.7261345852895149,0.904875946499439,1.0,6/16,20.32%,NIPBL;MAU2;HASPIN;RB1;RAD21;PDS5B
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3061046771048958,-0.8039923980815575,0.76775956284153,0.9279325095954181,1.0,1/15,0.42%,IGF1
prerank,androgen receptor signaling pathway (GO:0030521),-0.3379321952448207,-0.8039397984952986,0.7222222222222222,0.927078433211711,1.0,4/11,22.73%,DDX5;PLPP1;AR;ARID1A
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3023071236357705,0.8039386786382502,0.7422535211267606,0.9050489216672217,1.0,9/35,18.81%,ALOX5AP;GGTA1;FAR1;BDH1;ACAT1;PPT1;HMGCLL1;SLC25A1;HPGD
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2810828420011057,-0.8038165946921698,0.73224043715847,0.9263439757511948,1.0,7/20,38.13%,STARD3;AKR1B1;FDX1;TSPOAP1;HSD17B10;STAR;CYP46A1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.28595810834649993,-0.8038029978023707,0.7554945054945055,0.9254291907140527,1.0,10/21,24.94%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;FBXO5;BUB1B;BUB1;CENPF
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.35179283545441314,0.8035737888116001,0.7087227414330218,0.9052405227088346,1.0,7/16,18.70%,CLEC16A;ETF1;MTRF1;IRAK3;INSR;GSPT1;TBC1D25
prerank,regulation of brown fat cell differentiation (GO:0090335),0.35068694059021766,0.801667035332127,0.746031746031746,0.9080260582384172,1.0,2/16,2.01%,METRNL;PIM1
prerank,regulation of keratinocyte migration (GO:0051547),-0.32150249016874444,-0.801374563771517,0.7213930348258707,0.928654573249528,1.0,2/12,4.09%,EPB41L4B;IQSEC1
prerank,Wnt signaling pathway (GO:0016055),0.2620428360061736,0.8013331209042323,0.8007334963325183,0.9081076596915209,1.0,8/92,8.90%,LRRK2;PLCG2;CCDC88C;CSNK1G1;AXIN1;PTEN;RARG;CSNK1G3
prerank,histone H4 acetylation (GO:0043967),0.2876488497922649,0.801158569234488,0.7403100775193798,0.9079602734299365,1.0,16/47,20.73%,KAT7;ATF2;TRIM16;TADA3;KANSL1;ING3;MORF4L1;JADE3;MSL3;KMT2A;PHF20;MSL2;HAT1;WDR5;EP400;KANSL3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.35532127175378464,0.8008939461686458,0.7044334975369458,0.9079747822561165,1.0,6/16,22.79%,ATP7A;ABCD1;VCP;COX7A2;PINK1;COX7A2L
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3092034971681815,0.8003835027354926,0.7164634146341463,0.9083871487093581,1.0,4/27,9.13%,BMPR2;PARP4;HGF;TNKS
prerank,cellular zinc ion homeostasis (GO:0006882),-0.26847355315414145,-0.8000326960691995,0.7537091988130564,0.9300950350853451,1.0,17/26,43.36%,SLC39A10;SLC39A7;SLC30A9;SLC39A6;MT2A;MT3;LCK;ATP13A2;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SLC39A14
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.30036343121402415,-0.7993588810738977,0.738544474393531,0.9304038010419721,1.0,5/17,14.52%,SMAD7;DGKQ;PARD3;CALM1;EIF4G1
prerank,regulation of protein localization (GO:0032880),0.2712484620351629,0.7983908600124286,0.7692307692307693,0.9110990371651889,1.0,13/58,13.16%,PICALM;FBXW7;SUMO1;ZDHHC7;AFDN;RABGAP1L;STX6;TRIM25;TRIM46;TRIM14;DVL3;TRIM17;MAPK8
prerank,early endosome to Golgi transport (GO:0034498),0.37339462967871406,0.7983883714834232,0.7330016583747927,0.9106724099907243,1.0,3/11,8.38%,SNX1;RAB6A;STX5
prerank,negative regulation of heart contraction (GO:0045822),-0.3311321521862596,-0.7983594439268434,0.72,0.9311276092913696,1.0,2/11,7.88%,ATP1A2;PIK3CG
prerank,regulation of pseudopodium assembly (GO:0031272),0.38910577388848944,0.7981489749876782,0.6946428571428571,0.9102132741833276,1.0,2/10,15.92%,CDC42;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.38910577388848944,0.7981489749876782,0.6946428571428571,0.9102132741833276,1.0,2/10,15.92%,CDC42;APC
prerank,positive regulation of viral process (GO:0048524),-0.21509280223518523,-0.798077267965557,0.883177570093458,0.9306494438609465,1.0,25/60,26.97%,LARP1;PPIA;KPNA6;SRPK1;TBC1D20;POLR2A;ADAR;SRPK2;DHX9;PPIE;POLR2K;VAPB;DDX3X;CDK9;PPID;POLR2H;ADARB1;NELFCD;POLR2J;RAD23A;CNOT7;TYRO3;PDE12;CD28;NELFE
prerank,carboxylic acid transport (GO:0046942),0.2777044284653561,0.797987630121415,0.7346666666666667,0.9100546281700791,1.0,14/55,19.16%,SLC23A2;SLC23A1;PSAP;SLC15A4;SLC1A5;SLC1A4;SLC38A1;SLC66A1;SLC6A9;SLC16A3;SLC16A4;SLC16A7;SLC6A11;SLC38A2
prerank,cGMP biosynthetic process (GO:0006182),0.3917613826961319,0.7979701460042552,0.7162162162162162,0.9096535980842732,1.0,3/10,23.39%,GUCY1A1;NPR2;NPPC
prerank,regulation of chromatin binding (GO:0035561),0.3803666369351214,0.7978889061129599,0.7115044247787611,0.9093501005571765,1.0,2/10,9.68%,DTX3L;PARP9
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.3038968020320048,-0.7977037565247396,0.731457800511509,0.9303344763103041,1.0,9/16,43.36%,PRMT5;C3;CHGA;ACP3;GRP;PDE6G;NECAB2;GSK3A;SLC39A14
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.3157102626424586,-0.7976639746954112,0.7352185089974294,0.9294549434597187,1.0,6/13,32.31%,GLUL;GAD1;GLS;PRODH;GLS2;NOS1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.3361601310505879,0.7972450784184042,0.7351598173515982,0.9099115309564483,1.0,3/18,10.33%,LILRB1;SMAD4;FN1
prerank,activation of protein kinase activity (GO:0032147),0.2564513709728912,0.797151930287948,0.8156359393232205,0.9096240638552846,1.0,27/106,18.81%,PAK1;JAK2;MALT1;CCDC88A;AXIN1;TAOK3;ADRA2A;TIRAP;STK4;PTK2B;PDPK1;PAK2;TLR3;MINK1;PRKAR2A;ADCY7;MAP3K7;ADCY5;AKT1;MAPKAP1;IL18;PRR5;INSR;TRAF2;PRKCD;STK3;PINK1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.23369647219507556,0.7968220680638475,0.8829015544041451,0.9097398627715957,1.0,60/327,16.39%,SP3;RUNX3;LIMD1;SAP30;PITX3;STAT3;NSD3;NAB1;SPI1;KAT7;RYBP;ATF2;IRF2;RFX3;RPL6;BTG1;RNF20;RPS6KA5;AHR;PHF19;CREM;SRSF10;CLOCK;ENG;PHF12;NFYC;ZBTB11;BACH1;RBAK;ASCC1;CREBL2;NCOA2;SBNO2;BNC2;DAXX;NR3C1;ING2;SRRT;NLK;REST;BAZ2A;NFYA;PQBP1;MSL3;ATRX;MYB;NSD1;HCLS1;EZH2;NFIL3;ZNF431;SERTAD3;CREBBP;RELA;DVL2;BHLHE40;FOXN2;INSR;RB1;DAPK3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2765952298088107,0.7966329838046134,0.7767857142857143,0.9096135894829429,1.0,10/57,14.60%,XPO1;RPL5;DHX37;RPL35A;RIOK1;RPF2;RPL11;RRP36;RPL7;MRTO4
prerank,modulation by symbiont of entry into host (GO:0052372),0.34438673209843995,0.7964279736018857,0.7098360655737705,0.9094948907895998,1.0,5/16,15.94%,TRIM62;TRIM25;EXOC7;TRIM14;EXOC2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.33853137044418313,0.7960107727933189,0.728414442700157,0.9097852517958617,1.0,9/17,22.11%,BBC3;FIS1;DNM1L;TIMM50;GGCT;BAD;FZD9;BID;BCL2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.28018815517689777,-0.7958878451996931,0.7595307917888563,0.9305675635884175,1.0,9/21,31.22%,GTF2H2;GTF2H1;ERCC2;GTF2H3;GTF2H5;ERCC1;GTF2H4;DDB1;CHD1L
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.28018815517689777,-0.7958878451996931,0.7595307917888563,0.9305675635884175,1.0,9/21,31.22%,GTF2H2;GTF2H1;ERCC2;GTF2H3;GTF2H5;ERCC1;GTF2H4;DDB1;CHD1L
prerank,DNA strand elongation (GO:0022616),-0.28807434023592693,-0.7952909905970533,0.764525993883792,0.9306793779575846,1.0,12/18,38.35%,POLD3;GINS1;POLA1;RFC3;GINS3;RFC4;MCM4;GINS4;GINS2;DCLRE1B;POLD2;NBN
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3208070768235056,0.7946819619021129,0.7364457831325302,0.9114864329798914,1.0,9/25,19.83%,RPL5;HIPK2;CSNK2A2;CSNK2A1;RPL11;TAF1;EFNA1;PRKCG;PSMF1
prerank,mRNA metabolic process (GO:0016071),0.25924082501856255,0.7942723427659372,0.8023668639053254,0.9117216074874948,1.0,25/90,21.02%,ZC3H12D;HSPA1A;ERN1;SNRPB;DCP2;LSM5;ZFP36L2;PRPF3;SRSF4;NUDT21;SF3A1;METTL3;RNH1;PNPT1;CPSF3;NCBP1;CELF1;AURKAIP1;SUPT4H1;CSTF3;SF3B2;SF3A2;PRPF18;NONO;SLBP
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3340125406807999,0.7939915573958451,0.713166144200627,0.9117328401640212,1.0,2/20,5.23%,RAPGEF2;ADRA2A
prerank,regulation of inclusion body assembly (GO:0090083),-0.33949398114170853,-0.7938469281068582,0.7416267942583732,0.9321211673266059,1.0,3/11,9.87%,SNCAIP;SACS;DNAJB2
prerank,activation of protein kinase A activity (GO:0034199),-0.29604384371428394,-0.7934142778814068,0.7696476964769647,0.9319637961581035,1.0,5/16,17.65%,ADCY9;PRKACA;PRKAR1A;ADCY3;ADCY8
prerank,protein targeting to peroxisome (GO:0006625),0.30513312835533307,0.7933109663473717,0.7316715542521994,0.912387946726432,1.0,6/29,13.07%,PEX16;PEX12;ZFAND6;PEX14;FIS1;ABCD1
prerank,response to metal ion (GO:0010038),0.27028090254557147,0.793047899932451,0.7972465581977471,0.9123779458508143,1.0,7/67,6.73%,PLSCR1;NEDD4L;SLC30A4;PPP3CA;HAAO;SLC25A13;CRIP1
prerank,negative regulation of developmental process (GO:0051093),0.26766181491808755,0.7929305518687287,0.8007334963325183,0.9121069262577199,1.0,4/69,5.45%,BCL11A;FOXJ1;SPI1;RC3H1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.25977717771506853,0.7928834761312002,0.8070388349514563,0.9117590958361008,1.0,22/87,18.81%,ARHGEF18;FOS;CBL;ZFYVE9;F11R;ENG;PXN;RHOA;USP15;NRROS;SMAD4;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;SMAD5;SIRT1;APPL1;HPGD
prerank,iron-sulfur cluster assembly (GO:0016226),0.31106588969030075,0.7925249038505469,0.7424023154848046,0.9119002124813022,1.0,7/24,18.12%,ABCB7;GLRX5;LYRM4;HSPA9;NUBP2;NUBP1;NFU1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3503359743368891,0.7922780645513618,0.7138263665594855,0.9118867480721908,1.0,2/15,7.20%,PTK2B;DYRK1A
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.2549544134905884,-0.791863911290954,0.8175675675675675,0.9336420466608679,1.0,8/30,16.72%,BCL9;SMAD7;NREP;SMAD3;TRIM33;FSTL1;DKK3;SOX11
prerank,positive regulation of double-strand break repair (GO:2000781),0.2932307533395515,0.7912727034519266,0.7601683029453016,0.9130364531712972,1.0,9/39,12.80%,DTX3L;MAD2L2;SMCHD1;ACTR2;WRAP53;PARP9;ARID2;KMT5B;SPIDR
prerank,sensory perception of light stimulus (GO:0050953),0.2575262680693881,0.7912094959096165,0.8103241296518607,0.9126999596927559,1.0,15/87,17.46%,CRYBG3;RP2;ATF6;WFS1;ATXN7;DNAJC19;OPA3;KIFC3;UNC119;IMPG2;USH2A;GRM8;EYA3;PRPH2;PITPNA
prerank,negative regulation of translational initiation (GO:0045947),0.35943565756957235,0.7907712897761131,0.7398373983739838,0.9130001633064493,1.0,4/13,14.62%,EIF4EBP1;EIF2AK1;PAIP2;EIF3E
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.18977253217087417,-0.7906987042359779,0.9772727272727273,0.9346935630409137,1.0,73/125,40.40%,NEK6;CLIP1;RMDN1;CENPO;CLASP2;PPP1CC;CKAP5;BUB3;NUP133;DYNLL2;DYNLL1;WDR62;ZW10;CEP126;MAPRE1;RANBP2;MAD1L1;BCCIP;SEC13;NUP85;RAN;CENPE;KNL1;CENPA;NUP37;DCTN6;KIF18A;NDEL1;CENPP;SUN2;TACC3;PMF1;BUB1B;CENPK;CENPU;BUB1;CENPF;PLK2;DLGAP5;CENPT;SPDL1;EFHC1;NDC80;NSL1;CDCA8;B9D2;RCC1;KIF4A;DSN1;RANGAP1;CENPN;MIS12;CENPH;STIL;BIRC5;SKA2;KIF2A;MAD2L1;CENPI;TBCE;INCENP;SPC25;KNTC1;KIF2C;TTK;SGO1;ZWINT;PLK1;DYNC1I1;NDE1;NUF2;TUBG1;AURKA
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.3466812814488871,0.7906289898205136,0.7176656151419558,0.9128047361577131,1.0,8/17,17.23%,SEC14L2;ERLIN1;MBTPS1;PRKAA1;SREBF2;ABCG1;KPNB1;SCAP
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3680349678974252,0.7905821070179239,0.7397260273972602,0.9124461484592397,1.0,4/12,14.37%,UCK2;CAD;UCK1;DCK
prerank,L-serine metabolic process (GO:0006563),-0.34029997334830336,-0.7898513641983359,0.7398190045248869,0.9352036632913843,1.0,4/10,25.86%,PSAT1;SERINC3;PHGDH;SHMT2
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3402109831028447,-0.7895749962094553,0.7719298245614035,0.9347612413050213,1.0,3/10,14.30%,RIF1;TERF2IP;DCLRE1A
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3281707057903471,0.7895525036509801,0.7348484848484849,0.913624360884112,1.0,9/21,22.01%,PNLDC1;CNOT6;CNOT2;TUT7;CNOT8;TNKS1BP1;CNOT6L;PARN;CNOT3
prerank,sterol homeostasis (GO:0055092),-0.21280103537992762,-0.7895324579121813,0.9013452914798207,0.933903324010053,1.0,8/65,13.45%,ABCA1;APOE;TTC39B;LIMA1;CNBP;MTTP;NPC1;NR1H2
prerank,sprouting angiogenesis (GO:0002040),0.2798330363497372,0.7892954459185624,0.771505376344086,0.9136105985580529,1.0,8/51,9.48%,RSPO3;ADGRA2;VEGFC;RNF213;PTK2B;ENG;NAXE;PGF
prerank,apoptotic mitochondrial changes (GO:0008637),0.299919445434262,0.7892889410887864,0.7607449856733525,0.9131980732181587,1.0,13/32,22.11%,IFIT2;BBC3;ATP2A1;FIS1;DNM1L;TIMM50;HSPD1;AIFM2;GGCT;BAD;FZD9;BID;BCL2
prerank,endocardial cushion development (GO:0003197),0.3253622447123462,0.7887677227937825,0.7316341829085458,0.9136020488740971,1.0,2/21,8.16%,BMPR2;ENG
prerank,retina homeostasis (GO:0001895),-0.2721826354704789,-0.7885293378486071,0.7818181818181819,0.9347058905907416,1.0,2/23,5.31%,WHRN;CCDC66
prerank,RNA 3'-end processing (GO:0031123),0.2667808279536733,0.7881002804612027,0.8007566204287516,0.9141893851088219,1.0,22/69,20.05%,THOC3;FIP1L1;TUT1;MAGOHB;TENT2;RPRD2;SRSF4;SLU7;RPRD1B;NUDT21;MTPAP;TUT7;PNPT1;TENT4B;CPSF3;PAPOLA;NCBP1;CSTF3;UPF3B;WDR33;CDC40;SUPV3L1
prerank,water transport (GO:0006833),-0.3098552589352018,-0.7878625975215028,0.7679012345679013,0.9348277939937886,1.0,5/12,52.78%,AQP4;PDPN;AQP11;AQP1;SLC5A1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.2677223728482042,-0.7877918821138713,0.7629179331306991,0.9339936295422832,1.0,5/24,11.94%,NRP1;IQSEC1;PIK3R1;PPM1F;VEGFA
prerank,negative regulation of interleukin-10 production (GO:0032693),0.33783545282818284,0.7873178698155352,0.7044334975369458,0.9149713617213724,1.0,1/16,1.35%,LILRB1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.33040360492621446,0.7871327215899723,0.7250384024577573,0.9148204832409744,1.0,3/19,8.00%,HSPA1A;CHMP4B;PDCD6IP
prerank,protein localization to nucleus (GO:0034504),0.2528594318993126,0.7870263516235075,0.8299643281807372,0.9145604866131656,1.0,19/102,16.04%,BCL3;SYK;STAT3;PTTG1IP;WRN;LMNA;RPF2;PIKFYVE;HIKESHI;TOR1AIP1;NUP153;MORC3;RPL11;EIF4ENIF1;AKT1;FAM53C;GBP2;TNPO1;KPNB1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2685894404473657,0.7864571962859076,0.7902621722846442,0.9149863902338062,1.0,19/68,19.38%,TAF1A;SNRPB;POLR1G;SETX;SSU72;FIP1L1;CCNH;SCAF8;NUDT21;ERCC3;POLR1B;MAZ;CPSF3;PAPOLA;NCBP1;TAF1C;CSTF3;POLR3K;WDR33
prerank,embryonic skeletal system development (GO:0048706),0.29431686547631847,0.7864375285766936,0.7334293948126801,0.9145870030458556,1.0,3/35,8.21%,SULF2;DEAF1;XYLT1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3323802229600413,0.7860924357025522,0.7457886676875957,0.9147003719491437,1.0,5/20,11.52%,ITCH;HSPA1A;DCUN1D1;DAXX;DCUN1D3
prerank,cGMP-mediated signaling (GO:0019934),0.35794844155666816,0.7854756718170568,0.7275693311582382,0.9152503181604047,1.0,3/13,11.50%,CD36;PDE2A;IRAG1
prerank,negative regulation of secretion by cell (GO:1903531),0.2843689502635052,0.7853244283584895,0.7730978260869565,0.9150440779716489,1.0,5/38,13.54%,LILRB1;STXBP6;SLC30A1;ANXA1;TNFRSF1B
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3281227513157784,0.7851072736176863,0.7536945812807881,0.9149598557954877,1.0,10/19,19.97%,FBXW7;CSNK2A2;CAMKK2;HTT;DNM1L;SREBF2;FBXO7;HAX1;PINK1;PARK7
prerank,negative regulation of phosphatase activity (GO:0010923),0.31245977562886085,0.784841598463,0.746606334841629,0.914941421676615,1.0,9/25,21.96%,CRY2;PPP1R15A;GPATCH2;FKBP1B;ZCCHC9;SEMA4D;PTPA;TIPRL;GSK3B
prerank,oligodendrocyte development (GO:0014003),0.3479846651221977,0.7847037252642003,0.7350993377483444,0.9147356113382067,1.0,2/15,4.27%,MYRF;B4GALT5
prerank,regulation of exit from mitosis (GO:0007096),0.2880188663349309,0.7844614237922061,0.7682926829268293,0.9146801123100509,1.0,4/38,6.86%,CDC14A;UBE2E1;PPP1R9B;MAD2L1BP
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3334884326511932,-0.7842036996388155,0.7523809523809524,0.9379295538433677,1.0,3/11,13.16%,CCT2;DKC1;CCT8
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3334884326511932,-0.7842036996388155,0.7523809523809524,0.9379295538433677,1.0,3/11,13.16%,CCT2;DKC1;CCT8
prerank,microtubule anchoring (GO:0034453),0.3606886520307721,0.7834812055850917,0.696078431372549,0.9157530310122936,1.0,3/12,13.92%,GCC2;PEX14;CLASP1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.251287214012832,-0.7828011593118889,0.801948051948052,0.9392016638038461,1.0,3/27,6.51%,GNA15;C3AR1;GPR157
prerank,amyloid precursor protein catabolic process (GO:0042987),0.34835964895710275,0.7827979245303042,0.7472178060413355,0.9164052831092214,1.0,5/14,16.95%,ADAM17;DYRK1A;ADAM19;ABCG1;PSEN1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2798642991041615,0.7826958723912969,0.799475753604194,0.9161336184621647,1.0,7/52,12.50%,TAT;ME2;HAAO;IDH1;MDH2;MTRR;OGDH
prerank,regulation of amyloid-beta formation (GO:1902003),0.2994849638177631,0.7824584422964757,0.7773049645390071,0.9160610792579956,1.0,12/34,15.81%,IFNGR1;SORL1;PICALM;PRNP;RTN2;GSAP;TMED10;RTN4;ROCK1;ABCG1;RELA;RTN1
prerank,cellular response to amino acid stimulus (GO:0071230),0.29169430434744764,0.7823939416505196,0.7550143266475645,0.9157431063141027,1.0,6/33,12.68%,SPAAR;FYN;CAPN2;UBR2;SH3BP4;CASTOR2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.2781150756114217,-0.7822484894686652,0.7988668555240793,0.9391410177278826,1.0,3/20,5.82%,MAFB;CTR9;LDB1
prerank,aminoglycan metabolic process (GO:0006022),-0.33404531410881844,-0.7821590485403475,0.7452380952380953,0.9383399608773858,1.0,3/10,13.75%,CHST9;B3GAT1;B3GAT2
prerank,positive regulation of rRNA processing (GO:2000234),-0.3474732831667003,-0.7820461124880428,0.7458432304038005,0.9375938316740839,1.0,6/10,29.21%,DIMT1;UTP15;WDR43;TRMT112;BUD23;WDR75
prerank,mRNA 3'-end processing (GO:0031124),0.25677286287628054,0.781898411967492,0.8090024330900243,0.9160727736844966,1.0,24/78,19.57%,SSU72;THOC3;FIP1L1;TUT1;MAGOHB;SCAF8;TENT2;RPRD2;SRSF4;SLU7;RPRD1B;PAPOLG;NUDT21;MTPAP;APP;TENT4B;CPSF3;PAPOLA;NCBP1;PABPC1;CSTF3;UPF3B;WDR33;CDC40
prerank,vasculogenesis (GO:0001570),-0.24080894203863284,-0.7816998635002115,0.846875,0.9372232340523586,1.0,4/32,11.94%,TGFBR2;RASA1;ITGB8;VEGFA
prerank,glycogen biosynthetic process (GO:0005978),0.36537673589133046,0.7816899702704563,0.7415540540540541,0.9155465561706415,1.0,3/12,12.77%,PGM1;UGP2;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),0.36537673589133046,0.7816899702704563,0.7415540540540541,0.9155465561706415,1.0,3/12,12.77%,PGM1;UGP2;PGM2L1
prerank,glycerolipid metabolic process (GO:0046486),0.3691361563714959,0.7814702236882027,0.7466887417218543,0.9154712547953892,1.0,1/11,1.04%,DGKG
prerank,regulation of cellular metabolic process (GO:0031323),0.2817325483518212,0.7812991061107061,0.7755376344086021,0.9153091989333659,1.0,8/45,15.86%,PID1;PARL;ARF4;ARF1;PDK3;AGPAT1;ABCG1;RNF41
prerank,membrane lipid catabolic process (GO:0046466),0.3699524700760896,0.7812397207293317,0.7341337907375644,0.9149668732504058,1.0,3/10,16.32%,SMPDL3B;FUCA1;PPT1
prerank,vasoconstriction (GO:0042310),-0.33243317712509957,-0.7811119774460978,0.7800511508951407,0.9372772854046053,1.0,2/11,7.38%,SLC8A1;HTR2B
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3773310585204159,0.780605285211295,0.743103448275862,0.9155320218790014,1.0,4/10,18.67%,PXYLP1;XYLT1;CSGALNACT1;DSEL
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2774067622616949,-0.7803242234291219,0.7955801104972375,0.9376744472034979,1.0,6/19,15.90%,RPTOR;ICE2;NAB2;TENM1;AR;MAF1
prerank,response to nitric oxide (GO:0071731),0.3507085683157977,0.7803096117776893,0.7377049180327869,0.9155773387960907,1.0,1/13,4.37%,DPEP1
prerank,kidney development (GO:0001822),0.264888278161208,0.7798367987645436,0.8241895261845387,0.9158835185512114,1.0,5/65,6.84%,ACE;SULF2;NIPBL;GDNF;WFS1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3023299902992257,0.7797989292273565,0.7884344146685472,0.9155114680224925,1.0,11/32,21.67%,PICALM;SAMD8;MTPN;TMED10;FOXO3;APP;ROCK1;PRKCD;PUM3;PCIF1;EIF4E
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3677062252360174,0.77957388858919,0.7206405693950177,0.9154277666883066,1.0,5/10,24.63%,NFE2L2;EIF2AK3;HSPA5;QRICH1;EIF2S1
prerank,negative regulation of potassium ion transport (GO:0043267),0.3492573461180773,0.7795572806355339,0.7296849087893864,0.9150321261696819,1.0,3/13,13.74%,NEDD4L;PTK2B;STK39
prerank,positive regulation of actin nucleation (GO:0051127),0.36094536464142096,0.7795567964516122,0.7474402730375427,0.914612263531847,1.0,1/11,2.44%,WASF2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.33130763346281966,0.7794946891348175,0.720125786163522,0.9143010954131915,1.0,7/18,20.54%,SETD7;ASH1L;SETD2;KMT2A;SETMAR;EHMT1;PRDM9
prerank,regulation of multicellular organism growth (GO:0040014),0.3427746575865426,0.7793988953838957,0.7627388535031847,0.9140407035662949,1.0,2/15,3.80%,STAT5A;STAT5B
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3097632568095396,0.7791955513878331,0.7294469357249627,0.9139228598805959,1.0,8/25,22.65%,HSPA1A;DNAJB12;HSPA9;HSPA5;DNAJB14;DNAJB4;SDF2;HSPA8
prerank,regulation of cell division (GO:0051302),0.25680462748248284,0.7791044785875503,0.8312655086848635,0.9136269783934402,1.0,12/72,15.07%,UVRAG;KIF20A;BIRC6;NCOA3;CIB1;GIT1;SETD2;INSC;CSPP1;PIK3R4;AURKB;ORC6
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.32119731184913863,0.778936419994225,0.7755725190839695,0.9134544686291847,1.0,3/23,3.95%,CCDC88C;KIF5B;CCDC88A
prerank,histone H3 deacetylation (GO:0070932),0.34341369575318775,0.7789312205249982,0.740924092409241,0.9130442013255766,1.0,5/15,18.06%,HDAC9;HDAC3;ELK4;SIRT1;HDAC1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3190658514075712,0.7784693904649702,0.7401812688821753,0.9133091541740582,1.0,2/22,4.01%,ACE;MRE11
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.24662220969078874,-0.7782750051160076,0.8398791540785498,0.9400549164588945,1.0,16/30,32.26%,GTF2H2;TTF1;GTF2H1;TAF1D;ERCC2;POLR2K;GTF2H3;CDK7;POLR2H;GTF2H5;TBP;GTF2H4;CAVIN1;POLR1F;MNAT1;POLR2L
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.24569804038496507,0.7781427327967738,0.8337209302325581,0.9133828897307639,1.0,24/112,17.18%,ARHGEF18;FOS;CBL;ZFYVE9;PDE2A;F11R;ENG;PXN;ZFP36L2;RHOA;USP15;NRROS;SMAD4;NR3C1;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;WNT7A;SMAD5;SIRT1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.2801019070196634,-0.7779398699035377,0.7526881720430108,0.9396462987508853,1.0,5/17,15.49%,SASH1;TRIM5;NFKBIL1;CX3CL1;BMP6
prerank,ncRNA processing (GO:0034470),0.23404193047106187,0.7775681071912363,0.8991507430997877,0.913865537500978,1.0,37/200,14.69%,RPL5;NOL6;FARS2;RPL37A;DGCR8;RPL6;XRN2;DHX37;RPS14;RPL35A;TUT1;UTP6;RPL13;DDX49;NOC4L;MPHOSPH6;INTS2;SRRT;TUT7;NOL11;INTS11;RPL34;RPLP0;UTP20;RPL19;RPL11;RPL30;NOP58;METTL3;RRP36;INTS4;RPS2;RPL4;RPL7;UTP18;MRTO4;DDX10
prerank,meiosis I (GO:0007127),-0.2675907795491365,-0.7770660705667388,0.7964601769911505,0.94009399902782,1.0,13/23,51.66%,FOXJ2;ZCWPW1;ZSCAN21;DDX4;SYCP3;SGO1;HSF2BP;FOXJ3;SLC25A31;TDRD9;BCL2L11;MEIOB;MOV10L1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3238339024018767,0.7767696510212823,0.749613601236476,0.9146174020284863,1.0,2/20,6.35%,PLSCR1;GSS
prerank,regulation of cellular pH (GO:0030641),0.2993985203227383,0.7766570731411723,0.7608695652173914,0.9143570306993233,1.0,3/29,7.52%,SLC9A7;SLC4A7;SLC4A8
prerank,regulation of cholesterol efflux (GO:0010874),0.30072547561020513,0.7762871243202547,0.7514792899408284,0.9145035052623891,1.0,7/30,14.70%,PPARG;NFKBIA;ABCA3;NAXE;ABCA5;SREBF2;GPS2
prerank,negative regulation of chemokine production (GO:0032682),0.3468892275432508,0.7761031340446142,0.7262658227848101,0.9143696952504141,1.0,4/14,14.83%,KLF4;IL6;MAP2K5;GSTP1
prerank,mitochondrial transport (GO:0006839),-0.2150462815525921,-0.7758091685887877,0.8451327433628318,0.9411116059144619,1.0,25/53,28.62%,BCL2L1;FLVCR1;TIMM44;TIMM17A;STARD3;TIMM9;GDAP1;MFF;OXA1L;SPG7;BCAP31;TMEM14C;COX18;TIMM10B;TOMM34;TIMM13;BCS1L;TOMM7;MFN2;TIMM8B;HSP90AA1;TMEM14A;ABCB10;SLC25A4;TIMM17B
prerank,mitotic spindle organization (GO:0007052),-0.17840732696333442,-0.7757893094190753,0.990990990990991,0.9402258023225559,1.0,65/153,31.42%,NEK6;CLIP1;RMDN1;PIBF1;CENPO;CLASP2;PPP1CC;CKAP5;BUB3;NUP133;GOLGA2;DYNLL2;LSM14A;DYNLL1;WDR62;ZW10;CEP126;MAPRE1;RANBP2;MAD1L1;BCCIP;SEC13;NUP85;SMC1A;RAN;CENPE;RAB11A;SPICE1;KNL1;CENPA;NUP37;DCTN6;KIF18A;NDEL1;MAP9;CENPP;SUN2;PMF1;BUB1B;CENPK;CENPU;TPX2;BUB1;PRC1;CENPF;PLK2;DLGAP5;CCDC61;CENPT;KIFC2;SPDL1;EFHC1;NDC80;NSL1;CDCA8;B9D2;RCC1;KIF4A;DSN1;CEP192;KIFC1;RANGAP1;TOGARAM2;CENPN;MIS12
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3214804617915243,-0.775722415701287,0.7573529411764706,0.9385022481835669,1.0,2/11,4.92%,AGO3;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3214804617915243,-0.775722415701287,0.7573529411764706,0.9385022481835669,1.0,2/11,4.92%,AGO3;AGO1
prerank,positive regulation of axon extension (GO:0045773),-0.2667931024203385,-0.7753200671570518,0.8114285714285714,0.9382050785129203,1.0,6/22,18.10%,NRP1;LIMK1;GOLGA4;VEGFA;MACF1;SEMA7A
prerank,retinoid metabolic process (GO:0001523),-0.20955796809356175,-0.7752779746739636,0.9035532994923858,0.9373444675317646,1.0,20/71,33.74%,APOE;LRP1;BCO2;DHRS3;GPC6;AGRN;AKR1B1;RDH13;NAPEPLD;GPC4;SCPEP1;AWAT2;SDC2;ALDH1A2;GPC2;DHRS13;RDH11;RETSAT;CYP26B1;RBP1
prerank,negative regulation of cellular senescence (GO:2000773),0.35024738483231094,0.7748330139893477,0.7269736842105263,0.9158994070038415,1.0,1/13,1.61%,AKT3
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3403010944326819,-0.7747959076329138,0.7595238095238095,0.9371503708104024,1.0,3/10,10.70%,BIN1;ATP1A2;VDAC1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.2557302807776323,-0.7741260881936717,0.8338870431893688,0.9372376170561959,1.0,2/26,2.15%,ANAPC15;NEK6
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.35674047210207693,0.7735779885161193,0.724561403508772,0.9173427144776806,1.0,1/11,3.37%,RSPO3
prerank,DNA biosynthetic process (GO:0071897),0.3376398948788938,0.7735071153394927,0.7625201938610663,0.9170306217883103,1.0,3/16,7.02%,POLL;POLD4;WRN
prerank,purine-containing compound salvage (GO:0043101),-0.3178026453071743,-0.7731660675584868,0.7723004694835681,0.9378146641755337,1.0,4/12,27.68%,GMPR;AMPD2;HPRT1;ADK
prerank,histone H2A acetylation (GO:0043968),-0.28715028903895584,-0.7730348404064655,0.7799442896935933,0.9370974920356754,1.0,8/16,28.61%,NAA40;MEAF6;SPHK2;RUVBL1;MORF4L2;DMAP1;RUVBL2;TRRAP
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.33453803081560024,-0.7727032731011327,0.7725,0.9366826473640468,1.0,6/10,24.40%,NELL1;FURIN;RIC1;DAB2IP;RGP1;EPHA4
prerank,response to interleukin-4 (GO:0070670),-0.33840968702679386,-0.77211984338664,0.7622549019607843,0.9366493559893556,1.0,4/10,35.69%,JAK3;SHPK;LEF1;TCF7
prerank,ribosome assembly (GO:0042255),0.27198254059647586,0.7716910943802435,0.782258064516129,0.9193218603958682,1.0,7/47,12.91%,RPL5;RPL6;DHX37;RPS14;RPF2;RPLP0;RPL11
prerank,regulation of calcium ion import (GO:0090279),0.31967513155745697,0.7705340601122853,0.7709923664122137,0.9206519081287845,1.0,4/21,12.85%,FYN;PRNP;SLC30A1;LGALS3
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.33838213892880464,-0.770480445081966,0.755,0.9383362353792076,1.0,3/10,21.89%,WHRN;ADGRV1;SOD1
prerank,negative regulation of DNA replication (GO:0008156),-0.30855723813729796,-0.7698953032396266,0.751269035532995,0.9383300319315147,1.0,1/13,1.57%,WAPL
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3371367892939952,0.7691437889913431,0.75,0.9222867595171292,1.0,3/15,13.64%,ZC3H12D;KHNYN;RNASEH1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.31031252807288173,0.7673086326774347,0.7626339969372129,0.9245824021964727,1.0,5/23,16.09%,IL10RA;CRLF3;IL6;KIT;OCIAD1
prerank,triglyceride homeostasis (GO:0070328),-0.25330930245289907,-0.767301931518249,0.8244514106583072,0.9412692852478046,1.0,2/26,5.86%,APOE;PNPLA8
prerank,RNA biosynthetic process (GO:0032774),0.29466753695892123,0.7672901372544645,0.7755102040816326,0.9241888113930055,1.0,6/31,14.55%,TAF13;SMARCA5;SETX;TAF7;POLA2;RSF1
prerank,alcohol catabolic process (GO:0046164),-0.32440108007075286,-0.7670175979797615,0.7806004618937644,0.9407785287965696,1.0,1/10,0.41%,APOE
prerank,autophagosome maturation (GO:0097352),0.29131555579472923,0.7668694874097183,0.7749627421758569,0.9243738700138976,1.0,6/32,14.19%,UVRAG;STX17;TSG101;WIPI2;VMP1;VCP
prerank,cytosolic calcium ion transport (GO:0060401),0.29764641137478576,0.7668521211963881,0.8029197080291971,0.9239825339232494,1.0,4/28,5.27%,MCUB;ATP2B1;ATP2A3;MAIP1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3542739839085789,0.7662832552050596,0.7571669477234402,0.9243818724329295,1.0,2/12,7.30%,ATF7IP;SETDB2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2992233186382032,0.766272373147936,0.8037790697674418,0.9239755840749163,1.0,11/28,23.71%,NGF;SPI1;DAXX;DEDD2;BAG3;ZDHHC3;DIABLO;BID;BCL2;TNF;CASP8AP2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.28704124032638934,0.7656057513379501,0.806970509383378,0.9245198858694695,1.0,8/38,14.93%,H3-3A;RBBP4;SMARCA5;CENPL;CENPQ;ATRX;RSF1;CENPC
prerank,autonomic nervous system development (GO:0048483),-0.28353142702530476,-0.7653628245197105,0.7928994082840237,0.9423171236450716,1.0,4/17,16.72%,NRP1;NF1;SOX4;SOX11
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.27289559917361533,0.7653532862835088,0.8128342245989305,0.9244741222887822,1.0,10/48,18.20%,NUP210;PRKAG2;NOA1;NUP98;PRKAG1;NUP153;PNPT1;SEH1L;GCK;NUP93
prerank,heart development (GO:0007507),0.23709408390640008,0.7647483276400925,0.8947951273532669,0.9249183631771902,1.0,15/150,10.33%,KDM6A;PDLIM5;HEG1;PDLIM1;NIPBL;BMPR2;GPC3;DLC1;PTEN;CRIP1;SGCD;HDAC9;ID2;FBN1;FN1
prerank,hyaluronan catabolic process (GO:0030214),0.32716113838402866,0.7645290392400912,0.7492260061919505,0.9248293273136254,1.0,1/18,0.26%,CD44
prerank,protein localization to cell surface (GO:0034394),0.29948154142955064,0.764503867515025,0.7804511278195488,0.9244511517633549,1.0,7/26,18.46%,PTPRU;CD177;FLNA;USP4;PIGK;UNC50;VCL
prerank,gluconeogenesis (GO:0006094),0.2782417159030778,0.7642667602635933,0.7825484764542936,0.9243960753895369,1.0,7/39,11.17%,CRY1;SLC25A13;SLC37A4;PGM1;MDH2;SLC25A12;GPI
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2689621289353716,0.7639123231806392,0.8204456094364351,0.9244927072323498,1.0,13/54,17.55%,RPL5;RPL6;RPL35A;NHP2;RPF2;NSA2;MAK16;RPLP0;RPL11;RPL7;MRTO4;MRPL20;LTO1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.3157082650437903,0.7638325776500886,0.7579113924050633,0.9241995135391303,1.0,4/18,14.65%,IL27RA;RPS3;ICOSLG;IL18
prerank,ceramide transport (GO:0035627),-0.3153414615007376,-0.7637536824532444,0.7582159624413145,0.94385275109753,1.0,2/12,5.06%,ABCB4;PLEKHA8
prerank,phosphate ion transmembrane transport (GO:0035435),-0.31296324620394655,-0.7635782775157793,0.8042452830188679,0.9432332266873709,1.0,4/12,12.25%,SLC37A2;SLC25A3;SLC25A11;SLC25A14
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2503972253443665,0.7633932262191668,0.8367103694874851,0.92441628791643,1.0,20/88,18.37%,DAPK1;NFKB1;DNAJC1;BTG2;EIF2AK2;GIGYF2;MRPL13;TRIM71;RPS3;IGF2BP3;PAIP2;EIF4ENIF1;EIF2AK3;AKT1;SYNCRIP;DAPK3;CNOT8;CAPRIN1;DDX6;SHMT1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.29715981796512897,0.7628825809233665,0.7786032689450223,0.9247498164309856,1.0,3/26,7.18%,PLCG2;PRNP;CIB1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3238295650585043,0.762782250605881,0.7584541062801933,0.9244663095464162,1.0,4/19,11.42%,PAPSS1;SULT2B1;PAPSS2;TPST1
prerank,oxoacid metabolic process (GO:0043436),-0.2477484838767706,-0.7626444273495377,0.8358662613981763,0.9436845582500544,1.0,2/27,3.14%,TPST2;ENPP1
prerank,protein localization to chromatin (GO:0071168),0.32309447198442415,0.7624758688337875,0.7597402597402597,0.9244991208720715,1.0,7/18,18.32%,NIPBL;FAM47E;LEMD2;MCM9;PPHLN1;LRWD1;RAD21
prerank,regulation of mitotic nuclear division (GO:0007088),0.2672904826719985,0.7624743164295803,0.8236040609137056,0.9240835296908254,1.0,3/55,5.44%,IL1B;CDK13;CAV2
prerank,mitotic recombination (GO:0006312),0.33205390020682335,0.7621564180245677,0.7737704918032787,0.924143320697609,1.0,4/15,18.88%,TEP1;MSH3;SMC6;SMC5
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.3569455577154319,0.7621461866399936,0.7620689655172413,0.9237412300698232,1.0,2/11,10.66%,TLR3;RIPK1
prerank,cellular response to osmotic stress (GO:0071470),-0.26627304682091285,-0.7619398332340896,0.8495575221238938,0.943860510147286,1.0,6/21,21.63%,CAPN3;PKD2;RCSD1;TRPV4;DDX3X;WNK3
prerank,histone H3-K36 demethylation (GO:0070544),-0.33417702922220827,-0.7616871845631583,0.7788461538461539,0.943321120233786,1.0,4/10,11.66%,KDM2A;KDM2B;KDM4A;PHF8
prerank,regulation of cellular senescence (GO:2000772),-0.2489694523374871,-0.7613200561921917,0.8604651162790697,0.9429540061340262,1.0,3/28,3.42%,NUAK1;NEK6;ZKSCAN3
prerank,macrophage chemotaxis (GO:0048246),0.365762477619859,0.7612330581855677,0.7637271214642263,0.9246667138703321,1.0,2/10,12.85%,CKLF;LGALS3
prerank,long-chain fatty acid transport (GO:0015909),0.2916357343136109,0.7612239934697724,0.8072463768115942,0.9242602830677169,1.0,4/30,6.35%,PPARG;PRKAG2;CD36;PRKAB2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3481233815550291,0.7609952413811629,0.7637271214642263,0.9241663010128734,1.0,2/12,11.91%,ZFP36L2;REST
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3134119148139868,0.7603879643622726,0.7575301204819277,0.9246293473869206,1.0,5/22,15.92%,HEXIM1;PTEN;LATS1;LATS2;APC
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.25835698726272593,0.759896640090388,0.8399503722084367,0.9249197946414904,1.0,16/71,15.86%,LONP1;RSPRY1;MALT1;CHMP4B;FAP;CAPN2;NEDD8;PDCD6IP;ATXN3;UBE2W;FBXL17;ADAMTS12;YME1L1;VCP;USP9X;RNF41
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.30973347806445845,0.7594346328324875,0.7755417956656346,0.9251417628471365,1.0,4/23,16.74%,TNNC1;ID2;TGFB1;PROX1
prerank,regulation of lipid kinase activity (GO:0043550),0.36196771071639,0.7593539943490536,0.7774086378737541,0.9248465576194147,1.0,4/11,17.10%,PPP2R5A;RBL2;RB1;PIK3R2
prerank,renal absorption (GO:0070293),0.3600580951326512,0.7593117952245703,0.7487603305785124,0.9244879159940464,1.0,1/10,3.31%,KCNQ1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.35677185464015526,0.7592633792948029,0.7602040816326531,0.9241482977984059,1.0,3/11,15.28%,RTN4;ATL1;VCPIP1
prerank,regulation of protein dephosphorylation (GO:0035304),0.2793006486925693,0.7586618291233092,0.7891891891891892,0.9245896316440452,1.0,12/37,18.58%,PPP2R5A;DLC1;PPP1R15A;PPP1R2;ANKLE2;HTT;PPP6R2;TGFB1;PPP1R7;PTPA;PRKCD;PIN1
prerank,steroid metabolic process (GO:0008202),0.2555762678356018,0.7585935064377214,0.8296568627450981,0.9242569456632991,1.0,9/72,13.24%,HSD17B14;HSD17B7;CYP27A1;SULT2B1;MSMO1;DHRS4;DHRS9;RDH5;DHCR24
prerank,positive regulation of translation (GO:0045727),0.24498200136388928,0.7584981892542987,0.8621908127208481,0.9239703589302262,1.0,4/94,2.39%,NIBAN1;BCL3;RPL5;VIM
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.29775842321433327,-0.7584119388476253,0.8059299191374663,0.9462368986266043,1.0,8/14,34.23%,ENPP1;AK3;ITPA;AK1;CMPK2;ENPP3;AK4;NME2
prerank,endosome organization (GO:0007032),0.275284297728599,0.7579840820001191,0.7991858887381276,0.9242885056830056,1.0,13/41,23.35%,PLEKHF1;TMCC1;PI4K2B;SNX3;SNX33;PI4K2A;SNX10;HOOK3;USP8;AKTIP;CHMP2B;CORO1C;USP50
prerank,mitochondrial transcription (GO:0006390),0.3611339842032426,0.7575605108703024,0.7566137566137566,0.9244428763266933,1.0,3/10,15.90%,FOXO3;TFAM;TFB1M
prerank,linoleic acid metabolic process (GO:0043651),0.322778448195285,0.7568786694746971,0.7848101265822784,0.9249909984822589,1.0,4/17,20.17%,ELOVL5;ABCD1;GSTP1;ACSL1
prerank,chromosome organization (GO:0051276),0.2446013117086127,0.7568581168215902,0.8582949308755761,0.9246149344748114,1.0,28/99,22.41%,PADI1;H3-3A;SETD7;PHF19;MSH3;DOT1L;MSH6;COPS3;LATS1;EZH1;EZH2;HDAC3;HMGN1;SIRT1;SUPT4H1;LRWD1;PADI2;HDAC1;GATAD1;EHMT1;SATB1;XPA;BRWD1;HDAC5;PARP1;CUL4A;GPS1;HMG20A
prerank,response to hydroxyurea (GO:0072710),0.3597663374724523,0.7558204649142246,0.7667238421955404,0.9257281709057915,1.0,3/11,12.80%,KAT7;ATRX;SPIDR
prerank,striated muscle cell development (GO:0055002),-0.2922095188383707,-0.7556026923578666,0.8244274809160306,0.9494070480007134,1.0,3/14,18.61%,CAPN3;TMOD1;TMOD2
prerank,embryonic eye morphogenesis (GO:0048048),-0.31712003377090453,-0.7554053883600744,0.7839080459770115,0.9487912369386603,1.0,3/11,16.22%,LRP6;KDM2B;EFEMP1
prerank,establishment of protein localization to organelle (GO:0072594),0.2523951576338725,0.7546508034676088,0.8409937888198757,0.92696502724709,1.0,17/72,18.81%,NEURL1B;SYK;STAT3;IL10RA;PTTG1IP;LAMP5;HIKESHI;NUP153;EIF4ENIF1;AKT1;FAM53C;TNPO1;KPNB1;TSPAN17;APPL1;NUP93;PINK1
prerank,embryonic heart tube development (GO:0035050),-0.3015577934379329,-0.7545582821131405,0.7859078590785907,0.9491357822277278,1.0,3/14,25.53%,ACVR1;RYR2;NDRG4
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2657327413754649,0.754261623820693,0.8088426527958388,0.9266874579433574,1.0,10/50,16.20%,NUP210;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;PUM1;SEH1L
prerank,regulation of gene silencing by RNA (GO:0060966),0.2657327413754649,0.754261623820693,0.8088426527958388,0.9266874579433574,1.0,10/50,16.20%,NUP210;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;PUM1;SEH1L
prerank,regulation of gastrulation (GO:0010470),0.3390148156679771,0.7540374588333006,0.7713365539452496,0.9265949187645298,1.0,4/14,15.52%,SCX;PHLDB2;CLASP1;POGLUT1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.25909734411764224,-0.7535004653224798,0.8170731707317073,0.9497202088966136,1.0,7/24,19.54%,NRP1;SEMA3D;SEMA3E;SEMA6D;VEGFA;SEMA7A;SEMA5B
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2993919639131887,-0.7533592294586626,0.8010335917312662,0.9490085703309711,1.0,6/13,20.43%,KPNA6;NUP54;IPO5;RANBP2;NUP35;RGPD1
prerank,negative regulation of histone acetylation (GO:0035067),0.35303514660704877,0.7523720037445751,0.7609075043630017,0.9285445514386156,1.0,3/11,17.18%,SPI1;TAF7;SIRT1
prerank,regulation of rRNA processing (GO:2000232),-0.28913961894849666,-0.7520875257638157,0.7838541666666666,0.9499108159375197,1.0,9/16,29.21%,DIMT1;UTP15;WDR43;TRMT112;YTHDF2;BUD23;NUDT16;USP36;WDR75
prerank,regulation of lipase activity (GO:0060191),0.34337296064804096,0.7514680336973532,0.7516447368421053,0.929466323549959,1.0,3/13,15.06%,RHOA;PCSK5;ANGPTL3
prerank,RNA stabilization (GO:0043489),0.28597142479125054,0.7510084070331347,0.8140495867768595,0.9296950949550071,1.0,7/33,16.01%,TENT5A;GDNF;TRDMT1;TENT2;EIF4ENIF1;PAIP1;PABPC1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.24430056560844743,0.7507549427969464,0.8615751789976134,0.9296221575643336,1.0,7/85,8.63%,CDC14A;NIPBL;KCNQ1;RIPOR2;MYO3B;WFS1;PDZD7
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.2826982888439561,-0.7506127023619843,0.8126721763085399,0.9509793366840268,1.0,3/16,15.29%,PTN;TGFB2;SOX5
prerank,iron ion transmembrane transport (GO:0034755),0.3634571239229953,0.750161694708239,0.7732656514382402,0.9300132717375733,1.0,1/10,3.48%,ABCB7
prerank,regulation of synapse organization (GO:0050807),0.30061551486582566,0.7500627872535957,0.813953488372093,0.9297225019234392,1.0,8/26,17.56%,PDLIM5;SETD5;ABHD17B;YWHAZ;SLITRK4;GRIPAP1;MDGA1;ABHD17A
prerank,regulation of transport (GO:0051049),0.2795492119824145,0.7500080145171437,0.830110497237569,0.929387399822326,1.0,1/36,0.22%,LRRK2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2702420859876734,0.7499371853741912,0.8083441981747066,0.9290812807302924,1.0,10/40,18.78%,FAM111A;WRN;MSH3;EXD2;ATRX;DONSON;MCM9;POLD1;PRIMPOL;SETMAR
prerank,neuromuscular process (GO:0050905),0.32349761683707184,0.7490704242166847,0.7656500802568218,0.9298495255062241,1.0,3/16,13.68%,MYCBP2;PAFAH1B1;TIFAB
prerank,regulation of ATP metabolic process (GO:1903578),0.2610262943847771,0.7490124346380547,0.833976833976834,0.929522309554564,1.0,13/54,18.81%,NUP210;PRKAG2;NUP98;ATP7A;FIS1;PRKAG1;NUP153;ABCD1;SEH1L;COX7A2;GCK;NUP93;PINK1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3538271888907438,0.7484129981085879,0.7753001715265866,0.929946800305838,1.0,2/11,7.30%,ATF7IP;SETDB2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.35940158190870963,0.7482664051286221,0.7768166089965398,0.9297467009207323,1.0,1/10,2.97%,MAD2L2
prerank,histone exchange (GO:0043486),0.2805340604812753,0.7481967513255694,0.8340192043895748,0.9294327360649963,1.0,8/37,14.93%,RBBP4;SMARCA5;CENPL;ACTR6;CENPQ;SRCAP;RSF1;CENPC
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.268772381220363,-0.7481048318250832,0.8324324324324325,0.9516958226481823,1.0,9/20,24.94%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.268772381220363,-0.7481048318250832,0.8324324324324325,0.9516958226481823,1.0,9/20,24.94%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.268772381220363,-0.7481048318250832,0.8324324324324325,0.9516958226481823,1.0,9/20,24.94%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,skeletal muscle tissue development (GO:0007519),0.2867299296601758,0.7476996504982482,0.810958904109589,0.9296876927477582,1.0,4/32,14.07%,SVIL;CAV2;LEMD2;MYH14
prerank,plasma membrane organization (GO:0007009),0.25873266398593664,0.7476555368483676,0.8431122448979592,0.9293366386916829,1.0,12/61,15.67%,PLSCR1;DYSF;MYH9;EHD2;CHMP4A;BIN3;SNX9;PACSIN2;ABCD1;ARL8B;FA2H;SNX33
prerank,rRNA metabolic process (GO:0016072),0.22703832899823972,0.747324355332458,0.9038251366120219,0.9293825374652238,1.0,29/160,14.69%,RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;UTP6;RPL13;DDX49;NOC4L;MPHOSPH6;NOL11;DEDD2;RPL34;RPLP0;UTP20;RPL19;RPL11;RPL30;NOP58;RRP36;RPS2;RPL4;RPL7;UTP18;MRTO4;DDX10
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.2740587520764576,-0.7472384214962712,0.8559782608695652,0.9520098452266281,1.0,2/18,7.61%,BIN1;ATP1A2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2397074908037522,0.7468534335378614,0.8832369942196532,0.9296420121649185,1.0,18/104,13.60%,UVRAG;CCNJL;CCND3;CDKN2C;CCND1;TSG101;CIB1;CCNH;RALB;SNF8;RHOA;CCNT2;HTT;CCNT1;CDK12;CCND2;AKT1;EZH2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3048056603556695,-0.7467310366372242,0.8147321428571429,0.9518139482511884,1.0,5/12,28.63%,PSAT1;SERINC3;PHGDH;MTHFD1;SEPHS2
prerank,peroxisome organization (GO:0007031),0.29612854579509446,0.7464972939466518,0.7835820895522388,0.9297299120620679,1.0,6/25,13.07%,PEX16;PEX12;PEX14;FIS1;DNM1L;ABCD1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.25483138150049933,-0.7458768170810264,0.8132530120481928,0.9520751248271456,1.0,6/23,17.64%,HMGB1;REXO4;CECR2;CASP3;HMGB2;FBH1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.29292194070743943,0.7453930222093671,0.8099547511312217,0.9308954104004206,1.0,7/27,14.60%,SLC25A13;SLC25A12;SLC1A4;SLC6A5;SLC25A18;SLC38A1;SLC6A9
prerank,negative regulation of cell aging (GO:0090344),0.3211059638072992,0.7453864328288842,0.7866043613707165,0.9304949967630772,1.0,1/16,1.61%,AKT3
prerank,monocyte differentiation (GO:0030224),0.3531436418201709,0.7452085215990624,0.7624113475177305,0.9303112473503993,1.0,3/10,10.41%,PPARG;MYH9;IL31RA
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23222402640541218,0.7449157978992152,0.9018264840182648,0.9302947549428282,1.0,33/132,20.61%,RPL5;CRNKL1;SNRPD2;PRPF6;RPL6;SNRPB;SETX;RPS14;SRSF10;RPF2;COIL;CELF2;YTHDC1;NUDT21;MCTS1;RPLP0;DDX23;RPL11;GEMIN7;NCBP1;TXNL4A;CELF1;MRPL20;RPSA;SHQ1;SF3B1;DDX20;RPS27;SF3A2;LUC7L3;SNUPN;LUC7L;PRPF18
prerank,embryonic organ morphogenesis (GO:0048562),0.27201169724917473,0.7449053693620337,0.8203753351206434,0.9298990836180882,1.0,4/42,9.64%,NIPBL;RARG;ID2;FBN1
prerank,histone H4-K16 acetylation (GO:0043984),0.31984920690061674,0.7445463428693672,0.7838258164852255,0.9299493913945103,1.0,9/19,20.73%,KAT7;KANSL1;JADE3;MSL3;KMT2A;PHF20;MSL2;WDR5;KANSL3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2637337463122305,0.7442373197925007,0.8358008075370121,0.9299689956500496,1.0,15/49,22.43%,MCL1;BBC3;SGMS1;CYLD;FIS1;DNM1L;EIF2AK3;PLAUR;BECN1;PINK1;BAD;BCLAF1;BID;BCL2;SIAH1
prerank,magnesium ion transport (GO:0015693),0.35181584987770553,0.7437573215864915,0.7764900662251656,0.9302101059014245,1.0,3/12,10.59%,MMGT1;MAGT1;NIPA2
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2628517724792102,-0.7436354697791872,0.8228228228228228,0.9541647475828453,1.0,5/21,11.18%,ENSA;PPP1R8;PPP1R11;PPP4R4;MFHAS1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.23647034607625098,0.7431893369645004,0.8899297423887588,0.9305582152089648,1.0,20/113,14.99%,LCP1;SYK;CD36;MMP1;SUMO1;FAF1;TIRAP;TPPP3;PIEZO1;RPS3;PSMC4;RPA3;SPIDR;LGALS3;ERCC3;GBP5;ERCC4;VCP;TGFB1;MYD88
prerank,hexose biosynthetic process (GO:0019319),0.2686930281432851,0.7428496124447066,0.8294360385144429,0.9306085807086467,1.0,8/42,12.55%,CRY1;SLC25A13;SLC37A4;PGM1;MDH2;SLC25A12;GPI;CHST15
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.30603558433862876,-0.7424732552888369,0.8205128205128205,0.9547296712334346,1.0,5/12,27.58%,PRPSAP1;AMPD2;HPRT1;MTHFD1;PRPSAP2
prerank,chromosome condensation (GO:0030261),0.27904497655958427,0.7421515603030351,0.8085991678224688,0.9311192878681811,1.0,9/36,17.72%,SMC4;CSNK2A2;CSNK2A1;AIFM1;DFFB;RB1;ACIN1;MCPH1;PHF13
prerank,regulation of epithelial cell proliferation (GO:0050678),0.2450522798150895,0.7421272460968997,0.873341375150784,0.9307437031240744,1.0,5/85,5.24%,RUNX3;MARVELD3;GPX1;LAMB1;DEAF1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.23982660139311435,0.741298953923859,0.8783132530120482,0.9314740620769725,1.0,20/95,15.65%,HSPA1A;ZEB2;LEMD3;HIPK2;ADAM17;PDPK1;MTMR4;ENG;LATS1;SPRED3;SMAD4;PMEPA1;ING2;LATS2;ITGA3;CITED2;TGFB1;CREBBP;SPRED1;THBS1
prerank,regulation of protein localization to centrosome (GO:1904779),0.3549877202529262,0.7404490660221741,0.7770034843205574,0.9322116369888781,1.0,4/10,21.96%,CEP250;APC;MARK4;GSK3B
prerank,organic acid transport (GO:0015849),0.23768322933823444,0.7404006513020565,0.8752969121140143,0.9318788388754182,1.0,14/94,13.59%,SLC23A2;SLC23A1;LRRC8D;SLC25A30;SLCO1B1;NCOA2;SLC1A5;SLC43A2;NCOA1;SLC1A4;ABCC4;SLC38A1;SLCO1C1;SLC26A7
prerank,response to organophosphorus (GO:0046683),0.31292511173329063,0.7403105961618711,0.7809076682316118,0.9315877776186948,1.0,3/16,12.17%,STAT1;TRIM16;NDUFS4
prerank,diol metabolic process (GO:0034311),0.30589134193545386,0.7395826177587986,0.8078078078078078,0.9321878423467049,1.0,5/19,15.01%,NAAA;PRKG2;AKT1;SGPP2;SGPP1
prerank,sulfur compound transport (GO:0072348),0.2925252930395675,0.7394200395923958,0.8107302533532041,0.9320054323020182,1.0,3/27,5.59%,RACGAP1;LRRC8D;SLC25A30
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.24073362478587845,0.7391139873238387,0.8922363847045192,0.9319961461124756,1.0,20/102,19.20%,CYSLTR2;PPARG;NFKB1;C2CD5;PDPK1;HDAC9;PRKAR2A;ADCY7;ADCY5;AKT1;KAT2B;RELA;RPS6KB1;INSR;GCK;PIK3R2;NR4A1;SYAP1;PRKCD;RAB10
prerank,regulation of myelination (GO:0031641),0.2927206703713425,0.7379607536594585,0.7881619937694704,0.9330990964845595,1.0,5/25,13.54%,ITGAX;MYRF;EIF2AK3;ZPR1;TNFRSF1B
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.310212441566645,-0.7371034015974549,0.8060747663551402,0.9607497678150408,1.0,5/11,27.19%,LGALS9;PIH1D1;HTRA2;GSN;FAS
prerank,positive regulation of ERAD pathway (GO:1904294),0.3382260624755682,0.7367891765473638,0.7837837837837838,0.9343055485535949,1.0,2/13,8.58%,NFE2L2;ATXN3
prerank,regulation of protein autophosphorylation (GO:0031952),0.27439187353564926,0.7366684955008164,0.827538247566064,0.9340498670481018,1.0,9/36,17.13%,PPP2R5A;MRE11;MOB1B;ENG;PDGFD;MVP;PPP2R5C;PPP2R5E;RASSF2
prerank,piRNA metabolic process (GO:0034587),0.3113615350977792,0.7366388222621206,0.8243670886075949,0.9336800281645657,1.0,1/19,5.46%,EXD1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.25981192242923035,0.7365380429844663,0.8562005277044855,0.9333896329009861,1.0,11/54,15.38%,RPL5;HSPA1A;CRY1;RPS3;CAMLG;DCUN1D3;USP4;RPL11;AKT1;PRMT3;SVBP
prerank,response to ethanol (GO:0045471),-0.2990161442611574,-0.73599955518527,0.8025974025974026,0.9612179565044401,1.0,4/14,22.55%,SDF4;GLRA2;SOD1;GRIN2B
prerank,regulation of endopeptidase activity (GO:0052548),0.25496462374395407,0.7351895781466735,0.8428927680798005,0.9348011128936975,1.0,8/59,13.17%,PSME3;PICALM;PSME2;BIRC3;SERPINB9;PSMB8;PRELID1;AKT1
prerank,autophagosome organization (GO:1905037),0.261399355584986,0.7348221351903047,0.8688085676037484,0.9348879222211538,1.0,14/50,21.56%,RAB19;RAB7A;ATG5;STX12;PACS2;WIPI2;VMP1;RB1CC1;AMBRA1;BECN1;ATG13;RAB43;ULK1;GABARAPL1
prerank,positive regulation of response to stimulus (GO:0048584),0.2714048106450463,0.7343950286332441,0.8349514563106796,0.9350336998496803,1.0,9/40,20.60%,TAF9;IFIH1;ARG2;B2M;FCGR2B;NSMCE4A;SIRT1;PRKCD;BCLAF1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.32532502153554943,0.7340287629589849,0.7936507936507936,0.9351051427446876,1.0,2/15,6.65%,KLF4;PDPK1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.2789119951458133,0.7336402273402594,0.8328488372093024,0.9347878127691384,1.0,4/31,7.89%,GTF2F2;POLR2C;CMTR1;CCNH
prerank,7-methylguanosine RNA capping (GO:0009452),0.2789119951458133,0.7336402273402594,0.8328488372093024,0.9347878127691384,1.0,4/31,7.89%,GTF2F2;POLR2C;CMTR1;CCNH
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2806563049500604,0.7334283995240582,0.8282387190684134,0.9346768121493062,1.0,9/30,20.27%,BMPR2;CERS1;DCP2;ERCC4;TENT4B;STN1;NIBAN2;TERF2;HNRNPC
prerank,sensory perception of sound (GO:0007605),0.23724702490195992,0.7330452158003316,0.8928150765606596,0.9347920394149499,1.0,7/88,8.63%,CDC14A;NIPBL;KCNQ1;RIPOR2;MYO3B;WFS1;PDZD7
prerank,axonogenesis (GO:0007409),0.21985570887217123,0.7320598151370954,0.94375,0.935672730549291,1.0,22/237,9.01%,NOTCH2;EMB;FYN;RET;LMTK2;NTNG2;PTPRO;SEMA4A;SHTN1;NPTN;KIF5B;B4GALT5;GDNF;RPS6KA5;PTEN;GRB2;EFNA2;IGSF9;EZR;EPHB2;SOS1;ZDHHC17
prerank,protein K63-linked deubiquitination (GO:0070536),0.2823508589516214,0.73145280809615,0.8215297450424929,0.9360687569280235,1.0,7/31,14.87%,OTUD1;SPATA2;UIMC1;ATXN3;CYLD;OTUD4;USP7
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.29286819735727104,0.7308780907557147,0.8218562874251497,0.9364631396823272,1.0,5/22,13.84%,VPS37C;TSG101;SNF8;STAM;UBAP1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.19638979537180226,-0.7308442804977041,0.9405940594059405,0.966675706091657,1.0,33/69,32.09%,UQCRC2;COX7C;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;COX10;NDUFA5;UQCRC1;UQCR10;COX5B;NDUFB5;NDUFB9;NDUFB7;NDUFA13;NDUFAF1;NDUFB8;NDUFAB1;COX6A1;NDUFB6;NDUFS8;NDUFB10;SDHA;UQCC3;COX6C;NDUFS3;CYC1;COA6;NDUFS6;NDUFA11
prerank,epithelial structure maintenance (GO:0010669),-0.3078774627913289,-0.7306892334720332,0.8059701492537313,0.9659536428394625,1.0,6/11,57.39%,CXADR;TLR9;NOD2;PIWIL4;MUC6;STRAP
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.29290556122941525,-0.7306302712391353,0.8313817330210773,0.9651264684545185,1.0,5/13,15.70%,USP19;CLU;NR1H2;MANF;MBTPS2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3080511616014274,-0.730546429807775,0.8023809523809524,0.9643276808812891,1.0,5/11,24.78%,CCT2;DKC1;CCT8;TERF1;CCT3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.28167367385873615,-0.7300914895856216,0.8204419889502762,0.9639468558272815,1.0,7/15,31.16%,RTN3;TMEM33;REEP1;TMEM170A;ARL6IP1;REEP4;REEP2
prerank,negative regulation of cell division (GO:0051782),-0.30818462239046107,-0.729847459394746,0.8093023255813954,0.9633228411252215,1.0,3/11,15.71%,BLM;ZFYVE19;TXNIP
prerank,fatty acid elongation (GO:0030497),0.3301275514277661,0.7293133980395594,0.7792421746293245,0.9381454315149989,1.0,4/13,16.43%,ELOVL5;ELOVL6;ABCD1;HACD4
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.31779138096856285,0.7290880311607935,0.7845659163987139,0.9376100915556642,1.0,3/15,16.01%,ZFP36L2;TNRC6B;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.31779138096856285,0.7290880311607935,0.7845659163987139,0.9376100915556642,1.0,3/15,16.01%,ZFP36L2;TNRC6B;PABPC1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.29324652115259026,-0.7290438464025828,0.8010610079575596,0.9634444010095219,1.0,4/13,17.39%,IRAK2;EPG5;IRAK1;TLR7
prerank,transcription by RNA polymerase I (GO:0006360),-0.22569349208128703,-0.7287306712317794,0.9144736842105263,0.9629432716859335,1.0,12/34,22.97%,GTF2H2;TTF1;GTF2H1;TAF1D;ERCC2;POLR2K;GTF2H3;CDK7;TCOF1;POLR2H;GTF2H5;TBP
prerank,positive regulation of macrophage differentiation (GO:0045651),0.34048238253032836,0.7281979959572527,0.7993138936535163,0.9383352307130215,1.0,3/11,14.22%,ID2;RIPK1;TGFB1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2828440183240633,0.7280584886866419,0.836552748885587,0.938103109930306,1.0,4/29,16.74%,TNNC1;ENG;TGFB1;PROX1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.3304198151782661,0.7279431680807357,0.8087520259319287,0.9378582461495398,1.0,1/15,1.71%,ANKRD11
prerank,regulation of DNA metabolic process (GO:0051052),-0.21026504956682843,-0.7278525924927551,0.9271255060728745,0.9631336329985107,1.0,8/44,11.58%,MPHOSPH8;YLPM1;PDGFA;UPF1;POLH;TERF2IP;TOM1L1;XRCC5
prerank,aortic valve development (GO:0003176),-0.2199371653981675,-0.7277769290051457,0.9256756756756757,0.962324034669773,1.0,5/34,12.71%,ROBO2;ROBO1;TNFRSF1A;SLIT2;SLIT3
prerank,myelination (GO:0042552),0.26341265700817956,0.7275058348540825,0.8514588859416445,0.9380134251831678,1.0,4/46,4.27%,ACER3;ADGRG6;MYRF;B4GALT5
prerank,mammary gland development (GO:0030879),-0.2516812742615396,-0.7273564604159731,0.8780487804878049,0.9619329335860061,1.0,14/21,44.39%,ERBB4;ARHGAP35;VEGFA;GPAT4;WNT4;CAV1;NOTCH4;GLI2;WNT7B;ZBTB7B;PRLR;WNT3;TGFB3;APLN
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.2907844936866847,-0.7272664778250986,0.8369829683698297,0.9611259657573336,1.0,1/13,1.57%,DDX5
prerank,regulation of trophoblast cell migration (GO:1901163),0.3253824642144947,0.7271372746698447,0.8094462540716613,0.9380615494401128,1.0,2/14,7.80%,ARHGDIB;YTHDF3
prerank,regulation of glycogen metabolic process (GO:0070873),-0.2978608937015278,-0.7268271265228259,0.7995110024449877,0.960762366887,1.0,5/12,35.91%,PPP1R3B;KHK;PPP1R3D;PPP1R3C;PPP1R3E
prerank,negative regulation of interleukin-12 production (GO:0032695),0.3235158960676066,0.7267876918117052,0.8078817733990148,0.9381165269010285,1.0,4/14,17.76%,LILRB1;THBS1;IRAK3;LILRA5
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.28656175809290935,0.7267824776279478,0.8348623853211009,0.9377157194654554,1.0,2/22,6.96%,BCL6;CBFB
prerank,ethanol metabolic process (GO:0006067),-0.2954139554838521,-0.7267654615324249,0.8344988344988346,0.9599465993589141,1.0,3/12,25.62%,ADH5;ACSS1;SULT1A1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24854814758123214,0.7267256815873996,0.8655778894472361,0.9373802757652919,1.0,13/68,20.68%,LRRK2;ACOT11;ACOT2;SULT2B1;TPST1;ACAT1;NT5C2;EFL1;BAD;GLYAT;ABHD14B;GMPR2;ACOT1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2659026717506274,-0.7263147133047725,0.8264462809917356,0.9595999497011456,1.0,3/18,4.98%,FOLH1;GOT1;NAALAD2
prerank,regulation of hemopoiesis (GO:1903706),0.3566511877203621,0.7260783372238544,0.7996289424860853,0.9378017302420069,1.0,4/10,15.26%,CBFB;PURB;LGALS3;CREBBP
prerank,epithelium development (GO:0060429),0.23239772078537144,0.725973553805293,0.912485414235706,0.9375142917660401,1.0,13/107,15.19%,PPARG;JAK2;EHF;FOXJ1;STAT1;ANXA4;TRIM71;PPP2R3A;DHRS9;LGALS3;TGFB1;TAGLN2;CASP6
prerank,canonical Wnt signaling pathway (GO:0060070),0.24395608859085635,0.7253578953752685,0.879021879021879,0.9379194121957865,1.0,12/68,19.50%,LRRK2;AXIN1;PTEN;RARG;DVL3;DVL2;APC;WNT7A;WNT5B;FZD7;FZD9;FZD3
prerank,stress granule assembly (GO:0034063),-0.2617037712363347,-0.7251105999856909,0.8563685636856369,0.960188275554887,1.0,6/20,18.25%,LSM14A;ATXN2L;RPS23;OGFOD1;ATXN2;DDX3X
prerank,cholesterol transport (GO:0030301),0.26081910753600035,0.7250404857204082,0.854251012145749,0.9379167124449445,1.0,9/45,15.35%,LDLR;CD36;SCARB1;CEL;STX12;ABCA5;SOAT1;ABCG1;RELCH
prerank,microtubule bundle formation (GO:0001578),0.26536591749242017,0.7249969666076924,0.8703956343792633,0.937564723309759,1.0,7/42,13.95%,FOXJ1;NAV1;KIF20A;TPPP3;SPAST;CLASP1;CAPN6
prerank,synaptic vesicle localization (GO:0097479),0.32914806625047033,0.7247493956027166,0.8281786941580757,0.9374505233646474,1.0,4/13,14.64%,KIF5B;SYNJ1;SNAPIN;KIF5A
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.27806612962262656,-0.7246497174000165,0.8264462809917356,0.9598496189730735,1.0,3/14,12.28%,SLC27A1;CHKA;PCYT2
prerank,DNA modification (GO:0006304),-0.24695942196675807,-0.7242552125486602,0.8498498498498499,0.9594614612041137,1.0,10/22,25.58%,TERF2IP;EXOSC5;NEIL2;TERF1;OGG1;EXOSC3;PARP3;TINF2;NEIL3;PARP2
prerank,histone H4-K8 acetylation (GO:0043982),-0.2791728599026261,-0.7241738647973491,0.8302872062663186,0.9577809776888957,1.0,4/15,10.44%,JADE2;HCFC1;MEAF6;ING4
prerank,histone H4-K5 acetylation (GO:0043981),-0.2791728599026261,-0.7241738647973491,0.8302872062663186,0.9577809776888957,1.0,4/15,10.44%,JADE2;HCFC1;MEAF6;ING4
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.27420915889377395,0.7241488727279356,0.840057636887608,0.9378189116783421,1.0,7/32,15.82%,PKIB;FBXO4;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,epithelial cell differentiation (GO:0030855),0.23579342892968752,0.7238640109914132,0.9121540312876053,0.9377836503974992,1.0,16/88,19.20%,GLI1;PPARG;EHF;ZDHHC7;ANXA4;LATS1;ANXA1;DHRS9;LGALS3;AKT1;TAGLN2;CASP6;PROX1;HDAC1;FZD7;RAB10
prerank,positive regulation of intracellular transport (GO:0032388),0.26677964238633306,0.7238142558169588,0.8522099447513812,0.9374387614235565,1.0,7/38,14.84%,SORL1;EHD2;ATP2A1;BCAS3;DYNC1H1;RAB29;EHD1
prerank,negative regulation of growth (GO:0045926),0.2294989312017207,0.7236617010898164,0.9233409610983981,0.9372154940229604,1.0,22/121,17.18%,NOTCH2;BCL6;HSPA1A;BMPR2;CRLF3;BTG1;PPP1R9B;CDKN2C;OSGIN2;SMAD4;RTN4;DCUN1D3;SH3BP4;PNPT1;TGFB1;FGFR3;PTPRJ;SERTAD3;PPT1;RB1;ST7L;SIRT1
prerank,striated muscle contraction (GO:0006941),0.25344721344211574,0.7236150374003362,0.8687898089171975,0.936868577791216,1.0,3/53,3.70%,TNNC1;KCNQ1;MYL4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.31139054112146436,-0.7231890023670193,0.8246013667425968,0.9580758684871176,1.0,2/10,4.29%,TREM2;CD68
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2859012569741386,0.7231062503464164,0.8479880774962743,0.9371289098990635,1.0,7/24,19.99%,ATF6;RBPJ;NFE2L2;ATF6B;HSPA5;KLF2;GCN1
prerank,nuclear pore organization (GO:0006999),0.3284926584601974,0.7220566729365306,0.8013468013468014,0.9380509345623812,1.0,5/14,18.20%,NUP98;RTN4;NUP153;SEH1L;NUP93
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.23748743313475393,0.7217739938965825,0.9004854368932039,0.9380075331417911,1.0,15/88,14.22%,SYK;MMP1;SUMO1;RAB7A;FAF1;TIRAP;TSG101;PDCD6IP;SNF8;RPS3;STAM;SPIDR;LGALS3;VCP;TGFB1
prerank,mesenchyme morphogenesis (GO:0072132),-0.2624559683744724,-0.7212938780540603,0.8379120879120879,0.9593568471615546,1.0,11/17,46.87%,ACVR1;TGFB2;MDM4;SOX9;BMP2;ACVRL1;HEY1;TBX2;HEYL;ISL1;NOG
prerank,determination of bilateral symmetry (GO:0009855),0.28965357344582554,0.7211465439020487,0.8175074183976261,0.9384026425092218,1.0,3/25,13.95%,FOXJ1;KIF3B;CITED2
prerank,regulation of phosphatase activity (GO:0010921),0.28690665272502336,0.7208716347510927,0.8372434017595308,0.9383510025150504,1.0,8/24,22.57%,PPP1R2;GPATCH2;HTT;PPP6R2;ZCCHC9;PTPA;TIPRL;PPP6R1
prerank,neuron apoptotic process (GO:0051402),0.30065334624746276,0.7207600312609719,0.8229813664596274,0.9380882665571625,1.0,7/19,22.43%,NGFR;APP;TRPC5;DIABLO;BID;BCL2;SIAH1
prerank,regulation of stem cell population maintenance (GO:2000036),0.3086746932452398,0.7206231317156543,0.8213166144200627,0.9378671979878088,1.0,3/18,11.91%,NCOA3;CNOT2;REST
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.3003556301062381,-0.7204958111638553,0.8404494382022472,0.9594360239735286,1.0,2/11,12.72%,AUP1;DERL1
prerank,integrated stress response signaling (GO:0140467),0.3198317920371631,0.720382009257976,0.8016949152542373,0.937771443107726,1.0,4/14,17.99%,EIF2AK1;NFE2L2;EIF2AK3;HSPA5
prerank,negative regulation of dephosphorylation (GO:0035305),-0.2669070636748456,-0.7202644670976753,0.8387096774193549,0.9587889082549282,1.0,4/18,12.14%,ENSA;PPP1R8;MFHAS1;CHP1
prerank,histone H3-K4 trimethylation (GO:0080182),0.3454307075607125,0.7202288209672855,0.817717206132879,0.937559665406697,1.0,1/11,2.29%,TET2
prerank,response to gamma radiation (GO:0010332),0.2851984094209524,0.7196413680325802,0.8187134502923976,0.9378690389388059,1.0,5/24,12.87%,WRN;TLK2;DCUN1D3;PRKAA1;MAP3K20
prerank,snRNA processing (GO:0016180),0.31161760248004455,0.7192847097377156,0.7984,0.9379086043194019,1.0,6/16,16.67%,TUT1;INTS2;INTS11;INTS14;INTS4;INTS6
prerank,regulation of TORC1 signaling (GO:1903432),0.27248834484825024,0.719256401355456,0.8507042253521127,0.9375354705609025,1.0,6/33,12.68%,SPAAR;SIK3;CLEC16A;DEPDC5;GPR137C;CASTOR2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.27107191547685705,-0.7191632695987196,0.8732394366197183,0.9591842142945672,1.0,3/16,14.64%,IGF1;AKAP6;TRPC3
prerank,DNA dealkylation (GO:0035510),-0.3178136677353926,-0.7189693261623256,0.815068493150685,0.9576510739695061,1.0,3/10,10.68%,MGMT;ALKBH5;ASCC2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.3178136677353926,-0.7189693261623256,0.815068493150685,0.9576510739695061,1.0,3/10,10.68%,MGMT;ALKBH5;ASCC2
prerank,potassium ion import across plasma membrane (GO:1990573),-0.21598215907638213,-0.7170406929007969,0.9355932203389831,0.9589553675347586,1.0,7/41,13.32%,ATP1B3;KCNJ2;ATP1B1;ATP1A2;KCNJ6;HCN2;KCNJ9
prerank,muscle tissue development (GO:0060537),-0.2892680138829653,-0.7167813879605562,0.8263157894736842,0.9583743954684874,1.0,2/13,4.00%,SMO;NF1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.31465667327450036,0.7154741388954111,0.8397976391231029,0.9418270070797834,1.0,4/15,14.99%,CD36;EIF2AK2;GBP5;MYD88
prerank,response to steroid hormone (GO:0048545),-0.22580342520450472,-0.7148378893542637,0.8962264150943396,0.9596803093696785,1.0,13/31,30.93%,PAQR8;ATP1A2;CATSPER2;TGFB2;AR;PAQR7;TFPI;NR1H3;CAV1;ABCA2;ATP1A1;ATP1A3;WBP2
prerank,regulation of spindle assembly (GO:0090169),0.28564626429928963,0.7140340503896213,0.8498542274052479,0.9431929031220264,1.0,5/25,11.89%,HSPA1A;CHMP4B;PDCD6IP;SENP6;DYNC1H1
prerank,sulfur amino acid metabolic process (GO:0000096),0.28583999749682915,0.7139015921074727,0.8340807174887892,0.9429559257680896,1.0,3/24,10.45%,DPEP1;ADO;MTRR
prerank,positive regulation of neuron differentiation (GO:0045666),-0.21339158831962635,-0.7136999383521239,0.9335664335664335,0.9600455218518403,1.0,15/40,26.96%,MEF2C;BEND6;IMPACT;GPRC5B;ZEB1;SOX11;TCF4;TRIM32;TCF3;MMD;HOXD3;ZC4H2;ECT2;BRINP2;NBL1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.28088364007594047,0.7123867861807219,0.8510324483775811,0.9443954908729973,1.0,9/26,23.07%,TET2;SETD5;SETD2;KMT5B;KMT2A;PRDM9;SMYD5;ATPSCKMT;ANTKMT
prerank,negative regulation of TOR signaling (GO:0032007),0.27181715178770494,0.7120595594105583,0.8575418994413407,0.9443989727320284,1.0,8/36,13.78%,SPAAR;DDIT4;UBR2;DEPDC5;PRKAA1;SH3BP4;CASTOR2;PRKAA2
prerank,cellular response to copper ion (GO:0071280),0.3135415420223817,0.7115669359744944,0.8222222222222222,0.9445942211381224,1.0,2/16,10.38%,PRNP;DAXX
prerank,proteasome assembly (GO:0043248),0.3344174404358471,0.7105762515510178,0.8083623693379791,0.945366064103549,1.0,3/11,13.22%,PSMD9;PSMD10;POMP
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3315702514218682,0.7105050190815781,0.7861952861952862,0.9450424195890434,1.0,3/12,20.17%,ELOVL5;ABCD1;ACSL1
prerank,regulation of fibrinolysis (GO:0051917),0.32398691349007974,0.7102300505891271,0.8020304568527918,0.9449551650712211,1.0,2/13,15.65%,FAP;THBS1
prerank,membrane fusion (GO:0061025),0.266135720712792,0.7094860293336134,0.8787446504992867,0.9454291494365288,1.0,7/33,17.58%,STX11;DYSF;DNM1L;SNAP23;VAPA;HACE1;MYOF
prerank,odontogenesis (GO:0042476),0.27143994679356065,0.7093051815420602,0.8722222222222222,0.9452128170265393,1.0,2/35,3.88%,ANKRD11;LAMB1
prerank,ribosome biogenesis (GO:0042254),0.2142687328847027,0.7090713077475993,0.948663101604278,0.9450785245139333,1.0,31/187,14.69%,XPO1;RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;UTP6;RIOK1;RPL13;RPF2;DDX49;NOC4L;MPHOSPH6;NOL11;RPL34;RPLP0;UTP20;RPL19;RPL11;RPL30;NOP58;RRP36;RPS2;RPL4;RPL7;UTP18;MRTO4;DDX10
prerank,protein-containing complex disassembly (GO:0032984),0.24763408135414144,0.7090603141888979,0.8888888888888888,0.9446882892164067,1.0,9/54,15.92%,UVRAG;AXIN1;STX17;TSG101;DVL3;WIPI2;VCP;DVL2;APC
prerank,motor neuron axon guidance (GO:0008045),0.315489259417124,0.7080239011181498,0.8274193548387097,0.9454687996828335,1.0,6/15,18.51%,RAC2;RAC1;NTN1;RHOG;TMEFF1;SEMA3A
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2556901230308833,0.7070455062371962,0.8857142857142857,0.9462435601560262,1.0,8/47,14.22%,KLF4;NFKB1;NFKBIA;MTPN;FOXO3;APP;AKT1;TGFB1
prerank,negative regulation of receptor binding (GO:1900121),0.3374590022135121,0.7069813160644872,0.8252595155709342,0.9459147193021882,1.0,2/10,10.77%,ATP2A3;B2M
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.25774274673721664,0.7068837594573306,0.8836265223274695,0.9456200162664298,1.0,9/41,18.20%,NUP210;PRKAG2;NUP98;PRKAG1;SCARB2;NUP153;SEH1L;GCK;NUP93
prerank,mitotic sister chromatid segregation (GO:0000070),0.22909802470533605,0.7062669850214475,0.9136522753792299,0.9459499597880747,1.0,21/98,18.32%,NIPBL;CUL3;KIF23;CHMP4A;CHMP4B;TEX14;PDCD6IP;SMC4;CSNK2A2;CSNK2A1;EML4;HASPIN;INO80;KPNB1;SEH1L;RB1;KNSTRN;MCPH1;PHF13;BECN1;RAD21
prerank,protein acetylation (GO:0006473),0.27261935365448464,0.7061853791593312,0.8706395348837209,0.9456516875087836,1.0,8/30,19.14%,NAA16;CLOCK;KAT6A;NAA15;KAT2B;CREBBP;SIRT1;HAT1
prerank,aerobic electron transport chain (GO:0019646),-0.1914710295184303,-0.7059571738087986,0.98,0.9676164649569907,1.0,32/68,32.09%,UQCRC2;COX7C;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;COX10;NDUFA5;UQCRC1;UQCR10;COX5B;NDUFB5;NDUFB9;NDUFB7;NDUFA13;NDUFAF1;NDUFB8;NDUFAB1;COX6A1;NDUFB6;NDUFS8;NDUFB10;SDHA;UQCC3;COX6C;NDUFS3;CYC1;NDUFS6;NDUFA11
prerank,establishment of mitotic spindle localization (GO:0040001),0.28080182474037285,0.7058796979364763,0.8398835516739447,0.9456017775235129,1.0,7/28,16.28%,FBXW11;PAFAH1B1;INSC;HTT;CLASP1;KPNB1;GPSM2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.24822526586099056,0.7052782382227879,0.8923476005188068,0.9459127172982051,1.0,15/52,22.01%,RC3H1;PNLDC1;DCP2;CNOT6;LSM5;CNOT2;DCP1A;TUT7;CNOT8;DDX6;TNKS1BP1;CNOT6L;EDC3;PARN;CNOT3
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.27201217801416155,-0.7047510967569262,0.8571428571428571,0.9679700168349497,1.0,7/14,27.12%,ERCC6;MMS19;FUS;MRNIP;TIMELESS;WDR48;RAD51AP1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.24899499176580983,0.7037857043178191,0.8790637191157347,0.9472517190641989,1.0,4/48,6.65%,CXCL10;DIAPH1;PTK2B;PDPK1
prerank,protein targeting to mitochondrion (GO:0006626),0.24250117697641793,0.703171842396832,0.8712998712998713,0.9475903961914929,1.0,13/52,17.38%,GRPEL2;DNAJC19;TIMM21;TOMM40;FIS1;IMMP2L;AIFM1;PMPCA;TIMM50;FBXO7;MIPEP;AIP;HSPD1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2819724325194331,-0.7030387664735596,0.8779904306220095,0.9689119503868489,1.0,4/13,21.43%,DERL2;BCAP31;UBE2G2;BRSK2
prerank,organelle disassembly (GO:1903008),0.2635630562684026,0.7028292129353824,0.8643356643356643,0.9475743458685036,1.0,7/33,14.77%,VRK1;KIF5B;GBF1;STX5;MCTS1;VCP;RB1CC1
prerank,acyl-CoA metabolic process (GO:0006637),-0.2138339001626009,-0.7026808304916032,0.9044368600682594,0.9683930432901331,1.0,9/35,21.91%,ACACA;SUCLG2;ACSF2;ACOT9;GPAT4;ACOT7;MLYCD;OXSM;ACOT6
prerank,glial cell development (GO:0021782),-0.23560863571944196,-0.7025488145639159,0.9017857142857143,0.9676555309776431,1.0,8/25,16.91%,NF1;EIF2B5;SOX4;MDK;EIF2B4;TPPP;SOX11;NSUN5
prerank,endoderm development (GO:0007492),0.31692616775489724,0.7025159118902148,0.819935691318328,0.9475313158136243,1.0,13/13,68.33%,DUSP1;TBX20;GATA4;APELA;SOX17;EOMES;DUSP4;DUSP2;SOX7;DUSP5;KIF16B;LHX1;LAMC1
prerank,rRNA 3'-end processing (GO:0031125),0.3318817444608596,0.7024714414727385,0.8444055944055944,0.9471763440292433,1.0,2/10,10.24%,ERI1;RPS21
prerank,sulfation (GO:0051923),-0.2939239268710045,-0.7021830873337981,0.8422330097087378,0.967152657115212,1.0,1/11,1.65%,HS3ST5
prerank,synaptic vesicle membrane organization (GO:0048499),0.29534305072306666,0.7019598830017751,0.8304,0.9473598186158275,1.0,4/17,15.38%,STX11;SYP;SYNGR2;SNAP23
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.251166766239944,0.7005913789514457,0.88,0.9485574687258636,1.0,6/46,11.73%,LNPEP;ACOT11;RBPJ;ADAM17;RHEB;PGAM5
prerank,ether lipid biosynthetic process (GO:0008611),0.34273526594248394,0.6998437845440525,0.8164335664335665,0.9490096759513625,1.0,4/10,19.45%,AGPS;FAR1;GNPAT;PEDS1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2707967379917603,0.6998301764722152,0.8523391812865497,0.948620167483992,1.0,4/29,8.29%,ACSL5;ELOVL5;HSD17B12;ELOVL6
prerank,chloride transmembrane transport (GO:1902476),0.24848313281939258,0.6993717358239467,0.8893333333333333,0.9487328819348007,1.0,6/48,11.22%,GABRB2;SLC12A7;GABRR2;SLC4A8;SLC12A6;SLC12A9
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.27821053548789,0.6985839185736338,0.8602620087336245,0.9491941111068343,1.0,3/26,11.64%,GPR35;ADRA2A;FKBP1B
prerank,serine family amino acid metabolic process (GO:0009069),0.30397723325874293,0.6985157737802399,0.7993311036789298,0.9488642880331277,1.0,4/16,19.33%,SEPSECS;SRR;SHMT1;GLYAT
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.2629394874249122,0.6984463870015898,0.8707865168539326,0.9485481897925883,1.0,2/35,3.22%,PCDHB11;SELL
prerank,endothelial tube morphogenesis (GO:0061154),0.33243446732644044,0.6979246471635471,0.8204225352112676,0.9487308811254213,1.0,4/10,20.34%,RBPJ;RHOA;STARD13;CCM2
prerank,negative regulation of transposition (GO:0010529),0.3108788499631907,0.6977470445334008,0.8245315161839863,0.9485288747695844,1.0,2/16,11.54%,UBR2;TUT7
prerank,chordate embryonic development (GO:0043009),0.2382515651910166,0.6975596046748597,0.9184993531694696,0.9483337535239754,1.0,9/55,16.74%,MBNL1;SULF2;DEAF1;XYLT1;TRIM71;PCSK5;TGFB1;FUT8;PROX1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.31913778851810365,0.6972303104969094,0.8278829604130808,0.9478991439523687,1.0,1/12,3.39%,RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.31913778851810365,0.6972303104969094,0.8278829604130808,0.9478991439523687,1.0,1/12,3.39%,RCC2
prerank,regulation of microtubule-based process (GO:0032886),0.26152159142262815,0.6970656736600204,0.8732193732193733,0.9476823243657867,1.0,9/36,16.40%,DIAPH1;PHLDB2;CYLD;PRKAA1;PRKAA2;ROCK1;CLASP1;APC;TRIM36
prerank,response to interferon-alpha (GO:0035455),0.30445055013362926,0.6962350696869115,0.8251968503937008,0.948211783737781,1.0,7/16,24.75%,EIF2AK2;IFNAR1;IFITM3;IFNAR2;AXL;BST2;GATA3
prerank,DNA duplex unwinding (GO:0032508),0.24288603682831683,0.6960130313371902,0.8993103448275862,0.9480607578499941,1.0,8/50,12.97%,MRE11;MCM6;WRN;ASCC3;ANXA1;RECQL5;MCM2;ERCC3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.2366007257607384,-0.6953880374077765,0.8994252873563219,0.9731667631486557,1.0,2/23,5.81%,LTA4H;LTC4S
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.29206338108338575,-0.6951718429525697,0.8676844783715013,0.9724853696347021,1.0,5/11,30.14%,QDPR;CALM1;DHFR;HSP90AA1;SPR
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2205617899975643,-0.6946891527544957,0.9178082191780822,0.9720944148977567,1.0,12/30,29.07%,ABCD2;ABCD4;HACD2;ELOVL7;ELOVL4;ABCD3;ELOVL1;TECR;ACSBG1;ACOX1;SLC27A2;ACSL6
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.30059440225686745,0.6926623339740429,0.8440944881889764,0.9513856291794813,1.0,4/16,15.26%,NAA16;NAA15;KAT2B;CREBBP
prerank,centromere complex assembly (GO:0034508),-0.21054752411752187,-0.692540671053979,0.9434628975265018,0.9733414811959317,1.0,19/36,31.94%,CENPO;NPM1;POGZ;CENPE;KNL1;CENPA;RUVBL1;CENPP;MIS18BP1;CENPK;CENPU;CENPF;DLGAP5;CENPT;CENPX;RBBP7;CENPN;MIS12;CENPH
prerank,establishment of spindle orientation (GO:0051294),0.27675984124172176,0.6922383130458929,0.8680057388809183,0.9514480246233267,1.0,6/28,16.28%,FBXW11;PAFAH1B1;INSC;HTT;CLASP1;GPSM2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2264905458053491,0.6921618769047896,0.9221556886227545,0.9511185023090146,1.0,18/87,16.22%,SDHAF2;NDUFA2;NDUFS5;TIMM21;NDUFA3;NDUFA10;IMMP2L;AIFM1;NDUFS2;NDUFS4;UQCC1;COA5;NDUFA12;NDUFA9;COX17;NDUFAF5;COX16;NDUFC2
prerank,telomere capping (GO:0016233),-0.25376411223311224,-0.6912070129795783,0.8715846994535519,0.973822035615719,1.0,5/16,17.49%,CTC1;TERF2IP;DCLRE1A;TEN1;TERF1
prerank,apoptotic DNA fragmentation (GO:0006309),0.3006434314760521,0.691059738207669,0.8559870550161812,0.951923807941974,1.0,4/16,16.04%,DFFA;DFFB;EXOG;KPNB1
prerank,dicarboxylic acid transport (GO:0006835),-0.22186143371369793,-0.690773866344272,0.8892307692307693,0.9733616022533803,1.0,12/28,31.13%,SLC1A3;GJA1;GIPC1;SLC13A3;SLC1A1;SLC26A8;SLC26A6;PDPN;SLC25A10;SLC46A1;PRAF2;SLC1A6
prerank,regulation of dephosphorylation (GO:0035303),0.29489597170759907,0.6907211101583359,0.8448275862068966,0.9518814326160779,1.0,4/15,16.71%,MTMR3;MTMR4;SMG6;MTMR2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.25233223632073687,0.690506462144219,0.8898071625344353,0.9517330013253726,1.0,5/40,10.77%,ANXA2;CBL;HIP1;TBC1D5;B2M
prerank,epithelial to mesenchymal transition (GO:0001837),0.246774705931141,0.690405665629622,0.901749663526245,0.9514356447845981,1.0,8/47,14.22%,AKNA;RBPJ;S100A4;ENG;HGF;OLFM1;ROCK1;TGFB1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.26502755983807036,-0.6894599961407657,0.8746736292428199,0.9736814912582523,1.0,3/16,5.67%,APPL2;PPARGC1A;LONP2
prerank,CENP-A containing chromatin organization (GO:0061641),0.272100743321095,0.6891905427418519,0.8882602545968883,0.9519571588130992,1.0,6/29,14.93%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.272100743321095,0.6891905427418519,0.8882602545968883,0.9519571588130992,1.0,6/29,14.93%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2548235404698195,-0.689186668990698,0.867816091954023,0.9730808409928577,1.0,8/18,37.68%,BCL2L1;SPG7;CAMK2A;SLC25A4;PPIF;NAIF1;ALKBH7;PMAIP1
prerank,mitotic nuclear division (GO:0140014),0.2318664338405936,0.6890772308854533,0.9113924050632911,0.9516792643833341,1.0,14/71,17.36%,EPS8;CHMP4B;FLNA;RHOA;SMC4;SPAST;STAG1;KIF3B;STAG2;UBE2S;CLASP1;INO80;KPNB1;KNSTRN
prerank,microtubule depolymerization (GO:0007019),0.2989966433144833,0.6885287223895334,0.8543046357615894,0.9518621738097913,1.0,4/17,15.53%,KATNB1;KIF24;STMN3;STMN2
prerank,regulation of telomere maintenance (GO:0032204),0.2661325806354487,0.6885095142066782,0.86608442503639,0.9514837283846306,1.0,6/26,16.35%,MRE11;SMG1;ATRX;ERCC4;USP7;SMG6
prerank,establishment of spindle localization (GO:0051293),0.30851810651217976,0.6883035592044952,0.8394648829431438,0.9512980033272865,1.0,4/14,21.10%,DYNC1H1;CLASP1;KPNB1;LLGL2
prerank,nucleoside salvage (GO:0043174),0.3331997268556443,0.6880884853133112,0.8636363636363636,0.9511369948187403,1.0,3/10,14.37%,UCK2;UCK1;DCK
prerank,response to unfolded protein (GO:0006986),0.24396169930872674,0.6879494814838928,0.8992042440318302,0.9508758400418108,1.0,11/48,17.99%,HSPA1A;ERN1;ERP44;TM7SF3;DAXX;PTPN1;HSPA9;STT3B;HSPD1;BAG3;HSPA5
prerank,peroxisomal membrane transport (GO:0015919),0.2664195192114479,0.6874200629238078,0.8866279069767442,0.951074924146289,1.0,5/27,13.07%,PEX16;PEX12;PEX14;FIS1;ABCD1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.2515940449989489,0.6870166906997589,0.8895104895104895,0.9510875823018067,1.0,9/37,16.40%,PHLDB2;CYLD;PRKAA1;PRKAA2;ROCK1;CLASP1;STMN3;STMN2;TRIM36
prerank,positive regulation of calcium ion import (GO:0090280),0.31682774547624715,0.6869049729105111,0.8353344768439108,0.9508089067038801,1.0,2/12,12.85%,ATP2A1;LGALS3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2440953238528889,0.6868219271690394,0.9136786188579017,0.9504901701175676,1.0,10/50,15.44%,DTX3L;HSPA1A;CRY1;RPS3;CAMLG;USP4;AKT1;PRMT3;SVBP;TAF1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.29340063548434914,0.6867878870240801,0.8832807570977917,0.9501314228918285,1.0,3/17,10.70%,MBD4;SMUG1;TDG
prerank,cellular response to UV (GO:0034644),0.23056378109094405,0.6867713034097365,0.9228886168910648,0.9497489026365591,1.0,22/76,22.09%,MMP1;CERS1;CRIP1;CARD16;ERCC4;METTL3;AURKB;CREBBP;TAF1;INO80;USP47;POLD1;SIRT1;PRKCD;N4BP1;RHBDD1;XPA;STK11;POLK;PARP1;CASP9;SDE2
prerank,response to copper ion (GO:0046688),-0.24829888278727666,-0.6863412859276345,0.9176829268292683,0.9749104680525011,1.0,14/20,42.23%,IL1A;ATP5F1D;MT2A;MT3;ATP7B;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;HSF1
prerank,positive regulation of dephosphorylation (GO:0035306),0.27097038881705504,0.6860053160924465,0.8542274052478134,0.9501773906360554,1.0,8/27,18.58%,PPP2R5A;DLC1;ANKLE2;TGFB1;PPP1R7;PTPA;PRKCD;PIN1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.3194210309728842,0.6857224754485075,0.8398058252427184,0.9500846407856443,1.0,4/12,15.53%,DYRK1A;CLIP3;TBCD;STMN2
prerank,inorganic anion transmembrane transport (GO:0098661),0.23379516465956274,0.6854710256841026,0.926208651399491,0.9499405656374236,1.0,8/63,11.22%,GABRB2;SLC12A7;GABRR2;SLC25A30;SLC37A4;SLC4A8;SLC12A6;SLC12A9
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.28815980884298087,0.6854638084877025,0.849925705794948,0.9495504775168603,1.0,4/21,12.63%,ADCY10;GUCY1A1;ADCY7;ADCY5
prerank,negative regulation of viral release from host cell (GO:1902187),0.31318999602738123,0.6846123141122961,0.8527508090614887,0.9500437746774032,1.0,1/13,2.61%,TRIM26
prerank,peptidyl-lysine methylation (GO:0018022),-0.2235295433735967,-0.684439072745399,0.9321533923303835,0.9757770435828061,1.0,10/26,26.96%,SETD3;SETD4;KMT5A;EHMT2;SUV39H1;N6AMT1;ETFBKMT;TRMT112;METTL21A;SMYD1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.28602621729843136,0.6842502692958229,0.8480243161094225,0.9500344536070879,1.0,3/21,7.95%,PTEN;DDIT4;PAQR3
prerank,negative regulation of complement activation (GO:0045916),-0.29450275460348047,-0.6841981940332876,0.8845265588914549,0.9751245954479915,1.0,7/10,42.64%,SUSD4;CD46;A2M;SERPING1;VSIG4;CR2;CD55
prerank,regulation of histone deacetylation (GO:0031063),0.3059980479953781,0.6836342052131329,0.8609715242881072,0.9502941408808414,1.0,2/13,11.13%,NIPBL;ING2
prerank,regulation of response to stress (GO:0080134),-0.29500392545338294,-0.6827061577636427,0.882494004796163,0.9755747655448888,1.0,7/10,39.58%,CORO2B;EIF4G1;ADCY8;MLC1;STOX1;DYRK3;CRHBP
prerank,cellular response to pH (GO:0071467),0.2968259953599448,0.6825526036116106,0.8632075471698113,0.9510218906854668,1.0,1/17,1.67%,GPR68
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.24656781890677126,-0.6820413786198354,0.8910614525139665,0.9752773254588186,1.0,3/19,11.71%,GOT1;PHYKPL;ALDH7A1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.24234628308732697,-0.681792018973018,0.9257142857142857,0.9746160759585694,1.0,10/21,31.69%,OXA1L;COX10;SMIM20;COX18;BCS1L;SCO1;SURF1;FASTKD3;COA3;COA6
prerank,negative regulation of ATPase activity (GO:0032780),-0.2552896871079112,-0.681415728876577,0.8947368421052632,0.9740999721847604,1.0,11/16,44.13%,OXA1L;PAM16;TSC1;PXK;PPIF;ATP5IF1;TLR9;PLN;LTF;VCPKMT;THADA
prerank,cellular transition metal ion homeostasis (GO:0046916),0.22249363109541875,0.6812125208935116,0.9485645933014354,0.9520190498906361,1.0,18/91,17.57%,CYB561A3;ABCB7;HEPH;PRNP;NEDD8;ARF1;ATP7A;SLC30A1;SMAD4;ATOX1;APP;HMOX2;IREB2;CCDC115;SLC31A1;SLC39A13;SLC39A12;NUBP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.30832709137672487,0.6812109860581403,0.8291032148900169,0.9516232844364735,1.0,3/13,11.91%,NFKB1;ERLIN1;REST
prerank,regulation of protein localization to cell surface (GO:2000008),0.25557031216435694,0.6805032425784175,0.9033149171270718,0.951985578831699,1.0,10/33,23.08%,NEDD4L;PICALM;GBF1;TAX1BP3;SNX33;GOPC;KCNAB2;TNF;RAB11B;COMMD1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.28350758754824784,0.6804555487795516,0.875,0.9516380633691643,1.0,8/19,23.61%,EXT1;XYLT1;CSGALNACT1;GLCE;HS2ST1;NDST2;EXT2;NDST4
prerank,chromatin remodeling at centromere (GO:0031055),0.2655841935457145,0.6803985067915235,0.8966480446927374,0.9512986808259887,1.0,6/31,14.93%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.2396074560641562,-0.6801559711337004,0.9186746987951807,0.9744175271770408,1.0,7/21,22.18%,CHST11;CHST9;CHPF2;CSPG4;CHST3;BGN;CHSY1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2524839837072069,0.6791442757520776,0.8975817923186344,0.9521616040032214,1.0,7/35,15.82%,PKIB;FBXO4;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,regulation of leukocyte migration (GO:0002685),0.29828014577583145,0.67823831783574,0.8384991843393148,0.9526612485065756,1.0,4/16,15.04%,RAC2;RAC1;ANXA1;RHOG
prerank,glycerol metabolic process (GO:0006071),-0.28855573968380055,-0.678112961819173,0.8820638820638821,0.9753806953220502,1.0,3/10,10.60%,GOT1;COQ3;GK5
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.23356680551707504,-0.6777171326003795,0.8989071038251366,0.9748652944109838,1.0,9/22,27.98%,WDR12;PES1;EXOSC9;FTSJ3;EXOSC10;EXOSC3;RPP40;ERI2;RRS1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3211228385180427,0.6774569152085668,0.8475177304964538,0.9530627627840975,1.0,2/10,11.54%,NEDD8;TUT7
prerank,muscle tissue morphogenesis (GO:0060415),0.29004709576138143,0.6771460060199646,0.8653846153846154,0.9529998890177717,1.0,16/16,71.02%,PROX1;TGFBR3;TBX20;ANKRD1;MYLK2;ACTC1;TCAP;NOTCH1;TBX1;TTN;MYLK;HEY2;BMP4;BMP2;EFEMP2;ZFPM1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.31480953307025256,0.6759480484574204,0.8581314878892734,0.953810000048678,1.0,3/11,17.99%,ATF6;ATF6B;HSPA5
prerank,glycosaminoglycan catabolic process (GO:0006027),0.2353992748848409,0.6750529771701069,0.9066496163682864,0.9543246007506441,1.0,7/55,11.57%,CD44;GPC3;HSPG2;ACAN;FUCA1;NCAN;SDC3
prerank,negative regulation of cell differentiation (GO:0045596),0.2055803884293528,0.6747080949352549,0.9753483386923901,0.9542979148348135,1.0,30/181,17.71%,LIMD1;PPARG;SDHAF2;MAD2L2;COL5A2;NFKBIA;PTEN;PTK2B;PDCD4;ZFP36L2;IL6;ID2;SPRED3;ABCA5;REST;USF3;IQCB1;USH2A;MYB;ADAMTS12;TGFB1;GPS2;ABCG1;SPRED1;MED1;RB1;SEMA4D;SIRT1;EFNA1;HDAC7
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.2709548940678938,0.6735823682024287,0.8793363499245852,0.9550200753818988,1.0,2/23,4.33%,HERC4;GPC3
prerank,tRNA metabolic process (GO:0006399),0.28760679345371304,0.672281749600843,0.8569254185692542,0.9558777673943267,1.0,2/17,6.02%,FARS2;DARS2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.2584863090798212,-0.6722053761943199,0.8924205378973105,0.9789619253167182,1.0,3/15,11.94%,NTRK3;SCG2;VEGFA
prerank,dendrite morphogenesis (GO:0048813),0.2556362640052923,0.6719000954390683,0.898921832884097,0.9558640368040876,1.0,8/35,16.50%,DOCK10;CDC42;PTEN;EPHB2;MINK1;LRP4;PHACTR1;WNT7A
prerank,neural tube closure (GO:0001843),0.2509112319956553,0.6715422026477912,0.9044862518089725,0.9558260727182463,1.0,7/34,15.53%,CELSR1;DLC1;DEAF1;VASP;DVL3;TGFB1;DVL2
prerank,transcription preinitiation complex assembly (GO:0070897),-0.2744988532800897,-0.6712868780568975,0.8995098039215687,0.9789033873393738,1.0,1/12,2.04%,BDP1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.27620850894559124,-0.6709201234921088,0.8924205378973105,0.9783178186185374,1.0,3/12,19.45%,TARDBP;CCL3;HMGA2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.28945746228908464,-0.6708965194364365,0.8894009216589862,0.9765990439993759,1.0,5/10,28.79%,TNFRSF1A;SPHK2;RACK1;SMPD3;SMPD2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.28945746228908464,-0.6708965194364365,0.8894009216589862,0.9765990439993759,1.0,5/10,28.79%,TNFRSF1A;SPHK2;RACK1;SMPD3;SMPD2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.22306007728177,0.6708269306560238,0.939540507859734,0.9561405720801818,1.0,11/83,13.92%,SDCCAG8;CNTRL;HAUS8;CEP63;PAFAH1B1;HAUS1;DCTN3;CEP250;DYNC1H1;HAUS3;CLASP1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.25575792440545664,-0.6703633456582653,0.8862433862433863,0.9761817280504895,1.0,1/15,0.58%,ABHD12
prerank,regulation of protein import into nucleus (GO:0042306),0.24993494412658257,0.6693170745554623,0.90014064697609,0.9572665467711431,1.0,12/36,18.82%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD;MDFIC
prerank,cAMP biosynthetic process (GO:0006171),0.32648507221284445,0.6683990163555381,0.8350694444444444,0.9577357382791382,1.0,3/10,12.63%,ADCY10;ADCY7;ADCY5
prerank,nuclear envelope organization (GO:0006998),0.27869816848245493,0.6679669550139988,0.8817204301075269,0.9577618818109007,1.0,4/20,12.04%,LEMD3;LEMD2;DMPK;TOR1AIP1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.25451873160313393,0.6669751129498162,0.9033189033189033,0.9583038844760611,1.0,7/33,17.45%,TAT;KYAT1;GLUD1;CAD;SIRT4;PYCR2;DDAH1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.27655495520252266,-0.6668019436253168,0.863080684596577,0.978300562165542,1.0,3/12,13.16%,CCT2;DKC1;CCT8
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2556389625413137,0.6667329229325225,0.9001512859304085,0.9581342441071381,1.0,7/32,18.95%,CDC45;CDK14;BACH1;ID2;ZPR1;RB1;BRD4
prerank,synaptonemal complex organization (GO:0070193),0.29392188873540115,0.6667159095231451,0.8660287081339713,0.9573579613504014,1.0,15/15,70.64%,STAG3;RAD21;SYCE1;SYCE3;SYCE2;SYCP2;BAG6;SYCP1;RAD21L1;TEX12;HORMAD1;REC8;TEX11;TRIP13;P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.29392188873540115,0.6667159095231451,0.8660287081339713,0.9573579613504014,1.0,15/15,70.64%,STAG3;RAD21;SYCE1;SYCE3;SYCE2;SYCP2;BAG6;SYCP1;RAD21L1;TEX12;HORMAD1;REC8;TEX11;TRIP13;P3H4
prerank,positive regulation of cilium assembly (GO:0045724),0.2864227582479878,0.6666333161587507,0.8753894080996885,0.9570366241553496,1.0,5/18,20.72%,CCDC88A;TAPT1;HTT;CEP135;MARK4
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3191704619328003,0.666376528944856,0.8353982300884956,0.9568698333486938,1.0,2/11,10.39%,RC3H1;ANXA1
prerank,regulation of muscle contraction (GO:0006937),0.2625032449950027,0.6655585763782559,0.8910891089108911,0.9572206469742788,1.0,1/26,1.85%,TNNC1
prerank,muscle cell migration (GO:0014812),-0.2859169726596032,-0.6651753315174754,0.8954869358669834,0.9787450158749124,1.0,2/10,8.49%,ITGB3;AAMP
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.22027898696645354,-0.665094437166674,0.932475884244373,0.9779450024861629,1.0,7/25,20.24%,VPS4B;SORT1;CHMP5;LYST;CHMP1B;CHMP7;CHMP2A
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.25501080209129745,-0.6650391531289922,0.9081081081081082,0.9771219405843851,1.0,2/15,4.48%,CPEB2;ATF3
prerank,endothelial cell differentiation (GO:0045446),0.30907102979877893,0.6648856922993741,0.8715277777777778,0.9574464579075598,1.0,1/12,2.93%,BMPR2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.28920848125063864,-0.6644519022005111,0.9002320185614849,0.9767205016537295,1.0,3/10,13.16%,CCT2;DKC1;CCT8
prerank,regulation of sister chromatid cohesion (GO:0007063),0.30266726900448654,0.6640663743818221,0.8689075630252101,0.9577844826012281,1.0,4/12,18.32%,FEN1;CTCF;RB1;RAD21
prerank,negative regulation of establishment of protein localization (GO:1904950),0.32460068255159114,0.6629915430575095,0.8706293706293706,0.9584082197733232,1.0,4/10,19.92%,WWP2;SNX3;SNX12;NDFIP2
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25695537171285643,0.6616832045503592,0.8997134670487106,0.9592625919371424,1.0,3/30,7.45%,GOLPH3L;RAB34;GCC2
prerank,metal ion homeostasis (GO:0055065),0.2378600066254657,0.6607520759896273,0.9269340974212035,0.9597215094270073,1.0,5/40,11.22%,SLC12A7;WFS1;SLC12A6;LETM1;SLC12A9
prerank,mitochondrial membrane organization (GO:0007006),-0.20959333078894543,-0.6607091482824926,0.9565217391304348,0.978727224469122,1.0,7/32,15.53%,BCL2L1;APOO;TMEM11;RCC1L;CHCHD6;SPG7;MFN1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.29995079480015285,0.6604303100043041,0.8633217993079585,0.9592342667827769,1.0,3/12,21.96%,PRNP;DYRK2;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.29995079480015285,0.6604303100043041,0.8633217993079585,0.9592342667827769,1.0,3/12,21.96%,PRNP;DYRK2;GSK3B
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.28286099847825985,0.6598269897570025,0.8748019017432647,0.9594055957889817,1.0,2/19,4.42%,SYK;ZAP70
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.25751681060888193,0.6594079184934087,0.9078947368421053,0.9593827897076013,1.0,8/27,18.64%,CHST12;PXYLP1;XYLT1;NCAN;CHST15;CSGALNACT1;CHSY3;VCAN
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.30606450438139654,0.6591081544004915,0.8691910499139415,0.9592589713116448,1.0,1/11,3.31%,KCNQ1
prerank,cellular response to light stimulus (GO:0071482),0.22441200105275858,0.6585641624707972,0.9490049751243781,0.9593498574578149,1.0,19/66,22.09%,GNB1;GPR88;PDE6B;ERCC4;METTL3;AURKB;CREBBP;TAF1;INO80;USP47;POLD1;PRKCD;N4BP1;RHBDD1;POLK;SAG;PARP1;CASP9;SDE2
prerank,pharyngeal system development (GO:0060037),0.2858328999195977,0.6579887297328305,0.883177570093458,0.9594785244839766,1.0,1/15,2.93%,BMPR2
prerank,replicative senescence (GO:0090399),-0.2753713844398834,-0.6576479067228236,0.8852459016393442,0.9802594500858796,1.0,9/12,50.98%,SERPINE1;ROMO1;CDKN2A;CHEK1;ATM;TERT;MME;PLA2R1;ATR
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.2786631374861429,-0.6572327740285655,0.8785714285714286,0.9796847073153588,1.0,5/10,35.09%,DAB2IP;CADM4;PIK3CB;SPRY2;DCN
prerank,cellular response to gamma radiation (GO:0071480),0.2781698232897048,0.6568715638905713,0.8929133858267716,0.9600566900516758,1.0,3/17,12.87%,WRN;TLK2;MAP3K20
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.25446647058280736,0.6554357153180613,0.905848787446505,0.9609625998526247,1.0,7/29,20.36%,DCP2;CNOT6;LSM5;DCP1A;CNOT8;DDX6;EDC3
prerank,primary neural tube formation (GO:0014020),0.24699983998619457,0.6535957624884691,0.9008746355685131,0.9621421862788301,1.0,6/30,15.53%,CELSR1;DLC1;DEAF1;VASP;TGFB1;DVL2
prerank,regulation of receptor binding (GO:1900120),0.3091363329577585,0.6531276841235012,0.8683760683760684,0.9621666829940173,1.0,2/10,10.77%,ATP2A3;B2M
prerank,protein localization to centrosome (GO:0071539),-0.24400060645697308,-0.6530125643483748,0.8932291666666666,0.9820687674883023,1.0,7/17,34.25%,PIBF1;CEP83;CCDC14;NEDD1;CEP192;STIL;CEP131
prerank,intermediate filament organization (GO:0045109),0.2803323516063191,0.6529852949781787,0.8736349453978159,0.9619047783430178,1.0,1/17,2.39%,VIM
prerank,DNA recombination (GO:0006310),-0.1969960338276314,-0.6528819501106529,0.9560439560439561,0.981281584976329,1.0,14/37,28.46%,RAD51B;HMGB1;TSN;BLM;MSH2;RHNO1;IGHMBP2;FBH1;RAD51C;DMC1;ERCC1;GEN1;RAD51D;RAD54B
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.25151272971073674,-0.6523762093106432,0.8925,0.9807840236237101,1.0,7/15,28.56%,CCT2;DKC1;CCT8;RUVBL1;CCT3;NAF1;RUVBL2
prerank,positive regulation of ATPase activity (GO:0032781),0.23662391275133687,0.6521397638947669,0.9317548746518106,0.9622192706448488,1.0,7/41,13.94%,PLSCR1;MYL4;ATP2A1;MSH3;MSH6;TOR1AIP1;VMP1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.2596972441936307,-0.651876759979467,0.9195121951219513,0.980254943280912,1.0,3/13,14.55%,EPN2;HGS;DAB2IP
prerank,regulation of actin filament depolymerization (GO:0030834),0.30024951761553564,0.651814974800102,0.865546218487395,0.9621048940894736,1.0,2/12,10.65%,MTPN;PIK3CA
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.24617945152806064,-0.65050781498836,0.918848167539267,0.9803633810622154,1.0,6/17,22.58%,IK;BUB3;ZW10;KNL1;CENPA;BOD1
prerank,oogenesis (GO:0048477),-0.2463446330783905,-0.6498846977533675,0.9166666666666666,0.9799577777571945,1.0,3/15,13.68%,PTN;FMN2;MDK
prerank,protein lipidation (GO:0006497),0.22477170689033873,0.6480153071880596,0.9510939510939511,0.9649933135137934,1.0,10/59,13.10%,HHAT;ZDHHC7;ATG5;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17;PIGF;WIPI2;ATG10
prerank,negative regulation of cell cycle process (GO:0010948),0.22113542991428917,0.6474017666593584,0.9400510204081632,0.9651248753153845,1.0,10/61,16.39%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;AURKB;PHC3;AURKAIP1
prerank,lysosome localization (GO:0032418),0.24133665706675667,0.6473176808532882,0.9070735090152566,0.96480351569854,1.0,10/37,19.82%,KIF5B;MYH9;RAB34;SNAPIN;KIT;ARL8B;MILR1;BORCS5;PLEKHM1;DEF8
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.27610515688850296,-0.6467615775483683,0.9221698113207547,0.981342600013688,1.0,3/11,13.28%,NECAB1;ITM2C;ABCA7
prerank,regulation of extracellular matrix organization (GO:1903053),-0.24303529810565863,-0.6452165012660963,0.9120603015075377,0.9815278131085254,1.0,3/15,18.51%,LRP1;RIC1;AEBP1
prerank,tube closure (GO:0060606),0.24394983027994432,0.6442567945722029,0.9073529411764706,0.9669716739606944,1.0,6/31,15.53%,CELSR1;DLC1;DEAF1;VASP;TGFB1;DVL2
prerank,cell proliferation in forebrain (GO:0021846),0.3141372237495801,0.6436303104257358,0.8690265486725663,0.9671010508269933,1.0,3/10,19.32%,AKNA;WNT7A;HOOK3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2423323147076371,0.6436034862262334,0.9391796322489392,0.9667351450788659,1.0,9/38,16.22%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,regulation of peptidase activity (GO:0052547),0.2685846693472493,0.6435582326414914,0.9096477794793262,0.9663808703607009,1.0,6/19,19.48%,MAPK12;PSMB8;SVBP;HDAC1;PINK1;ECM1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.2929495339237992,0.6433339127759552,0.8928571428571429,0.9661620067416441,1.0,3/12,15.01%,FUT4;AKT1;ASS1
prerank,embryonic axis specification (GO:0000578),-0.242017084598611,-0.642717013017701,0.9076923076923077,0.9823613836771982,1.0,6/15,41.97%,TASOR;PTCH1;STIL;FZD5;RIPPLY2;HOXD8
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.20798571003728747,0.6413432839541372,0.9738717339667459,0.9673542437092295,1.0,13/95,13.92%,SDCCAG8;CNTRL;HAUS8;CEP63;PAFAH1B1;HAUS1;DCTN3;KIF24;CEP250;DYNC1H1;IQCB1;HAUS3;CLASP1
prerank,sulfur amino acid catabolic process (GO:0000098),0.30462316249499066,0.6406070143747056,0.8722316865417377,0.9675353459632519,1.0,2/10,10.45%,ADO;MTRR
prerank,electron transport chain (GO:0022900),-0.25337596374228405,-0.6405931964329975,0.9177377892030848,0.982957161892303,1.0,4/15,22.10%,PPARGC1A;SDHB;NDUFA5;PDIA5
prerank,sphingoid metabolic process (GO:0046519),-0.26714203767928424,-0.6404634528024973,0.896,0.982177203483948,1.0,4/12,18.08%,PLPP3;PLPP1;SPHK2;KDSR
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.26040575262313853,-0.6400255180483665,0.9027431421446384,0.9816202287977882,1.0,1/13,2.74%,B3GALNT1
prerank,positive regulation of protein depolymerization (GO:1901881),0.2953954303178995,0.6398593861615475,0.8830508474576271,0.9677360995878554,1.0,2/11,15.53%,KATNB1;STMN2
prerank,mitotic metaphase plate congression (GO:0007080),-0.18394141595269134,-0.6396358621626153,0.9952153110047847,0.9810294090730227,1.0,24/51,32.37%,VPS4B;RMDN1;PIBF1;CHMP5;ZW10;MAD1L1;EML3;CHMP1B;CENPE;RAB11A;CHMP7;KIF18A;CHMP2A;BOD1;PINX1;SPDL1;NDC80;RRS1;CDCA8;CEP55;KIFC1;CHMP6;MIS12;KIF22
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.23282807675981929,0.6395743252227977,0.9476510067114094,0.9675606613536256,1.0,8/41,18.20%,NUP210;PRKAG2;NUP98;PRKAG1;NUP153;SEH1L;GCK;NUP93
prerank,response to glucose (GO:0009749),0.23131122944580515,0.6390156989835998,0.9353970390309556,0.9676239720260353,1.0,9/46,18.96%,ERN1;ZBTB20;SELENOT;PRKAA1;PDK3;PRKAA2;THBS1;GCK;EIF2B3
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.21038649536233545,-0.6387060318893791,0.96,0.9808053643029916,1.0,8/25,27.68%,PRPSAP1;GMPR;AMPD2;HPRT1;SHMT2;MTHFD1;PRPSAP2;ADK
prerank,smooth muscle contraction (GO:0006939),0.28359218041544726,0.6376972903454452,0.8895800933125972,0.9683042869849007,1.0,3/14,14.63%,PIK3C2A;ROCK1;EDNRA
prerank,stabilization of membrane potential (GO:0030322),0.27964125368722026,0.636925844620385,0.9087947882736156,0.9685193267705902,1.0,2/16,8.10%,KCNK7;KCNN4
prerank,amide transport (GO:0042886),0.24822652269458073,0.6361507094125062,0.9287833827893175,0.9687410466627396,1.0,2/26,6.29%,SLC14A1;TAP1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.2565882729417425,-0.6360793841629454,0.9086294416243654,0.9816111301701428,1.0,5/12,25.24%,NABP2;ZW10;BUB1B;BUB1;PLK2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2604074671310665,-0.6359014944693047,0.9048723897911833,0.980870482510455,1.0,1/12,2.74%,B3GALNT1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.26359665293217094,-0.635325336572589,0.9014084507042254,0.9803704611332267,1.0,3/12,17.65%,C2CD2L;GPLD1;ADCY8
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.2715496569661487,0.6349848437896333,0.9121405750798722,0.9692798069435516,1.0,5/19,15.30%,S100A10;RAC1;ROCK1;PTPRJ;COL16A1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.25832008309389937,0.6339854862340666,0.9095163806552262,0.9696485032416828,1.0,4/22,14.99%,IL6;TGFB1;IL18;MYD88
prerank,regulation of phosphate metabolic process (GO:0019220),0.2762329753297485,0.633898568286468,0.8975206611570248,0.9693221590653522,1.0,4/16,18.20%,IKBKB;SMG6;PSEN1;RAD17
prerank,aorta morphogenesis (GO:0035909),0.2718987072019574,0.6338851850978164,0.8938461538461538,0.9689377052082451,1.0,2/17,8.16%,RBPJ;ENG
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.27176840881567943,0.633362733465943,0.8905228758169934,0.9689241935297869,1.0,2/16,7.27%,PRDX6;NUP98
prerank,regulation of epidermal cell differentiation (GO:0045604),0.25957605981169646,0.6309522925266186,0.9063492063492063,0.9703399153353248,1.0,4/21,15.01%,CBFB;SULT2B1;ROCK1;SGPP1
prerank,I-kappaB phosphorylation (GO:0007252),0.3111395385681036,0.6291273635563428,0.8877374784110535,0.9712751915188331,1.0,3/10,12.51%,TLR3;MAP3K7;TLR2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2127529970481905,-0.6290633411163438,0.9539877300613497,0.9834510757531691,1.0,4/23,10.78%,PLK3;ZFYVE19;NABP2;ZW10
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.27904048180914093,0.6273492355812705,0.9153976311336718,0.9722165420044024,1.0,4/13,19.89%,RPS21;UTP20;TBL3;NOP9
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.22648445479423576,-0.626475084337886,0.9388888888888889,0.9841682418109063,1.0,4/19,14.70%,ROBO1;CD63;DAB2IP;CCBE1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.2890178939289698,0.6263035150574197,0.8791018998272885,0.9725797875858855,1.0,1/12,4.77%,GDNF
prerank,establishment of mitotic spindle orientation (GO:0000132),0.26146799714376956,0.6258885111797292,0.9254185692541856,0.9724989641753098,1.0,5/23,16.28%,FBXW11;PAFAH1B1;INSC;HTT;GPSM2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2328001472629856,0.6258506303472234,0.9627586206896551,0.9721384002283142,1.0,12/37,22.43%,BBC3;RPS3;FIS1;DNM1L;BECN1;BAD;BCLAF1;NCK1;RPS7;BID;BCL2;SIAH1
prerank,epidermis development (GO:0008544),0.21516885106837236,0.6255175456950642,0.9630118890356671,0.9719863929767901,1.0,1/56,0.98%,GLI1
prerank,telomere maintenance via telomerase (GO:0007004),0.24625056950633398,0.6251138443670647,0.9363241678726484,0.9718758239549724,1.0,10/28,25.21%,MRE11;NHP2;WRAP53;SHQ1;TNKS1BP1;TERF2;TELO2;RFC1;ANKRD28;RPA1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.30046005485230065,0.6250019701590211,0.8888888888888888,0.9715696777890667,1.0,2/10,15.76%,NHP2;TSR3
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.28742071902925637,0.6245693628758627,0.880672268907563,0.9714757992488308,1.0,3/12,19.55%,TRIM16;EZH2;KLF2
prerank,hexose metabolic process (GO:0019318),-0.18724747674004,-0.623904851131643,0.9858156028368794,0.9847608118620056,1.0,6/39,13.59%,HK1;APOD;AKR1A1;GAA;CHST1;BRAT1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.2796424714309441,0.6233368682231168,0.899505766062603,0.9719673199733325,1.0,2/13,8.29%,ELOVL5;ELOVL6
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.2971123666038921,0.6231490243496397,0.9013157894736842,0.9717239812678454,1.0,11/11,70.31%,ABCG1;MPO;APOB;AGT;PLA2G7;AGTR1;APOA2;PLA2G10;PLA2G5;LIPC;PLA2G3
prerank,negative regulation of vascular permeability (GO:0043116),-0.24985207638614507,-0.622593689427021,0.9392405063291139,0.9846997977817634,1.0,4/12,18.26%,SH3GL2;SLIT2;VEGFA;ANGPT1
prerank,ubiquinone biosynthetic process (GO:0006744),0.27217603458066064,0.6224580010521453,0.9130434782608695,0.9718347117474961,1.0,5/15,20.84%,COQ2;COQ8A;NDUFA9;PDSS1;COQ10A
prerank,methylguanosine-cap decapping (GO:0110156),0.2943243650407346,0.6214135874154099,0.8863636363636364,0.9721762375190043,1.0,2/10,10.97%,DCP2;DCP1A
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.24544480433641735,-0.621039845423301,0.9293785310734464,0.9847354475232907,1.0,6/14,34.23%,AK3;AK1;NMNAT2;CMPK2;AK4;NME2
prerank,regulation of centrosome cycle (GO:0046605),-0.21673212751035922,-0.6207956676267242,0.9613095238095238,0.9840204854714143,1.0,8/21,25.14%,VPS4B;CHMP5;NPM1;CHMP1B;ATF5;CHMP2A;NAT10;GEN1
prerank,nuclear body organization (GO:0030575),0.29026907598996465,0.6191753494209403,0.9066213921901528,0.9733078586205555,1.0,3/12,13.02%,HIPK2;WRAP53;ZPR1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.2991490285267758,0.6189975785706789,0.8883248730964467,0.9730363841199775,1.0,1/10,3.50%,SORL1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2012395350184067,-0.6188783307368682,0.959866220735786,0.9842450215957841,1.0,12/27,34.33%,AK2;AK6;RRM1;DTYMK;GLRX;DCTD;AK1;DUT;GUK1;AK4;NME2;RRM2B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.23852078176652017,0.6187055872023838,0.9487554904831625,0.9728510560402185,1.0,7/32,17.05%,TAF1A;POLR1G;CCNH;ERCC3;POLR1B;TAF1;TAF1C
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.272068533576819,0.6171204924891038,0.903010033444816,0.9735643565776092,1.0,1/15,4.77%,GDNF
prerank,negative regulation of transferase activity (GO:0051348),0.24247444628323586,0.6167871647308886,0.9364599092284418,0.9734009288531537,1.0,4/28,13.36%,DTX3L;CERS1;EIF4A2;ERCC4
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2412542383517488,0.6155500384285868,0.9324712643678161,0.9734391716729319,1.0,3/29,11.96%,ACOT11;ACOT2;ACAT1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2412542383517488,0.6155500384285868,0.9324712643678161,0.9734391716729319,1.0,3/29,11.96%,ACOT11;ACOT2;ACAT1
prerank,regulation of synapse maturation (GO:0090128),-0.26118354650588793,-0.6143081622730031,0.9354838709677419,0.9858634080974906,1.0,3/10,19.15%,ADGRL1;DAB2IP;NRXN1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.21444711241319223,0.6137587261591518,0.9576158940397351,0.9742172979005859,1.0,15/51,21.44%,PKIB;DCP2;FBXO4;TNKS;MAP3K4;AURKB;TENT4B;MAPK1;STN1;TCP1;SMG6;TERF2;HNRNPC;PARN;CCT7
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.276203659215254,0.6119947576113357,0.9142857142857143,0.9749848306678504,1.0,2/13,9.64%,NRROS;FBN1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.22789669401382967,-0.6114030771660931,0.941025641025641,0.9864567288872649,1.0,5/16,28.68%,ADSS2;AMPD2;ATIC;NUDT2;ADSS1
prerank,glycine transport (GO:0015816),-0.2669647388592563,-0.610600627730304,0.9411764705882353,0.9860285261901038,1.0,2/10,11.92%,SLC36A1;SLC7A8
prerank,male meiosis I (GO:0007141),-0.23009592539576992,-0.6102881140032884,0.9307692307692308,0.9853340426566055,1.0,9/16,51.66%,FOXJ2;ZSCAN21;DDX4;SYCP3;HSF2BP;FOXJ3;SLC25A31;TDRD9;MOV10L1
prerank,regulation of transferase activity (GO:0051338),0.2588874655193617,0.6096984976553662,0.9415584415584416,0.9761080390263832,1.0,5/17,20.13%,PARP4;SLAMF8;SPTSSB;SMG6;FEM1B
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.2520433122254873,0.6096348717766926,0.9486049926578561,0.9753627268347538,1.0,9/23,24.96%,BBC3;YWHAZ;MAPK8;BAD;BID;BCL2;YWHAQ;TP53;PPP3CC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.2520433122254873,0.6096348717766926,0.9486049926578561,0.9753627268347538,1.0,9/23,24.96%,BBC3;YWHAZ;MAPK8;BAD;BID;BCL2;YWHAQ;TP53;PPP3CC
prerank,glycogen metabolic process (GO:0005977),0.23970929231677884,0.609495965876843,0.9414414414414415,0.9750677429105279,1.0,8/27,21.96%,PRKAG2;PGM1;UGP2;PGM2L1;PHKA2;PYGL;PHKG1;GSK3B
prerank,response to progesterone (GO:0032570),0.25759624370659856,0.6088234992280893,0.9234449760765551,0.9751004657759684,1.0,5/18,20.06%,CATSPER3;ACOD1;TGFB1;THBS1;ABHD2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.23236099823719664,-0.6083628264603994,0.9420289855072463,0.9855494309765788,1.0,7/16,25.00%,TERF1;TNKS2;HNRNPA2B1;SLX4;TINF2;PINX1;NAF1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.2397929685829042,-0.6079725740957321,0.9345088161209067,0.9848952676506242,1.0,6/13,42.83%,SRA1;SOX9;EID2B;BMP4;PRICKLE1;SOX8
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.29439407304388804,0.607952004332089,0.9226713532513181,0.975242938123222,1.0,1/10,2.96%,DHX58
prerank,negative regulation of myotube differentiation (GO:0010832),-0.2511271131859468,-0.6074123399435561,0.9396325459317585,0.9843213402497545,1.0,2/12,14.20%,TMEM119;BHLHE41
prerank,membrane depolarization (GO:0051899),0.23371792855811332,0.6065929996935775,0.9495677233429395,0.9757061421523328,1.0,2/32,3.56%,CACNA1A;CHRNA4
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.2388647378066356,-0.6054988372176628,0.9329896907216495,0.9843912595378597,1.0,5/13,30.14%,QDPR;CALM1;FPGS;HSP90AA1;SPR
prerank,peptidyl-lysine monomethylation (GO:0018026),0.2871687083093331,0.604798534585686,0.929701230228471,0.9763871578935326,1.0,2/10,10.80%,SETD7;SETD2
prerank,intraciliary retrograde transport (GO:0035721),0.2774012878818334,0.6039145280704119,0.9089285714285714,0.9765507925209472,1.0,2/12,15.02%,IFT140;DYNLT2B
prerank,regulation of mitotic spindle organization (GO:0060236),0.2266994065774546,0.6034853101211185,0.9700854700854701,0.9764279863523012,1.0,5/35,12.18%,HSPA1A;CHMP4B;PDCD6IP;DYNC1H1;GNAI1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.17122785179908784,-0.6029455139735836,1.0,0.9847418474565923,1.0,7/47,14.55%,RAP2A;PPIA;LGALS9;NBR1;PER1;TGFB2;DAB2IP
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.2573621009721209,-0.6027960679677544,0.9299516908212561,0.9839731491625506,1.0,7/11,46.06%,DGKQ;WNT4;BMP5;STAR;BMP2;NR1H4;FGFR4
prerank,neural tube development (GO:0021915),-0.23539246194036817,-0.6026468693050434,0.9301075268817204,0.9831900044142982,1.0,7/15,33.30%,PKD2;SOX4;SOX11;PTCH1;ALDH1A2;DACT1;STIL
prerank,regulation of spindle organization (GO:0090224),-0.22141890336218523,-0.6021966449152152,0.9416666666666667,0.9825552387242974,1.0,10/18,38.76%,NUMA1;MAP9;TACC3;PARP3;TPX2;RNF4;FSD1;RAE1;BORA;NUP62
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.21442713029494356,0.6015718884591849,0.9605442176870749,0.977165054423256,1.0,12/46,18.81%,GRPEL2;DNAJC19;TIMM21;TOMM40;FIS1;AIFM1;AKT1;TIMM50;FBXO7;AIP;HSPD1;PINK1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23055522353888808,0.6011537192780271,0.9507042253521126,0.97700321595571,1.0,7/31,20.36%,DCP2;CNOT6;LSM5;DCP1A;CNOT8;DDX6;EDC3
prerank,secretion (GO:0046903),-0.23142764635215102,-0.6002593713305285,0.9387755102040817,0.9826412385950902,1.0,11/14,55.67%,SLC22A4;RIMS1;GUCA1B;PRKCI;NPR1;FBLN5;DRD3;VIP;ABCB11;SLC22A2;SLC22A6
prerank,lung development (GO:0030324),0.22344203398857196,0.5994415165817513,0.9559471365638766,0.9776089746264612,1.0,5/33,16.74%,FOXJ1;ABCA3;CCDC39;ITGA3;PROX1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.17962083004984314,-0.5979517986235662,0.9787985865724381,0.9828284409814599,1.0,15/35,35.14%,ADCY9;ADORA3;ADCY3;ADRB1;LGR4;ADCY8;RXFP1;ADCY1;GIPR;RAF1;TMIGD3;ADCY6;CRHR1;ADCY2;TSHR
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.25128425961449896,0.596909939469366,0.9429037520391517,0.9786840602380644,1.0,6/18,24.95%,IL6;RIPK1;TGFB1;MAP2K1;TNF;TP53
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.19208178688066496,-0.5956351545984029,0.9832214765100671,0.9830196876058691,1.0,19/31,55.33%,NFS1;CYP51A1;LSS;DHRS11;PYCR3;NOXRED1;STAR;HSD17B1;MOCS3;GPHN;PRLR;SRD5A1;SRD5A2;PYCR1;HSD3B2;ALOX5;HDC;HSD17B3;CYP19A1
prerank,cAMP metabolic process (GO:0046058),0.2749073685443236,0.5947234546650819,0.9188741721854304,0.9795173315186781,1.0,3/13,12.63%,ADCY10;ADCY7;ADCY5
prerank,vitamin transport (GO:0051180),0.23305820181393824,0.5938907782823856,0.9507246376811594,0.9795845777699468,1.0,1/29,2.23%,SLC23A1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2787881862696404,0.5927987755355713,0.9156414762741653,0.9797879909356803,1.0,3/11,15.49%,ZC3H3;PAPOLA;NCBP1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2766354375355434,0.5926963137507189,0.9292929292929293,0.9794477641440836,1.0,6/12,23.79%,HUS1;RAD17;CHEK2;SETMAR;STK33;ORC1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.23657764695885225,0.5918608689701697,0.9504643962848297,0.9795383024038129,1.0,6/25,18.58%,KATNB1;TPPP3;KIF24;STMN3;STMN2;PIN1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.2081791864811327,-0.5911041519839901,0.954177897574124,0.9841351509667186,1.0,7/20,30.73%,ADSS2;AK3;AMPD2;ATIC;HPRT1;ADSS1;AK4
prerank,regulation of biosynthetic process (GO:0009889),0.2807450748062498,0.5909049674462391,0.9271758436944938,0.979663969348355,1.0,2/11,14.83%,PIKFYVE;GSTP1
prerank,ubiquinone metabolic process (GO:0006743),0.25829900597215705,0.5906812713658537,0.9382303839732888,0.9793898286596896,1.0,5/15,20.84%,COQ2;COQ8A;AIFM2;PDSS1;COQ10A
prerank,long-chain fatty acid metabolic process (GO:0001676),0.20215639289293003,0.5878692587096229,0.9835443037974684,0.9805271686358726,1.0,5/64,8.29%,GPX1;ACSL5;ELOVL5;ACOT2;ELOVL6
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.26799076446228043,0.5862485733749394,0.9368770764119602,0.980962005129092,1.0,1/12,6.35%,GSS
prerank,nuclear membrane organization (GO:0071763),0.2491610918705483,0.586194390573043,0.9592760180995475,0.9805976409682423,1.0,3/19,12.04%,CHMP4B;SPAST;TOR1AIP1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.24637389708850804,0.5836387450251957,0.934375,0.9815140667142926,1.0,6/20,19.79%,SEMA4A;SEMA4D;SEMA3A;SEMA3C;SEMA6A;SEMA4F
prerank,ribosomal small subunit assembly (GO:0000028),-0.22000474682552545,-0.5832076219163276,0.953125,0.9865977365772758,1.0,7/16,31.96%,XRCC5;RRP7A;MRPS7;MRPS11;RPS28;RPS27L;PRKDC
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.19325924780041037,-0.5829080348413622,0.9710610932475884,0.9858884311565941,1.0,6/25,19.92%,FAM162A;PYCARD;MFF;BAX;PDCD5;TNFSF10
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.23125938101018267,0.5797641747046175,0.958273381294964,0.9830642337907646,1.0,3/23,12.89%,CAMKMT;NMT2;PDE6B
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.19857452526528546,0.579121711069139,0.9833119383825417,0.9830039560466609,1.0,7/63,10.49%,BTG2;WAC;CCND1;CNOT6;PIDD1;CNOT2;CASP2
prerank,positive regulation of insulin secretion (GO:0032024),-0.17376800213436128,-0.5765031819303096,0.9894366197183099,0.987585827081194,1.0,8/36,18.05%,SOX4;NLGN2;C2CD2L;GPLD1;LRRC8A;ADCY8;CAPN10;TCF7L2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.20087370091930748,-0.5764616299072924,0.9851190476190477,0.9867525877994583,1.0,2/22,6.15%,DDX5;RPS20
prerank,mitotic chromosome condensation (GO:0007076),0.22655033722576273,0.5757730563911175,0.9696969696969697,0.9842333428612969,1.0,6/26,17.72%,SMC4;CSNK2A2;CSNK2A1;RB1;MCPH1;PHF13
prerank,negative regulation of neuron differentiation (GO:0045665),-0.19931466093018624,-0.5744557637420065,0.9817629179331308,0.9866346721770991,1.0,2/22,5.14%,CNTN4;EIF2AK4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.24218955231930892,0.574245447897599,0.9509001636661211,0.9845462557899547,1.0,7/18,23.00%,DCP2;NHP2;TCP1;SHQ1;PARN;CCT7;CCT4
prerank,glutathione biosynthetic process (GO:0006750),0.26799474871490614,0.5732590348700217,0.9420783645655877,0.98458394692978,1.0,1/11,6.35%,GSS
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.21815417360193612,-0.5717974951417109,0.9733727810650887,0.9867781522435574,1.0,5/17,30.15%,COX7C;COX10;COX5B;COX6A1;COX6C
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.23860296786031854,0.571076375587801,0.9503759398496241,0.9847895313562659,1.0,3/19,12.73%,POLR2C;DAXX;ATRX
prerank,regulation of DNA recombination at telomere (GO:0072695),0.23860296786031854,0.571076375587801,0.9503759398496241,0.9847895313562659,1.0,3/19,12.73%,POLR2C;DAXX;ATRX
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.24010686379221988,0.5673293109686942,0.9640062597809077,0.9860527557529951,1.0,4/18,16.17%,TIMM21;COA5;COX17;COX16
prerank,megakaryocyte differentiation (GO:0030219),-0.23598284364652689,-0.5661952629654621,0.9696969696969697,0.9879028543977466,1.0,1/11,4.87%,TAL1
prerank,quinone biosynthetic process (GO:1901663),0.251645046710293,0.564688560883431,0.958974358974359,0.9868044496713924,1.0,2/14,8.26%,COQ2;COQ8A
prerank,sensory perception of smell (GO:0007608),0.26164969198377885,0.5629581597434331,0.9435897435897436,0.9871045894285848,1.0,2/11,16.44%,SLC24A4;UBR3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.21884322162528036,-0.5629296071298655,0.9705882352941176,0.9881455020029187,1.0,3/14,14.11%,WDR12;PES1;FTSJ3
prerank,positive regulation of mRNA processing (GO:0050685),0.2278690429903011,0.5628381307089287,0.9625,0.9867638897915307,1.0,2/21,7.27%,PRDX6;NUP98
prerank,lipid modification (GO:0030258),0.20632016716528417,0.5598203098615661,0.9714285714285714,0.987645620343929,1.0,1/37,1.04%,DGKG
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.26684229675837356,0.5578436600410858,0.9283154121863799,0.9880063305972042,1.0,1/10,6.85%,SVIP
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.21490727090101866,-0.5546435975339918,0.9824561403508771,0.9899249500110343,1.0,7/15,28.79%,TNFRSF1A;SPHK2;ORMDL3;RACK1;SMPD3;ORMDL1;SMPD2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.20652089028701998,0.5543454833365807,0.9817158931082982,0.9889551726604935,1.0,12/39,23.69%,RPS14;RIOK1;NOL11;RRP36;TSR3;RPSA;RPS6;DDX52;RPS27;RPS7;RPS25;RPS16
prerank,modified amino acid transport (GO:0072337),-0.21192945220524348,-0.5539086225734795,0.970074812967581,0.9893032519788367,1.0,6/15,33.93%,SLC6A8;MGST1;PDPN;SLC46A1;SLC5A6;SLC16A12
prerank,isotype switching (GO:0045190),0.26495126651881745,0.5532972083282972,0.9637931034482758,0.9889595784018615,1.0,4/10,23.02%,MSH6;HSPD1;RNF168;BATF
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.21577889273657921,-0.5523555812983636,0.9754901960784313,0.9889064045151462,1.0,5/14,28.68%,ADSS2;ATIC;RFK;ADK;ADSS1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.1906244228962653,0.5519688191872781,0.9935400516795866,0.9890585079330291,1.0,16/55,22.73%,BBC3;PAK2;RPS3;CYLD;FIS1;RIPK1;DEDD2;DNM1L;TRAF2;BECN1;BAD;BCLAF1;BID;BCL2;SIAH1;TNF
prerank,lipid biosynthetic process (GO:0008610),0.18317401245882198,0.5502825705096226,0.9975579975579976,0.989265963753338,1.0,12/77,20.68%,AGPAT4;AGPS;ACSL5;PRKAA1;PIP5K1A;PRKAA2;GNPAT;MVD;MVK;ACSS2;ACSL1;PDSS1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23031122283304126,0.5499497349255764,0.9698890649762282,0.9889970737099851,1.0,5/19,23.19%,POLL;DCK;POLD1;GMPR2;TYMS
prerank,nucleotide biosynthetic process (GO:0009165),-0.20499750924320753,-0.5494102537059978,0.9813829787234043,0.9889108229588284,1.0,6/18,27.58%,PRPSAP1;RRM1;HPRT1;NMNAT2;MTHFD1;PRPSAP2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.26025757548572126,0.5469395419794107,0.941696113074205,0.9897168174809716,1.0,1/10,4.15%,CRY1
prerank,male gonad development (GO:0008584),0.20689428042333144,0.546574623958332,0.9845070422535211,0.989453052705575,1.0,1/34,1.50%,ADAM21
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.2607444268329014,0.5461840752464574,0.9498207885304659,0.9891988911908504,1.0,3/11,17.81%,ELOF1;ZMIZ2;PADI2
prerank,spermatid development (GO:0007286),-0.17315075507783134,-0.5458257693003543,1.0,0.9890868949898671,1.0,10/32,33.72%,CEP57;JAM2;NECTIN2;RNF8;IQCG;TDRD5;ZMYND15;NME5;MKKS;SYCP3
prerank,error-free translesion synthesis (GO:0070987),0.22044615243641597,0.5441431296670053,0.9643962848297214,0.9895080114556934,1.0,5/22,16.82%,POLDIP2;RPA3;RCHY1;VCP;POLD1
prerank,response to UV-B (GO:0010224),0.25288603126202525,0.542212466107463,0.9563025210084034,0.9897570424262281,1.0,3/12,20.65%,CRIP1;RELA;STK11
prerank,protein localization to kinetochore (GO:0034501),0.24462201440474007,0.5422031770977123,0.9498327759197325,0.9893716886133728,1.0,3/14,14.74%,RCC2;MTBP;AURKB
prerank,interstrand cross-link repair (GO:0036297),0.19081099590382108,0.541268755980875,0.9934640522875817,0.9892883651668769,1.0,12/53,20.38%,MSH6;FANCC;FANCL;RPA3;FANCI;ERCC4;FANCA;VCP;MCM9;FANCG;RNF168;XPA
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.250855050895732,0.5409063152671334,0.9510603588907015,0.9890226582928386,1.0,2/12,11.33%,PTEN;UBE2S
prerank,cellular response to superoxide (GO:0071451),0.26158852376056285,0.5361753110588092,0.951473136915078,0.9901654097978047,1.0,1/10,7.74%,ATP7A
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.20033590193787684,0.5353125348332067,0.9772727272727273,0.9900545459011119,1.0,10/38,22.23%,PTEN;CIB1;PHLPP1;AKT1;PTPRJ;PPP2R5C;SIRT1;MUL1;XDH;PPP2R5B
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2410590375999796,0.5320428011608709,0.9639344262295082,0.9906625580218955,1.0,1/13,3.64%,GLRX5
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.24778017610181483,0.5314660888433006,0.9675767918088737,0.9904532885178163,1.0,3/12,14.83%,TAF7;TGFB1;GSTP1
prerank,homologous chromosome segregation (GO:0045143),-0.18661486367700764,-0.5312096318508649,0.9968652037617555,0.9918862601703147,1.0,5/20,26.53%,FMN2;ZCWPW1;FANCD2;MEI4;TERB1
prerank,neural crest cell development (GO:0014032),0.19085020827066723,0.5272116036667523,0.9849726775956285,0.9913094310917121,1.0,10/44,19.87%,SEMA4A;GDNF;TAPT1;KLHL12;SEMA4D;SEMA3A;SEMA3C;SEMA6A;SEMA4F;ANXA6
prerank,positive regulation of transporter activity (GO:0032411),-0.2102916527274283,-0.5270820555316252,0.9718670076726342,0.9920009627768697,1.0,7/13,42.40%,SGK1;WNK3;NR1H3;SGK2;KCTD7;TRPC6;PDZK1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.20276594358032296,0.525426409124625,0.9874651810584958,0.9914364360096803,1.0,11/31,25.91%,BBC3;YWHAZ;MAPK8;BAD;BID;GSK3B;BCL2;YWHAQ;TP53;PPP3CC;BAK1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2045876532499675,0.525177786357041,0.981294964028777,0.9911047720713261,1.0,3/29,9.11%,MRE11;NHP2;WRAP53
prerank,respiratory tube development (GO:0030323),0.20145482127711592,0.5236044604698463,0.9911894273127754,0.9911550349144053,1.0,5/28,16.74%,ABCA3;CCDC39;PCSK5;ITGA3;PROX1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.2073447071828981,-0.5133282697627828,0.986013986013986,0.9938888274327173,1.0,4/12,23.33%,HNMT;ODC1;DDC;MAOA
prerank,regulation of transposition (GO:0010528),0.2376840346729997,0.5133279337740813,0.975736568457539,0.993462043586431,1.0,1/13,7.93%,UBR2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.18504422058538553,0.5111605523725866,0.9919137466307277,0.9936222490402812,1.0,3/44,9.56%,PRKAG2;CYP27A1;MSMO1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.22249724162346973,-0.5105571262716582,0.9928057553956835,0.9935889877513098,1.0,7/10,42.25%,CPEB1;CPEB3;LEO1;CDC73;NCBP2;HSF1;PAF1
prerank,glycoprotein catabolic process (GO:0006516),0.21941723185129397,0.5078100292277191,0.9804878048780488,0.9940145597767222,1.0,17/17,78.08%,ADAMTS12;STT3B;NGLY1;EDEM2;MANBA;EDEM1;NEU2;OGA;FBXO27;MMP12;NEU4;CTSL;ADAMTS9;FBXO2;FBXO6;FBXO17;FBXO44
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.1947646332919954,0.5069977668456979,0.9886524822695035,0.9938092981649587,1.0,8/33,21.07%,MRE11;NHP2;WRAP53;STN1;SHQ1;TNKS1BP1;TERF2;TELO2
prerank,negative regulation of telomere maintenance (GO:0032205),0.22143931934954453,0.5054518365362741,0.9707792207792207,0.9937728897009972,1.0,5/15,21.67%,TNKS;ERCC4;SMG6;TERF2;PARP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.23180293320350384,0.5043985264666414,0.9759615384615384,0.9936125657637286,1.0,3/14,19.35%,ACOX3;ABCD1;CRAT
prerank,steroid biosynthetic process (GO:0006694),0.17384190188138796,0.5043411733358834,0.9961389961389961,0.9932372010787528,1.0,3/56,9.56%,PRKAG2;CYP27A1;MSMO1
prerank,lysine metabolic process (GO:0006553),0.23638950261945743,0.5041388451446054,0.9699499165275459,0.9924997721878158,1.0,2/12,12.50%,DLD;OGDH
prerank,lysine catabolic process (GO:0006554),0.23638950261945743,0.5041388451446054,0.9699499165275459,0.9924997721878158,1.0,2/12,12.50%,DLD;OGDH
prerank,gas transport (GO:0015669),-0.21144728609550156,-0.5009823306158727,0.9849246231155779,0.9943728331116667,1.0,2/10,26.35%,CA2;MYC
prerank,'de novo' posttranslational protein folding (GO:0051084),0.19263930934994297,0.49831679378737537,0.9927849927849928,0.9933798525046036,1.0,8/30,22.65%,HSPA1A;DNAJB12;HSPA9;HSPA5;DNAJB14;DNAJB4;SDF2;HSPA8
prerank,regulation of ERAD pathway (GO:1904292),-0.20975822676085532,-0.49391265767965736,0.9688249400479616,0.9946275278900047,1.0,2/11,15.13%,USP19;HERPUD1
prerank,non-motile cilium assembly (GO:1905515),0.18953675842379436,0.4938803859633857,0.9913169319826338,0.9939145084850697,1.0,4/30,17.43%,TBC1D32;CEP250;DISC1;BBS10
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.2049055655530181,0.48273045886495014,0.9847560975609756,0.9955573610210378,1.0,5/18,20.24%,IL6;CLASP1;TGFB1;RB1;RUNX1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2045930055175945,0.47585649336859337,0.9920760697305864,0.9962616246357551,1.0,7/18,26.72%,HDAC3;FRS2;HDAC1;FZD7;HDAC5;BDNF;XBP1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.19660056718167596,0.4712447381866966,0.9846390168970814,0.9965412174132556,1.0,3/21,14.74%,PDE2A;ACAT1;NT5C2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.21823963362467913,0.46568651875658185,0.9913494809688581,0.9969313233176637,1.0,3/12,16.66%,ADSL;GMPS;LHPP
prerank,regulation of cilium movement (GO:0003352),0.2249074132195092,0.46442921437458773,0.9839285714285714,0.9966956968541906,1.0,10/10,77.52%,CCDC39;CFAP43;CCDC65;DNAAF1;DRC1;CFAP206;CCDC40;ODAD2;CFAP298;DNAH11
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.21187332370345285,0.4629574845735319,0.9887459807073955,0.9964861746898289,1.0,4/13,21.94%,VDAC2;BAD;BNIP3L;RHOT1
prerank,axonal transport of mitochondrion (GO:0019896),0.21182686310197218,0.45070237435582255,0.9926062846580407,0.9975309492904418,1.0,3/11,21.45%,SPAST;TRAK1;TRAK2
prerank,mesonephros development (GO:0001823),0.2105461393596989,0.4504504487500378,0.9949409780775716,0.9971647042449202,1.0,11/11,78.96%,ZBTB16;FGF1;GATA3;PAX8;OSR2;FGF8;PAX2;BMP7;BMP4;OSR1;FGF10
prerank,retinol metabolic process (GO:0042572),-0.17441166991831808,-0.4500055293809358,0.9899497487437185,0.9985589254111004,1.0,6/14,46.07%,DHRS3;RDH11;RETSAT;CYP1A1;CYP1B1;RDH12
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.192027583617115,-0.44897435280204506,1.0,0.9978029117352675,1.0,1/10,9.25%,DGKQ
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.19592801833368823,0.44546121295920305,0.9867986798679867,0.9972956790370043,1.0,3/14,20.70%,SPRED3;SPRED1;XDH
prerank,heterocycle biosynthetic process (GO:0018130),-0.16920951842782697,-0.4246555851965874,1.0,0.9984016615186527,1.0,14/14,83.10%,NFS1;PYCR3;NOXRED1;MOCS3;GPHN;PYCR1;ALOX5;HDC;MOCOS;LIAS;GCH1;MOCS2;MOCS1;PYCR2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.1796947257530283,0.4127166334366196,0.9968304278922345,0.999383771532308,1.0,4/17,20.06%,NR3C1;ACOD1;MED1;ABHD2
prerank,mesenchymal cell development (GO:0014031),0.16724235382779618,0.40059267717893204,1.0,0.9995987256682849,1.0,18/18,83.29%,TAPT1;KLHL12;FOXC1;TBX20;NOTCH1;NRG1;PEF1;SNAI2;HEYL;CYP26C1;SOX8;PDCD6;HEY2;NOLC1;CDH2;KBTBD8;TCOF1;SOX11
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.18634684579542934,0.39972417264915044,0.9932546374367622,0.9992496144101215,1.0,3/12,20.70%,ADAMTS12;SEMA6A;XDH
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.192310340867953,0.3988988984678713,0.994661921708185,0.9988915153341481,1.0,2/10,15.63%,ATRX;INO80
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.14260459328490893,0.3684984929193512,1.0,0.9994388548473685,1.0,4/29,20.54%,IHO1;STAG3;RAD21;PRDM9
